<SEC-DOCUMENT>0001213900-23-066764.txt : 20230814
<SEC-HEADER>0001213900-23-066764.hdr.sgml : 20230814
<ACCEPTANCE-DATETIME>20230814130857
ACCESSION NUMBER:		0001213900-23-066764
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		51
CONFORMED PERIOD OF REPORT:	20230630
FILED AS OF DATE:		20230814
DATE AS OF CHANGE:		20230814

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			VS Trust
		CENTRAL INDEX KEY:			0001793497
		STANDARD INDUSTRIAL CLASSIFICATION:	 [6221]
		IRS NUMBER:				846704517
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41280
		FILM NUMBER:		231168152

	BUSINESS ADDRESS:	
		STREET 1:		2000 PGA BOULEVARD
		STREET 2:		SUITE 4440
		CITY:			PALM BEACH GARDENS
		STATE:			FL
		ZIP:			33408
		BUSINESS PHONE:		866-261-0273

	MAIL ADDRESS:	
		STREET 1:		2000 PGA BOULEVARD
		STREET 2:		SUITE 4440
		CITY:			PALM BEACH GARDENS
		STATE:			FL
		ZIP:			33408
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>f10q0623_vstrust.htm
<DESCRIPTION>QUARTERLY REPORT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Mon Aug 14 16:04:02 UTC 2023 -->
<html xmlns:dtr="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:compsci="http://compsciresources.com" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:cik0001793497="http://www.vts.com/20230630" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml">
<head>
     <title> </title>

<meta content="text/html" http-equiv="Content-Type" />
</head>
<body><div style="font: 10pt Times New Roman, Times, Serif"><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-variant: small-caps"><b>UNITED
STATES</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-variant: small-caps"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p><div>

</div><p style="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-variant: small-caps"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 25%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-variant: small-caps"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-variant: small-caps"><b>FORM&#160;<ix:nonNumeric contextRef="c0" name="dei:DocumentType">10-Q</ix:nonNumeric></b></span></p><div>

</div><p style="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 25%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-variant: small-caps"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="dei:DocumentQuarterlyReport">&#9746;</ix:nonNumeric>&#160;<b>Quarterly report pursuant to Section
13 or 15(d) of the Securities Exchange Act of 1934</b></p><div>

</div><p style="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-variant: small-caps"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>for the quarterly period ended&#160;<ix:nonNumeric contextRef="c0" format="ixt:date-monthname-day-year-en" name="dei:DocumentPeriodEndDate"><span style="-sec-ix-hidden: hidden-fact-0">June 30</span>, <ix:nonNumeric contextRef="c0" name="dei:DocumentFiscalYearFocus">2023</ix:nonNumeric></ix:nonNumeric>.</b></p><div>

</div><p style="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>or</b></p><div>

</div><p style="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:DocumentTransitionReport">&#9744;</ix:nonNumeric>&#160;<b>Transition report pursuant to Section
13 or 15(d) of the Securities Exchange Act of 1934</b></p><div>

</div><p style="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-variant: small-caps">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>for the transition period from&#160;<span style="text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span>&#160;to&#160;<span style="text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span>.</b></p><div>

</div><p style="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Commission file number:&#160;<ix:nonNumeric contextRef="c0" name="dei:EntityFileNumber">001-34200</ix:nonNumeric></b></p><div>

</div><p style="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 25%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonNumeric contextRef="c0" name="dei:EntityRegistrantName"><b>VS Trust</b></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Exact name of registrant as specified in its
charter)</b></p><div>

</div><p style="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 25%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 49%; border-bottom: black 1.5pt solid; text-align: center"><ix:nonNumeric contextRef="c0" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Delaware</b></span></ix:nonNumeric></td> <td style="width: 2%">&#160;</td> <td style="width: 49%; border-bottom: black 1.5pt solid; text-align: center"><ix:nonNumeric contextRef="c0" name="dei:EntityTaxIdentificationNumber"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>84-6704517</b></span></ix:nonNumeric></td></tr> <tr style="vertical-align: top"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(State or other jurisdiction of<br/>
incorporation or organization)</b></span></td> <td>&#160;</td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(I.R.S. Employer<br/>
Identification No.)</b></span></td></tr> </table><div>
</div><p style="font: 6pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>c/o Volatility Shares LLC</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><ix:nonNumeric contextRef="c0" name="dei:EntityAddressAddressLine1">2000 PGA Boulevard</ix:nonNumeric>,&#160;<ix:nonNumeric contextRef="c0" name="dei:EntityAddressAddressLine2">Suite 4440</ix:nonNumeric></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><ix:nonNumeric contextRef="c0" name="dei:EntityAddressCityOrTown">Palm Beach Gardens</ix:nonNumeric>,&#160;<ix:nonNumeric contextRef="c0" name="dei:EntityAddressStateOrProvince">FL</ix:nonNumeric>.&#160;<ix:nonNumeric contextRef="c0" name="dei:EntityAddressPostalZipCode">33408</ix:nonNumeric></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Address of principal executive offices) (Zip
Code)</b></p><div>

</div><p style="font: 6pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><ix:nonNumeric contextRef="c0" name="dei:CityAreaCode">(866)</ix:nonNumeric>&#160;<ix:nonNumeric contextRef="c0" name="dei:LocalPhoneNumber">261-0273</ix:nonNumeric></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Registrant&#8217;s telephone number, including
area code)</b></p><div>

</div><p style="font: 6pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 25%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 6pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Securities registered pursuant to Section 12(b)
of the Act:</b></p><div>

</div><p style="font: 6pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="white-space: nowrap; vertical-align: bottom; width: 32%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title of each class</b></span></td> <td style="vertical-align: top; width: 2%; text-align: center">&#160;</td> <td style="vertical-align: bottom; width: 32%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading Symbol(s)</b></span></td> <td style="vertical-align: top; width: 2%; text-align: center">&#160;</td> <td style="white-space: nowrap; vertical-align: bottom; width: 32%; border-bottom: black 1.5pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Name of each exchange on which registered</b></p></td></tr> <tr style="vertical-align: top; background-color: #CCEEFF"> <td style="text-align: center"><ix:nonNumeric contextRef="c1" name="dei:Security12bTitle"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>-1x Short VIX Futures ETF</b></span></ix:nonNumeric></td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><ix:nonNumeric contextRef="c1" name="dei:TradingSymbol"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SVIX</b></span></ix:nonNumeric></td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><ix:nonNumeric contextRef="c1" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cboe BZX Exchange</b></span></ix:nonNumeric></td></tr> <tr style="vertical-align: top"> <td style="text-align: center"><ix:nonNumeric contextRef="c2" name="dei:Security12bTitle"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2x Long VIX Futures ETF</b></span></ix:nonNumeric></td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><ix:nonNumeric contextRef="c2" name="dei:TradingSymbol"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>UVIX</b></span></ix:nonNumeric></td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><ix:nonNumeric contextRef="c2" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cboe BZX Exchange</b></span></ix:nonNumeric></td></tr> </table><div>
</div><p style="font: 6pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Securities registered pursuant to Section 12(g)
of the Act: None</b></p><div>

</div><p style="font: 6pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 25%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter
period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.&#160;&#9746;&#160;<ix:nonNumeric contextRef="c0" name="dei:EntityCurrentReportingStatus">Yes</ix:nonNumeric>&#160;&#9744;&#160;No</p><div>

</div><p style="font: 6pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant has submitted electronically
every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the
preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#9746;&#160;<ix:nonNumeric contextRef="c0" name="dei:EntityInteractiveDataCurrent">Yes</ix:nonNumeric>&#160;&#9744;&#160;No</p><div>

</div><p style="font: 6pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant is a large accelerated
filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of
&#8220;large accelerated filer&#8221;, &#8220;accelerated filer&#8221;, &#8220;smaller reporting company&#8221; and &#8220;emerging growth
company&#8221; in Rule 12b-2 of the Exchange Act.</p><div>

</div><p style="font: 6pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="white-space: nowrap; vertical-align: bottom; width: 26%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large Accelerated Filer</span></td> <td style="white-space: nowrap; vertical-align: bottom; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td> <td style="vertical-align: top; width: 19%">&#160;</td> <td style="white-space: nowrap; vertical-align: bottom; width: 25%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated Filer</span></td> <td style="white-space: nowrap; vertical-align: bottom; width: 25%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td></tr> <tr> <td style="white-space: nowrap; vertical-align: bottom"><ix:nonNumeric contextRef="c0" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Accelerated Filer</span></ix:nonNumeric></td> <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td> <td style="vertical-align: top">&#160;</td> <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller Reporting Company</span></td> <td style="white-space: nowrap; vertical-align: bottom"><ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="dei:EntitySmallBusiness"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></ix:nonNumeric></td></tr> <tr> <td style="vertical-align: bottom">&#160;</td> <td style="vertical-align: bottom">&#160;</td> <td style="vertical-align: top">&#160;</td> <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging Growth Company</span></td> <td style="white-space: nowrap; vertical-align: bottom"><ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="dei:EntityEmergingGrowthCompany"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></ix:nonNumeric></td></tr> </table><div>
</div><p style="font: 6pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act.&#160;<ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></p><div>

</div><p style="font: 6pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant is a shell company (as
defined in Rule 12b-2 of the Exchange Act.).&#160;&#9744;&#160;Yes&#160;&#9746;&#160;<ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:EntityShellCompany">No</ix:nonNumeric></p><div>

</div><p style="font: 6pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Indicate by check mark whether the registrant
has filed all documents and reports required to be filed by Sections 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent
to the distribution of securities under a plan confirmed by a court.&#160;&#9746;&#160;Yes&#160;&#9744;&#160;No</p><div>

</div><p style="font: 6pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt">As of June 30, 2023, the registrant had
<ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" unitRef="shares">21,800,000</ix:nonFraction> shares of common stock, $0 par value per share, outstanding.</p><div>

</div><p style="font: 6pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 6pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>VS Trust</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Table of Contents</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 89%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 10%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Page</b></span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><a href="#k_001"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Part I. FINANCIAL INFORMATION</b></span></a></td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><a href="#k_002"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 1. Financial Statements</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><a href="#k_003"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td></tr>
  <tr style="vertical-align: top">
    <td><a href="#k_004"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 3. Quantitative and Qualitative Disclosures About Market Risk</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><a href="#k_005"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 4. Controls and Procedures</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><a href="#k_006"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Part II. OTHER INFORMATION</b></span></a></td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><a href="#k_007"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 1. Legal Proceedings</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><a href="#k_008"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 1A. Risk Factors</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td></tr>
  <tr style="vertical-align: top">
    <td><a href="#k_009"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><a href="#k_010"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 3. Defaults Upon Senior Securities</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td></tr>
  <tr style="vertical-align: top">
    <td><a href="#k_011"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 4. Mine Safety Disclosures</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><a href="#k_012"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 5. Other Information</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td></tr>
  <tr style="vertical-align: top">
    <td><a href="#k_013"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 6. Exhibits</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 2; Options: NewSection --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="k_001"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Part I. FINANCIAL INFORMATION</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><div><a id="k_002"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 1. Financial Statements.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Index</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 89%; border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Documents</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 10%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Page</b></span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Statements of Financial Condition, Schedule of Investments, Statements of Operations, Statements of Changes in Shareholders&#8217; Equity, and Statements of Cash Flows:</span></td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><a href="#fin_001"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-1x Short VIX Futures ETF</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-7</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><a href="#fin_002"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2x Long VIX Futures ETF</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-9</span></td></tr>
  <tr style="vertical-align: top">
    <td><a href="#fin_003"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">VS&#160;Trust</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-11</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><a href="#fin_004"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes to Financial Statements</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-11</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 3; Options: NewSection --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->-</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>VS Trust</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Statements of Assets and Liabilities</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">June 30, 2023 (Unaudited) and December 31, 2022</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">-1x&#160;Short&#160;VIX <br/>
Futures ETF</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2x Long VIX Futures ETF</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">-1x&#160;Short&#160;VIX <br/>
Futures ETF</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2x Long VIX Futures ETF</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">June 30, <br/>
2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">June 30, <br/>
2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December 31, <br/>
2022</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31, <br/>
2022</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold">ASSETS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%">Cash</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-1">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-2">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="0" unitRef="usd">504,600</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-3">-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Investments in securities, at value*</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-4">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" id="ix_0_fact" name="us-gaap:InvestmentOwnedAtFairValue" scale="0" unitRef="usd">9,517,548</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-5">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" id="ix_1_fact" name="us-gaap:InvestmentOwnedAtFairValue" scale="0" unitRef="usd">8,250,285</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Interest receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InterestReceivable" scale="0" unitRef="usd">13,203</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InterestReceivable" scale="0" unitRef="usd">65,352</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InterestReceivable" scale="0" unitRef="usd">12,909</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InterestReceivable" scale="0" unitRef="usd">50,483</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Prepaid expenses and other assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssets" scale="0" unitRef="usd">34,380</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssets" scale="0" unitRef="usd">25,767</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssets" scale="0" unitRef="usd">10,295</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssets" scale="0" unitRef="usd">15,666</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Receivable for shares sold</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:ReceivableForSharesSold" scale="0" unitRef="usd">3,609,654</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:ReceivableForSharesSold" scale="0" unitRef="usd">1,014,706</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-6">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:ReceivableForSharesSold" scale="0" unitRef="usd">1,931,028</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Deposit at Broker for Futures</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommodityContractAssetCurrent" scale="0" unitRef="usd">68,703,813</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommodityContractAssetCurrent" scale="0" unitRef="usd">83,302,779</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommodityContractAssetCurrent" scale="0" unitRef="usd">48,144,554</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommodityContractAssetCurrent" scale="0" unitRef="usd">114,821,272</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Variation margin receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:VariationMarginReceivable" scale="0" unitRef="usd">1,242,108</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-7">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:VariationMarginReceivable" scale="0" unitRef="usd">830,840</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Other receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherReceivablesNetCurrent" scale="0" unitRef="usd">253</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherReceivablesNetCurrent" scale="0" unitRef="usd">560</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherReceivablesNetCurrent" scale="0" unitRef="usd">571</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherReceivablesNetCurrent" scale="0" unitRef="usd">579</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Due from Other</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-8">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-9">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-10">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Total Assets</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="0" unitRef="usd">73,603,411</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="0" unitRef="usd">93,926,712</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="0" unitRef="usd">48,672,929</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="0" unitRef="usd">125,900,153</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold">LIABILITIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Payables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Variation margin payable</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-11">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableCurrent" scale="0" unitRef="usd">3,406,049</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableCurrent" scale="0" unitRef="usd">187,030</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">Due to Custodian</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:DueToCustodian" scale="0" unitRef="usd">1,023,713</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:DueToCustodian" scale="0" unitRef="usd">2,874,781</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in">Fund shares redeemed</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-12">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:FundSharesRedeemed" scale="0" unitRef="usd">1,865,052</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:FundSharesRedeemed" scale="0" unitRef="usd">1,903,018</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-13">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">Payable to Sponsor</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherNotesPayable" scale="0" unitRef="usd">70,620</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherNotesPayable" scale="0" unitRef="usd">138,850</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherNotesPayable" scale="0" unitRef="usd">54,374</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherNotesPayable" scale="0" unitRef="usd">176,838</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Administrative, accounting and custodian fees payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:AdministrativeAccountingAndCustodianFeesPayable" scale="0" unitRef="usd">14,706</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:AdministrativeAccountingAndCustodianFeesPayable" scale="0" unitRef="usd">18,097</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:AdministrativeAccountingAndCustodianFeesPayable" scale="0" unitRef="usd">15,869</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:AdministrativeAccountingAndCustodianFeesPayable" scale="0" unitRef="usd">19,957</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">Professional fees payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent" scale="0" unitRef="usd">169,032</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent" scale="0" unitRef="usd">246,032</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent" scale="0" unitRef="usd">125,274</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent" scale="0" unitRef="usd">203,411</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Licensing and registration fees payable</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:LicensingAndRegistrationFeesPayable" scale="0" unitRef="usd">22,927</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:LicensingAndRegistrationFeesPayable" scale="0" unitRef="usd">39,049</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:LicensingAndRegistrationFeesPayable" scale="0" unitRef="usd">8,761</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:LicensingAndRegistrationFeesPayable" scale="0" unitRef="usd">11,181</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">Total Liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="0" unitRef="usd">1,300,998</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="0" unitRef="usd">8,587,910</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="0" unitRef="usd">2,294,326</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="0" unitRef="usd">411,387</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left">NET ASSETS</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsNet" scale="0" unitRef="usd">72,302,413</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsNet" scale="0" unitRef="usd">85,338,802</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsNet" scale="0" unitRef="usd">46,378,603</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsNet" scale="0" unitRef="usd">125,488,766</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left">NET ASSETS CONSIST OF:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Paid-in capital</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapital" scale="0" sign="-" unitRef="usd">8,033,985</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapital" scale="0" sign="-" unitRef="usd">360,476,596</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapital" scale="0" sign="-" unitRef="usd">29,386,125</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapital" scale="0" sign="-" unitRef="usd">203,182,472</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Total distributable earnings (accumulated deficit)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="0" sign="-" unitRef="usd">64,268,428</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="0" unitRef="usd">275,137,794</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="0" sign="-" unitRef="usd">16,992,478</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="0" unitRef="usd">77,693,706</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">Net Assets</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsNet" scale="0" unitRef="usd">72,302,413</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsNet" scale="0" unitRef="usd">85,338,802</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsNet" scale="0" unitRef="usd">46,378,603</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsNet" scale="0" unitRef="usd">125,488,766</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net Asset Value (unlimited shares authorized):</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left">Class I (unlimited shares authorized):</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net Assets</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsNet" scale="0" unitRef="usd">72,302,413</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsNet" scale="0" unitRef="usd">85,338,802</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsNet" scale="0" unitRef="usd">46,378,603</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsNet" scale="0" unitRef="usd">125,488,766</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Shares Outstanding&#x5e;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" id="ix_2_fact" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares">2,570,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="INF" format="ixt:num-dot-decimal" id="ix_3_fact" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares">19,230,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c6" decimals="INF" format="ixt:num-dot-decimal" id="ix_4_fact" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares">3,170,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c7" decimals="INF" format="ixt:num-dot-decimal" id="ix_5_fact" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares">21,450,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Net Asset Value, Offering and Redemption Price per Share</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c4" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:NetAssetValuePerShare" scale="0" unitRef="usdPershares">28.13</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c5" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:NetAssetValuePerShare" scale="0" unitRef="usdPershares">4.44</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c6" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:NetAssetValuePerShare" scale="0" unitRef="usdPershares">14.63</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c7" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:NetAssetValuePerShare" scale="0" unitRef="usdPershares">5.85</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Market Value per Share (Note 2)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c4" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:AuctionMarketPreferredSecuritiesStockSeriesParValuePerShare" scale="0" unitRef="usdPershares">28.07</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c5" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:AuctionMarketPreferredSecuritiesStockSeriesParValuePerShare" scale="0" unitRef="usdPershares">4.46</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c6" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:AuctionMarketPreferredSecuritiesStockSeriesParValuePerShare" scale="0" unitRef="usdPershares">14.66</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c7" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:AuctionMarketPreferredSecuritiesStockSeriesParValuePerShare" scale="0" unitRef="usdPershares">5.82</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">*&#160;&#160;&#160;&#160;&#160;&#160;Investments in securities, at cost</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-14">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherInvestmentsAndSecuritiesAtCost" scale="0" unitRef="usd">9,517,548</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherInvestmentsAndSecuritiesAtCost" scale="0" unitRef="usd">8,250,285</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left">&#x5e;</td><td style="text-align: justify"><ix:footnote id="ix_1_footnote" xml:lang="en-US">No Par Value</ix:footnote></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 4; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>VS Trust </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Statements of Operations</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">For the Three Months Ended June 30, 2023 and June
30, 2022 (Unaudited)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">-1x Short VIX Futures ETF</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2x Long VIX Futures ETF</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">-1x Short VIX Futures ETF</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2x Long VIX Futures ETF</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Quarter<br/>
Ended</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Quarter<br/>
 Ended</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Quarter<br/>
Ended</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Quarter<br/>
Ended</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">June 30,<br/>
 2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">June 30,<br/>
 2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">June 30,<br/>
 2022</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">June 30,<br/>
 2022</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold">INVESTMENT INCOME</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Income:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; width: 52%; text-align: left">Interest income</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InterestAndOtherIncome" scale="0" unitRef="usd">74,800</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InterestAndOtherIncome" scale="0" unitRef="usd">301,835</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c10" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InterestAndOtherIncome" scale="0" unitRef="usd">18,977</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InterestAndOtherIncome" scale="0" unitRef="usd">16,778</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; padding-left: 0.25in; text-indent: -0.125in; text-align: left">Other Income</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-15">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-16">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c10" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherIncome" scale="0" unitRef="usd">61</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherIncome" scale="0" unitRef="usd">153</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt; padding-left: 0.375in; text-indent: -0.125in; text-align: left">Total Income</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InvestmentIncomeNet" scale="0" unitRef="usd">74,800</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InvestmentIncomeNet" scale="0" unitRef="usd">301,835</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c10" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InvestmentIncomeNet" scale="0" unitRef="usd">19,037</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InvestmentIncomeNet" scale="0" unitRef="usd">16,931</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Expenses:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left">Management fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ManagementFeeExpense" scale="0" unitRef="usd">225,408</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ManagementFeeExpense" scale="0" unitRef="usd">521,809</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c10" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ManagementFeeExpense" scale="0" unitRef="usd">163,452</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ManagementFeeExpense" scale="0" unitRef="usd">111,085</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left">Administrative, accounting and custodian fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="0" unitRef="usd">24,727</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="0" unitRef="usd">33,684</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c10" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="0" unitRef="usd">23,357</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="0" unitRef="usd">23,323</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left">Professional fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProfessionalFees" scale="0" unitRef="usd">80,185</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProfessionalFees" scale="0" unitRef="usd">81,279</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c10" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProfessionalFees" scale="0" unitRef="usd">15,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProfessionalFees" scale="0" unitRef="usd">14,963</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left">Licensing and registration fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LegalFees" scale="0" unitRef="usd">31,769</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LegalFees" scale="0" unitRef="usd">24,392</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c10" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LegalFees" scale="0" unitRef="usd">40,055</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LegalFees" scale="0" unitRef="usd">40,027</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; padding-left: 0.25in; text-indent: -0.125in; text-align: left">Broker interest expense</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FloorBrokerageExchangeAndClearanceFees" scale="0" unitRef="usd">5,462</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FloorBrokerageExchangeAndClearanceFees" scale="0" unitRef="usd">40</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c10" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FloorBrokerageExchangeAndClearanceFees" scale="0" unitRef="usd">19,953</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FloorBrokerageExchangeAndClearanceFees" scale="0" unitRef="usd">8,143</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 0.375in; text-indent: -0.125in; text-align: left">Total Expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CostsAndExpenses" scale="0" unitRef="usd">367,551</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CostsAndExpenses" scale="0" unitRef="usd">661,204</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c10" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CostsAndExpenses" scale="0" unitRef="usd">261,816</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CostsAndExpenses" scale="0" unitRef="usd">197,542</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Net Investment loss</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetInvestmentInLeaseAccruedInterestWriteoff" scale="0" unitRef="usd">292,751</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetInvestmentInLeaseAccruedInterestWriteoff" scale="0" unitRef="usd">359,369</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c10" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetInvestmentInLeaseAccruedInterestWriteoff" scale="0" unitRef="usd">242,779</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetInvestmentInLeaseAccruedInterestWriteoff" scale="0" unitRef="usd">180,611</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS AND FUTURES CONTRACTS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Net realized gain (loss) on:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left">Short Term Investments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-17">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-18">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-19">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-20">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Futures</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:FuturesContracts" scale="0" sign="-" unitRef="usd">37,164,451</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:FuturesContracts" scale="0" unitRef="usd">142,872,642</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c10" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:FuturesContracts" scale="0" unitRef="usd">4,573,051</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:FuturesContracts" scale="0" sign="-" unitRef="usd">7,528,449</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Net change in unrealized appreciation (depreciation) of:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left">Short Term Investments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-21">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-22">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-23">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-24">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 0.25in; text-indent: -0.125in">Futures</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:FuturesContractsUnrealizedAppreciation" scale="0" unitRef="usd">811,301</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:FuturesContractsUnrealizedAppreciation" scale="0" unitRef="usd">4,374,661</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c10" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:FuturesContractsUnrealizedAppreciation" scale="0" sign="-" unitRef="usd">835,808</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:FuturesContractsUnrealizedAppreciation" scale="0" unitRef="usd">256,944</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in"><b>Net realized and unrealized gain (loss) on investments and futures contracts</b></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="0" unitRef="usd">36,353,150</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="0" sign="-" unitRef="usd">147,247,303</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c10" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="0" sign="-" unitRef="usd">3,737,244</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="0" unitRef="usd">7,271,505</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt; padding-left: 0.125in; text-indent: -0.125in"><b>NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS</b></td><td style="padding-bottom: 4pt; font-weight: bold"><b>&#160;</b></td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><b>$</b></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><b><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:NetIncreasedecreaseInNetAssetsResultingFromOperations" scale="0" unitRef="usd">36,060,399</ix:nonFraction></b></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"><b>&#160;</b></td><td style="padding-bottom: 4pt; font-weight: bold"><b>&#160;</b></td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><b>$</b></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><b>(<ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:NetIncreasedecreaseInNetAssetsResultingFromOperations" scale="0" sign="-" unitRef="usd">147,606,672</ix:nonFraction></b></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"><b>)</b></td><td style="padding-bottom: 4pt; font-weight: bold"><b>&#160;</b></td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><b>$</b></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><b>(<ix:nonFraction contextRef="c10" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:NetIncreasedecreaseInNetAssetsResultingFromOperations" scale="0" sign="-" unitRef="usd">3,980,023</ix:nonFraction></b></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"><b>)</b></td><td style="padding-bottom: 4pt; font-weight: bold"><b>&#160;</b></td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><b>$</b></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><b><ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:NetIncreasedecreaseInNetAssetsResultingFromOperations" scale="0" unitRef="usd">7,090,894</ix:nonFraction></b></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"><b>&#160;</b></td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 5; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>VS Trust</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Statements of Operations</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">For the Six Months Ended June 30, 2023 and June
30, 2022 (Unaudited)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">-1x Short VIX <br/>
Futures ETF</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2x Long VIX <br/>
Futures ETF</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">-1x Short VIX <br/>
Futures ETF</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2x Long VIX <br/>
Futures ETF</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Six Months <br/>
Ended</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Six Months <br/>
Ended</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Six Months <br/>
Ended</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Six Months <br/>
Ended</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">June 30, <br/>
2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">June 30, <br/>
2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">June 30, <br/>
2022</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">June 30, <br/>
2022</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold">INVESTMENT INCOME</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Income:</td><td>&#160;</td>
    <td colspan="2"><div style="-sec-ix-hidden: hidden-fact-25">&#160;</div></td><td>&#160;</td><td>&#160;</td>
    <td colspan="2"><div style="-sec-ix-hidden: hidden-fact-26">&#160;</div></td><td>&#160;</td><td>&#160;</td>
    <td colspan="2"><div style="-sec-ix-hidden: hidden-fact-27">&#160;</div></td><td>&#160;</td><td>&#160;</td>
    <td colspan="2"><div style="-sec-ix-hidden: hidden-fact-28">&#160;</div></td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; width: 52%; text-align: left">Interest income</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c12" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InterestAndOtherIncome" scale="0" unitRef="usd">121,531</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c13" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InterestAndOtherIncome" scale="0" unitRef="usd">434,271</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c14" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InterestAndOtherIncome" scale="0" unitRef="usd">18,984</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c15" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InterestAndOtherIncome" scale="0" unitRef="usd">16,782</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Other Income</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c14" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherIncome" scale="0" unitRef="usd">61</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c15" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherIncome" scale="0" unitRef="usd">153</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.375in; text-indent: -0.125in; text-align: left; padding-bottom: 4pt">Total Income</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c12" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InvestmentIncomeNet" scale="0" unitRef="usd">121,531</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c13" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InvestmentIncomeNet" scale="0" unitRef="usd">434,271</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c14" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InvestmentIncomeNet" scale="0" unitRef="usd">19,045</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c15" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InvestmentIncomeNet" scale="0" unitRef="usd">16,935</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Expenses:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left">Management fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c12" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ManagementFeeExpense" scale="0" unitRef="usd">394,913</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c13" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ManagementFeeExpense" scale="0" unitRef="usd">919,658</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c14" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ManagementFeeExpense" scale="0" unitRef="usd">163,562</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c15" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ManagementFeeExpense" scale="0" unitRef="usd">111,223</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left">Administrative, accounting and custodian fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c12" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="0" unitRef="usd">46,808</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c13" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="0" unitRef="usd">62,699</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c14" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="0" unitRef="usd">23,901</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c15" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="0" unitRef="usd">23,867</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left">Professional fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c12" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProfessionalFees" scale="0" unitRef="usd">159,092</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c13" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProfessionalFees" scale="0" unitRef="usd">160,949</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c14" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProfessionalFees" scale="0" unitRef="usd">15,759</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c15" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProfessionalFees" scale="0" unitRef="usd">15,722</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left">Licensing and registration fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c12" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LegalFees" scale="0" unitRef="usd">50,134</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c13" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LegalFees" scale="0" unitRef="usd">44,821</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c14" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LegalFees" scale="0" unitRef="usd">40,395</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c15" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LegalFees" scale="0" unitRef="usd">40,367</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Broker interest expense</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c12" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FloorBrokerageExchangeAndClearanceFees" scale="0" unitRef="usd">8,613</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c13" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FloorBrokerageExchangeAndClearanceFees" scale="0" unitRef="usd">320</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c14" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FloorBrokerageExchangeAndClearanceFees" scale="0" unitRef="usd">20,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c15" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FloorBrokerageExchangeAndClearanceFees" scale="0" unitRef="usd">8,143</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.375in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Total Expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c12" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CostsAndExpenses" scale="0" unitRef="usd">659,560</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c13" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CostsAndExpenses" scale="0" unitRef="usd">1,188,447</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c14" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CostsAndExpenses" scale="0" unitRef="usd">263,617</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c15" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CostsAndExpenses" scale="0" unitRef="usd">199,322</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Net Investment loss</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c12" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetInvestmentInLeaseAccruedInterestWriteoff" scale="0" unitRef="usd">538,029</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c13" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetInvestmentInLeaseAccruedInterestWriteoff" scale="0" unitRef="usd">754,176</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c14" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetInvestmentInLeaseAccruedInterestWriteoff" scale="0" unitRef="usd">244,572</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c15" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetInvestmentInLeaseAccruedInterestWriteoff" scale="0" unitRef="usd">182,387</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS AND FUTURES CONTRACTS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Net realized gain (loss) on:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left">Short Term Investments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Futures</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c12" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:FuturesContracts" scale="0" sign="-" unitRef="usd">42,451,505</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c13" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:FuturesContracts" scale="0" unitRef="usd">186,102,397</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c14" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:FuturesContracts" scale="0" unitRef="usd">4,577,129</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c15" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:FuturesContracts" scale="0" sign="-" unitRef="usd">7,527,995</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt; text-indent: 0pt; text-align: left">Net change in unrealized appreciation (depreciation) of:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left">Short Term Investments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 0.25in; text-indent: -0.125in">Futures</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c12" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:FuturesContractsUnrealizedAppreciation" scale="0" sign="-" unitRef="usd">5,362,473</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c13" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:FuturesContractsUnrealizedAppreciation" scale="0" unitRef="usd">10,587,514</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c14" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:FuturesContractsUnrealizedAppreciation" scale="0" sign="-" unitRef="usd">700,531</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c15" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:FuturesContractsUnrealizedAppreciation" scale="0" sign="-" unitRef="usd">19,258</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Net realized and unrealized gain (loss) on investments and futures contracts</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c12" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="0" unitRef="usd">47,813,978</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c13" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="0" sign="-" unitRef="usd">196,689,911</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c14" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="0" sign="-" unitRef="usd">3,876,598</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c15" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="0" unitRef="usd">7,547,253</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 4pt">NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c12" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:NetIncreasedecreaseInNetAssetsResultingFromOperations" scale="0" unitRef="usd">47,275,949</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c13" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:NetIncreasedecreaseInNetAssetsResultingFromOperations" scale="0" sign="-" unitRef="usd">197,444,087</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c14" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:NetIncreasedecreaseInNetAssetsResultingFromOperations" scale="0" sign="-" unitRef="usd">4,121,170</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c15" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:NetIncreasedecreaseInNetAssetsResultingFromOperations" scale="0" unitRef="usd">7,364,866</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 6; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>VS Trust </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Statement of Changes in Net Assets </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">For the Three Months Ended June 30, 2023 and June
30, 2022 (Unaudited)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">-1x Short VIX Futures ETF</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2x Long VIX Futures ETF</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">-1x Short VIX Futures ETF</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2x Long VIX Futures ETF</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Quarter&#160;Ended</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Quarter&#160;Ended</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Quarter&#160;Ended</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Quarter&#160;Ended</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">June 30, 2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">June 30, 2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">June 30, 2022</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">June 30, 2022</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">INCREASE (DECREASE) IN NET ASSETS:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">OPERATIONS</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; text-indent: -0.125in; padding-left: 0.25in">Net investment loss</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:GainLossOnInvestments" scale="0" sign="-" unitRef="usd">292,751</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:GainLossOnInvestments" scale="0" sign="-" unitRef="usd">359,369</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c10" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:GainLossOnInvestments" scale="0" sign="-" unitRef="usd">242,779</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:GainLossOnInvestments" scale="0" sign="-" unitRef="usd">180,611</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Net realized gain (loss) on investments and futures contracts</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:NetRealizedGainlossOnInvestmentsAndFuturesContracts" scale="0" unitRef="usd">37,164,451</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:NetRealizedGainlossOnInvestmentsAndFuturesContracts" scale="0" sign="-" unitRef="usd">142,872,642</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c10" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:NetRealizedGainlossOnInvestmentsAndFuturesContracts" scale="0" sign="-" unitRef="usd">4,573,051</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:NetRealizedGainlossOnInvestmentsAndFuturesContracts" scale="0" unitRef="usd">7,528,449</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.25in">Net change in unrealized appreciation (depreciation) of investments and futures contracts</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:NetChangeInUnrealizedAppreciationdepreciationOfInvestmentsAndFuturesContracts" scale="0" sign="-" unitRef="usd">811,301</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:NetChangeInUnrealizedAppreciationdepreciationOfInvestmentsAndFuturesContracts" scale="0" sign="-" unitRef="usd">4,374,661</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c10" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:NetChangeInUnrealizedAppreciationdepreciationOfInvestmentsAndFuturesContracts" scale="0" unitRef="usd">835,808</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:NetChangeInUnrealizedAppreciationdepreciationOfInvestmentsAndFuturesContracts" scale="0" sign="-" unitRef="usd">256,944</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.25in">Net increase (decrease) in net assets resulting from operations</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:NetIncreasedecreaseInNetAssetsResultingFromOperations" scale="0" unitRef="usd">36,060,399</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:NetIncreasedecreaseInNetAssetsResultingFromOperations" scale="0" sign="-" unitRef="usd">147,606,672</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c10" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:NetIncreasedecreaseInNetAssetsResultingFromOperations" scale="0" sign="-" unitRef="usd">3,980,023</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:NetIncreasedecreaseInNetAssetsResultingFromOperations" scale="0" unitRef="usd">7,090,894</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-indent: -0.125in; padding-left: 0.125in">CAPITAL SHARE TRANSACTIONS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in">Shares sold</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:SharesSoldinShares" scale="0" sign="-" unitRef="usd">33,849,864</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:SharesSoldinShares" scale="0" sign="-" unitRef="usd">174,563,374</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c10" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:SharesSoldinShares" scale="0" sign="-" unitRef="usd">126,466,848</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:SharesSoldinShares" scale="0" sign="-" unitRef="usd">101,014,240</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.25in">Shares redeemed</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:SharesSoldNetOfSharesRedeemedinDollarsPerShare" scale="0" unitRef="usd">72,249,312</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:SharesSoldNetOfSharesRedeemedinDollarsPerShare" scale="0" unitRef="usd">48,655,759</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c10" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:SharesSoldNetOfSharesRedeemedinDollarsPerShare" scale="0" unitRef="usd">80,976,664</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:SharesSoldNetOfSharesRedeemedinDollarsPerShare" scale="0" unitRef="usd">51,662,990</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.25in">Net increase (decrease) in net assets from capital share transactions</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:NetIncreaseInNetAssetsFromCapitalShareTransactions" scale="0" sign="-" unitRef="usd">38,399,448</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:NetIncreaseInNetAssetsFromCapitalShareTransactions" scale="0" unitRef="usd">125,907,615</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c10" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:NetIncreaseInNetAssetsFromCapitalShareTransactions" scale="0" unitRef="usd">45,490,184</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:NetIncreaseInNetAssetsFromCapitalShareTransactions" scale="0" unitRef="usd">49,351,250</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Total increase (decrease) in net assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:IncreasedecreaseInNetAssets" scale="0" sign="-" unitRef="usd">2,339,049</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:IncreasedecreaseInNetAssets" scale="0" sign="-" unitRef="usd">21,699,057</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c10" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:IncreasedecreaseInNetAssets" scale="0" unitRef="usd">41,510,161</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:IncreasedecreaseInNetAssets" scale="0" unitRef="usd">56,442,145</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in">NET ASSETS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Beginning of Period</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c16" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsNet" scale="0" unitRef="usd">74,641,462</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c17" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsNet" scale="0" unitRef="usd">107,037,859</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c18" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsNet" scale="0" unitRef="usd">5,379,210</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c19" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsNet" scale="0" unitRef="usd">3,994,311</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.125in">End of Period</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsNet" scale="0" unitRef="usd">72,302,413</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsNet" scale="0" unitRef="usd">85,338,802</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c20" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsNet" scale="0" unitRef="usd">46,889,371</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c21" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsNet" scale="0" unitRef="usd">60,436,456</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>VS Trust</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Statement of Changes in Net Assets</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">For the Six Months Ended June 30, 2023 and June
30, 2022 (Unaudited)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">-1x Short VIX Futures ETF</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2x Long VIX Futures ETF</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">-1x Short VIX Futures ETF</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2x Long VIX Futures ETF</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Six Months Ended</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Six Months Ended</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Six Months Ended</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Six Months Ended</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">June 30, 2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">June 30, 2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">June 30, 2022</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">June 30, 2022</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">INCREASE (DECREASE) IN NET ASSETS:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">OPERATIONS</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; padding-left: 10pt">Net investment loss</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c12" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:GainLossOnInvestments" scale="0" sign="-" unitRef="usd">538,029</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c13" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:GainLossOnInvestments" scale="0" sign="-" unitRef="usd">754,176</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c14" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:GainLossOnInvestments" scale="0" sign="-" unitRef="usd">244,572</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c15" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:GainLossOnInvestments" scale="0" sign="-" unitRef="usd">182,387</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 10pt">Net realized gain (loss) on investments and futures contracts</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c12" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:NetRealizedGainlossOnInvestmentsAndFuturesContracts" scale="0" unitRef="usd">42,451,505</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c13" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:NetRealizedGainlossOnInvestmentsAndFuturesContracts" scale="0" sign="-" unitRef="usd">186,102,397</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c14" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:NetRealizedGainlossOnInvestmentsAndFuturesContracts" scale="0" sign="-" unitRef="usd">4,577,129</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c15" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:NetRealizedGainlossOnInvestmentsAndFuturesContracts" scale="0" unitRef="usd">7,527,995</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-bottom: 1.5pt; text-align: left; padding-left: 0.25in">Net change in unrealized appreciation (depreciation) of investments and futures
    contracts</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c12" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:NetChangeInUnrealizedAppreciationdepreciationOfInvestmentsAndFuturesContracts" scale="0" unitRef="usd">5,362,473</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c13" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:NetChangeInUnrealizedAppreciationdepreciationOfInvestmentsAndFuturesContracts" scale="0" sign="-" unitRef="usd">10,587,514</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c14" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:NetChangeInUnrealizedAppreciationdepreciationOfInvestmentsAndFuturesContracts" scale="0" unitRef="usd">700,531</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c15" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:NetChangeInUnrealizedAppreciationdepreciationOfInvestmentsAndFuturesContracts" scale="0" unitRef="usd">19,258</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in">Net increase (decrease) in net assets resulting from operations</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c12" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:NetIncreasedecreaseInNetAssetsResultingFromOperations" scale="0" unitRef="usd">47,275,949</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c13" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:NetIncreasedecreaseInNetAssetsResultingFromOperations" scale="0" sign="-" unitRef="usd">197,444,087</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c14" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:NetIncreasedecreaseInNetAssetsResultingFromOperations" scale="0" sign="-" unitRef="usd">4,121,170</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c15" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:NetIncreasedecreaseInNetAssetsResultingFromOperations" scale="0" unitRef="usd">7,364,866</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold">CAPITAL SHARE TRANSACTIONS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Shares sold</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c12" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:SharesSoldinShares" scale="0" sign="-" unitRef="usd">118,500,459</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c13" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:SharesSoldinShares" scale="0" sign="-" unitRef="usd">278,060,557</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c14" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:SharesSoldinShares" scale="0" sign="-" unitRef="usd">131,987,205</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c15" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:SharesSoldinShares" scale="0" sign="-" unitRef="usd">104,734,579</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt">Shares redeemed</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c12" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:SharesSoldNetOfSharesRedeemedinDollarsPerShare" scale="0" unitRef="usd">139,852,598</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c13" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:SharesSoldNetOfSharesRedeemedinDollarsPerShare" scale="0" unitRef="usd">120,766,434</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c14" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:SharesSoldNetOfSharesRedeemedinDollarsPerShare" scale="0" unitRef="usd">80,976,664</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c15" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:SharesSoldNetOfSharesRedeemedinDollarsPerShare" scale="0" unitRef="usd">51,662,990</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in">Net increase (decrease) in net assets from capital share transactions</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c12" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:NetIncreaseInNetAssetsFromCapitalShareTransactions" scale="0" sign="-" unitRef="usd">21,352,139</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c13" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:NetIncreaseInNetAssetsFromCapitalShareTransactions" scale="0" unitRef="usd">157,294,123</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c14" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:NetIncreaseInNetAssetsFromCapitalShareTransactions" scale="0" unitRef="usd">51,010,541</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c15" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:NetIncreaseInNetAssetsFromCapitalShareTransactions" scale="0" unitRef="usd">53,071,589</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total increase (decrease) in net assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c12" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:IncreasedecreaseInNetAssets" scale="0" unitRef="usd">25,923,810</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c13" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:IncreasedecreaseInNetAssets" scale="0" sign="-" unitRef="usd">40,149,964</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c14" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:IncreasedecreaseInNetAssets" scale="0" unitRef="usd">46,889,371</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c15" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:IncreasedecreaseInNetAssets" scale="0" unitRef="usd">60,436,456</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left">NET ASSETS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Beginning of Period</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsNet" scale="0" unitRef="usd">46,378,603</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsNet" scale="0" unitRef="usd">125,488,766</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 4pt">End of Period</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsNet" scale="0" unitRef="usd">72,302,413</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsNet" scale="0" unitRef="usd">85,338,802</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c20" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsNet" scale="0" unitRef="usd">46,889,371</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c21" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsNet" scale="0" unitRef="usd">60,436,456</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 7; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>VS Trust</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Statements of Cash Flows</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">For the Three Months Ended June 30, 2023 and June
30, 2022 (Unaudited)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.25in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">-1x Short VIX <br/>
Futures ETF</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2x Long VIX <br/>
Futures ETF</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">-1x Short VIX <br/>
Futures ETF</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2x Long VIX <br/>
Futures ETF</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.25in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Quarter&#160;Ended</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Quarter&#160;Ended</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Quarter&#160;Ended</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Quarter&#160;Ended</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.25in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">June 30, <br/>
2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">June 30, <br/>
2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">June 30, <br/>
2022</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">June 30, <br/>
2022</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.25in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left; font-weight: bold">CASH FLOW FROM OPERATING ACTIVITIES</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; width: 52%; text-align: left">Net increase (decrease) in net assets resulting from operations</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" unitRef="usd">36,060,399</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd">147,606,672</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c10" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd">242,779</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd">180,611</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Purchase of investments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:PurchasesOfInvestments" scale="0" unitRef="usd">117,945,818</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:PurchasesOfInvestments" scale="0" unitRef="usd">170,380,218</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c10" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:PurchasesOfInvestments" scale="0" unitRef="usd">86,248,199</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:PurchasesOfInvestments" scale="0" unitRef="usd">60,472,471</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left">Proceeds from sales or maturities of investments held</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:ProceedsFromSalesOrMaturitiesOfInvestments" scale="0" unitRef="usd">123,386,374</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:ProceedsFromSalesOrMaturitiesOfInvestments" scale="0" unitRef="usd">176,796,775</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c10" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:ProceedsFromSalesOrMaturitiesOfInvestments" scale="0" unitRef="usd">78,851,911</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:ProceedsFromSalesOrMaturitiesOfInvestments" scale="0" unitRef="usd">43,818,993</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left">Decrease (Increase) in Deposits at broker for futures contracts</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInEarnestMoneyDepositsOutstanding" scale="0" sign="-" unitRef="usd">12,091,557</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInEarnestMoneyDepositsOutstanding" scale="0" unitRef="usd">9,303,378</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-29">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left">Decrease (Increase) in Variation margin receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInPrepaidExpensesOther" scale="0" unitRef="usd">777,982</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-30">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c10" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInPrepaidExpensesOther" scale="0" sign="-" unitRef="usd">835,808</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInPrepaidExpensesOther" scale="0" unitRef="usd">256,944</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left">Decrease (Increase) in interest receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet" scale="0" sign="-" unitRef="usd">19,618</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet" scale="0" sign="-" unitRef="usd">9,245</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c10" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet" scale="0" unitRef="usd">4,573,051</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet" scale="0" sign="-" unitRef="usd">7,528,449</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left">Decrease (Increase) in other receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherReceivables" scale="0" sign="-" unitRef="usd">492</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherReceivables" scale="0" sign="-" unitRef="usd">1,775</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c10" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherReceivables" scale="0" unitRef="usd">37,960,927</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherReceivables" scale="0" unitRef="usd">39,378,470</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left">Decrease (Increase) in Prepaid expenses and other assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:IncreaseDecreaseInVariationMarginPayable" scale="0" sign="-" unitRef="usd">13,235</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:IncreaseDecreaseInVariationMarginPayable" scale="0" sign="-" unitRef="usd">10,933</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c10" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:IncreaseDecreaseInVariationMarginPayable" scale="0" unitRef="usd">4,018,702</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:IncreaseDecreaseInVariationMarginPayable" scale="0" sign="-" unitRef="usd">121,254</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left">Decrease (Increase) in Due from Other</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInReceivables" scale="0" sign="-" unitRef="usd">26</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-31">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c10" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInReceivables" scale="0" unitRef="usd">9,596</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInReceivables" scale="0" unitRef="usd">12,371</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left">Increase (Decrease) in Due to Custodian</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:IncreaseDecreaseInDueToCustodian" scale="0" sign="-" unitRef="usd">3,086,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:IncreaseDecreaseInDueToCustodian" scale="0" unitRef="usd">2,491,372</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c10" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:IncreaseDecreaseInDueToCustodian" scale="0" unitRef="usd">764</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:IncreaseDecreaseInDueToCustodian" scale="0" unitRef="usd">200</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left">Increase (Decrease) in Due to Other</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-32">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-33">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-34">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInCustomerAdvances" scale="0" sign="-" unitRef="usd">161,534</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left">Increase (Decrease) in Variation margin payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-35">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent" scale="0" unitRef="usd">2,165,122</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c10" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent" scale="0" unitRef="usd">4,105,647</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-36">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left">Increase (Decrease) in Payable to Sponsor</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:IncreaseDecreaseInPayableToSponsor" scale="0" unitRef="usd">6,936</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:IncreaseDecreaseInPayableToSponsor" scale="0" sign="-" unitRef="usd">4,019</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c10" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:IncreaseDecreaseInPayableToSponsor" scale="0" sign="-" unitRef="usd">62,014</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:IncreaseDecreaseInPayableToSponsor" scale="0" sign="-" unitRef="usd">70,197</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left">Increase (Decrease) in Administrative, accounting and custodian fees payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" scale="0" unitRef="usd">6,731</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" scale="0" unitRef="usd">1,677</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c10" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" scale="0" unitRef="usd">21,906</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" scale="0" unitRef="usd">22,082</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left">Increase (Decrease) in Professional fees payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:IncreaseInProfessionalFeesPayable" scale="0" unitRef="usd">13,987</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:IncreaseInProfessionalFeesPayable" scale="0" unitRef="usd">12,757</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c10" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:IncreaseInProfessionalFeesPayable" scale="0" unitRef="usd">15,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:IncreaseInProfessionalFeesPayable" scale="0" unitRef="usd">14,963</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Increase (Decrease) in Licensing and registration fees payable</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:IncreaseInLicensingAndRegistrationFeesPayable" scale="0" unitRef="usd">8,348</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:IncreaseInLicensingAndRegistrationFeesPayable" scale="0" unitRef="usd">15,892</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c10" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:IncreaseInLicensingAndRegistrationFeesPayable" scale="0" unitRef="usd">34,725</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:IncreaseInLicensingAndRegistrationFeesPayable" scale="0" unitRef="usd">36,514</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.375in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Net cash provided by (used in) operating activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="0" unitRef="usd">49,757,561</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="0" sign="-" unitRef="usd">145,802,567</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c10" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="0" sign="-" unitRef="usd">41,088,075</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="0" sign="-" unitRef="usd">49,092,257</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left">CASH FLOW FROM FINANCING ACTIVITIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left">Proceeds from shares sold, net of cost from shares purchased</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:ProceedsFromSaleOfUnits" scale="0" unitRef="usd">30,240,210</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:ProceedsFromSaleOfUnits" scale="0" unitRef="usd">192,593,274</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c10" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:ProceedsFromSaleOfUnits" scale="0" unitRef="usd">45,490,185</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:ProceedsFromSaleOfUnits" scale="0" unitRef="usd">49,351,251</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1.5pt">Cost of shares redeemed</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="0" unitRef="usd">79,997,771</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="0" unitRef="usd">46,790,707</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-37">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-38">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.375in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Net cash provided by (used in) financing activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="0" sign="-" unitRef="usd">49,757,561</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="0" unitRef="usd">145,802,567</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c10" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="0" unitRef="usd">45,490,185</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="0" unitRef="usd">49,351,251</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">NET INCREASE (DECREASE) IN CASH</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-39">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-40">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c10" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" scale="0" sign="-" unitRef="usd">4,402,110</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" scale="0" sign="-" unitRef="usd">258,994</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Beginning of Period</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-41">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-42">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c18" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" sign="-" unitRef="usd">862,580</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c19" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" sign="-" unitRef="usd">151,213</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt">End of Period</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-43">-</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">-</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c20" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" unitRef="usd">3,539,530</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c21" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" unitRef="usd">107,781</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 8; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.4pt; text-align: center"><b>VS Trust</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.4pt; text-align: center"><b>Statements of Cash Flows</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.4pt; text-align: center">For the Six Months Ended June 30, 2023
and June 30, 2022 (Unaudited)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.25in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">-1x Short VIX <br/>
Futures ETF</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2x Long VIX <br/>
Futures ETF</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">-1x Short VIX <br/>
Futures ETF</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2x Long VIX <br/>
Futures ETF</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.25in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Six Months Ended</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Six Months Ended</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Six Months Ended</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Six Months Ended</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.25in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">June 30, 2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">June 30, 2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">June 30, 2022</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">June 30, 2022</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.25in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left; font-weight: bold">CASH FLOW FROM OPERATING ACTIVITIES</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; width: 52%; text-align: left; padding-left: 0.25in">Net increase (decrease) in net assets resulting from operations</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c12" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" unitRef="usd">47,275,949</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c13" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd">197,444,087</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c14" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd">4,121,170</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c15" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" unitRef="usd">7,364,866</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in">Purchase of investments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c12" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:PurchasesOfInvestments" scale="0" unitRef="usd">227,091,533</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c13" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:PurchasesOfInvestments" scale="0" unitRef="usd">309,353,524</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c14" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:PurchasesOfInvestments" scale="0" unitRef="usd">87,243,243</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c15" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:PurchasesOfInvestments" scale="0" unitRef="usd">60,968,753</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.25in">Proceeds from sales or maturities of investments held</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c12" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:ProceedsFromSalesOrMaturitiesOfInvestments" scale="0" unitRef="usd">227,091,533</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c13" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:ProceedsFromSalesOrMaturitiesOfInvestments" scale="0" unitRef="usd">308,086,262</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c14" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:ProceedsFromSalesOrMaturitiesOfInvestments" scale="0" unitRef="usd">78,951,910</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c15" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:ProceedsFromSalesOrMaturitiesOfInvestments" scale="0" unitRef="usd">43,818,993</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.25in">Decrease (Increase) in Deposits at broker for futures contracts</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c12" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInEarnestMoneyDepositsOutstanding" scale="0" unitRef="usd">20,559,259</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c13" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInEarnestMoneyDepositsOutstanding" scale="0" sign="-" unitRef="usd">31,518,493</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c14" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInEarnestMoneyDepositsOutstanding" scale="0" unitRef="usd">39,872,983</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c15" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInEarnestMoneyDepositsOutstanding" scale="0" unitRef="usd">40,554,763</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.25in">Decrease (Increase) in Variation margin receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c12" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInPrepaidExpensesOther" scale="0" unitRef="usd">1,242,108</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c13" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInPrepaidExpensesOther" scale="0" sign="-" unitRef="usd">830,840</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-44">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c15" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInPrepaidExpensesOther" scale="0" unitRef="usd">1,433,096</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.25in">Decrease (Increase) in interest receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c12" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet" scale="0" unitRef="usd">294</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c13" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet" scale="0" unitRef="usd">14,869</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c14" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet" scale="0" unitRef="usd">9,602</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c15" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet" scale="0" unitRef="usd">12,375</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.25in">Decrease (Increase) in other receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c12" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherReceivables" scale="0" sign="-" unitRef="usd">318</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c13" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherReceivables" scale="0" sign="-" unitRef="usd">19</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-45">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-46">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.25in">Decrease (Increase) in Prepaid expenses and other assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c12" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:IncreaseDecreaseInVariationMarginPayable" scale="0" sign="-" unitRef="usd">24,085</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c13" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:IncreaseDecreaseInVariationMarginPayable" scale="0" sign="-" unitRef="usd">10,101</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-47">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-48">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.25in">Decrease (Increase) in Due from Other</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-49">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-50">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.25in">Increase (Decrease) in Due to Custodian</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c12" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:IncreaseDecreaseInDueToCustodian" scale="0" unitRef="usd">1,023,713</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c13" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:IncreaseDecreaseInDueToCustodian" scale="0" unitRef="usd">2,874,781</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-51">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-52">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.25in">Increase (Decrease) in Due to Other</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-53">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c15" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInCustomerAdvances" scale="0" unitRef="usd">1,016,260</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.25in">Increase (Decrease) in Variation margin payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c12" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent" scale="0" sign="-" unitRef="usd">187,030</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c13" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent" scale="0" unitRef="usd">3,406,049</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c14" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent" scale="0" unitRef="usd">583,031</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-54">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.25in">Increase (Decrease) in Payable to Sponsor</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c12" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:IncreaseDecreaseInPayableToSponsor" scale="0" sign="-" unitRef="usd">16,246</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c13" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:IncreaseDecreaseInPayableToSponsor" scale="0" unitRef="usd">37,988</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c14" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:IncreaseDecreaseInPayableToSponsor" scale="0" sign="-" unitRef="usd">62,124</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c15" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:IncreaseDecreaseInPayableToSponsor" scale="0" sign="-" unitRef="usd">70,335</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.25in">Increase (Decrease) in Administrative, accounting and custodian fees payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c12" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" scale="0" sign="-" unitRef="usd">1,163</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c13" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" scale="0" sign="-" unitRef="usd">1,860</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c14" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" scale="0" unitRef="usd">22,421</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c15" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" scale="0" unitRef="usd">22,597</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.25in">Increase (Decrease) in Professional fees payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c12" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:IncreaseInProfessionalFeesPayable" scale="0" unitRef="usd">43,758</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c13" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:IncreaseInProfessionalFeesPayable" scale="0" unitRef="usd">42,621</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c14" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:IncreaseInProfessionalFeesPayable" scale="0" unitRef="usd">15,210</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c15" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:IncreaseInProfessionalFeesPayable" scale="0" unitRef="usd">15,174</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in">Increase (Decrease) in Licensing and registration fees payable</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c12" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:IncreaseInLicensingAndRegistrationFeesPayable" scale="0" unitRef="usd">14,166</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c13" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:IncreaseInLicensingAndRegistrationFeesPayable" scale="0" unitRef="usd">27,868</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c14" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:IncreaseInLicensingAndRegistrationFeesPayable" scale="0" unitRef="usd">35,642</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c15" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:IncreaseInLicensingAndRegistrationFeesPayable" scale="0" unitRef="usd">37,431</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 0.375in">Net cash provided by (used in) operating activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c12" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="0" unitRef="usd">26,360,211</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c13" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="0" sign="-" unitRef="usd">160,075,496</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c14" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="0" sign="-" unitRef="usd">51,576,659</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c15" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="0" sign="-" unitRef="usd">50,623,331</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">CASH FLOW FROM FINANCING ACTIVITIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.25in">Proceeds from shares sold, net of cost from shares purchased</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c12" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:ProceedsFromSaleOfUnits" scale="0" unitRef="usd">114,890,805</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c13" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:ProceedsFromSaleOfUnits" scale="0" unitRef="usd">278,976,878</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c14" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:ProceedsFromSaleOfUnits" scale="0" unitRef="usd">131,987,206</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c15" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:ProceedsFromSaleOfUnits" scale="0" unitRef="usd">102,394,101</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-bottom: 1.5pt; padding-left: 0.25in">Cost of shares redeemed</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c12" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="0" unitRef="usd">141,755,616</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c13" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="0" unitRef="usd">118,901,382</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c14" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="0" unitRef="usd">76,871,017</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c15" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="0" unitRef="usd">51,662,990</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 0.375in">Net cash provided by (used in) financing activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c12" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="0" sign="-" unitRef="usd">26,864,811</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c13" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="0" unitRef="usd">160,075,496</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c14" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="0" unitRef="usd">55,116,189</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c15" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="0" unitRef="usd">50,731,111</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">NET INCREASE (DECREASE) IN CASH</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c12" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" scale="0" unitRef="usd">504,600</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-55">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c14" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" scale="0" sign="-" unitRef="usd">3,539,530</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c15" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" scale="0" sign="-" unitRef="usd">107,781</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt">Beginning of Period</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" unitRef="usd">504,600</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-56">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-57">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-58">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 4pt">End of Period</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-59">-</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-60">-</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c20" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" unitRef="usd">3,539,530</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c21" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" unitRef="usd">107,781</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 9; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="fin_001"></a></div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>-1x Short VIX Futures ETF</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>Schedule of Investments</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>June 30, 2023 (Unaudited)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">TOTAL INVESTMENTS (Cost $0) 0.0%</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-61">&#8211;</div></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="width: 88%; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Other Assets in Excess of Liabilities - <ix:nonFraction contextRef="c25" decimals="2" format="ixt:num-dot-decimal" name="cik0001793497:OtherAssetsInExcessOfLiabilitiesPercentage" scale="-2" unitRef="pure">100</ix:nonFraction>.0% (a)</td><td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c24" decimals="0" format="ixt:num-dot-decimal" id="ix_6_fact" name="us-gaap:OtherAssets" scale="0" unitRef="usd">72,302,413</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">TOTAL NET ASSETS - <ix:nonFraction contextRef="c24" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DerivativeNetAssetsPercentage" scale="-2" unitRef="pure">100</ix:nonFraction>.0%</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c24" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsNet" scale="0" unitRef="usd">72,302,413</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">Percentages are stated as a percent of net assets.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.4pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(a)</td><td style="text-align: justify"><ix:footnote id="ix_2_footnote" xml:lang="en-US">$68,703,813 of cash is pledged as collateral for futures
contracts.</ix:footnote></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.4pt; text-align: center"><b>-1x Short VIX Futures ETF</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.4pt; text-align: center"><b>Short Futures Contracts</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.4pt; text-align: center"><b>June 30, 2023 (Unaudited)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.4pt; text-align: center">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold">Contracts</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Unrealized Appreciation/ (Depreciation)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c26" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:NumberOfContracts" scale="0" sign="-" unitRef="usd">2,590</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 76%; text-align: left">CBOE VIX Futures</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c27" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InvestmentOwnedUnrecognizedUnrealizedAppreciation" scale="0" unitRef="usd">5,483,830</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="padding-left: 0.125in; text-align: left">Expiring July 2023 (Underlying Face Amount at Market Value $38,772,300)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c28" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:NumberOfContracts" scale="0" sign="-" unitRef="usd">1,883</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">CBOE VIX Futures</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c29" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InvestmentOwnedUnrecognizedUnrealizedAppreciation" scale="0" unitRef="usd">1,034,749</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="padding-left: 0.125in; text-align: left">Expiring August 2023 (Underlying Face Amount at Market Value $30,805,880)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt; text-align: right">&#160;</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c25" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:UnderlyingFaceAmountAtMarketValues" scale="0" unitRef="usd">6,518,579</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">See accompanying notes to financial statements</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 10; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>-1x Short VIX Futures ETF</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Schedule of Investments</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>December 31, 2022</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; font-weight: bold">Cash - <ix:nonFraction contextRef="c31" decimals="1" format="ixt:num-dot-decimal" name="cik0001793497:Cash1" scale="0" unitRef="usd">1.1</ix:nonFraction>% (a)</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c30" decimals="0" format="ixt:num-dot-decimal" id="ix_7_fact" name="us-gaap:CashEquivalentsAtCarryingValue" scale="0" unitRef="usd">504,600</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left">Other assets in excess of liabilities - <ix:nonFraction contextRef="c32" decimals="3" format="ixt:num-dot-decimal" name="cik0001793497:OtherAssetsInExcessOfLiabilitiesPercentage" scale="-2" unitRef="pure">98.9</ix:nonFraction>% (a)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c30" decimals="0" format="ixt:num-dot-decimal" id="ix_8_fact" name="us-gaap:OtherAssets" scale="0" unitRef="usd">45,874,003</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">TOTAL NET ASSETS - <ix:nonFraction contextRef="c31" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DerivativeNetAssetsPercentage" scale="-2" unitRef="pure">100</ix:nonFraction>%</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c30" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsNet" scale="0" unitRef="usd">46,378,603</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><div>



</div><p style="font-size: 10pt; margin: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="text-align: justify"><ix:footnote id="ix_3_footnote" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$48,144,554
of cash os pledged as collateral for futures contracts</span></ix:footnote></td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>-1x Short VIX Futures ETF</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Short Futures Contracts</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>December 31, 2022</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.4pt; text-align: center">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td colspan="2" style="font-weight: bold; border-bottom: Black 1.5pt solid">Contracts</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Unrealized Appreciation/<br/> (Depreciation)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c33" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:NumberOfContracts" scale="0" sign="-" unitRef="usd">1,150</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 76%; text-align: left">CBOE VIX Futures</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c34" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InvestmentOwnedUnrecognizedUnrealizedAppreciation" scale="0" unitRef="usd">1,058,570</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="padding-left: 0.125in; text-align: left">Expiring January 2023 (Underlying Face Amount at Market Value $26,634,000)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">(<ix:nonFraction contextRef="c35" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:NumberOfContracts" scale="0" sign="-" unitRef="usd">804</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">CBOE VIX Futures</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c36" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InvestmentOwnedUnrecognizedUnrealizedAppreciation" scale="0" unitRef="usd">97,536</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt; text-align: right">&#160;</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="padding-left: 0.125in; text-align: left">Expiring February 2023 (Underlying Face Amount at Market Value $19,754,280)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c33" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:UnderlyingFaceAmountAtMarketValues" scale="0" unitRef="usd">1,156,106</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.4pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.4pt; text-align: center">See accompanying notes to financial statements</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 11; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><div><a id="fin_002"></a></div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>2x Long VIX Futures ETF</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>Schedule of Investments</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>June 30, 2023 (Unaudited)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>&#160;</b></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt/normal Times New Roman, Times, Serif; border-collapse: collapse; font-size-adjust: none; font-stretch: normal; width: 100%">
  <tr style="vertical-align: bottom">
    <td colspan="5" style="font-weight: bold">SHORT TERM INVESTMENT - 11.2%</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="5" style="font-weight: bold">Money Market Fund - 11.2%</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 8%; padding-bottom: 1.5pt; text-align: right">9,517,548</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 78%; text-align: left; padding-bottom: 1.5pt">First American Government Obligations Fund, <ix:nonFraction contextRef="c37" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:InvestmentInterestRate" scale="-2" unitRef="pure">5.00</ix:nonFraction>% (a)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 8%; text-align: right"><ix:nonFraction contextRef="c37" decimals="0" format="ixt:num-dot-decimal" id="ix_9_fact" name="us-gaap:MoneyMarketFundsAtCarryingValue" scale="0" unitRef="usd">9,517,548</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt; text-align: right">&#160;</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="text-align: left; padding-bottom: 4pt">TOTAL SHORT TERM INVESTMENT (Cost $<ix:nonFraction contextRef="c13" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:CashPledgedAsCollateral" scale="0" unitRef="usd">9,517,548</ix:nonFraction>)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherShortTermInvestments" scale="0" unitRef="usd">9,517,548</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">TOTAL INVESTMENTS (Cost $9,517,548) <ix:nonFraction contextRef="c5" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentInterestRate" scale="-2" unitRef="pure">11.2</ix:nonFraction>%</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherInvestments" scale="0" unitRef="usd">9,517,548</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Other Assets in Excess of Liabilities - <ix:nonFraction contextRef="c13" decimals="3" format="ixt:num-dot-decimal" name="cik0001793497:OtherAssetsInExcessOfLiabilitiesPercentage" scale="-2" unitRef="pure">88.8</ix:nonFraction>% (b)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" id="ix_11_fact" name="us-gaap:OtherAssets" scale="0" unitRef="usd">75,821,254</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt; text-align: right">&#160;</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">TOTAL NET ASSETS - <ix:nonFraction contextRef="c5" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:DerivativeNetAssetsPercentage" scale="-2" unitRef="pure">100.0</ix:nonFraction>%</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsNet" scale="0" unitRef="usd">85,338,802</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">Percentages are stated as a percent of net assets.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.4pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(a)</td><td style="text-align: justify"><ix:footnote id="ix_4_footnote" xml:lang="en-US">Represents annualized seven-day yield at June 30, 2023 (Unaudited)</ix:footnote></td>
</tr><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left">&#160;</td><td style="text-align: justify">&#160;</td></tr> </table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(b)</td><td style="text-align: justify"><ix:footnote id="ix_6_footnote" xml:lang="en-US">$83,302,779 of cash is pledged as collateral for futures
contracts.</ix:footnote></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>2x Long VIX Futures ETF</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>Long Futures Contracts</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>June 30, 2023 (Unaudited)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.4pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt/normal Times New Roman, Times, Serif; border-collapse: collapse; font-size-adjust: none; font-stretch: normal; width: 100%">
  <tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Contracts</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Unrealized Appreciation/ (Depreciation)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%; text-align: right"><ix:nonFraction contextRef="c38" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:NumberOfContracts" scale="0" unitRef="usd">6,356</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 78%; text-align: left">CBOE VIX Futures</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">(<ix:nonFraction contextRef="c39" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InvestmentOwnedUnrecognizedUnrealizedAppreciation" scale="0" sign="-" unitRef="usd">16,558,756</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="padding-left: 0.125in; text-align: left">Expiring July 2023 (Underlying Face Amount at Market Value $95,149,320)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c40" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:NumberOfContracts" scale="0" unitRef="usd">4,623</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">CBOE VIX Futures</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c41" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InvestmentOwnedUnrecognizedUnrealizedAppreciation" scale="0" sign="-" unitRef="usd">3,232,280</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="padding-left: 0.125in; text-align: left">Expiring August 2023 (Underlying Face Amount at Market Value $75,632,280)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt; text-align: right">&#160;</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c13" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:UnderlyingFaceAmountAtMarketValues" scale="0" sign="-" unitRef="usd">19,791,036</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">)</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">See accompanying notes to financial statements</p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 12; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2x Long VIX Futures ETF</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Schedule of Investments</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2022</b></span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt/normal Times New Roman, Times, Serif; border-collapse: collapse; font-size-adjust: none; font-stretch: normal; width: 100%">
  <tr style="vertical-align: bottom">
    <td colspan="5" style="font-weight: bold">SHORT TERM INVESTMENT - 6.57%</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="5" style="font-weight: bold">Money Market Fund - 6.57%</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 8%; padding-bottom: 1.5pt; text-align: right">8,250,285</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 78%; text-align: left; padding-bottom: 1.5pt">First American Government Obligations Fund, <ix:nonFraction contextRef="c42" decimals="5" format="ixt:num-dot-decimal" name="us-gaap:InvestmentInterestRate" scale="-2" unitRef="pure">4.105</ix:nonFraction>% (a)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 8%; border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c42" decimals="0" format="ixt:num-dot-decimal" id="ix_10_fact" name="us-gaap:MoneyMarketFundsAtCarryingValue" scale="0" unitRef="usd">8,250,285</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt; text-align: right">&#160;</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="text-align: left; padding-bottom: 4pt">TOTAL SHORT TERM INVESTMENT (Cost $<ix:nonFraction contextRef="c43" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:CashPledgedAsCollateral" scale="0" unitRef="usd">8,250,285</ix:nonFraction>)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherShortTermInvestments" scale="0" unitRef="usd">8,250,285</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">TOTAL INVESTMENTS(Cost $8,250,285) - <ix:nonFraction contextRef="c7" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:InvestmentInterestRate" scale="-2" unitRef="pure">6.57</ix:nonFraction>%</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherInvestments" scale="0" unitRef="usd">8,250,285</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Other Assets in Excess of Liabilities - <ix:nonFraction contextRef="c43" decimals="4" format="ixt:num-dot-decimal" name="cik0001793497:OtherAssetsInExcessOfLiabilitiesPercentage" scale="-2" unitRef="pure">93.43</ix:nonFraction>% (b)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" id="ix_12_fact" name="us-gaap:OtherAssets" scale="0" unitRef="usd">117,238,481</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt; text-align: right">&#160;</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">TOTAL NET ASSETS - <ix:nonFraction contextRef="c7" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:DerivativeNetAssetsPercentage" scale="-2" unitRef="pure">100.0</ix:nonFraction>%</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsNet" scale="0" unitRef="usd">125,488,766</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">Percentages are stated as a percent of net assets.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.4pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left">(a)</td><td style="text-align: justify"><ix:footnote id="ix_5_footnote" xml:lang="en-US">Represents annualized seven-day yield at December 31, 2022</ix:footnote></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.4pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left">(b)</td><td style="text-align: justify"><ix:footnote id="ix_7_footnote" xml:lang="en-US">$114,821,272 of cash is pledged as collateral for futures contracts.</ix:footnote></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>2x Long VIX Futures ETF</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Long Futures Contracts</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>December 31, 2022</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.4pt; text-align: center">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt/normal Times New Roman, Times, Serif; border-collapse: collapse; font-size-adjust: none; font-stretch: normal; width: 100%">
  <tr style="vertical-align: bottom">
    <td colspan="2" style="font-weight: bold; border-bottom: Black 1.5pt solid">Contracts</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Unrealized Appreciation/<br/> (Depreciation)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%; text-align: right"><ix:nonFraction contextRef="c44" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:NumberOfContracts" scale="0" unitRef="usd">6,221</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 78%; text-align: left">CBOE VIX Futures</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">(<ix:nonFraction contextRef="c45" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InvestmentOwnedUnrecognizedUnrealizedAppreciation" scale="0" sign="-" unitRef="usd">8,416,975</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="padding-left: 0.125in; text-align: left">Expiring January 2023 (Underlying Face Amount at Market Value $144,078,360)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right"><ix:nonFraction contextRef="c46" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:NumberOfContracts" scale="0" unitRef="usd">4,355</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left; padding-bottom: 1.5pt">CBOE VIX Futures</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c47" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InvestmentOwnedUnrecognizedUnrealizedAppreciation" scale="0" sign="-" unitRef="usd">786,547</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt; text-align: right">&#160;</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 4pt">Expiring February 2023 (Underlying Face Amount at Market Value $107,002,350)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c44" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:UnderlyingFaceAmountAtMarketValues" scale="0" sign="-" unitRef="usd">9,203,522</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">)</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.4pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">See accompanying notes to
financial statements</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 13; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="fin_003"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 104.65pt 0pt 104.6pt; text-align: center"><b>VS Trust</b></p><div>

</div><div><a id="fin_004"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 104.7pt 0pt 102.95pt; text-align: center">NOTES TO FINANCIAL STATEMENTS</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 104.7pt 0pt 102.9pt; text-align: center"><b>June 30, 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 104.7pt 0pt 102.6pt; text-align: center"><b>(Unaudited)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"><p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">NOTE 1 &#8211; ORGANIZATION</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">VS Trust (the &#8220;Trust&#8221;)
is a Delaware statutory trust formed on October 24, 2019 and is currently organized into separate series (each, a &#8220;Fund&#8221; and
collectively, the &#8220;Funds&#8221;). As of June 30, 2023, the following two series of the Trust have commenced investment operations:
-1x Short VIX Futures ETF (&#8220;SVIX&#8221;) and 2x Long VIX Futures ETF (&#8220;UVIX&#8221;). Each of the Funds listed above issues
common units of beneficial interest (&#8220;Shares&#8221;), which represent units of fractional undivided beneficial interest in and ownership
of only that Fund. The Shares of each Fund are listed on the Cboe BZX Exchange (&#8220;Cboe BZX&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">The Funds&#8217; inception of operation
was March 28, 2022. Neither the Trust nor the Funds had any operations prior to March 28, 2022, other than matters relating to its organization
and the registration of each series under the Securities Act of 1933.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Each Fund&#8217;s investment exposure
to VIX futures contracts will cause each to be deemed a commodity pool, thereby subjecting each Fund to regulation under the Commodity
Exchange Act of 1934 (&#8220;CEA&#8221;) and Commodity Futures Trading Commission (&#8220;CFTC&#8221;) rules. The Sponsor is registered
as a Commodity Pool Operator (&#8220;CPO&#8221;) and the Fund will be operated in accordance with applicable CFTC rules. Registration
as a CPO imposes additional compliance obligations on the Sponsor and the Funds related to additional laws, regulations and enforcement
policies, which could increase compliance costs and may affect the operations and financial performance of the Funds.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Volatility Shares LLC (the &#8220;Sponsor&#8221;)
is the sponsor of the Trust and the Funds. The Sponsor also will serve as the Trust&#8217;s commodity pool operator. The Funds are commodity
pools, as defined under the Commodity Exchange Act (the &#8220;CEA&#8221;), and the applicable regulations of the CFTC and are operated
by the Sponsor, which is registered as a commodity pool operator with the CFTC. The Trust is not an investment company registered under
the Investment Company Act of 1940.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_1" escape="true" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 7.7pt">NOTE 2 &#8211; SIGNIFICANT ACCOUNTING POLICIES</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Each Fund is an investment company,
as defined by Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards Codification (&#8220;ASC&#8221;) Topic 946
&#8220;Financial Services &#8212; Investment Companies.&#8221; As such, the Funds follow the investment company accounting and reporting
guidance. The following is a summary of significant accounting policies followed by each Fund, as applicable, in preparation of its financial
statements. These policies are in conformity with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">The accompanying unaudited financial
statements were prepared in accordance with GAAP for interim financial information and with the instructions for Form 10-Q and the rules
and regulations of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;). In the opinion of management, all material adjustments,
consisting only of normal recurring adjustments, considered necessary for a fair statement of the interim period financial statements
have been made. Interim period results are not necessarily indicative of results for a full-year period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="cik0001793497_EmergingGrowthCompanyPolicyTextBlock-c0_cont_1" escape="true" name="cik0001793497:EmergingGrowthCompanyPolicyTextBlock"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 7.7pt">Emerging growth company</p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<ix:continuation continuedAt="cik0001793497_EmergingGrowthCompanyPolicyTextBlock-c0_cont_2" id="cik0001793497_EmergingGrowthCompanyPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">The Trust is an &#8220;emerging
growth company,&#8221; as defined in the Jumpstart Our Business Startups Act of 2012. It will remain an emerging growth company until
the earlier of (1) the beginning of the first fiscal year following the fifth anniversary of its initial public offering, (2) the beginning
of the first fiscal year after annual gross revenue is $<ix:nonFraction contextRef="c0" decimals="-7" format="ixt:num-dot-decimal" name="cik0001793497:GrossRevenue" scale="9" unitRef="usd">1.07</ix:nonFraction> billion (subject to adjustment for inflation) or more, (3) the date on which
the Fund has, during the previous three-year period, issued more than $<ix:nonFraction contextRef="c0" decimals="-8" format="ixt:num-dot-decimal" name="cik0001793497:NonconvertibleDebtSecurities" scale="9" unitRef="usd">1.0</ix:nonFraction> billion in non-convertible debt securities and (4) as of the
end of any fiscal year in which the market value of common equity held by non-affiliates exceeded $<ix:nonFraction contextRef="c0" decimals="-6" format="ixt:num-dot-decimal" name="cik0001793497:NonaffiliatesExceeded" scale="6" unitRef="usd">700</ix:nonFraction> million as of the end of the second
quarter of that fiscal year.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:continuation id="cik0001793497_EmergingGrowthCompanyPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">For as
long as the Trust remains an &#8220;emerging growth company,&#8221; it may take advantage of certain exemptions from the various reporting
requirements that are applicable to public companies that are not &#8220;emerging growth companies&#8221; including, but not limited
to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure
obligations regarding executive compensation and financial statements in our periodic reports and proxy statements, and exemptions from
the requirements of holding a nonbinding advisory vote to approve executive compensation and shareholder approval of any golden parachute
payments not previously approved. The Trust will take advantage of these reporting exemptions until it is no longer an &#8220;emerging
growth company.&#8221;</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></ix:continuation></ix:nonNumeric><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 14; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><ix:continuation continuedAt="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_2" id="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_1"><ix:nonNumeric contextRef="c0" continuedAt="_UseOfEstimates-c0_cont_1" escape="true" name="us-gaap:UseOfEstimates"><p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Use of Estimates &amp; Indemnifications</p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<ix:continuation continuedAt="_UseOfEstimates-c0_cont_2" id="_UseOfEstimates-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">The preparation of financial statements
in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities
and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and
expenses during the reporting period. Actual results could differ from those estimates.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:continuation id="_UseOfEstimates-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">In
the normal course of business, the Trust enters into contracts that contain a variety of representations which provide general
indemnifications. The Trust&#8217;s maximum exposure under these arrangements cannot be known; however, the Trust expects any risk
of loss to be remote.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_BasisOfAccountingPolicyPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock"><p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Basis of Presentation</p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<ix:continuation id="_BasisOfAccountingPolicyPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Pursuant to rules and regulations
of the SEC, these financial statements are presented for the Trust as a whole, as the SEC registrant, and for each Fund individually.
The debts, liabilities, obligations and expenses incurred, contracted for or otherwise existing with respect to a particular Fund shall
be enforceable only against the assets of such Fund and not against the assets of the Trust generally or any other Fund. Accordingly,
the assets of each Fund of the Trust include only those funds and other assets that are paid to, held by or distributed to the Trust for
the purchase of Shares in that Fund.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="cik0001793497_StatementsOfCashFlowsPolicyTextBlock-c0_cont_1" escape="true" name="cik0001793497:StatementsOfCashFlowsPolicyTextBlock"><p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Statements of Cash Flows</p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<ix:continuation id="cik0001793497_StatementsOfCashFlowsPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">The
cash amount shown in the Statements of Cash Flows is the amount reported as cash in the Statements of Financial Condition dated June
30, 2023 and December 31, 2022, and represents cash, but does not include short-term investments.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="cik0001793497_FinalNetAssetValueForFiscalPeriodPolcyTextBlock-c0_cont_1" escape="true" name="cik0001793497:FinalNetAssetValueForFiscalPeriodPolcyTextBlock"><p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Final Net Asset Value for Fiscal Period</p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<ix:continuation continuedAt="cik0001793497_FinalNetAssetValueForFiscalPeriodPolcyTextBlock-c0_cont_2" id="cik0001793497_FinalNetAssetValueForFiscalPeriodPolcyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><ix:nonNumeric contextRef="c0" continuedAt="cik0001793497_ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock-c0_cont_1" escape="true" name="cik0001793497:ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock">The cut-off times and the times
of the calculation of the Funds&#8217; final net asset value for creation and redemption of fund Shares for the three months ended June
30, 2023 were typically as follows. All times are Eastern Standard Time:</ix:nonNumeric></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:continuation continuedAt="cik0001793497_ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock-c0_cont_2" id="cik0001793497_ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock-c0_cont_1"><ix:continuation continuedAt="cik0001793497_FinalNetAssetValueForFiscalPeriodPolcyTextBlock-c0_cont_3" id="cik0001793497_FinalNetAssetValueForFiscalPeriodPolcyTextBlock-c0_cont_2"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">NAV</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">NAV</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">Create/Redeem</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">Calculation</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">Calculation</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; width: 64%; font-weight: bold; text-align: left">Fund</td><td style="padding-bottom: 1.5pt; width: 1%; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 11%; font-weight: bold; text-align: center">Cut-off*(EST)</td><td style="padding-bottom: 1.5pt; width: 1%; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 11%; font-weight: bold; text-align: center">Time (EST)</td><td style="padding-bottom: 1.5pt; width: 1%; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 11%; font-weight: bold; text-align: center">Date</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">-1x Short VIX Futures ETF and</td><td>&#160;</td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c12" name="cik0001793497:CreateRedeemCutoffDescription">2:00 p.m.</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c12" name="cik0001793497:NAVCalculationTimeESTDescription">4:00 p.m.</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c12" format="ixt:date-monthname-day-year-en" name="cik0001793497:NAVCalculationDate">June 30, 2023</ix:nonNumeric></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">2x Long VIX Futures ETF</td><td>&#160;</td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c13" name="cik0001793497:CreateRedeemCutoffDescription">2:00 p.m.</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c13" name="cik0001793497:NAVCalculationTimeESTDescription">4:00 p.m.</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c13" format="ixt:date-monthname-day-year-en" name="cik0001793497:NAVCalculationDate">June 30, 2023</ix:nonNumeric></td></tr>
  </table></ix:continuation></ix:continuation>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:continuation id="cik0001793497_ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock-c0_cont_2"><ix:continuation continuedAt="cik0001793497_FinalNetAssetValueForFiscalPeriodPolcyTextBlock-c0_cont_4" id="cik0001793497_FinalNetAssetValueForFiscalPeriodPolcyTextBlock-c0_cont_3"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 7.7pt"></td><td style="width: 14.95pt">*</td><td style="padding-right: 7.8pt">Although the Funds&#8217; shares may continue to trade on secondary markets subsequent to the calculation
of the final NAV, these times represent the final opportunity to transact in creation or redemption units for the three months ended June
30, 2023.</td></tr></table></ix:continuation></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<ix:continuation continuedAt="cik0001793497_FinalNetAssetValueForFiscalPeriodPolcyTextBlock-c0_cont_5" id="cik0001793497_FinalNetAssetValueForFiscalPeriodPolcyTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Market value per Share is determined at the close of Cboe
BZX and may be later than when the Funds&#8217; NAV per Share is calculated.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:continuation id="cik0001793497_FinalNetAssetValueForFiscalPeriodPolcyTextBlock-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">For financial reporting purposes,
the Funds value transactions based upon the final closing price in their primary markets. Accordingly, the investment valuations in these
financial statements may differ from those used in the calculation of certain of the Funds&#8217; final creation/redemption NAV for the
three months ended June 30, 2023.</p><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 15; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><ix:continuation continuedAt="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_3" id="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_2"><ix:nonNumeric contextRef="c0" continuedAt="_InvestmentPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:InvestmentPolicyTextBlock"><p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Investment Valuation</p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<ix:continuation continuedAt="_InvestmentPolicyTextBlock-c0_cont_2" id="_InvestmentPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Short-term investments are valued
at amortized cost which approximates fair value for daily NAV purposes. For financial reporting purposes, short-term investments are valued
at their market price using information provided by a third-party pricing service or market quotations. In each of these situations, valuations
are typically categorized as Level I in the fair value hierarchy.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:continuation continuedAt="_InvestmentPolicyTextBlock-c0_cont_3" id="_InvestmentPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">VIX futures
contracts are valued using the Time Weighted Average Price (TWAP) of the futures during the last 15 minutes of NYSE&#8217;s regular trading
session, rather than solely from the VIX futures&#8217; settlement price. The value of a Fund&#8217;s non-exchange-traded Financial Instruments
typically is determined by applying the then-current disseminated levels for the Index to the terms of the Fund&#8217;s non-exchange-traded
Financial Instruments.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:continuation continuedAt="_InvestmentPolicyTextBlock-c0_cont_4" id="_InvestmentPolicyTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">In certain circumstances (e.g.,
if the Sponsor believes market quotations do not accurately reflect the fair value of a Fund&#8217;s investment, or a trading halt closes
an exchange or market early), the Sponsor may, in its sole discretion, choose to determine a fair value price as the basis for determining
the market value of such investment for such day. Such fair value prices would generally be determined based on available inputs about
the current value of the underlying VIX futures contract and would be based on principles that the Sponsor deems fair and equitable.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:continuation continuedAt="_InvestmentPolicyTextBlock-c0_cont_5" id="_InvestmentPolicyTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">The Funds may use a variety of
money market instruments. Money market instruments generally will be valued using market prices or at amortized cost.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:continuation id="_InvestmentPolicyTextBlock-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Fair value pricing may require
subjective determinations about the value of an investment. While the Funds&#8217; policies are intended to result in a calculation of
its respective Fund&#8217;s NAV that fairly reflects investment values as of the time of pricing, such Fund cannot ensure that fair values
determined by the Sponsor or persons acting at their direction would accurately reflect the price that a Fund could obtain for an investment
if it were to dispose of that investment as of the time of pricing (for instance, in a forced or distressed sale). The prices used by
such Fund may differ from the value that would be realized if the investments were sold and the differences could be material to the financial
statements.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_FairValueOfFinancialInstrumentsPolicy-c0_cont_1" escape="true" name="us-gaap:FairValueOfFinancialInstrumentsPolicy"><p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Fair Value of Financial Instruments</p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<ix:continuation continuedAt="_FairValueOfFinancialInstrumentsPolicy-c0_cont_2" id="_FairValueOfFinancialInstrumentsPolicy-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">The
Funds disclose the fair value of their investments in a hierarchy that prioritizes the inputs to valuation techniques used to
measure fair value. The disclosure requirements establish a fair value hierarchy that distinguishes between: (1) market participant
assumptions developed based on market data obtained from sources independent of the Funds (observable inputs); and (2) the
Funds&#8217; own assumptions about market participant assumptions developed based on the best information available under the
circumstances (unobservable inputs). The three levels defined by the disclosure requirements hierarchy are as follows:</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:continuation continuedAt="_FairValueOfFinancialInstrumentsPolicy-c0_cont_3" id="_FairValueOfFinancialInstrumentsPolicy-c0_cont_2"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.5in; text-align: left">Level I</td><td style="text-align: center; width: 0.25in">&#8211;</td>
                                                                                      <td style="text-align: left">Quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access
at the measurement date.</td>
</tr></table></ix:continuation>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:continuation continuedAt="_FairValueOfFinancialInstrumentsPolicy-c0_cont_4" id="_FairValueOfFinancialInstrumentsPolicy-c0_cont_3"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.5in"></td><td style="width: 0.5in; text-align: left">Level II</td><td style="text-align: center; width: 0.25in">&#8211;</td>
                                                                                       <td style="text-align: left">Inputs other than quoted prices included within Level I that are observable for the asset or liability, either directly or indirectly.
Level II assets include the following: quoted prices for similar assets or liabilities in active markets, quoted prices for identical
or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or
liability, and inputs that are derived principally from or corroborated by observable market data by correlation or other means (market-corroborated
inputs).</td>
</tr></table></ix:continuation>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:continuation continuedAt="_FairValueOfFinancialInstrumentsPolicy-c0_cont_5" id="_FairValueOfFinancialInstrumentsPolicy-c0_cont_4"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.5in"></td><td style="width: 0.5in; text-align: left">Level III</td><td style="text-align: center; width: 0.25in">&#8211;</td>
                                                                                        <td style="text-align: left">Unobservable pricing input at the measurement date for the asset or liability. Unobservable inputs shall be used to measure fair value
to the extent that observable inputs are not available.</td>
</tr></table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:continuation continuedAt="_FairValueOfFinancialInstrumentsPolicy-c0_cont_6" id="_FairValueOfFinancialInstrumentsPolicy-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">In some instances, the inputs used
to measure fair value might fall in different levels of the fair value hierarchy. The level in the fair value hierarchy within which the
fair value measurement in its entirety falls is determined based on the lowest input level that is significant to the fair value measurement
in its entirety.</p><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 16; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><ix:continuation id="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_3"><ix:continuation continuedAt="_FairValueOfFinancialInstrumentsPolicy-c0_cont_7" id="_FairValueOfFinancialInstrumentsPolicy-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Fair value measurements also require additional
disclosure when the volume and level of activity for the asset or liability have significantly decreased, as well as when circumstances
indicate that a transaction is not orderly.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<ix:continuation continuedAt="_FairValueOfFinancialInstrumentsPolicy-c0_cont_8" id="_FairValueOfFinancialInstrumentsPolicy-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock-c0_cont_1" escape="true" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">The following table summarizes the valuation of investments
at June 30, 2023 (unaudited) and December 31, 2022 using the fair value hierarchy:</ix:nonNumeric></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<ix:continuation continuedAt="_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock-c0_cont_2" id="_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock-c0_cont_1"><ix:continuation continuedAt="_FairValueOfFinancialInstrumentsPolicy-c0_cont_9" id="_FairValueOfFinancialInstrumentsPolicy-c0_cont_8"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"><b>June 30, 2023 (Unaudited)</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"><b>December 31, 2022</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Fund</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Level 1 - <br/>
Money <br/>
Market <br/>
Fund</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Level 2 - <br/>
Futures <br/>
Contracts*</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total <br/>
June 30, <br/>
2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Level 1 - <br/>
Money <br/>
Market <br/>
Fund</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Level 2 - <br/>
Futures <br/>
Contracts*</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total <br/>
December&#160;31, <br/>
2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; text-align: left">-1x Short VIX Futures ETF</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-62">&#8211;</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c51" decimals="0" format="ixt:num-dot-decimal" id="ix_13_fact" name="cik0001793497:AmountOfTotalTrust" scale="0" unitRef="usd">6,518,579</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:AmountOfTotalTrust" scale="0" unitRef="usd">6,518,579</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c52" decimals="0" format="ixt:num-dot-decimal" id="ix_14_fact" name="cik0001793497:AmountOfTotalTrust" scale="0" unitRef="usd">1,156,106</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:AmountOfTotalTrust" scale="0" unitRef="usd">1,156,106</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">2x Long VIX Futures ETF</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c53" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:AmountOfTotalTrust" scale="0" unitRef="usd">9,517,548</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c54" decimals="0" format="ixt:num-dot-decimal" id="ix_15_fact" name="cik0001793497:AmountOfTotalTrust" scale="0" sign="-" unitRef="usd">19,791,036</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:AmountOfTotalTrust" scale="0" sign="-" unitRef="usd">10,273,488</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c55" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:AmountOfTotalTrust" scale="0" unitRef="usd">8,250,285</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c56" decimals="0" format="ixt:num-dot-decimal" id="ix_16_fact" name="cik0001793497:AmountOfTotalTrust" scale="0" sign="-" unitRef="usd">9,203,522</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:AmountOfTotalTrust" scale="0" sign="-" unitRef="usd">953,237</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Total Trust</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c57" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:AmountOfTotalTrust" scale="0" unitRef="usd">9,517,548</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c58" decimals="0" format="ixt:num-dot-decimal" id="ix_17_fact" name="cik0001793497:AmountOfTotalTrust" scale="0" sign="-" unitRef="usd">13,272,457</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:AmountOfTotalTrust" scale="0" sign="-" unitRef="usd">3,754,909</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c59" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:AmountOfTotalTrust" scale="0" unitRef="usd">8,250,285</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c60" decimals="0" format="ixt:num-dot-decimal" id="ix_18_fact" name="cik0001793497:AmountOfTotalTrust" scale="0" sign="-" unitRef="usd">8,047,416</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c31" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:AmountOfTotalTrust" scale="0" unitRef="usd">202,869</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table></ix:continuation></ix:continuation>




<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<ix:continuation id="_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock-c0_cont_2"><ix:continuation continuedAt="_FairValueOfFinancialInstrumentsPolicy-c0_cont_10" id="_FairValueOfFinancialInstrumentsPolicy-c0_cont_9"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left">*</td><td style="text-align: left"><ix:footnote id="ix_8_footnote" xml:lang="en-US">Includes cumulative appreciation (depreciation) of futures
contracts as reported in the Schedule of Investments. Only current day&#8217;s variation margin is reported within the Statements of
Financial Condition in receivable/payable on open futures.</ix:footnote></td>
</tr></table></ix:continuation></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<ix:continuation id="_FairValueOfFinancialInstrumentsPolicy-c0_cont_10"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The inputs or methodology used for valuing investments
are not necessarily an indication of the risk associated with investing in those securities.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_UnremittedEarningsInForeignInvestmentPolicy-c0_cont_1" escape="true" name="us-gaap:UnremittedEarningsInForeignInvestmentPolicy"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Investment Transactions and Related Income</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<ix:continuation continuedAt="_UnremittedEarningsInForeignInvestmentPolicy-c0_cont_2" id="_UnremittedEarningsInForeignInvestmentPolicy-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Investment transactions are recorded on the trade
date. All such transactions are recorded on the identified cost basis and marked to market daily. Unrealized appreciation (depreciation)
on open contracts are reflected in the Statements of Financial Condition and changes in the unrealized appreciation (depreciation) between
periods are reflected in the Statements of Operations.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<ix:continuation id="_UnremittedEarningsInForeignInvestmentPolicy-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Interest income is recognized on an accrual basis
and includes, where applicable, the amortization of premium or discount, and is reflected as Interest Income in the Statement of Operations.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_FloorBrokeragePolicy-c0_cont_1" escape="true" name="us-gaap:FloorBrokeragePolicy"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Brokerage Commissions and Futures Account Fees</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<ix:continuation id="_FloorBrokeragePolicy-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Each Fund pays its respective brokerage commissions,
including applicable exchange fees, National Futures Association (&#8220;NFA&#8221;) fees, give-up fees, pit brokerage fees and other
transaction related fees and expenses charged in connection with trading activities for each Fund&#8217;s investment in U.S. Commodity
Futures Trading Commission (&#8220;CFTC&#8221;) regulated investments. The effects of trading spreads, financing costs/fees associated
with Financial Instruments, and costs relating to the purchase of U.S. Treasury securities or similar high credit quality short-term fixed-income
would also be borne by the Funds. Brokerage commissions on futures contracts are recognized on a half-turn basis (e.g., the first half
is recognized when the contract is purchased (opened) and the second half is recognized when the transaction is closed). The Sponsor is
currently paying brokerage commissions on VIX futures contracts for the Funds that exceed variable create/redeem fees collected by more
than&#160;<ix:nonFraction contextRef="c48" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:DerivativeNetAssetsPercentage" scale="-2" unitRef="pure">0.03</ix:nonFraction>% and <ix:nonFraction contextRef="c49" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:DerivativeNetAssetsPercentage" scale="-2" unitRef="pure">0.00</ix:nonFraction>%, for SVIX and UVIX, respectively, of each Fund's average net assets annually.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_IncomeTaxPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:IncomeTaxPolicyTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Federal Income Tax</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<ix:continuation continuedAt="_IncomeTaxPolicyTextBlock-c0_cont_2" id="_IncomeTaxPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Each Fund is registered as a series of a Delaware
statutory trust and is treated as a partnership for U.S. federal income tax purposes. Accordingly, no Fund expects to incur U.S. federal
income tax liability; rather, each beneficial owner of a Fund&#8217;s Shares is required to take into account its allocable share of its
Fund&#8217;s income, gain, loss, deductions and other items for its Fund&#8217;s taxable year ending with or within the beneficial owner&#8217;s
taxable year.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<ix:continuation id="_IncomeTaxPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Management of the Funds has reviewed all open tax
years and major jurisdictions (i.e., the last four tax year ends and the interim tax period since then, as applicable) and concluded that
there is no tax liability resulting from unrecognized tax benefits relating to uncertain income tax positions taken or expected to be
taken in future tax returns. The Funds are also not aware of any tax positions for which it is reasonably possible that the total amounts
of unrecognized tax benefits will significantly change in the next twelve months. On an ongoing basis, management monitors its tax positions
taken under the interpretation to determine if adjustments to conclusions are necessary based on factors including, but not limited to,
on-going analysis of tax law, regulation, and interpretations thereof.</p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 17; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_InvestmentTextBlock-c0_cont_1" escape="true" name="us-gaap:InvestmentTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 3 &#8211; INVESTMENTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Short-Term Investments</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Funds may purchase U.S. Treasury Bills, agency
securities, and other high-credit quality short-term fixed income or similar securities with original maturities of one year or less.
A portion of these investments may be posted as collateral in connection with swap agreements, futures, and/or forward contracts.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Accounting for Derivative Instruments</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In seeking to achieve each Fund&#8217;s investment
objective, the Sponsor uses a mathematical approach to investing. Using this approach, the Sponsor determines the type, quantity and mix
of investment positions, including derivative positions, which the Sponsor believes in combination, should produce returns consistent
with a Fund&#8217;s objective.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">All open derivative positions at period end are
reflected on each respective Fund&#8217;s Schedule of Investments. Certain Funds utilized a varying level of derivative instruments in
conjunction with investment securities in seeking to meet their investment objectives during the period. While the volume of open positions
may vary on a daily basis as each Fund transacts derivatives contracts in order to achieve the appropriate exposure to meet its investment
objective, the volume of these open positions relative to the net assets of each respective Fund at the date of this report is generally
representative of open positions throughout the reporting period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Following is a description of the derivative instruments
used by the Funds during the reporting period, including the primary underlying risk exposures related to each instrument type.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Futures Contracts</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Funds may enter into futures contracts to gain
exposure to changes in the value of, or as a substitute for investing directly in (or shorting), an underlying benchmark. A futures contract
obligates the seller to deliver (and the purchaser to accept) the future delivery of a specified quantity and type of asset at a specified
time and place. The contractual obligations of a buyer or seller may generally be satisfied by taking or making physical delivery of the
underlying commodity, if applicable, or by making an offsetting sale or purchase of an identical futures contract on the same or linked
exchange before the designated date of delivery, or by cash settlement at expiration of contract.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Upon entering into a futures contract, each Fund
is required to deposit and maintain as collateral at least such initial margin as required by the exchange on which the transaction is
affected. The initial margin is segregated as cash and/or securities balances with brokers for futures contracts, as disclosed in the
Statements of Financial Condition, and is restricted as to its use. The Funds that enter into futures contracts maintain collateral at
the broker in the form of cash and/or securities. Pursuant to the futures contract, each Fund generally agrees to receive from or pay
to the broker(s) an amount of cash equal to the daily fluctuation in value of the futures contract. Such receipts or payments are known
as variation margin and are recorded by each Fund as unrealized gains or losses. Each Fund will realize a gain or loss upon closing of
a futures transaction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Futures contracts involve, to varying degrees,
elements of market risk (specifically exchange rate sensitivity, commodity price risk or equity market volatility risk) and exposure to
loss in excess of the amount of variation margin. The face or contract amounts reflect the extent of the total exposure each Fund has
in the particular classes of instruments. Additional risks associated with the use of futures contracts are imperfect correlation between
movements in the price of the futures contracts and the market value of the underlying Index or commodity and the possibility of an illiquid
market for a futures contract. With futures contracts, there is minimal but some counterparty risk to the Funds since futures contracts
are exchange-traded and the credit risk resides with the Funds&#8217; clearing broker or clearinghouse itself. Many futures exchanges
and boards of trade limit the amount of fluctuation permitted in futures contract prices during a single trading day. Once the daily limit
has been reached in a particular contract, no trades may be made that day at a price beyond that limit or trading may be suspended for
specified times during the trading day. Futures contracts prices could move to the limit for several consecutive trading days with little
or no trading, thereby preventing prompt liquidation of futures positions and potentially subjecting a Fund to substantial losses. If
trading is not possible, or if a Fund determines not to close a futures position in anticipation of adverse price movements, the Fund
will be required to make daily cash payments of variation margin. The risk the Fund will be unable to close out a futures position will
be minimized by entering into such transactions on a national exchange with an active and liquid secondary market.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p></ix:nonNumeric><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 18; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><ix:continuation continuedAt="_InvestmentTextBlock-c0_cont_2" id="_InvestmentTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Option Contracts</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">An option is a contract that gives the buyer the
right, but not the obligation, to buy or sell a specified quantity of a commodity or other instrument at a specific (or strike) price
within a specified period of time, regardless of the market price of that instrument. There are two types of options: calls and puts.
A call option conveys to the option buyer the right to purchase a particular futures contract at a stated price at any time during the
life of the option. A put option conveys to the option buyer the right to sell a particular futures contract at a stated price at any
time during the life of the option. Options written by a Fund may be wholly or partially covered (meaning that the Fund holds an offsetting
position) or uncovered. In the case of the purchase of an option, the risk of loss of an investor&#8217;s entire investment (i.e., the
premium paid plus transaction charges) reflects the nature of an option as a wasting asset that may become worthless when the option expires.
Where an option is written or granted (i.e., sold) uncovered, the seller may be liable to pay substantial additional margin, and the risk
of loss is unlimited, as the seller will be obligated to deliver, or take delivery of, an asset at a predetermined price which may, upon
exercise of the option, be significantly different from the market value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">When a Fund writes a call or put, an amount equal
to the premium received is recorded and subsequently marked to market to reflect the current value of the option written. Premiums received
from writing options which expire are treated as realized gains. Premiums received from writing options which are exercised or closed
are added to the proceeds or offset against amounts paid on the underlying futures, swap or security transaction to determine the realized
gain (loss).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">When a Fund purchases an option, the Fund pays
a premium which is included as an asset on the Statement of Financial Condition and subsequently marked to market to reflect the current
value of the option. Premiums paid for purchasing options which expire are treated as realized losses. The risk associated with purchasing
put and call options is limited to the premium paid. Premiums paid for purchasing options which are exercised or closed are added to the
amounts paid or offset against the proceeds on the underlying investment transaction to determine the realized gain (loss) when the underlying
transaction is executed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Certain options transactions may subject the writer
(seller) to unlimited risk of loss in the event of an increase in the price of the contract to be purchased or delivered. The value of
a Fund&#8217;s options transactions, if any, will be affected by, among other things, changes in the value of a Fund&#8217;s underlying
benchmark relative to the strike price, changes in interest rates, changes in the actual and implied volatility of the Fund&#8217;s underlying
benchmark, and the remaining time until the options expire, or any combination thereof. The value of the options should not be expected
to increase or decrease at the same rate as the level of the Fund&#8217;s underlying benchmark, which may contribute to tracking error.
Options may be less liquid than certain other securities. A Fund&#8217;s ability to trade options will be dependent on the willingness
of counterparties to trade such options with the Fund. In a less liquid market for options, a Fund may have difficulty closing out certain
option positions at desired times and prices. A Fund may experience substantial downside from specific option positions and certain option
positions may expire worthless. Over-the-counter options generally are not assignable except by agreement between the parties concerned,
and no party or purchaser has any obligation to permit such assignments. The over-the-counter market for options is relatively illiquid,
particularly for relatively small transactions. The use of options transactions exposes a Fund to liquidity risk and counterparty credit
risk, and in certain circumstances may expose the Fund to unlimited risk of loss. The Funds may buy and sell options on futures contracts,
which may present even greater volatility and risk of loss.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Swap Agreements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Funds may enter into swap agreements for purposes
of pursuing their investment objectives or as a substitute for investing directly in (or shorting) an underlying Index or to create an
economic hedge against a position. Swap agreements are two-party contracts that have traditionally been entered into primarily with institutional
investors in over-the-counter (&#8220;OTC&#8221;) markets for a specified period, ranging from a day to more than one year. However, the
Dodd-Frank Wall Street Reform and Consumer Protection Act (the &#8220;Dodd-Frank Act&#8221;) provides for significant reforms of the OTC
derivative markets, including a requirement to execute certain swap transactions on a CFTC-regulated market and/or to clear such transactions
through a CFTC-regulated central clearing organization. In a standard swap transaction, two parties agree to exchange the returns earned
or realized on a particular predetermined investment, instrument or Index in exchange for a fixed or floating rate of return in respect
of a predetermined notional amount. Transaction or commission costs are reflected in the benchmark level at which the transaction is entered
into. The gross returns to be exchanged are calculated with respect to a notional amount and the benchmark returns to which the swap is
linked. Swap agreements do not involve the delivery of underlying instruments.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 19; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><ix:continuation continuedAt="_InvestmentTextBlock-c0_cont_3" id="_InvestmentTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Generally, swap agreements entered into by the
Funds calculate and settle the obligations of the parties to the agreement on a &#8220;net basis&#8221; with a single payment. Consequently,
each Fund&#8217;s current obligations (or rights) under a swap agreement will generally be equal only to the net amount to be paid or
received under the agreement based on the relative values of such obligations (or rights) (the &#8220;net amount&#8221;). In a typical
swap agreement entered into by UVIX, the would be entitled to settlement payments in the event the level of the benchmark increases and
would be required to make payments to the swap counterparties in the event the level of the benchmark decreases, adjusted for any transaction
costs or trading spreads on the notional amount the Funds may pay. In a typical swap agreement entered into by SVIX, the Fund would be
required to make payments to the swap counterparties in the event the level of the benchmark increases and would be entitled to settlement
payments in the event the level of the benchmark decreases, adjusted for any transaction costs or trading spreads on the notional amount
the Funds may pay.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The net amount of the excess, if any, of each Fund&#8217;s
obligations over its entitlements with respect to each OTC swap agreement is accrued on a daily basis and an amount of cash and/or securities
having an aggregate value at least equal to such accrued excess is maintained for the benefit of the counterparty in a segregated account
by the Funds&#8217; Custodian. The net amount of the excess, if any, of each Fund&#8217;s entitlements over its obligations with respect
to each OTC swap agreement is accrued on a daily basis and an amount of cash and/or securities having an aggregate value at least equal
to such accrued excess is maintained for the benefit of the Fund in a segregated account by a third party custodian. Until a swap agreement
is settled in cash, the gain or loss on the notional amount less any transaction costs or trading spreads payable by each Fund on the
notional amount are recorded as &#8220;unrealized appreciation or depreciation on swap agreements&#8221; and, when cash is exchanged,
the gain or loss realized is recorded as &#8220;realized gains or losses on swap agreements.&#8221; Swap agreements are generally valued
at the last settled price of the benchmark referenced asset.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Swap agreements contain various conditions, events
of default, termination events, covenants and representations. The triggering of certain events or the default on certain terms of the
agreement could allow a party to terminate a transaction under the agreement and request immediate payment in an amount equal to the net
positions owed to the party under the agreement. This could cause a Fund to have to enter into a new transaction with the same counterparty,
enter into a transaction with a different counterparty or seek to achieve its investment objective through any number of different investments
or investment techniques.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Swap agreements involve, to varying degrees, elements
of market risk and exposure to loss in excess of the unrealized gain/loss reflected. The notional amounts reflect the extent of the total
investment exposure each Fund has under the swap agreement, which may exceed the NAV of each Fund. Additional risks associated with the
use of swap agreements are imperfect correlations between movements in the notional amount and the price of the underlying reference Index
and the inability of counterparties to perform. Each Fund bears the risk of loss of the amount expected to be received under a swap agreement
in the event of the default or bankruptcy of a swap agreement counterparty. A Fund will typically enter into swap agreements only with
major global financial institutions. The creditworthiness of each of the firms that is a party to a swap agreement is monitored by the
Sponsor. The Sponsor may use various techniques to minimize credit risk including early termination and payment, using different counterparties,
limiting the net amount due from any individual counterparty and generally requiring collateral to be posted by the counterparty in an
amount approximately equal to that owed to the Funds. Outstanding swap agreements contractually terminate within one month but may be
terminated without penalty by either party at any time. Upon termination, the Fund is obligated to pay or receive the &#8220;unrealized
appreciation or depreciation&#8221; amount.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Funds, as applicable, collateralize swap agreements
by segregating or designating cash and/or certain securities as indicated on the Statements of Financial Condition or Schedules of Investments.
As noted above, collateral posted in connection with OTC derivative transactions is held for the benefit of the counterparty in a segregated
tri-party account at the Custodian to protect the counterparty against non-payment by the Funds. The collateral held in this account is
restricted as to its use. In the event of a default by the counterparty, the Funds will seek withdrawal of this collateral from the segregated
account and may incur certain costs in exercising its right with respect to the collateral. If a counterparty becomes bankrupt or otherwise
fails to perform its obligations due to financial difficulties, the Funds may experience significant delays in obtaining any recovery
in a bankruptcy or other reorganizational proceeding. The Funds may obtain only limited recovery or may obtain no recovery in such circumstances.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 20; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>


</div><ix:continuation continuedAt="_InvestmentTextBlock-c0_cont_4" id="_InvestmentTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Funds remain subject to credit risk with respect
to the amount they expect to receive from counterparties. However, the Funds have sought to mitigate these risks in connection with OTC
swaps by generally requiring that the counterparties for each Fund agree to post collateral for the benefit of the Fund, marked to market
daily, in an amount approximately equal to what the counterparty owes the Fund, subject to certain minimum thresholds. In the event of
a bankruptcy of a counterparty, such Fund will have direct access to the collateral received from the counterparty, generally as of the
day prior to the bankruptcy, because there is a one day time lag between the Fund&#8217;s request for collateral and the delivery of such
collateral. To the extent any such collateral is insufficient, the Funds will be exposed to counterparty risk as described above, including
the possible delays in recovering amounts as a result of bankruptcy proceedings.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock-c0_cont_1" escape="true" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">The counterparty/credit risk for cleared derivative
transactions is generally lower than for OTC derivatives since generally a clearing organization becomes substituted for each counterparty
to a cleared derivative contract and, in effect, guarantees the parties&#8217; performance under the contract as each party to a trade
looks only to the clearing organization for performance of financial obligations. In addition, cleared derivative transactions benefit
from daily marking-to-market and settlement, and segregation and minimum capital requirements applicable to intermediaries.</ix:nonNumeric></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<ix:continuation continuedAt="_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock-c0_cont_2" id="_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; white-space: nowrap; text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair Values of Derivative Instruments as of June 30, 2023 (Unaudited)</b></span></td>
    <td style="text-align: left; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td></tr>
  <tr>
    <td style="text-align: center; padding-bottom: 1.5pt; white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt; white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="4" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Asset Derivatives</b></span></td>
    <td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="4" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Liability Derivatives</b></span></td>
    <td style="text-align: left; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td></tr>
  <tr>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: left; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Derivatives Not <br/>
Accounted for as <br/>
Hedging Instruments</b></span></td>
    <td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fund</b></span></td>
    <td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Statements of <br/>
Financial <br/>
Condition&#160;Location</b></span></td>
    <td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unrealized <br/> Appreciation</b></span></td>
    <td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Statements of <br/>
Financial <br/>
Condition&#160;Location</b></span></td>
    <td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unrealized <br/> Depreciation</b></span></td>
    <td style="text-align: left; vertical-align: bottom">&#160;</td></tr>
  <tr>
    <td style="white-space: nowrap; font-size: 10pt; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">VIX Futures Contracts </span></td>
    <td style="width: 1%">&#160;</td>
    <td style="white-space: nowrap; width: 20%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: center; font-size: 10pt; width: 17%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: center; font-size: 10pt; width: 9%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: center; font-size: 10pt; width: 16%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: center; font-size: 10pt; width: 9%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="text-align: right; white-space: nowrap">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left; white-space: nowrap; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-1x Short VIX Futures ETF </span></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right; font-size: 10pt">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">$</td>
    <td style="text-align: right; white-space: nowrap; font-size: 10pt"><span style="-sec-ix-hidden: hidden-fact-63; font-family: Times New Roman, Times, Serif; font-size: 10pt"> 6,518,579</span></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right; white-space: nowrap">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">$</td>
    <td style="text-align: right; white-space: nowrap; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> - </span></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr>
    <td style="padding-bottom: 1.5pt; text-align: right; white-space: nowrap">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left; white-space: nowrap; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2x Long VIX Futures ETF </span></td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right; white-space: nowrap">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right; white-space: nowrap; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- </span></td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right; white-space: nowrap">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right; white-space: nowrap; font-size: 10pt"><ix:nonNumeric contextRef="c62" continuedAt="cik0001793497_TotalTrust1-c62_cont_1" name="cik0001793497:TotalTrust1"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(19,791,036</span></ix:nonNumeric></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><ix:continuation id="cik0001793497_TotalTrust1-c62_cont_1">)</ix:continuation></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt; text-align: right; white-space: nowrap">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: left; white-space: nowrap; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total Trust </b></span></td>
    <td style="padding-bottom: 4pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: right; white-space: nowrap">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><b>$</b></td>
    <td style="border-bottom: Black 4pt double; text-align: right; white-space: nowrap; font-size: 10pt"><span style="-sec-ix-hidden: hidden-fact-64; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160; 6,518,579</b></span></td>
    <td style="padding-bottom: 4pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: right; white-space: nowrap">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><b>$</b></td>
    <td style="border-bottom: Black 4pt double; text-align: right; white-space: nowrap; font-size: 10pt"><span style="-sec-ix-hidden: hidden-fact-65; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160; (19,791,036</b></span></td>
    <td style="padding-bottom: 4pt; text-align: left">)</td></tr>
  </table></ix:continuation>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left">*</td><td style="text-align: left">Includes cumulative appreciation (depreciation) of futures contracts
as reported in the Schedule of Investments. Only current day&#8217;s variation margin is reported within the Statements of Financial
Condition in receivable/payable on open futures.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:continuation id="_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock-c0_cont_2"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; white-space: nowrap; text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair Values of Derivative Instruments as of December 31, 2022</b></span></td>
    <td style="text-align: left; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td></tr>
  <tr>
    <td style="text-align: center; padding-bottom: 1.5pt; white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt; white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="4" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Asset Derivatives</b></span></td>
    <td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="4" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Liability Derivatives</b></span></td>
    <td style="text-align: left; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td></tr>
  <tr>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: left; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Derivatives Not <br/>
Accounted for as <br/>
Hedging Instruments</b></span></td>
    <td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fund</b></span></td>
    <td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Statements of <br/>
Financial <br/>
Condition&#160;Location</b></span></td>
    <td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unrealized <br/> Appreciation</b></span></td>
    <td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Statements of <br/>
Financial <br/>
Condition&#160;Location</b></span></td>
    <td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unrealized <br/> Depreciation</b></span></td>
    <td style="text-align: left; vertical-align: bottom">&#160;</td></tr>
  <tr>
    <td style="white-space: nowrap; font-size: 10pt; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">VIX Futures Contracts </span></td>
    <td style="width: 1%">&#160;</td>
    <td style="white-space: nowrap; width: 20%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: center; font-size: 10pt; width: 17%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: center; font-size: 10pt; width: 9%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: center; font-size: 10pt; width: 16%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: center; font-size: 10pt; width: 9%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="text-align: right; white-space: nowrap">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left; white-space: nowrap; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-1x Short VIX Futures ETF </span></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right; font-size: 10pt">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">$</td>
    <td style="text-align: right; white-space: nowrap; font-size: 10pt"><span style="-sec-ix-hidden: hidden-fact-66; font-family: Times New Roman, Times, Serif; font-size: 10pt"> 1,156,106 </span></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right; white-space: nowrap">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">$</td>
    <td style="text-align: right; white-space: nowrap; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> - </span></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr>
    <td style="padding-bottom: 1.5pt; text-align: right; white-space: nowrap">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left; white-space: nowrap; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2x Long VIX Futures ETF </span></td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right; white-space: nowrap">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right; white-space: nowrap; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- </span></td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right; white-space: nowrap">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right; white-space: nowrap; font-size: 10pt"><ix:nonNumeric contextRef="c66" continuedAt="cik0001793497_TotalTrust1-c66_cont_1" name="cik0001793497:TotalTrust1"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9,203,522</span></ix:nonNumeric></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><ix:continuation id="cik0001793497_TotalTrust1-c66_cont_1">)</ix:continuation></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt; text-align: right; white-space: nowrap">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: left; white-space: nowrap; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total Trust </b></span></td>
    <td style="padding-bottom: 4pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: right; white-space: nowrap">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><b>$</b></td>
    <td style="border-bottom: Black 4pt double; text-align: right; white-space: nowrap; font-size: 10pt"><span style="-sec-ix-hidden: hidden-fact-67; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160; 1,156,106 </b></span></td>
    <td style="padding-bottom: 4pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: right; white-space: nowrap">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><b>$</b></td>
    <td style="border-bottom: Black 4pt double; text-align: right; white-space: nowrap; font-size: 10pt"><span style="-sec-ix-hidden: hidden-fact-68; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160; (9,203,522</b></span></td>
    <td style="padding-bottom: 4pt; text-align: left">)</td></tr>
  </table></ix:continuation>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left">*</td><td style="text-align: left">Includes cumulative appreciation (depreciation) of futures contracts
as reported in the Schedule of Investments. Only current day&#8217;s variation margin is reported within the Statements of Financial
Condition in receivable/payable on open futures.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:continuation><div>

</div><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><!-- Field: Page; Sequence: 21; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font-size: 10pt; margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><ix:continuation continuedAt="_InvestmentTextBlock-c0_cont_5" id="_InvestmentTextBlock-c0_cont_4"><ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock-c0_cont_1" escape="true" name="us-gaap:ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td colspan="21" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">The Effect of Derivative Instruments on the Statement of Operations</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="21" style="font-weight: bold; text-align: center">For the Three Months Ended June 30, 2023 (Unaudited) and June 30, 2022 (Unaudited)</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="21" style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Derivatives Not <br/>
Accounted for as Hedging Instruments</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Location of Gain (Loss) on Derivatives Recognized in Income</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Fund</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Realized Gain <br/>
(Loss) on <br/>
Derivatives Recognized <br/>
in Income <br/>
June 30, <br/>
2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Change in <br/>
Unrealized <br/>
Appreciation <br/>
(Depreciation) <br/>
on Derivatives <br/>
Recognized <br/>
in Income <br/>
June 30, <br/>
2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Realized&#160;Gain<br/>
 (Loss) on <br/>
Derivatives <br/>
Recognized <br/>
in Income <br/>
June 30, <br/>
2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Change in <br/>
Unrealized <br/>
Appreciation <br/>
(Depreciation) <br/>
on Derivatives <br/>
Recognized <br/>
in Income <br/>
June 30, <br/>
2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; vertical-align: top; text-align: left">VIX Futures Contracts</td><td>&#160;</td>
    <td style="text-align: left">Net realized gain (loss) on futures contracts/changes in unrealized appreciation (depreciation) on futures contracts</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 15%">&#160;</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 26%">&#160;</td><td style="width: 0.5%">&#160;</td>
    <td style="white-space: nowrap; width: 16%; text-align: left">-1x Short VIX Futures ETF</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c69" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:RealizedGainLossOnDerivativesRecognizedInIncome" scale="0" unitRef="usd">37,164,451</ix:nonFraction></td><td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%; text-align: left">$</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c69" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:ChangeInUnrealizedAppreciationDepreciationsOnDerivativesRecognizedInIncome" scale="0" sign="-" unitRef="usd">811,301</ix:nonFraction></td><td style="width: 0.5%; text-align: left">)</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%; text-align: left">$</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c70" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:RealizedGainLossOnDerivativesRecognizedInIncome" scale="0" sign="-" unitRef="usd">4,573,051</ix:nonFraction></td><td style="width: 0.5%; text-align: left">)</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c70" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:ChangeInUnrealizedAppreciationDepreciationsOnDerivativesRecognizedInIncome" scale="0" unitRef="usd">835,808</ix:nonFraction></td><td style="width: 0.5%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">2x Long VIX Futures ETF</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c71" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:RealizedGainLossOnDerivativesRecognizedInIncome" scale="0" sign="-" unitRef="usd">142,872,642</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c71" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:ChangeInUnrealizedAppreciationDepreciationsOnDerivativesRecognizedInIncome" scale="0" sign="-" unitRef="usd">4,374,661</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c72" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:RealizedGainLossOnDerivativesRecognizedInIncome" scale="0" unitRef="usd">7,528,449</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c72" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:ChangeInUnrealizedAppreciationDepreciationsOnDerivativesRecognizedInIncome" scale="0" sign="-" unitRef="usd">256,944</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 4pt; font-weight: bold; text-align: left">Total Trust</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c73" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:RealizedGainLossOnDerivativesRecognizedInIncome" scale="0" sign="-" unitRef="usd">105,708,191</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c73" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:ChangeInUnrealizedAppreciationDepreciationsOnDerivativesRecognizedInIncome" scale="0" sign="-" unitRef="usd">5,185,962</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c74" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:RealizedGainLossOnDerivativesRecognizedInIncome" scale="0" unitRef="usd">2,955,398</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c74" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:ChangeInUnrealizedAppreciationDepreciationsOnDerivativesRecognizedInIncome" scale="0" unitRef="usd">578,864</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
cumulative appreciation (depreciation) of futures contracts as reported in the Schedule of Investments. Only current day&#8217;s variation
margin is reported within the Statements of Financial Condition in receivable/payable on open futures.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:continuation id="_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td colspan="21" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">The Effect of Derivative Instruments on the Statement of Operations</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="21" style="font-weight: bold; text-align: center">For the Six Months Ended June 30, 2023 (Unaudited) and June 30, 2022 (Unaudited)</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="21" style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Derivatives Not <br/>
Accounted for as Hedging Instruments</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Location of Gain (Loss) on Derivatives Recognized in Income</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Fund</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Realized Gain <br/>
(Loss) on <br/>
Derivatives <br/>
Recognized <br/>
in Income<br/>
 June 30, <br/>
2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Change in <br/>
Unrealized <br/>
Appreciation <br/>
(Depreciation) <br/>
on Derivatives <br/>
Recognized in <br/>
Income <br/>
June 30, <br/>
2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Realized&#160;Gain<br/>
 (Loss) on <br/>
Derivatives <br/>
Recognized <br/>
in Income <br/>
June 30, <br/>
2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Change in <br/>
Unrealized <br/>
Appreciation <br/>
(Depreciation) <br/>
on Derivatives <br/>
Recognized<br/>
 in Income <br/>
June 30, <br/>
2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; vertical-align: top; text-align: left">VIX Futures Contracts</td><td>&#160;</td>
    <td style="text-align: left">Net realized gain (loss) on futures contracts/changes in unrealized appreciation (depreciation) on futures contracts</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 15%">&#160;</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 26%">&#160;</td><td style="width: 0.5%">&#160;</td>
    <td style="white-space: nowrap; width: 16%; text-align: left">-1x Short VIX Futures ETF</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c25" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:RealizedGainLossOnDerivativesRecognizedInIncome" scale="0" unitRef="usd">42,451,505</ix:nonFraction></td><td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c25" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:ChangeInUnrealizedAppreciationDepreciationsOnDerivativesRecognizedInIncome" scale="0" unitRef="usd">5,362,473</ix:nonFraction></td><td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%; text-align: left">$</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c75" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:RealizedGainLossOnDerivativesRecognizedInIncome" scale="0" sign="-" unitRef="usd">4,577,129</ix:nonFraction></td><td style="width: 0.5%; text-align: left">)</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c75" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:ChangeInUnrealizedAppreciationDepreciationsOnDerivativesRecognizedInIncome" scale="0" unitRef="usd">700,531</ix:nonFraction></td><td style="width: 0.5%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">2x Long VIX Futures ETF</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c13" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:RealizedGainLossOnDerivativesRecognizedInIncome" scale="0" sign="-" unitRef="usd">186,102,397</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c13" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:ChangeInUnrealizedAppreciationDepreciationsOnDerivativesRecognizedInIncome" scale="0" sign="-" unitRef="usd">10,587,514</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c15" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:RealizedGainLossOnDerivativesRecognizedInIncome" scale="0" unitRef="usd">7,527,995</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c15" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:ChangeInUnrealizedAppreciationDepreciationsOnDerivativesRecognizedInIncome" scale="0" unitRef="usd">19,258</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 4pt; font-weight: bold; text-align: left">Total Trust</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:RealizedGainLossOnDerivativesRecognizedInIncome" scale="0" sign="-" unitRef="usd">143,650,892</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:ChangeInUnrealizedAppreciationDepreciationsOnDerivativesRecognizedInIncome" scale="0" sign="-" unitRef="usd">5,225,041</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c76" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:RealizedGainLossOnDerivativesRecognizedInIncome" scale="0" unitRef="usd">2,950,866</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c76" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:ChangeInUnrealizedAppreciationDepreciationsOnDerivativesRecognizedInIncome" scale="0" unitRef="usd">719,789</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
cumulative appreciation (depreciation) of futures contracts as reported in the Schedule of Investments. Only current day&#8217;s variation
margin is reported within the Statements of Financial Condition in receivable/payable on open futures.</span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:continuation><div>
</div><div>

</div><!-- Field: Page; Sequence: 22; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><ix:continuation continuedAt="_InvestmentTextBlock-c0_cont_6" id="_InvestmentTextBlock-c0_cont_5"><p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt"><b>Offsetting Assets and Liabilities</b></span></p>

<p style="text-indent: 0.5in; margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Each Fund is subject to master netting agreements or similar arrangements that allow for amounts owed
between each Fund and the counterparty to be netted upon an early termination. The party that has the larger payable pays the excess of
the larger amount over the smaller amount to the other party. The master netting agreements or similar arrangements do not apply to amounts
owed to/from different counterparties. As described above, the Funds utilize derivative instruments to achieve their investment objective
during the year. The amounts shown in the Statements of Financial Condition do not take into consideration the effects of legally enforceable
master netting agreements or similar arrangements.</p>

<p style="text-indent: 0.5in; margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><ix:nonNumeric contextRef="c0" continuedAt="cik0001793497_ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsTableTextBlock-c0_cont_1" escape="true" name="cik0001793497:ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsTableTextBlock">For financial reporting purposes, the Funds do not offset derivative assets and derivative
liabilities that are subject to netting arrangements in the Statements of Financial Condition. The following table presents each Fund&#8217;s
derivatives by investment type and by counterparty net of amounts available for offset under a master netting agreement and the related
collateral received or pledged by the Funds as of June 30, 2023 and December 31, 2022.</ix:nonNumeric></p>

<p style="text-align: center; margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:continuation continuedAt="cik0001793497_ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsTableTextBlock-c0_cont_2" id="cik0001793497_ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsTableTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td colspan="25" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Fair Values of Derivative Instruments as of June 30, 2023 (Unaudited)</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="25" style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Assets</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Liabilities</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Fund</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross<br/> Amounts of<br/> Recognized<br/> Assets<br/> presented<br/> in the<br/> Statements<br/> of Financial<br/> Condition</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross<br/> Amounts<br/> Offset<br/> in the<br/> Statements<br/> of Financial<br/> Condition</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Net Amounts<br/> of Assets<br/> presented<br/> in the<br/> Statements<br/> of Financial<br/> Condition</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross<br/> Amounts of<br/> Recognized<br/> Liabilities<br/> presented<br/> in the<br/> Statements<br/> of Financial<br/> Condition</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross<br/> Amounts<br/> Offset<br/> in the<br/> Statements<br/> of Financial<br/> Condition</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Net Amounts<br/> of&#160;Liabilities<br/> presented<br/> in the<br/> Statements<br/> of Financial<br/> Condition</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; text-align: left">-1x Short VIX Futures ETF</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c77" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition" scale="0" unitRef="usd">1,242,108</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-69">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c77" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition" scale="0" unitRef="usd">1,242,108</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-70">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-71">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-72">-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">2x Long VIX Futures ETF</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-73">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-74">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-75">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c81" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:GrossAmountsOfRecognizedLiabilitiesPresentedInTheStatementsOfFinancialCondition" scale="0" unitRef="usd">3,406,049</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-76">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c82" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:NetAmountsOfLiabilitiesPresentedInTheStatementsOfFinancialCondition" scale="0" unitRef="usd">3,406,049</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table></ix:continuation>



<p style="text-align: center; margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:continuation id="cik0001793497_ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsTableTextBlock-c0_cont_2"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td colspan="25" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Fair Values of Derivative Instruments as of December 31, 2022</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="25" style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Assets</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Liabilities</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Fund</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross<br/> Amounts of<br/> Recognized<br/> Assets<br/> presented<br/> in the<br/> Statements<br/> of Financial<br/> Condition</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross<br/> Amounts<br/> Offset<br/> in the<br/> Statements<br/> of Financial<br/> Condition</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Net Amounts<br/> of Assets<br/> presented<br/> in the<br/> Statements<br/> of Financial<br/> Condition</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross<br/> Amounts of<br/> Recognized<br/> Liabilities<br/> presented<br/> in the<br/> Statements<br/> of Financial<br/> Condition</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross<br/> Amounts<br/> Offset<br/> in the<br/> Statements<br/> of Financial<br/> Condition</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Net Amounts<br/> of Liabilities<br/> presented<br/> in the<br/> Statements<br/> of Financial<br/> Condition</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; text-align: left">-1x Short VIX Futures ETF</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-77">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c84" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:GrossAmountsOfRecognizedLiabilitiesPresentedInTheStatementsOfFinancialCondition" scale="0" unitRef="usd">187,030</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-78">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c85" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:NetAmountsOfLiabilitiesPresentedInTheStatementsOfFinancialCondition" scale="0" unitRef="usd">187,030</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">2x Long VIX Futures ETF</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c86" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition" scale="0" unitRef="usd">830,840</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-79">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c86" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition" scale="0" unitRef="usd">830,840</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-80">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  </table><p style="text-align: center; margin-top: 0; margin-bottom: 0">&#160;</p></ix:continuation></ix:continuation><div>



</div><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><!-- Field: Page; Sequence: 23; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><ix:continuation id="_InvestmentTextBlock-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock-c0_cont_1" escape="true" name="us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock">Asset (Liability) amounts shown in the table below represent amounts owed to (by) the Funds for the derivative-related investments at
June 30, 2023 and December 31, 2022. These amounts may be collateralized by cash or financial instruments, segregated for the benefit of
the Funds or the counterparties, depending on whether the related contracts are in an appreciated or depreciated position at period end.
Amounts shown in the column labeled &#8220;Net Amount&#8221; represent the uncollateralized portions of these amounts at period end. These
amounts may be un-collateralized due to timing differences related to market movements or due to minimum thresholds for collateral movement,
as further described above under the caption &#8220;Accounting for Derivative Instruments&#8221;.</ix:nonNumeric></p>

<p style="text-align: center; margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:continuation continuedAt="_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock-c0_cont_2" id="_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td colspan="17" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross Amounts Not Offset in the Statements of Financial Condition as of June 30, 2023 (Unaudited)</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="17" style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Fund</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amounts of<br/> Recognized<br/> Assets /<br/> (Liabilities)<br/> presented<br/> in the<br/> Statements<br/> of Financial<br/> Condition</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Financial<br/> Instruments<br/> for the Benefit<br/> of (the Funds) / the<br/> Counterparties</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Cash<br/> Collateral for<br/> the Benefit of<br/> (the Funds) / the<br/> Counterparties</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Net Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">-1x Short VIX Futures ETF</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c12" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne" scale="0" unitRef="usd">1,242,108</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-81">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-82">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:CapitalUnitNetAmount" scale="0" unitRef="usd">1,242,108</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">2x Long VIX Futures ETF</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c13" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne" scale="0" sign="-" unitRef="usd">3,406,049</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-83">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-84">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:CapitalUnitNetAmount" scale="0" sign="-" unitRef="usd">3,406,049</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  </table></ix:continuation>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:continuation id="_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock-c0_cont_2"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td colspan="17" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross Amounts Not Offset in the Statements of Financial Condition as of December 31, 2022</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="17" style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Fund</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amounts of<br/> Recognized<br/> Assets /<br/> (Liabilities)<br/> presented<br/> in the<br/> Statements<br/> of Financial<br/> Condition</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Financial<br/> Instruments<br/> for the Benefit<br/> of (the<br/>
 Funds) / the<br/> Counterparties</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Cash<br/> Collateral for<br/> the Benefit of<br/> (the Funds) / the<br/> Counterparties</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Net Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">-1x Short VIX Futures ETF</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c88" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne" scale="0" sign="-" unitRef="usd">187,030</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:CapitalUnitNetAmount" scale="0" sign="-" unitRef="usd">187,030</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">2x Long VIX Futures ETF</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c43" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne" scale="0" unitRef="usd">830,840</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:CapitalUnitNetAmount" scale="0" unitRef="usd">830,840</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table></ix:continuation></ix:continuation><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="text-align: center; margin-top: 0; margin-bottom: 0"></p><div>

</div><!-- Field: Page; Sequence: 24; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="text-align: center; margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="cik0001793497:AgreementsDisclosureTextBlock"><p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">NOTE 4 &#8211; AGREEMENTS</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Management Fee</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">SVIX pays
the Sponsor a management fee (the &#8220;Management Fee&#8221;), monthly in arrears, in an amount equal to <ix:nonFraction contextRef="c89" decimals="4" format="ixt:num-dot-decimal" name="cik0001793497:AverageDailyNetAssetsRate" scale="-2" unitRef="pure">1.35</ix:nonFraction>% per annum of its average
daily net assets. UVIX pays the Sponsor a Management Fee, monthly in arrears, in an amount equal to <ix:nonFraction contextRef="c90" decimals="4" format="ixt:num-dot-decimal" name="cik0001793497:AverageDailyNetAssetsRate" scale="-2" unitRef="pure">1.65</ix:nonFraction>% per annum of its average daily
net assets. &#8220;Average daily net assets&#8221; is calculated by dividing the month-end net assets of each Fund by the number of calendar
days in such month.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">No other Management Fee is paid by
the Funds. The Management Fee is paid in consideration of the Sponsor&#8217;s trading advisory services and the other services provided
to the Fund that the Sponsor pays directly.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the Sponsor Agreement
between Sponsor and the Trust, on behalf of the Funds, the Sponsor oversees and pays Penserra Capital Management LLC (&#8220;Commodity
Sub-Adviser&#8221;) for its services as Commodity Sub-Adviser. The Commodity Sub-Adviser is paid by the Sponsor an annual sub-advisory
fee of <ix:nonFraction contextRef="c3" decimals="4" format="ixt:num-dot-decimal" name="cik0001793497:SubadvisoryFeeRate" scale="-2" unitRef="pure">0.20</ix:nonFraction>% based on each Fund&#8217;s average daily net assets (total assets of the Fund, minus the sum of its accrued liabilities).
The Funds do not directly pay the Commodity Sub-Adviser.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Non-Recurring Fees and Expenses</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Each Fund pays all its non-recurring
and unusual fees and expenses, if any, as determined by the Sponsor. Non-recurring and unusual fees and expenses are fees and expenses
that are unexpected or unusual in nature, such as legal claims and liabilities, litigation costs or indemnification or other material
expenses which are not currently anticipated obligations of the Funds.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">The Administrator, Transfer Agent and Custodian</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">U.S. Bancorp Fund Services, LLC,
doing business as U.S. Bank Global Fund Services (&#8220;Fund Services&#8221;), an indirect subsidiary of U.S. Bancorp, serves as
the Fund&#8217;s fund accountant, administrator and transfer agent pursuant to certain fund accounting servicing, fund
administration servicing and transfer agent servicing agreements. U.S. Bank National Association, a subsidiary of U.S. Bancorp and
parent company of Fund Services, intends to serve as the Fund&#8217;s custodian pursuant to a custody agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">The Marketing Agent</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Foreside Fund Services, LLC (the
&#8220;Marketing Agent&#8221;) serves as the Marketing Agent of the Funds. Its principal duties are: (i) to work with the Transfer Agent
to review and approve orders placed by Authorized Participants and transmitted to the Transfer Agent; (ii) maintain copies of confirmations
of Creation Unit creation and redemption order acceptances; (iii) maintain telephonic, facsimile and/or access to direct computer communications
links with the Transfer Agent; and (iv) review and approve, prior to use, all Trust marketing materials for compliance with applicable
SEC and FINRA advertising rules.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Marketing Agent retains all marketing
materials separately for the Funds, at their offices located at Three Canal Plaza, Suite 100 Portland, Maine 04101.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As compensation for the services it provides, the Marketing
Agent receives a fee from the Funds.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="cik0001793497:OfferingCostsTextBlock"><p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">NOTE 5 &#8211; OFFERING COSTS</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Offering costs will be amortized
by the Funds over a twelve month period on a straight-line basis beginning once the fund commences operations. The Sponsor will not charge
its Management Fee in the first year of operations of a Fund in an amount equal to the offering costs. Normal and expected expenses incurred
in connection with the continuous offering of Shares of a Fund after the commencement of its trading operations will be paid by the Sponsor.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_1" escape="true" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"><p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">NOTE 6 &#8211; CREATION AND REDEMPTION OF CREATION UNITS</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Each Fund issues and redeems shares
from time to time, but only in one or more Creation Units. A Creation Unit is a block of at least <ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SharesIssued" scale="0" unitRef="shares">10,000</ix:nonFraction> Shares of a Fund. Creation Units
may be created or redeemed only by Authorized Participants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Except when aggregated in Creation
Units, the Shares are not redeemable securities. Retail investors, therefore, generally will not be able to purchase or redeem Shares
directly from or with a Fund. Rather, most retail investors will purchase or sell Shares in the secondary market with the assistance of
a broker. Thus, some of the information contained in these Notes to Financial Statements&#8212;such as references to the Transaction Fees
imposed on purchases and redemptions is not relevant to retail investors.</p>

<p style="text-align: left; text-indent: 0.5in; margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="text-align: left; margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt"><b>Transaction Fees on Creation and Redemption
Transactions</b></span></p>

<p style="text-align: left; text-indent: 0.5in; margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The manner by which Creation Units are purchased or redeemed is governed by the
terms of the Authorized Participant Agreement and Authorized Participant Procedures Handbook. By placing a purchase order, an Authorized
Participant agrees to: (1) deposit cash with the Custodian; and (2) if permitted by the Sponsor in its sole discretion, enter into or
arrange for an exchange of futures contract for related position or block trade with the relevant fund whereby the Authorized Participant
would also transfer to such Fund a number and type of exchange-traded futures contracts at or near the closing settlement price for such
contracts on the purchase order date.</p><p style="text-align: left; text-indent: 0.5in; margin-top: 0; margin-bottom: 0">&#160;</p></ix:nonNumeric><div>


</div><div>

</div><!-- Field: Page; Sequence: 25; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="text-align: left; text-indent: 0.5in; margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><ix:continuation id="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Authorized Participants may pay a fee up to <ix:nonFraction contextRef="c0" decimals="4" format="ixt:num-dot-decimal" name="cik0001793497:AuthorizedParticipantsPercentage" scale="-2" unitRef="pure">0.20</ix:nonFraction>% of the value of each order they place with each
order to create or redeem a Creation Unit in order to compensate the Administrator, the Custodian and the Transfer Agent of each Fund
and its Shares, for services in processing the creation and redemption of Creation Units and to offset the costs of increasing or decreasing
derivative positions, unless the transaction fee is waived or otherwise adjusted by the Sponsor. The Sponsor provides such Authorized
Participant with prompt notice in advance of any such waiver or adjustment of the transaction fee. Authorized Participants may sell the
Shares included in the Creation Units they purchase from the Funds to other investors in the secondary market.</p>

<p style="text-align: left; text-indent: 0.5in; margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Transaction fees for the three months ended June 30, 2023
and June 30, 2022 were as follows.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="cik0001793497_ScheduleOfTransactionFeesTableTextBlock-c0_cont_1" escape="true" name="cik0001793497:ScheduleOfTransactionFeesTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Fund</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Three <br/>
Months <br/>
Ended <br/>
June 30, <br/>
2023 <br/>
(Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Three <br/>
Months <br/>
Ended <br/>
June 30, <br/>
2022 <br/>
(Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">-1x Short VIX Futures ETF</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c91" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SaleOfTrustAssetsToPayExpenses" scale="0" unitRef="usd">31,820</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c92" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SaleOfTrustAssetsToPayExpenses" scale="0" unitRef="usd">62,214</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">2x Long VIX Futures ETF</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SaleOfTrustAssetsToPayExpenses" scale="0" unitRef="usd">66,946</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SaleOfTrustAssetsToPayExpenses" scale="0" unitRef="usd">45,789</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Trust</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c93" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SaleOfTrustAssetsToPayExpenses" scale="0" unitRef="usd">98,766</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c94" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SaleOfTrustAssetsToPayExpenses" scale="0" unitRef="usd">108,003</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Transaction fees for the Six months ended June 30, 2023 and
June 30, 2022 were as follows.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.4pt">&#160;</p>

<ix:continuation id="cik0001793497_ScheduleOfTransactionFeesTableTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Fund</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Six Months <br/>
Ended <br/>
June 30, <br/>
2023 <br/>
(Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Six Months <br/>
Ended <br/>
June 30, <br/>
2022 <br/>
(Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">-1x Short VIX Futures ETF</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c25" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SaleOfTrustAssetsToPayExpenses" scale="0" unitRef="usd">77,483</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c75" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SaleOfTrustAssetsToPayExpenses" scale="0" unitRef="usd">63,870</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">2x Long VIX Futures ETF</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c13" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SaleOfTrustAssetsToPayExpenses" scale="0" unitRef="usd">119,613</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c15" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SaleOfTrustAssetsToPayExpenses" scale="0" unitRef="usd">46,905</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Trust</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SaleOfTrustAssetsToPayExpenses" scale="0" unitRef="usd">197,096</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c76" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SaleOfTrustAssetsToPayExpenses" scale="0" unitRef="usd">110,775</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table></ix:continuation></ix:continuation><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_QuarterlyFinancialInformationTextBlock-c0_cont_1" escape="true" name="us-gaap:QuarterlyFinancialInformationTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 7 - FINANCIAL HIGHLIGHTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><ix:nonNumeric contextRef="c0" continuedAt="cik0001793497_ScheduleOfShareOutstandingTableTextBlock-c0_cont_1" escape="true" name="cik0001793497:ScheduleOfShareOutstandingTableTextBlock">Selected data is for a Share outstanding throughout the Three Months
Ended June 30, 2023 (Unaudited) and June 30, 2022 (Unaudited)</ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:continuation continuedAt="cik0001793497_ScheduleOfShareOutstandingTableTextBlock-c0_cont_2" id="cik0001793497_ScheduleOfShareOutstandingTableTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">-1x Short VIX Futures ETF</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2x Long VIX Futures ETF</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">-1x Short VIX Futures ETF</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2x Long VIX Futures ETF</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Quarter Ended</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Quarter Ended</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Quarter Ended</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Quarter Ended</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">June 30, <br/>
2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">June 30, <br/>
2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">June 30, <br/>
2022</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">June 30, <br/>
2022</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -10pt; padding-left: 10pt; width: 52%">Net Asset Value, Beginning of Period</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c99" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:InvestmentCompanyMarketValuePerShare" scale="0" unitRef="usdPershares">16.55</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c17" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:InvestmentCompanyMarketValuePerShare" scale="0" unitRef="usdPershares">15.88</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c100" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:InvestmentCompanyMarketValuePerShare" scale="0" unitRef="usdPershares">14.16</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c19" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:InvestmentCompanyMarketValuePerShare" scale="0" unitRef="usdPershares">83.20</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net investment loss <sup>(1)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c91" decimals="2" format="ixt:num-dot-decimal" id="ix_19_fact" name="us-gaap:InvestmentCompanyGainLossOnInvestmentPerShare" scale="0" sign="-" unitRef="usdPershares">0.09</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c9" decimals="2" format="ixt:num-dot-decimal" id="ix_20_fact" name="us-gaap:InvestmentCompanyGainLossOnInvestmentPerShare" scale="0" sign="-" unitRef="usdPershares">0.03</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c92" decimals="2" format="ixt:num-dot-decimal" id="ix_21_fact" name="us-gaap:InvestmentCompanyGainLossOnInvestmentPerShare" scale="0" sign="-" unitRef="usdPershares">0.05</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c11" decimals="2" format="ixt:num-dot-decimal" id="ix_22_fact" name="us-gaap:InvestmentCompanyGainLossOnInvestmentPerShare" scale="0" sign="-" unitRef="usdPershares">0.60</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net Realized and Unrealized Gain (Loss) on Investments and Futures Contracts <sup>(2)</sup></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c91" decimals="2" format="ixt:num-dot-decimal" id="ix_27_fact" name="cik0001793497:NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts" scale="0" unitRef="usdPershares">11.67</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c9" decimals="2" format="ixt:num-dot-decimal" id="ix_28_fact" name="cik0001793497:NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts" scale="0" sign="-" unitRef="usdPershares">11.41</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c92" decimals="2" format="ixt:num-dot-decimal" id="ix_29_fact" name="cik0001793497:NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts" scale="0" sign="-" unitRef="usdPershares">3.71</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c11" decimals="2" format="ixt:num-dot-decimal" id="ix_30_fact" name="cik0001793497:NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts" scale="0" unitRef="usdPershares">3.00</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Net Increase (Decrease) in Net Asset Value Resulting from Operations</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c91" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease" scale="0" unitRef="usdPershares">11.58</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c9" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease" scale="0" sign="-" unitRef="usdPershares">11.44</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c92" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease" scale="0" sign="-" unitRef="usdPershares">3.76</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c11" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease" scale="0" unitRef="usdPershares">2.40</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -10pt; padding-left: 10pt; padding-bottom: 4pt">Net Asset Value, End of Period</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c24" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:InvestmentCompanyMarketValuePerShare" scale="0" unitRef="usdPershares">28.13</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c5" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:InvestmentCompanyMarketValuePerShare" scale="0" unitRef="usdPershares">4.44</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c101" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:InvestmentCompanyMarketValuePerShare" scale="0" unitRef="usdPershares">10.40</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c21" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:InvestmentCompanyMarketValuePerShare" scale="0" unitRef="usdPershares">85.60</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -10pt; padding-left: 10pt; padding-bottom: 4pt">Market Value Per Share, at June 30, 2023 and June 30, 2022</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c24" decimals="2" format="ixt:num-dot-decimal" name="cik0001793497:MarketValuePerShare" scale="0" unitRef="usdPershares">28.07</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c5" decimals="2" format="ixt:num-dot-decimal" name="cik0001793497:MarketValuePerShare" scale="0" unitRef="usdPershares">4.46</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c101" decimals="2" format="ixt:num-dot-decimal" name="cik0001793497:MarketValuePerShare" scale="0" unitRef="usdPershares">10.40</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c21" decimals="2" format="ixt:num-dot-decimal" name="cik0001793497:MarketValuePerShare" scale="0" unitRef="usdPershares">85.40</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total Return at Net Asset Value <sup>(4)</sup></b></span></td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c91" decimals="4" format="ixt:num-dot-decimal" id="ix_35_fact" name="us-gaap:InvestmentCompanyTotalReturn" scale="-2" unitRef="pure">69.97</ix:nonFraction></td><td style="font-weight: bold; text-align: left">%</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-<ix:nonFraction contextRef="c9" decimals="4" format="ixt:num-dot-decimal" id="ix_36_fact" name="us-gaap:InvestmentCompanyTotalReturn" scale="-2" sign="-" unitRef="pure">72.04</ix:nonFraction></td><td style="font-weight: bold; text-align: left">%</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-<ix:nonFraction contextRef="c92" decimals="4" format="ixt:num-dot-decimal" id="ix_37_fact" name="us-gaap:InvestmentCompanyTotalReturn" scale="-2" sign="-" unitRef="pure">26.56</ix:nonFraction></td><td style="font-weight: bold; text-align: left">%</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c11" decimals="4" format="ixt:num-dot-decimal" id="ix_38_fact" name="us-gaap:InvestmentCompanyTotalReturn" scale="-2" unitRef="pure">2.88</ix:nonFraction></td><td style="font-weight: bold; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -10pt; padding-left: 10pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total Return at Market Value <sup>(4)</sup></b></span></td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c91" decimals="4" format="ixt:num-dot-decimal" id="ix_39_fact" name="cik0001793497:TotalReturnAtMarketValue" scale="-2" unitRef="pure">70.02</ix:nonFraction></td><td style="font-weight: bold; text-align: left">%</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-<ix:nonFraction contextRef="c9" decimals="4" format="ixt:num-dot-decimal" id="ix_40_fact" name="cik0001793497:TotalReturnAtMarketValue" scale="-2" sign="-" unitRef="pure">72.09</ix:nonFraction></td><td style="font-weight: bold; text-align: left">%</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-<ix:nonFraction contextRef="c92" decimals="4" format="ixt:num-dot-decimal" id="ix_41_fact" name="cik0001793497:TotalReturnAtMarketValue" scale="-2" sign="-" unitRef="pure">25.93</ix:nonFraction></td><td style="font-weight: bold; text-align: left">%</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c11" decimals="4" format="ixt:num-dot-decimal" id="ix_42_fact" name="cik0001793497:TotalReturnAtMarketValue" scale="-2" unitRef="pure">1.30</ix:nonFraction></td><td style="font-weight: bold; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -10pt; padding-left: 10pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -10pt; padding-left: 10pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ratios to Average Net Assets: <sup>(5)</sup></b></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expense ratio <sup>(6)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c91" decimals="4" format="ixt:num-dot-decimal" id="ix_51_fact" name="us-gaap:InvestmentCompanyExpenseRatioAfterIncentiveAllocation" scale="-2" unitRef="pure">2.20</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c9" decimals="4" format="ixt:num-dot-decimal" id="ix_52_fact" name="us-gaap:InvestmentCompanyExpenseRatioAfterIncentiveAllocation" scale="-2" unitRef="pure">2.09</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c92" decimals="4" format="ixt:num-dot-decimal" id="ix_53_fact" name="us-gaap:InvestmentCompanyExpenseRatioAfterIncentiveAllocation" scale="-2" unitRef="pure">2.18</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c11" decimals="4" format="ixt:num-dot-decimal" id="ix_54_fact" name="us-gaap:InvestmentCompanyExpenseRatioAfterIncentiveAllocation" scale="-2" unitRef="pure">2.91</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">Net Investment Loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-<ix:nonFraction contextRef="c91" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:InvestmentCompanyTotalReturnAfterIncentiveFees" scale="-2" sign="-" unitRef="pure">1.75</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-<ix:nonFraction contextRef="c9" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:InvestmentCompanyTotalReturnAfterIncentiveFees" scale="-2" sign="-" unitRef="pure">1.14</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-<ix:nonFraction contextRef="c92" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:InvestmentCompanyTotalReturnAfterIncentiveFees" scale="-2" sign="-" unitRef="pure">0.50</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-<ix:nonFraction contextRef="c11" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:InvestmentCompanyTotalReturnAfterIncentiveFees" scale="-2" sign="-" unitRef="pure">0.67</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  </table></ix:continuation>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:continuation continuedAt="cik0001793497_ScheduleOfShareOutstandingTableTextBlock-c0_cont_3" id="cik0001793497_ScheduleOfShareOutstandingTableTextBlock-c0_cont_2"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0in"></td><td style="width: 0.25in; text-align: left">(1)</td><td style="text-align: left"><ix:footnote id="ix_9_footnote" xml:lang="en-US">Net investment loss per share represents net investment loss
divided by the daily average shares of beneficial interest outstanding during the period.</ix:footnote></td>
</tr></table></ix:continuation>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0in"></td><td style="width: 0.25in; text-align: left">(2)</td><td style="text-align: left">Due to timing of capital share transactions, per share amounts
may not compare with amounts appearing elsewhere within these Financial Statements.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0in"></td><td style="width: 0.25in; text-align: left">(3)</td><td style="text-align: left">Market values are determined at the close of the applicable
primary listing exchange, which may be later than when the Funds' net asset value is calculated.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0in"></td><td style="width: 0.25in; text-align: left">(4)</td><td style="text-align: left">Percentages are not annualized for the period ended June 30,
2023 and June 30, 2022</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0in"></td><td style="width: 0.25in; text-align: left">(5)</td><td style="text-align: left">Percentages are annualized.</td>
</tr></table>

<ix:continuation continuedAt="cik0001793497_ScheduleOfShareOutstandingTableTextBlock-c0_cont_4" id="cik0001793497_ScheduleOfShareOutstandingTableTextBlock-c0_cont_3"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0in"></td><td style="width: 0.25in; text-align: left">(6)</td><td style="text-align: left"><ix:footnote id="ix_13_footnote" xml:lang="en-US">The expense ratio would be <ix:nonFraction contextRef="c95" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpenseRatio" scale="-2" unitRef="pure">2.17</ix:nonFraction>% and <ix:nonFraction contextRef="c96" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpenseRatio" scale="-2" unitRef="pure">2.09</ix:nonFraction>% respectively, for
the three months ended June 30, 2023, and <ix:nonFraction contextRef="c97" decimals="4" format="ixt:num-dot-decimal" name="cik0001793497:BrokerageCommissionsRate" scale="-2" unitRef="pure">2.00</ix:nonFraction>% and <ix:nonFraction contextRef="c98" decimals="4" format="ixt:num-dot-decimal" name="cik0001793497:BrokerageCommissionsRate" scale="-2" unitRef="pure">2.81</ix:nonFraction>% for the three months ended June 30, 2022 if brokerage commissions and futures
and futures account fees were excluded.</ix:footnote></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:continuation></ix:nonNumeric><div>

</div><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 26; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><ix:continuation id="_QuarterlyFinancialInformationTextBlock-c0_cont_1"><p style="margin: 0; text-indent: 0.5in">Selected data is for a Share outstanding throughout the Six Months
Ended June 30, 2023 (Unaudited) and June 30, 2022 (Unaudited)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:continuation continuedAt="cik0001793497_ScheduleOfShareOutstandingTableTextBlock-c0_cont_5" id="cik0001793497_ScheduleOfShareOutstandingTableTextBlock-c0_cont_4"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">-1x Short VIX Futures ETF</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2x Long VIX Futures ETF</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">-1x Short VIX Futures ETF</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2x Long VIX Futures ETF</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Six Months Ended</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Six Months Ended</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Six Months Ended</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Six Months Ended</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">June 30, <br/>
2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, <br/>
2023 <sup>(7)</sup></b></span></td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">June 30, <br/>
2022</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, <br/>
2022 <sup>(7)</sup></b></span></td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; width: 52%">Net Asset Value, Beginning of Period</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c30" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:InvestmentCompanyMarketValuePerShare" scale="0" unitRef="usdPershares">14.63</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c7" decimals="2" format="ixt:num-dot-decimal" id="ix_63_fact" name="us-gaap:InvestmentCompanyMarketValuePerShare" scale="0" unitRef="usdPershares">29.25</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c102" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:InvestmentCompanyMarketValuePerShare" scale="0" unitRef="usdPershares">15.00</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c23" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:InvestmentCompanyMarketValuePerShare" scale="0" unitRef="usdPershares">75.00</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net investment loss <sup>(1)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c25" decimals="2" format="ixt:num-dot-decimal" id="ix_23_fact" name="us-gaap:InvestmentCompanyGainLossOnInvestmentPerShare" scale="0" sign="-" unitRef="usdPershares">0.17</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c13" decimals="2" format="ixt:num-dot-decimal" id="ix_24_fact" name="us-gaap:InvestmentCompanyGainLossOnInvestmentPerShare" scale="0" sign="-" unitRef="usdPershares">0.08</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c75" decimals="2" format="ixt:num-dot-decimal" id="ix_25_fact" name="us-gaap:InvestmentCompanyGainLossOnInvestmentPerShare" scale="0" sign="-" unitRef="usdPershares">0.06</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c15" decimals="2" format="ixt:num-dot-decimal" id="ix_26_fact" name="us-gaap:InvestmentCompanyGainLossOnInvestmentPerShare" scale="0" sign="-" unitRef="usdPershares">1.20</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net Realized and Unrealized Gain (Loss) on Investments and Futures Contracts <sup>(2)</sup></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c25" decimals="2" format="ixt:num-dot-decimal" id="ix_31_fact" name="cik0001793497:NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts" scale="0" unitRef="usdPershares">13.67</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c13" decimals="2" format="ixt:num-dot-decimal" id="ix_32_fact" name="cik0001793497:NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts" scale="0" sign="-" unitRef="usdPershares">24.73</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c75" decimals="2" format="ixt:num-dot-decimal" id="ix_33_fact" name="cik0001793497:NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts" scale="0" sign="-" unitRef="usdPershares">4.54</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c15" decimals="2" format="ixt:num-dot-decimal" id="ix_34_fact" name="cik0001793497:NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts" scale="0" unitRef="usdPershares">11.80</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Net Increase (Decrease) in Net Asset Value Resulting from Operations</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c25" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease" scale="0" unitRef="usdPershares">13.50</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c13" decimals="2" format="ixt:num-dot-decimal" id="ix_64_fact" name="us-gaap:InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease" scale="0" sign="-" unitRef="usdPershares">24.81</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c75" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease" scale="0" sign="-" unitRef="usdPershares">4.60</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c15" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease" scale="0" unitRef="usdPershares">10.60</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 4pt">Net Asset Value, End of Period</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c24" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:InvestmentCompanyMarketValuePerShare" scale="0" unitRef="usdPershares">28.13</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c5" decimals="2" format="ixt:num-dot-decimal" id="ix_65_fact" name="us-gaap:InvestmentCompanyMarketValuePerShare" scale="0" unitRef="usdPershares">4.44</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c101" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:InvestmentCompanyMarketValuePerShare" scale="0" unitRef="usdPershares">10.40</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c21" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:InvestmentCompanyMarketValuePerShare" scale="0" unitRef="usdPershares">85.60</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 4pt">Market Value Per Share, at June 30, 2023 and June 30, 2022</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c24" decimals="2" format="ixt:num-dot-decimal" name="cik0001793497:MarketValuePerShare" scale="0" unitRef="usdPershares">28.07</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c5" decimals="2" format="ixt:num-dot-decimal" id="ix_66_fact" name="cik0001793497:MarketValuePerShare" scale="0" unitRef="usdPershares">4.46</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c101" decimals="2" format="ixt:num-dot-decimal" name="cik0001793497:MarketValuePerShare" scale="0" unitRef="usdPershares">10.40</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c21" decimals="2" format="ixt:num-dot-decimal" name="cik0001793497:MarketValuePerShare" scale="0" unitRef="usdPershares">85.40</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total Return at Net Asset Value <sup>(4)</sup></b></span></td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c25" decimals="4" format="ixt:num-dot-decimal" id="ix_43_fact" name="us-gaap:InvestmentCompanyTotalReturn" scale="-2" unitRef="pure">92.28</ix:nonFraction></td><td style="font-weight: bold; text-align: left">%</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-<ix:nonFraction contextRef="c13" decimals="4" format="ixt:num-dot-decimal" id="ix_44_fact" name="us-gaap:InvestmentCompanyTotalReturn" scale="-2" sign="-" unitRef="pure">84.82</ix:nonFraction></td><td style="font-weight: bold; text-align: left">%</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-<ix:nonFraction contextRef="c75" decimals="4" format="ixt:num-dot-decimal" id="ix_45_fact" name="us-gaap:InvestmentCompanyTotalReturn" scale="-2" sign="-" unitRef="pure">30.67</ix:nonFraction></td><td style="font-weight: bold; text-align: left">%</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c15" decimals="4" format="ixt:num-dot-decimal" id="ix_46_fact" name="us-gaap:InvestmentCompanyTotalReturn" scale="-2" unitRef="pure">14.13</ix:nonFraction></td><td style="font-weight: bold; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total Return at Market Value <sup>(4)</sup></b></span></td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c25" decimals="4" format="ixt:num-dot-decimal" id="ix_47_fact" name="cik0001793497:TotalReturnAtMarketValue" scale="-2" unitRef="pure">91.47</ix:nonFraction></td><td style="font-weight: bold; text-align: left">%</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-<ix:nonFraction contextRef="c13" decimals="4" format="ixt:num-dot-decimal" id="ix_48_fact" name="cik0001793497:TotalReturnAtMarketValue" scale="-2" sign="-" unitRef="pure">84.67</ix:nonFraction></td><td style="font-weight: bold; text-align: left">%</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-<ix:nonFraction contextRef="c75" decimals="4" format="ixt:num-dot-decimal" id="ix_49_fact" name="cik0001793497:TotalReturnAtMarketValue" scale="-2" sign="-" unitRef="pure">30.67</ix:nonFraction></td><td style="font-weight: bold; text-align: left">%</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c15" decimals="4" format="ixt:num-dot-decimal" id="ix_50_fact" name="cik0001793497:TotalReturnAtMarketValue" scale="-2" unitRef="pure">13.87</ix:nonFraction></td><td style="font-weight: bold; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ratios to Average Net Assets: <sup>(5)</sup></b></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expense ratio <sup>(6)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c25" decimals="4" format="ixt:num-dot-decimal" id="ix_55_fact" name="us-gaap:InvestmentCompanyExpenseRatioAfterIncentiveAllocation" scale="-2" unitRef="pure">2.25</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c13" decimals="4" format="ixt:num-dot-decimal" id="ix_56_fact" name="us-gaap:InvestmentCompanyExpenseRatioAfterIncentiveAllocation" scale="-2" unitRef="pure">2.13</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c75" decimals="4" format="ixt:num-dot-decimal" id="ix_57_fact" name="us-gaap:InvestmentCompanyExpenseRatioAfterIncentiveAllocation" scale="-2" unitRef="pure">2.18</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c15" decimals="4" format="ixt:num-dot-decimal" id="ix_58_fact" name="us-gaap:InvestmentCompanyExpenseRatioAfterIncentiveAllocation" scale="-2" unitRef="pure">2.91</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Net Investment Loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-<ix:nonFraction contextRef="c25" decimals="4" format="ixt:num-dot-decimal" id="ix_59_fact" name="us-gaap:InvestmentCompanyTotalReturnAfterIncentiveFees" scale="-2" sign="-" unitRef="pure">1.84</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-<ix:nonFraction contextRef="c13" decimals="4" format="ixt:num-dot-decimal" id="ix_60_fact" name="us-gaap:InvestmentCompanyTotalReturnAfterIncentiveFees" scale="-2" sign="-" unitRef="pure">1.35</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-<ix:nonFraction contextRef="c75" decimals="4" format="ixt:num-dot-decimal" id="ix_61_fact" name="us-gaap:InvestmentCompanyTotalReturnAfterIncentiveFees" scale="-2" sign="-" unitRef="pure">0.50</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-<ix:nonFraction contextRef="c15" decimals="4" format="ixt:num-dot-decimal" id="ix_62_fact" name="us-gaap:InvestmentCompanyTotalReturnAfterIncentiveFees" scale="-2" sign="-" unitRef="pure">0.67</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  </table></ix:continuation>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0in"></td><td style="width: 0.25in; text-align: left">(1)</td><td style="text-align: left">Net investment loss per share represents net investment loss
divided by the daily average shares of beneficial interest outstanding during the period.</td>
</tr></table>

<ix:continuation continuedAt="cik0001793497_ScheduleOfShareOutstandingTableTextBlock-c0_cont_6" id="cik0001793497_ScheduleOfShareOutstandingTableTextBlock-c0_cont_5"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0in"></td><td style="width: 0.25in; text-align: left">(2)</td><td style="text-align: left"><ix:footnote id="ix_10_footnote" xml:lang="en-US">Due to timing of capital share transactions, per share amounts
may not compare with amounts appearing elsewhere within these Financial Statements.</ix:footnote></td>
</tr></table></ix:continuation>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0in"></td><td style="width: 0.25in; text-align: left">(3)</td><td style="text-align: left">Market values are determined at the close of the applicable
primary listing exchange, which may be later than when the Funds' net asset value is calculated.</td>
</tr></table>

<ix:continuation continuedAt="cik0001793497_ScheduleOfShareOutstandingTableTextBlock-c0_cont_7" id="cik0001793497_ScheduleOfShareOutstandingTableTextBlock-c0_cont_6"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0in"></td><td style="width: 0.25in; text-align: left">(4)</td><td style="text-align: left"><ix:footnote id="ix_11_footnote" xml:lang="en-US">Percentages are not annualized for the period ended June 30,
2023 and June 30, 2022</ix:footnote></td>
</tr></table></ix:continuation>

<ix:continuation continuedAt="cik0001793497_ScheduleOfShareOutstandingTableTextBlock-c0_cont_8" id="cik0001793497_ScheduleOfShareOutstandingTableTextBlock-c0_cont_7"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0in"></td><td style="width: 0.25in; text-align: left">(5)</td><td style="text-align: left"><ix:footnote id="ix_12_footnote" xml:lang="en-US">Percentages are annualized.</ix:footnote></td>
</tr></table></ix:continuation>

<ix:continuation continuedAt="cik0001793497_ScheduleOfShareOutstandingTableTextBlock-c0_cont_9" id="cik0001793497_ScheduleOfShareOutstandingTableTextBlock-c0_cont_8"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0in"></td><td style="width: 0.25in; text-align: left">(6)</td><td style="text-align: left"><ix:footnote id="ix_14_footnote" xml:lang="en-US">The expense ratio would be 2.23% and 2.13% respectively, for
the six months ended June 30, 2023, and 2.01% and 2.84% for the six months ended June 30, 2022 if brokerage commissions and futures and
futures account fees were excluded.</ix:footnote></td>
</tr></table></ix:continuation>

<ix:continuation id="cik0001793497_ScheduleOfShareOutstandingTableTextBlock-c0_cont_9"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0in"></td><td style="width: 0.25in; text-align: left">(7)</td><td style="text-align: left"><ix:footnote id="ix_15_footnote" xml:lang="en-US">For 2x Long VIX Futures ETF, fianancial highlights have been
adjusted to reflect a 1:5 reverse stock split occurring on January 25, 2023, as if it occurred at the commencment of operations.</ix:footnote></td>
</tr></table></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="margin: 0; text-indent: 0.5in"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 27; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_ConcentrationRiskDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:ConcentrationRiskDisclosureTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 8 &#8211; RISK</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Correlation and Compounding Risk</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Funds do not seek to achieve their stated investment objective over a period
of time greater than a single day (as measured from NAV calculation time to NAV calculation time). The return of a Fund for a period longer
than a single day is the result of its return for each day compounded over the period and usually will differ in amount and possibly even
direction from the inverse (-1x) or two times (2x) the return of the Fund&#8217;s benchmark for the period. A Fund will lose money if
its benchmark performance is flat over time, and it is possible for a Fund to lose money over time even if the performance of its benchmark
increases in the case of UVIX (or decreases in the case of SVIX), as a result of daily rebalancing, the benchmark&#8217;s volatility,
compounding, and other factors. Compounding is the cumulative effect of applying investment gains and losses and income to the principal
amount invested over time. Gains or losses experienced over a given period will increase or reduce the principal amount invested from
which the subsequent period&#8217;s returns are calculated. The effects of compounding will likely cause the performance of a Fund to
differ from the Fund&#8217;s stated multiple times the return of its benchmark for the same period. The effect of compounding becomes
more pronounced as benchmark volatility and holding period increase. The impact of compounding will impact each shareholder differently
depending on the period of time an investment in a Fund is held and the volatility of the benchmark during the holding period of an investment
in the Fund. Longer holding periods, higher benchmark volatility, inverse exposure and greater leverage each affect the impact of compounding
on a Fund&#8217;s returns. Daily compounding of a Fund&#8217;s investment returns can dramatically and adversely affect its longer-term
performance during periods of high volatility. Volatility may be at least as important to a Fund&#8217;s return for a period as the return
of the Fund&#8217;s underlying benchmark.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Each Fund uses leverage and should produce daily returns that are more volatile than that of
its benchmark. For example, the daily return of UVIX should be approximately two times as volatile on a daily basis as is the return of
a fund with an objective of matching the same benchmark. The daily return of SVIX is designed to return the inverse (-1x) of the return
that would be expected of a fund with an objective of matching the same benchmark. The Funds are not appropriate for all investors and
present significant risks not applicable to other types of funds. The Funds use leverage and are riskier than similarly benchmarked exchange-traded
funds that do not use leverage. An investor should only consider an investment in a Fund if he or she understands the consequences of
seeking daily leveraged or daily inverse investment results. Shareholders who invest in the Funds should actively manage and monitor their
investments, as frequently as daily.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">While the Funds seek to meet their investment objectives, there is no guarantee they will do so.
Factors that may affect a Fund&#8217;s ability to meet its investment objective include: (1) the Sponsor&#8217;s ability to purchase and
sell Financial Instruments in a manner that correlates to a Fund&#8217;s objective; (2) an imperfect correlation between the performance
of Financial Instruments held by a Fund and the performance of the applicable benchmark; (3) bid-ask spreads on such Financial Instruments;
(4) fees, expenses, transaction costs, financing costs associated with the use of Financial Instruments and commission costs; (5) holding
or trading instruments in a market that has become illiquid or disrupted; (6) a Fund&#8217;s Share prices being rounded to the nearest
cent and/or valuation methodology; (7) changes to a benchmark Index that are not disseminated in advance; (8) the need to conform a Fund&#8217;s
portfolio holdings to comply with investment restrictions or policies or regulatory or tax law requirements; (9) early and unanticipated
closings of the markets on which the holdings of a Fund trade, resulting in the inability of the Fund to execute intended portfolio transactions;
(10) accounting standards; and (11) differences caused by a Fund obtaining exposure to only a representative sample of the components
of a benchmark, over weighting or under weighting certain components of a benchmark or obtaining exposure to assets that are not included
in a benchmark.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">A number of factors may affect a Fund&#8217;s ability to achieve a high degree of correlation with its benchmark, and
there can be no guarantee that a Fund will achieve a high degree of correlation. Failure to achieve a high degree of correlation may prevent
a Fund from achieving its investment objective. In order to achieve a high degree of correlation with their underlying benchmarks, the
Funds seek to rebalance their portfolios daily to keep exposure consistent with their investment objectives. Being materially under- or
over-exposed to the benchmark may prevent such Funds from achieving a high degree of correlation with such benchmark. Market disruptions
or closure, large amounts of assets into or out of the Funds, regulatory restrictions, extreme market volatility, and other factors will
adversely affect such Funds&#8217; ability to adjust exposure to requisite levels. The target amount of portfolio exposure is impacted
dynamically by the benchmarks&#8217; movements during each day. Other things being equal, more significant movement in the value of its
benchmark up or down will require more significant adjustments to a Fund&#8217;s portfolio. Because of this, it is unlikely that the Funds
will be perfectly exposed (i.e., --1x, -2x, as applicable) to its benchmark at the end of each day, and the likelihood of being materially
under- or over-exposed is higher on days when the benchmark levels are volatile near the close of the trading day.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Each Fund seeks to
rebalance its portfolio on a daily basis. The time and manner in which a Fund rebalances its portfolio may vary from day to day depending
upon market conditions and other circumstances at the discretion of the Sponsor. Unlike other funds that do not rebalance their portfolios
as frequently, each Fund may be subject to increased trading costs associated with daily portfolio rebalancing in order to maintain appropriate
exposure to the underlying benchmarks.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p></ix:nonNumeric><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 28; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><ix:continuation continuedAt="_ConcentrationRiskDisclosureTextBlock-c0_cont_2" id="_ConcentrationRiskDisclosureTextBlock-c0_cont_1"><p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Counterparty Risk</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Each Fund may use derivatives such
as swap agreements and forward contracts (collectively referred to herein as &#8220;derivatives&#8221;) in the manner described herein
as a means to achieve their respective investment objectives. The use of derivatives by a Fund exposes the Fund to counterparty risks.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><span style="text-decoration:underline">Regulatory Treatment</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Derivatives are generally traded
in OTC markets and have only recently become subject to comprehensive regulation in the United States. Cash- settled forwards are generally
regulated as &#8220;swaps&#8221;, whereas physically settled forwards are generally not subject to regulation (in the case of commodities
other than currencies) or subject to the federal securities laws (in the case of securities). Title VII of the Dodd-Frank Act (&#8220;Title
VII&#8221;) created a regulatory regime for derivatives, with the CFTC responsible for the regulation of swaps and the SEC responsible
for the regulation of &#8220;security-based swaps.&#8221; The SEC requirements have largely yet to be made effective, but the CFTC requirements
are largely in place. The CFTC requirements have included rules for some of the types of transactions in which the Funds will engage,
including mandatory clearing and exchange trading, reporting, and margin for OTC swaps. Title VII also created new categories of regulated
market participants, such as &#8220;swap dealers,&#8221; &#8220;security- based swap dealers,&#8221; &#8220;major swap participants,&#8221;
and &#8220;major security-based swap participants&#8221; who are, or will be, subject to significant new capital, registration, recordkeeping,
reporting, disclosure, business conduct and other regulatory requirements. The regulatory requirements under Title VII continue to be
developed and there may be further modifications that could materially and adversely impact the Funds, the markets in which a Fund trades
and the counterparties with which the Fund engages in transactions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As noted, the CFTC rules may not
apply to all of the swap agreements and forward contracts entered into by the Funds. Investors, therefore, may not receive the protection
of CFTC regulation or the statutory scheme of the Commodity Exchange Act (the &#8220;CEA&#8221;) in connection with each Fund&#8217;s
swap agreements or forward contracts. The lack of regulation in these markets could expose investors to significant losses under certain
circumstances, including in the event of trading abuses or financial failure by participants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><span style="text-decoration:underline">Counterparty Credit Risk</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Funds will be subject to the
credit risk of the counterparties to the derivatives. In the case of cleared derivatives, the Funds will have credit risk to the clearing
corporation in a similar manner as the Funds would for futures contracts. In the case of OTC derivatives, the Funds will be subject to
the credit risk of the counterparty to the transaction &#8211; typically a single bank or financial institution. As a result, a Fund is
subject to increased credit risk with respect to the amount it expects to receive from counterparties to OTC derivatives entered into
as part of that Fund&#8217;s principal investment strategy. If a counterparty becomes bankrupt or otherwise fails to perform its obligations
due to financial difficulties, a Fund could suffer significant losses on these contracts and the value of an investor&#8217;s investment
in a Fund may decline.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Funds have sought to mitigate
these risks by generally requiring that the counterparties for each Fund agree to post collateral for the benefit of the Fund, marked
to market daily, subject to certain minimum thresholds. However, there are no limitations on the percentage of assets each Fund may invest
in swap agreements or forward contracts with a particular counterparty. To the extent any such collateral is insufficient or there are
delays in accessing the collateral, the Funds will be exposed to counterparty risk as described above, including possible delays in recovering
amounts as a result of bankruptcy proceedings. The Funds typically enter into transactions only with major global financial institutions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">OTC derivatives of the type that
may be utilized by the Funds are generally less liquid than futures contracts because they are not traded on an exchange, do not have
uniform terms and conditions, and are generally entered into based upon the creditworthiness of the parties and the availability of credit
support, such as collateral, and in general, are not transferable without the consent of the counterparty. These agreements contain various
conditions, events of default, termination events, covenants and representations. The triggering of certain events or the default on certain
terms of the agreement could allow a party to terminate a transaction under the agreement and request immediate payment in an amount equal
to the net positions owed to the party under the agreement. For example, if the level of the Fund&#8217;s benchmark has a dramatic intraday
move that would cause a material decline in the Fund&#8217;s NAV, the terms of the swap may permit the counterparty to immediately close
out the transaction with the Fund. In that event, it may not be possible for the Fund to enter into another swap or to invest in other
Financial Instruments necessary to achieve the desired exposure consistent with the Fund&#8217;s objective. This, in turn, may prevent
the Fund from achieving its investment objective, particularly if the level of the Fund&#8217;s benchmark reverses all or part of its
intraday move by the end of the day.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 29; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><ix:continuation continuedAt="_ConcentrationRiskDisclosureTextBlock-c0_cont_3" id="_ConcentrationRiskDisclosureTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In addition, cleared derivatives
benefit from daily marking-to-market and settlement, and segregation and minimum capital requirements applicable to intermediaries. To
the extent the Fund enters into cleared swap transactions, the Fund will deposit collateral with a FCM in cleared swaps customer accounts,
which are required by CFTC regulations to be separate from its proprietary collateral posted for cleared swaps transactions. Cleared swap
customer collateral is subject to regulations that closely parallel the regulations governing customer segregated funds for futures transactions
but provide certain additional protections to cleared swaps collateral in the event of a clearing broker or clearing broker customer default.
For example, in the event of a default of both the clearing broker and a customer of the clearing broker, a clearing house is only permitted
to access the cleared swaps collateral in the legally separate (but operationally comingled) account of the defaulting cleared swap customer
of the clearing broker, as opposed to the treatment of customer segregated funds, under which the clearing house may access all of the
commingled customer segregated funds of a defaulting clearing broker. Derivatives entered into directly between two counterparties do
not necessarily benefit from such protections, particularly if entered into with an entity that is not registered as a &#8220;swap dealer&#8221;
with the CFTC. This exposes the Funds to the risk that a counterparty will not settle a transaction in accordance with its terms and conditions
because of a dispute over the terms of the contract (whether or not bona fide) or because of a credit or liquidity problem, thus causing
the Funds to suffer a loss.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Sponsor regularly reviews the performance of its counterparties
for, among other things, creditworthiness and execution quality. In addition, the Sponsor periodically considers the addition of new counterparties
and the counterparties used by a Fund may change at any time. Each day, the Funds disclose their portfolio holdings as of the prior Business
Day. Each Fund&#8217;s portfolio holdings identifies its counterparties, as applicable. This portfolio holdings information may be accessed
through the web on the Sponsor&#8217;s website at www.volatilityshares.com.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Each counterparty and/or any of its affiliates may be an
Authorized Participant or shareholder of a Fund, subject to applicable law.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The counterparty risk for cleared derivatives
transactions is generally lower than for OTC derivatives. Once a transaction is cleared, the clearing organization is substituted and
is a Fund&#8217;s counterparty on the derivative. The clearing organization guarantees the performance of the other side of the derivative.
Nevertheless, some risk remains, as there is no assurance that the clearing organization, or its members, will satisfy its obligations
to a Fund.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Leverage Risk</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Funds
may utilize leverage in seeking to achieve their respective investment objectives and will lose more money in market environments adverse
to their respective daily investment objectives than funds that do not employ leverage. The use of leveraged and/or inverse leveraged
positions increases the risk of total loss of an investor&#8217;s investment, even over periods as short as a single day.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For example, because UVIX includes
a two times (2x) multiplier, a single-day movement in the relevant benchmark approaching <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="cik0001793497:RelevantBenchmark" scale="-2" unitRef="pure">50</ix:nonFraction>% at any point in the day could result in the
total loss or almost total loss of an investor&#8217;s investment if that movement is contrary to the investment objective of the Fund
in which an investor has invested, even if such Fund&#8217;s benchmark subsequently moves in an opposite direction, eliminating all or
a portion of the movement. This would be the case with downward single-day or intraday movements in the underlying benchmark of a Fund
or upward single-day or intraday movements in the benchmark of a Fund, even if the underlying benchmark maintains a level greater than
zero at all times.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Liquidity Risk</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Financial Instruments cannot always
be liquidated at the desired price. It is difficult to execute a trade at a specific price when there is a relatively small volume of
buy and sell orders in a market. A market disruption can also make it difficult to liquidate a position or find a swap or forward contract
counterparty at a reasonable cost. Market illiquidity may cause losses for the Funds. The large size of the positions which the Funds
may acquire increases the risk of illiquidity by both making their positions more difficult to liquidate and increasing the losses incurred
while trying to do so. Any type of disruption or illiquidity will potentially be exacerbated due to the fact that the Funds will typically
invest in Financial Instruments related to one benchmark, which in many cases is highly concentrated.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 30; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><ix:continuation id="_ConcentrationRiskDisclosureTextBlock-c0_cont_3"><p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#8220;Contango&#8221; and &#8220;Backwardation&#8221;
Risk</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Funds typically hold futures
contracts. As the futures contracts near expiration, they are generally replaced by contracts that have a later expiration. Thus, for
example, a contract purchased and held in November 2019 may specify a January 2020 expiration. As that contract nears expiration, it may
be replaced by selling the January 2020 contract and purchasing the contract expiring in March 2020. This process is referred to as &#8220;rolling.&#8221;
Rolling may have a positive or negative impact on performance. For example, historically, the prices of certain types of futures contracts
have frequently been higher for contracts with shorter-term expirations than for contracts with longer-term expirations, which is referred
to as &#8220;backwardation.&#8221; In these circumstances, absent other factors, the sale of the January 2020 contract would take place
at a price that is higher than the price at which the March 2020 contract is purchased, thereby creating a gain in connection with rolling.
While certain types of futures contracts have historically exhibited consistent periods of backwardation, backwardation will likely not
exist in these markets at all times.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Since the introduction of VIX
futures contracts, there have frequently been periods where VIX futures prices reflect higher expected volatility levels further out in
time. This can result in a loss from &#8220;rolling&#8221; the VIX futures to maintain the constant weighted average maturity of the applicable
Fund benchmark. Losses from exchanging a lower priced VIX future for a higher priced longer-term future in the rolling process could adversely
affect the value of a Fund and, accordingly, decrease the return of a Fund.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Natural Disaster/Epidemic Risk</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Natural or environmental disasters,
such as earthquakes, fires, floods, hurricanes, tsunamis and other severe weather-related phenomena generally, and widespread disease,
including pandemics and epidemics (for example, the novel coronavirus COVID-19), have been and can be highly disruptive to economies and
markets and have recently led, and may continue to lead, to increased market volatility and significant market losses. Such natural disaster
and health crises could exacerbate political, social, and economic risks previously mentioned, and result in significant breakdowns, delays,
shutdowns, social isolation, and other disruptions to important global, local and regional supply chains affected, with potential corresponding
results on the operating performance of the Funds and their investments. A climate of uncertainty and panic, including the contagion of
infectious viruses or diseases, may adversely affect global, regional, and local economies and reduce the availability of potential investment
opportunities, and increases the difficulty of performing due diligence and modeling market conditions, potentially reducing the accuracy
of financial projections. Under these circumstances, the Funds may have difficulty achieving their investment objectives which may adversely
impact performance. Further, such events can be highly disruptive to economies and markets, significantly disrupt the operations of individual
companies (including, but not limited to, the Funds&#8217; Sponsor and third party service providers), sectors, industries, markets, securities
and commodity exchanges, currencies, interest and inflation rates, credit ratings, investor sentiment, and other factors affecting the
value of the Funds&#8217; investments. These factors can cause substantial market volatility, exchange trading suspensions and closures
and can impact the ability of the Funds to complete redemptions and otherwise affect Fund performance and Fund trading in the secondary
market. A widespread crisis may also affect the global economy in ways that cannot necessarily be foreseen at the current time. How long
such events will last and whether they will continue or recur cannot be predicted. Impacts from these events could have significant impact
on a Fund&#8217;s performance, resulting in losses to your investment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Risk that Current Assumptions and Expectations Could
Become Outdated As a Result of Global Economic Shocks</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The onset of the novel coronavirus
(COVID-19) has caused significant shocks to global financial markets and economies, with many governments taking extreme actions to slow
and contain the spread of COVID-19. These actions have had, and likely will continue to have, a severe economic impact on global economies
as economic activity in some instances has essentially ceased. Financial markets across the globe are experiencing severe distress at
least equal to what was experienced during the global financial crisis in 2008. In March 2020, U.S. equity markets entered a bear market
in the fastest such move in the history of U.S. financial markets. Contemporaneous with the onset of the COVID-19 pandemic in the US,
oil experienced shocks to supply and demand, impacting the price and volatility of oil. The global economic shocks being experienced as
of the date hereof may cause the underlying assumptions and expectations of the Funds to become outdated quickly or inaccurate, resulting
in significant losses.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:SubsequentEventsTextBlock"><p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">NOTE 9 &#8211; SUBSEQUENT EVENTS</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Management has evaluated the possibility
of subsequent events existing in the Trust&#8217;s and the Funds&#8217; financial statements through the date the financial statements
were issued. Management has determined that there are no material events that would require disclosure in the Trust&#8217;s or the Funds&#8217;
financial statements through this date.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 31; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><div><a id="k_003"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Item 2. Management&#8217;s Discussion and Analysis of
Financial Condition and Results of Operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 11.65pt; margin-bottom: 0pt"><i>This information should be read in conjunction with
the financial statements and notes to the financial statements included with this Quarterly Report on Form 10-Q. The discussion and analysis
that follows may contain statements that relate to future events or future performance. In some cases, such forward-looking statements
can be identified by terminology such as &#8220;will,&#8221; &#8220;may,&#8221; &#8220;should,&#8221; &#8220;expect,&#8221; &#8220;plan,&#8221;
&#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;predict,&#8221; &#8220;potential,&#8221; &#8220;intend,&#8221;
&#8220;project,&#8221; &#8220;seek&#8221; or the negative of these terms or other comparable terminology. None of the Trust, the Sponsor,
the Trustee, or the Administrator assumes responsibility for the accuracy or completeness of any forward-looking statements. Except as
expressly required by federal securities laws, none of the Trust, the Sponsor, the Trustee, or the Administrator is under a duty to update
any of the forward-looking statements to conform such statements to actual results or to a change in expectations or predictions.</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 9.3pt; margin-bottom: 0pt"><i>Because forward-looking statements relate to the future,
they are subject to inherent uncertainties, risk and changes in circumstances that are difficult to predict and many of which are outside
of the Funds&#8217; control. The Funds&#8217; forward-looking statements are not guarantees of future results and conditions and important
factors, risks and uncertainties in the markets for financial instruments that the Funds trade, in the markets for related physical commodities,
in the legal and regulatory regimes applicable to the Sponsor, the Funds, and the Funds&#8217; service providers, and in the broader economy
may cause the Funds&#8217; actual results to differ materially from those expressed in forward-looking statements.</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Introduction</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 11.65pt; margin-bottom: 0pt">VS Trust (the &#8220;Trust&#8221;) is a Delaware statutory
trust formed on October 24, 2019 and is currently organized into two separate series (each, a &#8220;Fund&#8221; and collectively, the
&#8220;Funds&#8221;). As of June 30, 2023, the following two series of the Trust have commenced investment operations: -1x Short VIX Futures
ETF and 2x Long VIX Futures ETF. Each of the Funds listed above issues common units of beneficial interest (&#8220;Shares&#8221;), which
represent units of fractional undivided beneficial interest in and ownership of only that Fund. The Shares of each Fund are listed on
the Cboe BZX Exchange (&#8220;Cboe BZX&#8221;).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 11.65pt; margin-bottom: 0pt">The Trust had no operations prior to March 28, 2022,
other than matters relating to its organization, the registration of each series under the Securities Act of 1933, as amended.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 11.65pt; margin-bottom: 0pt">The Sponsor also serves as the Trust&#8217;s commodity
pool operator. Wilmington Trust Company serves as the Trustee of the Trust (the &#8220;Trustee&#8221;). The Funds are commodity pools,
as defined under the Commodity Exchange Act (the &#8220;CEA&#8221;), and the applicable regulations of the Commodity Futures Trading Commission
(the &#8220;CFTC&#8221;) and are operated by the Sponsor, a commodity pool operator registered with the CFTC. The Trust is not an investment
company registered under the Investment Company Act of 1940, as amended.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 11.65pt; margin-bottom: 0pt">SVIX seeks daily investment results, before fees and
expenses, that correspond to the performance of the Short VIX Futures Index (the &#8220;Short Index&#8221;) for a single day, not for
any other period. UVIX seeks daily investment results, before fees and expenses, that correspond to twice the performance of the Long
VIX Futures Index (the &#8220;Long Index&#8221;). A &#8220;single day&#8221; is measured from the time a Fund calculates its net asset
value (&#8220;NAV&#8221;) to the time of the Fund&#8217;s next NAV calculation. The NAV calculation time for a Fund typically is 4:00
p.m. (Eastern Time).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 11.65pt; margin-bottom: 0pt">The Funds seek to achieve their investment objective
through the appropriate amount of exposure to the VIX futures contracts included in their respective index. The Funds also have the ability
to engage in options transactions, swaps, forward contracts and other instruments in order to achieve their investment objective, in the
manner and to the extent described herein.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">SVIX is not benchmarked to the inverse of, and UVIX is
not benchmarked to twice, the widely referenced VIX. The Short Index and the inverse of the VIX are separate measurements and can be
expected to perform very differently. The Long Index and twice the VIX also are separate measurements and can be expected to perform
very differently. As such, SVIX can be expected to perform very differently from the inverse (-1x) of the performance of the VIX
over any period, and UVIX can be expected to perform very differently from twice (2x) of the performance of the VIX over any
period.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 32; Options: NewSection; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">The
Funds continuously offer and redeem Shares in blocks of at least 10,000 Shares (each such block, a &#8220;Creation Unit&#8221;). Only
Authorized Participants (as defined herein) may purchase and redeem Shares from a Fund and then only in Creation Units. An Authorized
Participant is an entity that has entered into an Authorized Participant Agreement with the Trust and Volatility Shares LLC (the &#8220;Sponsor&#8221;).
Shares are offered on a continuous basis to Authorized Participants in Creation Units at NAV. Authorized Participants may then offer to
the public, from time to time, Shares from any Creation Unit they create at a per-Share market price. The form of Authorized Participant
Agreement and the related Authorized Participant Procedures Handbook set forth the terms and conditions under which an Authorized Participant
may purchase or redeem a Creation Unit. Authorized Participants will not receive from a Fund, the Sponsor, or any of their affiliates,
any fee or other compensation in connection with their sale of Shares to the public. An Authorized Participant may receive commissions
or fees from investors who purchase Shares through their commission or fee-based brokerage accounts.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">The form of Authorized Participant Agreement and related
Authorized Participant Handbook set forth the terms and conditions under which an Authorized Participant may purchase or redeem a Creation
Unit. Authorized Participants do not receive from any Fund, the Sponsor, or any of their affiliates, any underwriting fees or compensation
in connection with their sale of Shares to the public.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">The
Sponsor maintains a website at www.volatilityshares.com, through which monthly account statements and the Trust&#8217;s Quarterly
Reports on Form 10-Q, Current Reports on Form 8-K and amendments to those reports filed or furnished pursuant to Section 13(a) or
15(d) of the Securities Exchange Act of 1934, as amended (the &#8220;1934 Act&#8221;), can be accessed free of charge, as soon as
reasonably practicable after such material is electronically filed with, or furnished to, the U.S. Securities and Exchange
Commission (the &#8220;SEC&#8221;). Additional information regarding the Trust may also be found on the SEC&#8217;s EDGAR database
at www.sec.gov.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Liquidity and Capital Resources</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">In order
to collateralize derivatives positions in indices, commodities or currencies, a portion of the NAV of each Fund is held in cash and/or
U.S. Treasury securities, agency securities, or other high credit quality short term fixed-income or similar securities (such as shares
of money market funds, bank deposits, bank money market accounts, certain variable rate-demand notes and repurchase agreements collateralized
by government securities. A portion of these investments may be posted as collateral in connection with swap agreements, futures, and/or
forward contracts. The percentage that U.S. Treasury bills and other short-term fixed-income securities bear to the shareholders&#8217;
equity of each Fund varies from period to period as the market values of the underlying swaps, futures contracts and forward contracts
change.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">Interest Income for the three months ended June 30, 2023
and June 30, 2022 were as follows.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.4pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Fund</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Three Months Ended <br/>
June 30, <br/>
2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Three Months Ended <br/>
June 30, <br/>
2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">-1x Short VIX Futures ETF</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">74,800</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">18,977</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">2x Long VIX Futures ETF</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">301,835</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">16,778</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Total Trust</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">376,635</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">35,755</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">Interest Income for the six months ended June 30, 2023 and
June 30, 2022 were as follows.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Fund</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Six Months Ended<br/>
 June 30, <br/>
2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Six Months Ended<br/>
 June 30, <br/>
2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">-1x Short VIX Futures ETF</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">121,531</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">18,984</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">2x Long VIX Futures ETF</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">434,271</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">16,782</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Total Trust</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">555,802</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">35,766</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>Futures
Contracts</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">A futures contract is a standardized contract traded on, or subject to the rules of, an exchange that calls for the
future delivery of a specified quantity and type of a particular underlying asset at a specified time and place or alternatively may call
for cash settlement. Futures contracts are traded on a wide variety of underlying assets, including bonds, interest rates, agricultural
products, stock indexes, currencies, energy, metals, economic indicators and statistical measures. The notional size and calendar term
futures contracts on a particular underlying asset are identical and are not subject to any negotiation, other than with respect to price
and the number of contracts traded between the buyer and seller. A Fund generally deposits cash and/or securities with an FCM for its
open positions in futures contracts, which may, in turn, transfer such deposits to the clearinghouse to protect the clearing house against
non-payment by the Fund. The clearing house becomes substituted for each counterparty to a futures contract, and, in effect, guarantees
performance. In addition, the FCM may require a Fund to deposit collateral in excess of the clearing house&#8217;s margin requirements
for the FCM&#8217;s own protection.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 33; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Certain futures contracts, including stock index contracts, VIX futures contracts and certain commodity futures contracts settle in cash.
The cash settlement amount reflects the difference between the contract purchase/sale price and the contract settlement price. The cash
settlement mechanism avoids the potential for either side to have to deliver the underlying asset. For other futures contracts, the contractual
obligations of a buyer or seller may generally be satisfied by taking or making physical delivery of the underlying asset or by making
an offsetting sale or purchase of an identical futures contract on the same or linked exchange before the designated date of delivery.
The difference between the price at which the futures contract is purchased or sold and the price paid for the offsetting sale or purchase,
after allowance for brokerage commissions and exchange fees, constitutes the profit or loss to the trader.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Futures contracts involve,
to varying degrees, elements of market risk and exposure to loss in excess of the amounts of variation margin, which are the amounts of
cash that a Fund agrees to pay to or receive from FCMs equal to the daily fluctuation in the value of a futures contract. Additional risks
associated with the use of futures contracts are imperfect correlation between movements in the price of the futures contracts and the
level of the underlying benchmark and the possibility of an illiquid market for a futures contract. With futures contracts, there is minimal
but some counterparty risk to a Fund since futures contracts are exchange traded and the exchange&#8217;s clearing house, as counterparty
to all exchange-traded futures contracts, effectively guarantees futures contracts against default. Many futures exchanges and boards
of trade limit the amount of fluctuation permitted in futures contract prices during a single trading day. Once the daily limit has been
reached in a particular contract, no trades may be made that day at a price beyond that limit or trading may be suspended for specified
times during the trading day. Futures contracts prices could move to the limit for several consecutive trading days with little or no
trading, thereby preventing prompt liquidation of futures positions and potentially subjecting a Fund to substantial losses. If trading
is not possible or if a Fund determines not to close a futures position in anticipation of adverse price movements, the Fund may be required
to make daily cash payments of variation margin.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>Futures
Account Agreements</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Each Fund has entered into a written agreement (each, a &#8220;Futures
Account Agreement&#8221;) with one or more FCMs governing the terms of futures transactions of a Fund cleared by such FCM. Each FCM has
its own agreement and other documentation used for establishing customer relationships. As such, the terms of the Futures Account Agreement
and other documentation that a Fund has with a particular FCM may differ in material respects from that with another FCM.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Most Futures
Account Agreements do not require the FCM to enter into new transactions or maintain existing transactions with a Fund. In general, each
FCM is permitted to terminate its agreement with a Fund at any time in its sole discretion. In addition, an FCM generally will have the
discretion to set margin requirements and/or position limits that would be in addition to any margin requirements and/or position limits
required by applicable law, set by the exchange, or set by the clearing house that clears the futures contracts in which a Fund transacts.
As a result, a Fund&#8217;s ability to engage in futures transactions or maintain open positions in such contracts will be dependent on
the willingness of its FCMs to continue to accept or maintain such transactions on terms that are economically appropriate for a Fund&#8217;s
investment strategy.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">When a Fund has an open futures contract position, it is subject to at least daily variation margin calls by an FCM
that could be substantial in the event of adverse price movements. Because futures contracts may require only a small initial investment
in the form of a deposit or margin, they may involve a high degree of leverage. A Fund with open positions is subject to maintenance or
variance margin on its open positions. If a Fund has insufficient cash to meet daily variation margin requirements, it may need to sell
Financial Instruments at a time when such sales are disadvantageous. Futures markets are highly volatile and the use of or exposure to
futures contracts may increase volatility of a Fund&#8217;s NAV.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Margin posted by a Fund to an FCM typically will be held by relevant
exchange&#8217;s clearing house (in the case of clearing house-required margin) or the FCM (in the case of &#8220;house&#8221; margin
requirements of the FCM). In the event that market movements favorable to a Fund result in the Fund having posted more margin than is
required, the Fund typically would have a right to return of margin from the FCM. However, the timing of such return may be uncertain.
As a result, it is possible that a Fund may face liquidity constraints including potential delays in its ability to pay redemption proceeds,
where margin is not immediately returned by an FCM.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 34; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->-</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">In the event that a Fund fails to comply with its obligations under a Futures Account Agreement (including, for example, failing to deliver
the margin required by an FCM on a timely basis), the Futures Account Agreement typically will provide the FCM with broad discretion to
take remedial action against the Fund. Among other things, the FCM typically will have the right, upon the occurrence of such a failure
by a Fund, to terminate any or all futures contracts in the Fund&#8217;s account with that FCM, to sell the collateral posted as margin
by the Fund, to close out any open positions of the Fund in whole or in part, and to cancel any or all pending transactions with the Fund.
Futures Account Agreements typically provide that the Fund will remain liable for paying to the relevant FCM, on demand, the amount of
any deficiency in a Fund&#8217;s account with that FCM.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">The Futures Account Agreement between the Fund and an FCM generally requires the
Fund to indemnify and hold harmless the FCM, its directors, officers, employees, agents and affiliates (collectively, &#8220;indemnified
persons&#8221;) from and against all claims, damages, losses and costs (including reasonable attorneys&#8217; fees) incurred by the indemnified
persons, in connection with: (1) any failure by the Fund to perform its obligations under the Futures Account Agreement and the FCM&#8217;s
exercise of its rights and remedies thereunder; (2) any failure by the Fund to comply with applicable law; (3) any action reasonably taken
by the indemnified persons pursuant to the Futures Account Agreement to comply with applicable law; and (4) any actions taken by the FCM
in reliance on instructions, notices and other communications that the FCM and its relevant personnel, as applicable, reasonably believes
to originate from a person authorized to act on behalf of the Fund.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">To the extent that the Fund trades in futures contracts on U.S. exchanges,
the assets deposited by the Fund with the FCMs (or another eligible financial institution, as applicable) as margin must be segregated
pursuant to the regulations of the CFTC. Such segregated funds may be invested only in a limited range of instruments &#8212; principally
U.S. government obligations to margin futures and forward contract positions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>Options</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">An option is a contract that gives the purchaser
of the option, in return for the premium paid, the right to buy an underlying reference instrument, such as a specified security index,
or other instrument, from the writer of the option (in the case of a call option), or to sell a specified reference instrument to the
writer of the option (in the case of a put option) at a designated price during the term of the option. The premium paid by the buyer
of an option will reflect, among other things, the relationship of the exercise price to the market price and the volatility of the underlying
reference instrument, the remaining term of the option, supply, demand or interest rates. An American style put or call option may be
exercised at any time during the option period while a European style put or call option may be exercised only upon expiration or during
a fixed period prior thereto. Put and call options are traded on national securities exchanges and in the OTC market. Options traded on
national securities exchanges are within the jurisdiction of the SEC or other appropriate national securities regulator, as are securities
traded on such exchanges. As a result, many of the protections provided to traders on organized exchanges will be available with respect
to such transactions. In particular, all option positions entered into on a national securities exchange in the United States are cleared
and guaranteed by the Options Clearing Corporation, thereby reducing the risk of counterparty default. Furthermore, a liquid secondary
market in options traded on a national securities exchange may be more readily available than in the OTC market, potentially permitting
a Fund to liquidate open positions at a profit prior to exercise or expiration, or to limit losses in the event of adverse market movements.
There is no assurance, however, that higher than anticipated trading activity or other unforeseen events might not temporarily render
the capabilities of the Options Clearing Corporation inadequate, and thereby result in the exchange instituting special procedures which
may interfere with the timely execution of a Fund&#8217;s orders to close out open options positions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>Swap
Agreements</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Swaps are contracts
that have traditionally been entered into primarily by institutional investors in OTC markets for a specified period ranging from a day
to many years. Certain types of swaps may be cleared, and certain types are, in fact, required to be cleared. The types of swaps that
may be cleared are generally limited to only swaps where the most liquidity exists and a clearing organization is willing to clear the
trade on standardized terms. Swaps with customized terms or those for which significant market liquidity does not exist are generally
not able to be cleared.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 35; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->-</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">In a standard swap transaction, the parties agree to exchange the returns on, among other things, a particular predetermined security,
commodity, interest rate, or index for a fixed or floating rate of return (the &#8220;interest rate leg,&#8221; which will also include
the cost of borrowing for short swaps) in respect of a predetermined notional amount. The notional amount of the swap reflects the extent
of a Fund&#8217;s total investment exposure under the swap.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">In the case of futures contracts-based indexes, such as those used by a Fund,
the reference interest rate typically is zero, although a financing spread or fee is generally still applied. Transaction or commission
costs are reflected in the benchmark level at which the transaction is entered into. The gross returns to be exchanged are calculated
with respect to the notional amount and the benchmark returns to which the swap is linked. Swaps are usually closed out on a net basis,
i.e., the two payment streams are netted out in a cash settlement on the payment date specified in the agreement, with the parties receiving
or paying, as the case may be, only the net amount of the two payments. Thus, while the notional amount reflects a Fund&#8217;s total
investment exposure under the swap (i.e., the entire face amount or principal of a swap), the net amount is the Fund&#8217;s current obligations
(or rights) under the swap. That is the amount to be paid or received under the agreement based on the relative values of the positions
held by each party to the agreement on any given termination date.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Swaps may also expose a Fund to liquidity risk. Although a Fund may
have the ability to terminate a swap at any time, doing so may subject the Fund to certain early termination charges. In addition, there
may not be a liquid market within which to dispose of an outstanding swap even if a permitted disposal might avoid an early termination
charge. Uncleared swaps generally are not assignable except by agreement between the parties to the swap, and generally no party or purchaser
has any obligation to permit such assignments.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Swaps involve, to varying degrees, elements of market risk and exposure to loss in excess
of the amount which would be reflected on a Fund&#8217;s Statement of Financial Condition. In addition to market risk and other risks,
the use of swaps also comes with counterparty credit risk &#8212; i.e., the inability of a counterparty to a swap to perform its obligations.
A Fund that invests in swaps bears the risk of loss of the net amount, if any, expected to be received under a swap agreement in the event
of the default or bankruptcy of a swap counterparty. A Fund enters or intends to enter into swaps only with major, global financial institutions.
However, there are no limitations on the percentage of its assets a Fund may invest in swaps with a particular counterparty.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">A Fund that
invests in swaps may use various techniques to minimize counterparty credit risk. A Fund that invests in swaps generally enters into arrangements
with its counterparties whereby both sides exchange collateral on a mark-to-market basis. In addition, the Fund may post &#8220;initial
margin&#8221; or &#8220;independent amount&#8221; to counterparties in swaps. Such collateral serves as protection for the counterparty
in the event of a failure by the Fund and is in addition to any mark-to-market collateral that (i.e., the Fund may post initial margin
to the counterparty even where the counterparty would owe money to the Fund if the swap were to be terminated). The amount of initial
margin posted by the Fund may vary depending on the risk profile of the swap. The collateral, whether for mark-to-market or for initial
margin, generally consists of cash and/or securities.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Collateral posted by a Fund to a counterparty in connection with uncleared derivatives
transactions is generally held for the benefit of the counterparty in a segregated tri-party account at a third-party custodian to protect
the counterparty against non-payment by the Fund. In the event of a default by a Fund where the counterparty is owed money in the uncleared
swap transaction, such counterparty will seek withdrawal of this collateral from the segregated account.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Collateral posted by the counterparty
to a Fund is typically held for the benefit of the Fund in a segregated tri-party account at a third-party custodian. In the event of
a default by the counterparty where the Fund is owed money in the uncleared swap transaction, the Fund will seek withdrawal of this collateral
from the segregated account. The Fund may incur certain costs exercising its right with respect to the collateral.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Notwithstanding the
use of collateral arrangements, to the extent any collateral provided to a Fund is insufficient or there are delays in accessing the collateral,
a Fund will be exposed to counterparty risk as described above, including possible delays in recovering amounts as a result of bankruptcy
proceedings.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b>Off-Balance
Sheet Arrangements and Contractual Obligations</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">As of June 30, 2023, the Funds have not used, nor do they expect
to use in the future, special purpose entities to facilitate off-balance sheet financing arrangements and have no loan guarantee arrangements
or off-balance sheet arrangements of any kind other than agreements entered into in the normal course of business, which may include indemnification
provisions related to certain risks service providers undertake in performing services which are in the best interests of the Funds. While
each Fund&#8217;s exposure under such indemnification provisions cannot be estimated, these general business indemnifications are not
expected to have a material impact on a Fund&#8217;s financial position.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 36; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->-</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Management fee payments made to the Sponsor are calculated
as a fixed percentage of each Fund&#8217;s NAV. As such, the Sponsor cannot anticipate the payment amounts that will be required under
these arrangements for future periods as NAVs are not known until a future date. The agreement with the Sponsor may be terminated by either
party upon 30 days written notice to the other party.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Critical Accounting Policies</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Preparation of the financial statements and related disclosures
in compliance with accounting principles generally accepted in the United States of America requires the application of appropriate accounting
rules and guidance, as well as the use of estimates. The Trust&#8217;s and the Funds&#8217; application of these policies involves judgments
and actual results may differ from the estimates used.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Each Fund has significant exposure to Financial Instruments.
The Funds hold a significant portion of their assets in futures, all of which are recorded on a trade date basis and at fair value in
the financial statements, with changes in fair value reported in the Statements of Operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">The use of fair value to measure Financial Instruments,
with related unrealized gains or losses recognized in earnings in each period, is fundamental to the Trust&#8217;s and the Funds&#8217;
financial statements. The fair value of a Financial Instrument is the amount that would be received to sell an asset or paid to transfer
a liability in an orderly transaction between market participants at the measurement date (the exit price).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">For financial reporting purposes, the Funds value investments
based upon the closing price in their primary markets. Accordingly, the investment valuations in these financial statements may differ
from those used in the calculation of certain Funds&#8217; final creation/redemption NAV for the period ended June 30, 2023.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Short-term investments are valued at amortized cost which
approximates fair value for daily NAV purposes. For financial reporting purposes, short-term investments are valued at their market price
using information provided by a third-party pricing service or market quotations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Derivatives (e.g., futures contracts, options, swap agreements)
are generally valued using independent sources and/or agreements with counterparties or other procedures as determined by the Sponsor.
Futures contracts, are generally valued at the last settled price on the applicable exchange on which that future trades. Futures contracts
valuations are typically categorized as Level I in the fair value hierarchy. Swap agreement valuations are typically categorized as Level
II in the fair value hierarchy. The Sponsor may in its sole discretion choose to determine a fair value price as the basis for determining
the market value of such position. Such fair value prices would be generally determined based on available inputs about the current value
of the underlying financial instrument or commodity and would be based on principles that the Sponsor deems fair and equitable so long
as such principles are consistent with normal industry standards. The Sponsor may fair value an asset of a Fund pursuant to the policies
the Sponsor has adopted, which are consistent with normal industry standards. Depending on the source and relevant significance of valuation
inputs, these instruments may be classified as Level II or Level III in the fair value hierarchy.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Fair value pricing may require subjective determinations
about the value of an investment. While each Fund&#8217;s policy is intended to result in a calculation of the Fund&#8217;s NAV that fairly
reflects investment values as of the time of pricing, the Funds cannot ensure that fair values determined by the Sponsor or persons acting
at their direction would accurately reflect the price that the Fund could obtain for an investment if it were to dispose of that investment
as of the time of pricing (for instance, in a forced or distressed sale).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">The prices used by a Fund may differ from the value that
would be realized if the investments were sold and the differences could be material to the financial statements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">The Funds disclose the fair value of their investments
in a hierarchy that prioritizes the inputs to valuation techniques used to measure fair value.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Discounts on short-term securities purchased
are amortized and reflected as Interest Income in the Statements of Operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 7.7pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Realized gains (losses) and changes in unrealized gain (loss)
on open investments are determined on a specific identification basis and recognized in the Statements of Operations in the period in
which the contract is closed or the changes occur, respectively.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Each Fund pays its respective brokerage commissions, including
applicable exchange fees, NFA fees, give up fees, pit futures account fees and other transaction related fees and expenses charged in
connection with trading activities for each Fund&#8217;s investment in U.S. Commodity Futures Trading Commission regulated investments.
Brokerage commissions on futures contracts are recognized on a half-turn basis. The Sponsor is currently paying brokerage commissions
in VIX futures contracts exceed variable create/redeem fees collected by more than 0.02% of the Fund&#8217;s average net assets annually.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 37; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->-</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="k_004"></a></div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
3. Quantitative and Qualitative Disclosures About Market Risk.</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Quantitative
Disclosure</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Equity
Market Volatility Sensitivity</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
of the Funds is exposed to certain risks pertaining to the use of Financial Instruments. Each Fund is exposed to equity market volatility
risk through its holdings of Financial Instruments.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
tables below provide information about each Fund&#8217;s Financial Instruments. As of June 30, 2023 and December 31, 2022, each of the Fund&#8217;s
positions were as follows:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">-1x
Short VIX Futures ETF</span></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2023, SVIX was exposed to inverse equity market volatility risk through its holding of VIX futures contracts. The following
tables provide information about the Fund&#8217;s positions in VIX futures contracts as of June 30, 2023 and December 31, 2022, which were
sensitive to equity market volatility risk.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td colspan="21" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Futures Positions as of June 30, 2023</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid">Contract</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Long or Short</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Expiration</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Contracts</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Valuation Price</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Contract Multiplier</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Notional Amount at Value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="white-space: nowrap; width: 28%; text-align: left">VIX Futures (Cboe)</td><td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: center; padding-left: 0pt">Short</td><td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: center; padding-left: 0pt">July, 2023</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(2,590</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">14.97</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(38,772,300</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">VIX Futures (Cboe)</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 0pt">Short</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 0pt">August, 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,883</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16.36</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(30,805,880</td><td style="text-align: left">)</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td colspan="21" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Futures Positions as of December 31, 2022</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Contract</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Long or Short</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Expiration</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Contracts</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Valuation Price</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Contract Multiplier</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Notional Amount at Value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; text-align: left">VIX Futures (Cboe)</td><td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: center">Short</td><td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: center">January, 2023</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(1,150</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">23.16</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(26,634,000</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">VIX Futures (Cboe)</td><td>&#160;</td>
    <td style="text-align: center">Short</td><td>&#160;</td>
    <td style="text-align: center">February,&#160;2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(804</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">24.57</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(19,754,280</td><td style="text-align: left">)</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
short futures notional values are calculated by multiplying the number of contracts held times the valuation price times the contract
multiplier. The short notional values will increase (decrease) proportionally with decreases (increases) in the price of the futures
contract. Additional gains (losses) associated with these contracts will be equal to any such subsequent decreases (increases) in short
notional values, before accounting for spreads or transaction or financing costs. The Fund will generally attempt to adjust its position
in Financial Instruments each day to have -$1.00 of short exposure to the Index for every $1.00 of net assets. Future period returns,
before fees and expenses, cannot be estimated simply by estimating the return of the Index and multiplying by negative one-half. See
&#8220;Item 1A. Risk Factors&#8221; in the Annual Report on Form 10-K for additional information regarding performance for periods longer
than a single day.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">2x
Long VIX Futures ETF</span></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2023, UVIX was exposed to equity market volatility risk through its holding of VIX futures contracts. The following tables
provide information about the Fund&#8217;s positions in these Financial Instruments as of June 30, 2023 and December 31, 2022, which were
sensitive to equity market volatility risk.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td colspan="21" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Futures Positions as of June 30, 2023</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Contract</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Long or Short</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Expiration</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Contracts</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Valuation Price</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Contract Multiplier</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Notional Amount at Value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; text-align: left">VIX Futures (Cboe)</td><td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: center">Long</td><td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: center">July, 2023</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">6,356</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">14.97</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">95,149,320</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">VIX Futures (Cboe)</td><td>&#160;</td>
    <td style="text-align: center">Long</td><td>&#160;</td>
    <td style="text-align: center">August, 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,623</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16.36</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">75,632,280</td><td style="text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td colspan="21" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Futures Positions as of December 31, 2022</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Contract</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Long or Short</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Expiration</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Contracts</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Valuation Price</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Contract Multiplier</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Notional Amount at Value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; text-align: left">VIX Futures (Cboe)</td><td style="width: 1%">&#160;</td>
    <td style="text-align: center; width: 11%">Long</td><td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: center">January, 2023</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">6,221</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">23.16</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">144,078,360</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">VIX Futures (Cboe)</td><td>&#160;</td>
    <td style="text-align: center">Long</td><td>&#160;</td>
    <td style="text-align: center">February,&#160;2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,355</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">24.57</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">107,002,350</td><td style="text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><!-- Field: Page; Sequence: 38; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->-</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font-size: 10pt; margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><p style="font: normal 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">The
futures notional values are calculated by multiplying the number of contracts held times the valuation price times the contract multiplier.
The swap notional values are calculated by multiplying the number of units times the closing level of the Index. These notional values
will increase (decrease) proportionally with increases (decreases) in the price of the futures contract or the level of the Index, as
applicable. Additional gains (losses) associated with these contracts will be equal to any such subsequent increases (decreases) in notional
values, before accounting for spreads or transaction or financing costs. The Fund will generally attempt to adjust its positions in Financial
Instruments each day to have $2.00 of exposure to the Index for every $1.00 of net assets. Future period returns, before fees and expenses,
cannot be estimated simply by estimating the return of the Index and multiplying by one and one-half. See &#8220;Item 1A. Risk Factors&#8221;
in the Annual Report on Form 10-K.</span></p><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><div><a id="k_005"></a></div><p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt"><b>Item 4. Controls and Procedures.</b></span></p><div>

</div><p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt">&#160;</span></p><div>

</div><p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt"><b>Disclosure Controls and Procedures</b></span></p><div>

</div><p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt">&#160;</span></p><div>

</div><p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt">Under the supervision and with the participation of the principal
executive officer and principal financial officer of the Trust, Trust management has evaluated the effectiveness of the Trust&#8217;s
and the Funds&#8217; disclosure controls and procedures, and have concluded that the disclosure controls and procedures of the Trust and
the Funds (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the &#8220;1934 Act&#8221;))
were effective, as of March 31, 2022, including providing reasonable assurance that information required to be disclosed in the reports
that the Trust files or submits under the 1934 Act on behalf of the Trust and the Funds is recorded, processed, summarized and reported,
within the time periods specified in the applicable rules and forms, and that such information is accumulated and communicated to management,
including the principal executive officer and principal financial officer, of the Trust as appropriate to allow timely decisions regarding
required disclosure.</span></p><div>

</div><p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt">&#160;</span></p><div>

</div><p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt"><b>Changes in Internal Control over Financial Reporting</b></span></p><div>

</div><p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt">&#160;</span></p><div>

</div><p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt">There were no changes in the Trust&#8217;s or the Funds&#8217;
internal control over financial reporting that occurred during the quarter ended June 30, 2023 that have materially affected, or are reasonably
likely to materially affect, the Trust&#8217;s or the Funds&#8217; internal control over financial reporting.</span></p><div>

</div><p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt">&#160;</span></p><div>

</div><p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt"><b>Certifications</b></span></p><div>

</div><p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt">&#160;</span></p><div>

</div><p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt">The certifications by the Principal Executive Officer and Principal
Financial Officer of the Trust required by Section 302 and Section 906 of the Sarbanes-Oxley Act of 2002, which are filed or furnished
as exhibits to this Quarterly Report on Form 10-Q, apply both to the Trust taken as a whole and each Fund, and the Principal Executive
Officer and Principal Financial Officer of the Trust are certifying both as to the Trust taken as a whole and each Fund.</span></p><div>

</div><p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt">&#160;</span></p><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><!-- Field: Page; Sequence: 39; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->-</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt">&#160;</span></p><div>

</div><div><a id="k_006"></a></div><p style="text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt"><b>Part II. OTHER INFORMATION</b></span></p><div>

</div><p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt">&#160;</span></p><div>

</div><div><a id="k_007"></a></div><p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt"><b>Item 1. Legal Proceedings.</b></span></p><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt">None.</span></p><div>

</div><p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt">&#160;</span></p><div>

</div><div><a id="k_008"></a></div><p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt"><b>Item 1A. Risk Factors.</b></span></p><div>

</div><p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt">&#160;</span></p><div>

</div><p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt">Investments in futures contracts are subject to current
position limits and accountability levels established by the exchanges. Accordingly, the Sponsor and the Funds may be required to reduce
the size of outstanding positions or be restricted from entering into new positions that would otherwise be taken for a Fund or not trade
in certain markets on behalf of the Fund in order to comply with those limits or any future limits. These restrictions, if implemented,
could limit the ability of each Fund to invest in additional futures contracts, add to existing positions in the desired amount, or create
additional Creation Units and could otherwise have a significant negative impact on Fund operations and performance, decreasing a Fund&#8217;s
correlation to the performance of its benchmark, and otherwise preventing a Fund from achieving its investment objective.</span></p><div>

</div><p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt">&#160;</span></p><div>

</div><div><a id="k_009"></a></div><p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt"><b>Item 2. Unregistered Sales of Equity Securities and Use of
Proceeds.</b></span></p><div>

</div><p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt">&#160;</span></p><div>

</div><p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt">a) None.</span></p><div>

</div><p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt">&#160;</span></p><div>

</div><p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt">Not applicable.</span></p><div>

</div><p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Title of Securities Registered</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount<br/>
 Registered<br/>
 as of<br/>
 June 30,<br/>
 2023</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares Sold<br/>
 For the<br/>
 Three Months<br/>
 Ended<br/>
 June 30,<br/>
 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Sale Price of<br/>
 Shares Sold<br/>
 For the Three<br/>
 Months Ended<br/>
 June 30,<br/>
 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">-1x Short VIX Futures ETF</td><td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: center">Unlimited</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,630,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">33,849,864</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-align: left">2x Long VIX Futures ETF</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">Unlimited</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">17,000,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">174,563,374</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt; font-weight: bold; text-align: left">Total Trust</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">18,630,000</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">208,413,238</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Title of Securities Registered</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount<br/>
 Registered<br/>
 as of<br/>
 June 30,<br/>
 2023</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares Sold<br/>
 For the<br/>
 Six Months<br/>
 Ended<br/>
 June 30,<br/>
 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Sale Price of<br/>
 Shares Sold<br/>
 For the Six<br/>
 Months Ended<br/>
 June 30,<br/>
 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">-1x Short VIX Futures ETF</td><td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: center">Unlimited</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">7,160,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">118,500,459</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-align: left">2x Long VIX Futures ETF</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">Unlimited</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">22,680,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">278,060,557</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt; font-weight: bold; text-align: left">Total Trust</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">29,840,000</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">396,561,016</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="k_010"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><b>Item 3. Defaults Upon Senior Securities.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">None.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><div><a id="k_011"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><b>Item 4. Mine Safety Disclosures.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><div><a id="k_012"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><b>Item 5. Other Information.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">None.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><!-- Field: Page; Sequence: 40; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->-</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><div><a id="k_013"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><b>Item 6. Exhibits.</b></p><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="padding: 0pt; border-bottom: Black 1.5pt solid; width: 9%"><p style="text-align: left; margin-top: 0pt; margin-bottom: 0pt"><b>Exhibit No.</b></p></td>
  <td style="padding: 0pt; width: 1%"><b>&#160;</b></td>
  <td style="padding: 0pt; width: 90%"><b>&#160;</b></td></tr>
<tr style="vertical-align: top; text-align: left; background-color: rgb(204,238,255)">
  <td style="padding: 0pt">31.1*</td>
  <td style="padding: 0pt">&#160;</td>
  <td style="padding: 0pt"><a href="f10q0623ex31-1_vstrust.htm">Description of Document Certification by Principal Executive Officer of the Trust Pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934</a></td></tr>
<tr style="vertical-align: top; text-align: left; ">
  <td style="padding: 0pt">&#160;</td>
  <td style="padding: 0pt">&#160;</td>
  <td style="padding: 0pt">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left; background-color: rgb(204,238,255)">
  <td style="padding: 0pt">31.2*</td>
  <td style="padding: 0pt">&#160;</td>
  <td style="padding: 0pt; text-align: left"><a href="f10q0623ex31-2_vstrust.htm">Description of Document Certification by Principal Financial Officer of the Trust Pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934</a></td></tr>
<tr style="vertical-align: top; text-align: left; ">
  <td style="padding: 0pt">&#160;</td>
  <td style="padding: 0pt">&#160;</td>
  <td style="padding: 0pt">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left; background-color: rgb(204,238,255)">
  <td style="padding: 0pt">32.1*</td>
  <td style="padding: 0pt">&#160;</td>
  <td style="padding: 0pt; text-align: left"><a href="f10q0623ex32-1_vstrust.htm">Description of Document Certification by Principal Executive Officer of the Trust Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 under the Securities Exchange Act of 1934</a></td></tr>
<tr style="vertical-align: top; text-align: left; ">
  <td style="padding: 0pt">&#160;</td>
  <td style="padding: 0pt">&#160;</td>
  <td style="padding: 0pt">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left; background-color: rgb(204,238,255)">
  <td style="padding: 0pt">32.2*</td>
  <td style="padding: 0pt">&#160;</td>
  <td style="padding: 0pt; text-align: left"><a href="f10q0623ex32-2_vstrust.htm">Description of Document Certification by Principal Financial Officer of the Trust Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 under the Securities Exchange Act of 1934</a></td></tr>
<tr style="vertical-align: top; text-align: left; ">
  <td style="padding: 0pt">&#160;</td>
  <td style="padding: 0pt">&#160;</td>
  <td style="padding: 0pt">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left; background-color: rgb(204,238,255)">
  <td style="padding: 0pt">101.INS</td>
  <td style="padding: 0pt">&#160;</td>
  <td style="padding: 0pt"> Inline XBRL Instance Document (1)</td></tr>
<tr style="vertical-align: top; text-align: left; ">
  <td style="padding: 0pt">&#160;</td>
  <td style="padding: 0pt">&#160;</td>
  <td style="padding: 0pt">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left; background-color: rgb(204,238,255)">
  <td style="padding: 0pt">101.SCH</td>
  <td style="padding: 0pt">&#160;</td>
  <td style="padding: 0pt">Inline XBRL Taxonomy Extension Schema (1)</td></tr>
<tr style="vertical-align: top; text-align: left; ">
  <td style="padding: 0pt">&#160;</td>
  <td style="padding: 0pt">&#160;</td>
  <td style="padding: 0pt">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left; background-color: rgb(204,238,255)">
  <td style="padding: 0pt">101.CAL</td>
  <td style="padding: 0pt">&#160;</td>
  <td style="padding: 0pt">Inline XBRL Taxonomy Extension Calculation
Linkbase (1)</td></tr>
<tr style="vertical-align: top; text-align: left; ">
  <td style="padding: 0pt">&#160;</td>
  <td style="padding: 0pt">&#160;</td>
  <td style="padding: 0pt">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left; background-color: rgb(204,238,255)">
  <td style="padding: 0pt">101.DEF</td>
  <td style="padding: 0pt">&#160;</td>
  <td style="padding: 0pt">Inline XBRL Taxonomy Extension Definition Linkbase</td></tr>
<tr style="vertical-align: top; text-align: left; ">
  <td style="padding: 0pt">&#160;</td>
  <td style="padding: 0pt">&#160;</td>
  <td style="padding: 0pt">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left; background-color: rgb(204,238,255)">
  <td style="padding: 0pt">101.LAB</td>
  <td style="padding: 0pt">&#160;</td>
  <td style="padding: 0pt">Inline XBRL Taxonomy Extension Label Linkbase (1)</td></tr>
<tr style="vertical-align: top; text-align: left; ">
  <td style="padding: 0pt">&#160;</td>
  <td style="padding: 0pt">&#160;</td>
  <td style="padding: 0pt">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left; background-color: rgb(204,238,255)">
  <td style="padding: 0pt">101.PRE</td>
  <td style="padding: 0pt">&#160;</td>
  <td style="padding: 0pt">Inline XBRL Taxonomy Extension Presentation Linkbase (1)</td></tr>
<tr style="vertical-align: top; text-align: left; ">
  <td style="padding: 0pt">&#160;</td>
  <td style="padding: 0pt">&#160;</td>
  <td style="padding: 0pt">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left; background-color: rgb(204,238,255)">
  <td colspan="3" style="padding: 0pt">Cover Page Interactive Data File - The cover page interactive data file does not appear in the interactive data file because its XBRL</td></tr>
<tr style="vertical-align: top; text-align: left; ">
  <td style="padding: 0pt">&#160;</td>
  <td style="padding: 0pt">&#160;</td>
  <td style="padding: 0pt">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left; background-color: rgb(204,238,255)">
  <td style="padding: 0pt">104.1</td>
  <td style="padding: 0pt">&#160;</td>
  <td style="padding: 0pt">tags are embedded within the inline XBRL document.</td></tr>
</table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">*</td><td style="text-align: justify">Filed herewith.</td>
</tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These certifications
are furnished to the SEC pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and are deemed not filed for purposes of Section 18
of the Securities Exchange Act of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities
Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.</span></p><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><!-- Field: Page; Sequence: 41; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->-</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><p style="text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Signatures</b></span></p><div>

</div><p style="text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to the
requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized.</span></p><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td colspan="2"><b>VS Trust</b></td>
  <td>&#160;</td>
  </tr>

<tr style="vertical-align: top; text-align: left">
  <td colspan="2">&#160;</td>
  <td>&#160;</td>
  </tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="2" style="border-bottom: Black 1.5pt solid">/s/ Justin Young</td>
  <td>&#160;</td>
  </tr>
<tr style="vertical-align: top; text-align: left">
  <td style="width: 4%">By:</td>
  <td style="width: 36%">Justin Young</td>
  <td style="width: 60%">&#160;</td>
  </tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="2">Principal Executive
Officer</td>
  <td>&#160;</td>
  </tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="2">&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="2">Date: August 14, 2023</td>
  <td>&#160;</td></tr>

<tr style="vertical-align: top; text-align: left">
  <td colspan="2">&#160;</td>
  <td>&#160;</td>
  </tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="2" style="border-bottom: Black 1.5pt solid">/s/ Justin Young</td>
  <td>&#160;</td>
  </tr>
<tr style="vertical-align: top; text-align: left">
  <td style="width: 4%">By:</td>
  <td style="width: 36%">Justin Young</td>
  <td style="width: 60%">&#160;</td>
  </tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="2">Principal Financial and Accounting Officer</td>
  <td>&#160;</td>
  </tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="2">&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="2">Date:  August 14, 2023</td>
  <td>&#160;</td></tr>
</table><div>
</div><p style="text-align: center; margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><p style="text-align: center; margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><p style="text-align: center; margin-top: 0; margin-bottom: 0">-12-</p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="text-align: center; margin-top: 0; margin-bottom: 0"></p><div>



</div><div style="display: none"><ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="c0" id="hidden-fact-0" name="dei:CurrentFiscalYearEndDate">--12-31</ix:nonNumeric>
<ix:nonFraction contextRef="c4" id="hidden-fact-1" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-2" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c7" id="hidden-fact-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-4" name="us-gaap:InvestmentOwnedAtFairValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-5" name="us-gaap:InvestmentOwnedAtFairValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-6" name="cik0001793497:ReceivableForSharesSold" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-7" name="cik0001793497:VariationMarginReceivable" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-8" name="cik0001793497:DueFromOther" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-9" name="cik0001793497:DueFromOther" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c7" id="hidden-fact-10" name="cik0001793497:DueFromOther" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-11" name="us-gaap:AccountsPayableCurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-12" name="cik0001793497:FundSharesRedeemed" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c7" id="hidden-fact-13" name="cik0001793497:FundSharesRedeemed" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-14" name="us-gaap:OtherInvestmentsAndSecuritiesAtCost" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:footnote id="ix_0_footnote" xml:lang="en-US">Investments in securities, at cost</ix:footnote><!--Text not found in sections after Statements of Assets and Liabilities (Unaudited) -->
<ix:nonFraction contextRef="c8" id="hidden-fact-15" name="us-gaap:OtherIncome" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c9" id="hidden-fact-16" name="us-gaap:OtherIncome" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c8" id="hidden-fact-17" name="cik0001793497:ShortTermInvestmentsRealized" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c9" id="hidden-fact-18" name="cik0001793497:ShortTermInvestmentsRealized" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c10" id="hidden-fact-19" name="cik0001793497:ShortTermInvestmentsRealized" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c11" id="hidden-fact-20" name="cik0001793497:ShortTermInvestmentsRealized" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c8" id="hidden-fact-21" name="cik0001793497:ShortTermInvestmentsUnrealized" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c9" id="hidden-fact-22" name="cik0001793497:ShortTermInvestmentsUnrealized" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c10" id="hidden-fact-23" name="cik0001793497:ShortTermInvestmentsUnrealized" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c11" id="hidden-fact-24" name="cik0001793497:ShortTermInvestmentsUnrealized" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c12" id="hidden-fact-25" name="us-gaap:OtherInterestAndDividendIncome" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c13" id="hidden-fact-26" name="us-gaap:OtherInterestAndDividendIncome" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c14" id="hidden-fact-27" name="us-gaap:OtherInterestAndDividendIncome" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c15" id="hidden-fact-28" name="us-gaap:OtherInterestAndDividendIncome" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c10" id="hidden-fact-29" name="us-gaap:IncreaseDecreaseInEarnestMoneyDepositsOutstanding" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c9" id="hidden-fact-30" name="us-gaap:IncreaseDecreaseInPrepaidExpensesOther" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c9" id="hidden-fact-31" name="us-gaap:IncreaseDecreaseInReceivables" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c8" id="hidden-fact-32" name="us-gaap:IncreaseDecreaseInCustomerAdvances" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c9" id="hidden-fact-33" name="us-gaap:IncreaseDecreaseInCustomerAdvances" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c10" id="hidden-fact-34" name="us-gaap:IncreaseDecreaseInCustomerAdvances" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c8" id="hidden-fact-35" name="us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c11" id="hidden-fact-36" name="us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c10" id="hidden-fact-37" name="us-gaap:PaymentsOfStockIssuanceCosts" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c11" id="hidden-fact-38" name="us-gaap:PaymentsOfStockIssuanceCosts" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c8" id="hidden-fact-39" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c9" id="hidden-fact-40" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c16" id="hidden-fact-41" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c17" id="hidden-fact-42" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-43" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c14" id="hidden-fact-44" name="us-gaap:IncreaseDecreaseInPrepaidExpensesOther" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c14" id="hidden-fact-45" name="us-gaap:IncreaseDecreaseInOtherReceivables" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c15" id="hidden-fact-46" name="us-gaap:IncreaseDecreaseInOtherReceivables" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c14" id="hidden-fact-47" name="cik0001793497:IncreaseDecreaseInVariationMarginPayable" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c15" id="hidden-fact-48" name="cik0001793497:IncreaseDecreaseInVariationMarginPayable" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c14" id="hidden-fact-49" name="us-gaap:IncreaseDecreaseInReceivables" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c15" id="hidden-fact-50" name="us-gaap:IncreaseDecreaseInReceivables" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c14" id="hidden-fact-51" name="cik0001793497:IncreaseDecreaseInDueToCustodian" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c15" id="hidden-fact-52" name="cik0001793497:IncreaseDecreaseInDueToCustodian" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c14" id="hidden-fact-53" name="us-gaap:IncreaseDecreaseInCustomerAdvances" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c15" id="hidden-fact-54" name="us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c13" id="hidden-fact-55" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c7" id="hidden-fact-56" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c22" id="hidden-fact-57" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c23" id="hidden-fact-58" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-59" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-60" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c24" id="hidden-fact-61" name="us-gaap:OtherInvestments" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c50" id="hidden-fact-62" name="cik0001793497:AmountOfTotalTrust" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonNumeric contextRef="c61" id="hidden-fact-63" name="cik0001793497:TotalTrust">$6,518,579</ix:nonNumeric>
<ix:nonNumeric contextRef="c63" id="hidden-fact-64" name="cik0001793497:TotalTrust">$6,518,579</ix:nonNumeric>
<ix:nonNumeric contextRef="c64" id="hidden-fact-65" name="cik0001793497:TotalTrust1">$(19,791,036)</ix:nonNumeric>
<ix:nonNumeric contextRef="c65" id="hidden-fact-66" name="cik0001793497:TotalTrust">$1,156,106</ix:nonNumeric>
<ix:nonNumeric contextRef="c67" id="hidden-fact-67" name="cik0001793497:TotalTrust">$1,156,106</ix:nonNumeric>
<ix:nonNumeric contextRef="c68" id="hidden-fact-68" name="cik0001793497:TotalTrust1">$(9,203,522)</ix:nonNumeric>
<ix:nonFraction contextRef="c77" id="hidden-fact-69" name="cik0001793497:GrossAmountsOffsetInTheStatementsOfFinancialCondition" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c78" id="hidden-fact-70" name="cik0001793497:GrossAmountsOfRecognizedLiabilitiesPresentedInTheStatementsOfFinancialCondition" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c78" id="hidden-fact-71" name="cik0001793497:GrossAmountsOffsetInTheStatementsOfFinancialCondition1" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c79" id="hidden-fact-72" name="cik0001793497:NetAmountsOfLiabilitiesPresentedInTheStatementsOfFinancialCondition" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c80" id="hidden-fact-73" name="cik0001793497:GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c80" id="hidden-fact-74" name="cik0001793497:GrossAmountsOffsetInTheStatementsOfFinancialCondition" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c80" id="hidden-fact-75" name="cik0001793497:NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c81" id="hidden-fact-76" name="cik0001793497:GrossAmountsOffsetInTheStatementsOfFinancialCondition1" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c83" id="hidden-fact-77" name="cik0001793497:GrossAmountsOffsetInTheStatementsOfFinancialCondition" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c84" id="hidden-fact-78" name="cik0001793497:GrossAmountsOffsetInTheStatementsOfFinancialCondition1" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c86" id="hidden-fact-79" name="cik0001793497:GrossAmountsOffsetInTheStatementsOfFinancialCondition" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c87" id="hidden-fact-80" name="cik0001793497:GrossAmountsOffsetInTheStatementsOfFinancialCondition1" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c12" id="hidden-fact-81" name="cik0001793497:FinancialInstrumentsForTheBenefitOftheFundsTheCounterpartiesTwo" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c12" id="hidden-fact-82" name="cik0001793497:CashCollateralForTheBenefitOftheFundsTheCounterparties" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c13" id="hidden-fact-83" name="cik0001793497:FinancialInstrumentsForTheBenefitOftheFundsTheCounterpartiesTwo" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c13" id="hidden-fact-84" name="cik0001793497:CashCollateralForTheBenefitOftheFundsTheCounterparties" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonNumeric contextRef="c0" name="dei:AmendmentFlag">false</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:DocumentFiscalPeriodFocus">Q2</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:EntityCentralIndexKey">0001793497</ix:nonNumeric>
</ix:hidden>
<ix:references><link:schemaRef xlink:href="cik0001793497-20230630.xsd" xlink:type="simple"></link:schemaRef></ix:references>
<ix:resources><ix:relationship fromRefs="hidden-fact-4 ix_0_fact hidden-fact-5 ix_1_fact" toRefs="ix_0_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_2_fact ix_3_fact ix_4_fact ix_5_fact" toRefs="ix_1_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_6_fact" toRefs="ix_2_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_7_fact ix_8_fact" toRefs="ix_3_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_9_fact" toRefs="ix_4_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_10_fact" toRefs="ix_5_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_11_fact" toRefs="ix_6_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_12_fact" toRefs="ix_7_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_13_fact ix_14_fact ix_15_fact ix_16_fact ix_17_fact ix_18_fact" toRefs="ix_8_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_19_fact ix_20_fact ix_21_fact ix_22_fact ix_23_fact ix_24_fact ix_25_fact ix_26_fact" toRefs="ix_9_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_27_fact ix_28_fact ix_29_fact ix_30_fact ix_31_fact ix_32_fact ix_33_fact ix_34_fact" toRefs="ix_10_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_35_fact ix_36_fact ix_37_fact ix_38_fact ix_39_fact ix_40_fact ix_41_fact ix_42_fact ix_43_fact ix_44_fact ix_45_fact ix_46_fact ix_47_fact ix_48_fact ix_49_fact ix_50_fact" toRefs="ix_11_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_51_fact ix_52_fact ix_53_fact ix_54_fact ix_55_fact ix_56_fact ix_57_fact ix_58_fact" toRefs="ix_12_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_51_fact ix_52_fact ix_53_fact ix_54_fact" toRefs="ix_13_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_55_fact ix_56_fact ix_57_fact ix_58_fact ix_59_fact ix_60_fact ix_61_fact ix_62_fact" toRefs="ix_14_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_63_fact ix_24_fact ix_32_fact ix_64_fact ix_65_fact ix_66_fact ix_44_fact ix_48_fact ix_56_fact ix_60_fact" toRefs="ix_15_footnote"></ix:relationship>
<xbrli:context id="c0">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c1">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c2">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c3">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c4">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OneShortVIXFuturesETFMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c5">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c6">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OneShortVIXFuturesETFMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c7">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c8">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OneShortVIXFuturesETFMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-04-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c9">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-04-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c10">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OneShortVIXFuturesETFMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-04-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c11">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-04-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c12">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OneShortVIXFuturesETFMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c13">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c14">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OneShortVIXFuturesETFMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c15">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c16">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OneShortVIXFuturesETFMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c17">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c18">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OneShortVIXFuturesETFMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c19">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c20">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OneShortVIXFuturesETFMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c21">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c22">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OneShortVIXFuturesETFMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c23">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c24">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c25">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c26">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0001793497:CBOEVIXFuturesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c27">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0001793497:CBOEVIXFuturesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c28">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0001793497:CBOEVIXFuturesOneMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c29">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0001793497:CBOEVIXFuturesOneMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c30">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c31">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c32">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c33">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0001793497:CBOEVIXFuturesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c34">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0001793497:CBOEVIXFuturesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c35">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0001793497:CBOEVIXFuturesOneMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c36">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0001793497:CBOEVIXFuturesOneMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c37">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cik0001793497:FirstAmericanGovernmentObligationsFundMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c38">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0001793497:CBOEVIXFuturesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c39">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0001793497:CBOEVIXFuturesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c40">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0001793497:CBOEVIXFuturesOneMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c41">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0001793497:CBOEVIXFuturesOneMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c42">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cik0001793497:FirstAmericanGovernmentObligationsFundMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c43">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c44">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0001793497:CBOEVIXFuturesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c45">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0001793497:CBOEVIXFuturesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c46">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0001793497:CBOEVIXFuturesOneMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c47">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0001793497:CBOEVIXFuturesOneMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSraoTMKpdMOVUMtRpuB8tV6eMGW/07nN8r724IYYtHu3Fk2iU8V8d5zeroA9ghPrxP68aa5UlyuaOj/7VPlLXQx0GT+xTdf3pIEmLVakfoittQNiZUQ0abAliT/vrVleUY3WZOYnY1Y7WqYa/6c4Wf84KjMb46gvmMDpDYv2CdGwz6oicUufEEoh] CSR-->
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c48">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RetirementPlanFundingStatusAxis">cik0001793497:SVIXMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c49">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RetirementPlanFundingStatusAxis">cik0001793497:UVIXMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c50">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OneShortVIXFuturesETFMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c51">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OneShortVIXFuturesETFMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">cik0001793497:FuturesContractsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c52">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OneShortVIXFuturesETFMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">cik0001793497:FuturesContractsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c53">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c54">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">cik0001793497:FuturesContractsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c55">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c56">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">cik0001793497:FuturesContractsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c57">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c58">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">cik0001793497:FuturesContractsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c59">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c60">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">cik0001793497:FuturesContractsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c61">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">cik0001793497:AssetDerivativesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FinancingReceivablesPeriodPastDueAxis">cik0001793497:StatementsOfFinancialConditionLocationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c62">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">cik0001793497:AssetDerivativesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FinancingReceivablesPeriodPastDueAxis">cik0001793497:UnrealizedAppreciationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c63">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">cik0001793497:AssetDerivativesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FinancingReceivablesPeriodPastDueAxis">cik0001793497:StatementsOfFinancialConditionLocationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c64">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">cik0001793497:AssetDerivativesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FinancingReceivablesPeriodPastDueAxis">cik0001793497:UnrealizedAppreciationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c65">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">cik0001793497:LiabilityDerivativesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FinancingReceivablesPeriodPastDueAxis">cik0001793497:StatementsOfFinancialConditionLocationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c66">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">cik0001793497:LiabilityDerivativesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FinancingReceivablesPeriodPastDueAxis">cik0001793497:UnrealizedDepreciationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c67">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">cik0001793497:LiabilityDerivativesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FinancingReceivablesPeriodPastDueAxis">cik0001793497:StatementsOfFinancialConditionLocationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c68">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">cik0001793497:LiabilityDerivativesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FinancingReceivablesPeriodPastDueAxis">cik0001793497:UnrealizedDepreciationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c69">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c70">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c71">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c72">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c73">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c74">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c75">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c76">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c77">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c78">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c79">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c80">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c81">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c82">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c83">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c84">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c85">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c86">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c87">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c88">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OneShortVIXFuturesETFMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c89">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cik0001793497:SVIXMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c90">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cik0001793497:UVIXMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c91">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-04-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c92">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-04-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c93">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-04-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c94">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-04-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c95">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c96">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c97">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c98">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c99">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c100">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c101">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c102">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:unit id="shares">
  <xbrli:measure>xbrli:shares</xbrli:measure>
</xbrli:unit><xbrli:unit id="usd">
  <xbrli:measure>iso4217:USD</xbrli:measure>
</xbrli:unit><xbrli:unit id="usdPershares">
  <xbrli:divide>
    <xbrli:unitNumerator>
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unitNumerator>
    <xbrli:unitDenominator>
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unitDenominator>
  </xbrli:divide>
</xbrli:unit><xbrli:unit id="pure">
  <xbrli:measure>xbrli:pure</xbrli:measure>
</xbrli:unit></ix:resources></ix:header>

</div></div></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>f10q0623ex31-1_vstrust.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 31.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Certification of Principal Executive Officer</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Pursuant to Section&nbsp;302 of the Sarbanes-Oxley
Act of 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">I, Justin Young, certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">1.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">I have reviewed this Quarterly
Report on Form&nbsp;10-Q&nbsp;of VS Trust and each of its Funds;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">2.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Based on my knowledge, this report
does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light
of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">3.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Based on my knowledge, the financial
statements, and other financial information included in this report, fairly present in all material respects the financial condition,
results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">4.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">The registrant&rsquo;s other certifying
officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&nbsp;13a-15(e)&nbsp;and&nbsp;15d-15(e))&nbsp;and
internal control over financial reporting (as defined in Exchange Act Rules&nbsp;13a-15(f)&nbsp;and&nbsp;15d-15(f))&nbsp;for the registrant
and have:</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Designed such disclosure controls
and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information
relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly
during the period in which this report is being prepared;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Designed such internal control
over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable
assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance
with generally accepted accounting principles;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Evaluated the effectiveness
of the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of
the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Disclosed in this report any
change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s most recent fiscal
quarter (the registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably
likely to materially affect, the registrant&rsquo;s internal control over financial reporting; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">5.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">The registrant&rsquo;s other certifying
officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&rsquo;s
auditors and the audit committee of the registrant&rsquo;s board of directors (or persons performing the equivalent functions):</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">All significant deficiencies
and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely
affect the registrant&rsquo;s ability to record, process, summarize and report financial information; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Any fraud, whether or not material,
that involves management or other employees who have a significant role in the registrant&rsquo;s internal control over financial reporting.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: August
    14,
2023&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: top; width: 35%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Justin Young</FONT></P></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Justin Young</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal Executive Officer</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">VS Trust</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>f10q0623ex31-2_vstrust.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Exhibit 31.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Certification of Principal Financial Officer</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Pursuant to Section&nbsp;302 of the Sarbanes-Oxley
Act of 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">I, Justin Young, certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">1.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">I have reviewed this Quarterly
Report on Form&nbsp;10-Q&nbsp;of VS Trust and each of its Funds;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">2.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Based on my knowledge, this report
does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light
of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">3.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Based on my knowledge, the financial
statements, and other financial information included in this report, fairly present in all material respects the financial condition,
results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">4.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">The registrant&rsquo;s other certifying
officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&nbsp;13a-15(e)&nbsp;and&nbsp;15d-15(e))&nbsp;and
internal control over financial reporting (as defined in Exchange Act Rules&nbsp;13a-15(f)&nbsp;and&nbsp;15d-15(f))&nbsp;for the registrant
and have:</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Designed such disclosure controls
and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information
relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly
during the period in which this report is being prepared;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Designed such internal control
over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable
assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance
with generally accepted accounting principles;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Evaluated the effectiveness
of the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of
the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Disclosed in this report any
change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s most recent fiscal
quarter (the registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably
likely to materially affect, the registrant&rsquo;s internal control over financial reporting; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">5.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">The registrant&rsquo;s other certifying
officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&rsquo;s
auditors and the audit committee of the registrant&rsquo;s board of directors (or persons performing the equivalent functions):</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">All significant deficiencies
and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely
affect the registrant&rsquo;s ability to record, process, summarize and report financial information; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Any fraud, whether or not material,
that involves management or other employees who have a significant role in the registrant&rsquo;s internal control over financial reporting.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 60%"><FONT STYLE="font-size: 10pt">Date: August 14,
    2023&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 5%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: top; width: 35%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ Justin Young</P></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top">Justin Young</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Principal Financial and Accounting Officer</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">VS Trust</FONT></TD></TR>
  </TABLE>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>f10q0623ex32-1_vstrust.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 32.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Certification of Principal Executive Officer</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Pursuant to Section&nbsp;906 of the Sarbanes-Oxley
Act of 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In connection with this Quarterly Report on Form&nbsp;10-Q&nbsp;for
the quarter ended June 30, 2023 (the &ldquo;Report&rdquo;) of VS Trust (the &ldquo;Registrant&rdquo;) and each of its Funds, as filed
with the U.S. Securities and Exchange Commission on the date hereof, I, Justin Young, the Principal Executive Officer of the Registrant,
hereby certify, to the best of my knowledge, that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">(1)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">The Report fully complies with
the requirements of Section&nbsp;13(a) or 15(d) of the Securities Exchange Act of 1934, as amended;&nbsp;<U>and</U></FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">(2)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">The information contained in the
Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: August
    14,
    2023&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="vertical-align: top; width: 35%"><P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Justin Young</FONT></P></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Justin Young</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal Executive Officer</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">VS Trust</FONT></TD></TR></TABLE>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>f10q0623ex32-2_vstrust.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><B>Exhibit 32.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Certification of Principal Financial Officer</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Pursuant to Section&nbsp;906 of the Sarbanes-Oxley
Act of 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">In connection with this Quarterly Report on Form&nbsp;10-Q&nbsp;for
the quarter ended June 30, 2023 (the &ldquo;Report&rdquo;) of VS Trust (the &ldquo;Registrant&rdquo;) and each of its Funds, as filed
with the U.S. Securities and Exchange Commission on the date hereof, I, Justin Young, the Principal Financial and Accounting Officer
of the Registrant, hereby certify, to the best of my knowledge, that:</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: justify; width: 0in"></TD><TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">(3)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">The Report fully complies with
the requirements of Section&nbsp;13(a) or 15(d) of the Securities Exchange Act of 1934, as amended;&nbsp;<U>and</U></FONT></TD>
</TR></TABLE>
<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">(4)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">The information contained in the
Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt; width: 60%"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 10pt">Date: August 14,
                                                                 2023&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&nbsp;</P></TD>
    <TD STYLE="vertical-align: top; font-size: 10pt; width: 5%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: top; width: 35%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ Justin Young</P></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">Name:</FONT>&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">Justin Young</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">Principal Financial and Accounting Officer</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">VS Trust</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>cik0001793497-20230630.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Mon Aug 14 16:04:01 UTC 2023 -->
<xs:schema elementFormDefault="qualified" xmlns:cik0001793497="http://www.vts.com/20230630" xmlns:srt-types="http://fasb.org/srt-types/2023" targetNamespace="http://www.vts.com/20230630" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dtr="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="cik0001793497-20230630_lab.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="cik0001793497-20230630_pre.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="cik0001793497-20230630_def.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="cik0001793497-20230630_cal.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef"/>
      <link:roleType roleURI="http://www.vts.com/role/ConsolidatedBalanceSheet" id="cik0001793497_r_ConsolidatedBalanceSheet">
        <link:definition>001 - Statement - Statements of Assets and Liabilities (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vts.com/role/ConsolidatedBalanceSheetAlt0" id="cik0001793497_r_ConsolidatedBalanceSheetAlt0">
        <link:definition>001 - Statement - Statements of Assets and Liabilities (Unaudited) Alternate 0</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vts.com/role/ConsolidatedIncomeStatement" id="cik0001793497_r_ConsolidatedIncomeStatement">
        <link:definition>002 - Statement - Statements of Operations (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vts.com/role/ConsolidatedIncomeStatement0" id="cik0001793497_r_ConsolidatedIncomeStatement0">
        <link:definition>003 - Statement - Statement of Changes in Net Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vts.com/role/ConsolidatedCashFlow" id="cik0001793497_r_ConsolidatedCashFlow">
        <link:definition>004 - Statement - Statements of Cash Flows (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable" id="cik0001793497_r_ScheduleofInvestmentsUnauditedTable">
        <link:definition>005 - Statement - Schedule of Investments (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable_Parentheticals" id="cik0001793497_r_ScheduleofInvestmentsUnauditedTable_Parentheticals">
        <link:definition>006 - Statement - Schedule of Investments (Unaudited) (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vts.com/role/Organization" id="cik0001793497_r_Organization">
        <link:definition>007 - Disclosure - Organization</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vts.com/role/SignificantAccountingPolicies" id="cik0001793497_r_SignificantAccountingPolicies">
        <link:definition>008 - Disclosure - Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vts.com/role/Investments" id="cik0001793497_r_Investments">
        <link:definition>009 - Disclosure - Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vts.com/role/Agreements" id="cik0001793497_r_Agreements">
        <link:definition>010 - Disclosure - Agreements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vts.com/role/OfferingCosts" id="cik0001793497_r_OfferingCosts">
        <link:definition>011 - Disclosure - Offering Costs</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vts.com/role/CreationandRedemptionofCreationUnits" id="cik0001793497_r_CreationandRedemptionofCreationUnits">
        <link:definition>012 - Disclosure - Creation and Redemption of Creation Units</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vts.com/role/FinancialHighlights" id="cik0001793497_r_FinancialHighlights">
        <link:definition>013 - Disclosure - Financial Highlights</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vts.com/role/Risk" id="cik0001793497_r_Risk">
        <link:definition>014 - Disclosure - Risk</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vts.com/role/SubsequentEvents" id="cik0001793497_r_SubsequentEvents">
        <link:definition>015 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vts.com/role/AccountingPoliciesByPolicy" id="cik0001793497_r_AccountingPoliciesByPolicy">
        <link:definition>016 - Disclosure - Accounting Policies, by Policy (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vts.com/role/SignificantAccountingPoliciesTables" id="cik0001793497_r_SignificantAccountingPoliciesTables">
        <link:definition>017 - Disclosure - Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vts.com/role/InvestmentsTables" id="cik0001793497_r_InvestmentsTables">
        <link:definition>018 - Disclosure - Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vts.com/role/CreationandRedemptionofCreationUnitsTables" id="cik0001793497_r_CreationandRedemptionofCreationUnitsTables">
        <link:definition>019 - Disclosure - Creation and Redemption of Creation Units (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vts.com/role/FinancialHighlightsTables" id="cik0001793497_r_FinancialHighlightsTables">
        <link:definition>020 - Disclosure - Financial Highlights (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vts.com/role/SignificantAccountingPoliciesDetails" id="cik0001793497_r_SignificantAccountingPoliciesDetails">
        <link:definition>021 - Disclosure - Significant Accounting Policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vts.com/role/ScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsTable" id="cik0001793497_r_ScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsTable">
        <link:definition>022 - Disclosure - Significant Accounting Policies (Details) - Schedule of Cut-Off Times and the Times of the Calculation of the Funds</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vts.com/role/ScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyTable" id="cik0001793497_r_ScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyTable">
        <link:definition>023 - Disclosure - Significant Accounting Policies (Details) - Schedule of Valuation of Investments at Using the Fair Value Hierarchy</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vts.com/role/ScheduleofFairValueofDerivativeInstrumentsTable" id="cik0001793497_r_ScheduleofFairValueofDerivativeInstrumentsTable">
        <link:definition>024 - Disclosure - Investments (Details) - Schedule of Fair Value of Derivative Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vts.com/role/ScheduleofEffectofDerivativeInstrumentsonTheStatementofOperationsTable" id="cik0001793497_r_ScheduleofEffectofDerivativeInstrumentsonTheStatementofOperationsTable">
        <link:definition>025 - Disclosure - Investments (Details) - Schedule of Effect of Derivative Instruments on The Statement of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vts.com/role/ScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsTable" id="cik0001793497_r_ScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsTable">
        <link:definition>026 - Disclosure - Investments (Details) - Schedule of Pledged By Funds Fair Values of Derivative Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vts.com/role/ScheduleofGrossAmountsNotOffsetInTheStatementsofFinancialConditionTable" id="cik0001793497_r_ScheduleofGrossAmountsNotOffsetInTheStatementsofFinancialConditionTable">
        <link:definition>027 - Disclosure - Investments (Details) - Schedule of Gross Amounts Not Offset In The Statements of Financial Condition</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vts.com/role/AgreementsDetails" id="cik0001793497_r_AgreementsDetails">
        <link:definition>028 - Disclosure - Agreements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vts.com/role/CreationandRedemptionofCreationUnitsDetails" id="cik0001793497_r_CreationandRedemptionofCreationUnitsDetails">
        <link:definition>029 - Disclosure - Creation and Redemption of Creation Units (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vts.com/role/ScheduleofTransactionFeesTable" id="cik0001793497_r_ScheduleofTransactionFeesTable">
        <link:definition>030 - Disclosure - Creation and Redemption of Creation Units (Details) - Schedule of Transaction Fees</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vts.com/role/FinancialHighlightsDetails" id="cik0001793497_r_FinancialHighlightsDetails">
        <link:definition>031 - Disclosure - Financial Highlights (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vts.com/role/ScheduleofShareOutstandingTable" id="cik0001793497_r_ScheduleofShareOutstandingTable">
        <link:definition>032 - Disclosure - Financial Highlights (Details) - Schedule of Share Outstanding</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSraoTMKpdMOVUMtRpuB8tV6eMGW/07nN8r724IYYtHu3Fk2iU8V8d5zeroA9ghPrxP68aa5UlyuaOj/7VPlLXQx0GT+xTdf3pIEmLVakfoittQNiZUQ0abAliT/vrVleUY3WZOYnY1Y7WqYa/6c4Wf84lUKYnTNtHYpaaL0yCEwEecLYwpli5pQc] CSR-->
      <link:roleType roleURI="http://www.vts.com/role/RiskDetails" id="cik0001793497_r_RiskDetails">
        <link:definition>033 - Disclosure - Risk (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vts.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/sic/2023" schemaLocation="https://xbrl.sec.gov/sic/2023/sic-2023.xsd"/>
  <xs:element name="ScheduleOfInvestmentsUnauditedAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_ScheduleOfInvestmentsUnauditedAbstract"/>
  <xs:element name="ScheduleOfCutOffTimesAndTheTimesOfTheCalculationOfTheFundsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_ScheduleOfCutOffTimesAndTheTimesOfTheCalculationOfTheFundsAbstract"/>
  <xs:element name="ScheduleOfValuationOfInvestmentsAtUsingTheFairValueHierarchyAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_ScheduleOfValuationOfInvestmentsAtUsingTheFairValueHierarchyAbstract"/>
  <xs:element name="ScheduleOfFairValueOfDerivativeInstrumentsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_ScheduleOfFairValueOfDerivativeInstrumentsAbstract"/>
  <xs:element name="ScheduleOfEffectOfDerivativeInstrumentsOnTheStatementOfOperationsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_ScheduleOfEffectOfDerivativeInstrumentsOnTheStatementOfOperationsAbstract"/>
  <xs:element name="ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsAbstract"/>
  <xs:element name="ScheduleOfGrossAmountsNotOffsetInTheStatementsOfFinancialConditionAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_ScheduleOfGrossAmountsNotOffsetInTheStatementsOfFinancialConditionAbstract"/>
  <xs:element name="AgreementsDisclosureAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_AgreementsDisclosureAbstract"/>
  <xs:element name="OfferingCostsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_OfferingCostsAbstract"/>
  <xs:element name="ScheduleOfTransactionFeesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_ScheduleOfTransactionFeesAbstract"/>
  <xs:element name="ScheduleOfShareOutstandingAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_ScheduleOfShareOutstandingAbstract"/>
  <xs:element name="UnlabeledAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_UnlabeledAbstract"/>
  <xs:element name="PayablesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_PayablesAbstract"/>
  <xs:element name="UnlabeledAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_UnlabeledAbstract0"/>
  <xs:element name="NetAssetsConsistOfAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_NetAssetsConsistOfAbstract"/>
  <xs:element name="UnlabeledAbstract1" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_UnlabeledAbstract1"/>
  <xs:element name="NetAssetValueUnlimitedSharesAuthorizedAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_NetAssetValueUnlimitedSharesAuthorizedAbstract"/>
  <xs:element name="ClassIUnlimitedSharesAuthorizedAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_ClassIUnlimitedSharesAuthorizedAbstract"/>
  <xs:element name="UnlabeledAbstract2" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_UnlabeledAbstract2"/>
  <xs:element name="InvestmentIncomeAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_InvestmentIncomeAbstract"/>
  <xs:element name="IncomeAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_IncomeAbstract"/>
  <xs:element name="UnlabeledAbstract3" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_UnlabeledAbstract3"/>
  <xs:element name="ExpensesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_ExpensesAbstract"/>
  <xs:element name="UnlabeledAbstract4" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_UnlabeledAbstract4"/>
  <xs:element name="RealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContractsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_RealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContractsAbstract"/>
  <xs:element name="UnlabeledAbstract5" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_UnlabeledAbstract5"/>
  <xs:element name="NetRealizedGainLossOnAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_NetRealizedGainLossOnAbstract"/>
  <xs:element name="NetChangeInUnrealizedAppreciationDepreciationOfAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_NetChangeInUnrealizedAppreciationDepreciationOfAbstract"/>
  <xs:element name="InvestmentIncomeAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_InvestmentIncomeAbstract0"/>
  <xs:element name="UnlabeledAbstract6" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_UnlabeledAbstract6"/>
  <xs:element name="ExpensesAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_ExpensesAbstract0"/>
  <xs:element name="UnlabeledAbstract7" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_UnlabeledAbstract7"/>
  <xs:element name="RealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContractsAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_RealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContractsAbstract0"/>
  <xs:element name="UnlabeledAbstract8" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_UnlabeledAbstract8"/>
  <xs:element name="NetRealizedGainLossOnAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_NetRealizedGainLossOnAbstract0"/>
  <xs:element name="NetChangeInUnrealizedAppreciationDepreciationOfAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_NetChangeInUnrealizedAppreciationDepreciationOfAbstract0"/>
  <xs:element name="IncreaseDecreaseInNetAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_IncreaseDecreaseInNetAssetsAbstract"/>
  <xs:element name="OperationsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_OperationsAbstract"/>
  <xs:element name="UnlabeledAbstract9" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_UnlabeledAbstract9"/>
  <xs:element name="CapitalShareTransactionsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_CapitalShareTransactionsAbstract"/>
  <xs:element name="UnlabeledAbstract10" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_UnlabeledAbstract10"/>
  <xs:element name="NetAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_NetAssetsAbstract"/>
  <xs:element name="IncreaseDecreaseInNetAssetsAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_IncreaseDecreaseInNetAssetsAbstract0"/>
  <xs:element name="OperationsAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_OperationsAbstract0"/>
  <xs:element name="UnlabeledAbstract11" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_UnlabeledAbstract11"/>
  <xs:element name="CapitalShareTransactionsAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_CapitalShareTransactionsAbstract0"/>
  <xs:element name="UnlabeledAbstract12" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_UnlabeledAbstract12"/>
  <xs:element name="NetAssetsAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_NetAssetsAbstract0"/>
  <xs:element name="AdjustmentsToReconcileNetIncomeLossToNetCashProvidedByUsedInOperatingActivitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_AdjustmentsToReconcileNetIncomeLossToNetCashProvidedByUsedInOperatingActivitiesAbstract"/>
  <xs:element name="UnlabeledAbstract13" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_UnlabeledAbstract13"/>
  <xs:element name="UnlabeledAbstract14" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_UnlabeledAbstract14"/>
  <xs:element name="CashFlowFromOperatingActivitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_CashFlowFromOperatingActivitiesAbstract"/>
  <xs:element name="UnlabeledAbstract15" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_UnlabeledAbstract15"/>
  <xs:element name="CashFlowFromFinancingActivitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_CashFlowFromFinancingActivitiesAbstract"/>
  <xs:element name="UnlabeledAbstract16" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_UnlabeledAbstract16"/>
  <xs:element name="ShortTermInvestment112Abstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_ShortTermInvestment112Abstract"/>
  <xs:element name="MoneyMarketFund112Abstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_MoneyMarketFund112Abstract"/>
  <xs:element name="UnlabeledAbstract17" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_UnlabeledAbstract17"/>
  <xs:element name="ShortTermInvestment657Abstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_ShortTermInvestment657Abstract"/>
  <xs:element name="MoneyMarketFund657Abstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_MoneyMarketFund657Abstract"/>
  <xs:element name="UnlabeledAbstract18" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_UnlabeledAbstract18"/>
  <xs:element name="VixFuturesContractsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_VixFuturesContractsAbstract"/>
  <xs:element name="VixFuturesContractsAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_VixFuturesContractsAbstract0"/>
  <xs:element name="VixFuturesContractsNetRealizedGainLossOnFuturesContractsChangesInUnrealizedAppreciationDepreciationOnFuturesContractsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_VixFuturesContractsNetRealizedGainLossOnFuturesContractsChangesInUnrealizedAppreciationDepreciationOnFuturesContractsAbstract"/>
  <xs:element name="VixFuturesContractsNetRealizedGainLossOnFuturesContractsChangesInUnrealizedAppreciationDepreciationOnFuturesContractsAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_VixFuturesContractsNetRealizedGainLossOnFuturesContractsChangesInUnrealizedAppreciationDepreciationOnFuturesContractsAbstract0"/>
  <xs:element name="UnlabeledAbstract19" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_UnlabeledAbstract19"/>
  <xs:element name="RatiosToAverageNetAssets5Abstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_RatiosToAverageNetAssets5Abstract"/>
  <xs:element name="UnlabeledAbstract20" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_UnlabeledAbstract20"/>
  <xs:element name="RatiosToAverageNetAssets5Abstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_RatiosToAverageNetAssets5Abstract0"/>
  <xs:element name="ReceivableForSharesSold" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_ReceivableForSharesSold"/>
  <xs:element name="VariationMarginReceivable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_VariationMarginReceivable"/>
  <xs:element name="DueFromOther" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_DueFromOther"/>
  <xs:element name="DueToCustodian" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_DueToCustodian"/>
  <xs:element name="FundSharesRedeemed" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_FundSharesRedeemed"/>
  <xs:element name="AdministrativeAccountingAndCustodianFeesPayable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_AdministrativeAccountingAndCustodianFeesPayable"/>
  <xs:element name="LicensingAndRegistrationFeesPayable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_LicensingAndRegistrationFeesPayable"/>
  <xs:element name="ShortTermInvestmentsRealized" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_ShortTermInvestmentsRealized"/>
  <xs:element name="FuturesContracts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_FuturesContracts"/>
  <xs:element name="ShortTermInvestmentsUnrealized" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_ShortTermInvestmentsUnrealized"/>
  <xs:element name="FuturesContractsUnrealizedAppreciation" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_FuturesContractsUnrealizedAppreciation"/>
  <xs:element name="NetIncreasedecreaseInNetAssetsResultingFromOperations" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_NetIncreasedecreaseInNetAssetsResultingFromOperations"/>
  <xs:element name="NetRealizedGainlossOnInvestmentsAndFuturesContracts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_NetRealizedGainlossOnInvestmentsAndFuturesContracts"/>
  <xs:element name="NetChangeInUnrealizedAppreciationdepreciationOfInvestmentsAndFuturesContracts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_NetChangeInUnrealizedAppreciationdepreciationOfInvestmentsAndFuturesContracts"/>
  <xs:element name="SharesSoldinShares" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_SharesSoldinShares"/>
  <xs:element name="SharesSoldNetOfSharesRedeemedinDollarsPerShare" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_SharesSoldNetOfSharesRedeemedinDollarsPerShare"/>
  <xs:element name="NetIncreaseInNetAssetsFromCapitalShareTransactions" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_NetIncreaseInNetAssetsFromCapitalShareTransactions"/>
  <xs:element name="IncreasedecreaseInNetAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_IncreasedecreaseInNetAssets"/>
  <xs:element name="PurchasesOfInvestments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_PurchasesOfInvestments"/>
  <xs:element name="ProceedsFromSalesOrMaturitiesOfInvestments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_ProceedsFromSalesOrMaturitiesOfInvestments"/>
  <xs:element name="IncreaseDecreaseInVariationMarginPayable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_IncreaseDecreaseInVariationMarginPayable"/>
  <xs:element name="IncreaseDecreaseInDueToCustodian" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_IncreaseDecreaseInDueToCustodian"/>
  <xs:element name="IncreaseDecreaseInPayableToSponsor" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_IncreaseDecreaseInPayableToSponsor"/>
  <xs:element name="IncreaseInProfessionalFeesPayable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_IncreaseInProfessionalFeesPayable"/>
  <xs:element name="IncreaseInLicensingAndRegistrationFeesPayable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_IncreaseInLicensingAndRegistrationFeesPayable"/>
  <xs:element name="ProceedsFromSaleOfUnits" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_ProceedsFromSaleOfUnits"/>
  <xs:element name="NumberOfContracts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_NumberOfContracts"/>
  <xs:element name="UnderlyingFaceAmountAtMarketValues" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_UnderlyingFaceAmountAtMarketValues"/>
  <xs:element name="OtherAssetsInExcessOfLiabilitiesPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_OtherAssetsInExcessOfLiabilitiesPercentage"/>
  <xs:element name="Cash1" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_Cash1"/>
  <xs:element name="CashPledgedAsCollateral" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_CashPledgedAsCollateral"/>
  <xs:element name="InvestmentsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cik0001793497_InvestmentsTable"/>
  <xs:element name="InvestmentsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_InvestmentsLineItems"/>
  <xs:element name="AgreementsDisclosureTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_AgreementsDisclosureTextBlock"/>
  <xs:element name="AgreementsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cik0001793497_AgreementsTable"/>
  <xs:element name="AgreementsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_AgreementsLineItems"/>
  <xs:element name="OfferingCostsTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_OfferingCostsTextBlock"/>
  <xs:element name="OfferingCostsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cik0001793497_OfferingCostsTable"/>
  <xs:element name="OfferingCostsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_OfferingCostsLineItems"/>
  <xs:element name="CreationandRedemptionofCreationUnitsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cik0001793497_CreationandRedemptionofCreationUnitsTable"/>
  <xs:element name="CreationandRedemptionofCreationUnitsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_CreationandRedemptionofCreationUnitsLineItems"/>
  <xs:element name="FinancialHighlightsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cik0001793497_FinancialHighlightsTable"/>
  <xs:element name="FinancialHighlightsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_FinancialHighlightsLineItems"/>
  <xs:element name="RiskTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cik0001793497_RiskTable"/>
  <xs:element name="RiskLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_RiskLineItems"/>
  <xs:element name="SubsequentEventsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cik0001793497_SubsequentEventsTable"/>
  <xs:element name="SubsequentEventsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_SubsequentEventsLineItems"/>
  <xs:element name="EmergingGrowthCompanyPolicyTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_EmergingGrowthCompanyPolicyTextBlock"/>
  <xs:element name="StatementsOfCashFlowsPolicyTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_StatementsOfCashFlowsPolicyTextBlock"/>
  <xs:element name="FinalNetAssetValueForFiscalPeriodPolcyTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_FinalNetAssetValueForFiscalPeriodPolcyTextBlock"/>
  <xs:element name="ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock"/>
  <xs:element name="ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsTableTextBlock"/>
  <xs:element name="InvestmentsTablesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cik0001793497_InvestmentsTablesTable"/>
  <xs:element name="InvestmentsTablesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_InvestmentsTablesLineItems"/>
  <xs:element name="ScheduleOfTransactionFeesTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_ScheduleOfTransactionFeesTableTextBlock"/>
  <xs:element name="CreationandRedemptionofCreationUnitsTablesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cik0001793497_CreationandRedemptionofCreationUnitsTablesTable"/>
  <xs:element name="CreationandRedemptionofCreationUnitsTablesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_CreationandRedemptionofCreationUnitsTablesLineItems"/>
  <xs:element name="ScheduleOfShareOutstandingTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_ScheduleOfShareOutstandingTableTextBlock"/>
  <xs:element name="FinancialHighlightsTablesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cik0001793497_FinancialHighlightsTablesTable"/>
  <xs:element name="FinancialHighlightsTablesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_FinancialHighlightsTablesLineItems"/>
  <xs:element name="SignificantAccountingPoliciesDetailsScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsTable"/>
  <xs:element name="SignificantAccountingPoliciesDetailsScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsLineItems"/>
  <xs:element name="CreateRedeemCutoffDescription" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_CreateRedeemCutoffDescription"/>
  <xs:element name="NAVCalculationTimeESTDescription" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_NAVCalculationTimeESTDescription"/>
  <xs:element name="NAVCalculationDate" type="xbrli:dateItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_NAVCalculationDate"/>
  <xs:element name="SignificantAccountingPoliciesDetailsScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyTable"/>
  <xs:element name="SignificantAccountingPoliciesDetailsScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyLineItems"/>
  <xs:element name="AmountOfTotalTrust" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_AmountOfTotalTrust"/>
  <xs:element name="TotalTrust" type="xbrli:stringItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_TotalTrust"/>
  <xs:element name="TotalTrust1" type="xbrli:stringItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_TotalTrust1"/>
  <xs:element name="InvestmentsDetailsScheduleofEffectofDerivativeInstrumentsonTheStatementofOperationsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cik0001793497_InvestmentsDetailsScheduleofEffectofDerivativeInstrumentsonTheStatementofOperationsTable"/>
  <xs:element name="InvestmentsDetailsScheduleofEffectofDerivativeInstrumentsonTheStatementofOperationsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_InvestmentsDetailsScheduleofEffectofDerivativeInstrumentsonTheStatementofOperationsLineItems"/>
  <xs:element name="RealizedGainLossOnDerivativesRecognizedInIncome" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_RealizedGainLossOnDerivativesRecognizedInIncome"/>
  <xs:element name="ChangeInUnrealizedAppreciationDepreciationsOnDerivativesRecognizedInIncome" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_ChangeInUnrealizedAppreciationDepreciationsOnDerivativesRecognizedInIncome"/>
  <xs:element name="InvestmentsDetailsScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cik0001793497_InvestmentsDetailsScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsTable"/>
  <xs:element name="InvestmentsDetailsScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_InvestmentsDetailsScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsLineItems"/>
  <xs:element name="GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition"/>
  <xs:element name="GrossAmountsOffsetInTheStatementsOfFinancialCondition" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_GrossAmountsOffsetInTheStatementsOfFinancialCondition"/>
  <xs:element name="NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition"/>
  <xs:element name="GrossAmountsOfRecognizedLiabilitiesPresentedInTheStatementsOfFinancialCondition" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_GrossAmountsOfRecognizedLiabilitiesPresentedInTheStatementsOfFinancialCondition"/>
  <xs:element name="GrossAmountsOffsetInTheStatementsOfFinancialCondition1" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_GrossAmountsOffsetInTheStatementsOfFinancialCondition1"/>
  <xs:element name="NetAmountsOfLiabilitiesPresentedInTheStatementsOfFinancialCondition" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_NetAmountsOfLiabilitiesPresentedInTheStatementsOfFinancialCondition"/>
  <xs:element name="InvestmentsDetailsScheduleofGrossAmountsNotOffsetInTheStatementsofFinancialConditionTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cik0001793497_InvestmentsDetailsScheduleofGrossAmountsNotOffsetInTheStatementsofFinancialConditionTable"/>
  <xs:element name="InvestmentsDetailsScheduleofGrossAmountsNotOffsetInTheStatementsofFinancialConditionLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_InvestmentsDetailsScheduleofGrossAmountsNotOffsetInTheStatementsofFinancialConditionLineItems"/>
  <xs:element name="AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne"/>
  <xs:element name="FinancialInstrumentsForTheBenefitOftheFundsTheCounterpartiesTwo" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_FinancialInstrumentsForTheBenefitOftheFundsTheCounterpartiesTwo"/>
  <xs:element name="CashCollateralForTheBenefitOftheFundsTheCounterparties" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_CashCollateralForTheBenefitOftheFundsTheCounterparties"/>
  <xs:element name="CapitalUnitNetAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_CapitalUnitNetAmount"/>
  <xs:element name="CreationandRedemptionofCreationUnitsDetailsScheduleofTransactionFeesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cik0001793497_CreationandRedemptionofCreationUnitsDetailsScheduleofTransactionFeesTable"/>
  <xs:element name="CreationandRedemptionofCreationUnitsDetailsScheduleofTransactionFeesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_CreationandRedemptionofCreationUnitsDetailsScheduleofTransactionFeesLineItems"/>
  <xs:element name="FinancialHighlightsDetailsScheduleofShareOutstandingTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cik0001793497_FinancialHighlightsDetailsScheduleofShareOutstandingTable"/>
  <xs:element name="FinancialHighlightsDetailsScheduleofShareOutstandingLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_FinancialHighlightsDetailsScheduleofShareOutstandingLineItems"/>
  <xs:element name="NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts"/>
  <xs:element name="MarketValuePerShare" type="dtr:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_MarketValuePerShare"/>
  <xs:element name="TotalReturnAtMarketValue" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_TotalReturnAtMarketValue"/>
  <xs:element name="SignificantAccountingPoliciesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cik0001793497_SignificantAccountingPoliciesDetailsTable"/>
  <xs:element name="SignificantAccountingPoliciesDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_SignificantAccountingPoliciesDetailsLineItems"/>
  <xs:element name="GrossRevenue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_GrossRevenue"/>
  <xs:element name="NonconvertibleDebtSecurities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_NonconvertibleDebtSecurities"/>
  <xs:element name="NonaffiliatesExceeded" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_NonaffiliatesExceeded"/>
  <xs:element name="AgreementsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cik0001793497_AgreementsDetailsTable"/>
  <xs:element name="AgreementsDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_AgreementsDetailsLineItems"/>
  <xs:element name="AverageDailyNetAssetsRate" type="dtr:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_AverageDailyNetAssetsRate"/>
  <xs:element name="SubadvisoryFeeRate" type="dtr:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_SubadvisoryFeeRate"/>
  <xs:element name="AuthorizedParticipantsPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_AuthorizedParticipantsPercentage"/>
  <xs:element name="FinancialHighlightsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cik0001793497_FinancialHighlightsDetailsTable"/>
  <xs:element name="FinancialHighlightsDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_FinancialHighlightsDetailsLineItems"/>
  <xs:element name="BrokerageCommissionsRate" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_BrokerageCommissionsRate"/>
  <xs:element name="RelevantBenchmark" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_RelevantBenchmark"/>
  <xs:element name="AssetDerivativesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_AssetDerivativesMember"/>
  <xs:element name="CBOEVIXFuturesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_CBOEVIXFuturesMember"/>
  <xs:element name="CBOEVIXFuturesOneMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_CBOEVIXFuturesOneMember"/>
  <xs:element name="FirstAmericanGovernmentObligationsFundMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_FirstAmericanGovernmentObligationsFundMember"/>
  <xs:element name="FuturesContractsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_FuturesContractsMember"/>
  <xs:element name="LiabilityDerivativesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_LiabilityDerivativesMember"/>
  <xs:element name="OneShortVIXFuturesETFMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_OneShortVIXFuturesETFMember"/>
  <xs:element name="OnexShortVIXFuturesETFMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_OnexShortVIXFuturesETFMember"/>
  <xs:element name="SVIXMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_SVIXMember"/>
  <xs:element name="StatementsOfFinancialConditionLocationMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_StatementsOfFinancialConditionLocationMember"/>
  <xs:element name="TwoxLongVIXFuturesETFMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_TwoxLongVIXFuturesETFMember"/>
  <xs:element name="UVIXMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_UVIXMember"/>
  <xs:element name="UnrealizedAppreciationMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_UnrealizedAppreciationMember"/>
  <xs:element name="UnrealizedDepreciationMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_UnrealizedDepreciationMember"/>
  <xs:element name="VIXFuturesContractsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_VIXFuturesContractsMember"/>
  <xs:element name="DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_DocumentAndEntityInformationAbstract"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>cik0001793497-20230630_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Mon Aug 14 16:04:01 UTC 2023 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_ConsolidatedBalanceSheet" roleURI="http://www.vts.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_ConsolidatedBalanceSheetAlt0" roleURI="http://www.vts.com/role/ConsolidatedBalanceSheetAlt0"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_ConsolidatedIncomeStatement" roleURI="http://www.vts.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_ConsolidatedIncomeStatement0" roleURI="http://www.vts.com/role/ConsolidatedIncomeStatement0"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_ConsolidatedCashFlow" roleURI="http://www.vts.com/role/ConsolidatedCashFlow"/>
  <calculationLink xlink:type="extended" xlink:role="http://www.vts.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentOwnedAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedAtFairValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_InvestmentOwnedAtFairValue" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestReceivable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_InterestReceivable" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PrepaidExpenseAndOtherAssets" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ReceivableForSharesSold" xlink:href="cik0001793497-20230630.xsd#cik0001793497_ReceivableForSharesSold"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="cik0001793497_ReceivableForSharesSold" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommodityContractAssetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommodityContractAssetCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_CommodityContractAssetCurrent" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_VariationMarginReceivable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_VariationMarginReceivable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="cik0001793497_VariationMarginReceivable" order="7" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OtherReceivablesNetCurrent" order="8" weight="1"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_DueFromOther" xlink:href="cik0001793497-20230630.xsd#cik0001793497_DueFromOther"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="cik0001793497_DueFromOther" order="9" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_AccountsPayableCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_DueToCustodian" xlink:href="cik0001793497-20230630.xsd#cik0001793497_DueToCustodian"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="cik0001793497_DueToCustodian" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_FundSharesRedeemed" xlink:href="cik0001793497-20230630.xsd#cik0001793497_FundSharesRedeemed"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="cik0001793497_FundSharesRedeemed" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNotesPayable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_OtherNotesPayable" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_AdministrativeAccountingAndCustodianFeesPayable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_AdministrativeAccountingAndCustodianFeesPayable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="cik0001793497_AdministrativeAccountingAndCustodianFeesPayable" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_LicensingAndRegistrationFeesPayable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_LicensingAndRegistrationFeesPayable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="cik0001793497_LicensingAndRegistrationFeesPayable" order="7" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsNet" xlink:to="us-gaap_Assets" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsNet" xlink:to="us-gaap_Liabilities" order="2" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.vts.com/role/ConsolidatedBalanceSheetAlt0">
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNet"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsNet" xlink:to="us-gaap_AdditionalPaidInCapital" order="1" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsNet" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="2" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.vts.com/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeNet"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestAndOtherIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestAndOtherIncome"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InvestmentIncomeNet" xlink:to="us-gaap_InterestAndOtherIncome" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIncome"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InvestmentIncomeNet" xlink:to="us-gaap_OtherIncome" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherInterestAndDividendIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherInterestAndDividendIncome"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InvestmentIncomeNet" xlink:to="us-gaap_OtherInterestAndDividendIncome" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsAndExpenses"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ManagementFeeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ManagementFeeExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_ManagementFeeExpense" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProfessionalFees" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfessionalFees"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_ProfessionalFees" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LegalFees" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LegalFees"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_LegalFees" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FloorBrokerageExchangeAndClearanceFees" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FloorBrokerageExchangeAndClearanceFees"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_FloorBrokerageExchangeAndClearanceFees" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetInvestmentInLeaseAccruedInterestWriteoff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetInvestmentInLeaseAccruedInterestWriteoff"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSraoTMKpdMOVUMtRpuB8tV6eMGW/07nN8r724IYYtHu3Fk2iU8V8d5zeroA9ghPrxP68aa5UlyuaOj/7VPlLXQx0GT+xTdf3pIEmLVakfoittQNiZUQ0abAliT/vrVleUY3WZOYnY1Y7WqYa/6c4Wf84KjMb46gvmMAxplrY6I0tFQipwB6oEiZ/] CSR-->
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetInvestmentInLeaseAccruedInterestWriteoff" xlink:to="us-gaap_CostsAndExpenses" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetInvestmentInLeaseAccruedInterestWriteoff" xlink:to="us-gaap_InvestmentIncomeNet" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrealizedGainLossOnDerivatives" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ShortTermInvestmentsRealized" xlink:href="cik0001793497-20230630.xsd#cik0001793497_ShortTermInvestmentsRealized"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_UnrealizedGainLossOnDerivatives" xlink:to="cik0001793497_ShortTermInvestmentsRealized" order="1" weight="-1"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_FuturesContracts" xlink:href="cik0001793497-20230630.xsd#cik0001793497_FuturesContracts"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_UnrealizedGainLossOnDerivatives" xlink:to="cik0001793497_FuturesContracts" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ShortTermInvestmentsUnrealized" xlink:href="cik0001793497-20230630.xsd#cik0001793497_ShortTermInvestmentsUnrealized"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_UnrealizedGainLossOnDerivatives" xlink:to="cik0001793497_ShortTermInvestmentsUnrealized" order="3" weight="-1"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_FuturesContractsUnrealizedAppreciation" xlink:href="cik0001793497-20230630.xsd#cik0001793497_FuturesContractsUnrealizedAppreciation"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_UnrealizedGainLossOnDerivatives" xlink:to="cik0001793497_FuturesContractsUnrealizedAppreciation" order="4" weight="-1"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_NetIncreasedecreaseInNetAssetsResultingFromOperations" xlink:href="cik0001793497-20230630.xsd#cik0001793497_NetIncreasedecreaseInNetAssetsResultingFromOperations"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="cik0001793497_NetIncreasedecreaseInNetAssetsResultingFromOperations" xlink:to="us-gaap_UnrealizedGainLossOnDerivatives" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="cik0001793497_NetIncreasedecreaseInNetAssetsResultingFromOperations" xlink:to="us-gaap_NetInvestmentInLeaseAccruedInterestWriteoff" order="2" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.vts.com/role/ConsolidatedIncomeStatement0">
    <loc xlink:type="locator" xlink:label="cik0001793497_NetIncreasedecreaseInNetAssetsResultingFromOperations" xlink:href="cik0001793497-20230630.xsd#cik0001793497_NetIncreasedecreaseInNetAssetsResultingFromOperations"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnInvestments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="cik0001793497_NetIncreasedecreaseInNetAssetsResultingFromOperations" xlink:to="us-gaap_GainLossOnInvestments" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_NetRealizedGainlossOnInvestmentsAndFuturesContracts" xlink:href="cik0001793497-20230630.xsd#cik0001793497_NetRealizedGainlossOnInvestmentsAndFuturesContracts"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="cik0001793497_NetIncreasedecreaseInNetAssetsResultingFromOperations" xlink:to="cik0001793497_NetRealizedGainlossOnInvestmentsAndFuturesContracts" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_NetChangeInUnrealizedAppreciationdepreciationOfInvestmentsAndFuturesContracts" xlink:href="cik0001793497-20230630.xsd#cik0001793497_NetChangeInUnrealizedAppreciationdepreciationOfInvestmentsAndFuturesContracts"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="cik0001793497_NetIncreasedecreaseInNetAssetsResultingFromOperations" xlink:to="cik0001793497_NetChangeInUnrealizedAppreciationdepreciationOfInvestmentsAndFuturesContracts" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_NetIncreaseInNetAssetsFromCapitalShareTransactions" xlink:href="cik0001793497-20230630.xsd#cik0001793497_NetIncreaseInNetAssetsFromCapitalShareTransactions"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_SharesSoldinShares" xlink:href="cik0001793497-20230630.xsd#cik0001793497_SharesSoldinShares"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="cik0001793497_NetIncreaseInNetAssetsFromCapitalShareTransactions" xlink:to="cik0001793497_SharesSoldinShares" order="1" weight="-1"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_SharesSoldNetOfSharesRedeemedinDollarsPerShare" xlink:href="cik0001793497-20230630.xsd#cik0001793497_SharesSoldNetOfSharesRedeemedinDollarsPerShare"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="cik0001793497_NetIncreaseInNetAssetsFromCapitalShareTransactions" xlink:to="cik0001793497_SharesSoldNetOfSharesRedeemedinDollarsPerShare" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_IncreasedecreaseInNetAssets" xlink:href="cik0001793497-20230630.xsd#cik0001793497_IncreasedecreaseInNetAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="cik0001793497_IncreasedecreaseInNetAssets" xlink:to="cik0001793497_NetIncreasedecreaseInNetAssetsResultingFromOperations" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="cik0001793497_IncreasedecreaseInNetAssets" xlink:to="cik0001793497_NetIncreaseInNetAssetsFromCapitalShareTransactions" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.vts.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetIncomeLoss" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ProceedsFromSalesOrMaturitiesOfInvestments" xlink:href="cik0001793497-20230630.xsd#cik0001793497_ProceedsFromSalesOrMaturitiesOfInvestments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="cik0001793497_ProceedsFromSalesOrMaturitiesOfInvestments" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_IncreaseDecreaseInVariationMarginPayable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_IncreaseDecreaseInVariationMarginPayable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="cik0001793497_IncreaseDecreaseInVariationMarginPayable" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_IncreaseDecreaseInDueToCustodian" xlink:href="cik0001793497-20230630.xsd#cik0001793497_IncreaseDecreaseInDueToCustodian"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="cik0001793497_IncreaseDecreaseInDueToCustodian" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInCustomerAdvances" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInCustomerAdvances"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInCustomerAdvances" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" order="7" weight="1"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_IncreaseInProfessionalFeesPayable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_IncreaseInProfessionalFeesPayable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="cik0001793497_IncreaseInProfessionalFeesPayable" order="8" weight="1"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_IncreaseInLicensingAndRegistrationFeesPayable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_IncreaseInLicensingAndRegistrationFeesPayable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="cik0001793497_IncreaseInLicensingAndRegistrationFeesPayable" order="9" weight="1"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_PurchasesOfInvestments" xlink:href="cik0001793497-20230630.xsd#cik0001793497_PurchasesOfInvestments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="cik0001793497_PurchasesOfInvestments" order="10" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInEarnestMoneyDepositsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInEarnestMoneyDepositsOutstanding"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInEarnestMoneyDepositsOutstanding" order="11" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpensesOther" order="12" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet" order="13" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherReceivables"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInOtherReceivables" order="14" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInReceivables" order="15" weight="-1"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_IncreaseDecreaseInPayableToSponsor" xlink:href="cik0001793497-20230630.xsd#cik0001793497_IncreaseDecreaseInPayableToSponsor"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="cik0001793497_IncreaseDecreaseInPayableToSponsor" order="16" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ProceedsFromSaleOfUnits" xlink:href="cik0001793497-20230630.xsd#cik0001793497_ProceedsFromSaleOfUnits"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="cik0001793497_ProceedsFromSaleOfUnits" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="2" weight="1"/>
  </calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>cik0001793497-20230630_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Mon Aug 14 16:04:01 UTC 2023 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_ConsolidatedBalanceSheet" roleURI="http://www.vts.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_ConsolidatedIncomeStatement" roleURI="http://www.vts.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_ConsolidatedIncomeStatement0" roleURI="http://www.vts.com/role/ConsolidatedIncomeStatement0"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_ConsolidatedCashFlow" roleURI="http://www.vts.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_ScheduleofInvestmentsUnauditedTable" roleURI="http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_ScheduleofInvestmentsUnauditedTable_Parentheticals" roleURI="http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_Organization" roleURI="http://www.vts.com/role/Organization"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_SignificantAccountingPolicies" roleURI="http://www.vts.com/role/SignificantAccountingPolicies"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_Investments" roleURI="http://www.vts.com/role/Investments"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_Agreements" roleURI="http://www.vts.com/role/Agreements"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_OfferingCosts" roleURI="http://www.vts.com/role/OfferingCosts"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_CreationandRedemptionofCreationUnits" roleURI="http://www.vts.com/role/CreationandRedemptionofCreationUnits"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_FinancialHighlights" roleURI="http://www.vts.com/role/FinancialHighlights"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_Risk" roleURI="http://www.vts.com/role/Risk"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_SubsequentEvents" roleURI="http://www.vts.com/role/SubsequentEvents"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_AccountingPoliciesByPolicy" roleURI="http://www.vts.com/role/AccountingPoliciesByPolicy"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_SignificantAccountingPoliciesTables" roleURI="http://www.vts.com/role/SignificantAccountingPoliciesTables"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_InvestmentsTables" roleURI="http://www.vts.com/role/InvestmentsTables"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_CreationandRedemptionofCreationUnitsTables" roleURI="http://www.vts.com/role/CreationandRedemptionofCreationUnitsTables"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_FinancialHighlightsTables" roleURI="http://www.vts.com/role/FinancialHighlightsTables"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_ScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsTable" roleURI="http://www.vts.com/role/ScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsTable"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_ScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyTable" roleURI="http://www.vts.com/role/ScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyTable"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_ScheduleofFairValueofDerivativeInstrumentsTable" roleURI="http://www.vts.com/role/ScheduleofFairValueofDerivativeInstrumentsTable"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_ScheduleofEffectofDerivativeInstrumentsonTheStatementofOperationsTable" roleURI="http://www.vts.com/role/ScheduleofEffectofDerivativeInstrumentsonTheStatementofOperationsTable"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_ScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsTable" roleURI="http://www.vts.com/role/ScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsTable"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_ScheduleofGrossAmountsNotOffsetInTheStatementsofFinancialConditionTable" roleURI="http://www.vts.com/role/ScheduleofGrossAmountsNotOffsetInTheStatementsofFinancialConditionTable"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_ScheduleofTransactionFeesTable" roleURI="http://www.vts.com/role/ScheduleofTransactionFeesTable"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_ScheduleofShareOutstandingTable" roleURI="http://www.vts.com/role/ScheduleofShareOutstandingTable"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_SignificantAccountingPoliciesDetails" roleURI="http://www.vts.com/role/SignificantAccountingPoliciesDetails"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_AgreementsDetails" roleURI="http://www.vts.com/role/AgreementsDetails"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_CreationandRedemptionofCreationUnitsDetails" roleURI="http://www.vts.com/role/CreationandRedemptionofCreationUnitsDetails"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_FinancialHighlightsDetails" roleURI="http://www.vts.com/role/FinancialHighlightsDetails"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_RiskDetails" roleURI="http://www.vts.com/role/RiskDetails"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#DocumentAndEntityInformation" roleURI="http://www.vts.com/role/DocumentAndEntityInformation"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all"/>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_OneShortVIXFuturesETFMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_OneShortVIXFuturesETFMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="cik0001793497_OneShortVIXFuturesETFMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_TwoxLongVIXFuturesETFMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_TwoxLongVIXFuturesETFMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="cik0001793497_TwoxLongVIXFuturesETFMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentOwnedAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedAtFairValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_InvestmentOwnedAtFairValue" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestReceivable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_InterestReceivable" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssets" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ReceivableForSharesSold" xlink:href="cik0001793497-20230630.xsd#cik0001793497_ReceivableForSharesSold"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="cik0001793497_ReceivableForSharesSold" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommodityContractAssetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommodityContractAssetCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_CommodityContractAssetCurrent" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_VariationMarginReceivable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_VariationMarginReceivable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="cik0001793497_VariationMarginReceivable" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OtherReceivablesNetCurrent" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_DueFromOther" xlink:href="cik0001793497-20230630.xsd#cik0001793497_DueFromOther"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="cik0001793497_DueFromOther" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_DueFromOther" xlink:to="us-gaap_Assets" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAbstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_PayablesAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_PayablesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="cik0001793497_PayablesAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_PayablesAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_DueToCustodian" xlink:href="cik0001793497-20230630.xsd#cik0001793497_DueToCustodian"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_PayablesAbstract" xlink:to="cik0001793497_DueToCustodian" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_FundSharesRedeemed" xlink:href="cik0001793497-20230630.xsd#cik0001793497_FundSharesRedeemed"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_PayablesAbstract" xlink:to="cik0001793497_FundSharesRedeemed" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNotesPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_PayablesAbstract" xlink:to="us-gaap_OtherNotesPayable" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_AdministrativeAccountingAndCustodianFeesPayable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_AdministrativeAccountingAndCustodianFeesPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_PayablesAbstract" xlink:to="cik0001793497_AdministrativeAccountingAndCustodianFeesPayable" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_PayablesAbstract" xlink:to="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_LicensingAndRegistrationFeesPayable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_LicensingAndRegistrationFeesPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_PayablesAbstract" xlink:to="cik0001793497_LicensingAndRegistrationFeesPayable" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_LicensingAndRegistrationFeesPayable" xlink:to="us-gaap_Liabilities" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsNet" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_NetAssetsConsistOfAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_NetAssetsConsistOfAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="cik0001793497_NetAssetsConsistOfAbstract" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_NetAssetsConsistOfAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_NetAssetsConsistOfAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ClassIUnlimitedSharesAuthorizedAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_ClassIUnlimitedSharesAuthorizedAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="cik0001793497_ClassIUnlimitedSharesAuthorizedAbstract" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_ClassIUnlimitedSharesAuthorizedAbstract" xlink:to="us-gaap_SharesOutstanding" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetAssetValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetAssetValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_ClassIUnlimitedSharesAuthorizedAbstract" xlink:to="us-gaap_NetAssetValuePerShare" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesParValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AuctionMarketPreferredSecuritiesStockSeriesParValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_ClassIUnlimitedSharesAuthorizedAbstract" xlink:to="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesParValuePerShare" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherInvestmentsAndSecuritiesAtCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherInvestmentsAndSecuritiesAtCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherInvestmentsAndSecuritiesAtCost" order="6" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_OneShortVIXFuturesETFMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_OneShortVIXFuturesETFMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="cik0001793497_OneShortVIXFuturesETFMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_TwoxLongVIXFuturesETFMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_TwoxLongVIXFuturesETFMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="cik0001793497_TwoxLongVIXFuturesETFMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_InvestmentIncomeAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_InvestmentIncomeAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="cik0001793497_InvestmentIncomeAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_IncomeAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_IncomeAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_InvestmentIncomeAbstract" xlink:to="cik0001793497_IncomeAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestAndOtherIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestAndOtherIncome"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_IncomeAbstract" xlink:to="us-gaap_InterestAndOtherIncome" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIncome"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_IncomeAbstract" xlink:to="us-gaap_OtherIncome" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherIncome" xlink:to="us-gaap_InvestmentIncomeNet" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ExpensesAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_ExpensesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_InvestmentIncomeAbstract" xlink:to="cik0001793497_ExpensesAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ManagementFeeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ManagementFeeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_ExpensesAbstract" xlink:to="us-gaap_ManagementFeeExpense" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_ExpensesAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProfessionalFees" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfessionalFees"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_ExpensesAbstract" xlink:to="us-gaap_ProfessionalFees" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LegalFees" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LegalFees"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_ExpensesAbstract" xlink:to="us-gaap_LegalFees" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FloorBrokerageExchangeAndClearanceFees" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FloorBrokerageExchangeAndClearanceFees"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_ExpensesAbstract" xlink:to="us-gaap_FloorBrokerageExchangeAndClearanceFees" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsAndExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FloorBrokerageExchangeAndClearanceFees" xlink:to="us-gaap_CostsAndExpenses" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetInvestmentInLeaseAccruedInterestWriteoff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetInvestmentInLeaseAccruedInterestWriteoff"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetInvestmentInLeaseAccruedInterestWriteoff" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_NetRealizedGainLossOnAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_NetRealizedGainLossOnAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="cik0001793497_NetRealizedGainLossOnAbstract" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ShortTermInvestmentsRealized" xlink:href="cik0001793497-20230630.xsd#cik0001793497_ShortTermInvestmentsRealized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_NetRealizedGainLossOnAbstract" xlink:to="cik0001793497_ShortTermInvestmentsRealized" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_FuturesContracts" xlink:href="cik0001793497-20230630.xsd#cik0001793497_FuturesContracts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_NetRealizedGainLossOnAbstract" xlink:to="cik0001793497_FuturesContracts" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_NetChangeInUnrealizedAppreciationDepreciationOfAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_NetChangeInUnrealizedAppreciationDepreciationOfAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="cik0001793497_NetChangeInUnrealizedAppreciationDepreciationOfAbstract" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ShortTermInvestmentsUnrealized" xlink:href="cik0001793497-20230630.xsd#cik0001793497_ShortTermInvestmentsUnrealized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_NetChangeInUnrealizedAppreciationDepreciationOfAbstract" xlink:to="cik0001793497_ShortTermInvestmentsUnrealized" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_FuturesContractsUnrealizedAppreciation" xlink:href="cik0001793497-20230630.xsd#cik0001793497_FuturesContractsUnrealizedAppreciation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_NetChangeInUnrealizedAppreciationDepreciationOfAbstract" xlink:to="cik0001793497_FuturesContractsUnrealizedAppreciation" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrealizedGainLossOnDerivatives" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_UnrealizedGainLossOnDerivatives" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_NetIncreasedecreaseInNetAssetsResultingFromOperations" xlink:href="cik0001793497-20230630.xsd#cik0001793497_NetIncreasedecreaseInNetAssetsResultingFromOperations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="cik0001793497_NetIncreasedecreaseInNetAssetsResultingFromOperations" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_InvestmentIncomeAbstract0" xlink:href="cik0001793497-20230630.xsd#cik0001793497_InvestmentIncomeAbstract0"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="cik0001793497_InvestmentIncomeAbstract0" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherInterestAndDividendIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherInterestAndDividendIncome"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_InvestmentIncomeAbstract0" xlink:to="us-gaap_OtherInterestAndDividendIncome" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ExpensesAbstract0" xlink:href="cik0001793497-20230630.xsd#cik0001793497_ExpensesAbstract0"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_InvestmentIncomeAbstract0" xlink:to="cik0001793497_ExpensesAbstract0" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/ConsolidatedIncomeStatement0">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_OneShortVIXFuturesETFMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_OneShortVIXFuturesETFMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="cik0001793497_OneShortVIXFuturesETFMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_TwoxLongVIXFuturesETFMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_TwoxLongVIXFuturesETFMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="cik0001793497_TwoxLongVIXFuturesETFMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_OperationsAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_OperationsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="cik0001793497_OperationsAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_OperationsAbstract" xlink:to="us-gaap_GainLossOnInvestments" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_NetRealizedGainlossOnInvestmentsAndFuturesContracts" xlink:href="cik0001793497-20230630.xsd#cik0001793497_NetRealizedGainlossOnInvestmentsAndFuturesContracts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_OperationsAbstract" xlink:to="cik0001793497_NetRealizedGainlossOnInvestmentsAndFuturesContracts" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_NetChangeInUnrealizedAppreciationdepreciationOfInvestmentsAndFuturesContracts" xlink:href="cik0001793497-20230630.xsd#cik0001793497_NetChangeInUnrealizedAppreciationdepreciationOfInvestmentsAndFuturesContracts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_OperationsAbstract" xlink:to="cik0001793497_NetChangeInUnrealizedAppreciationdepreciationOfInvestmentsAndFuturesContracts" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_NetIncreasedecreaseInNetAssetsResultingFromOperations" xlink:href="cik0001793497-20230630.xsd#cik0001793497_NetIncreasedecreaseInNetAssetsResultingFromOperations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_OperationsAbstract" xlink:to="cik0001793497_NetIncreasedecreaseInNetAssetsResultingFromOperations" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_CapitalShareTransactionsAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_CapitalShareTransactionsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="cik0001793497_CapitalShareTransactionsAbstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_SharesSoldinShares" xlink:href="cik0001793497-20230630.xsd#cik0001793497_SharesSoldinShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_CapitalShareTransactionsAbstract" xlink:to="cik0001793497_SharesSoldinShares" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_SharesSoldNetOfSharesRedeemedinDollarsPerShare" xlink:href="cik0001793497-20230630.xsd#cik0001793497_SharesSoldNetOfSharesRedeemedinDollarsPerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_CapitalShareTransactionsAbstract" xlink:to="cik0001793497_SharesSoldNetOfSharesRedeemedinDollarsPerShare" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_NetIncreaseInNetAssetsFromCapitalShareTransactions" xlink:href="cik0001793497-20230630.xsd#cik0001793497_NetIncreaseInNetAssetsFromCapitalShareTransactions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_CapitalShareTransactionsAbstract" xlink:to="cik0001793497_NetIncreaseInNetAssetsFromCapitalShareTransactions" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_IncreasedecreaseInNetAssets" xlink:href="cik0001793497-20230630.xsd#cik0001793497_IncreasedecreaseInNetAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="cik0001793497_IncreasedecreaseInNetAssets" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_NetAssetsAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_NetAssetsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="cik0001793497_NetAssetsAbstract" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_NetAssetsAbstract" xlink:to="us-gaap_AssetsNet" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_OneShortVIXFuturesETFMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_OneShortVIXFuturesETFMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="cik0001793497_OneShortVIXFuturesETFMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_TwoxLongVIXFuturesETFMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_TwoxLongVIXFuturesETFMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="cik0001793497_TwoxLongVIXFuturesETFMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_AdjustmentsToReconcileNetIncomeLossToNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_AdjustmentsToReconcileNetIncomeLossToNetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="cik0001793497_AdjustmentsToReconcileNetIncomeLossToNetCashProvidedByUsedInOperatingActivitiesAbstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_PurchasesOfInvestments" xlink:href="cik0001793497-20230630.xsd#cik0001793497_PurchasesOfInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_AdjustmentsToReconcileNetIncomeLossToNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="cik0001793497_PurchasesOfInvestments" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ProceedsFromSalesOrMaturitiesOfInvestments" xlink:href="cik0001793497-20230630.xsd#cik0001793497_ProceedsFromSalesOrMaturitiesOfInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_AdjustmentsToReconcileNetIncomeLossToNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="cik0001793497_ProceedsFromSalesOrMaturitiesOfInvestments" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInEarnestMoneyDepositsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInEarnestMoneyDepositsOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_AdjustmentsToReconcileNetIncomeLossToNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInEarnestMoneyDepositsOutstanding" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_AdjustmentsToReconcileNetIncomeLossToNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpensesOther" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_AdjustmentsToReconcileNetIncomeLossToNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherReceivables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_AdjustmentsToReconcileNetIncomeLossToNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherReceivables" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_IncreaseDecreaseInVariationMarginPayable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_IncreaseDecreaseInVariationMarginPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_AdjustmentsToReconcileNetIncomeLossToNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="cik0001793497_IncreaseDecreaseInVariationMarginPayable" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_AdjustmentsToReconcileNetIncomeLossToNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInReceivables" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_IncreaseDecreaseInDueToCustodian" xlink:href="cik0001793497-20230630.xsd#cik0001793497_IncreaseDecreaseInDueToCustodian"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_AdjustmentsToReconcileNetIncomeLossToNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="cik0001793497_IncreaseDecreaseInDueToCustodian" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInCustomerAdvances" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInCustomerAdvances"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_AdjustmentsToReconcileNetIncomeLossToNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInCustomerAdvances" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_AdjustmentsToReconcileNetIncomeLossToNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_IncreaseDecreaseInPayableToSponsor" xlink:href="cik0001793497-20230630.xsd#cik0001793497_IncreaseDecreaseInPayableToSponsor"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_AdjustmentsToReconcileNetIncomeLossToNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="cik0001793497_IncreaseDecreaseInPayableToSponsor" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_AdjustmentsToReconcileNetIncomeLossToNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_IncreaseInProfessionalFeesPayable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_IncreaseInProfessionalFeesPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_AdjustmentsToReconcileNetIncomeLossToNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="cik0001793497_IncreaseInProfessionalFeesPayable" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_IncreaseInLicensingAndRegistrationFeesPayable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_IncreaseInLicensingAndRegistrationFeesPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_AdjustmentsToReconcileNetIncomeLossToNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="cik0001793497_IncreaseInLicensingAndRegistrationFeesPayable" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_AdjustmentsToReconcileNetIncomeLossToNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ProceedsFromSaleOfUnits" xlink:href="cik0001793497-20230630.xsd#cik0001793497_ProceedsFromSaleOfUnits"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="cik0001793497_ProceedsFromSaleOfUnits" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_EquityMethodInvesteeNameDomain_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityDomain_0" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_OnexShortVIXFuturesETFMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_OnexShortVIXFuturesETFMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="cik0001793497_OnexShortVIXFuturesETFMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_TwoxLongVIXFuturesETFMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_TwoxLongVIXFuturesETFMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="cik0001793497_TwoxLongVIXFuturesETFMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_FirstAmericanGovernmentObligationsFundMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_FirstAmericanGovernmentObligationsFundMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="cik0001793497_FirstAmericanGovernmentObligationsFundMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_CBOEVIXFuturesMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_CBOEVIXFuturesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="cik0001793497_CBOEVIXFuturesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_CBOEVIXFuturesOneMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_CBOEVIXFuturesOneMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="cik0001793497_CBOEVIXFuturesOneMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherInvestments" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherAssets" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsNet" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_NumberOfContracts" xlink:href="cik0001793497-20230630.xsd#cik0001793497_NumberOfContracts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="cik0001793497_NumberOfContracts" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentOwnedUnrecognizedUnrealizedAppreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedUnrecognizedUnrealizedAppreciation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InvestmentOwnedUnrecognizedUnrealizedAppreciation" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_UnderlyingFaceAmountAtMarketValues" xlink:href="cik0001793497-20230630.xsd#cik0001793497_UnderlyingFaceAmountAtMarketValues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="cik0001793497_UnderlyingFaceAmountAtMarketValues" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MoneyMarketFundsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MoneyMarketFundsAtCarryingValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_MoneyMarketFundsAtCarryingValue" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherShortTermInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherShortTermInvestments" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashEquivalentsAtCarryingValue" order="9" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_EquityMethodInvesteeNameDomain_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_OnexShortVIXFuturesETFMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_OnexShortVIXFuturesETFMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="cik0001793497_OnexShortVIXFuturesETFMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_TwoxLongVIXFuturesETFMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_TwoxLongVIXFuturesETFMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="cik0001793497_TwoxLongVIXFuturesETFMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_FirstAmericanGovernmentObligationsFundMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_FirstAmericanGovernmentObligationsFundMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="cik0001793497_FirstAmericanGovernmentObligationsFundMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_OtherAssetsInExcessOfLiabilitiesPercentage" xlink:href="cik0001793497-20230630.xsd#cik0001793497_OtherAssetsInExcessOfLiabilitiesPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="cik0001793497_OtherAssetsInExcessOfLiabilitiesPercentage" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeNetAssetsPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeNetAssetsPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DerivativeNetAssetsPercentage" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_Cash1" xlink:href="cik0001793497-20230630.xsd#cik0001793497_Cash1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="cik0001793497_Cash1" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentInterestRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InvestmentInterestRate" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_CashPledgedAsCollateral" xlink:href="cik0001793497-20230630.xsd#cik0001793497_CashPledgedAsCollateral"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="cik0001793497_CashPledgedAsCollateral" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/Organization">
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/SignificantAccountingPolicies">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/Investments">
    <loc xlink:type="locator" xlink:label="cik0001793497_InvestmentsLineItems" xlink:href="cik0001793497-20230630.xsd#cik0001793497_InvestmentsLineItems"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_InvestmentsTable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_InvestmentsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cik0001793497_InvestmentsLineItems" xlink:to="cik0001793497_InvestmentsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_InvestmentsLineItems" xlink:to="us-gaap_InvestmentTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/Agreements">
    <loc xlink:type="locator" xlink:label="cik0001793497_AgreementsLineItems" xlink:href="cik0001793497-20230630.xsd#cik0001793497_AgreementsLineItems"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_AgreementsTable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_AgreementsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cik0001793497_AgreementsLineItems" xlink:to="cik0001793497_AgreementsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_AgreementsDisclosureTextBlock" xlink:href="cik0001793497-20230630.xsd#cik0001793497_AgreementsDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_AgreementsLineItems" xlink:to="cik0001793497_AgreementsDisclosureTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/OfferingCosts">
    <loc xlink:type="locator" xlink:label="cik0001793497_OfferingCostsLineItems" xlink:href="cik0001793497-20230630.xsd#cik0001793497_OfferingCostsLineItems"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_OfferingCostsTable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_OfferingCostsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cik0001793497_OfferingCostsLineItems" xlink:to="cik0001793497_OfferingCostsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_OfferingCostsTextBlock" xlink:href="cik0001793497-20230630.xsd#cik0001793497_OfferingCostsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_OfferingCostsLineItems" xlink:to="cik0001793497_OfferingCostsTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/CreationandRedemptionofCreationUnits">
    <loc xlink:type="locator" xlink:label="cik0001793497_CreationandRedemptionofCreationUnitsLineItems" xlink:href="cik0001793497-20230630.xsd#cik0001793497_CreationandRedemptionofCreationUnitsLineItems"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_CreationandRedemptionofCreationUnitsTable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_CreationandRedemptionofCreationUnitsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cik0001793497_CreationandRedemptionofCreationUnitsLineItems" xlink:to="cik0001793497_CreationandRedemptionofCreationUnitsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_CreationandRedemptionofCreationUnitsLineItems" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/FinancialHighlights">
    <loc xlink:type="locator" xlink:label="cik0001793497_FinancialHighlightsLineItems" xlink:href="cik0001793497-20230630.xsd#cik0001793497_FinancialHighlightsLineItems"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_FinancialHighlightsTable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_FinancialHighlightsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cik0001793497_FinancialHighlightsLineItems" xlink:to="cik0001793497_FinancialHighlightsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_QuarterlyFinancialInformationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_QuarterlyFinancialInformationTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_FinancialHighlightsLineItems" xlink:to="us-gaap_QuarterlyFinancialInformationTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/Risk">
    <loc xlink:type="locator" xlink:label="cik0001793497_RiskLineItems" xlink:href="cik0001793497-20230630.xsd#cik0001793497_RiskLineItems"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_RiskTable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_RiskTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cik0001793497_RiskLineItems" xlink:to="cik0001793497_RiskTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_RiskLineItems" xlink:to="us-gaap_ConcentrationRiskDisclosureTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/SubsequentEvents">
    <loc xlink:type="locator" xlink:label="cik0001793497_SubsequentEventsLineItems" xlink:href="cik0001793497-20230630.xsd#cik0001793497_SubsequentEventsLineItems"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_SubsequentEventsTable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_SubsequentEventsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cik0001793497_SubsequentEventsLineItems" xlink:to="cik0001793497_SubsequentEventsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_SubsequentEventsLineItems" xlink:to="us-gaap_SubsequentEventsTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/AccountingPoliciesByPolicy">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_EmergingGrowthCompanyPolicyTextBlock" xlink:href="cik0001793497-20230630.xsd#cik0001793497_EmergingGrowthCompanyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="cik0001793497_EmergingGrowthCompanyPolicyTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="1" xbrldt:closed="true"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSraoTMKpdMOVUMtRpuB8tV6eMGW/07nN8r724IYYtHu3Fk2iU8V8d5zeroA9ghPrxP68aa5UlyuaOj/7VPlLXQx0GT+xTdf3pIEmLVakfoittQNiZUQ0abAliT/vrVleUY3WZOYnY1Y7WqYa/6c4Wf84lUKYnTNtHYpEkySIyInYO/eVUfeqx7Uf] CSR-->
    <loc xlink:type="locator" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_StatementsOfCashFlowsPolicyTextBlock" xlink:href="cik0001793497-20230630.xsd#cik0001793497_StatementsOfCashFlowsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="cik0001793497_StatementsOfCashFlowsPolicyTextBlock" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_FinalNetAssetValueForFiscalPeriodPolcyTextBlock" xlink:href="cik0001793497-20230630.xsd#cik0001793497_FinalNetAssetValueForFiscalPeriodPolcyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="cik0001793497_FinalNetAssetValueForFiscalPeriodPolcyTextBlock" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_InvestmentPolicyTextBlock" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnremittedEarningsInForeignInvestmentPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnremittedEarningsInForeignInvestmentPolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UnremittedEarningsInForeignInvestmentPolicy" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FloorBrokeragePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FloorBrokeragePolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FloorBrokeragePolicy" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="9" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/SignificantAccountingPoliciesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock" xlink:href="cik0001793497-20230630.xsd#cik0001793497_ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="cik0001793497_ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/InvestmentsTables">
    <loc xlink:type="locator" xlink:label="cik0001793497_InvestmentsTablesLineItems" xlink:href="cik0001793497-20230630.xsd#cik0001793497_InvestmentsTablesLineItems"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_InvestmentsTablesTable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_InvestmentsTablesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cik0001793497_InvestmentsTablesLineItems" xlink:to="cik0001793497_InvestmentsTablesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_InvestmentsTablesLineItems" xlink:to="us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_InvestmentsTablesLineItems" xlink:to="us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsTableTextBlock" xlink:href="cik0001793497-20230630.xsd#cik0001793497_ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_InvestmentsTablesLineItems" xlink:to="cik0001793497_ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsTableTextBlock" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_InvestmentsTablesLineItems" xlink:to="us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/CreationandRedemptionofCreationUnitsTables">
    <loc xlink:type="locator" xlink:label="cik0001793497_CreationandRedemptionofCreationUnitsTablesLineItems" xlink:href="cik0001793497-20230630.xsd#cik0001793497_CreationandRedemptionofCreationUnitsTablesLineItems"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_CreationandRedemptionofCreationUnitsTablesTable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_CreationandRedemptionofCreationUnitsTablesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cik0001793497_CreationandRedemptionofCreationUnitsTablesLineItems" xlink:to="cik0001793497_CreationandRedemptionofCreationUnitsTablesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ScheduleOfTransactionFeesTableTextBlock" xlink:href="cik0001793497-20230630.xsd#cik0001793497_ScheduleOfTransactionFeesTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_CreationandRedemptionofCreationUnitsTablesLineItems" xlink:to="cik0001793497_ScheduleOfTransactionFeesTableTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/FinancialHighlightsTables">
    <loc xlink:type="locator" xlink:label="cik0001793497_FinancialHighlightsTablesLineItems" xlink:href="cik0001793497-20230630.xsd#cik0001793497_FinancialHighlightsTablesLineItems"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_FinancialHighlightsTablesTable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_FinancialHighlightsTablesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cik0001793497_FinancialHighlightsTablesLineItems" xlink:to="cik0001793497_FinancialHighlightsTablesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ScheduleOfShareOutstandingTableTextBlock" xlink:href="cik0001793497-20230630.xsd#cik0001793497_ScheduleOfShareOutstandingTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_FinancialHighlightsTablesLineItems" xlink:to="cik0001793497_ScheduleOfShareOutstandingTableTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/ScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsTable">
    <loc xlink:type="locator" xlink:label="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsLineItems" xlink:href="cik0001793497-20230630.xsd#cik0001793497_SignificantAccountingPoliciesDetailsScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsLineItems"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsTable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_SignificantAccountingPoliciesDetailsScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsLineItems" xlink:to="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_OneShortVIXFuturesETFMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_OneShortVIXFuturesETFMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="cik0001793497_OneShortVIXFuturesETFMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_TwoxLongVIXFuturesETFMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_TwoxLongVIXFuturesETFMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="cik0001793497_TwoxLongVIXFuturesETFMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_CreateRedeemCutoffDescription" xlink:href="cik0001793497-20230630.xsd#cik0001793497_CreateRedeemCutoffDescription"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsLineItems" xlink:to="cik0001793497_CreateRedeemCutoffDescription" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_NAVCalculationTimeESTDescription" xlink:href="cik0001793497-20230630.xsd#cik0001793497_NAVCalculationTimeESTDescription"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsLineItems" xlink:to="cik0001793497_NAVCalculationTimeESTDescription" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_NAVCalculationDate" xlink:href="cik0001793497-20230630.xsd#cik0001793497_NAVCalculationDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsLineItems" xlink:to="cik0001793497_NAVCalculationDate" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/ScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyTable">
    <loc xlink:type="locator" xlink:label="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyLineItems" xlink:href="cik0001793497-20230630.xsd#cik0001793497_SignificantAccountingPoliciesDetailsScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyLineItems"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyTable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_SignificantAccountingPoliciesDetailsScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyLineItems" xlink:to="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyTable" xlink:to="us-gaap_CashAndCashEquivalentsAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MoneyMarketFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MoneyMarketFundsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_MoneyMarketFundsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_FuturesContractsMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_FuturesContractsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="cik0001793497_FuturesContractsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_OneShortVIXFuturesETFMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_OneShortVIXFuturesETFMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="cik0001793497_OneShortVIXFuturesETFMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_TwoxLongVIXFuturesETFMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_TwoxLongVIXFuturesETFMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="cik0001793497_TwoxLongVIXFuturesETFMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_AmountOfTotalTrust" xlink:href="cik0001793497-20230630.xsd#cik0001793497_AmountOfTotalTrust"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyLineItems" xlink:to="cik0001793497_AmountOfTotalTrust" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/ScheduleofFairValueofDerivativeInstrumentsTable">
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativesFairValueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DerivativesFairValueLineItems" xlink:to="us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="us-gaap_DerivativeInstrumentRiskAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DerivativeInstrumentRiskAxis" xlink:to="us-gaap_DerivativeContractTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeContractTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DerivativeInstrumentRiskAxis" xlink:to="us-gaap_DerivativeContractTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FinancingReceivablesPeriodPastDueAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancingReceivablesPeriodPastDueAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="us-gaap_FinancingReceivablesPeriodPastDueAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FinancingReceivablesPeriodPastDueDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancingReceivablesPeriodPastDueDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FinancingReceivablesPeriodPastDueAxis" xlink:to="us-gaap_FinancingReceivablesPeriodPastDueDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FinancingReceivablesPeriodPastDueDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancingReceivablesPeriodPastDueDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FinancingReceivablesPeriodPastDueAxis" xlink:to="us-gaap_FinancingReceivablesPeriodPastDueDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_StatementsOfFinancialConditionLocationMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_StatementsOfFinancialConditionLocationMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FinancingReceivablesPeriodPastDueDomain" xlink:to="cik0001793497_StatementsOfFinancialConditionLocationMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_UnrealizedAppreciationMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_UnrealizedAppreciationMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FinancingReceivablesPeriodPastDueDomain" xlink:to="cik0001793497_UnrealizedAppreciationMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_UnrealizedDepreciationMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_UnrealizedDepreciationMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FinancingReceivablesPeriodPastDueDomain" xlink:to="cik0001793497_UnrealizedDepreciationMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_OnexShortVIXFuturesETFMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_OnexShortVIXFuturesETFMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="cik0001793497_OnexShortVIXFuturesETFMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_TwoxLongVIXFuturesETFMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_TwoxLongVIXFuturesETFMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="cik0001793497_TwoxLongVIXFuturesETFMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_AssetDerivativesMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_AssetDerivativesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DerivativeContractTypeDomain" xlink:to="cik0001793497_AssetDerivativesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_LiabilityDerivativesMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_LiabilityDerivativesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DerivativeContractTypeDomain" xlink:to="cik0001793497_LiabilityDerivativesMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_TotalTrust" xlink:href="cik0001793497-20230630.xsd#cik0001793497_TotalTrust"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DerivativesFairValueLineItems" xlink:to="cik0001793497_TotalTrust" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_TotalTrust1" xlink:href="cik0001793497-20230630.xsd#cik0001793497_TotalTrust1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DerivativesFairValueLineItems" xlink:to="cik0001793497_TotalTrust1" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/ScheduleofEffectofDerivativeInstrumentsonTheStatementofOperationsTable">
    <loc xlink:type="locator" xlink:label="cik0001793497_InvestmentsDetailsScheduleofEffectofDerivativeInstrumentsonTheStatementofOperationsLineItems" xlink:href="cik0001793497-20230630.xsd#cik0001793497_InvestmentsDetailsScheduleofEffectofDerivativeInstrumentsonTheStatementofOperationsLineItems"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_InvestmentsDetailsScheduleofEffectofDerivativeInstrumentsonTheStatementofOperationsTable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_InvestmentsDetailsScheduleofEffectofDerivativeInstrumentsonTheStatementofOperationsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cik0001793497_InvestmentsDetailsScheduleofEffectofDerivativeInstrumentsonTheStatementofOperationsLineItems" xlink:to="cik0001793497_InvestmentsDetailsScheduleofEffectofDerivativeInstrumentsonTheStatementofOperationsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cik0001793497_InvestmentsDetailsScheduleofEffectofDerivativeInstrumentsonTheStatementofOperationsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_OnexShortVIXFuturesETFMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_OnexShortVIXFuturesETFMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="cik0001793497_OnexShortVIXFuturesETFMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_TwoxLongVIXFuturesETFMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_TwoxLongVIXFuturesETFMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="cik0001793497_TwoxLongVIXFuturesETFMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_VixFuturesContractsNetRealizedGainLossOnFuturesContractsChangesInUnrealizedAppreciationDepreciationOnFuturesContractsAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_VixFuturesContractsNetRealizedGainLossOnFuturesContractsChangesInUnrealizedAppreciationDepreciationOnFuturesContractsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_InvestmentsDetailsScheduleofEffectofDerivativeInstrumentsonTheStatementofOperationsLineItems" xlink:to="cik0001793497_VixFuturesContractsNetRealizedGainLossOnFuturesContractsChangesInUnrealizedAppreciationDepreciationOnFuturesContractsAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_RealizedGainLossOnDerivativesRecognizedInIncome" xlink:href="cik0001793497-20230630.xsd#cik0001793497_RealizedGainLossOnDerivativesRecognizedInIncome"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_VixFuturesContractsNetRealizedGainLossOnFuturesContractsChangesInUnrealizedAppreciationDepreciationOnFuturesContractsAbstract" xlink:to="cik0001793497_RealizedGainLossOnDerivativesRecognizedInIncome" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ChangeInUnrealizedAppreciationDepreciationsOnDerivativesRecognizedInIncome" xlink:href="cik0001793497-20230630.xsd#cik0001793497_ChangeInUnrealizedAppreciationDepreciationsOnDerivativesRecognizedInIncome"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_VixFuturesContractsNetRealizedGainLossOnFuturesContractsChangesInUnrealizedAppreciationDepreciationOnFuturesContractsAbstract" xlink:to="cik0001793497_ChangeInUnrealizedAppreciationDepreciationsOnDerivativesRecognizedInIncome" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/ScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsTable">
    <loc xlink:type="locator" xlink:label="cik0001793497_InvestmentsDetailsScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsLineItems" xlink:href="cik0001793497-20230630.xsd#cik0001793497_InvestmentsDetailsScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsLineItems"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_InvestmentsDetailsScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsTable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_InvestmentsDetailsScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cik0001793497_InvestmentsDetailsScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsLineItems" xlink:to="cik0001793497_InvestmentsDetailsScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cik0001793497_InvestmentsDetailsScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cik0001793497_InvestmentsDetailsScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsTable" xlink:to="us-gaap_BalanceSheetLocationAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_OnexShortVIXFuturesETFMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_OnexShortVIXFuturesETFMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="cik0001793497_OnexShortVIXFuturesETFMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_TwoxLongVIXFuturesETFMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_TwoxLongVIXFuturesETFMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="cik0001793497_TwoxLongVIXFuturesETFMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_OtherAssetsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_OtherLiabilitiesMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition" xlink:href="cik0001793497-20230630.xsd#cik0001793497_GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_InvestmentsDetailsScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsLineItems" xlink:to="cik0001793497_GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_GrossAmountsOffsetInTheStatementsOfFinancialCondition" xlink:href="cik0001793497-20230630.xsd#cik0001793497_GrossAmountsOffsetInTheStatementsOfFinancialCondition"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_InvestmentsDetailsScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsLineItems" xlink:to="cik0001793497_GrossAmountsOffsetInTheStatementsOfFinancialCondition" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition" xlink:href="cik0001793497-20230630.xsd#cik0001793497_NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_InvestmentsDetailsScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsLineItems" xlink:to="cik0001793497_NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_GrossAmountsOfRecognizedLiabilitiesPresentedInTheStatementsOfFinancialCondition" xlink:href="cik0001793497-20230630.xsd#cik0001793497_GrossAmountsOfRecognizedLiabilitiesPresentedInTheStatementsOfFinancialCondition"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_InvestmentsDetailsScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsLineItems" xlink:to="cik0001793497_GrossAmountsOfRecognizedLiabilitiesPresentedInTheStatementsOfFinancialCondition" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_GrossAmountsOffsetInTheStatementsOfFinancialCondition1" xlink:href="cik0001793497-20230630.xsd#cik0001793497_GrossAmountsOffsetInTheStatementsOfFinancialCondition1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_InvestmentsDetailsScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsLineItems" xlink:to="cik0001793497_GrossAmountsOffsetInTheStatementsOfFinancialCondition1" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_NetAmountsOfLiabilitiesPresentedInTheStatementsOfFinancialCondition" xlink:href="cik0001793497-20230630.xsd#cik0001793497_NetAmountsOfLiabilitiesPresentedInTheStatementsOfFinancialCondition"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_InvestmentsDetailsScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsLineItems" xlink:to="cik0001793497_NetAmountsOfLiabilitiesPresentedInTheStatementsOfFinancialCondition" order="6" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/ScheduleofGrossAmountsNotOffsetInTheStatementsofFinancialConditionTable">
    <loc xlink:type="locator" xlink:label="cik0001793497_InvestmentsDetailsScheduleofGrossAmountsNotOffsetInTheStatementsofFinancialConditionLineItems" xlink:href="cik0001793497-20230630.xsd#cik0001793497_InvestmentsDetailsScheduleofGrossAmountsNotOffsetInTheStatementsofFinancialConditionLineItems"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_InvestmentsDetailsScheduleofGrossAmountsNotOffsetInTheStatementsofFinancialConditionTable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_InvestmentsDetailsScheduleofGrossAmountsNotOffsetInTheStatementsofFinancialConditionTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cik0001793497_InvestmentsDetailsScheduleofGrossAmountsNotOffsetInTheStatementsofFinancialConditionLineItems" xlink:to="cik0001793497_InvestmentsDetailsScheduleofGrossAmountsNotOffsetInTheStatementsofFinancialConditionTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cik0001793497_InvestmentsDetailsScheduleofGrossAmountsNotOffsetInTheStatementsofFinancialConditionTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_OneShortVIXFuturesETFMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_OneShortVIXFuturesETFMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="cik0001793497_OneShortVIXFuturesETFMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_TwoxLongVIXFuturesETFMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_TwoxLongVIXFuturesETFMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="cik0001793497_TwoxLongVIXFuturesETFMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne" xlink:href="cik0001793497-20230630.xsd#cik0001793497_AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_InvestmentsDetailsScheduleofGrossAmountsNotOffsetInTheStatementsofFinancialConditionLineItems" xlink:to="cik0001793497_AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_FinancialInstrumentsForTheBenefitOftheFundsTheCounterpartiesTwo" xlink:href="cik0001793497-20230630.xsd#cik0001793497_FinancialInstrumentsForTheBenefitOftheFundsTheCounterpartiesTwo"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_InvestmentsDetailsScheduleofGrossAmountsNotOffsetInTheStatementsofFinancialConditionLineItems" xlink:to="cik0001793497_FinancialInstrumentsForTheBenefitOftheFundsTheCounterpartiesTwo" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_CashCollateralForTheBenefitOftheFundsTheCounterparties" xlink:href="cik0001793497-20230630.xsd#cik0001793497_CashCollateralForTheBenefitOftheFundsTheCounterparties"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_InvestmentsDetailsScheduleofGrossAmountsNotOffsetInTheStatementsofFinancialConditionLineItems" xlink:to="cik0001793497_CashCollateralForTheBenefitOftheFundsTheCounterparties" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_CapitalUnitNetAmount" xlink:href="cik0001793497-20230630.xsd#cik0001793497_CapitalUnitNetAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_InvestmentsDetailsScheduleofGrossAmountsNotOffsetInTheStatementsofFinancialConditionLineItems" xlink:to="cik0001793497_CapitalUnitNetAmount" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/ScheduleofTransactionFeesTable">
    <loc xlink:type="locator" xlink:label="cik0001793497_CreationandRedemptionofCreationUnitsDetailsScheduleofTransactionFeesLineItems" xlink:href="cik0001793497-20230630.xsd#cik0001793497_CreationandRedemptionofCreationUnitsDetailsScheduleofTransactionFeesLineItems"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_CreationandRedemptionofCreationUnitsDetailsScheduleofTransactionFeesTable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_CreationandRedemptionofCreationUnitsDetailsScheduleofTransactionFeesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cik0001793497_CreationandRedemptionofCreationUnitsDetailsScheduleofTransactionFeesLineItems" xlink:to="cik0001793497_CreationandRedemptionofCreationUnitsDetailsScheduleofTransactionFeesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cik0001793497_CreationandRedemptionofCreationUnitsDetailsScheduleofTransactionFeesTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_OnexShortVIXFuturesETFMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_OnexShortVIXFuturesETFMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="cik0001793497_OnexShortVIXFuturesETFMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_TwoxLongVIXFuturesETFMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_TwoxLongVIXFuturesETFMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="cik0001793497_TwoxLongVIXFuturesETFMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfTrustAssetsToPayExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfTrustAssetsToPayExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_CreationandRedemptionofCreationUnitsDetailsScheduleofTransactionFeesLineItems" xlink:to="us-gaap_SaleOfTrustAssetsToPayExpenses" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/ScheduleofShareOutstandingTable">
    <loc xlink:type="locator" xlink:label="cik0001793497_FinancialHighlightsDetailsScheduleofShareOutstandingLineItems" xlink:href="cik0001793497-20230630.xsd#cik0001793497_FinancialHighlightsDetailsScheduleofShareOutstandingLineItems"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_FinancialHighlightsDetailsScheduleofShareOutstandingTable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_FinancialHighlightsDetailsScheduleofShareOutstandingTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cik0001793497_FinancialHighlightsDetailsScheduleofShareOutstandingLineItems" xlink:to="cik0001793497_FinancialHighlightsDetailsScheduleofShareOutstandingTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cik0001793497_FinancialHighlightsDetailsScheduleofShareOutstandingTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_OnexShortVIXFuturesETFMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_OnexShortVIXFuturesETFMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="cik0001793497_OnexShortVIXFuturesETFMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_TwoxLongVIXFuturesETFMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_TwoxLongVIXFuturesETFMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="cik0001793497_TwoxLongVIXFuturesETFMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentCompanyMarketValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyMarketValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_FinancialHighlightsDetailsScheduleofShareOutstandingLineItems" xlink:to="us-gaap_InvestmentCompanyMarketValuePerShare" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentCompanyGainLossOnInvestmentPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyGainLossOnInvestmentPerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_FinancialHighlightsDetailsScheduleofShareOutstandingLineItems" xlink:to="us-gaap_InvestmentCompanyGainLossOnInvestmentPerShare" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts" xlink:href="cik0001793497-20230630.xsd#cik0001793497_NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_FinancialHighlightsDetailsScheduleofShareOutstandingLineItems" xlink:to="cik0001793497_NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_FinancialHighlightsDetailsScheduleofShareOutstandingLineItems" xlink:to="us-gaap_InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_MarketValuePerShare" xlink:href="cik0001793497-20230630.xsd#cik0001793497_MarketValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_FinancialHighlightsDetailsScheduleofShareOutstandingLineItems" xlink:to="cik0001793497_MarketValuePerShare" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentCompanyTotalReturn" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyTotalReturn"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_FinancialHighlightsDetailsScheduleofShareOutstandingLineItems" xlink:to="us-gaap_InvestmentCompanyTotalReturn" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_TotalReturnAtMarketValue" xlink:href="cik0001793497-20230630.xsd#cik0001793497_TotalReturnAtMarketValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_FinancialHighlightsDetailsScheduleofShareOutstandingLineItems" xlink:to="cik0001793497_TotalReturnAtMarketValue" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_RatiosToAverageNetAssets5Abstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_RatiosToAverageNetAssets5Abstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_FinancialHighlightsDetailsScheduleofShareOutstandingLineItems" xlink:to="cik0001793497_RatiosToAverageNetAssets5Abstract" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentCompanyExpenseRatioAfterIncentiveAllocation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyExpenseRatioAfterIncentiveAllocation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_RatiosToAverageNetAssets5Abstract" xlink:to="us-gaap_InvestmentCompanyExpenseRatioAfterIncentiveAllocation" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentCompanyTotalReturnAfterIncentiveFees" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyTotalReturnAfterIncentiveFees"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_RatiosToAverageNetAssets5Abstract" xlink:to="us-gaap_InvestmentCompanyTotalReturnAfterIncentiveFees" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/SignificantAccountingPoliciesDetails">
    <loc xlink:type="locator" xlink:label="cik0001793497_SignificantAccountingPoliciesDetailsLineItems" xlink:href="cik0001793497-20230630.xsd#cik0001793497_SignificantAccountingPoliciesDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_SignificantAccountingPoliciesDetailsTable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_SignificantAccountingPoliciesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cik0001793497_SignificantAccountingPoliciesDetailsLineItems" xlink:to="cik0001793497_SignificantAccountingPoliciesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetirementPlanFundingStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanFundingStatusAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cik0001793497_SignificantAccountingPoliciesDetailsTable" xlink:to="us-gaap_RetirementPlanFundingStatusAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetirementPlanFundingStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanFundingStatusDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RetirementPlanFundingStatusAxis" xlink:to="us-gaap_RetirementPlanFundingStatusDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetirementPlanFundingStatusDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanFundingStatusDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RetirementPlanFundingStatusAxis" xlink:to="us-gaap_RetirementPlanFundingStatusDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_SVIXMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_SVIXMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RetirementPlanFundingStatusDomain" xlink:to="cik0001793497_SVIXMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_UVIXMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_UVIXMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RetirementPlanFundingStatusDomain" xlink:to="cik0001793497_UVIXMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_GrossRevenue" xlink:href="cik0001793497-20230630.xsd#cik0001793497_GrossRevenue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_SignificantAccountingPoliciesDetailsLineItems" xlink:to="cik0001793497_GrossRevenue" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_NonconvertibleDebtSecurities" xlink:href="cik0001793497-20230630.xsd#cik0001793497_NonconvertibleDebtSecurities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_SignificantAccountingPoliciesDetailsLineItems" xlink:to="cik0001793497_NonconvertibleDebtSecurities" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_NonaffiliatesExceeded" xlink:href="cik0001793497-20230630.xsd#cik0001793497_NonaffiliatesExceeded"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_SignificantAccountingPoliciesDetailsLineItems" xlink:to="cik0001793497_NonaffiliatesExceeded" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeNetAssetsPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeNetAssetsPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_SignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_DerivativeNetAssetsPercentage" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/AgreementsDetails">
    <loc xlink:type="locator" xlink:label="cik0001793497_AgreementsDetailsLineItems" xlink:href="cik0001793497-20230630.xsd#cik0001793497_AgreementsDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_AgreementsDetailsTable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_AgreementsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cik0001793497_AgreementsDetailsLineItems" xlink:to="cik0001793497_AgreementsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cik0001793497_AgreementsDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_SVIXMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_SVIXMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="cik0001793497_SVIXMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_UVIXMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_UVIXMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="cik0001793497_UVIXMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_AverageDailyNetAssetsRate" xlink:href="cik0001793497-20230630.xsd#cik0001793497_AverageDailyNetAssetsRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_AgreementsDetailsLineItems" xlink:to="cik0001793497_AverageDailyNetAssetsRate" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_SubadvisoryFeeRate" xlink:href="cik0001793497-20230630.xsd#cik0001793497_SubadvisoryFeeRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_AgreementsDetailsLineItems" xlink:to="cik0001793497_SubadvisoryFeeRate" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/CreationandRedemptionofCreationUnitsDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_SharesIssued" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_AuthorizedParticipantsPercentage" xlink:href="cik0001793497-20230630.xsd#cik0001793497_AuthorizedParticipantsPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="cik0001793497_AuthorizedParticipantsPercentage" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/FinancialHighlightsDetails">
    <loc xlink:type="locator" xlink:label="cik0001793497_FinancialHighlightsDetailsLineItems" xlink:href="cik0001793497-20230630.xsd#cik0001793497_FinancialHighlightsDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_FinancialHighlightsDetailsTable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_FinancialHighlightsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cik0001793497_FinancialHighlightsDetailsLineItems" xlink:to="cik0001793497_FinancialHighlightsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cik0001793497_FinancialHighlightsDetailsTable" xlink:to="srt_RangeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpenseRatio" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpenseRatio"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_FinancialHighlightsDetailsLineItems" xlink:to="us-gaap_GeneralAndAdministrativeExpenseRatio" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_BrokerageCommissionsRate" xlink:href="cik0001793497-20230630.xsd#cik0001793497_BrokerageCommissionsRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_FinancialHighlightsDetailsLineItems" xlink:to="cik0001793497_BrokerageCommissionsRate" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/RiskDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_RisksAndUncertaintiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RisksAndUncertaintiesAbstract"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_RelevantBenchmark" xlink:href="cik0001793497-20230630.xsd#cik0001793497_RelevantBenchmark"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RisksAndUncertaintiesAbstract" xlink:to="cik0001793497_RelevantBenchmark" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_OnexShortVIXFuturesETFMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_OnexShortVIXFuturesETFMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="cik0001793497_OnexShortVIXFuturesETFMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_TwoxLongVIXFuturesETFMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_TwoxLongVIXFuturesETFMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="cik0001793497_TwoxLongVIXFuturesETFMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntitySmallBusiness" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityShellCompany" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityExTransitionPeriod" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentQuarterlyReport" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentTransitionReport" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine2" order="23" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="24" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="25" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="26" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" order="27" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="28" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" order="29" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" order="30" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityInteractiveDataCurrent" order="31" xbrldt:closed="true"/>
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>cik0001793497-20230630_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Mon Aug 14 16:04:01 UTC 2023 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsNet_lbl" xml:lang="en-US">NET ASSETS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNet" xlink:to="us-gaap_AssetsNet_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_AssetsNet_lbl0" xml:lang="en-US">Beginning of Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNet" xlink:to="us-gaap_AssetsNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_AssetsNet_lbl1" xml:lang="en-US">End of Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNet" xlink:to="us-gaap_AssetsNet_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsNet_lbl2" xml:lang="en-US">TOTAL NET ASSETS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNet" xlink:to="us-gaap_AssetsNet_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AssetsNet_lbl3" xml:lang="en-US">Net Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNet" xlink:to="us-gaap_AssetsNet_lbl3"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ConsolidatedEntitiesAxis_lbl" xml:lang="en-US">Consolidated Entities [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_InvestmentIncomeNet_lbl" xml:lang="en-US">Total Income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeNet" xlink:to="us-gaap_InvestmentIncomeNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsAndExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CostsAndExpenses_lbl" xml:lang="en-US">Total Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostsAndExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetInvestmentInLeaseAccruedInterestWriteoff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetInvestmentInLeaseAccruedInterestWriteoff"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_NetInvestmentInLeaseAccruedInterestWriteoff_lbl" xml:lang="en-US">Net Investment loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetInvestmentInLeaseAccruedInterestWriteoff" xlink:to="us-gaap_NetInvestmentInLeaseAccruedInterestWriteoff_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrealizedGainLossOnDerivatives" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_UnrealizedGainLossOnDerivatives_lbl" xml:lang="en-US">Net realized and unrealized gain (loss) on investments and futures contracts</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrealizedGainLossOnDerivatives" xlink:to="us-gaap_UnrealizedGainLossOnDerivatives_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_NetIncreasedecreaseInNetAssetsResultingFromOperations" xlink:href="cik0001793497-20230630.xsd#cik0001793497_NetIncreasedecreaseInNetAssetsResultingFromOperations"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="cik0001793497_NetIncreasedecreaseInNetAssetsResultingFromOperations_lbl" xml:lang="en-US">NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NetIncreasedecreaseInNetAssetsResultingFromOperations" xlink:to="cik0001793497_NetIncreasedecreaseInNetAssetsResultingFromOperations_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_NetIncreasedecreaseInNetAssetsResultingFromOperations_lbl0" xml:lang="en-US">Net increase (decrease) in net assets resulting from operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NetIncreasedecreaseInNetAssetsResultingFromOperations" xlink:to="cik0001793497_NetIncreasedecreaseInNetAssetsResultingFromOperations_lbl0"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_NetIncreaseInNetAssetsFromCapitalShareTransactions" xlink:href="cik0001793497-20230630.xsd#cik0001793497_NetIncreaseInNetAssetsFromCapitalShareTransactions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="cik0001793497_NetIncreaseInNetAssetsFromCapitalShareTransactions_lbl" xml:lang="en-US">Net increase (decrease) in net assets from capital share transactions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NetIncreaseInNetAssetsFromCapitalShareTransactions" xlink:to="cik0001793497_NetIncreaseInNetAssetsFromCapitalShareTransactions_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_IncreasedecreaseInNetAssets" xlink:href="cik0001793497-20230630.xsd#cik0001793497_IncreasedecreaseInNetAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="cik0001793497_IncreasedecreaseInNetAssets_lbl" xml:lang="en-US">Total increase (decrease) in net assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_IncreasedecreaseInNetAssets" xlink:to="cik0001793497_IncreasedecreaseInNetAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash provided by (used in) operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash provided by (used in) financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xml:lang="en-US">NET INCREASE (DECREASE) IN CASH</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US">Beginning of Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl0" xml:lang="en-US">End of Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LegalEntityAxis_lbl" xml:lang="en-US">Legal Entity [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl" xml:lang="en-US">Investment, Name [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US">Organization [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Significant Accounting Policies [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAxis_lbl" xml:lang="en-US">Cash and Cash Equivalents [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_CashAndCashEquivalentsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentRiskAxis_lbl" xml:lang="en-US">Derivative Instrument [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentRiskAxis" xlink:to="us-gaap_DerivativeInstrumentRiskAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FinancingReceivablesPeriodPastDueAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancingReceivablesPeriodPastDueAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinancingReceivablesPeriodPastDueAxis_lbl" xml:lang="en-US">Financial Asset, Aging [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancingReceivablesPeriodPastDueAxis" xlink:to="us-gaap_FinancingReceivablesPeriodPastDueAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BalanceSheetLocationAxis_lbl" xml:lang="en-US">Balance Sheet Location [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentCompanyMarketValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyMarketValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_InvestmentCompanyMarketValuePerShare_lbl" xml:lang="en-US">Net Asset Value, Beginning of Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentCompanyMarketValuePerShare" xlink:to="us-gaap_InvestmentCompanyMarketValuePerShare_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_InvestmentCompanyMarketValuePerShare_lbl0" xml:lang="en-US">Net Asset Value, End of Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentCompanyMarketValuePerShare" xlink:to="us-gaap_InvestmentCompanyMarketValuePerShare_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RisksAndUncertaintiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RisksAndUncertaintiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RisksAndUncertaintiesAbstract_lbl" xml:lang="en-US">Risk [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RisksAndUncertaintiesAbstract" xlink:to="us-gaap_RisksAndUncertaintiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Entity Ex Transition Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">ASSETS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentOwnedAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedAtFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InvestmentOwnedAtFairValue_lbl" xml:lang="en-US">Investments in securities, at value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentOwnedAtFairValue" xlink:to="us-gaap_InvestmentOwnedAtFairValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestReceivable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InterestReceivable_lbl" xml:lang="en-US">Interest receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestReceivable" xlink:to="us-gaap_InterestReceivable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PrepaidExpenseAndOtherAssets_lbl" xml:lang="en-US">Prepaid expenses and other assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssets" xlink:to="us-gaap_PrepaidExpenseAndOtherAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ReceivableForSharesSold" xlink:href="cik0001793497-20230630.xsd#cik0001793497_ReceivableForSharesSold"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_ReceivableForSharesSold_lbl" xml:lang="en-US">Receivable for shares sold</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ReceivableForSharesSold" xlink:to="cik0001793497_ReceivableForSharesSold_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommodityContractAssetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommodityContractAssetCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommodityContractAssetCurrent_lbl" xml:lang="en-US">Deposit at Broker for Futures</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommodityContractAssetCurrent" xlink:to="us-gaap_CommodityContractAssetCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_VariationMarginReceivable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_VariationMarginReceivable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_VariationMarginReceivable_lbl" xml:lang="en-US">Variation margin receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_VariationMarginReceivable" xlink:to="cik0001793497_VariationMarginReceivable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherReceivablesNetCurrent_lbl" xml:lang="en-US">Other receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherReceivablesNetCurrent" xlink:to="us-gaap_OtherReceivablesNetCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_DueFromOther" xlink:href="cik0001793497-20230630.xsd#cik0001793497_DueFromOther"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_DueFromOther_lbl" xml:lang="en-US">Due from Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_DueFromOther" xlink:to="cik0001793497_DueFromOther_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_UnlabeledAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_UnlabeledAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_UnlabeledAbstract_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract" xlink:to="cik0001793497_UnlabeledAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesAbstract_lbl" xml:lang="en-US">LIABILITIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_LiabilitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_PayablesAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_PayablesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_PayablesAbstract_lbl" xml:lang="en-US">Payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_PayablesAbstract" xlink:to="cik0001793497_PayablesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Variation margin payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_DueToCustodian" xlink:href="cik0001793497-20230630.xsd#cik0001793497_DueToCustodian"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_DueToCustodian_lbl" xml:lang="en-US">Due to Custodian</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_DueToCustodian" xlink:to="cik0001793497_DueToCustodian_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_FundSharesRedeemed" xlink:href="cik0001793497-20230630.xsd#cik0001793497_FundSharesRedeemed"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_FundSharesRedeemed_lbl" xml:lang="en-US">Fund shares redeemed</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_FundSharesRedeemed" xlink:to="cik0001793497_FundSharesRedeemed_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNotesPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherNotesPayable_lbl" xml:lang="en-US">Payable to Sponsor</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNotesPayable" xlink:to="us-gaap_OtherNotesPayable_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_AdministrativeAccountingAndCustodianFeesPayable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_AdministrativeAccountingAndCustodianFeesPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_AdministrativeAccountingAndCustodianFeesPayable_lbl" xml:lang="en-US">Administrative, accounting and custodian fees payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_AdministrativeAccountingAndCustodianFeesPayable" xlink:to="cik0001793497_AdministrativeAccountingAndCustodianFeesPayable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_lbl" xml:lang="en-US">Professional fees payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_LicensingAndRegistrationFeesPayable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_LicensingAndRegistrationFeesPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_LicensingAndRegistrationFeesPayable_lbl" xml:lang="en-US">Licensing and registration fees payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_LicensingAndRegistrationFeesPayable" xlink:to="cik0001793497_LicensingAndRegistrationFeesPayable_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_UnlabeledAbstract0" xlink:href="cik0001793497-20230630.xsd#cik0001793497_UnlabeledAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_UnlabeledAbstract0_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract0" xlink:to="cik0001793497_UnlabeledAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_NetAssetsConsistOfAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_NetAssetsConsistOfAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_NetAssetsConsistOfAbstract_lbl" xml:lang="en-US">NET ASSETS CONSIST OF:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NetAssetsConsistOfAbstract" xlink:to="cik0001793497_NetAssetsConsistOfAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_UnlabeledAbstract1" xlink:href="cik0001793497-20230630.xsd#cik0001793497_UnlabeledAbstract1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_UnlabeledAbstract1_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract1" xlink:to="cik0001793497_UnlabeledAbstract1_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_NetAssetValueUnlimitedSharesAuthorizedAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_NetAssetValueUnlimitedSharesAuthorizedAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_NetAssetValueUnlimitedSharesAuthorizedAbstract_lbl" xml:lang="en-US">Net Asset Value (unlimited shares authorized):</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NetAssetValueUnlimitedSharesAuthorizedAbstract" xlink:to="cik0001793497_NetAssetValueUnlimitedSharesAuthorizedAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ClassIUnlimitedSharesAuthorizedAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_ClassIUnlimitedSharesAuthorizedAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_ClassIUnlimitedSharesAuthorizedAbstract_lbl" xml:lang="en-US">Class I (unlimited shares authorized):</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ClassIUnlimitedSharesAuthorizedAbstract" xlink:to="cik0001793497_ClassIUnlimitedSharesAuthorizedAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Shares Outstanding (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetAssetValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetAssetValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetAssetValuePerShare_lbl" xml:lang="en-US">Net Asset Value, Offering and Redemption Price per Share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetAssetValuePerShare" xlink:to="us-gaap_NetAssetValuePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesParValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AuctionMarketPreferredSecuritiesStockSeriesParValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesParValuePerShare_lbl" xml:lang="en-US">Market Value per Share (Note 2) (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesParValuePerShare" xlink:to="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesParValuePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_UnlabeledAbstract2" xlink:href="cik0001793497-20230630.xsd#cik0001793497_UnlabeledAbstract2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_UnlabeledAbstract2_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract2" xlink:to="cik0001793497_UnlabeledAbstract2_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherInvestmentsAndSecuritiesAtCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherInvestmentsAndSecuritiesAtCost"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherInvestmentsAndSecuritiesAtCost_lbl" xml:lang="en-US">Investments in securities, at cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherInvestmentsAndSecuritiesAtCost" xlink:to="us-gaap_OtherInvestmentsAndSecuritiesAtCost_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_InvestmentIncomeAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_InvestmentIncomeAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_InvestmentIncomeAbstract_lbl" xml:lang="en-US">INVESTMENT INCOME</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_InvestmentIncomeAbstract" xlink:to="cik0001793497_InvestmentIncomeAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_IncomeAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_IncomeAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_IncomeAbstract_lbl" xml:lang="en-US">Income:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_IncomeAbstract" xlink:to="cik0001793497_IncomeAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestAndOtherIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestAndOtherIncome"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InterestAndOtherIncome_lbl" xml:lang="en-US">Interest income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestAndOtherIncome" xlink:to="us-gaap_InterestAndOtherIncome_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIncome"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherIncome_lbl" xml:lang="en-US">Other Income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncome" xlink:to="us-gaap_OtherIncome_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_UnlabeledAbstract3" xlink:href="cik0001793497-20230630.xsd#cik0001793497_UnlabeledAbstract3"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_UnlabeledAbstract3_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract3" xlink:to="cik0001793497_UnlabeledAbstract3_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ExpensesAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_ExpensesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_ExpensesAbstract_lbl" xml:lang="en-US">Expenses:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ExpensesAbstract" xlink:to="cik0001793497_ExpensesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ManagementFeeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ManagementFeeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ManagementFeeExpense_lbl" xml:lang="en-US">Management fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ManagementFeeExpense" xlink:to="us-gaap_ManagementFeeExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">Administrative, accounting and custodian fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProfessionalFees" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfessionalFees"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProfessionalFees_lbl" xml:lang="en-US">Professional fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfessionalFees" xlink:to="us-gaap_ProfessionalFees_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LegalFees" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LegalFees"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LegalFees_lbl" xml:lang="en-US">Licensing and registration fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LegalFees" xlink:to="us-gaap_LegalFees_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FloorBrokerageExchangeAndClearanceFees" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FloorBrokerageExchangeAndClearanceFees"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FloorBrokerageExchangeAndClearanceFees_lbl" xml:lang="en-US">Broker interest expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FloorBrokerageExchangeAndClearanceFees" xlink:to="us-gaap_FloorBrokerageExchangeAndClearanceFees_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_UnlabeledAbstract4" xlink:href="cik0001793497-20230630.xsd#cik0001793497_UnlabeledAbstract4"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_UnlabeledAbstract4_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract4" xlink:to="cik0001793497_UnlabeledAbstract4_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_RealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContractsAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_RealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContractsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_RealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContractsAbstract_lbl" xml:lang="en-US">REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS AND FUTURES CONTRACTS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_RealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContractsAbstract" xlink:to="cik0001793497_RealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContractsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_UnlabeledAbstract5" xlink:href="cik0001793497-20230630.xsd#cik0001793497_UnlabeledAbstract5"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_UnlabeledAbstract5_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract5" xlink:to="cik0001793497_UnlabeledAbstract5_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_NetRealizedGainLossOnAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_NetRealizedGainLossOnAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_NetRealizedGainLossOnAbstract_lbl" xml:lang="en-US">Net realized gain (loss) on:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NetRealizedGainLossOnAbstract" xlink:to="cik0001793497_NetRealizedGainLossOnAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_NetChangeInUnrealizedAppreciationDepreciationOfAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_NetChangeInUnrealizedAppreciationDepreciationOfAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_NetChangeInUnrealizedAppreciationDepreciationOfAbstract_lbl" xml:lang="en-US">Net change in unrealized appreciation (depreciation) of:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NetChangeInUnrealizedAppreciationDepreciationOfAbstract" xlink:to="cik0001793497_NetChangeInUnrealizedAppreciationDepreciationOfAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_InvestmentIncomeAbstract0" xlink:href="cik0001793497-20230630.xsd#cik0001793497_InvestmentIncomeAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_InvestmentIncomeAbstract0_lbl" xml:lang="en-US">INVESTMENT INCOME</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_InvestmentIncomeAbstract0" xlink:to="cik0001793497_InvestmentIncomeAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherInterestAndDividendIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherInterestAndDividendIncome"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherInterestAndDividendIncome_lbl" xml:lang="en-US">Dividends</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherInterestAndDividendIncome" xlink:to="us-gaap_OtherInterestAndDividendIncome_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_UnlabeledAbstract6" xlink:href="cik0001793497-20230630.xsd#cik0001793497_UnlabeledAbstract6"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_UnlabeledAbstract6_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract6" xlink:to="cik0001793497_UnlabeledAbstract6_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ExpensesAbstract0" xlink:href="cik0001793497-20230630.xsd#cik0001793497_ExpensesAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_ExpensesAbstract0_lbl" xml:lang="en-US">Expenses:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ExpensesAbstract0" xlink:to="cik0001793497_ExpensesAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_UnlabeledAbstract7" xlink:href="cik0001793497-20230630.xsd#cik0001793497_UnlabeledAbstract7"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_UnlabeledAbstract7_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract7" xlink:to="cik0001793497_UnlabeledAbstract7_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_RealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContractsAbstract0" xlink:href="cik0001793497-20230630.xsd#cik0001793497_RealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContractsAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_RealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContractsAbstract0_lbl" xml:lang="en-US">REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS AND FUTURES CONTRACTS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_RealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContractsAbstract0" xlink:to="cik0001793497_RealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContractsAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_UnlabeledAbstract8" xlink:href="cik0001793497-20230630.xsd#cik0001793497_UnlabeledAbstract8"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_UnlabeledAbstract8_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract8" xlink:to="cik0001793497_UnlabeledAbstract8_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_NetRealizedGainLossOnAbstract0" xlink:href="cik0001793497-20230630.xsd#cik0001793497_NetRealizedGainLossOnAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_NetRealizedGainLossOnAbstract0_lbl" xml:lang="en-US">Net realized gain (loss) on:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NetRealizedGainLossOnAbstract0" xlink:to="cik0001793497_NetRealizedGainLossOnAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_NetChangeInUnrealizedAppreciationDepreciationOfAbstract0" xlink:href="cik0001793497-20230630.xsd#cik0001793497_NetChangeInUnrealizedAppreciationDepreciationOfAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_NetChangeInUnrealizedAppreciationDepreciationOfAbstract0_lbl" xml:lang="en-US">Net change in unrealized appreciation (depreciation) of:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NetChangeInUnrealizedAppreciationDepreciationOfAbstract0" xlink:to="cik0001793497_NetChangeInUnrealizedAppreciationDepreciationOfAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_IncreaseDecreaseInNetAssetsAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_IncreaseDecreaseInNetAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_IncreaseDecreaseInNetAssetsAbstract_lbl" xml:lang="en-US">INCREASE (DECREASE) IN NET ASSETS:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_IncreaseDecreaseInNetAssetsAbstract" xlink:to="cik0001793497_IncreaseDecreaseInNetAssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_OperationsAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_OperationsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_OperationsAbstract_lbl" xml:lang="en-US">OPERATIONS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_OperationsAbstract" xlink:to="cik0001793497_OperationsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GainLossOnInvestments_lbl" xml:lang="en-US">Net investment loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnInvestments" xlink:to="us-gaap_GainLossOnInvestments_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_NetRealizedGainlossOnInvestmentsAndFuturesContracts" xlink:href="cik0001793497-20230630.xsd#cik0001793497_NetRealizedGainlossOnInvestmentsAndFuturesContracts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_NetRealizedGainlossOnInvestmentsAndFuturesContracts_lbl" xml:lang="en-US">Net realized gain (loss) on investments and futures contracts</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NetRealizedGainlossOnInvestmentsAndFuturesContracts" xlink:to="cik0001793497_NetRealizedGainlossOnInvestmentsAndFuturesContracts_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_NetChangeInUnrealizedAppreciationdepreciationOfInvestmentsAndFuturesContracts" xlink:href="cik0001793497-20230630.xsd#cik0001793497_NetChangeInUnrealizedAppreciationdepreciationOfInvestmentsAndFuturesContracts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_NetChangeInUnrealizedAppreciationdepreciationOfInvestmentsAndFuturesContracts_lbl" xml:lang="en-US">Net change in unrealized appreciation (depreciation) of investments and futures contracts</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NetChangeInUnrealizedAppreciationdepreciationOfInvestmentsAndFuturesContracts" xlink:to="cik0001793497_NetChangeInUnrealizedAppreciationdepreciationOfInvestmentsAndFuturesContracts_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_UnlabeledAbstract9" xlink:href="cik0001793497-20230630.xsd#cik0001793497_UnlabeledAbstract9"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_UnlabeledAbstract9_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract9" xlink:to="cik0001793497_UnlabeledAbstract9_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_CapitalShareTransactionsAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_CapitalShareTransactionsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_CapitalShareTransactionsAbstract_lbl" xml:lang="en-US">CAPITAL SHARE TRANSACTIONS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_CapitalShareTransactionsAbstract" xlink:to="cik0001793497_CapitalShareTransactionsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_UnlabeledAbstract10" xlink:href="cik0001793497-20230630.xsd#cik0001793497_UnlabeledAbstract10"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_UnlabeledAbstract10_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract10" xlink:to="cik0001793497_UnlabeledAbstract10_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_NetAssetsAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_NetAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_NetAssetsAbstract_lbl" xml:lang="en-US">NET ASSETS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NetAssetsAbstract" xlink:to="cik0001793497_NetAssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_IncreaseDecreaseInNetAssetsAbstract0" xlink:href="cik0001793497-20230630.xsd#cik0001793497_IncreaseDecreaseInNetAssetsAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_IncreaseDecreaseInNetAssetsAbstract0_lbl" xml:lang="en-US">INCREASE (DECREASE) IN NET ASSETS:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_IncreaseDecreaseInNetAssetsAbstract0" xlink:to="cik0001793497_IncreaseDecreaseInNetAssetsAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_OperationsAbstract0" xlink:href="cik0001793497-20230630.xsd#cik0001793497_OperationsAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_OperationsAbstract0_lbl" xml:lang="en-US">OPERATIONS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_OperationsAbstract0" xlink:to="cik0001793497_OperationsAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_UnlabeledAbstract11" xlink:href="cik0001793497-20230630.xsd#cik0001793497_UnlabeledAbstract11"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_UnlabeledAbstract11_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract11" xlink:to="cik0001793497_UnlabeledAbstract11_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_CapitalShareTransactionsAbstract0" xlink:href="cik0001793497-20230630.xsd#cik0001793497_CapitalShareTransactionsAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_CapitalShareTransactionsAbstract0_lbl" xml:lang="en-US">CAPITAL SHARE TRANSACTIONS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_CapitalShareTransactionsAbstract0" xlink:to="cik0001793497_CapitalShareTransactionsAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_UnlabeledAbstract12" xlink:href="cik0001793497-20230630.xsd#cik0001793497_UnlabeledAbstract12"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_UnlabeledAbstract12_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract12" xlink:to="cik0001793497_UnlabeledAbstract12_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_NetAssetsAbstract0" xlink:href="cik0001793497-20230630.xsd#cik0001793497_NetAssetsAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_NetAssetsAbstract0_lbl" xml:lang="en-US">NET ASSETS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NetAssetsAbstract0" xlink:to="cik0001793497_NetAssetsAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOW FROM OPERATING ACTIVITIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net increase (decrease) in net assets resulting from operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_AdjustmentsToReconcileNetIncomeLossToNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_AdjustmentsToReconcileNetIncomeLossToNetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_AdjustmentsToReconcileNetIncomeLossToNetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_AdjustmentsToReconcileNetIncomeLossToNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="cik0001793497_AdjustmentsToReconcileNetIncomeLossToNetCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ProceedsFromSalesOrMaturitiesOfInvestments" xlink:href="cik0001793497-20230630.xsd#cik0001793497_ProceedsFromSalesOrMaturitiesOfInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_ProceedsFromSalesOrMaturitiesOfInvestments_lbl" xml:lang="en-US">Proceeds from sales or maturities of investments held</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ProceedsFromSalesOrMaturitiesOfInvestments" xlink:to="cik0001793497_ProceedsFromSalesOrMaturitiesOfInvestments_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_IncreaseDecreaseInVariationMarginPayable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_IncreaseDecreaseInVariationMarginPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_IncreaseDecreaseInVariationMarginPayable_lbl" xml:lang="en-US">Decrease (Increase) in Prepaid expenses and other assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_IncreaseDecreaseInVariationMarginPayable" xlink:to="cik0001793497_IncreaseDecreaseInVariationMarginPayable_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_IncreaseDecreaseInDueToCustodian" xlink:href="cik0001793497-20230630.xsd#cik0001793497_IncreaseDecreaseInDueToCustodian"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_IncreaseDecreaseInDueToCustodian_lbl" xml:lang="en-US">Increase (Decrease) in Due to Custodian</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_IncreaseDecreaseInDueToCustodian" xlink:to="cik0001793497_IncreaseDecreaseInDueToCustodian_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInCustomerAdvances" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInCustomerAdvances"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInCustomerAdvances_lbl" xml:lang="en-US">Increase (Decrease) in Due to Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInCustomerAdvances" xlink:to="us-gaap_IncreaseDecreaseInCustomerAdvances_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent_lbl" xml:lang="en-US">Increase (Decrease) in Variation margin payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent" xlink:to="us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Increase (Decrease) in Administrative, accounting and custodian fees payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_IncreaseInProfessionalFeesPayable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_IncreaseInProfessionalFeesPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_IncreaseInProfessionalFeesPayable_lbl" xml:lang="en-US">Increase (Decrease) in Professional fees payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_IncreaseInProfessionalFeesPayable" xlink:to="cik0001793497_IncreaseInProfessionalFeesPayable_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_IncreaseInLicensingAndRegistrationFeesPayable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_IncreaseInLicensingAndRegistrationFeesPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_IncreaseInLicensingAndRegistrationFeesPayable_lbl" xml:lang="en-US">Increase (Decrease) in Licensing and registration fees payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_IncreaseInLicensingAndRegistrationFeesPayable" xlink:to="cik0001793497_IncreaseInLicensingAndRegistrationFeesPayable_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_UnlabeledAbstract13" xlink:href="cik0001793497-20230630.xsd#cik0001793497_UnlabeledAbstract13"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_UnlabeledAbstract13_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract13" xlink:to="cik0001793497_UnlabeledAbstract13_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOW FROM FINANCING ACTIVITIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ProceedsFromSaleOfUnits" xlink:href="cik0001793497-20230630.xsd#cik0001793497_ProceedsFromSaleOfUnits"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_ProceedsFromSaleOfUnits_lbl" xml:lang="en-US">Proceeds from shares sold, net of cost from shares purchased</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ProceedsFromSaleOfUnits" xlink:to="cik0001793497_ProceedsFromSaleOfUnits_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_UnlabeledAbstract14" xlink:href="cik0001793497-20230630.xsd#cik0001793497_UnlabeledAbstract14"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_UnlabeledAbstract14_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract14" xlink:to="cik0001793497_UnlabeledAbstract14_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_CashFlowFromOperatingActivitiesAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_CashFlowFromOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_CashFlowFromOperatingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOW FROM OPERATING ACTIVITIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_CashFlowFromOperatingActivitiesAbstract" xlink:to="cik0001793497_CashFlowFromOperatingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_UnlabeledAbstract15" xlink:href="cik0001793497-20230630.xsd#cik0001793497_UnlabeledAbstract15"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_UnlabeledAbstract15_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract15" xlink:to="cik0001793497_UnlabeledAbstract15_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_CashFlowFromFinancingActivitiesAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_CashFlowFromFinancingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_CashFlowFromFinancingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOW FROM FINANCING ACTIVITIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_CashFlowFromFinancingActivitiesAbstract" xlink:to="cik0001793497_CashFlowFromFinancingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_UnlabeledAbstract16" xlink:href="cik0001793497-20230630.xsd#cik0001793497_UnlabeledAbstract16"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_UnlabeledAbstract16_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract16" xlink:to="cik0001793497_UnlabeledAbstract16_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherInvestments_lbl" xml:lang="en-US">TOTAL INVESTMENTS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherInvestments" xlink:to="us-gaap_OtherInvestments_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherAssets_lbl" xml:lang="en-US">Other Assets in Excess of Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssets" xlink:to="us-gaap_OtherAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_OtherAssetsInExcessOfLiabilitiesPercentage" xlink:href="cik0001793497-20230630.xsd#cik0001793497_OtherAssetsInExcessOfLiabilitiesPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_OtherAssetsInExcessOfLiabilitiesPercentage_lbl" xml:lang="en-US">Other assets in excess of liabilities, percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_OtherAssetsInExcessOfLiabilitiesPercentage" xlink:to="cik0001793497_OtherAssetsInExcessOfLiabilitiesPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeNetAssetsPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeNetAssetsPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DerivativeNetAssetsPercentage_lbl" xml:lang="en-US">Total net assets, percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeNetAssetsPercentage" xlink:to="us-gaap_DerivativeNetAssetsPercentage_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DerivativeNetAssetsPercentage_lbl0" xml:lang="en-US">Fund&apos;s average net assets percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeNetAssetsPercentage" xlink:to="us-gaap_DerivativeNetAssetsPercentage_lbl0"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_NumberOfContracts" xlink:href="cik0001793497-20230630.xsd#cik0001793497_NumberOfContracts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_NumberOfContracts_lbl" xml:lang="en-US">Contracts</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NumberOfContracts" xlink:to="cik0001793497_NumberOfContracts_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentOwnedUnrecognizedUnrealizedAppreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedUnrecognizedUnrealizedAppreciation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InvestmentOwnedUnrecognizedUnrealizedAppreciation_lbl" xml:lang="en-US">Unrealized Appreciation/ (Depreciation)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentOwnedUnrecognizedUnrealizedAppreciation" xlink:to="us-gaap_InvestmentOwnedUnrecognizedUnrealizedAppreciation_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_UnderlyingFaceAmountAtMarketValues" xlink:href="cik0001793497-20230630.xsd#cik0001793497_UnderlyingFaceAmountAtMarketValues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_UnderlyingFaceAmountAtMarketValues_lbl" xml:lang="en-US">Underlying Face Amount at Market Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnderlyingFaceAmountAtMarketValues" xlink:to="cik0001793497_UnderlyingFaceAmountAtMarketValues_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash - 1.1% (a)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashEquivalentsAtCarryingValue_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_Cash1" xlink:href="cik0001793497-20230630.xsd#cik0001793497_Cash1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_Cash1_lbl" xml:lang="en-US">Cash (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_Cash1" xlink:to="cik0001793497_Cash1_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ShortTermInvestment112Abstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_ShortTermInvestment112Abstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_ShortTermInvestment112Abstract_lbl" xml:lang="en-US">SHORT TERM INVESTMENT - 11.2%</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ShortTermInvestment112Abstract" xlink:to="cik0001793497_ShortTermInvestment112Abstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_MoneyMarketFund112Abstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_MoneyMarketFund112Abstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_MoneyMarketFund112Abstract_lbl" xml:lang="en-US">Money Market Fund - 11.2%</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_MoneyMarketFund112Abstract" xlink:to="cik0001793497_MoneyMarketFund112Abstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MoneyMarketFundsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MoneyMarketFundsAtCarryingValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MoneyMarketFundsAtCarryingValue_lbl" xml:lang="en-US">First American Government Obligations Fund</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MoneyMarketFundsAtCarryingValue" xlink:to="us-gaap_MoneyMarketFundsAtCarryingValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentInterestRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InvestmentInterestRate_lbl" xml:lang="en-US">Money market fund, percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentInterestRate" xlink:to="us-gaap_InvestmentInterestRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherShortTermInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherShortTermInvestments_lbl" xml:lang="en-US">TOTAL SHORT TERM INVESTMENT</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherShortTermInvestments" xlink:to="us-gaap_OtherShortTermInvestments_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_CashPledgedAsCollateral" xlink:href="cik0001793497-20230630.xsd#cik0001793497_CashPledgedAsCollateral"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_CashPledgedAsCollateral_lbl" xml:lang="en-US">Cash pledged as collateral (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_CashPledgedAsCollateral" xlink:to="cik0001793497_CashPledgedAsCollateral_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_UnlabeledAbstract17" xlink:href="cik0001793497-20230630.xsd#cik0001793497_UnlabeledAbstract17"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_UnlabeledAbstract17_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract17" xlink:to="cik0001793497_UnlabeledAbstract17_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ShortTermInvestment657Abstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_ShortTermInvestment657Abstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_ShortTermInvestment657Abstract_lbl" xml:lang="en-US">SHORT TERM INVESTMENT - 6.57%</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ShortTermInvestment657Abstract" xlink:to="cik0001793497_ShortTermInvestment657Abstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_MoneyMarketFund657Abstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_MoneyMarketFund657Abstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_MoneyMarketFund657Abstract_lbl" xml:lang="en-US">Money Market Fund - 6.57%</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_MoneyMarketFund657Abstract" xlink:to="cik0001793497_MoneyMarketFund657Abstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_UnlabeledAbstract18" xlink:href="cik0001793497-20230630.xsd#cik0001793497_UnlabeledAbstract18"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_UnlabeledAbstract18_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract18" xlink:to="cik0001793497_UnlabeledAbstract18_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Paid-in capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Total distributable earnings (accumulated deficit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ShortTermInvestmentsRealized" xlink:href="cik0001793497-20230630.xsd#cik0001793497_ShortTermInvestmentsRealized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="cik0001793497_ShortTermInvestmentsRealized_lbl" xml:lang="en-US">Short Term Investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ShortTermInvestmentsRealized" xlink:to="cik0001793497_ShortTermInvestmentsRealized_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_FuturesContracts" xlink:href="cik0001793497-20230630.xsd#cik0001793497_FuturesContracts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="cik0001793497_FuturesContracts_lbl" xml:lang="en-US">Futures</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_FuturesContracts" xlink:to="cik0001793497_FuturesContracts_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ShortTermInvestmentsUnrealized" xlink:href="cik0001793497-20230630.xsd#cik0001793497_ShortTermInvestmentsUnrealized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="cik0001793497_ShortTermInvestmentsUnrealized_lbl" xml:lang="en-US">Short Term Investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ShortTermInvestmentsUnrealized" xlink:to="cik0001793497_ShortTermInvestmentsUnrealized_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_FuturesContractsUnrealizedAppreciation" xlink:href="cik0001793497-20230630.xsd#cik0001793497_FuturesContractsUnrealizedAppreciation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="cik0001793497_FuturesContractsUnrealizedAppreciation_lbl" xml:lang="en-US">Futures</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_FuturesContractsUnrealizedAppreciation" xlink:to="cik0001793497_FuturesContractsUnrealizedAppreciation_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_SharesSoldinShares" xlink:href="cik0001793497-20230630.xsd#cik0001793497_SharesSoldinShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="cik0001793497_SharesSoldinShares_lbl" xml:lang="en-US">Shares sold</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_SharesSoldinShares" xlink:to="cik0001793497_SharesSoldinShares_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_SharesSoldNetOfSharesRedeemedinDollarsPerShare" xlink:href="cik0001793497-20230630.xsd#cik0001793497_SharesSoldNetOfSharesRedeemedinDollarsPerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="cik0001793497_SharesSoldNetOfSharesRedeemedinDollarsPerShare_lbl" xml:lang="en-US">Shares redeemed</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_SharesSoldNetOfSharesRedeemedinDollarsPerShare" xlink:to="cik0001793497_SharesSoldNetOfSharesRedeemedinDollarsPerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_PurchasesOfInvestments" xlink:href="cik0001793497-20230630.xsd#cik0001793497_PurchasesOfInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="cik0001793497_PurchasesOfInvestments_lbl" xml:lang="en-US">Purchase of investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_PurchasesOfInvestments" xlink:to="cik0001793497_PurchasesOfInvestments_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInEarnestMoneyDepositsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInEarnestMoneyDepositsOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInEarnestMoneyDepositsOutstanding_lbl" xml:lang="en-US">Decrease (Increase) in Deposits at broker for futures contracts</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInEarnestMoneyDepositsOutstanding" xlink:to="us-gaap_IncreaseDecreaseInEarnestMoneyDepositsOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_lbl" xml:lang="en-US">Decrease (Increase) in Variation margin receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet_lbl" xml:lang="en-US">Decrease (Increase) in interest receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet" xlink:to="us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherReceivables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables_lbl" xml:lang="en-US">Decrease (Increase) in other receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherReceivables" xlink:to="us-gaap_IncreaseDecreaseInOtherReceivables_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInReceivables_lbl" xml:lang="en-US">Decrease (Increase) in Due from Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInReceivables" xlink:to="us-gaap_IncreaseDecreaseInReceivables_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_IncreaseDecreaseInPayableToSponsor" xlink:href="cik0001793497-20230630.xsd#cik0001793497_IncreaseDecreaseInPayableToSponsor"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="cik0001793497_IncreaseDecreaseInPayableToSponsor_lbl" xml:lang="en-US">Increase (Decrease) in Payable to Sponsor</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_IncreaseDecreaseInPayableToSponsor" xlink:to="cik0001793497_IncreaseDecreaseInPayableToSponsor_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xml:lang="en-US">Cost of shares redeemed</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_OnexShortVIXFuturesETFMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_OnexShortVIXFuturesETFMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_OnexShortVIXFuturesETFMember_lbl" xml:lang="en-US">-1x Short VIX Futures ETF</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_OnexShortVIXFuturesETFMember" xlink:to="cik0001793497_OnexShortVIXFuturesETFMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="cik0001793497_OnexShortVIXFuturesETFMember_lbl0" xml:lang="en-US">-1 x Short VIX Futures ETF [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_OnexShortVIXFuturesETFMember" xlink:to="cik0001793497_OnexShortVIXFuturesETFMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="cik0001793497_OnexShortVIXFuturesETFMember_lbl1" xml:lang="en-US">-1x Short VIX Futures ETF [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_OnexShortVIXFuturesETFMember" xlink:to="cik0001793497_OnexShortVIXFuturesETFMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_OnexShortVIXFuturesETFMember_lbl2" xml:lang="en-US">1 x Short VIX Futures ETF [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_OnexShortVIXFuturesETFMember" xlink:to="cik0001793497_OnexShortVIXFuturesETFMember_lbl2"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_TwoxLongVIXFuturesETFMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_TwoxLongVIXFuturesETFMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_TwoxLongVIXFuturesETFMember_lbl" xml:lang="en-US">2x Long VIX Futures ETF</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_TwoxLongVIXFuturesETFMember" xlink:to="cik0001793497_TwoxLongVIXFuturesETFMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="cik0001793497_TwoxLongVIXFuturesETFMember_lbl0" xml:lang="en-US">2x Long VIX Futures ETF [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_TwoxLongVIXFuturesETFMember" xlink:to="cik0001793497_TwoxLongVIXFuturesETFMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_OneShortVIXFuturesETFMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_OneShortVIXFuturesETFMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_OneShortVIXFuturesETFMember_lbl" xml:lang="en-US">1 Short VIX Futures ETF [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_OneShortVIXFuturesETFMember" xlink:to="cik0001793497_OneShortVIXFuturesETFMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="cik0001793497_OneShortVIXFuturesETFMember_lbl0" xml:lang="en-US">-1x Short VIX Futures ETF</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_OneShortVIXFuturesETFMember" xlink:to="cik0001793497_OneShortVIXFuturesETFMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="cik0001793497_OneShortVIXFuturesETFMember_lbl1" xml:lang="en-US">1x Short VIX Futures ETF</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_OneShortVIXFuturesETFMember" xlink:to="cik0001793497_OneShortVIXFuturesETFMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_OneShortVIXFuturesETFMember_lbl2" xml:lang="en-US">-1x Short VIX Futures ETF [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_OneShortVIXFuturesETFMember" xlink:to="cik0001793497_OneShortVIXFuturesETFMember_lbl2"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_CBOEVIXFuturesMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_CBOEVIXFuturesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_CBOEVIXFuturesMember_lbl" xml:lang="en-US">CBOE VIX Futures [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_CBOEVIXFuturesMember" xlink:to="cik0001793497_CBOEVIXFuturesMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="cik0001793497_CBOEVIXFuturesMember_lbl0" xml:lang="en-US">CBOE VIX Futures	[Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_CBOEVIXFuturesMember" xlink:to="cik0001793497_CBOEVIXFuturesMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_CBOEVIXFuturesOneMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_CBOEVIXFuturesOneMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_CBOEVIXFuturesOneMember_lbl" xml:lang="en-US">CBOE VIX Futures One [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_CBOEVIXFuturesOneMember" xlink:to="cik0001793497_CBOEVIXFuturesOneMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="cik0001793497_CBOEVIXFuturesOneMember_lbl0" xml:lang="en-US">CBOE VIX Futures [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_CBOEVIXFuturesOneMember" xlink:to="cik0001793497_CBOEVIXFuturesOneMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_FirstAmericanGovernmentObligationsFundMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_FirstAmericanGovernmentObligationsFundMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_FirstAmericanGovernmentObligationsFundMember_lbl" xml:lang="en-US">First American Government Obligations Fund [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_FirstAmericanGovernmentObligationsFundMember" xlink:to="cik0001793497_FirstAmericanGovernmentObligationsFundMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xml:lang="en-US">ORGANIZATION</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">SIGNIFICANT ACCOUNTING POLICIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock" xlink:href="cik0001793497-20230630.xsd#cik0001793497_ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock_lbl" xml:lang="en-US">Schedule of Cut-Off Times and the Times of the Calculation of the Funds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock" xlink:to="cik0001793497_ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_CreateRedeemCutoffDescription" xlink:href="cik0001793497-20230630.xsd#cik0001793497_CreateRedeemCutoffDescription"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_CreateRedeemCutoffDescription_lbl" xml:lang="en-US">Create/Redeem Cut-off (EST)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_CreateRedeemCutoffDescription" xlink:to="cik0001793497_CreateRedeemCutoffDescription_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_NAVCalculationTimeESTDescription" xlink:href="cik0001793497-20230630.xsd#cik0001793497_NAVCalculationTimeESTDescription"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_NAVCalculationTimeESTDescription_lbl" xml:lang="en-US">NAV Calculation Time (EST)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NAVCalculationTimeESTDescription" xlink:to="cik0001793497_NAVCalculationTimeESTDescription_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_NAVCalculationDate" xlink:href="cik0001793497-20230630.xsd#cik0001793497_NAVCalculationDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_NAVCalculationDate_lbl" xml:lang="en-US">NAV Calculation Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NAVCalculationDate" xlink:to="cik0001793497_NAVCalculationDate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" xml:lang="en-US">Schedule of Valuation of Investments at Using the Fair Value Hierarchy</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_AmountOfTotalTrust" xlink:href="cik0001793497-20230630.xsd#cik0001793497_AmountOfTotalTrust"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_AmountOfTotalTrust_lbl" xml:lang="en-US">Total Trust</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_AmountOfTotalTrust" xlink:to="cik0001793497_AmountOfTotalTrust_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InvestmentTextBlock_lbl" xml:lang="en-US">INVESTMENTS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTextBlock" xlink:to="us-gaap_InvestmentTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_lbl" xml:lang="en-US">Schedule of Fair Value of Derivative Instruments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_VixFuturesContractsAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_VixFuturesContractsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_VixFuturesContractsAbstract_lbl" xml:lang="en-US">VIX Futures Contracts</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_VixFuturesContractsAbstract" xlink:to="cik0001793497_VixFuturesContractsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_TotalTrust" xlink:href="cik0001793497-20230630.xsd#cik0001793497_TotalTrust"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_TotalTrust_lbl" xml:lang="en-US">Total Trust</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_TotalTrust" xlink:to="cik0001793497_TotalTrust_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_TotalTrust1" xlink:href="cik0001793497-20230630.xsd#cik0001793497_TotalTrust1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_TotalTrust1_lbl" xml:lang="en-US">Total Trust</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_TotalTrust1" xlink:to="cik0001793497_TotalTrust1_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_VixFuturesContractsAbstract0" xlink:href="cik0001793497-20230630.xsd#cik0001793497_VixFuturesContractsAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_VixFuturesContractsAbstract0_lbl" xml:lang="en-US">VIX Futures Contracts</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_VixFuturesContractsAbstract0" xlink:to="cik0001793497_VixFuturesContractsAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_lbl" xml:lang="en-US">Schedule of Effect of Derivative Instruments on The Statement of Operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:to="us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_VixFuturesContractsNetRealizedGainLossOnFuturesContractsChangesInUnrealizedAppreciationDepreciationOnFuturesContractsAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_VixFuturesContractsNetRealizedGainLossOnFuturesContractsChangesInUnrealizedAppreciationDepreciationOnFuturesContractsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_VixFuturesContractsNetRealizedGainLossOnFuturesContractsChangesInUnrealizedAppreciationDepreciationOnFuturesContractsAbstract_lbl" xml:lang="en-US">VIX Futures Contracts Net realized gain (loss) on futures contracts/changes in unrealized appreciation (depreciation) on futures contracts</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_VixFuturesContractsNetRealizedGainLossOnFuturesContractsChangesInUnrealizedAppreciationDepreciationOnFuturesContractsAbstract" xlink:to="cik0001793497_VixFuturesContractsNetRealizedGainLossOnFuturesContractsChangesInUnrealizedAppreciationDepreciationOnFuturesContractsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_RealizedGainLossOnDerivativesRecognizedInIncome" xlink:href="cik0001793497-20230630.xsd#cik0001793497_RealizedGainLossOnDerivativesRecognizedInIncome"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_RealizedGainLossOnDerivativesRecognizedInIncome_lbl" xml:lang="en-US">Realized Gain (Loss) on Derivatives Recognized in Income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_RealizedGainLossOnDerivativesRecognizedInIncome" xlink:to="cik0001793497_RealizedGainLossOnDerivativesRecognizedInIncome_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ChangeInUnrealizedAppreciationDepreciationsOnDerivativesRecognizedInIncome" xlink:href="cik0001793497-20230630.xsd#cik0001793497_ChangeInUnrealizedAppreciationDepreciationsOnDerivativesRecognizedInIncome"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_ChangeInUnrealizedAppreciationDepreciationsOnDerivativesRecognizedInIncome_lbl" xml:lang="en-US">Change in Unrealized Appreciation (Depreciation) on Derivatives Recognized in Income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ChangeInUnrealizedAppreciationDepreciationsOnDerivativesRecognizedInIncome" xlink:to="cik0001793497_ChangeInUnrealizedAppreciationDepreciationsOnDerivativesRecognizedInIncome_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_VixFuturesContractsNetRealizedGainLossOnFuturesContractsChangesInUnrealizedAppreciationDepreciationOnFuturesContractsAbstract0" xlink:href="cik0001793497-20230630.xsd#cik0001793497_VixFuturesContractsNetRealizedGainLossOnFuturesContractsChangesInUnrealizedAppreciationDepreciationOnFuturesContractsAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_VixFuturesContractsNetRealizedGainLossOnFuturesContractsChangesInUnrealizedAppreciationDepreciationOnFuturesContractsAbstract0_lbl" xml:lang="en-US">VIX Futures Contracts Net realized gain (loss) on futures contracts/changes in unrealized appreciation (depreciation) on futures contracts</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_VixFuturesContractsNetRealizedGainLossOnFuturesContractsChangesInUnrealizedAppreciationDepreciationOnFuturesContractsAbstract0" xlink:to="cik0001793497_VixFuturesContractsNetRealizedGainLossOnFuturesContractsChangesInUnrealizedAppreciationDepreciationOnFuturesContractsAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsTableTextBlock" xlink:href="cik0001793497-20230630.xsd#cik0001793497_ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsTableTextBlock_lbl" xml:lang="en-US">Schedule of Pledged By Funds Fair Values of Derivative Instruments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsTableTextBlock" xlink:to="cik0001793497_ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition" xlink:href="cik0001793497-20230630.xsd#cik0001793497_GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition_lbl" xml:lang="en-US">Gross Amounts of Recognized Assets presented in the Statements of Financial Condition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition" xlink:to="cik0001793497_GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_GrossAmountsOffsetInTheStatementsOfFinancialCondition" xlink:href="cik0001793497-20230630.xsd#cik0001793497_GrossAmountsOffsetInTheStatementsOfFinancialCondition"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_GrossAmountsOffsetInTheStatementsOfFinancialCondition_lbl" xml:lang="en-US">Gross Amounts Offset in the Statements of Financial Condition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_GrossAmountsOffsetInTheStatementsOfFinancialCondition" xlink:to="cik0001793497_GrossAmountsOffsetInTheStatementsOfFinancialCondition_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition" xlink:href="cik0001793497-20230630.xsd#cik0001793497_NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition_lbl" xml:lang="en-US">Net Amounts of Assets presented in the Statements of Financial Condition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition" xlink:to="cik0001793497_NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_GrossAmountsOfRecognizedLiabilitiesPresentedInTheStatementsOfFinancialCondition" xlink:href="cik0001793497-20230630.xsd#cik0001793497_GrossAmountsOfRecognizedLiabilitiesPresentedInTheStatementsOfFinancialCondition"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_GrossAmountsOfRecognizedLiabilitiesPresentedInTheStatementsOfFinancialCondition_lbl" xml:lang="en-US">Gross Amounts of Recognized Liabilities presented in the Statements of Financial Condition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_GrossAmountsOfRecognizedLiabilitiesPresentedInTheStatementsOfFinancialCondition" xlink:to="cik0001793497_GrossAmountsOfRecognizedLiabilitiesPresentedInTheStatementsOfFinancialCondition_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_GrossAmountsOffsetInTheStatementsOfFinancialCondition1" xlink:href="cik0001793497-20230630.xsd#cik0001793497_GrossAmountsOffsetInTheStatementsOfFinancialCondition1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_GrossAmountsOffsetInTheStatementsOfFinancialCondition1_lbl" xml:lang="en-US">Gross Amounts Offset in the Statements of Financial Condition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_GrossAmountsOffsetInTheStatementsOfFinancialCondition1" xlink:to="cik0001793497_GrossAmountsOffsetInTheStatementsOfFinancialCondition1_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_NetAmountsOfLiabilitiesPresentedInTheStatementsOfFinancialCondition" xlink:href="cik0001793497-20230630.xsd#cik0001793497_NetAmountsOfLiabilitiesPresentedInTheStatementsOfFinancialCondition"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_NetAmountsOfLiabilitiesPresentedInTheStatementsOfFinancialCondition_lbl" xml:lang="en-US">Net Amounts of Liabilities presented in the Statements of Financial Condition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NetAmountsOfLiabilitiesPresentedInTheStatementsOfFinancialCondition" xlink:to="cik0001793497_NetAmountsOfLiabilitiesPresentedInTheStatementsOfFinancialCondition_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_lbl" xml:lang="en-US">Schedule of Gross Amounts Not Offset In The Statements of Financial Condition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:to="us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne" xlink:href="cik0001793497-20230630.xsd#cik0001793497_AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne_lbl" xml:lang="en-US">Amounts of Recognized Assets / (Liabilities) presented in the Statements of Financial Condition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne" xlink:to="cik0001793497_AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_FinancialInstrumentsForTheBenefitOftheFundsTheCounterpartiesTwo" xlink:href="cik0001793497-20230630.xsd#cik0001793497_FinancialInstrumentsForTheBenefitOftheFundsTheCounterpartiesTwo"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_FinancialInstrumentsForTheBenefitOftheFundsTheCounterpartiesTwo_lbl" xml:lang="en-US">Financial Instruments for the Benefit of (the Funds) / the Counterparties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_FinancialInstrumentsForTheBenefitOftheFundsTheCounterpartiesTwo" xlink:to="cik0001793497_FinancialInstrumentsForTheBenefitOftheFundsTheCounterpartiesTwo_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_CashCollateralForTheBenefitOftheFundsTheCounterparties" xlink:href="cik0001793497-20230630.xsd#cik0001793497_CashCollateralForTheBenefitOftheFundsTheCounterparties"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_CashCollateralForTheBenefitOftheFundsTheCounterparties_lbl" xml:lang="en-US">Cash Collateral for the Benefit of (the Funds) / the Counterparties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_CashCollateralForTheBenefitOftheFundsTheCounterparties" xlink:to="cik0001793497_CashCollateralForTheBenefitOftheFundsTheCounterparties_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_CapitalUnitNetAmount" xlink:href="cik0001793497-20230630.xsd#cik0001793497_CapitalUnitNetAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_CapitalUnitNetAmount_lbl" xml:lang="en-US">Net Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_CapitalUnitNetAmount" xlink:to="cik0001793497_CapitalUnitNetAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_AgreementsDisclosureTextBlock" xlink:href="cik0001793497-20230630.xsd#cik0001793497_AgreementsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_AgreementsDisclosureTextBlock_lbl" xml:lang="en-US">AGREEMENTS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_AgreementsDisclosureTextBlock" xlink:to="cik0001793497_AgreementsDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_OfferingCostsTextBlock" xlink:href="cik0001793497-20230630.xsd#cik0001793497_OfferingCostsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_OfferingCostsTextBlock_lbl" xml:lang="en-US">OFFERING COSTS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_OfferingCostsTextBlock" xlink:to="cik0001793497_OfferingCostsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xml:lang="en-US">CREATION AND REDEMPTION OF CREATION UNITS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ScheduleOfTransactionFeesTableTextBlock" xlink:href="cik0001793497-20230630.xsd#cik0001793497_ScheduleOfTransactionFeesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_ScheduleOfTransactionFeesTableTextBlock_lbl" xml:lang="en-US">Schedule of Transaction Fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ScheduleOfTransactionFeesTableTextBlock" xlink:to="cik0001793497_ScheduleOfTransactionFeesTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfTrustAssetsToPayExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfTrustAssetsToPayExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SaleOfTrustAssetsToPayExpenses_lbl" xml:lang="en-US">Total Trust</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfTrustAssetsToPayExpenses" xlink:to="us-gaap_SaleOfTrustAssetsToPayExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_QuarterlyFinancialInformationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_QuarterlyFinancialInformationTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_QuarterlyFinancialInformationTextBlock_lbl" xml:lang="en-US">FINANCIAL HIGHLIGHTS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_QuarterlyFinancialInformationTextBlock" xlink:to="us-gaap_QuarterlyFinancialInformationTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ScheduleOfShareOutstandingTableTextBlock" xlink:href="cik0001793497-20230630.xsd#cik0001793497_ScheduleOfShareOutstandingTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_ScheduleOfShareOutstandingTableTextBlock_lbl" xml:lang="en-US">Schedule of Share Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ScheduleOfShareOutstandingTableTextBlock" xlink:to="cik0001793497_ScheduleOfShareOutstandingTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentCompanyGainLossOnInvestmentPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyGainLossOnInvestmentPerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InvestmentCompanyGainLossOnInvestmentPerShare_lbl" xml:lang="en-US">Net investment loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentCompanyGainLossOnInvestmentPerShare" xlink:to="us-gaap_InvestmentCompanyGainLossOnInvestmentPerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts" xlink:href="cik0001793497-20230630.xsd#cik0001793497_NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts_lbl" xml:lang="en-US">Net Realized and Unrealized Gain (Loss) on Investments and Futures Contracts</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts" xlink:to="cik0001793497_NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease_lbl" xml:lang="en-US">Net Increase (Decrease) in Net Asset Value Resulting from Operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease" xlink:to="us-gaap_InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_MarketValuePerShare" xlink:href="cik0001793497-20230630.xsd#cik0001793497_MarketValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_MarketValuePerShare_lbl" xml:lang="en-US">Market Value Per Share, at June 30, 2023 and June 30, 2022</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_MarketValuePerShare" xlink:to="cik0001793497_MarketValuePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentCompanyTotalReturn" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyTotalReturn"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InvestmentCompanyTotalReturn_lbl" xml:lang="en-US">Total Return at Net Asset Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentCompanyTotalReturn" xlink:to="us-gaap_InvestmentCompanyTotalReturn_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_TotalReturnAtMarketValue" xlink:href="cik0001793497-20230630.xsd#cik0001793497_TotalReturnAtMarketValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_TotalReturnAtMarketValue_lbl" xml:lang="en-US">Total Return at Market Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_TotalReturnAtMarketValue" xlink:to="cik0001793497_TotalReturnAtMarketValue_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_UnlabeledAbstract19" xlink:href="cik0001793497-20230630.xsd#cik0001793497_UnlabeledAbstract19"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_UnlabeledAbstract19_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract19" xlink:to="cik0001793497_UnlabeledAbstract19_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_RatiosToAverageNetAssets5Abstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_RatiosToAverageNetAssets5Abstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_RatiosToAverageNetAssets5Abstract_lbl" xml:lang="en-US">Ratios to Average Net Assets: (5)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_RatiosToAverageNetAssets5Abstract" xlink:to="cik0001793497_RatiosToAverageNetAssets5Abstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentCompanyExpenseRatioAfterIncentiveAllocation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyExpenseRatioAfterIncentiveAllocation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InvestmentCompanyExpenseRatioAfterIncentiveAllocation_lbl" xml:lang="en-US">Expense ratio</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentCompanyExpenseRatioAfterIncentiveAllocation" xlink:to="us-gaap_InvestmentCompanyExpenseRatioAfterIncentiveAllocation_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentCompanyTotalReturnAfterIncentiveFees" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyTotalReturnAfterIncentiveFees"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InvestmentCompanyTotalReturnAfterIncentiveFees_lbl" xml:lang="en-US">Net Investment Loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentCompanyTotalReturnAfterIncentiveFees" xlink:to="us-gaap_InvestmentCompanyTotalReturnAfterIncentiveFees_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_UnlabeledAbstract20" xlink:href="cik0001793497-20230630.xsd#cik0001793497_UnlabeledAbstract20"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_UnlabeledAbstract20_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract20" xlink:to="cik0001793497_UnlabeledAbstract20_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_RatiosToAverageNetAssets5Abstract0" xlink:href="cik0001793497-20230630.xsd#cik0001793497_RatiosToAverageNetAssets5Abstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_RatiosToAverageNetAssets5Abstract0_lbl" xml:lang="en-US">Ratios to Average Net Assets: (5)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_RatiosToAverageNetAssets5Abstract0" xlink:to="cik0001793497_RatiosToAverageNetAssets5Abstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl" xml:lang="en-US">RISK</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:to="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">SUBSEQUENT EVENTS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MoneyMarketFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MoneyMarketFundsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xml:lang="en-US">Money Market Fund [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MoneyMarketFundsMember" xlink:to="us-gaap_MoneyMarketFundsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xml:lang="en-US">Level 1 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_FuturesContractsMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_FuturesContractsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_FuturesContractsMember_lbl" xml:lang="en-US">Futures Contracts [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_FuturesContractsMember" xlink:to="cik0001793497_FuturesContractsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xml:lang="en-US">Level 2 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_VIXFuturesContractsMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_VIXFuturesContractsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_VIXFuturesContractsMember_lbl" xml:lang="en-US">VIX Futures Contracts [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_VIXFuturesContractsMember" xlink:to="cik0001793497_VIXFuturesContractsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_AssetDerivativesMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_AssetDerivativesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_AssetDerivativesMember_lbl" xml:lang="en-US">Asset Derivatives [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_AssetDerivativesMember" xlink:to="cik0001793497_AssetDerivativesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_StatementsOfFinancialConditionLocationMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_StatementsOfFinancialConditionLocationMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_StatementsOfFinancialConditionLocationMember_lbl" xml:lang="en-US">Statements of Financial Condition Location [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_StatementsOfFinancialConditionLocationMember" xlink:to="cik0001793497_StatementsOfFinancialConditionLocationMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_UnrealizedAppreciationMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_UnrealizedAppreciationMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_UnrealizedAppreciationMember_lbl" xml:lang="en-US">Unrealized Appreciation [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnrealizedAppreciationMember" xlink:to="cik0001793497_UnrealizedAppreciationMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_LiabilityDerivativesMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_LiabilityDerivativesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_LiabilityDerivativesMember_lbl" xml:lang="en-US">Liability Derivatives [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_LiabilityDerivativesMember" xlink:to="cik0001793497_LiabilityDerivativesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_UnrealizedDepreciationMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_UnrealizedDepreciationMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_UnrealizedDepreciationMember_lbl" xml:lang="en-US">Unrealized Depreciation [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnrealizedDepreciationMember" xlink:to="cik0001793497_UnrealizedDepreciationMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherAssetsMember_lbl" xml:lang="en-US">Other Assets [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsMember" xlink:to="us-gaap_OtherAssetsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherLiabilitiesMember_lbl" xml:lang="en-US">Other Liabilities [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesMember" xlink:to="us-gaap_OtherLiabilitiesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetirementPlanFundingStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanFundingStatusAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetirementPlanFundingStatusAxis_lbl" xml:lang="en-US">Defined Benefit Plan, Funding Status [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetirementPlanFundingStatusAxis" xlink:to="us-gaap_RetirementPlanFundingStatusAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionAxis_lbl" xml:lang="en-US">Related Party Transaction [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US">Statistical Measurement [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_GrossRevenue" xlink:href="cik0001793497-20230630.xsd#cik0001793497_GrossRevenue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_GrossRevenue_lbl" xml:lang="en-US">Annual gross revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_GrossRevenue" xlink:to="cik0001793497_GrossRevenue_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_NonconvertibleDebtSecurities" xlink:href="cik0001793497-20230630.xsd#cik0001793497_NonconvertibleDebtSecurities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_NonconvertibleDebtSecurities_lbl" xml:lang="en-US">Non-convertible debt securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NonconvertibleDebtSecurities" xlink:to="cik0001793497_NonconvertibleDebtSecurities_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_NonaffiliatesExceeded" xlink:href="cik0001793497-20230630.xsd#cik0001793497_NonaffiliatesExceeded"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_NonaffiliatesExceeded_lbl" xml:lang="en-US">Non-affiliates exceeded</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NonaffiliatesExceeded" xlink:to="cik0001793497_NonaffiliatesExceeded_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_AverageDailyNetAssetsRate" xlink:href="cik0001793497-20230630.xsd#cik0001793497_AverageDailyNetAssetsRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_AverageDailyNetAssetsRate_lbl" xml:lang="en-US">Average daily net assets rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_AverageDailyNetAssetsRate" xlink:to="cik0001793497_AverageDailyNetAssetsRate_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_SubadvisoryFeeRate" xlink:href="cik0001793497-20230630.xsd#cik0001793497_SubadvisoryFeeRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_SubadvisoryFeeRate_lbl" xml:lang="en-US">Sub-advisory fee rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_SubadvisoryFeeRate" xlink:to="cik0001793497_SubadvisoryFeeRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharesIssued_lbl" xml:lang="en-US">Shares of fund</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_AuthorizedParticipantsPercentage" xlink:href="cik0001793497-20230630.xsd#cik0001793497_AuthorizedParticipantsPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_AuthorizedParticipantsPercentage_lbl" xml:lang="en-US">Authorized participants percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_AuthorizedParticipantsPercentage" xlink:to="cik0001793497_AuthorizedParticipantsPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpenseRatio" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpenseRatio"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GeneralAndAdministrativeExpenseRatio_lbl" xml:lang="en-US">Expense ratio percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseRatio" xlink:to="us-gaap_GeneralAndAdministrativeExpenseRatio_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_BrokerageCommissionsRate" xlink:href="cik0001793497-20230630.xsd#cik0001793497_BrokerageCommissionsRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_BrokerageCommissionsRate_lbl" xml:lang="en-US">Brokerage commissions rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_BrokerageCommissionsRate" xlink:to="cik0001793497_BrokerageCommissionsRate_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_RelevantBenchmark" xlink:href="cik0001793497-20230630.xsd#cik0001793497_RelevantBenchmark"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_RelevantBenchmark_lbl" xml:lang="en-US">Relevant benchmark percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_RelevantBenchmark" xlink:to="cik0001793497_RelevantBenchmark_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_EmergingGrowthCompanyPolicyTextBlock" xlink:href="cik0001793497-20230630.xsd#cik0001793497_EmergingGrowthCompanyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_EmergingGrowthCompanyPolicyTextBlock_lbl" xml:lang="en-US">Emerging growth company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_EmergingGrowthCompanyPolicyTextBlock" xlink:to="cik0001793497_EmergingGrowthCompanyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of Estimates &amp; Indemnifications</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Basis of Presentation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_StatementsOfCashFlowsPolicyTextBlock" xlink:href="cik0001793497-20230630.xsd#cik0001793497_StatementsOfCashFlowsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_StatementsOfCashFlowsPolicyTextBlock_lbl" xml:lang="en-US">Statements of Cash Flows</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_StatementsOfCashFlowsPolicyTextBlock" xlink:to="cik0001793497_StatementsOfCashFlowsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_FinalNetAssetValueForFiscalPeriodPolcyTextBlock" xlink:href="cik0001793497-20230630.xsd#cik0001793497_FinalNetAssetValueForFiscalPeriodPolcyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_FinalNetAssetValueForFiscalPeriodPolcyTextBlock_lbl" xml:lang="en-US">Final Net Asset Value for Fiscal Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_FinalNetAssetValueForFiscalPeriodPolcyTextBlock" xlink:to="cik0001793497_FinalNetAssetValueForFiscalPeriodPolcyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InvestmentPolicyTextBlock_lbl" xml:lang="en-US">Investment Valuation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentPolicyTextBlock" xlink:to="us-gaap_InvestmentPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US">Fair Value of Financial Instruments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnremittedEarningsInForeignInvestmentPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnremittedEarningsInForeignInvestmentPolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_UnremittedEarningsInForeignInvestmentPolicy_lbl" xml:lang="en-US">Investment Transactions and Related Income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnremittedEarningsInForeignInvestmentPolicy" xlink:to="us-gaap_UnremittedEarningsInForeignInvestmentPolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FloorBrokeragePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FloorBrokeragePolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FloorBrokeragePolicy_lbl" xml:lang="en-US">Brokerage Commissions and Futures Account Fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FloorBrokeragePolicy" xlink:to="us-gaap_FloorBrokeragePolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Federal Income Tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_SVIXMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_SVIXMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_SVIXMember_lbl" xml:lang="en-US">SVIX [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_SVIXMember" xlink:to="cik0001793497_SVIXMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_UVIXMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_UVIXMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_UVIXMember_lbl" xml:lang="en-US">UVIX [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UVIXMember" xlink:to="cik0001793497_UVIXMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ConsolidatedEntitiesDomain_lbl" xml:lang="en-US">Consolidated Entities [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="srt_ConsolidatedEntitiesDomain_lbl"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSraoTMKpdMOVUMtRpuB8tV6eMGW/07nN8r724IYYtHu3Fk2iU8V8d5zeroA9ghPrxP68aa5UlyuaOj/7VPlLXQx0GT+xTdf3pIEmLVakfoittQNiZUQ0abAliT/vrVleUY3WZOYnY1Y7WqYa/6c4Wf84lUKYnTNtHYrHxwVjAE4Kl1CB8EhaeLFT] CSR-->
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_EquityMethodInvesteeNameDomain_lbl" xml:lang="en-US">Investment, Name [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="srt_EquityMethodInvesteeNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityDomain_lbl" xml:lang="en-US">Entity [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityDomain" xlink:to="dei_EntityDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_InvestmentsTable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_InvestmentsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_InvestmentsTable_lbl" xml:lang="en-US">Investments [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_InvestmentsTable" xlink:to="cik0001793497_InvestmentsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_InvestmentsLineItems" xlink:href="cik0001793497-20230630.xsd#cik0001793497_InvestmentsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_InvestmentsLineItems_lbl" xml:lang="en-US">Investments [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_InvestmentsLineItems" xlink:to="cik0001793497_InvestmentsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_AgreementsTable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_AgreementsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_AgreementsTable_lbl" xml:lang="en-US">Agreements [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_AgreementsTable" xlink:to="cik0001793497_AgreementsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_AgreementsLineItems" xlink:href="cik0001793497-20230630.xsd#cik0001793497_AgreementsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_AgreementsLineItems_lbl" xml:lang="en-US">Agreements [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_AgreementsLineItems" xlink:to="cik0001793497_AgreementsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_OfferingCostsTable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_OfferingCostsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_OfferingCostsTable_lbl" xml:lang="en-US">Offering Costs [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_OfferingCostsTable" xlink:to="cik0001793497_OfferingCostsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_OfferingCostsLineItems" xlink:href="cik0001793497-20230630.xsd#cik0001793497_OfferingCostsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_OfferingCostsLineItems_lbl" xml:lang="en-US">Offering Costs [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_OfferingCostsLineItems" xlink:to="cik0001793497_OfferingCostsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_CreationandRedemptionofCreationUnitsTable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_CreationandRedemptionofCreationUnitsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_CreationandRedemptionofCreationUnitsTable_lbl" xml:lang="en-US">Creation and Redemption of Creation Units [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_CreationandRedemptionofCreationUnitsTable" xlink:to="cik0001793497_CreationandRedemptionofCreationUnitsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_CreationandRedemptionofCreationUnitsLineItems" xlink:href="cik0001793497-20230630.xsd#cik0001793497_CreationandRedemptionofCreationUnitsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_CreationandRedemptionofCreationUnitsLineItems_lbl" xml:lang="en-US">Creation and Redemption of Creation Units [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_CreationandRedemptionofCreationUnitsLineItems" xlink:to="cik0001793497_CreationandRedemptionofCreationUnitsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_FinancialHighlightsTable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_FinancialHighlightsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_FinancialHighlightsTable_lbl" xml:lang="en-US">Financial Highlights [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_FinancialHighlightsTable" xlink:to="cik0001793497_FinancialHighlightsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_FinancialHighlightsLineItems" xlink:href="cik0001793497-20230630.xsd#cik0001793497_FinancialHighlightsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_FinancialHighlightsLineItems_lbl" xml:lang="en-US">Financial Highlights Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_FinancialHighlightsLineItems" xlink:to="cik0001793497_FinancialHighlightsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_RiskTable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_RiskTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_RiskTable_lbl" xml:lang="en-US">Risk [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_RiskTable" xlink:to="cik0001793497_RiskTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_RiskLineItems" xlink:href="cik0001793497-20230630.xsd#cik0001793497_RiskLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_RiskLineItems_lbl" xml:lang="en-US">Risk [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_RiskLineItems" xlink:to="cik0001793497_RiskLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_SubsequentEventsTable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_SubsequentEventsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_SubsequentEventsTable_lbl" xml:lang="en-US">Subsequent Events [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_SubsequentEventsTable" xlink:to="cik0001793497_SubsequentEventsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_SubsequentEventsLineItems" xlink:href="cik0001793497-20230630.xsd#cik0001793497_SubsequentEventsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_SubsequentEventsLineItems_lbl" xml:lang="en-US">Subsequent Events [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_SubsequentEventsLineItems" xlink:to="cik0001793497_SubsequentEventsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_InvestmentsTablesTable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_InvestmentsTablesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_InvestmentsTablesTable_lbl" xml:lang="en-US">Investments (Tables) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_InvestmentsTablesTable" xlink:to="cik0001793497_InvestmentsTablesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_InvestmentsTablesLineItems" xlink:href="cik0001793497-20230630.xsd#cik0001793497_InvestmentsTablesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_InvestmentsTablesLineItems_lbl" xml:lang="en-US">Investments [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_InvestmentsTablesLineItems" xlink:to="cik0001793497_InvestmentsTablesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_CreationandRedemptionofCreationUnitsTablesTable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_CreationandRedemptionofCreationUnitsTablesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_CreationandRedemptionofCreationUnitsTablesTable_lbl" xml:lang="en-US">Creation and Redemption of Creation Units (Tables) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_CreationandRedemptionofCreationUnitsTablesTable" xlink:to="cik0001793497_CreationandRedemptionofCreationUnitsTablesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_CreationandRedemptionofCreationUnitsTablesLineItems" xlink:href="cik0001793497-20230630.xsd#cik0001793497_CreationandRedemptionofCreationUnitsTablesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_CreationandRedemptionofCreationUnitsTablesLineItems_lbl" xml:lang="en-US">Creation and Redemption of Creation Units [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_CreationandRedemptionofCreationUnitsTablesLineItems" xlink:to="cik0001793497_CreationandRedemptionofCreationUnitsTablesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_FinancialHighlightsTablesTable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_FinancialHighlightsTablesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_FinancialHighlightsTablesTable_lbl" xml:lang="en-US">Financial Highlights (Tables) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_FinancialHighlightsTablesTable" xlink:to="cik0001793497_FinancialHighlightsTablesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_FinancialHighlightsTablesLineItems" xlink:href="cik0001793497-20230630.xsd#cik0001793497_FinancialHighlightsTablesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_FinancialHighlightsTablesLineItems_lbl" xml:lang="en-US">Financial Highlights [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_FinancialHighlightsTablesLineItems" xlink:to="cik0001793497_FinancialHighlightsTablesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsTable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_SignificantAccountingPoliciesDetailsScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsTable_lbl" xml:lang="en-US">Significant Accounting Policies (Details) - Schedule of Cut-Off Times and the Times of the Calculation of the Funds [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsTable" xlink:to="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsLineItems" xlink:href="cik0001793497-20230630.xsd#cik0001793497_SignificantAccountingPoliciesDetailsScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsLineItems_lbl" xml:lang="en-US">Significant Accounting Policies (Details) - Schedule of Cut-Off Times and the Times of the Calculation of the Funds [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsLineItems" xlink:to="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_lbl" xml:lang="en-US">Cash and Cash Equivalents [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyTable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_SignificantAccountingPoliciesDetailsScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyTable_lbl" xml:lang="en-US">Significant Accounting Policies (Details) - Schedule of Valuation of Investments at Using the Fair Value Hierarchy [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyTable" xlink:to="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyLineItems" xlink:href="cik0001793497-20230630.xsd#cik0001793497_SignificantAccountingPoliciesDetailsScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyLineItems_lbl" xml:lang="en-US">Significant Accounting Policies (Details) - Schedule of Valuation of Investments at Using the Fair Value Hierarchy [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyLineItems" xlink:to="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeContractTypeDomain_lbl" xml:lang="en-US">Derivative Contract [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeContractTypeDomain" xlink:to="us-gaap_DerivativeContractTypeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FinancingReceivablesPeriodPastDueDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancingReceivablesPeriodPastDueDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinancingReceivablesPeriodPastDueDomain_lbl" xml:lang="en-US">Financial Asset, Aging [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancingReceivablesPeriodPastDueDomain" xlink:to="us-gaap_FinancingReceivablesPeriodPastDueDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_lbl" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativesFairValueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativesFairValueLineItems_lbl" xml:lang="en-US">Derivatives, Fair Value [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativesFairValueLineItems" xlink:to="us-gaap_DerivativesFairValueLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_InvestmentsDetailsScheduleofEffectofDerivativeInstrumentsonTheStatementofOperationsTable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_InvestmentsDetailsScheduleofEffectofDerivativeInstrumentsonTheStatementofOperationsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_InvestmentsDetailsScheduleofEffectofDerivativeInstrumentsonTheStatementofOperationsTable_lbl" xml:lang="en-US">Investments (Details) - Schedule of Effect of Derivative Instruments on The Statement of Operations [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_InvestmentsDetailsScheduleofEffectofDerivativeInstrumentsonTheStatementofOperationsTable" xlink:to="cik0001793497_InvestmentsDetailsScheduleofEffectofDerivativeInstrumentsonTheStatementofOperationsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_InvestmentsDetailsScheduleofEffectofDerivativeInstrumentsonTheStatementofOperationsLineItems" xlink:href="cik0001793497-20230630.xsd#cik0001793497_InvestmentsDetailsScheduleofEffectofDerivativeInstrumentsonTheStatementofOperationsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_InvestmentsDetailsScheduleofEffectofDerivativeInstrumentsonTheStatementofOperationsLineItems_lbl" xml:lang="en-US">Investments (Details) - Schedule of Effect of Derivative Instruments on The Statement of Operations [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_InvestmentsDetailsScheduleofEffectofDerivativeInstrumentsonTheStatementofOperationsLineItems" xlink:to="cik0001793497_InvestmentsDetailsScheduleofEffectofDerivativeInstrumentsonTheStatementofOperationsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BalanceSheetLocationDomain_lbl" xml:lang="en-US">Balance Sheet Location [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_BalanceSheetLocationDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_InvestmentsDetailsScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsTable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_InvestmentsDetailsScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_InvestmentsDetailsScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsTable_lbl" xml:lang="en-US">Investments (Details) - Schedule of Pledged By Funds Fair Values of Derivative Instruments [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_InvestmentsDetailsScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsTable" xlink:to="cik0001793497_InvestmentsDetailsScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_InvestmentsDetailsScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsLineItems" xlink:href="cik0001793497-20230630.xsd#cik0001793497_InvestmentsDetailsScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_InvestmentsDetailsScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsLineItems_lbl" xml:lang="en-US">Investments (Details) - Schedule of Pledged By Funds Fair Values of Derivative Instruments [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_InvestmentsDetailsScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsLineItems" xlink:to="cik0001793497_InvestmentsDetailsScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_InvestmentsDetailsScheduleofGrossAmountsNotOffsetInTheStatementsofFinancialConditionTable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_InvestmentsDetailsScheduleofGrossAmountsNotOffsetInTheStatementsofFinancialConditionTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_InvestmentsDetailsScheduleofGrossAmountsNotOffsetInTheStatementsofFinancialConditionTable_lbl" xml:lang="en-US">Investments (Details) - Schedule of Gross Amounts Not Offset In The Statements of Financial Condition [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_InvestmentsDetailsScheduleofGrossAmountsNotOffsetInTheStatementsofFinancialConditionTable" xlink:to="cik0001793497_InvestmentsDetailsScheduleofGrossAmountsNotOffsetInTheStatementsofFinancialConditionTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_InvestmentsDetailsScheduleofGrossAmountsNotOffsetInTheStatementsofFinancialConditionLineItems" xlink:href="cik0001793497-20230630.xsd#cik0001793497_InvestmentsDetailsScheduleofGrossAmountsNotOffsetInTheStatementsofFinancialConditionLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_InvestmentsDetailsScheduleofGrossAmountsNotOffsetInTheStatementsofFinancialConditionLineItems_lbl" xml:lang="en-US">Investments (Details) - Schedule of Gross Amounts Not Offset In The Statements of Financial Condition [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_InvestmentsDetailsScheduleofGrossAmountsNotOffsetInTheStatementsofFinancialConditionLineItems" xlink:to="cik0001793497_InvestmentsDetailsScheduleofGrossAmountsNotOffsetInTheStatementsofFinancialConditionLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_CreationandRedemptionofCreationUnitsDetailsScheduleofTransactionFeesTable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_CreationandRedemptionofCreationUnitsDetailsScheduleofTransactionFeesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_CreationandRedemptionofCreationUnitsDetailsScheduleofTransactionFeesTable_lbl" xml:lang="en-US">Creation and Redemption of Creation Units (Details) - Schedule of Transaction Fees [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_CreationandRedemptionofCreationUnitsDetailsScheduleofTransactionFeesTable" xlink:to="cik0001793497_CreationandRedemptionofCreationUnitsDetailsScheduleofTransactionFeesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_CreationandRedemptionofCreationUnitsDetailsScheduleofTransactionFeesLineItems" xlink:href="cik0001793497-20230630.xsd#cik0001793497_CreationandRedemptionofCreationUnitsDetailsScheduleofTransactionFeesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_CreationandRedemptionofCreationUnitsDetailsScheduleofTransactionFeesLineItems_lbl" xml:lang="en-US">Creation and Redemption of Creation Units (Details) - Schedule of Transaction Fees [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_CreationandRedemptionofCreationUnitsDetailsScheduleofTransactionFeesLineItems" xlink:to="cik0001793497_CreationandRedemptionofCreationUnitsDetailsScheduleofTransactionFeesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_FinancialHighlightsDetailsScheduleofShareOutstandingTable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_FinancialHighlightsDetailsScheduleofShareOutstandingTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_FinancialHighlightsDetailsScheduleofShareOutstandingTable_lbl" xml:lang="en-US">Financial Highlights (Details) - Schedule of Share Outstanding [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_FinancialHighlightsDetailsScheduleofShareOutstandingTable" xlink:to="cik0001793497_FinancialHighlightsDetailsScheduleofShareOutstandingTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_FinancialHighlightsDetailsScheduleofShareOutstandingLineItems" xlink:href="cik0001793497-20230630.xsd#cik0001793497_FinancialHighlightsDetailsScheduleofShareOutstandingLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_FinancialHighlightsDetailsScheduleofShareOutstandingLineItems_lbl" xml:lang="en-US">Financial Highlights (Details) - Schedule of Share Outstanding [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_FinancialHighlightsDetailsScheduleofShareOutstandingLineItems" xlink:to="cik0001793497_FinancialHighlightsDetailsScheduleofShareOutstandingLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetirementPlanFundingStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanFundingStatusDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetirementPlanFundingStatusDomain_lbl" xml:lang="en-US">Defined Benefit Plan, Funding Status [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetirementPlanFundingStatusDomain" xlink:to="us-gaap_RetirementPlanFundingStatusDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_SignificantAccountingPoliciesDetailsTable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_SignificantAccountingPoliciesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_SignificantAccountingPoliciesDetailsTable_lbl" xml:lang="en-US">Significant Accounting Policies (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_SignificantAccountingPoliciesDetailsTable" xlink:to="cik0001793497_SignificantAccountingPoliciesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_SignificantAccountingPoliciesDetailsLineItems" xlink:href="cik0001793497-20230630.xsd#cik0001793497_SignificantAccountingPoliciesDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_SignificantAccountingPoliciesDetailsLineItems_lbl" xml:lang="en-US">Significant Accounting Policies (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_SignificantAccountingPoliciesDetailsLineItems" xlink:to="cik0001793497_SignificantAccountingPoliciesDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionDomain_lbl" xml:lang="en-US">Related Party Transaction [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="us-gaap_RelatedPartyTransactionDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_AgreementsDetailsTable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_AgreementsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_AgreementsDetailsTable_lbl" xml:lang="en-US">Agreements (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_AgreementsDetailsTable" xlink:to="cik0001793497_AgreementsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_AgreementsDetailsLineItems" xlink:href="cik0001793497-20230630.xsd#cik0001793497_AgreementsDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_AgreementsDetailsLineItems_lbl" xml:lang="en-US">Agreements (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_AgreementsDetailsLineItems" xlink:to="cik0001793497_AgreementsDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeMember_lbl" xml:lang="en-US">Statistical Measurement [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeMember" xlink:to="srt_RangeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_FinancialHighlightsDetailsTable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_FinancialHighlightsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_FinancialHighlightsDetailsTable_lbl" xml:lang="en-US">Financial Highlights (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_FinancialHighlightsDetailsTable" xlink:to="cik0001793497_FinancialHighlightsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_FinancialHighlightsDetailsLineItems" xlink:href="cik0001793497-20230630.xsd#cik0001793497_FinancialHighlightsDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_FinancialHighlightsDetailsLineItems_lbl" xml:lang="en-US">Financial Highlights (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_FinancialHighlightsDetailsLineItems" xlink:to="cik0001793497_FinancialHighlightsDetailsLineItems_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_AdministrativeAccountingAndCustodianFeesPayable_lbl0" xml:lang="en-US">Amount of obligations incurred classified as other, payable within one year or the normal operating cycle, if longer.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_AdministrativeAccountingAndCustodianFeesPayable" xlink:to="cik0001793497_AdministrativeAccountingAndCustodianFeesPayable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_AgreementsDisclosureTextBlock_lbl0" xml:lang="en-US">The entire disclosure of agreements disclosure.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_AgreementsDisclosureTextBlock" xlink:to="cik0001793497_AgreementsDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_AmountOfTotalTrust_lbl0" xml:lang="en-US">Total amount of trust.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_AmountOfTotalTrust" xlink:to="cik0001793497_AmountOfTotalTrust_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne_lbl0" xml:lang="en-US">The sales price you receive with any selling costs you paid deducted.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne" xlink:to="cik0001793497_AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_AuthorizedParticipantsPercentage_lbl0" xml:lang="en-US">Percentage of authorized participants percentage.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_AuthorizedParticipantsPercentage" xlink:to="cik0001793497_AuthorizedParticipantsPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_AverageDailyNetAssetsRate_lbl0" xml:lang="en-US">Average daily net assets rate.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_AverageDailyNetAssetsRate" xlink:to="cik0001793497_AverageDailyNetAssetsRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_BrokerageCommissionsRate_lbl0" xml:lang="en-US">Brokerage commissions rate.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_BrokerageCommissionsRate" xlink:to="cik0001793497_BrokerageCommissionsRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_CapitalUnitNetAmount_lbl0" xml:lang="en-US">The amount of capital unit net amount.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_CapitalUnitNetAmount" xlink:to="cik0001793497_CapitalUnitNetAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_Cash1_lbl0" xml:lang="en-US">The amount of cash.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_Cash1" xlink:to="cik0001793497_Cash1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_CashCollateralForTheBenefitOftheFundsTheCounterparties_lbl0" xml:lang="en-US">Amount of cash collateral for the benefit of (the funds) / the counterparties.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_CashCollateralForTheBenefitOftheFundsTheCounterparties" xlink:to="cik0001793497_CashCollateralForTheBenefitOftheFundsTheCounterparties_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_CashPledgedAsCollateral_lbl0" xml:lang="en-US">Amount of cash pledged as collateral.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_CashPledgedAsCollateral" xlink:to="cik0001793497_CashPledgedAsCollateral_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_ChangeInUnrealizedAppreciationDepreciationsOnDerivativesRecognizedInIncome_lbl0" xml:lang="en-US">Change in unrealized appreciation (depreciation) on derivatives recognized in income.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ChangeInUnrealizedAppreciationDepreciationsOnDerivativesRecognizedInIncome" xlink:to="cik0001793497_ChangeInUnrealizedAppreciationDepreciationsOnDerivativesRecognizedInIncome_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_CreateRedeemCutoffDescription_lbl0" xml:lang="en-US">Create/Redeem Cut-off (EST) 2x Long VIX Futures ETF, description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_CreateRedeemCutoffDescription" xlink:to="cik0001793497_CreateRedeemCutoffDescription_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_DueFromOther_lbl0" xml:lang="en-US">Amount of due from others.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_DueFromOther" xlink:to="cik0001793497_DueFromOther_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_DueToCustodian_lbl0" xml:lang="en-US">Amount payable to related parties classified as other, due within one year or the normal operating cycle, if longer.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_DueToCustodian" xlink:to="cik0001793497_DueToCustodian_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_EmergingGrowthCompanyPolicyTextBlock_lbl0" xml:lang="en-US">Disclosure of accounting policy for emerging growth company.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_EmergingGrowthCompanyPolicyTextBlock" xlink:to="cik0001793497_EmergingGrowthCompanyPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_FinalNetAssetValueForFiscalPeriodPolcyTextBlock_lbl0" xml:lang="en-US">The entire disclosure of final net asset value for fiscal period.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_FinalNetAssetValueForFiscalPeriodPolcyTextBlock" xlink:to="cik0001793497_FinalNetAssetValueForFiscalPeriodPolcyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_FinancialInstrumentsForTheBenefitOftheFundsTheCounterpartiesTwo_lbl0" xml:lang="en-US">The amount of financial instruments.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_FinancialInstrumentsForTheBenefitOftheFundsTheCounterpartiesTwo" xlink:to="cik0001793497_FinancialInstrumentsForTheBenefitOftheFundsTheCounterpartiesTwo_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_FundSharesRedeemed_lbl0" xml:lang="en-US">Tha amount of Fund shares redeemed.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_FundSharesRedeemed" xlink:to="cik0001793497_FundSharesRedeemed_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_FuturesContracts_lbl0" xml:lang="en-US">The amount of futures contracts.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_FuturesContracts" xlink:to="cik0001793497_FuturesContracts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_FuturesContractsUnrealizedAppreciation_lbl0" xml:lang="en-US">The amount of futures contracts unrealized appreciation.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_FuturesContractsUnrealizedAppreciation" xlink:to="cik0001793497_FuturesContractsUnrealizedAppreciation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition_lbl0" xml:lang="en-US">The amount of gross amounts of recognized assets presented.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition" xlink:to="cik0001793497_GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_GrossAmountsOfRecognizedLiabilitiesPresentedInTheStatementsOfFinancialCondition_lbl0" xml:lang="en-US">The amount of gross Amounts of Recognized Liabilities presented in the Statements of Financial Condition.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_GrossAmountsOfRecognizedLiabilitiesPresentedInTheStatementsOfFinancialCondition" xlink:to="cik0001793497_GrossAmountsOfRecognizedLiabilitiesPresentedInTheStatementsOfFinancialCondition_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_GrossAmountsOffsetInTheStatementsOfFinancialCondition_lbl0" xml:lang="en-US">The amount of gross amounts offset in the statements of financial condition.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_GrossAmountsOffsetInTheStatementsOfFinancialCondition" xlink:to="cik0001793497_GrossAmountsOffsetInTheStatementsOfFinancialCondition_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_GrossAmountsOffsetInTheStatementsOfFinancialCondition1_lbl0" xml:lang="en-US">The amount of gross amounts offset in the statements of financial condition.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_GrossAmountsOffsetInTheStatementsOfFinancialCondition1" xlink:to="cik0001793497_GrossAmountsOffsetInTheStatementsOfFinancialCondition1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_GrossRevenue_lbl0" xml:lang="en-US">The amount of gross revenue.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_GrossRevenue" xlink:to="cik0001793497_GrossRevenue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_IncreaseDecreaseInDueToCustodian_lbl0" xml:lang="en-US">Increase decrease in due to custodian.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_IncreaseDecreaseInDueToCustodian" xlink:to="cik0001793497_IncreaseDecreaseInDueToCustodian_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_IncreaseDecreaseInVariationMarginPayable_lbl0" xml:lang="en-US">Increase decrease in variation margin payable.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_IncreaseDecreaseInVariationMarginPayable" xlink:to="cik0001793497_IncreaseDecreaseInVariationMarginPayable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_IncreaseInLicensingAndRegistrationFeesPayable_lbl0" xml:lang="en-US">Increase in licensing and registration fees payable.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_IncreaseInLicensingAndRegistrationFeesPayable" xlink:to="cik0001793497_IncreaseInLicensingAndRegistrationFeesPayable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_IncreaseInProfessionalFeesPayable_lbl0" xml:lang="en-US">Increase in professional fees payable.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_IncreaseInProfessionalFeesPayable" xlink:to="cik0001793497_IncreaseInProfessionalFeesPayable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_IncreasedecreaseInNetAssets_lbl0" xml:lang="en-US">Amount of total increase (decrease) in net assets.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_IncreasedecreaseInNetAssets" xlink:to="cik0001793497_IncreasedecreaseInNetAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_LicensingAndRegistrationFeesPayable_lbl0" xml:lang="en-US">The amount of licensing and registration fees payable.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_LicensingAndRegistrationFeesPayable" xlink:to="cik0001793497_LicensingAndRegistrationFeesPayable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_MarketValuePerShare_lbl0" xml:lang="en-US">Per share excess of market value per share.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_MarketValuePerShare" xlink:to="cik0001793497_MarketValuePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_NAVCalculationDate_lbl0" xml:lang="en-US">Date the NAV calculation date.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NAVCalculationDate" xlink:to="cik0001793497_NAVCalculationDate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_NAVCalculationTimeESTDescription_lbl0" xml:lang="en-US">NAV Calculation Time (EST), description.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NAVCalculationTimeESTDescription" xlink:to="cik0001793497_NAVCalculationTimeESTDescription_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition_lbl0" xml:lang="en-US">The amount of net assets presented.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition" xlink:to="cik0001793497_NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_NetAmountsOfLiabilitiesPresentedInTheStatementsOfFinancialCondition_lbl0" xml:lang="en-US">Amounts of liabilities presented in the statements of financial condition.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NetAmountsOfLiabilitiesPresentedInTheStatementsOfFinancialCondition" xlink:to="cik0001793497_NetAmountsOfLiabilitiesPresentedInTheStatementsOfFinancialCondition_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_NetChangeInUnrealizedAppreciationdepreciationOfInvestmentsAndFuturesContracts_lbl0" xml:lang="en-US">Amount of unrealized gain (loss) on investment.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NetChangeInUnrealizedAppreciationdepreciationOfInvestmentsAndFuturesContracts" xlink:to="cik0001793497_NetChangeInUnrealizedAppreciationdepreciationOfInvestmentsAndFuturesContracts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_NetIncreaseInNetAssetsFromCapitalShareTransactions_lbl0" xml:lang="en-US">The amount of net increase in net assets from capital share transactions.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NetIncreaseInNetAssetsFromCapitalShareTransactions" xlink:to="cik0001793497_NetIncreaseInNetAssetsFromCapitalShareTransactions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_NetIncreasedecreaseInNetAssetsResultingFromOperations_lbl1" xml:lang="en-US">Amount of increase (decrease) in net assets from operations of investment company.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NetIncreasedecreaseInNetAssetsResultingFromOperations" xlink:to="cik0001793497_NetIncreasedecreaseInNetAssetsResultingFromOperations_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts_lbl0" xml:lang="en-US">Amount of realized and unrealized gain (loss) on investment, and future contracts.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts" xlink:to="cik0001793497_NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_NetRealizedGainlossOnInvestmentsAndFuturesContracts_lbl0" xml:lang="en-US">Amount of realized gain (loss) on investment.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NetRealizedGainlossOnInvestmentsAndFuturesContracts" xlink:to="cik0001793497_NetRealizedGainlossOnInvestmentsAndFuturesContracts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_NonaffiliatesExceeded_lbl0" xml:lang="en-US">The amount of non-affiliates exceeded.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NonaffiliatesExceeded" xlink:to="cik0001793497_NonaffiliatesExceeded_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_NonconvertibleDebtSecurities_lbl0" xml:lang="en-US">The amount of non-convertible debt securities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NonconvertibleDebtSecurities" xlink:to="cik0001793497_NonconvertibleDebtSecurities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_NumberOfContracts_lbl0" xml:lang="en-US">Amount of number of contracts.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NumberOfContracts" xlink:to="cik0001793497_NumberOfContracts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_OfferingCostsTextBlock_lbl0" xml:lang="en-US">The entire disclosure of offering costs .</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_OfferingCostsTextBlock" xlink:to="cik0001793497_OfferingCostsTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_OtherAssetsInExcessOfLiabilitiesPercentage_lbl0" xml:lang="en-US">Percentage of other assets in excess of liabilities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_OtherAssetsInExcessOfLiabilitiesPercentage" xlink:to="cik0001793497_OtherAssetsInExcessOfLiabilitiesPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_ProceedsFromSaleOfUnits_lbl0" xml:lang="en-US">Proceeds from sale of units.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ProceedsFromSaleOfUnits" xlink:to="cik0001793497_ProceedsFromSaleOfUnits_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_ProceedsFromSalesOrMaturitiesOfInvestments_lbl0" xml:lang="en-US">Proceeds from sales or maturities of investments.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ProceedsFromSalesOrMaturitiesOfInvestments" xlink:to="cik0001793497_ProceedsFromSalesOrMaturitiesOfInvestments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_PurchasesOfInvestments_lbl0" xml:lang="en-US">The cash outflow associated with the purchase of all investments during the period.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_PurchasesOfInvestments" xlink:to="cik0001793497_PurchasesOfInvestments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_RealizedGainLossOnDerivativesRecognizedInIncome_lbl0" xml:lang="en-US">Amount of realized gain (loss) on derivatives recognized in income.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_RealizedGainLossOnDerivativesRecognizedInIncome" xlink:to="cik0001793497_RealizedGainLossOnDerivativesRecognizedInIncome_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_ReceivableForSharesSold_lbl0" xml:lang="en-US">It represent receivable for shares sold.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ReceivableForSharesSold" xlink:to="cik0001793497_ReceivableForSharesSold_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_RelevantBenchmark_lbl0" xml:lang="en-US">Percentage of relevant benchmark.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_RelevantBenchmark" xlink:to="cik0001793497_RelevantBenchmark_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock_lbl0" xml:lang="en-US">The entire disclosure of cut-off times and times of calculation.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock" xlink:to="cik0001793497_ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsTableTextBlock_lbl0" xml:lang="en-US">The entire disclosure of pledged by funds fair values of derivative instruments.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsTableTextBlock" xlink:to="cik0001793497_ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_ScheduleOfShareOutstandingTableTextBlock_lbl0" xml:lang="en-US">The entire disclosure of share outstanding.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ScheduleOfShareOutstandingTableTextBlock" xlink:to="cik0001793497_ScheduleOfShareOutstandingTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_ScheduleOfTransactionFeesTableTextBlock_lbl0" xml:lang="en-US">The entire disclosure of transaction fees.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ScheduleOfTransactionFeesTableTextBlock" xlink:to="cik0001793497_ScheduleOfTransactionFeesTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_SharesSoldNetOfSharesRedeemedinDollarsPerShare_lbl0" xml:lang="en-US">The amount of shares sold, net of shares redeemed.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_SharesSoldNetOfSharesRedeemedinDollarsPerShare" xlink:to="cik0001793497_SharesSoldNetOfSharesRedeemedinDollarsPerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_ShortTermInvestmentsRealized_lbl0" xml:lang="en-US">Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ShortTermInvestmentsRealized" xlink:to="cik0001793497_ShortTermInvestmentsRealized_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_ShortTermInvestmentsUnrealized_lbl0" xml:lang="en-US">Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ShortTermInvestmentsUnrealized" xlink:to="cik0001793497_ShortTermInvestmentsUnrealized_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_StatementsOfCashFlowsPolicyTextBlock_lbl0" xml:lang="en-US">The entire disclosure of statements of cash flows.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_StatementsOfCashFlowsPolicyTextBlock" xlink:to="cik0001793497_StatementsOfCashFlowsPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_SubadvisoryFeeRate_lbl0" xml:lang="en-US">Percentage of sub-advisory fee rate.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_SubadvisoryFeeRate" xlink:to="cik0001793497_SubadvisoryFeeRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_TotalReturnAtMarketValue_lbl0" xml:lang="en-US">Percentage of return at market value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_TotalReturnAtMarketValue" xlink:to="cik0001793497_TotalReturnAtMarketValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_TotalTrust_lbl0" xml:lang="en-US">Total Trust amount.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_TotalTrust" xlink:to="cik0001793497_TotalTrust_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_TotalTrust1_lbl0" xml:lang="en-US">Total Trust amount.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_TotalTrust1" xlink:to="cik0001793497_TotalTrust1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_UnderlyingFaceAmountAtMarketValues_lbl0" xml:lang="en-US">The nominal value of any stock at its issuing is termed its face value. The market value of any stock refers to the current market price of that stock as stated on the stock exchange. This value remains unaffected by the market conditions. Market conditions (such as government policies) can alter the market value.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnderlyingFaceAmountAtMarketValues" xlink:to="cik0001793497_UnderlyingFaceAmountAtMarketValues_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_VariationMarginReceivable_lbl0" xml:lang="en-US">Amount of variation margin receivable.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_VariationMarginReceivable" xlink:to="cik0001793497_VariationMarginReceivable_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfStockDomain_lbl" xml:lang="en-US">Class of Stock [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_AgreementsDisclosureAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_AgreementsDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_AgreementsDisclosureAbstract_lbl" xml:lang="en-US">Agreements Disclosure Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_AgreementsDisclosureAbstract" xlink:to="cik0001793497_AgreementsDisclosureAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_RealizedGainLossOnDerivativesRecognizedInIncome_lbl1" xml:lang="en-US">Realized Gain Loss On Derivatives Recognized In Income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_RealizedGainLossOnDerivativesRecognizedInIncome" xlink:to="cik0001793497_RealizedGainLossOnDerivativesRecognizedInIncome_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_CashCollateralForTheBenefitOftheFundsTheCounterparties_lbl1" xml:lang="en-US">Cash Collateral For The Benefit Ofthe Funds The Counterparties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_CashCollateralForTheBenefitOftheFundsTheCounterparties" xlink:to="cik0001793497_CashCollateralForTheBenefitOftheFundsTheCounterparties_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_lbl0" xml:lang="en-US">Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentOwnedUnrecognizedUnrealizedAppreciation_lbl0" xml:lang="en-US">Investment Owned, Unrecognized Unrealized Appreciation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentOwnedUnrecognizedUnrealizedAppreciation" xlink:to="us-gaap_InvestmentOwnedUnrecognizedUnrealizedAppreciation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_RealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContractsAbstract_lbl0" xml:lang="en-US">Realized And Unrealized Gain Loss On Investments And Futures Contracts Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_RealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContractsAbstract" xlink:to="cik0001793497_RealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContractsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_TotalTrust1_lbl1" xml:lang="en-US">Total Trust1</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_TotalTrust1" xlink:to="cik0001793497_TotalTrust1_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentPolicyTextBlock_lbl0" xml:lang="en-US">Investment, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentPolicyTextBlock" xlink:to="us-gaap_InvestmentPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_OperationsAbstract_lbl0" xml:lang="en-US">Operations Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_OperationsAbstract" xlink:to="cik0001793497_OperationsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_VixFuturesContractsAbstract0_lbl0" xml:lang="en-US">Vix Futures Contracts Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_VixFuturesContractsAbstract0" xlink:to="cik0001793497_VixFuturesContractsAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl0" xml:lang="en-US">Assets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl0" xml:lang="en-US">Entity Address, City or Town</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl0" xml:lang="en-US">Entity File Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl0" xml:lang="en-US">Entity Small Business</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_IncreaseInLicensingAndRegistrationFeesPayable_lbl1" xml:lang="en-US">Increase In Licensing And Registration Fees Payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_IncreaseInLicensingAndRegistrationFeesPayable" xlink:to="cik0001793497_IncreaseInLicensingAndRegistrationFeesPayable_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_FinancialInstrumentsForTheBenefitOftheFundsTheCounterpartiesTwo_lbl1" xml:lang="en-US">Financial Instruments For The Benefit Ofthe Funds The Counterparties Two</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_FinancialInstrumentsForTheBenefitOftheFundsTheCounterpartiesTwo" xlink:to="cik0001793497_FinancialInstrumentsForTheBenefitOftheFundsTheCounterpartiesTwo_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_NAVCalculationDate_lbl1" xml:lang="en-US">NAVCalculation Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NAVCalculationDate" xlink:to="cik0001793497_NAVCalculationDate_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_NetIncreasedecreaseInNetAssetsResultingFromOperations_lbl2" xml:lang="en-US">Net Increasedecrease In Net Assets Resulting From Operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NetIncreasedecreaseInNetAssetsResultingFromOperations" xlink:to="cik0001793497_NetIncreasedecreaseInNetAssetsResultingFromOperations_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_IncreaseDecreaseInNetAssetsAbstract_lbl0" xml:lang="en-US">Increase Decrease In Net Assets Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_IncreaseDecreaseInNetAssetsAbstract" xlink:to="cik0001793497_IncreaseDecreaseInNetAssetsAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_QuarterlyFinancialInformationDisclosureAbstract_lbl" xml:lang="en-US">Quarterly Financial Information Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:to="us-gaap_QuarterlyFinancialInformationDisclosureAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_NetAssetsAbstract0_lbl0" xml:lang="en-US">Net Assets Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NetAssetsAbstract0" xlink:to="cik0001793497_NetAssetsAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_ShortTermInvestmentsUnrealized_lbl1" xml:lang="en-US">Short Term Investments Unrealized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ShortTermInvestmentsUnrealized" xlink:to="cik0001793497_ShortTermInvestmentsUnrealized_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_NetAssetValueUnlimitedSharesAuthorizedAbstract_lbl0" xml:lang="en-US">Net Asset Value Unlimited Shares Authorized Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NetAssetValueUnlimitedSharesAuthorizedAbstract" xlink:to="cik0001793497_NetAssetValueUnlimitedSharesAuthorizedAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl0" xml:lang="en-US">Entity Filer Category</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_DueFromOther_lbl1" xml:lang="en-US">Due From Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_DueFromOther" xlink:to="cik0001793497_DueFromOther_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_ShortTermInvestmentsRealized_lbl1" xml:lang="en-US">Short Term Investments Realized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ShortTermInvestmentsRealized" xlink:to="cik0001793497_ShortTermInvestmentsRealized_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_lbl0" xml:lang="en-US">Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetAssetValuePerShare_lbl0" xml:lang="en-US">Net Asset Value Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetAssetValuePerShare" xlink:to="us-gaap_NetAssetValuePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_StatementsOfCashFlowsPolicyTextBlock_lbl1" xml:lang="en-US">Statements Of Cash Flows Policy Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_StatementsOfCashFlowsPolicyTextBlock" xlink:to="cik0001793497_StatementsOfCashFlowsPolicyTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_lbl0" xml:lang="en-US">Accrued Professional Fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl0" xml:lang="en-US">Subsequent Events [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_ClassIUnlimitedSharesAuthorizedAbstract_lbl0" xml:lang="en-US">Class IUnlimited Shares Authorized Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ClassIUnlimitedSharesAuthorizedAbstract" xlink:to="cik0001793497_ClassIUnlimitedSharesAuthorizedAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl0" xml:lang="en-US">Entity Address, State or Province</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts_lbl1" xml:lang="en-US">Net Realized And Unrealized Gain Loss On Investments And Futures Contracts</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts" xlink:to="cik0001793497_NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition_lbl1" xml:lang="en-US">Gross Amounts Of Recognized Assets Presented In The Statements Of Financial Condition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition" xlink:to="cik0001793497_GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl0" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl0" xml:lang="en-US">Local Phone Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl0" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostsAndExpenses_lbl0" xml:lang="en-US">Costs and Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostsAndExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl0" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_SVIXMember_lbl0" xml:lang="en-US">SVIXMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_SVIXMember" xlink:to="cik0001793497_SVIXMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherInvestments_lbl0" xml:lang="en-US">Other Investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherInvestments" xlink:to="us-gaap_OtherInvestments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_StatementsOfFinancialConditionLocationMember_lbl0" xml:lang="en-US">Statements Of Financial Condition Location Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_StatementsOfFinancialConditionLocationMember" xlink:to="cik0001793497_StatementsOfFinancialConditionLocationMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsMember_lbl0" xml:lang="en-US">Other Assets [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsMember" xlink:to="us-gaap_OtherAssetsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock_lbl1" xml:lang="en-US">Schedule Of Cutoff Times And Times Of Calculation Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock" xlink:to="cik0001793497_ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl0" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_FinalNetAssetValueForFiscalPeriodPolcyTextBlock_lbl1" xml:lang="en-US">Final Net Asset Value For Fiscal Period Polcy Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_FinalNetAssetValueForFiscalPeriodPolcyTextBlock" xlink:to="cik0001793497_FinalNetAssetValueForFiscalPeriodPolcyTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_LicensingAndRegistrationFeesPayable_lbl1" xml:lang="en-US">Licensing And Registration Fees Payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_LicensingAndRegistrationFeesPayable" xlink:to="cik0001793497_LicensingAndRegistrationFeesPayable_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_RiskLineItems_lbl0" xml:lang="en-US">Risk Line Items</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_RiskLineItems" xlink:to="cik0001793497_RiskLineItems_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_InvestmentIncomeAbstract_lbl0" xml:lang="en-US">Investment Income Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_InvestmentIncomeAbstract" xlink:to="cik0001793497_InvestmentIncomeAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInCustomerAdvances_lbl0" xml:lang="en-US">Increase (Decrease) in Customer Advances</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInCustomerAdvances" xlink:to="us-gaap_IncreaseDecreaseInCustomerAdvances_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease_lbl0" xml:lang="en-US">Investment Company, Net Asset Value Per Share, Period Increase (Decrease)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease" xlink:to="us-gaap_InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_AdjustmentsToReconcileNetIncomeLossToNetCashProvidedByUsedInOperatingActivitiesAbstract_lbl0" xml:lang="en-US">Adjustments To Reconcile Net Income Loss To Net Cash Provided By Used In Operating Activities Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_AdjustmentsToReconcileNetIncomeLossToNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="cik0001793497_AdjustmentsToReconcileNetIncomeLossToNetCashProvidedByUsedInOperatingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_CashFlowFromOperatingActivitiesAbstract_lbl0" xml:lang="en-US">Cash Flow From Operating Activities Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_CashFlowFromOperatingActivitiesAbstract" xlink:to="cik0001793497_CashFlowFromOperatingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl0" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl0"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_OfferingCostsAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_OfferingCostsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_OfferingCostsAbstract_lbl" xml:lang="en-US">Offering Costs Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_OfferingCostsAbstract" xlink:to="cik0001793497_OfferingCostsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnremittedEarningsInForeignInvestmentPolicy_lbl0" xml:lang="en-US">Unremitted Earnings in Foreign Investment, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnremittedEarningsInForeignInvestmentPolicy" xlink:to="us-gaap_UnremittedEarningsInForeignInvestmentPolicy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_NetRealizedGainLossOnAbstract_lbl0" xml:lang="en-US">Net Realized Gain Loss On Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NetRealizedGainLossOnAbstract" xlink:to="cik0001793497_NetRealizedGainLossOnAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_OtherAssetsInExcessOfLiabilitiesPercentage_lbl1" xml:lang="en-US">Other Assets In Excess Of Liabilities Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_OtherAssetsInExcessOfLiabilitiesPercentage" xlink:to="cik0001793497_OtherAssetsInExcessOfLiabilitiesPercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_lbl0" xml:lang="en-US">Schedule of Fair Value Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:to="us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_lbl0"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ScheduleOfShareOutstandingAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_ScheduleOfShareOutstandingAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_ScheduleOfShareOutstandingAbstract_lbl" xml:lang="en-US">Schedule Of Share Outstanding Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ScheduleOfShareOutstandingAbstract" xlink:to="cik0001793497_ScheduleOfShareOutstandingAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl0" xml:lang="en-US">Document Transition Report</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_Cash1_lbl1" xml:lang="en-US">Cash1</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_Cash1" xlink:to="cik0001793497_Cash1_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_UnlabeledAbstract18_lbl0" xml:lang="en-US">Unlabeled Abstract18</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract18" xlink:to="cik0001793497_UnlabeledAbstract18_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_UnlabeledAbstract19_lbl0" xml:lang="en-US">Unlabeled Abstract19</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract19" xlink:to="cik0001793497_UnlabeledAbstract19_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_UnlabeledAbstract16_lbl0" xml:lang="en-US">Unlabeled Abstract16</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract16" xlink:to="cik0001793497_UnlabeledAbstract16_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_MoneyMarketFund112Abstract_lbl0" xml:lang="en-US">Money Market Fund112 Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_MoneyMarketFund112Abstract" xlink:to="cik0001793497_MoneyMarketFund112Abstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_GrossAmountsOffsetInTheStatementsOfFinancialCondition1_lbl1" xml:lang="en-US">Gross Amounts Offset In The Statements Of Financial Condition1</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_GrossAmountsOffsetInTheStatementsOfFinancialCondition1" xlink:to="cik0001793497_GrossAmountsOffsetInTheStatementsOfFinancialCondition1_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_UnlabeledAbstract17_lbl0" xml:lang="en-US">Unlabeled Abstract17</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract17" xlink:to="cik0001793497_UnlabeledAbstract17_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_NAVCalculationTimeESTDescription_lbl1" xml:lang="en-US">NAVCalculation Time ESTDescription</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NAVCalculationTimeESTDescription" xlink:to="cik0001793497_NAVCalculationTimeESTDescription_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_VariationMarginReceivable_lbl1" xml:lang="en-US">Variation Margin Receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_VariationMarginReceivable" xlink:to="cik0001793497_VariationMarginReceivable_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl0" xml:lang="en-US">Accounts Payable, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_UVIXMember_lbl0" xml:lang="en-US">UVIXMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UVIXMember" xlink:to="cik0001793497_UVIXMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureTextBlockSupplementAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureTextBlockSupplementAbstract_lbl" xml:lang="en-US">Disclosure Text Block Supplement [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:to="us-gaap_DisclosureTextBlockSupplementAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_GrossAmountsOffsetInTheStatementsOfFinancialCondition_lbl1" xml:lang="en-US">Gross Amounts Offset In The Statements Of Financial Condition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_GrossAmountsOffsetInTheStatementsOfFinancialCondition" xlink:to="cik0001793497_GrossAmountsOffsetInTheStatementsOfFinancialCondition_lbl1"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ScheduleOfCutOffTimesAndTheTimesOfTheCalculationOfTheFundsAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_ScheduleOfCutOffTimesAndTheTimesOfTheCalculationOfTheFundsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_ScheduleOfCutOffTimesAndTheTimesOfTheCalculationOfTheFundsAbstract_lbl" xml:lang="en-US">Schedule Of Cut Off Times And The Times Of The Calculation Of The Funds Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ScheduleOfCutOffTimesAndTheTimesOfTheCalculationOfTheFundsAbstract" xlink:to="cik0001793497_ScheduleOfCutOffTimesAndTheTimesOfTheCalculationOfTheFundsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_CashPledgedAsCollateral_lbl1" xml:lang="en-US">Cash Pledged As Collateral</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_CashPledgedAsCollateral" xlink:to="cik0001793497_CashPledgedAsCollateral_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl0" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MaximumMember_lbl0" xml:lang="en-US">Maximum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ManagementFeeExpense_lbl0" xml:lang="en-US">Management Fee Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ManagementFeeExpense" xlink:to="us-gaap_ManagementFeeExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl0" xml:lang="en-US">Entity Shell Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentCompanyTotalReturn_lbl0" xml:lang="en-US">Investment Company, Total Return</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentCompanyTotalReturn" xlink:to="us-gaap_InvestmentCompanyTotalReturn_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl0" xml:lang="en-US">Entity Address, Address Line One</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_PurchasesOfInvestments_lbl1" xml:lang="en-US">Purchases Of Investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_PurchasesOfInvestments" xlink:to="cik0001793497_PurchasesOfInvestments_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl0" xml:lang="en-US">Entity Address, Address Line Two</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl0" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl0" xml:lang="en-US">Security Exchange Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_UnlabeledAbstract20_lbl0" xml:lang="en-US">Unlabeled Abstract20</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract20" xlink:to="cik0001793497_UnlabeledAbstract20_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentTextBlock_lbl0" xml:lang="en-US">Investment [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTextBlock" xlink:to="us-gaap_InvestmentTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentOwnedAtFairValue_lbl0" xml:lang="en-US">Investment Owned, Fair Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentOwnedAtFairValue" xlink:to="us-gaap_InvestmentOwnedAtFairValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet_lbl0" xml:lang="en-US">Increase (Decrease) in Accrued Interest Receivable, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet" xlink:to="us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_GrossAmountsOfRecognizedLiabilitiesPresentedInTheStatementsOfFinancialCondition_lbl1" xml:lang="en-US">Gross Amounts Of Recognized Liabilities Presented In The Statements Of Financial Condition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_GrossAmountsOfRecognizedLiabilitiesPresentedInTheStatementsOfFinancialCondition" xlink:to="cik0001793497_GrossAmountsOfRecognizedLiabilitiesPresentedInTheStatementsOfFinancialCondition_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MinimumMember_lbl0" xml:lang="en-US">Minimum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl0" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl0" xml:lang="en-US">Concentration Risk Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:to="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_CBOEVIXFuturesMember_lbl1" xml:lang="en-US">CBOEVIXFutures Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_CBOEVIXFuturesMember" xlink:to="cik0001793497_CBOEVIXFuturesMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpenseRatio_lbl0" xml:lang="en-US">General and Administrative Expense Ratio</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseRatio" xlink:to="us-gaap_GeneralAndAdministrativeExpenseRatio_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl0" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl0"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ScheduleOfValuationOfInvestmentsAtUsingTheFairValueHierarchyAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_ScheduleOfValuationOfInvestmentsAtUsingTheFairValueHierarchyAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_ScheduleOfValuationOfInvestmentsAtUsingTheFairValueHierarchyAbstract_lbl" xml:lang="en-US">Schedule Of Valuation Of Investments At Using The Fair Value Hierarchy Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ScheduleOfValuationOfInvestmentsAtUsingTheFairValueHierarchyAbstract" xlink:to="cik0001793497_ScheduleOfValuationOfInvestmentsAtUsingTheFairValueHierarchyAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_LiabilityDerivativesMember_lbl0" xml:lang="en-US">Liability Derivatives Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_LiabilityDerivativesMember" xlink:to="cik0001793497_LiabilityDerivativesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl0" xml:lang="en-US">Title of 12(b) Security</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_VixFuturesContractsNetRealizedGainLossOnFuturesContractsChangesInUnrealizedAppreciationDepreciationOnFuturesContractsAbstract0_lbl0" xml:lang="en-US">Vix Futures Contracts Net Realized Gain Loss On Futures Contracts Changes In Unrealized Appreciation Depreciation On Futures Contracts Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_VixFuturesContractsNetRealizedGainLossOnFuturesContractsChangesInUnrealizedAppreciationDepreciationOnFuturesContractsAbstract0" xlink:to="cik0001793497_VixFuturesContractsNetRealizedGainLossOnFuturesContractsChangesInUnrealizedAppreciationDepreciationOnFuturesContractsAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsTableTextBlock_lbl1" xml:lang="en-US">Schedule Of Pledged By Funds Fair Values Of Derivative Instruments Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsTableTextBlock" xlink:to="cik0001793497_ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_PayablesAbstract_lbl0" xml:lang="en-US">Payables Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_PayablesAbstract" xlink:to="cik0001793497_PayablesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentCompanyExpenseRatioAfterIncentiveAllocation_lbl0" xml:lang="en-US">Investment Company, Expense Ratio after Incentive Allocation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentCompanyExpenseRatioAfterIncentiveAllocation" xlink:to="us-gaap_InvestmentCompanyExpenseRatioAfterIncentiveAllocation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfessionalFees_lbl0" xml:lang="en-US">Professional Fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfessionalFees" xlink:to="us-gaap_ProfessionalFees_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_AssetDerivativesMember_lbl0" xml:lang="en-US">Asset Derivatives Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_AssetDerivativesMember" xlink:to="cik0001793497_AssetDerivativesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_ProceedsFromSalesOrMaturitiesOfInvestments_lbl1" xml:lang="en-US">Proceeds From Sales Or Maturities Of Investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ProceedsFromSalesOrMaturitiesOfInvestments" xlink:to="cik0001793497_ProceedsFromSalesOrMaturitiesOfInvestments_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition_lbl1" xml:lang="en-US">Net Amounts Of Assets Presented In The Statements Of Financial Condition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition" xlink:to="cik0001793497_NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_InvestmentIncomeAbstract0_lbl0" xml:lang="en-US">Investment Income Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_InvestmentIncomeAbstract0" xlink:to="cik0001793497_InvestmentIncomeAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl0" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl0"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ScheduleOfGrossAmountsNotOffsetInTheStatementsOfFinancialConditionAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_ScheduleOfGrossAmountsNotOffsetInTheStatementsOfFinancialConditionAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_ScheduleOfGrossAmountsNotOffsetInTheStatementsOfFinancialConditionAbstract_lbl" xml:lang="en-US">Schedule Of Gross Amounts Not Offset In The Statements Of Financial Condition Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ScheduleOfGrossAmountsNotOffsetInTheStatementsOfFinancialConditionAbstract" xlink:to="cik0001793497_ScheduleOfGrossAmountsNotOffsetInTheStatementsOfFinancialConditionAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_FirstAmericanGovernmentObligationsFundMember_lbl0" xml:lang="en-US">First American Government Obligations Fund Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_FirstAmericanGovernmentObligationsFundMember" xlink:to="cik0001793497_FirstAmericanGovernmentObligationsFundMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FloorBrokeragePolicy_lbl0" xml:lang="en-US">Floor Brokerage, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FloorBrokeragePolicy" xlink:to="us-gaap_FloorBrokeragePolicy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_lbl0" xml:lang="en-US">Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:to="us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_GrossRevenue_lbl1" xml:lang="en-US">Gross Revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_GrossRevenue" xlink:to="cik0001793497_GrossRevenue_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl0" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl0" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_TwoxLongVIXFuturesETFMember_lbl1" xml:lang="en-US">Twox Long VIXFutures ETFMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_TwoxLongVIXFuturesETFMember" xlink:to="cik0001793497_TwoxLongVIXFuturesETFMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_CreationandRedemptionofCreationUnitsTablesLineItems_lbl0" xml:lang="en-US">Creationand Redemptionof Creation Units Tables Line Items</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_CreationandRedemptionofCreationUnitsTablesLineItems" xlink:to="cik0001793497_CreationandRedemptionofCreationUnitsTablesLineItems_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl0" xml:lang="en-US">City Area Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_IncreaseDecreaseInDueToCustodian_lbl1" xml:lang="en-US">Increase Decrease In Due To Custodian</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_IncreaseDecreaseInDueToCustodian" xlink:to="cik0001793497_IncreaseDecreaseInDueToCustodian_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_VIXFuturesContractsMember_lbl0" xml:lang="en-US">VIXFutures Contracts Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_VIXFuturesContractsMember" xlink:to="cik0001793497_VIXFuturesContractsMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ScheduleOfFairValueOfDerivativeInstrumentsAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_ScheduleOfFairValueOfDerivativeInstrumentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_ScheduleOfFairValueOfDerivativeInstrumentsAbstract_lbl" xml:lang="en-US">Schedule Of Fair Value Of Derivative Instruments Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ScheduleOfFairValueOfDerivativeInstrumentsAbstract" xlink:to="cik0001793497_ScheduleOfFairValueOfDerivativeInstrumentsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl0" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssued_lbl0" xml:lang="en-US">Shares, Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl0" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherIncome_lbl0" xml:lang="en-US">Other Income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncome" xlink:to="us-gaap_OtherIncome_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherInterestAndDividendIncome_lbl0" xml:lang="en-US">Other Interest and Dividend Income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherInterestAndDividendIncome" xlink:to="us-gaap_OtherInterestAndDividendIncome_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_UnlabeledAbstract10_lbl0" xml:lang="en-US">Unlabeled Abstract10</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract10" xlink:to="cik0001793497_UnlabeledAbstract10_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_BrokerageCommissionsRate_lbl1" xml:lang="en-US">Brokerage Commissions Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_BrokerageCommissionsRate" xlink:to="cik0001793497_BrokerageCommissionsRate_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_UnlabeledAbstract11_lbl0" xml:lang="en-US">Unlabeled Abstract11</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract11" xlink:to="cik0001793497_UnlabeledAbstract11_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_FuturesContractsMember_lbl0" xml:lang="en-US">Futures Contracts Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_FuturesContractsMember" xlink:to="cik0001793497_FuturesContractsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_UnlabeledAbstract14_lbl0" xml:lang="en-US">Unlabeled Abstract14</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract14" xlink:to="cik0001793497_UnlabeledAbstract14_lbl0"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsAbstract_lbl" xml:lang="en-US">Schedule Of Pledged By Funds Fair Values Of Derivative Instruments Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsAbstract" xlink:to="cik0001793497_ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_UnlabeledAbstract15_lbl0" xml:lang="en-US">Unlabeled Abstract15</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract15" xlink:to="cik0001793497_UnlabeledAbstract15_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_UnlabeledAbstract12_lbl0" xml:lang="en-US">Unlabeled Abstract12</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract12" xlink:to="cik0001793497_UnlabeledAbstract12_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl0" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_UnlabeledAbstract13_lbl0" xml:lang="en-US">Unlabeled Abstract13</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract13" xlink:to="cik0001793497_UnlabeledAbstract13_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_IncreaseDecreaseInPayableToSponsor_lbl0" xml:lang="en-US">Increase Decrease In Payable To Sponsor</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_IncreaseDecreaseInPayableToSponsor" xlink:to="cik0001793497_IncreaseDecreaseInPayableToSponsor_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAbstract_lbl0" xml:lang="en-US">Liabilities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_LiabilitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNotesPayable_lbl0" xml:lang="en-US">Other Notes Payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNotesPayable" xlink:to="us-gaap_OtherNotesPayable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_CapitalShareTransactionsAbstract0_lbl0" xml:lang="en-US">Capital Share Transactions Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_CapitalShareTransactionsAbstract0" xlink:to="cik0001793497_CapitalShareTransactionsAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInReceivables_lbl0" xml:lang="en-US">Increase (Decrease) in Receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInReceivables" xlink:to="us-gaap_IncreaseDecreaseInReceivables_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_CapitalShareTransactionsAbstract_lbl0" xml:lang="en-US">Capital Share Transactions Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_CapitalShareTransactionsAbstract" xlink:to="cik0001793497_CapitalShareTransactionsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherReceivablesNetCurrent_lbl0" xml:lang="en-US">Other Receivables, Net, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherReceivablesNetCurrent" xlink:to="us-gaap_OtherReceivablesNetCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_FuturesContracts_lbl1" xml:lang="en-US">Futures Contracts</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_FuturesContracts" xlink:to="cik0001793497_FuturesContracts_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_ExpensesAbstract0_lbl0" xml:lang="en-US">Expenses Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ExpensesAbstract0" xlink:to="cik0001793497_ExpensesAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_AuthorizedParticipantsPercentage_lbl1" xml:lang="en-US">Authorized Participants Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_AuthorizedParticipantsPercentage" xlink:to="cik0001793497_AuthorizedParticipantsPercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommodityContractAssetCurrent_lbl0" xml:lang="en-US">Commodity Contract Asset, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommodityContractAssetCurrent" xlink:to="us-gaap_CommodityContractAssetCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_NetChangeInUnrealizedAppreciationdepreciationOfInvestmentsAndFuturesContracts_lbl1" xml:lang="en-US">Net Change In Unrealized Appreciationdepreciation Of Investments And Futures Contracts</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NetChangeInUnrealizedAppreciationdepreciationOfInvestmentsAndFuturesContracts" xlink:to="cik0001793497_NetChangeInUnrealizedAppreciationdepreciationOfInvestmentsAndFuturesContracts_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_SharesSoldNetOfSharesRedeemedinDollarsPerShare_lbl1" xml:lang="en-US">Shares Sold Net Of Shares Redeemedin Dollars Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_SharesSoldNetOfSharesRedeemedinDollarsPerShare" xlink:to="cik0001793497_SharesSoldNetOfSharesRedeemedinDollarsPerShare_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_NetChangeInUnrealizedAppreciationDepreciationOfAbstract_lbl0" xml:lang="en-US">Net Change In Unrealized Appreciation Depreciation Of Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NetChangeInUnrealizedAppreciationDepreciationOfAbstract" xlink:to="cik0001793497_NetChangeInUnrealizedAppreciationDepreciationOfAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LegalFees_lbl0" xml:lang="en-US">Legal Fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LegalFees" xlink:to="us-gaap_LegalFees_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_DueToCustodian_lbl1" xml:lang="en-US">Due To Custodian</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_DueToCustodian" xlink:to="cik0001793497_DueToCustodian_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_UnlabeledAbstract2_lbl0" xml:lang="en-US">Unlabeled Abstract2</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract2" xlink:to="cik0001793497_UnlabeledAbstract2_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_UnlabeledAbstract1_lbl0" xml:lang="en-US">Unlabeled Abstract1</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract1" xlink:to="cik0001793497_UnlabeledAbstract1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_CBOEVIXFuturesOneMember_lbl1" xml:lang="en-US">CBOEVIXFutures One Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_CBOEVIXFuturesOneMember" xlink:to="cik0001793497_CBOEVIXFuturesOneMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_UnlabeledAbstract4_lbl0" xml:lang="en-US">Unlabeled Abstract4</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract4" xlink:to="cik0001793497_UnlabeledAbstract4_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl0" xml:lang="en-US">Payments of Stock Issuance Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_UnlabeledAbstract3_lbl0" xml:lang="en-US">Unlabeled Abstract3</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract3" xlink:to="cik0001793497_UnlabeledAbstract3_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentCompanyGainLossOnInvestmentPerShare_lbl0" xml:lang="en-US">Investment Company, Gain (Loss) on Investment, Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentCompanyGainLossOnInvestmentPerShare" xlink:to="us-gaap_InvestmentCompanyGainLossOnInvestmentPerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_TotalReturnAtMarketValue_lbl1" xml:lang="en-US">Total Return At Market Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_TotalReturnAtMarketValue" xlink:to="cik0001793497_TotalReturnAtMarketValue_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_UnlabeledAbstract0_lbl0" xml:lang="en-US">Unlabeled Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract0" xlink:to="cik0001793497_UnlabeledAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_UnlabeledAbstract9_lbl0" xml:lang="en-US">Unlabeled Abstract9</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract9" xlink:to="cik0001793497_UnlabeledAbstract9_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_UnrealizedDepreciationMember_lbl0" xml:lang="en-US">Unrealized Depreciation Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnrealizedDepreciationMember" xlink:to="cik0001793497_UnrealizedDepreciationMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfTrustAssetsToPayExpenses_lbl0" xml:lang="en-US">Sale of Trust Assets to Pay Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfTrustAssetsToPayExpenses" xlink:to="us-gaap_SaleOfTrustAssetsToPayExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_UnlabeledAbstract6_lbl0" xml:lang="en-US">Unlabeled Abstract6</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract6" xlink:to="cik0001793497_UnlabeledAbstract6_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_UnlabeledAbstract5_lbl0" xml:lang="en-US">Unlabeled Abstract5</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract5" xlink:to="cik0001793497_UnlabeledAbstract5_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_UnlabeledAbstract8_lbl0" xml:lang="en-US">Unlabeled Abstract8</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract8" xlink:to="cik0001793497_UnlabeledAbstract8_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_UnlabeledAbstract7_lbl0" xml:lang="en-US">Unlabeled Abstract7</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract7" xlink:to="cik0001793497_UnlabeledAbstract7_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_ShortTermInvestment657Abstract_lbl0" xml:lang="en-US">Short Term Investment657 Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ShortTermInvestment657Abstract" xlink:to="cik0001793497_ShortTermInvestment657Abstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashEquivalentsAtCarryingValue_lbl0" xml:lang="en-US">Cash Equivalents, at Carrying Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashEquivalentsAtCarryingValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_ScheduleOfTransactionFeesTableTextBlock_lbl1" xml:lang="en-US">Schedule Of Transaction Fees Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ScheduleOfTransactionFeesTableTextBlock" xlink:to="cik0001793497_ScheduleOfTransactionFeesTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MoneyMarketFundsMember_lbl0" xml:lang="en-US">Money Market Funds [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MoneyMarketFundsMember" xlink:to="us-gaap_MoneyMarketFundsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_NonconvertibleDebtSecurities_lbl1" xml:lang="en-US">Nonconvertible Debt Securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NonconvertibleDebtSecurities" xlink:to="cik0001793497_NonconvertibleDebtSecurities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrealizedGainLossOnDerivatives_lbl0" xml:lang="en-US">Unrealized Gain (Loss) on Derivatives</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrealizedGainLossOnDerivatives" xlink:to="us-gaap_UnrealizedGainLossOnDerivatives_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_ProceedsFromSaleOfUnits_lbl1" xml:lang="en-US">Proceeds From Sale Of Units</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ProceedsFromSaleOfUnits" xlink:to="cik0001793497_ProceedsFromSaleOfUnits_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesMember_lbl0" xml:lang="en-US">Other Liabilities [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesMember" xlink:to="us-gaap_OtherLiabilitiesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_NetAmountsOfLiabilitiesPresentedInTheStatementsOfFinancialCondition_lbl1" xml:lang="en-US">Net Amounts Of Liabilities Presented In The Statements Of Financial Condition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NetAmountsOfLiabilitiesPresentedInTheStatementsOfFinancialCondition" xlink:to="cik0001793497_NetAmountsOfLiabilitiesPresentedInTheStatementsOfFinancialCondition_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_ScheduleOfShareOutstandingTableTextBlock_lbl1" xml:lang="en-US">Schedule Of Share Outstanding Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ScheduleOfShareOutstandingTableTextBlock" xlink:to="cik0001793497_ScheduleOfShareOutstandingTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_NetRealizedGainlossOnInvestmentsAndFuturesContracts_lbl1" xml:lang="en-US">Net Realized Gainloss On Investments And Futures Contracts</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NetRealizedGainlossOnInvestmentsAndFuturesContracts" xlink:to="cik0001793497_NetRealizedGainlossOnInvestmentsAndFuturesContracts_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_IncreaseDecreaseInVariationMarginPayable_lbl1" xml:lang="en-US">Increase Decrease In Variation Margin Payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_IncreaseDecreaseInVariationMarginPayable" xlink:to="cik0001793497_IncreaseDecreaseInVariationMarginPayable_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesParValuePerShare_lbl0" xml:lang="en-US">Auction Market Preferred Securities, Stock Series, Par Value Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesParValuePerShare" xlink:to="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesParValuePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_ExpensesAbstract_lbl0" xml:lang="en-US">Expenses Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ExpensesAbstract" xlink:to="cik0001793497_ExpensesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_CreateRedeemCutoffDescription_lbl1" xml:lang="en-US">Create Redeem Cutoff Description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_CreateRedeemCutoffDescription" xlink:to="cik0001793497_CreateRedeemCutoffDescription_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl0" xml:lang="en-US">Current Fiscal Year End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_SharesSoldinShares_lbl0" xml:lang="en-US">Shares Soldin Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_SharesSoldinShares" xlink:to="cik0001793497_SharesSoldinShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_RelevantBenchmark_lbl1" xml:lang="en-US">Relevant Benchmark</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_RelevantBenchmark" xlink:to="cik0001793497_RelevantBenchmark_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_UnderlyingFaceAmountAtMarketValues_lbl1" xml:lang="en-US">Underlying Face Amount At Market Values</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnderlyingFaceAmountAtMarketValues" xlink:to="cik0001793497_UnderlyingFaceAmountAtMarketValues_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_OfferingCostsTextBlock_lbl1" xml:lang="en-US">Offering Costs Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_OfferingCostsTextBlock" xlink:to="cik0001793497_OfferingCostsTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne_lbl1" xml:lang="en-US">Amounts Of Recognized Assets Liabilities Presented In The Statements Of Financial Condition One</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne" xlink:to="cik0001793497_AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_UnlabeledAbstract_lbl0" xml:lang="en-US">Unlabeled Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract" xlink:to="cik0001793497_UnlabeledAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_lbl0" xml:lang="en-US">Increase (Decrease) in Other Accounts Payable and Accrued Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentCompanyMarketValuePerShare_lbl1" xml:lang="en-US">Investment Company, Market Value, Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentCompanyMarketValuePerShare" xlink:to="us-gaap_InvestmentCompanyMarketValuePerShare_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_MoneyMarketFund657Abstract_lbl0" xml:lang="en-US">Money Market Fund657 Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_MoneyMarketFund657Abstract" xlink:to="cik0001793497_MoneyMarketFund657Abstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_InvestmentsTablesLineItems_lbl0" xml:lang="en-US">Investments Tables Line Items</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_InvestmentsTablesLineItems" xlink:to="cik0001793497_InvestmentsTablesLineItems_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_ReceivableForSharesSold_lbl1" xml:lang="en-US">Receivable For Shares Sold</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ReceivableForSharesSold" xlink:to="cik0001793497_ReceivableForSharesSold_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MoneyMarketFundsAtCarryingValue_lbl0" xml:lang="en-US">Money Market Funds, at Carrying Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MoneyMarketFundsAtCarryingValue" xlink:to="us-gaap_MoneyMarketFundsAtCarryingValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_ShortTermInvestment112Abstract_lbl0" xml:lang="en-US">Short Term Investment112 Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ShortTermInvestment112Abstract" xlink:to="cik0001793497_ShortTermInvestment112Abstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent_lbl0" xml:lang="en-US">Increase (Decrease) in Due to Related Parties, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent" xlink:to="us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_lbl0" xml:lang="en-US">Increase (Decrease) in Prepaid Expenses, Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_lbl0"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ScheduleOfEffectOfDerivativeInstrumentsOnTheStatementOfOperationsAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_ScheduleOfEffectOfDerivativeInstrumentsOnTheStatementOfOperationsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_ScheduleOfEffectOfDerivativeInstrumentsOnTheStatementOfOperationsAbstract_lbl" xml:lang="en-US">Schedule Of Effect Of Derivative Instruments On The Statement Of Operations Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ScheduleOfEffectOfDerivativeInstrumentsOnTheStatementOfOperationsAbstract" xlink:to="cik0001793497_ScheduleOfEffectOfDerivativeInstrumentsOnTheStatementOfOperationsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FloorBrokerageExchangeAndClearanceFees_lbl0" xml:lang="en-US">Floor Brokerage, Exchange and Clearance Fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FloorBrokerageExchangeAndClearanceFees" xlink:to="us-gaap_FloorBrokerageExchangeAndClearanceFees_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_NetRealizedGainLossOnAbstract0_lbl0" xml:lang="en-US">Net Realized Gain Loss On Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NetRealizedGainLossOnAbstract0" xlink:to="cik0001793497_NetRealizedGainLossOnAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_MarketValuePerShare_lbl1" xml:lang="en-US">Market Value Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_MarketValuePerShare" xlink:to="cik0001793497_MarketValuePerShare_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeNetAssetsPercentage_lbl1" xml:lang="en-US">Derivative, Net Assets, Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeNetAssetsPercentage" xlink:to="us-gaap_DerivativeNetAssetsPercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnInvestments_lbl0" xml:lang="en-US">Gain (Loss) on Investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnInvestments" xlink:to="us-gaap_GainLossOnInvestments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetInvestmentInLeaseAccruedInterestWriteoff_lbl0" xml:lang="en-US">Net Investment in Lease, Accrued Interest, Writeoff</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetInvestmentInLeaseAccruedInterestWriteoff" xlink:to="us-gaap_NetInvestmentInLeaseAccruedInterestWriteoff_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssets_lbl0" xml:lang="en-US">Other Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssets" xlink:to="us-gaap_OtherAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl0" xml:lang="en-US">Entity Ex Transition Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_FundSharesRedeemed_lbl1" xml:lang="en-US">Fund Shares Redeemed</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_FundSharesRedeemed" xlink:to="cik0001793497_FundSharesRedeemed_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_NetChangeInUnrealizedAppreciationDepreciationOfAbstract0_lbl0" xml:lang="en-US">Net Change In Unrealized Appreciation Depreciation Of Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NetChangeInUnrealizedAppreciationDepreciationOfAbstract0" xlink:to="cik0001793497_NetChangeInUnrealizedAppreciationDepreciationOfAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsNet_lbl4" xml:lang="en-US">Net Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNet" xlink:to="us-gaap_AssetsNet_lbl4"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl0" xml:lang="en-US">General and Administrative Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables_lbl0" xml:lang="en-US">Increase (Decrease) in Other Receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherReceivables" xlink:to="us-gaap_IncreaseDecreaseInOtherReceivables_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_NonaffiliatesExceeded_lbl1" xml:lang="en-US">Nonaffiliates Exceeded</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NonaffiliatesExceeded" xlink:to="cik0001793497_NonaffiliatesExceeded_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_RatiosToAverageNetAssets5Abstract0_lbl0" xml:lang="en-US">Ratios To Average Net Assets5 Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_RatiosToAverageNetAssets5Abstract0" xlink:to="cik0001793497_RatiosToAverageNetAssets5Abstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_TotalTrust_lbl1" xml:lang="en-US">Total Trust</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_TotalTrust" xlink:to="cik0001793497_TotalTrust_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl0" xml:lang="en-US">Document Fiscal Year Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentIncomeNet_lbl0" xml:lang="en-US">Investment Income, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeNet" xlink:to="us-gaap_InvestmentIncomeNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_NetAssetsConsistOfAbstract_lbl0" xml:lang="en-US">Net Assets Consist Of Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NetAssetsConsistOfAbstract" xlink:to="cik0001793497_NetAssetsConsistOfAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_FuturesContractsUnrealizedAppreciation_lbl1" xml:lang="en-US">Futures Contracts Unrealized Appreciation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_FuturesContractsUnrealizedAppreciation" xlink:to="cik0001793497_FuturesContractsUnrealizedAppreciation_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl0" xml:lang="en-US">Entity Current Reporting Status</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl0" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl0" xml:lang="en-US">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_lbl0" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl0" xml:lang="en-US">Entity Tax Identification Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl0" xml:lang="en-US">Entity Address, Postal Zip Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl0" xml:lang="en-US">Entity Emerging Growth Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_CapitalUnitNetAmount_lbl1" xml:lang="en-US">Capital Unit Net Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_CapitalUnitNetAmount" xlink:to="cik0001793497_CapitalUnitNetAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl0" xml:lang="en-US">Document Fiscal Period Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl0" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_OperationsAbstract0_lbl0" xml:lang="en-US">Operations Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_OperationsAbstract0" xlink:to="cik0001793497_OperationsAbstract0_lbl0"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ScheduleOfTransactionFeesAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_ScheduleOfTransactionFeesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_ScheduleOfTransactionFeesAbstract_lbl" xml:lang="en-US">Schedule Of Transaction Fees Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ScheduleOfTransactionFeesAbstract" xlink:to="cik0001793497_ScheduleOfTransactionFeesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl0" xml:lang="en-US">Entity Interactive Data Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl0" xml:lang="en-US">Additional Paid in Capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentInterestRate_lbl0" xml:lang="en-US">Investment Interest Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentInterestRate" xlink:to="us-gaap_InvestmentInterestRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_CashFlowFromFinancingActivitiesAbstract_lbl0" xml:lang="en-US">Cash Flow From Financing Activities Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_CashFlowFromFinancingActivitiesAbstract" xlink:to="cik0001793497_CashFlowFromFinancingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_SubadvisoryFeeRate_lbl1" xml:lang="en-US">Subadvisory Fee Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_SubadvisoryFeeRate" xlink:to="cik0001793497_SubadvisoryFeeRate_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_NumberOfContracts_lbl1" xml:lang="en-US">Number Of Contracts</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NumberOfContracts" xlink:to="cik0001793497_NumberOfContracts_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_EmergingGrowthCompanyPolicyTextBlock_lbl1" xml:lang="en-US">Emerging Growth Company Policy Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_EmergingGrowthCompanyPolicyTextBlock" xlink:to="cik0001793497_EmergingGrowthCompanyPolicyTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_lbl0" xml:lang="en-US">Net Income (Loss) Attributable to Parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_UnrealizedAppreciationMember_lbl0" xml:lang="en-US">Unrealized Appreciation Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnrealizedAppreciationMember" xlink:to="cik0001793497_UnrealizedAppreciationMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentCompanyTotalReturnAfterIncentiveFees_lbl0" xml:lang="en-US">Investment Company, Total Return after Incentive Fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentCompanyTotalReturnAfterIncentiveFees" xlink:to="us-gaap_InvestmentCompanyTotalReturnAfterIncentiveFees_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_AverageDailyNetAssetsRate_lbl1" xml:lang="en-US">Average Daily Net Assets Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_AverageDailyNetAssetsRate" xlink:to="cik0001793497_AverageDailyNetAssetsRate_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl0" xml:lang="en-US">Document Quarterly Report</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_AmountOfTotalTrust_lbl1" xml:lang="en-US">Amount Of Total Trust</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_AmountOfTotalTrust" xlink:to="cik0001793497_AmountOfTotalTrust_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract] [Standard Label]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInEarnestMoneyDepositsOutstanding_lbl0" xml:lang="en-US">Increase (Decrease) in Earnest Money Deposits Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInEarnestMoneyDepositsOutstanding" xlink:to="us-gaap_IncreaseDecreaseInEarnestMoneyDepositsOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl0" xml:lang="en-US">Trading Symbol</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_NetAssetsAbstract_lbl0" xml:lang="en-US">Net Assets Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NetAssetsAbstract" xlink:to="cik0001793497_NetAssetsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestAndOtherIncome_lbl0" xml:lang="en-US">Interest and Other Income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestAndOtherIncome" xlink:to="us-gaap_InterestAndOtherIncome_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_VixFuturesContractsAbstract_lbl0" xml:lang="en-US">Vix Futures Contracts Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_VixFuturesContractsAbstract" xlink:to="cik0001793497_VixFuturesContractsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_IncreaseInProfessionalFeesPayable_lbl1" xml:lang="en-US">Increase In Professional Fees Payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_IncreaseInProfessionalFeesPayable" xlink:to="cik0001793497_IncreaseInProfessionalFeesPayable_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_RealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContractsAbstract0_lbl0" xml:lang="en-US">Realized And Unrealized Gain Loss On Investments And Futures Contracts Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_RealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContractsAbstract0" xlink:to="cik0001793497_RealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContractsAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherInvestmentsAndSecuritiesAtCost_lbl0" xml:lang="en-US">Other Investments and Securities, at Cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherInvestmentsAndSecuritiesAtCost" xlink:to="us-gaap_OtherInvestmentsAndSecuritiesAtCost_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_ChangeInUnrealizedAppreciationDepreciationsOnDerivativesRecognizedInIncome_lbl1" xml:lang="en-US">Change In Unrealized Appreciation Depreciations On Derivatives Recognized In Income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ChangeInUnrealizedAppreciationDepreciationsOnDerivativesRecognizedInIncome" xlink:to="cik0001793497_ChangeInUnrealizedAppreciationDepreciationsOnDerivativesRecognizedInIncome_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_IncreasedecreaseInNetAssets_lbl1" xml:lang="en-US">Increasedecrease In Net Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_IncreasedecreaseInNetAssets" xlink:to="cik0001793497_IncreasedecreaseInNetAssets_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_lbl0" xml:lang="en-US">Shares, Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl0"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ScheduleOfInvestmentsUnauditedAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_ScheduleOfInvestmentsUnauditedAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_ScheduleOfInvestmentsUnauditedAbstract_lbl" xml:lang="en-US">Schedule Of Investments Unaudited Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ScheduleOfInvestmentsUnauditedAbstract" xlink:to="cik0001793497_ScheduleOfInvestmentsUnauditedAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_AdministrativeAccountingAndCustodianFeesPayable_lbl1" xml:lang="en-US">Administrative Accounting And Custodian Fees Payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_AdministrativeAccountingAndCustodianFeesPayable" xlink:to="cik0001793497_AdministrativeAccountingAndCustodianFeesPayable_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_IncreaseDecreaseInNetAssetsAbstract0_lbl0" xml:lang="en-US">Increase Decrease In Net Assets Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_IncreaseDecreaseInNetAssetsAbstract0" xlink:to="cik0001793497_IncreaseDecreaseInNetAssetsAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssets_lbl0" xml:lang="en-US">Prepaid Expense and Other Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssets" xlink:to="us-gaap_PrepaidExpenseAndOtherAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_AgreementsDisclosureTextBlock_lbl1" xml:lang="en-US">Agreements Disclosure Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_AgreementsDisclosureTextBlock" xlink:to="cik0001793497_AgreementsDisclosureTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_RatiosToAverageNetAssets5Abstract_lbl0" xml:lang="en-US">Ratios To Average Net Assets5 Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_RatiosToAverageNetAssets5Abstract" xlink:to="cik0001793497_RatiosToAverageNetAssets5Abstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl0" xml:lang="en-US">Document Period End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestReceivable_lbl0" xml:lang="en-US">Interest Receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestReceivable" xlink:to="us-gaap_InterestReceivable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherShortTermInvestments_lbl0" xml:lang="en-US">Other Short-Term Investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherShortTermInvestments" xlink:to="us-gaap_OtherShortTermInvestments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl0" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_VixFuturesContractsNetRealizedGainLossOnFuturesContractsChangesInUnrealizedAppreciationDepreciationOnFuturesContractsAbstract_lbl0" xml:lang="en-US">Vix Futures Contracts Net Realized Gain Loss On Futures Contracts Changes In Unrealized Appreciation Depreciation On Futures Contracts Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_VixFuturesContractsNetRealizedGainLossOnFuturesContractsChangesInUnrealizedAppreciationDepreciationOnFuturesContractsAbstract" xlink:to="cik0001793497_VixFuturesContractsNetRealizedGainLossOnFuturesContractsChangesInUnrealizedAppreciationDepreciationOnFuturesContractsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_QuarterlyFinancialInformationTextBlock_lbl0" xml:lang="en-US">Quarterly Financial Information [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_QuarterlyFinancialInformationTextBlock" xlink:to="us-gaap_QuarterlyFinancialInformationTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_IncomeAbstract_lbl0" xml:lang="en-US">Income Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_IncomeAbstract" xlink:to="cik0001793497_IncomeAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_lbl0" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_NetIncreaseInNetAssetsFromCapitalShareTransactions_lbl1" xml:lang="en-US">Net Increase In Net Assets From Capital Share Transactions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NetIncreaseInNetAssetsFromCapitalShareTransactions" xlink:to="cik0001793497_NetIncreaseInNetAssetsFromCapitalShareTransactions_lbl1"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>cik0001793497-20230630_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Mon Aug 14 16:04:01 UTC 2023 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_ConsolidatedBalanceSheet" roleURI="http://www.vts.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_ConsolidatedIncomeStatement" roleURI="http://www.vts.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_ConsolidatedIncomeStatement0" roleURI="http://www.vts.com/role/ConsolidatedIncomeStatement0"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_ConsolidatedCashFlow" roleURI="http://www.vts.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_ScheduleofInvestmentsUnauditedTable" roleURI="http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_ScheduleofInvestmentsUnauditedTable_Parentheticals" roleURI="http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_Organization" roleURI="http://www.vts.com/role/Organization"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_SignificantAccountingPolicies" roleURI="http://www.vts.com/role/SignificantAccountingPolicies"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_Investments" roleURI="http://www.vts.com/role/Investments"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_Agreements" roleURI="http://www.vts.com/role/Agreements"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_OfferingCosts" roleURI="http://www.vts.com/role/OfferingCosts"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_CreationandRedemptionofCreationUnits" roleURI="http://www.vts.com/role/CreationandRedemptionofCreationUnits"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_FinancialHighlights" roleURI="http://www.vts.com/role/FinancialHighlights"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_Risk" roleURI="http://www.vts.com/role/Risk"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_SubsequentEvents" roleURI="http://www.vts.com/role/SubsequentEvents"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_AccountingPoliciesByPolicy" roleURI="http://www.vts.com/role/AccountingPoliciesByPolicy"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_SignificantAccountingPoliciesTables" roleURI="http://www.vts.com/role/SignificantAccountingPoliciesTables"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_InvestmentsTables" roleURI="http://www.vts.com/role/InvestmentsTables"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_CreationandRedemptionofCreationUnitsTables" roleURI="http://www.vts.com/role/CreationandRedemptionofCreationUnitsTables"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_FinancialHighlightsTables" roleURI="http://www.vts.com/role/FinancialHighlightsTables"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_ScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsTable" roleURI="http://www.vts.com/role/ScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsTable"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_ScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyTable" roleURI="http://www.vts.com/role/ScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyTable"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_ScheduleofFairValueofDerivativeInstrumentsTable" roleURI="http://www.vts.com/role/ScheduleofFairValueofDerivativeInstrumentsTable"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_ScheduleofEffectofDerivativeInstrumentsonTheStatementofOperationsTable" roleURI="http://www.vts.com/role/ScheduleofEffectofDerivativeInstrumentsonTheStatementofOperationsTable"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_ScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsTable" roleURI="http://www.vts.com/role/ScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsTable"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_ScheduleofGrossAmountsNotOffsetInTheStatementsofFinancialConditionTable" roleURI="http://www.vts.com/role/ScheduleofGrossAmountsNotOffsetInTheStatementsofFinancialConditionTable"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_ScheduleofTransactionFeesTable" roleURI="http://www.vts.com/role/ScheduleofTransactionFeesTable"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_ScheduleofShareOutstandingTable" roleURI="http://www.vts.com/role/ScheduleofShareOutstandingTable"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_SignificantAccountingPoliciesDetails" roleURI="http://www.vts.com/role/SignificantAccountingPoliciesDetails"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_AgreementsDetails" roleURI="http://www.vts.com/role/AgreementsDetails"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_CreationandRedemptionofCreationUnitsDetails" roleURI="http://www.vts.com/role/CreationandRedemptionofCreationUnitsDetails"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_FinancialHighlightsDetails" roleURI="http://www.vts.com/role/FinancialHighlightsDetails"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#cik0001793497_r_RiskDetails" roleURI="http://www.vts.com/role/RiskDetails"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20230630.xsd#DocumentAndEntityInformation" roleURI="http://www.vts.com/role/DocumentAndEntityInformation"/>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="OneShortVIXFuturesETFMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_OneShortVIXFuturesETFMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="OneShortVIXFuturesETFMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="TwoxLongVIXFuturesETFMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_TwoxLongVIXFuturesETFMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="TwoxLongVIXFuturesETFMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentOwnedAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedAtFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_InvestmentOwnedAtFairValue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestReceivable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_InterestReceivable" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssets" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ReceivableForSharesSold" xlink:href="cik0001793497-20230630.xsd#cik0001793497_ReceivableForSharesSold"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="ReceivableForSharesSold" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommodityContractAssetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommodityContractAssetCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_CommodityContractAssetCurrent" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="VariationMarginReceivable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_VariationMarginReceivable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="VariationMarginReceivable" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OtherReceivablesNetCurrent" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DueFromOther" xlink:href="cik0001793497-20230630.xsd#cik0001793497_DueFromOther"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="DueFromOther" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DueFromOther" xlink:to="us-gaap_Assets" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PayablesAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_PayablesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="PayablesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DueToCustodian" xlink:href="cik0001793497-20230630.xsd#cik0001793497_DueToCustodian"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAbstract" xlink:to="DueToCustodian" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FundSharesRedeemed" xlink:href="cik0001793497-20230630.xsd#cik0001793497_FundSharesRedeemed"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAbstract" xlink:to="FundSharesRedeemed" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNotesPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAbstract" xlink:to="us-gaap_OtherNotesPayable" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AdministrativeAccountingAndCustodianFeesPayable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_AdministrativeAccountingAndCustodianFeesPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAbstract" xlink:to="AdministrativeAccountingAndCustodianFeesPayable" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAbstract" xlink:to="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="LicensingAndRegistrationFeesPayable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_LicensingAndRegistrationFeesPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAbstract" xlink:to="LicensingAndRegistrationFeesPayable" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LicensingAndRegistrationFeesPayable" xlink:to="us-gaap_Liabilities" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsNet" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="NetAssetsConsistOfAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_NetAssetsConsistOfAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="NetAssetsConsistOfAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetAssetsConsistOfAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetAssetsConsistOfAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNet_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_AssetsNet_0" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ClassIUnlimitedSharesAuthorizedAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_ClassIUnlimitedSharesAuthorizedAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ClassIUnlimitedSharesAuthorizedAbstract" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNet_1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassIUnlimitedSharesAuthorizedAbstract" xlink:to="us-gaap_AssetsNet_1" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassIUnlimitedSharesAuthorizedAbstract" xlink:to="us-gaap_SharesOutstanding" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetAssetValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetAssetValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassIUnlimitedSharesAuthorizedAbstract" xlink:to="us-gaap_NetAssetValuePerShare" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesParValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AuctionMarketPreferredSecuritiesStockSeriesParValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassIUnlimitedSharesAuthorizedAbstract" xlink:to="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesParValuePerShare" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherInvestmentsAndSecuritiesAtCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherInvestmentsAndSecuritiesAtCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherInvestmentsAndSecuritiesAtCost" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_StatementTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="OneShortVIXFuturesETFMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_OneShortVIXFuturesETFMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="OneShortVIXFuturesETFMember" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="TwoxLongVIXFuturesETFMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_TwoxLongVIXFuturesETFMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="TwoxLongVIXFuturesETFMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="InvestmentIncomeAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_InvestmentIncomeAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="InvestmentIncomeAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IncomeAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_IncomeAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentIncomeAbstract" xlink:to="IncomeAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestAndOtherIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestAndOtherIncome"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeAbstract" xlink:to="us-gaap_InterestAndOtherIncome" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIncome"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeAbstract" xlink:to="us-gaap_OtherIncome" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherIncome" xlink:to="us-gaap_InvestmentIncomeNet" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ExpensesAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_ExpensesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentIncomeAbstract" xlink:to="ExpensesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ManagementFeeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ManagementFeeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesAbstract" xlink:to="us-gaap_ManagementFeeExpense" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProfessionalFees" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfessionalFees"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesAbstract" xlink:to="us-gaap_ProfessionalFees" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LegalFees" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LegalFees"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesAbstract" xlink:to="us-gaap_LegalFees" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FloorBrokerageExchangeAndClearanceFees" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FloorBrokerageExchangeAndClearanceFees"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesAbstract" xlink:to="us-gaap_FloorBrokerageExchangeAndClearanceFees" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsAndExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FloorBrokerageExchangeAndClearanceFees" xlink:to="us-gaap_CostsAndExpenses" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetInvestmentInLeaseAccruedInterestWriteoff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetInvestmentInLeaseAccruedInterestWriteoff"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetInvestmentInLeaseAccruedInterestWriteoff" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <loc xlink:type="locator" xlink:label="NetRealizedGainLossOnAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_NetRealizedGainLossOnAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="NetRealizedGainLossOnAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ShortTermInvestmentsRealized" xlink:href="cik0001793497-20230630.xsd#cik0001793497_ShortTermInvestmentsRealized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetRealizedGainLossOnAbstract" xlink:to="ShortTermInvestmentsRealized" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="FuturesContracts" xlink:href="cik0001793497-20230630.xsd#cik0001793497_FuturesContracts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetRealizedGainLossOnAbstract" xlink:to="FuturesContracts" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="NetChangeInUnrealizedAppreciationDepreciationOfAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_NetChangeInUnrealizedAppreciationDepreciationOfAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="NetChangeInUnrealizedAppreciationDepreciationOfAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ShortTermInvestmentsUnrealized" xlink:href="cik0001793497-20230630.xsd#cik0001793497_ShortTermInvestmentsUnrealized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetChangeInUnrealizedAppreciationDepreciationOfAbstract" xlink:to="ShortTermInvestmentsUnrealized" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="FuturesContractsUnrealizedAppreciation" xlink:href="cik0001793497-20230630.xsd#cik0001793497_FuturesContractsUnrealizedAppreciation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetChangeInUnrealizedAppreciationDepreciationOfAbstract" xlink:to="FuturesContractsUnrealizedAppreciation" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrealizedGainLossOnDerivatives" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_UnrealizedGainLossOnDerivatives" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="NetIncreasedecreaseInNetAssetsResultingFromOperations" xlink:href="cik0001793497-20230630.xsd#cik0001793497_NetIncreasedecreaseInNetAssetsResultingFromOperations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="NetIncreasedecreaseInNetAssetsResultingFromOperations" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="InvestmentIncomeAbstract0" xlink:href="cik0001793497-20230630.xsd#cik0001793497_InvestmentIncomeAbstract0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="InvestmentIncomeAbstract0" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherInterestAndDividendIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherInterestAndDividendIncome"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentIncomeAbstract0" xlink:to="us-gaap_OtherInterestAndDividendIncome" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ExpensesAbstract0" xlink:href="cik0001793497-20230630.xsd#cik0001793497_ExpensesAbstract0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentIncomeAbstract0" xlink:to="ExpensesAbstract0" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/ConsolidatedIncomeStatement0">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_StatementTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="OneShortVIXFuturesETFMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_OneShortVIXFuturesETFMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="OneShortVIXFuturesETFMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="TwoxLongVIXFuturesETFMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_TwoxLongVIXFuturesETFMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="TwoxLongVIXFuturesETFMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="OperationsAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_OperationsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="OperationsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperationsAbstract" xlink:to="us-gaap_GainLossOnInvestments" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NetRealizedGainlossOnInvestmentsAndFuturesContracts" xlink:href="cik0001793497-20230630.xsd#cik0001793497_NetRealizedGainlossOnInvestmentsAndFuturesContracts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperationsAbstract" xlink:to="NetRealizedGainlossOnInvestmentsAndFuturesContracts" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NetChangeInUnrealizedAppreciationdepreciationOfInvestmentsAndFuturesContracts" xlink:href="cik0001793497-20230630.xsd#cik0001793497_NetChangeInUnrealizedAppreciationdepreciationOfInvestmentsAndFuturesContracts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperationsAbstract" xlink:to="NetChangeInUnrealizedAppreciationdepreciationOfInvestmentsAndFuturesContracts" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NetIncreasedecreaseInNetAssetsResultingFromOperations" xlink:href="cik0001793497-20230630.xsd#cik0001793497_NetIncreasedecreaseInNetAssetsResultingFromOperations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperationsAbstract" xlink:to="NetIncreasedecreaseInNetAssetsResultingFromOperations" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CapitalShareTransactionsAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_CapitalShareTransactionsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="CapitalShareTransactionsAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SharesSoldinShares" xlink:href="cik0001793497-20230630.xsd#cik0001793497_SharesSoldinShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CapitalShareTransactionsAbstract" xlink:to="SharesSoldinShares" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="SharesSoldNetOfSharesRedeemedinDollarsPerShare" xlink:href="cik0001793497-20230630.xsd#cik0001793497_SharesSoldNetOfSharesRedeemedinDollarsPerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CapitalShareTransactionsAbstract" xlink:to="SharesSoldNetOfSharesRedeemedinDollarsPerShare" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="NetIncreaseInNetAssetsFromCapitalShareTransactions" xlink:href="cik0001793497-20230630.xsd#cik0001793497_NetIncreaseInNetAssetsFromCapitalShareTransactions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CapitalShareTransactionsAbstract" xlink:to="NetIncreaseInNetAssetsFromCapitalShareTransactions" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="IncreasedecreaseInNetAssets" xlink:href="cik0001793497-20230630.xsd#cik0001793497_IncreasedecreaseInNetAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="IncreasedecreaseInNetAssets" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="NetAssetsAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_NetAssetsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="NetAssetsAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetAssetsAbstract" xlink:to="us-gaap_AssetsNet" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNet_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetAssetsAbstract" xlink:to="us-gaap_AssetsNet_0" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="OneShortVIXFuturesETFMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_OneShortVIXFuturesETFMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="OneShortVIXFuturesETFMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="TwoxLongVIXFuturesETFMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_TwoxLongVIXFuturesETFMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="TwoxLongVIXFuturesETFMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AdjustmentsToReconcileNetIncomeLossToNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_AdjustmentsToReconcileNetIncomeLossToNetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="AdjustmentsToReconcileNetIncomeLossToNetCashProvidedByUsedInOperatingActivitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PurchasesOfInvestments" xlink:href="cik0001793497-20230630.xsd#cik0001793497_PurchasesOfInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="PurchasesOfInvestments" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ProceedsFromSalesOrMaturitiesOfInvestments" xlink:href="cik0001793497-20230630.xsd#cik0001793497_ProceedsFromSalesOrMaturitiesOfInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="ProceedsFromSalesOrMaturitiesOfInvestments" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInEarnestMoneyDepositsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInEarnestMoneyDepositsOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInEarnestMoneyDepositsOutstanding" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpensesOther" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherReceivables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherReceivables" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="IncreaseDecreaseInVariationMarginPayable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_IncreaseDecreaseInVariationMarginPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="IncreaseDecreaseInVariationMarginPayable" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInReceivables" order="7.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="IncreaseDecreaseInDueToCustodian" xlink:href="cik0001793497-20230630.xsd#cik0001793497_IncreaseDecreaseInDueToCustodian"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="IncreaseDecreaseInDueToCustodian" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInCustomerAdvances" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInCustomerAdvances"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInCustomerAdvances" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IncreaseDecreaseInPayableToSponsor" xlink:href="cik0001793497-20230630.xsd#cik0001793497_IncreaseDecreaseInPayableToSponsor"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="IncreaseDecreaseInPayableToSponsor" order="11.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IncreaseInProfessionalFeesPayable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_IncreaseInProfessionalFeesPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="IncreaseInProfessionalFeesPayable" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IncreaseInLicensingAndRegistrationFeesPayable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_IncreaseInLicensingAndRegistrationFeesPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="IncreaseInLicensingAndRegistrationFeesPayable" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ProceedsFromSaleOfUnits" xlink:href="cik0001793497-20230630.xsd#cik0001793497_ProceedsFromSaleOfUnits"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="ProceedsFromSaleOfUnits" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfInvestmentsUnauditedAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_ScheduleOfInvestmentsUnauditedAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfInvestmentsUnauditedAbstract" xlink:to="us-gaap_StatementTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="FirstAmericanGovernmentObligationsFundMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_FirstAmericanGovernmentObligationsFundMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="FirstAmericanGovernmentObligationsFundMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="OnexShortVIXFuturesETFMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_OnexShortVIXFuturesETFMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="OnexShortVIXFuturesETFMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="TwoxLongVIXFuturesETFMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_TwoxLongVIXFuturesETFMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="TwoxLongVIXFuturesETFMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="CBOEVIXFuturesMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_CBOEVIXFuturesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="CBOEVIXFuturesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="CBOEVIXFuturesOneMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_CBOEVIXFuturesOneMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="CBOEVIXFuturesOneMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherInvestments" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherAssets" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsNet" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NumberOfContracts" xlink:href="cik0001793497-20230630.xsd#cik0001793497_NumberOfContracts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="NumberOfContracts" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentOwnedUnrecognizedUnrealizedAppreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedUnrecognizedUnrealizedAppreciation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InvestmentOwnedUnrecognizedUnrealizedAppreciation" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="UnderlyingFaceAmountAtMarketValues" xlink:href="cik0001793497-20230630.xsd#cik0001793497_UnderlyingFaceAmountAtMarketValues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="UnderlyingFaceAmountAtMarketValues" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MoneyMarketFundsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MoneyMarketFundsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_MoneyMarketFundsAtCarryingValue" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherShortTermInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherShortTermInvestments" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashEquivalentsAtCarryingValue" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable_Parentheticals">
    <loc xlink:type="locator" xlink:label="ScheduleOfInvestmentsUnauditedAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_ScheduleOfInvestmentsUnauditedAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfInvestmentsUnauditedAbstract" xlink:to="us-gaap_StatementTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="FirstAmericanGovernmentObligationsFundMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_FirstAmericanGovernmentObligationsFundMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="FirstAmericanGovernmentObligationsFundMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="OnexShortVIXFuturesETFMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_OnexShortVIXFuturesETFMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="OnexShortVIXFuturesETFMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="TwoxLongVIXFuturesETFMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_TwoxLongVIXFuturesETFMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="TwoxLongVIXFuturesETFMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="OtherAssetsInExcessOfLiabilitiesPercentage" xlink:href="cik0001793497-20230630.xsd#cik0001793497_OtherAssetsInExcessOfLiabilitiesPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="OtherAssetsInExcessOfLiabilitiesPercentage" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeNetAssetsPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeNetAssetsPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DerivativeNetAssetsPercentage" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Cash1" xlink:href="cik0001793497-20230630.xsd#cik0001793497_Cash1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="Cash1" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentInterestRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InvestmentInterestRate" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CashPledgedAsCollateral" xlink:href="cik0001793497-20230630.xsd#cik0001793497_CashPledgedAsCollateral"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="CashPledgedAsCollateral" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/Organization">
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/SignificantAccountingPolicies">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/Investments">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureTextBlockSupplementAbstract"/>
    <loc xlink:type="locator" xlink:label="InvestmentsTable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_InvestmentsTable"/>
    <loc xlink:type="locator" xlink:label="InvestmentsLineItems" xlink:href="cik0001793497-20230630.xsd#cik0001793497_InvestmentsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:to="InvestmentsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsTable" xlink:to="InvestmentsLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsLineItems" xlink:to="us-gaap_InvestmentTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/Agreements">
    <loc xlink:type="locator" xlink:label="AgreementsDisclosureAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_AgreementsDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="AgreementsTable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_AgreementsTable"/>
    <loc xlink:type="locator" xlink:label="AgreementsLineItems" xlink:href="cik0001793497-20230630.xsd#cik0001793497_AgreementsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AgreementsDisclosureAbstract" xlink:to="AgreementsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AgreementsTable" xlink:to="AgreementsLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="AgreementsDisclosureTextBlock" xlink:href="cik0001793497-20230630.xsd#cik0001793497_AgreementsDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AgreementsLineItems" xlink:to="AgreementsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/OfferingCosts">
    <loc xlink:type="locator" xlink:label="OfferingCostsAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_OfferingCostsAbstract"/>
    <loc xlink:type="locator" xlink:label="OfferingCostsTable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_OfferingCostsTable"/>
    <loc xlink:type="locator" xlink:label="OfferingCostsLineItems" xlink:href="cik0001793497-20230630.xsd#cik0001793497_OfferingCostsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OfferingCostsAbstract" xlink:to="OfferingCostsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OfferingCostsTable" xlink:to="OfferingCostsLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="OfferingCostsTextBlock" xlink:href="cik0001793497-20230630.xsd#cik0001793497_OfferingCostsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OfferingCostsLineItems" xlink:to="OfferingCostsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/CreationandRedemptionofCreationUnits">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:label="CreationandRedemptionofCreationUnitsTable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_CreationandRedemptionofCreationUnitsTable"/>
    <loc xlink:type="locator" xlink:label="CreationandRedemptionofCreationUnitsLineItems" xlink:href="cik0001793497-20230630.xsd#cik0001793497_CreationandRedemptionofCreationUnitsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="CreationandRedemptionofCreationUnitsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CreationandRedemptionofCreationUnitsTable" xlink:to="CreationandRedemptionofCreationUnitsLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CreationandRedemptionofCreationUnitsLineItems" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/FinancialHighlights">
    <loc xlink:type="locator" xlink:label="us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="FinancialHighlightsTable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_FinancialHighlightsTable"/>
    <loc xlink:type="locator" xlink:label="FinancialHighlightsLineItems" xlink:href="cik0001793497-20230630.xsd#cik0001793497_FinancialHighlightsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:to="FinancialHighlightsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialHighlightsTable" xlink:to="FinancialHighlightsLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_QuarterlyFinancialInformationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_QuarterlyFinancialInformationTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialHighlightsLineItems" xlink:to="us-gaap_QuarterlyFinancialInformationTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/Risk">
    <loc xlink:type="locator" xlink:label="us-gaap_RisksAndUncertaintiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RisksAndUncertaintiesAbstract"/>
    <loc xlink:type="locator" xlink:label="RiskTable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_RiskTable"/>
    <loc xlink:type="locator" xlink:label="RiskLineItems" xlink:href="cik0001793497-20230630.xsd#cik0001793497_RiskLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RisksAndUncertaintiesAbstract" xlink:to="RiskTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RiskTable" xlink:to="RiskLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RiskLineItems" xlink:to="us-gaap_ConcentrationRiskDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/SubsequentEvents">
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract"/>
    <loc xlink:type="locator" xlink:label="SubsequentEventsTable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_SubsequentEventsTable"/>
    <loc xlink:type="locator" xlink:label="SubsequentEventsLineItems" xlink:href="cik0001793497-20230630.xsd#cik0001793497_SubsequentEventsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="SubsequentEventsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSraoTMKpdMOVUMtRpuB8tV6eMGW/07nN8r724IYYtHu3Fk2iU8V8d5zeroA9ghPrxP68aa5UlyuaOj/7VPlLXQx0GT+xTdf3pIEmLVakfoittQNiZUQ0abAliT/vrVleUY3WZOYnY1Y7WqYa/6c4Wf84KjMb46gvmMAqjc2mzlqwfywSyNCEddBT] CSR-->
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsTable" xlink:to="SubsequentEventsLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsLineItems" xlink:to="us-gaap_SubsequentEventsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/AccountingPoliciesByPolicy">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="EmergingGrowthCompanyPolicyTextBlock" xlink:href="cik0001793497-20230630.xsd#cik0001793497_EmergingGrowthCompanyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="EmergingGrowthCompanyPolicyTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StatementsOfCashFlowsPolicyTextBlock" xlink:href="cik0001793497-20230630.xsd#cik0001793497_StatementsOfCashFlowsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="StatementsOfCashFlowsPolicyTextBlock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FinalNetAssetValueForFiscalPeriodPolcyTextBlock" xlink:href="cik0001793497-20230630.xsd#cik0001793497_FinalNetAssetValueForFiscalPeriodPolcyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="FinalNetAssetValueForFiscalPeriodPolcyTextBlock" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_InvestmentPolicyTextBlock" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnremittedEarningsInForeignInvestmentPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnremittedEarningsInForeignInvestmentPolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UnremittedEarningsInForeignInvestmentPolicy" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FloorBrokeragePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FloorBrokeragePolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FloorBrokeragePolicy" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/SignificantAccountingPoliciesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock" xlink:href="cik0001793497-20230630.xsd#cik0001793497_ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/InvestmentsTables">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureTextBlockSupplementAbstract"/>
    <loc xlink:type="locator" xlink:label="InvestmentsTablesTable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_InvestmentsTablesTable"/>
    <loc xlink:type="locator" xlink:label="InvestmentsTablesLineItems" xlink:href="cik0001793497-20230630.xsd#cik0001793497_InvestmentsTablesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:to="InvestmentsTablesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsTablesTable" xlink:to="InvestmentsTablesLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsTablesLineItems" xlink:to="us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsTablesLineItems" xlink:to="us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsTableTextBlock" xlink:href="cik0001793497-20230630.xsd#cik0001793497_ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsTablesLineItems" xlink:to="ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsTablesLineItems" xlink:to="us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/CreationandRedemptionofCreationUnitsTables">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:label="CreationandRedemptionofCreationUnitsTablesTable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_CreationandRedemptionofCreationUnitsTablesTable"/>
    <loc xlink:type="locator" xlink:label="CreationandRedemptionofCreationUnitsTablesLineItems" xlink:href="cik0001793497-20230630.xsd#cik0001793497_CreationandRedemptionofCreationUnitsTablesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="CreationandRedemptionofCreationUnitsTablesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CreationandRedemptionofCreationUnitsTablesTable" xlink:to="CreationandRedemptionofCreationUnitsTablesLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfTransactionFeesTableTextBlock" xlink:href="cik0001793497-20230630.xsd#cik0001793497_ScheduleOfTransactionFeesTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CreationandRedemptionofCreationUnitsTablesLineItems" xlink:to="ScheduleOfTransactionFeesTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/FinancialHighlightsTables">
    <loc xlink:type="locator" xlink:label="us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="FinancialHighlightsTablesTable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_FinancialHighlightsTablesTable"/>
    <loc xlink:type="locator" xlink:label="FinancialHighlightsTablesLineItems" xlink:href="cik0001793497-20230630.xsd#cik0001793497_FinancialHighlightsTablesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:to="FinancialHighlightsTablesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialHighlightsTablesTable" xlink:to="FinancialHighlightsTablesLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfShareOutstandingTableTextBlock" xlink:href="cik0001793497-20230630.xsd#cik0001793497_ScheduleOfShareOutstandingTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialHighlightsTablesLineItems" xlink:to="ScheduleOfShareOutstandingTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/ScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfCutOffTimesAndTheTimesOfTheCalculationOfTheFundsAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_ScheduleOfCutOffTimesAndTheTimesOfTheCalculationOfTheFundsAbstract"/>
    <loc xlink:type="locator" xlink:label="SignificantAccountingPoliciesDetailsScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsTable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_SignificantAccountingPoliciesDetailsScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsTable"/>
    <loc xlink:type="locator" xlink:label="SignificantAccountingPoliciesDetailsScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsLineItems" xlink:href="cik0001793497-20230630.xsd#cik0001793497_SignificantAccountingPoliciesDetailsScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCutOffTimesAndTheTimesOfTheCalculationOfTheFundsAbstract" xlink:to="SignificantAccountingPoliciesDetailsScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="OneShortVIXFuturesETFMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_OneShortVIXFuturesETFMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="OneShortVIXFuturesETFMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="TwoxLongVIXFuturesETFMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_TwoxLongVIXFuturesETFMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="TwoxLongVIXFuturesETFMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsTable" xlink:to="SignificantAccountingPoliciesDetailsScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="CreateRedeemCutoffDescription" xlink:href="cik0001793497-20230630.xsd#cik0001793497_CreateRedeemCutoffDescription"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsLineItems" xlink:to="CreateRedeemCutoffDescription" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NAVCalculationTimeESTDescription" xlink:href="cik0001793497-20230630.xsd#cik0001793497_NAVCalculationTimeESTDescription"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsLineItems" xlink:to="NAVCalculationTimeESTDescription" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NAVCalculationDate" xlink:href="cik0001793497-20230630.xsd#cik0001793497_NAVCalculationDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsLineItems" xlink:to="NAVCalculationDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/ScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfValuationOfInvestmentsAtUsingTheFairValueHierarchyAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_ScheduleOfValuationOfInvestmentsAtUsingTheFairValueHierarchyAbstract"/>
    <loc xlink:type="locator" xlink:label="SignificantAccountingPoliciesDetailsScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyTable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_SignificantAccountingPoliciesDetailsScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyTable"/>
    <loc xlink:type="locator" xlink:label="SignificantAccountingPoliciesDetailsScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyLineItems" xlink:href="cik0001793497-20230630.xsd#cik0001793497_SignificantAccountingPoliciesDetailsScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfValuationOfInvestmentsAtUsingTheFairValueHierarchyAbstract" xlink:to="SignificantAccountingPoliciesDetailsScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueInputsLevel1Member" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueInputsLevel2Member" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyTable" xlink:to="us-gaap_CashAndCashEquivalentsAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MoneyMarketFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MoneyMarketFundsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_MoneyMarketFundsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FuturesContractsMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_FuturesContractsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="FuturesContractsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="OneShortVIXFuturesETFMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_OneShortVIXFuturesETFMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="OneShortVIXFuturesETFMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="TwoxLongVIXFuturesETFMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_TwoxLongVIXFuturesETFMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="TwoxLongVIXFuturesETFMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyTable" xlink:to="SignificantAccountingPoliciesDetailsScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyLineItems" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="AmountOfTotalTrust" xlink:href="cik0001793497-20230630.xsd#cik0001793497_AmountOfTotalTrust"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyLineItems" xlink:to="AmountOfTotalTrust" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/ScheduleofFairValueofDerivativeInstrumentsTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfFairValueOfDerivativeInstrumentsAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_ScheduleOfFairValueOfDerivativeInstrumentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativesFairValueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFairValueOfDerivativeInstrumentsAbstract" xlink:to="us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="us-gaap_DerivativeInstrumentRiskAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="AssetDerivativesMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_AssetDerivativesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeInstrumentRiskAxis" xlink:to="AssetDerivativesMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="LiabilityDerivativesMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_LiabilityDerivativesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeInstrumentRiskAxis" xlink:to="LiabilityDerivativesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="OnexShortVIXFuturesETFMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_OnexShortVIXFuturesETFMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="OnexShortVIXFuturesETFMember" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="TwoxLongVIXFuturesETFMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_TwoxLongVIXFuturesETFMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="TwoxLongVIXFuturesETFMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FinancingReceivablesPeriodPastDueAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancingReceivablesPeriodPastDueAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="us-gaap_FinancingReceivablesPeriodPastDueAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="StatementsOfFinancialConditionLocationMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_StatementsOfFinancialConditionLocationMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancingReceivablesPeriodPastDueAxis" xlink:to="StatementsOfFinancialConditionLocationMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="UnrealizedAppreciationMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_UnrealizedAppreciationMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancingReceivablesPeriodPastDueAxis" xlink:to="UnrealizedAppreciationMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="UnrealizedDepreciationMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_UnrealizedDepreciationMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancingReceivablesPeriodPastDueAxis" xlink:to="UnrealizedDepreciationMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="us-gaap_DerivativesFairValueLineItems" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="TotalTrust" xlink:href="cik0001793497-20230630.xsd#cik0001793497_TotalTrust"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativesFairValueLineItems" xlink:to="TotalTrust" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TotalTrust1" xlink:href="cik0001793497-20230630.xsd#cik0001793497_TotalTrust1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativesFairValueLineItems" xlink:to="TotalTrust1" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/ScheduleofEffectofDerivativeInstrumentsonTheStatementofOperationsTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfEffectOfDerivativeInstrumentsOnTheStatementOfOperationsAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_ScheduleOfEffectOfDerivativeInstrumentsOnTheStatementOfOperationsAbstract"/>
    <loc xlink:type="locator" xlink:label="InvestmentsDetailsScheduleofEffectofDerivativeInstrumentsonTheStatementofOperationsTable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_InvestmentsDetailsScheduleofEffectofDerivativeInstrumentsonTheStatementofOperationsTable"/>
    <loc xlink:type="locator" xlink:label="InvestmentsDetailsScheduleofEffectofDerivativeInstrumentsonTheStatementofOperationsLineItems" xlink:href="cik0001793497-20230630.xsd#cik0001793497_InvestmentsDetailsScheduleofEffectofDerivativeInstrumentsonTheStatementofOperationsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfEffectOfDerivativeInstrumentsOnTheStatementOfOperationsAbstract" xlink:to="InvestmentsDetailsScheduleofEffectofDerivativeInstrumentsonTheStatementofOperationsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsDetailsScheduleofEffectofDerivativeInstrumentsonTheStatementofOperationsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="OnexShortVIXFuturesETFMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_OnexShortVIXFuturesETFMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="OnexShortVIXFuturesETFMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="TwoxLongVIXFuturesETFMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_TwoxLongVIXFuturesETFMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="TwoxLongVIXFuturesETFMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsDetailsScheduleofEffectofDerivativeInstrumentsonTheStatementofOperationsTable" xlink:to="InvestmentsDetailsScheduleofEffectofDerivativeInstrumentsonTheStatementofOperationsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="VixFuturesContractsNetRealizedGainLossOnFuturesContractsChangesInUnrealizedAppreciationDepreciationOnFuturesContractsAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_VixFuturesContractsNetRealizedGainLossOnFuturesContractsChangesInUnrealizedAppreciationDepreciationOnFuturesContractsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsDetailsScheduleofEffectofDerivativeInstrumentsonTheStatementofOperationsLineItems" xlink:to="VixFuturesContractsNetRealizedGainLossOnFuturesContractsChangesInUnrealizedAppreciationDepreciationOnFuturesContractsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RealizedGainLossOnDerivativesRecognizedInIncome" xlink:href="cik0001793497-20230630.xsd#cik0001793497_RealizedGainLossOnDerivativesRecognizedInIncome"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="VixFuturesContractsNetRealizedGainLossOnFuturesContractsChangesInUnrealizedAppreciationDepreciationOnFuturesContractsAbstract" xlink:to="RealizedGainLossOnDerivativesRecognizedInIncome" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ChangeInUnrealizedAppreciationDepreciationsOnDerivativesRecognizedInIncome" xlink:href="cik0001793497-20230630.xsd#cik0001793497_ChangeInUnrealizedAppreciationDepreciationsOnDerivativesRecognizedInIncome"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="VixFuturesContractsNetRealizedGainLossOnFuturesContractsChangesInUnrealizedAppreciationDepreciationOnFuturesContractsAbstract" xlink:to="ChangeInUnrealizedAppreciationDepreciationsOnDerivativesRecognizedInIncome" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/ScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsAbstract"/>
    <loc xlink:type="locator" xlink:label="InvestmentsDetailsScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsTable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_InvestmentsDetailsScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsTable"/>
    <loc xlink:type="locator" xlink:label="InvestmentsDetailsScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsLineItems" xlink:href="cik0001793497-20230630.xsd#cik0001793497_InvestmentsDetailsScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsAbstract" xlink:to="InvestmentsDetailsScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsDetailsScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="OnexShortVIXFuturesETFMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_OnexShortVIXFuturesETFMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="OnexShortVIXFuturesETFMember" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="TwoxLongVIXFuturesETFMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_TwoxLongVIXFuturesETFMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="TwoxLongVIXFuturesETFMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsDetailsScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsTable" xlink:to="us-gaap_BalanceSheetLocationAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_OtherAssetsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_OtherLiabilitiesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsDetailsScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsTable" xlink:to="InvestmentsDetailsScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition" xlink:href="cik0001793497-20230630.xsd#cik0001793497_GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsDetailsScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsLineItems" xlink:to="GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="GrossAmountsOffsetInTheStatementsOfFinancialCondition" xlink:href="cik0001793497-20230630.xsd#cik0001793497_GrossAmountsOffsetInTheStatementsOfFinancialCondition"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsDetailsScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsLineItems" xlink:to="GrossAmountsOffsetInTheStatementsOfFinancialCondition" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition" xlink:href="cik0001793497-20230630.xsd#cik0001793497_NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsDetailsScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsLineItems" xlink:to="NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="GrossAmountsOfRecognizedLiabilitiesPresentedInTheStatementsOfFinancialCondition" xlink:href="cik0001793497-20230630.xsd#cik0001793497_GrossAmountsOfRecognizedLiabilitiesPresentedInTheStatementsOfFinancialCondition"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsDetailsScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsLineItems" xlink:to="GrossAmountsOfRecognizedLiabilitiesPresentedInTheStatementsOfFinancialCondition" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="GrossAmountsOffsetInTheStatementsOfFinancialCondition1" xlink:href="cik0001793497-20230630.xsd#cik0001793497_GrossAmountsOffsetInTheStatementsOfFinancialCondition1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsDetailsScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsLineItems" xlink:to="GrossAmountsOffsetInTheStatementsOfFinancialCondition1" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NetAmountsOfLiabilitiesPresentedInTheStatementsOfFinancialCondition" xlink:href="cik0001793497-20230630.xsd#cik0001793497_NetAmountsOfLiabilitiesPresentedInTheStatementsOfFinancialCondition"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsDetailsScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsLineItems" xlink:to="NetAmountsOfLiabilitiesPresentedInTheStatementsOfFinancialCondition" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/ScheduleofGrossAmountsNotOffsetInTheStatementsofFinancialConditionTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfGrossAmountsNotOffsetInTheStatementsOfFinancialConditionAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_ScheduleOfGrossAmountsNotOffsetInTheStatementsOfFinancialConditionAbstract"/>
    <loc xlink:type="locator" xlink:label="InvestmentsDetailsScheduleofGrossAmountsNotOffsetInTheStatementsofFinancialConditionTable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_InvestmentsDetailsScheduleofGrossAmountsNotOffsetInTheStatementsofFinancialConditionTable"/>
    <loc xlink:type="locator" xlink:label="InvestmentsDetailsScheduleofGrossAmountsNotOffsetInTheStatementsofFinancialConditionLineItems" xlink:href="cik0001793497-20230630.xsd#cik0001793497_InvestmentsDetailsScheduleofGrossAmountsNotOffsetInTheStatementsofFinancialConditionLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfGrossAmountsNotOffsetInTheStatementsOfFinancialConditionAbstract" xlink:to="InvestmentsDetailsScheduleofGrossAmountsNotOffsetInTheStatementsofFinancialConditionTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsDetailsScheduleofGrossAmountsNotOffsetInTheStatementsofFinancialConditionTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="OneShortVIXFuturesETFMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_OneShortVIXFuturesETFMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="OneShortVIXFuturesETFMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="TwoxLongVIXFuturesETFMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_TwoxLongVIXFuturesETFMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="TwoxLongVIXFuturesETFMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsDetailsScheduleofGrossAmountsNotOffsetInTheStatementsofFinancialConditionTable" xlink:to="InvestmentsDetailsScheduleofGrossAmountsNotOffsetInTheStatementsofFinancialConditionLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne" xlink:href="cik0001793497-20230630.xsd#cik0001793497_AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsDetailsScheduleofGrossAmountsNotOffsetInTheStatementsofFinancialConditionLineItems" xlink:to="AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FinancialInstrumentsForTheBenefitOftheFundsTheCounterpartiesTwo" xlink:href="cik0001793497-20230630.xsd#cik0001793497_FinancialInstrumentsForTheBenefitOftheFundsTheCounterpartiesTwo"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsDetailsScheduleofGrossAmountsNotOffsetInTheStatementsofFinancialConditionLineItems" xlink:to="FinancialInstrumentsForTheBenefitOftheFundsTheCounterpartiesTwo" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CashCollateralForTheBenefitOftheFundsTheCounterparties" xlink:href="cik0001793497-20230630.xsd#cik0001793497_CashCollateralForTheBenefitOftheFundsTheCounterparties"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsDetailsScheduleofGrossAmountsNotOffsetInTheStatementsofFinancialConditionLineItems" xlink:to="CashCollateralForTheBenefitOftheFundsTheCounterparties" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CapitalUnitNetAmount" xlink:href="cik0001793497-20230630.xsd#cik0001793497_CapitalUnitNetAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsDetailsScheduleofGrossAmountsNotOffsetInTheStatementsofFinancialConditionLineItems" xlink:to="CapitalUnitNetAmount" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/ScheduleofTransactionFeesTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfTransactionFeesAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_ScheduleOfTransactionFeesAbstract"/>
    <loc xlink:type="locator" xlink:label="CreationandRedemptionofCreationUnitsDetailsScheduleofTransactionFeesTable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_CreationandRedemptionofCreationUnitsDetailsScheduleofTransactionFeesTable"/>
    <loc xlink:type="locator" xlink:label="CreationandRedemptionofCreationUnitsDetailsScheduleofTransactionFeesLineItems" xlink:href="cik0001793497-20230630.xsd#cik0001793497_CreationandRedemptionofCreationUnitsDetailsScheduleofTransactionFeesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTransactionFeesAbstract" xlink:to="CreationandRedemptionofCreationUnitsDetailsScheduleofTransactionFeesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CreationandRedemptionofCreationUnitsDetailsScheduleofTransactionFeesTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="OnexShortVIXFuturesETFMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_OnexShortVIXFuturesETFMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="OnexShortVIXFuturesETFMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="TwoxLongVIXFuturesETFMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_TwoxLongVIXFuturesETFMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="TwoxLongVIXFuturesETFMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CreationandRedemptionofCreationUnitsDetailsScheduleofTransactionFeesTable" xlink:to="CreationandRedemptionofCreationUnitsDetailsScheduleofTransactionFeesLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfTrustAssetsToPayExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfTrustAssetsToPayExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CreationandRedemptionofCreationUnitsDetailsScheduleofTransactionFeesLineItems" xlink:to="us-gaap_SaleOfTrustAssetsToPayExpenses" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/ScheduleofShareOutstandingTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfShareOutstandingAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_ScheduleOfShareOutstandingAbstract"/>
    <loc xlink:type="locator" xlink:label="FinancialHighlightsDetailsScheduleofShareOutstandingTable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_FinancialHighlightsDetailsScheduleofShareOutstandingTable"/>
    <loc xlink:type="locator" xlink:label="FinancialHighlightsDetailsScheduleofShareOutstandingLineItems" xlink:href="cik0001793497-20230630.xsd#cik0001793497_FinancialHighlightsDetailsScheduleofShareOutstandingLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareOutstandingAbstract" xlink:to="FinancialHighlightsDetailsScheduleofShareOutstandingTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialHighlightsDetailsScheduleofShareOutstandingTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="OnexShortVIXFuturesETFMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_OnexShortVIXFuturesETFMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="OnexShortVIXFuturesETFMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="TwoxLongVIXFuturesETFMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_TwoxLongVIXFuturesETFMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="TwoxLongVIXFuturesETFMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialHighlightsDetailsScheduleofShareOutstandingTable" xlink:to="FinancialHighlightsDetailsScheduleofShareOutstandingLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentCompanyMarketValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyMarketValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialHighlightsDetailsScheduleofShareOutstandingLineItems" xlink:to="us-gaap_InvestmentCompanyMarketValuePerShare" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentCompanyGainLossOnInvestmentPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyGainLossOnInvestmentPerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialHighlightsDetailsScheduleofShareOutstandingLineItems" xlink:to="us-gaap_InvestmentCompanyGainLossOnInvestmentPerShare" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts" xlink:href="cik0001793497-20230630.xsd#cik0001793497_NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialHighlightsDetailsScheduleofShareOutstandingLineItems" xlink:to="NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialHighlightsDetailsScheduleofShareOutstandingLineItems" xlink:to="us-gaap_InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentCompanyMarketValuePerShare_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyMarketValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialHighlightsDetailsScheduleofShareOutstandingLineItems" xlink:to="us-gaap_InvestmentCompanyMarketValuePerShare_0" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="MarketValuePerShare" xlink:href="cik0001793497-20230630.xsd#cik0001793497_MarketValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialHighlightsDetailsScheduleofShareOutstandingLineItems" xlink:to="MarketValuePerShare" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentCompanyTotalReturn" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyTotalReturn"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialHighlightsDetailsScheduleofShareOutstandingLineItems" xlink:to="us-gaap_InvestmentCompanyTotalReturn" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TotalReturnAtMarketValue" xlink:href="cik0001793497-20230630.xsd#cik0001793497_TotalReturnAtMarketValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialHighlightsDetailsScheduleofShareOutstandingLineItems" xlink:to="TotalReturnAtMarketValue" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RatiosToAverageNetAssets5Abstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_RatiosToAverageNetAssets5Abstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialHighlightsDetailsScheduleofShareOutstandingLineItems" xlink:to="RatiosToAverageNetAssets5Abstract" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentCompanyExpenseRatioAfterIncentiveAllocation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyExpenseRatioAfterIncentiveAllocation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RatiosToAverageNetAssets5Abstract" xlink:to="us-gaap_InvestmentCompanyExpenseRatioAfterIncentiveAllocation" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentCompanyTotalReturnAfterIncentiveFees" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyTotalReturnAfterIncentiveFees"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RatiosToAverageNetAssets5Abstract" xlink:to="us-gaap_InvestmentCompanyTotalReturnAfterIncentiveFees" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/SignificantAccountingPoliciesDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="SignificantAccountingPoliciesDetailsTable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_SignificantAccountingPoliciesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="SignificantAccountingPoliciesDetailsLineItems" xlink:href="cik0001793497-20230630.xsd#cik0001793497_SignificantAccountingPoliciesDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="SignificantAccountingPoliciesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetirementPlanFundingStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanFundingStatusAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsTable" xlink:to="us-gaap_RetirementPlanFundingStatusAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetirementPlanFundingStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanFundingStatusDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RetirementPlanFundingStatusAxis" xlink:to="us-gaap_RetirementPlanFundingStatusDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="SVIXMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_SVIXMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RetirementPlanFundingStatusAxis" xlink:to="SVIXMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="UVIXMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_UVIXMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RetirementPlanFundingStatusAxis" xlink:to="UVIXMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsTable" xlink:to="SignificantAccountingPoliciesDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="GrossRevenue" xlink:href="cik0001793497-20230630.xsd#cik0001793497_GrossRevenue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsLineItems" xlink:to="GrossRevenue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NonconvertibleDebtSecurities" xlink:href="cik0001793497-20230630.xsd#cik0001793497_NonconvertibleDebtSecurities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsLineItems" xlink:to="NonconvertibleDebtSecurities" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NonaffiliatesExceeded" xlink:href="cik0001793497-20230630.xsd#cik0001793497_NonaffiliatesExceeded"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsLineItems" xlink:to="NonaffiliatesExceeded" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeNetAssetsPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeNetAssetsPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_DerivativeNetAssetsPercentage" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/AgreementsDetails">
    <loc xlink:type="locator" xlink:label="AgreementsDisclosureAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_AgreementsDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="AgreementsDetailsTable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_AgreementsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="AgreementsDetailsLineItems" xlink:href="cik0001793497-20230630.xsd#cik0001793497_AgreementsDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AgreementsDisclosureAbstract" xlink:to="AgreementsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AgreementsDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="SVIXMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_SVIXMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="SVIXMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="UVIXMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_UVIXMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="UVIXMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AgreementsDetailsTable" xlink:to="AgreementsDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="AverageDailyNetAssetsRate" xlink:href="cik0001793497-20230630.xsd#cik0001793497_AverageDailyNetAssetsRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AgreementsDetailsLineItems" xlink:to="AverageDailyNetAssetsRate" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SubadvisoryFeeRate" xlink:href="cik0001793497-20230630.xsd#cik0001793497_SubadvisoryFeeRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AgreementsDetailsLineItems" xlink:to="SubadvisoryFeeRate" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/CreationandRedemptionofCreationUnitsDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_SharesIssued" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AuthorizedParticipantsPercentage" xlink:href="cik0001793497-20230630.xsd#cik0001793497_AuthorizedParticipantsPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="AuthorizedParticipantsPercentage" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/FinancialHighlightsDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="FinancialHighlightsDetailsTable" xlink:href="cik0001793497-20230630.xsd#cik0001793497_FinancialHighlightsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="FinancialHighlightsDetailsLineItems" xlink:href="cik0001793497-20230630.xsd#cik0001793497_FinancialHighlightsDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:to="FinancialHighlightsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialHighlightsDetailsTable" xlink:to="srt_RangeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MaximumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MinimumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialHighlightsDetailsTable" xlink:to="FinancialHighlightsDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpenseRatio" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpenseRatio"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialHighlightsDetailsLineItems" xlink:to="us-gaap_GeneralAndAdministrativeExpenseRatio" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="BrokerageCommissionsRate" xlink:href="cik0001793497-20230630.xsd#cik0001793497_BrokerageCommissionsRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialHighlightsDetailsLineItems" xlink:to="BrokerageCommissionsRate" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/RiskDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_RisksAndUncertaintiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RisksAndUncertaintiesAbstract"/>
    <loc xlink:type="locator" xlink:label="RelevantBenchmark" xlink:href="cik0001793497-20230630.xsd#cik0001793497_RelevantBenchmark"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RisksAndUncertaintiesAbstract" xlink:to="RelevantBenchmark" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:label="DocumentAndEntityInformationAbstract" xlink:href="cik0001793497-20230630.xsd#cik0001793497_DocumentAndEntityInformationAbstract"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentInformationTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="OnexShortVIXFuturesETFMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_OnexShortVIXFuturesETFMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="OnexShortVIXFuturesETFMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TwoxLongVIXFuturesETFMember" xlink:href="cik0001793497-20230630.xsd#cik0001793497_TwoxLongVIXFuturesETFMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="TwoxLongVIXFuturesETFMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntitySmallBusiness" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityShellCompany" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityExTransitionPeriod" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentQuarterlyReport" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentTransitionReport" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine2" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" order="28.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" order="29.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityInteractiveDataCurrent" order="30.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140493289047824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2023 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information Line Items</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">VS Trust<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="nump">21,800,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001793497<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-34200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">84-6704517<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2000 PGA Boulevard<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 4440<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Palm Beach Gardens<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">FL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">33408<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(866)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">261-0273<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=cik0001793497_OnexShortVIXFuturesETFMember', window );">-1x Short VIX Futures ETF</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information Line Items</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SVIX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">-1x Short VIX Futures ETF<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">CboeBZX<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=cik0001793497_TwoxLongVIXFuturesETFMember', window );">2x Long VIX Futures ETF</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information Line Items</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">UVIX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">2x Long VIX Futures ETF<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">CboeBZX<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=cik0001793497_OnexShortVIXFuturesETFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=cik0001793497_OnexShortVIXFuturesETFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=cik0001793497_TwoxLongVIXFuturesETFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=cik0001793497_TwoxLongVIXFuturesETFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140493285812928">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Statements of Assets and Liabilities (Unaudited) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cik0001793497_OneShortVIXFuturesETFMember', window );">-1x Short VIX Futures ETF</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 504,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Investments in securities, at value</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestReceivable', window );">Interest receivable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">13,203<span></span>
</td>
<td class="nump">12,909<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">34,380<span></span>
</td>
<td class="nump">10,295<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_ReceivableForSharesSold', window );">Receivable for shares sold</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,609,654<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommodityContractAssetCurrent', window );">Deposit at Broker for Futures</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">68,703,813<span></span>
</td>
<td class="nump">48,144,554<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_VariationMarginReceivable', window );">Variation margin receivable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,242,108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">253<span></span>
</td>
<td class="nump">571<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_DueFromOther', window );">Due from Other</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">73,603,411<span></span>
</td>
<td class="nump">48,672,929<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_PayablesAbstract', window );"><strong>Payables</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Variation margin payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">187,030<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_DueToCustodian', window );">Due to Custodian</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,023,713<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_FundSharesRedeemed', window );">Fund shares redeemed</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,903,018<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNotesPayable', window );">Payable to Sponsor</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">70,620<span></span>
</td>
<td class="nump">54,374<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_AdministrativeAccountingAndCustodianFeesPayable', window );">Administrative, accounting and custodian fees payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">14,706<span></span>
</td>
<td class="nump">15,869<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent', window );">Professional fees payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">169,032<span></span>
</td>
<td class="nump">125,274<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_LicensingAndRegistrationFeesPayable', window );">Licensing and registration fees payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">22,927<span></span>
</td>
<td class="nump">8,761<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,300,998<span></span>
</td>
<td class="nump">2,294,326<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNet', window );">NET ASSETS</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">72,302,413<span></span>
</td>
<td class="nump">46,378,603<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_NetAssetsConsistOfAbstract', window );"><strong>NET ASSETS CONSIST OF:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Paid-in capital</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8,033,985<span></span>
</td>
<td class="nump">29,386,125<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Total distributable earnings (accumulated deficit)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">64,268,428<span></span>
</td>
<td class="nump">16,992,478<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNet', window );">Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">72,302,413<span></span>
</td>
<td class="nump">46,378,603<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_ClassIUnlimitedSharesAuthorizedAbstract', window );"><strong>Class I (unlimited shares authorized):</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNet', window );">Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 72,302,413<span></span>
</td>
<td class="nump">$ 46,378,603<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares Outstanding (in Shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">2,570,000<span></span>
</td>
<td class="nump">3,170,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetAssetValuePerShare', window );">Net Asset Value, Offering and Redemption Price per Share (in Dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 28.13<span></span>
</td>
<td class="nump">$ 14.63<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesParValuePerShare', window );">Market Value per Share (Note 2) (in Dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 28.07<span></span>
</td>
<td class="nump">$ 14.66<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherInvestmentsAndSecuritiesAtCost', window );">Investments in securities, at cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember', window );">2x Long VIX Futures ETF</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Investments in securities, at value</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">9,517,548<span></span>
</td>
<td class="nump">8,250,285<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestReceivable', window );">Interest receivable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">65,352<span></span>
</td>
<td class="nump">50,483<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">25,767<span></span>
</td>
<td class="nump">15,666<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_ReceivableForSharesSold', window );">Receivable for shares sold</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,014,706<span></span>
</td>
<td class="nump">1,931,028<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommodityContractAssetCurrent', window );">Deposit at Broker for Futures</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">83,302,779<span></span>
</td>
<td class="nump">114,821,272<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_VariationMarginReceivable', window );">Variation margin receivable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">830,840<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">560<span></span>
</td>
<td class="nump">579<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_DueFromOther', window );">Due from Other</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">93,926,712<span></span>
</td>
<td class="nump">125,900,153<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_PayablesAbstract', window );"><strong>Payables</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Variation margin payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,406,049<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_DueToCustodian', window );">Due to Custodian</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,874,781<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_FundSharesRedeemed', window );">Fund shares redeemed</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,865,052<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNotesPayable', window );">Payable to Sponsor</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">138,850<span></span>
</td>
<td class="nump">176,838<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_AdministrativeAccountingAndCustodianFeesPayable', window );">Administrative, accounting and custodian fees payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">18,097<span></span>
</td>
<td class="nump">19,957<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent', window );">Professional fees payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">246,032<span></span>
</td>
<td class="nump">203,411<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_LicensingAndRegistrationFeesPayable', window );">Licensing and registration fees payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">39,049<span></span>
</td>
<td class="nump">11,181<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8,587,910<span></span>
</td>
<td class="nump">411,387<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNet', window );">NET ASSETS</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">85,338,802<span></span>
</td>
<td class="nump">125,488,766<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_NetAssetsConsistOfAbstract', window );"><strong>NET ASSETS CONSIST OF:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Paid-in capital</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">360,476,596<span></span>
</td>
<td class="nump">203,182,472<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Total distributable earnings (accumulated deficit)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(275,137,794)<span></span>
</td>
<td class="num">(77,693,706)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNet', window );">Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">85,338,802<span></span>
</td>
<td class="nump">125,488,766<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_ClassIUnlimitedSharesAuthorizedAbstract', window );"><strong>Class I (unlimited shares authorized):</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNet', window );">Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 85,338,802<span></span>
</td>
<td class="nump">$ 125,488,766<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares Outstanding (in Shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">19,230,000<span></span>
</td>
<td class="nump">21,450,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetAssetValuePerShare', window );">Net Asset Value, Offering and Redemption Price per Share (in Dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 4.44<span></span>
</td>
<td class="nump">$ 5.85<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesParValuePerShare', window );">Market Value per Share (Note 2) (in Dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 4.46<span></span>
</td>
<td class="nump">$ 5.82<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherInvestmentsAndSecuritiesAtCost', window );">Investments in securities, at cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 9,517,548<span></span>
</td>
<td class="nump">$ 8,250,285<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Investments in securities, at cost</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">No Par Value</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_AdministrativeAccountingAndCustodianFeesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligations incurred classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_AdministrativeAccountingAndCustodianFeesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_ClassIUnlimitedSharesAuthorizedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_ClassIUnlimitedSharesAuthorizedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_DueFromOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of due from others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_DueFromOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_DueToCustodian">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount payable to related parties classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_DueToCustodian</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_FundSharesRedeemed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tha amount of Fund shares redeemed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_FundSharesRedeemed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_LicensingAndRegistrationFeesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of licensing and registration fees payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_LicensingAndRegistrationFeesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_NetAssetsConsistOfAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_NetAssetsConsistOfAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_PayablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_PayablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_ReceivableForSharesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>It represent receivable for shares sold.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_ReceivableForSharesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_VariationMarginReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of variation margin receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_VariationMarginReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of net assets (liabilities).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 30<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479910/205-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesParValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The par value of the auction market preferred security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AuctionMarketPreferredSecuritiesStockSeriesParValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommodityContractAssetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the asset arising from commodity contracts such as futures contracts tied to the movement of a particular commodity, which are expected to be converted into cash or otherwise disposed of within a year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommodityContractAssetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of interest earned but not received. Also called accrued interest or accrued interest receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480833/946-310-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentOwnedAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in security owned.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480493/946-210-55-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(2)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentOwnedAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetAssetValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net asset value per share or per unit of investments in certain entities that calculate net asset value per share. Includes, but is not limited to, by unit, membership interest, or other ownership interest. Investment includes, but is not limited to, investment in certain hedge funds, venture capital funds, private equity funds, real estate partnerships or funds. Excludes fair value disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 54B<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482134/820-10-35-54B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 59<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482134/820-10-35-59<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-6A<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480555/946-210-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480737/946-205-50-7<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480737/946-205-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetAssetValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherInvestmentsAndSecuritiesAtCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Includes other investments and securities that are not at fair value as of the balance sheet date and those that are not accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherInvestmentsAndSecuritiesAtCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term notes payable classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=cik0001793497_OneShortVIXFuturesETFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=cik0001793497_OneShortVIXFuturesETFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140493285212480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Statements of Operations (Unaudited) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cik0001793497_OneShortVIXFuturesETFMember', window );">1x Short VIX Futures ETF</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_IncomeAbstract', window );"><strong>Income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestAndOtherIncome', window );">Interest income</a></td>
<td class="nump">$ 74,800<span></span>
</td>
<td class="nump">$ 18,977<span></span>
</td>
<td class="nump">$ 121,531<span></span>
</td>
<td class="nump">$ 18,984<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other Income</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Total Income</a></td>
<td class="nump">74,800<span></span>
</td>
<td class="nump">19,037<span></span>
</td>
<td class="nump">121,531<span></span>
</td>
<td class="nump">19,045<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_ExpensesAbstract', window );"><strong>Expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ManagementFeeExpense', window );">Management fees</a></td>
<td class="nump">225,408<span></span>
</td>
<td class="nump">163,452<span></span>
</td>
<td class="nump">394,913<span></span>
</td>
<td class="nump">163,562<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">Administrative, accounting and custodian fees</a></td>
<td class="nump">24,727<span></span>
</td>
<td class="nump">23,357<span></span>
</td>
<td class="nump">46,808<span></span>
</td>
<td class="nump">23,901<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfessionalFees', window );">Professional fees</a></td>
<td class="nump">80,185<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="nump">159,092<span></span>
</td>
<td class="nump">15,759<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LegalFees', window );">Licensing and registration fees</a></td>
<td class="nump">31,769<span></span>
</td>
<td class="nump">40,055<span></span>
</td>
<td class="nump">50,134<span></span>
</td>
<td class="nump">40,395<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FloorBrokerageExchangeAndClearanceFees', window );">Broker interest expense</a></td>
<td class="nump">5,462<span></span>
</td>
<td class="nump">19,953<span></span>
</td>
<td class="nump">8,613<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total Expenses</a></td>
<td class="nump">367,551<span></span>
</td>
<td class="nump">261,816<span></span>
</td>
<td class="nump">659,560<span></span>
</td>
<td class="nump">263,617<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetInvestmentInLeaseAccruedInterestWriteoff', window );">Net Investment loss</a></td>
<td class="num">(292,751)<span></span>
</td>
<td class="num">(242,779)<span></span>
</td>
<td class="num">(538,029)<span></span>
</td>
<td class="num">(244,572)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_NetRealizedGainLossOnAbstract', window );"><strong>Net realized gain (loss) on:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_ShortTermInvestmentsRealized', window );">Short Term Investments</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_FuturesContracts', window );">Futures</a></td>
<td class="nump">37,164,451<span></span>
</td>
<td class="num">(4,573,051)<span></span>
</td>
<td class="nump">42,451,505<span></span>
</td>
<td class="num">(4,577,129)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_NetChangeInUnrealizedAppreciationDepreciationOfAbstract', window );"><strong>Net change in unrealized appreciation (depreciation) of:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_ShortTermInvestmentsUnrealized', window );">Short Term Investments</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_FuturesContractsUnrealizedAppreciation', window );">Futures</a></td>
<td class="num">(811,301)<span></span>
</td>
<td class="nump">835,808<span></span>
</td>
<td class="nump">5,362,473<span></span>
</td>
<td class="nump">700,531<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnDerivatives', window );">Net realized and unrealized gain (loss) on investments and futures contracts</a></td>
<td class="nump">36,353,150<span></span>
</td>
<td class="num">(3,737,244)<span></span>
</td>
<td class="nump">47,813,978<span></span>
</td>
<td class="num">(3,876,598)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_NetIncreasedecreaseInNetAssetsResultingFromOperations', window );">NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS</a></td>
<td class="nump">36,060,399<span></span>
</td>
<td class="num">(3,980,023)<span></span>
</td>
<td class="nump">47,275,949<span></span>
</td>
<td class="num">(4,121,170)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_InvestmentIncomeAbstract0', window );"><strong>INVESTMENT INCOME</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherInterestAndDividendIncome', window );">Dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember', window );">2x Long VIX Futures ETF</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_IncomeAbstract', window );"><strong>Income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestAndOtherIncome', window );">Interest income</a></td>
<td class="nump">301,835<span></span>
</td>
<td class="nump">16,778<span></span>
</td>
<td class="nump">434,271<span></span>
</td>
<td class="nump">16,782<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other Income</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">153<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">153<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Total Income</a></td>
<td class="nump">301,835<span></span>
</td>
<td class="nump">16,931<span></span>
</td>
<td class="nump">434,271<span></span>
</td>
<td class="nump">16,935<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_ExpensesAbstract', window );"><strong>Expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ManagementFeeExpense', window );">Management fees</a></td>
<td class="nump">521,809<span></span>
</td>
<td class="nump">111,085<span></span>
</td>
<td class="nump">919,658<span></span>
</td>
<td class="nump">111,223<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">Administrative, accounting and custodian fees</a></td>
<td class="nump">33,684<span></span>
</td>
<td class="nump">23,323<span></span>
</td>
<td class="nump">62,699<span></span>
</td>
<td class="nump">23,867<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfessionalFees', window );">Professional fees</a></td>
<td class="nump">81,279<span></span>
</td>
<td class="nump">14,963<span></span>
</td>
<td class="nump">160,949<span></span>
</td>
<td class="nump">15,722<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LegalFees', window );">Licensing and registration fees</a></td>
<td class="nump">24,392<span></span>
</td>
<td class="nump">40,027<span></span>
</td>
<td class="nump">44,821<span></span>
</td>
<td class="nump">40,367<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FloorBrokerageExchangeAndClearanceFees', window );">Broker interest expense</a></td>
<td class="nump">40<span></span>
</td>
<td class="nump">8,143<span></span>
</td>
<td class="nump">320<span></span>
</td>
<td class="nump">8,143<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total Expenses</a></td>
<td class="nump">661,204<span></span>
</td>
<td class="nump">197,542<span></span>
</td>
<td class="nump">1,188,447<span></span>
</td>
<td class="nump">199,322<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetInvestmentInLeaseAccruedInterestWriteoff', window );">Net Investment loss</a></td>
<td class="num">(359,369)<span></span>
</td>
<td class="num">(180,611)<span></span>
</td>
<td class="num">(754,176)<span></span>
</td>
<td class="num">(182,387)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_NetRealizedGainLossOnAbstract', window );"><strong>Net realized gain (loss) on:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_ShortTermInvestmentsRealized', window );">Short Term Investments</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_FuturesContracts', window );">Futures</a></td>
<td class="num">(142,872,642)<span></span>
</td>
<td class="nump">7,528,449<span></span>
</td>
<td class="num">(186,102,397)<span></span>
</td>
<td class="nump">7,527,995<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_NetChangeInUnrealizedAppreciationDepreciationOfAbstract', window );"><strong>Net change in unrealized appreciation (depreciation) of:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_ShortTermInvestmentsUnrealized', window );">Short Term Investments</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_FuturesContractsUnrealizedAppreciation', window );">Futures</a></td>
<td class="num">(4,374,661)<span></span>
</td>
<td class="num">(256,944)<span></span>
</td>
<td class="num">(10,587,514)<span></span>
</td>
<td class="nump">19,258<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnDerivatives', window );">Net realized and unrealized gain (loss) on investments and futures contracts</a></td>
<td class="num">(147,247,303)<span></span>
</td>
<td class="nump">7,271,505<span></span>
</td>
<td class="num">(196,689,911)<span></span>
</td>
<td class="nump">7,547,253<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_NetIncreasedecreaseInNetAssetsResultingFromOperations', window );">NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS</a></td>
<td class="num">$ (147,606,672)<span></span>
</td>
<td class="nump">$ 7,090,894<span></span>
</td>
<td class="num">(197,444,087)<span></span>
</td>
<td class="nump">7,364,866<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_InvestmentIncomeAbstract0', window );"><strong>INVESTMENT INCOME</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherInterestAndDividendIncome', window );">Dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_ExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_ExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_FuturesContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of futures contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_FuturesContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_FuturesContractsUnrealizedAppreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of futures contracts unrealized appreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_FuturesContractsUnrealizedAppreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_IncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_IncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_InvestmentIncomeAbstract0">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_InvestmentIncomeAbstract0</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_NetChangeInUnrealizedAppreciationDepreciationOfAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_NetChangeInUnrealizedAppreciationDepreciationOfAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_NetIncreasedecreaseInNetAssetsResultingFromOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in net assets from operations of investment company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_NetIncreasedecreaseInNetAssetsResultingFromOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_NetRealizedGainLossOnAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_NetRealizedGainLossOnAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_ShortTermInvestmentsRealized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_ShortTermInvestmentsRealized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_ShortTermInvestmentsUnrealized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_ShortTermInvestmentsUnrealized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FloorBrokerageExchangeAndClearanceFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense during the period for floor brokerage fees paid to other broker-dealers to execute trades on their behalf, stock exchange fees, order flow fees, and clearance fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FloorBrokerageExchangeAndClearanceFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndOtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndOtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ManagementFeeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for investment management fee, including, but not limited to, expense in connection with research, selection, supervision, and custody of investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ManagementFeeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetInvestmentInLeaseAccruedInterestWriteoff">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of writeoff of accrued interest on net investment in sales-type and direct financing leases recognized by reversing interest income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-3D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetInvestmentInLeaseAccruedInterestWriteoff</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue and income classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column E)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column E)(Footnote 6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(1)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherInterestAndDividendIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after discount, accretion and premium amortization, of interest income and dividend income classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherInterestAndDividendIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfessionalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (k)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfessionalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7)(c)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7)(c)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7)(c)(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7)(c)(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5A<br> -Subparagraph (SX 210.12-13A(Column F))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=cik0001793497_OneShortVIXFuturesETFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=cik0001793497_OneShortVIXFuturesETFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140493285715104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Statement of Changes in Net Assets - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cik0001793497_OneShortVIXFuturesETFMember', window );">-1x Short VIX Futures ETF</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_OperationsAbstract', window );"><strong>OPERATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnInvestments', window );">Net investment loss</a></td>
<td class="num">$ (292,751)<span></span>
</td>
<td class="num">$ (242,779)<span></span>
</td>
<td class="num">$ (538,029)<span></span>
</td>
<td class="num">$ (244,572)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_NetRealizedGainlossOnInvestmentsAndFuturesContracts', window );">Net realized gain (loss) on investments and futures contracts</a></td>
<td class="nump">37,164,451<span></span>
</td>
<td class="num">(4,573,051)<span></span>
</td>
<td class="nump">42,451,505<span></span>
</td>
<td class="num">(4,577,129)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_NetChangeInUnrealizedAppreciationdepreciationOfInvestmentsAndFuturesContracts', window );">Net change in unrealized appreciation (depreciation) of investments and futures contracts</a></td>
<td class="num">(811,301)<span></span>
</td>
<td class="nump">835,808<span></span>
</td>
<td class="nump">5,362,473<span></span>
</td>
<td class="nump">700,531<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_NetIncreasedecreaseInNetAssetsResultingFromOperations', window );">Net increase (decrease) in net assets resulting from operations</a></td>
<td class="nump">36,060,399<span></span>
</td>
<td class="num">(3,980,023)<span></span>
</td>
<td class="nump">47,275,949<span></span>
</td>
<td class="num">(4,121,170)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_CapitalShareTransactionsAbstract', window );"><strong>CAPITAL SHARE TRANSACTIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_SharesSoldinShares', window );">Shares sold</a></td>
<td class="nump">33,849,864<span></span>
</td>
<td class="nump">126,466,848<span></span>
</td>
<td class="nump">118,500,459<span></span>
</td>
<td class="nump">131,987,205<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_SharesSoldNetOfSharesRedeemedinDollarsPerShare', window );">Shares redeemed</a></td>
<td class="num">(72,249,312)<span></span>
</td>
<td class="num">(80,976,664)<span></span>
</td>
<td class="num">(139,852,598)<span></span>
</td>
<td class="num">(80,976,664)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_NetIncreaseInNetAssetsFromCapitalShareTransactions', window );">Net increase (decrease) in net assets from capital share transactions</a></td>
<td class="num">(38,399,448)<span></span>
</td>
<td class="nump">45,490,184<span></span>
</td>
<td class="num">(21,352,139)<span></span>
</td>
<td class="nump">51,010,541<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_IncreasedecreaseInNetAssets', window );">Total increase (decrease) in net assets</a></td>
<td class="num">(2,339,049)<span></span>
</td>
<td class="nump">41,510,161<span></span>
</td>
<td class="nump">25,923,810<span></span>
</td>
<td class="nump">46,889,371<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_NetAssetsAbstract', window );"><strong>NET ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNet', window );">Beginning of Period</a></td>
<td class="nump">74,641,462<span></span>
</td>
<td class="nump">5,379,210<span></span>
</td>
<td class="nump">46,378,603<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNet', window );">End of Period</a></td>
<td class="nump">72,302,413<span></span>
</td>
<td class="nump">46,889,371<span></span>
</td>
<td class="nump">72,302,413<span></span>
</td>
<td class="nump">46,889,371<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember', window );">2x Long VIX Futures ETF</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_OperationsAbstract', window );"><strong>OPERATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnInvestments', window );">Net investment loss</a></td>
<td class="num">(359,369)<span></span>
</td>
<td class="num">(180,611)<span></span>
</td>
<td class="num">(754,176)<span></span>
</td>
<td class="num">(182,387)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_NetRealizedGainlossOnInvestmentsAndFuturesContracts', window );">Net realized gain (loss) on investments and futures contracts</a></td>
<td class="num">(142,872,642)<span></span>
</td>
<td class="nump">7,528,449<span></span>
</td>
<td class="num">(186,102,397)<span></span>
</td>
<td class="nump">7,527,995<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_NetChangeInUnrealizedAppreciationdepreciationOfInvestmentsAndFuturesContracts', window );">Net change in unrealized appreciation (depreciation) of investments and futures contracts</a></td>
<td class="num">(4,374,661)<span></span>
</td>
<td class="num">(256,944)<span></span>
</td>
<td class="num">(10,587,514)<span></span>
</td>
<td class="nump">19,258<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_NetIncreasedecreaseInNetAssetsResultingFromOperations', window );">Net increase (decrease) in net assets resulting from operations</a></td>
<td class="num">(147,606,672)<span></span>
</td>
<td class="nump">7,090,894<span></span>
</td>
<td class="num">(197,444,087)<span></span>
</td>
<td class="nump">7,364,866<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_CapitalShareTransactionsAbstract', window );"><strong>CAPITAL SHARE TRANSACTIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_SharesSoldinShares', window );">Shares sold</a></td>
<td class="nump">174,563,374<span></span>
</td>
<td class="nump">101,014,240<span></span>
</td>
<td class="nump">278,060,557<span></span>
</td>
<td class="nump">104,734,579<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_SharesSoldNetOfSharesRedeemedinDollarsPerShare', window );">Shares redeemed</a></td>
<td class="num">(48,655,759)<span></span>
</td>
<td class="num">(51,662,990)<span></span>
</td>
<td class="num">(120,766,434)<span></span>
</td>
<td class="num">(51,662,990)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_NetIncreaseInNetAssetsFromCapitalShareTransactions', window );">Net increase (decrease) in net assets from capital share transactions</a></td>
<td class="nump">125,907,615<span></span>
</td>
<td class="nump">49,351,250<span></span>
</td>
<td class="nump">157,294,123<span></span>
</td>
<td class="nump">53,071,589<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_IncreasedecreaseInNetAssets', window );">Total increase (decrease) in net assets</a></td>
<td class="num">(21,699,057)<span></span>
</td>
<td class="nump">56,442,145<span></span>
</td>
<td class="num">(40,149,964)<span></span>
</td>
<td class="nump">60,436,456<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_NetAssetsAbstract', window );"><strong>NET ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNet', window );">Beginning of Period</a></td>
<td class="nump">107,037,859<span></span>
</td>
<td class="nump">3,994,311<span></span>
</td>
<td class="nump">125,488,766<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNet', window );">End of Period</a></td>
<td class="nump">$ 85,338,802<span></span>
</td>
<td class="nump">$ 60,436,456<span></span>
</td>
<td class="nump">$ 85,338,802<span></span>
</td>
<td class="nump">$ 60,436,456<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_CapitalShareTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_CapitalShareTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_IncreasedecreaseInNetAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of total increase (decrease) in net assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_IncreasedecreaseInNetAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_NetAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_NetAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_NetChangeInUnrealizedAppreciationdepreciationOfInvestmentsAndFuturesContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_NetChangeInUnrealizedAppreciationdepreciationOfInvestmentsAndFuturesContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_NetIncreaseInNetAssetsFromCapitalShareTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net increase in net assets from capital share transactions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_NetIncreaseInNetAssetsFromCapitalShareTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_NetIncreasedecreaseInNetAssetsResultingFromOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in net assets from operations of investment company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_NetIncreasedecreaseInNetAssetsResultingFromOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_NetRealizedGainlossOnInvestmentsAndFuturesContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_NetRealizedGainlossOnInvestmentsAndFuturesContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_OperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_OperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_SharesSoldNetOfSharesRedeemedinDollarsPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of shares sold, net of shares redeemed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_SharesSoldNetOfSharesRedeemedinDollarsPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_SharesSoldinShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_SharesSoldinShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of net assets (liabilities).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 30<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479910/205-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(c),9(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=cik0001793497_OneShortVIXFuturesETFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=cik0001793497_OneShortVIXFuturesETFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140493285441760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Statements of Cash Flows (Unaudited) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cik0001793497_OneShortVIXFuturesETFMember', window );">-1x Short VIX Futures ETF</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOW FROM OPERATING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net increase (decrease) in net assets resulting from operations</a></td>
<td class="nump">$ 36,060,399<span></span>
</td>
<td class="num">$ (242,779)<span></span>
</td>
<td class="nump">$ 47,275,949<span></span>
</td>
<td class="num">$ (4,121,170)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_AdjustmentsToReconcileNetIncomeLossToNetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_PurchasesOfInvestments', window );">Purchase of investments</a></td>
<td class="num">(117,945,818)<span></span>
</td>
<td class="num">(86,248,199)<span></span>
</td>
<td class="num">(227,091,533)<span></span>
</td>
<td class="num">(87,243,243)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_ProceedsFromSalesOrMaturitiesOfInvestments', window );">Proceeds from sales or maturities of investments held</a></td>
<td class="nump">123,386,374<span></span>
</td>
<td class="nump">78,851,911<span></span>
</td>
<td class="nump">227,091,533<span></span>
</td>
<td class="nump">78,951,910<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEarnestMoneyDepositsOutstanding', window );">Decrease (Increase) in Deposits at broker for futures contracts</a></td>
<td class="nump">12,091,557<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(20,559,259)<span></span>
</td>
<td class="num">(39,872,983)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpensesOther', window );">Decrease (Increase) in Variation margin receivable</a></td>
<td class="num">(777,982)<span></span>
</td>
<td class="nump">835,808<span></span>
</td>
<td class="num">(1,242,108)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet', window );">Decrease (Increase) in interest receivable</a></td>
<td class="nump">19,618<span></span>
</td>
<td class="num">(4,573,051)<span></span>
</td>
<td class="num">(294)<span></span>
</td>
<td class="num">(9,602)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherReceivables', window );">Decrease (Increase) in other receivables</a></td>
<td class="nump">492<span></span>
</td>
<td class="num">(37,960,927)<span></span>
</td>
<td class="nump">318<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_IncreaseDecreaseInVariationMarginPayable', window );">Decrease (Increase) in Prepaid expenses and other assets</a></td>
<td class="num">(13,235)<span></span>
</td>
<td class="nump">4,018,702<span></span>
</td>
<td class="num">(24,085)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInReceivables', window );">Decrease (Increase) in Due from Other</a></td>
<td class="nump">26<span></span>
</td>
<td class="num">(9,596)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_IncreaseDecreaseInDueToCustodian', window );">Increase (Decrease) in Due to Custodian</a></td>
<td class="num">(3,086,000)<span></span>
</td>
<td class="nump">764<span></span>
</td>
<td class="nump">1,023,713<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInCustomerAdvances', window );">Increase (Decrease) in Due to Other</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent', window );">Increase (Decrease) in Variation margin payable</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">4,105,647<span></span>
</td>
<td class="num">(187,030)<span></span>
</td>
<td class="nump">583,031<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_IncreaseDecreaseInPayableToSponsor', window );">Increase (Decrease) in Payable to Sponsor</a></td>
<td class="num">(6,936)<span></span>
</td>
<td class="nump">62,014<span></span>
</td>
<td class="nump">16,246<span></span>
</td>
<td class="nump">62,124<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities', window );">Increase (Decrease) in Administrative, accounting and custodian fees payable</a></td>
<td class="nump">6,731<span></span>
</td>
<td class="nump">21,906<span></span>
</td>
<td class="num">(1,163)<span></span>
</td>
<td class="nump">22,421<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_IncreaseInProfessionalFeesPayable', window );">Increase (Decrease) in Professional fees payable</a></td>
<td class="nump">13,987<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="nump">43,758<span></span>
</td>
<td class="nump">15,210<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_IncreaseInLicensingAndRegistrationFeesPayable', window );">Increase (Decrease) in Licensing and registration fees payable</a></td>
<td class="nump">8,348<span></span>
</td>
<td class="nump">34,725<span></span>
</td>
<td class="nump">14,166<span></span>
</td>
<td class="nump">35,642<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by (used in) operating activities</a></td>
<td class="nump">49,757,561<span></span>
</td>
<td class="num">(41,088,075)<span></span>
</td>
<td class="nump">26,360,211<span></span>
</td>
<td class="num">(51,576,659)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOW FROM FINANCING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_ProceedsFromSaleOfUnits', window );">Proceeds from shares sold, net of cost from shares purchased</a></td>
<td class="nump">30,240,210<span></span>
</td>
<td class="nump">45,490,185<span></span>
</td>
<td class="nump">114,890,805<span></span>
</td>
<td class="nump">131,987,206<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Cost of shares redeemed</a></td>
<td class="num">(79,997,771)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(141,755,616)<span></span>
</td>
<td class="num">(76,871,017)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="num">(49,757,561)<span></span>
</td>
<td class="nump">45,490,185<span></span>
</td>
<td class="num">(26,864,811)<span></span>
</td>
<td class="nump">55,116,189<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">NET INCREASE (DECREASE) IN CASH</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">4,402,110<span></span>
</td>
<td class="num">(504,600)<span></span>
</td>
<td class="nump">3,539,530<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Beginning of Period</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(862,580)<span></span>
</td>
<td class="nump">504,600<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">End of Period</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">3,539,530<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,539,530<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember', window );">2x Long VIX Futures ETF</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOW FROM OPERATING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net increase (decrease) in net assets resulting from operations</a></td>
<td class="num">(147,606,672)<span></span>
</td>
<td class="num">(180,611)<span></span>
</td>
<td class="num">(197,444,087)<span></span>
</td>
<td class="nump">7,364,866<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_AdjustmentsToReconcileNetIncomeLossToNetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_PurchasesOfInvestments', window );">Purchase of investments</a></td>
<td class="num">(170,380,218)<span></span>
</td>
<td class="num">(60,472,471)<span></span>
</td>
<td class="num">(309,353,524)<span></span>
</td>
<td class="num">(60,968,753)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_ProceedsFromSalesOrMaturitiesOfInvestments', window );">Proceeds from sales or maturities of investments held</a></td>
<td class="nump">176,796,775<span></span>
</td>
<td class="nump">43,818,993<span></span>
</td>
<td class="nump">308,086,262<span></span>
</td>
<td class="nump">43,818,993<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEarnestMoneyDepositsOutstanding', window );">Decrease (Increase) in Deposits at broker for futures contracts</a></td>
<td class="num">(9,303,378)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,518,493<span></span>
</td>
<td class="num">(40,554,763)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpensesOther', window );">Decrease (Increase) in Variation margin receivable</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(256,944)<span></span>
</td>
<td class="nump">830,840<span></span>
</td>
<td class="num">(1,433,096)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet', window );">Decrease (Increase) in interest receivable</a></td>
<td class="nump">9,245<span></span>
</td>
<td class="nump">7,528,449<span></span>
</td>
<td class="num">(14,869)<span></span>
</td>
<td class="num">(12,375)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherReceivables', window );">Decrease (Increase) in other receivables</a></td>
<td class="nump">1,775<span></span>
</td>
<td class="num">(39,378,470)<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_IncreaseDecreaseInVariationMarginPayable', window );">Decrease (Increase) in Prepaid expenses and other assets</a></td>
<td class="num">(10,933)<span></span>
</td>
<td class="num">(121,254)<span></span>
</td>
<td class="num">(10,101)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInReceivables', window );">Decrease (Increase) in Due from Other</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(12,371)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_IncreaseDecreaseInDueToCustodian', window );">Increase (Decrease) in Due to Custodian</a></td>
<td class="nump">2,491,372<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="nump">2,874,781<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInCustomerAdvances', window );">Increase (Decrease) in Due to Other</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(161,534)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,016,260<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent', window );">Increase (Decrease) in Variation margin payable</a></td>
<td class="nump">2,165,122<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,406,049<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_IncreaseDecreaseInPayableToSponsor', window );">Increase (Decrease) in Payable to Sponsor</a></td>
<td class="nump">4,019<span></span>
</td>
<td class="nump">70,197<span></span>
</td>
<td class="num">(37,988)<span></span>
</td>
<td class="nump">70,335<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities', window );">Increase (Decrease) in Administrative, accounting and custodian fees payable</a></td>
<td class="nump">1,677<span></span>
</td>
<td class="nump">22,082<span></span>
</td>
<td class="num">(1,860)<span></span>
</td>
<td class="nump">22,597<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_IncreaseInProfessionalFeesPayable', window );">Increase (Decrease) in Professional fees payable</a></td>
<td class="nump">12,757<span></span>
</td>
<td class="nump">14,963<span></span>
</td>
<td class="nump">42,621<span></span>
</td>
<td class="nump">15,174<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_IncreaseInLicensingAndRegistrationFeesPayable', window );">Increase (Decrease) in Licensing and registration fees payable</a></td>
<td class="nump">15,892<span></span>
</td>
<td class="nump">36,514<span></span>
</td>
<td class="nump">27,868<span></span>
</td>
<td class="nump">37,431<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by (used in) operating activities</a></td>
<td class="num">(145,802,567)<span></span>
</td>
<td class="num">(49,092,257)<span></span>
</td>
<td class="num">(160,075,496)<span></span>
</td>
<td class="num">(50,623,331)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOW FROM FINANCING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_ProceedsFromSaleOfUnits', window );">Proceeds from shares sold, net of cost from shares purchased</a></td>
<td class="nump">192,593,274<span></span>
</td>
<td class="nump">49,351,251<span></span>
</td>
<td class="nump">278,976,878<span></span>
</td>
<td class="nump">102,394,101<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Cost of shares redeemed</a></td>
<td class="num">(46,790,707)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(118,901,382)<span></span>
</td>
<td class="num">(51,662,990)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="nump">145,802,567<span></span>
</td>
<td class="nump">49,351,251<span></span>
</td>
<td class="nump">160,075,496<span></span>
</td>
<td class="nump">50,731,111<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">NET INCREASE (DECREASE) IN CASH</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">258,994<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">107,781<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Beginning of Period</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(151,213)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">End of Period</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 107,781<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 107,781<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_AdjustmentsToReconcileNetIncomeLossToNetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_AdjustmentsToReconcileNetIncomeLossToNetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_IncreaseDecreaseInDueToCustodian">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase decrease in due to custodian.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_IncreaseDecreaseInDueToCustodian</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_IncreaseDecreaseInPayableToSponsor">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_IncreaseDecreaseInPayableToSponsor</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_IncreaseDecreaseInVariationMarginPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase decrease in variation margin payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_IncreaseDecreaseInVariationMarginPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_IncreaseInLicensingAndRegistrationFeesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase in licensing and registration fees payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_IncreaseInLicensingAndRegistrationFeesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_IncreaseInProfessionalFeesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase in professional fees payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_IncreaseInProfessionalFeesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_ProceedsFromSaleOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from sale of units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_ProceedsFromSaleOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_ProceedsFromSalesOrMaturitiesOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from sales or maturities of investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_ProceedsFromSalesOrMaturitiesOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_PurchasesOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of all investments during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_PurchasesOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount due from borrowers for interest payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInCustomerAdvances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of prepayments by customers for goods or services to be provided at a later date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInCustomerAdvances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEarnestMoneyDepositsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of deposits given by the reporting entity to a seller which shows that the prospective buyer is serious about purchasing a property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEarnestMoneyDepositsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in receivables classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpensesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpensesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=cik0001793497_OneShortVIXFuturesETFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=cik0001793497_OneShortVIXFuturesETFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140493286265584">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Schedule of Investments (Unaudited) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th" colspan="2"><div>Jun. 30, 2023</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cik0001793497_OnexShortVIXFuturesETFMember', window );">-1 x Short VIX Futures ETF [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherInvestments', window );">TOTAL INVESTMENTS</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">Other Assets in Excess of Liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">72,302,413<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 45,874,003<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNet', window );">TOTAL NET ASSETS</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">72,302,413<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">46,378,603<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_UnderlyingFaceAmountAtMarketValues', window );">Underlying Face Amount at Market Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,518,579<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash - 1.1% (a)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">504,600<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cik0001793497_OnexShortVIXFuturesETFMember', window );">-1 x Short VIX Futures ETF [Member] | CBOE VIX Futures [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_NumberOfContracts', window );">Contracts</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,590)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,150)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedUnrecognizedUnrealizedAppreciation', window );">Unrealized Appreciation/ (Depreciation)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,483,830<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,058,570<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_UnderlyingFaceAmountAtMarketValues', window );">Underlying Face Amount at Market Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,156,106<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cik0001793497_OnexShortVIXFuturesETFMember', window );">-1 x Short VIX Futures ETF [Member] | CBOE VIX Futures [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_NumberOfContracts', window );">Contracts</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,883)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(804)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedUnrecognizedUnrealizedAppreciation', window );">Unrealized Appreciation/ (Depreciation)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,034,749<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">97,536<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember', window );">2x Long VIX Futures ETF [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherInvestments', window );">TOTAL INVESTMENTS</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">9,517,548<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">8,250,285<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">Other Assets in Excess of Liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">75,821,254<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">117,238,481<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNet', window );">TOTAL NET ASSETS</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">85,338,802<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">125,488,766<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_UnderlyingFaceAmountAtMarketValues', window );">Underlying Face Amount at Market Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(19,791,036)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherShortTermInvestments', window );">TOTAL SHORT TERM INVESTMENT</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">9,517,548<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">8,250,285<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember', window );">2x Long VIX Futures ETF [Member] | CBOE VIX Futures [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_NumberOfContracts', window );">Contracts</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,356<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6,221<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedUnrecognizedUnrealizedAppreciation', window );">Unrealized Appreciation/ (Depreciation)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(16,558,756)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(8,416,975)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_UnderlyingFaceAmountAtMarketValues', window );">Underlying Face Amount at Market Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(9,203,522)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember', window );">2x Long VIX Futures ETF [Member] | CBOE VIX Futures [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_NumberOfContracts', window );">Contracts</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,623<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,355<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedUnrecognizedUnrealizedAppreciation', window );">Unrealized Appreciation/ (Depreciation)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(3,232,280)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(786,547)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cik0001793497_FirstAmericanGovernmentObligationsFundMember', window );">First American Government Obligations Fund [Member] | 2x Long VIX Futures ETF [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MoneyMarketFundsAtCarryingValue', window );">First American Government Obligations Fund</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 9,517,548<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">$ 8,250,285<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[6]</sup></td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">$68,703,813 of cash is pledged as collateral for futures
contracts.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$48,144,554
of cash os pledged as collateral for futures contracts</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">$83,302,779 of cash is pledged as collateral for futures
contracts.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">$114,821,272 of cash is pledged as collateral for futures contracts.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[5]</td>
<td style="vertical-align: top;" valign="top">Represents annualized seven-day yield at June 30, 2023 (Unaudited)</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[6]</td>
<td style="vertical-align: top;" valign="top">Represents annualized seven-day yield at December 31, 2022</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_NumberOfContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of number of contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_NumberOfContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_UnderlyingFaceAmountAtMarketValues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal value of any stock at its issuing is termed its face value. The market value of any stock refers to the current market price of that stock as stated on the stock exchange. This value remains unaffected by the market conditions. Market conditions (such as government policies) can alter the market value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_UnderlyingFaceAmountAtMarketValues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of net assets (liabilities).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 30<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479910/205-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentOwnedUnrecognizedUnrealizedAppreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the excess of the cost (face amount, notional amount) of an investment (security, contract) over its fair value which deficiency has not been recognized in earnings of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentOwnedUnrecognizedUnrealizedAppreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MoneyMarketFundsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investment in short-term money-market instruments (such as commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and so forth) which are highly liquid (that is, readily convertible to known amounts of cash) and so near their maturity that they present an insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify as cash equivalents by definition. Original maturity means an original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MoneyMarketFundsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term investments classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.5)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=cik0001793497_OnexShortVIXFuturesETFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=cik0001793497_OnexShortVIXFuturesETFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=cik0001793497_CBOEVIXFuturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=cik0001793497_CBOEVIXFuturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=cik0001793497_CBOEVIXFuturesOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=cik0001793497_CBOEVIXFuturesOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cik0001793497_FirstAmericanGovernmentObligationsFundMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cik0001793497_FirstAmericanGovernmentObligationsFundMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140493288831296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Investments (Unaudited) (Parentheticals) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_OtherAssetsInExcessOfLiabilitiesPercentage', window );">Other assets in excess of liabilities, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98.90%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNetAssetsPercentage', window );">Total net assets, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_Cash1', window );">Cash (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cik0001793497_OnexShortVIXFuturesETFMember', window );">-1 x Short VIX Futures ETF [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_OtherAssetsInExcessOfLiabilitiesPercentage', window );">Other assets in excess of liabilities, percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNetAssetsPercentage', window );">Total net assets, percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember', window );">2x Long VIX Futures ETF [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_OtherAssetsInExcessOfLiabilitiesPercentage', window );">Other assets in excess of liabilities, percentage</a></td>
<td class="nump">88.80%<span></span>
</td>
<td class="nump">93.43%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNetAssetsPercentage', window );">Total net assets, percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentInterestRate', window );">Money market fund, percentage</a></td>
<td class="nump">11.20%<span></span>
</td>
<td class="nump">6.57%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_CashPledgedAsCollateral', window );">Cash pledged as collateral (in Dollars)</a></td>
<td class="nump">$ 9,517,548<span></span>
</td>
<td class="nump">$ 8,250,285<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cik0001793497_FirstAmericanGovernmentObligationsFundMember', window );">First American Government Obligations Fund [Member] | 2x Long VIX Futures ETF [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentInterestRate', window );">Money market fund, percentage</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">4.105%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_Cash1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_Cash1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_CashPledgedAsCollateral">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash pledged as collateral.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_CashPledgedAsCollateral</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_OtherAssetsInExcessOfLiabilitiesPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of other assets in excess of liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_OtherAssetsInExcessOfLiabilitiesPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNetAssetsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of value of derivative contract to net assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480493/946-210-55-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNetAssetsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Rate of interest on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480493/946-210-55-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.12-12A(Column A)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.12-12A(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 4)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=cik0001793497_OnexShortVIXFuturesETFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=cik0001793497_OnexShortVIXFuturesETFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cik0001793497_FirstAmericanGovernmentObligationsFundMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cik0001793497_FirstAmericanGovernmentObligationsFundMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140493289044464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">ORGANIZATION</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">NOTE 1 &#8211; ORGANIZATION</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">VS Trust (the &#8220;Trust&#8221;)
is a Delaware statutory trust formed on October 24, 2019 and is currently organized into separate series (each, a &#8220;Fund&#8221; and
collectively, the &#8220;Funds&#8221;). As of June 30, 2023, the following two series of the Trust have commenced investment operations:
-1x Short VIX Futures ETF (&#8220;SVIX&#8221;) and 2x Long VIX Futures ETF (&#8220;UVIX&#8221;). Each of the Funds listed above issues
common units of beneficial interest (&#8220;Shares&#8221;), which represent units of fractional undivided beneficial interest in and ownership
of only that Fund. The Shares of each Fund are listed on the Cboe BZX Exchange (&#8220;Cboe BZX&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">The Funds&#8217; inception of operation
was March 28, 2022. Neither the Trust nor the Funds had any operations prior to March 28, 2022, other than matters relating to its organization
and the registration of each series under the Securities Act of 1933.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Each Fund&#8217;s investment exposure
to VIX futures contracts will cause each to be deemed a commodity pool, thereby subjecting each Fund to regulation under the Commodity
Exchange Act of 1934 (&#8220;CEA&#8221;) and Commodity Futures Trading Commission (&#8220;CFTC&#8221;) rules. The Sponsor is registered
as a Commodity Pool Operator (&#8220;CPO&#8221;) and the Fund will be operated in accordance with applicable CFTC rules. Registration
as a CPO imposes additional compliance obligations on the Sponsor and the Funds related to additional laws, regulations and enforcement
policies, which could increase compliance costs and may affect the operations and financial performance of the Funds.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Volatility Shares LLC (the &#8220;Sponsor&#8221;)
is the sponsor of the Trust and the Funds. The Sponsor also will serve as the Trust&#8217;s commodity pool operator. The Funds are commodity
pools, as defined under the Commodity Exchange Act (the &#8220;CEA&#8221;), and the applicable regulations of the CFTC and are operated
by the Sponsor, which is registered as a commodity pool operator with the CFTC. The Trust is not an investment company registered under
the Investment Company Act of 1940.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480424/946-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480424/946-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//810/tableOfContent<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140493295524976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 7.7pt">NOTE 2 &#8211; SIGNIFICANT ACCOUNTING POLICIES</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Each Fund is an investment company,
as defined by Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards Codification (&#8220;ASC&#8221;) Topic 946
&#8220;Financial Services &#8212; Investment Companies.&#8221; As such, the Funds follow the investment company accounting and reporting
guidance. The following is a summary of significant accounting policies followed by each Fund, as applicable, in preparation of its financial
statements. These policies are in conformity with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">The accompanying unaudited financial
statements were prepared in accordance with GAAP for interim financial information and with the instructions for Form 10-Q and the rules
and regulations of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;). In the opinion of management, all material adjustments,
consisting only of normal recurring adjustments, considered necessary for a fair statement of the interim period financial statements
have been made. Interim period results are not necessarily indicative of results for a full-year period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 7.7pt">Emerging growth company</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">The Trust is an &#8220;emerging
growth company,&#8221; as defined in the Jumpstart Our Business Startups Act of 2012. It will remain an emerging growth company until
the earlier of (1) the beginning of the first fiscal year following the fifth anniversary of its initial public offering, (2) the beginning
of the first fiscal year after annual gross revenue is $1.07 billion (subject to adjustment for inflation) or more, (3) the date on which
the Fund has, during the previous three-year period, issued more than $1.0 billion in non-convertible debt securities and (4) as of the
end of any fiscal year in which the market value of common equity held by non-affiliates exceeded $700 million as of the end of the second
quarter of that fiscal year.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">For as
long as the Trust remains an &#8220;emerging growth company,&#8221; it may take advantage of certain exemptions from the various reporting
requirements that are applicable to public companies that are not &#8220;emerging growth companies&#8221; including, but not limited
to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure
obligations regarding executive compensation and financial statements in our periodic reports and proxy statements, and exemptions from
the requirements of holding a nonbinding advisory vote to approve executive compensation and shareholder approval of any golden parachute
payments not previously approved. The Trust will take advantage of these reporting exemptions until it is no longer an &#8220;emerging
growth company.&#8221;</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Use of Estimates &amp; Indemnifications</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">The preparation of financial statements
in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities
and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and
expenses during the reporting period. Actual results could differ from those estimates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">In
the normal course of business, the Trust enters into contracts that contain a variety of representations which provide general
indemnifications. The Trust&#8217;s maximum exposure under these arrangements cannot be known; however, the Trust expects any risk
of loss to be remote.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Basis of Presentation</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Pursuant to rules and regulations
of the SEC, these financial statements are presented for the Trust as a whole, as the SEC registrant, and for each Fund individually.
The debts, liabilities, obligations and expenses incurred, contracted for or otherwise existing with respect to a particular Fund shall
be enforceable only against the assets of such Fund and not against the assets of the Trust generally or any other Fund. Accordingly,
the assets of each Fund of the Trust include only those funds and other assets that are paid to, held by or distributed to the Trust for
the purchase of Shares in that Fund.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Statements of Cash Flows</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">The
cash amount shown in the Statements of Cash Flows is the amount reported as cash in the Statements of Financial Condition dated June
30, 2023 and December 31, 2022, and represents cash, but does not include short-term investments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Final Net Asset Value for Fiscal Period</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">The cut-off times and the times
of the calculation of the Funds&#8217; final net asset value for creation and redemption of fund Shares for the three months ended June
30, 2023 were typically as follows. All times are Eastern Standard Time:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">NAV</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">NAV</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">Create/Redeem</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">Calculation</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">Calculation</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; width: 64%; font-weight: bold; text-align: left">Fund</td><td style="padding-bottom: 1.5pt; width: 1%; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 11%; font-weight: bold; text-align: center">Cut-off*(EST)</td><td style="padding-bottom: 1.5pt; width: 1%; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 11%; font-weight: bold; text-align: center">Time (EST)</td><td style="padding-bottom: 1.5pt; width: 1%; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 11%; font-weight: bold; text-align: center">Date</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">-1x Short VIX Futures ETF and</td><td>&#160;</td>
    <td style="text-align: center">2:00 p.m.</td><td>&#160;</td>
    <td style="text-align: center">4:00 p.m.</td><td>&#160;</td>
    <td style="text-align: center">June 30, 2023</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">2x Long VIX Futures ETF</td><td>&#160;</td>
    <td style="text-align: center">2:00 p.m.</td><td>&#160;</td>
    <td style="text-align: center">4:00 p.m.</td><td>&#160;</td>
    <td style="text-align: center">June 30, 2023</td></tr>
  </table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 7.7pt"></td><td style="width: 14.95pt">*</td><td style="padding-right: 7.8pt">Although the Funds&#8217; shares may continue to trade on secondary markets subsequent to the calculation
of the final NAV, these times represent the final opportunity to transact in creation or redemption units for the three months ended June
30, 2023.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Market value per Share is determined at the close of Cboe
BZX and may be later than when the Funds&#8217; NAV per Share is calculated.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">For financial reporting purposes,
the Funds value transactions based upon the final closing price in their primary markets. Accordingly, the investment valuations in these
financial statements may differ from those used in the calculation of certain of the Funds&#8217; final creation/redemption NAV for the
three months ended June 30, 2023.</p><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Investment Valuation</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Short-term investments are valued
at amortized cost which approximates fair value for daily NAV purposes. For financial reporting purposes, short-term investments are valued
at their market price using information provided by a third-party pricing service or market quotations. In each of these situations, valuations
are typically categorized as Level I in the fair value hierarchy.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">VIX futures
contracts are valued using the Time Weighted Average Price (TWAP) of the futures during the last 15 minutes of NYSE&#8217;s regular trading
session, rather than solely from the VIX futures&#8217; settlement price. The value of a Fund&#8217;s non-exchange-traded Financial Instruments
typically is determined by applying the then-current disseminated levels for the Index to the terms of the Fund&#8217;s non-exchange-traded
Financial Instruments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">In certain circumstances (e.g.,
if the Sponsor believes market quotations do not accurately reflect the fair value of a Fund&#8217;s investment, or a trading halt closes
an exchange or market early), the Sponsor may, in its sole discretion, choose to determine a fair value price as the basis for determining
the market value of such investment for such day. Such fair value prices would generally be determined based on available inputs about
the current value of the underlying VIX futures contract and would be based on principles that the Sponsor deems fair and equitable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">The Funds may use a variety of
money market instruments. Money market instruments generally will be valued using market prices or at amortized cost.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Fair value pricing may require
subjective determinations about the value of an investment. While the Funds&#8217; policies are intended to result in a calculation of
its respective Fund&#8217;s NAV that fairly reflects investment values as of the time of pricing, such Fund cannot ensure that fair values
determined by the Sponsor or persons acting at their direction would accurately reflect the price that a Fund could obtain for an investment
if it were to dispose of that investment as of the time of pricing (for instance, in a forced or distressed sale). The prices used by
such Fund may differ from the value that would be realized if the investments were sold and the differences could be material to the financial
statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Fair Value of Financial Instruments</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">The
Funds disclose the fair value of their investments in a hierarchy that prioritizes the inputs to valuation techniques used to
measure fair value. The disclosure requirements establish a fair value hierarchy that distinguishes between: (1) market participant
assumptions developed based on market data obtained from sources independent of the Funds (observable inputs); and (2) the
Funds&#8217; own assumptions about market participant assumptions developed based on the best information available under the
circumstances (unobservable inputs). The three levels defined by the disclosure requirements hierarchy are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.5in; text-align: left">Level I</td><td style="text-align: center; width: 0.25in">&#8211;</td>
                                                                                      <td style="text-align: left">Quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access
at the measurement date.</td>
</tr></table>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.5in"></td><td style="width: 0.5in; text-align: left">Level II</td><td style="text-align: center; width: 0.25in">&#8211;</td>
                                                                                       <td style="text-align: left">Inputs other than quoted prices included within Level I that are observable for the asset or liability, either directly or indirectly.
Level II assets include the following: quoted prices for similar assets or liabilities in active markets, quoted prices for identical
or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or
liability, and inputs that are derived principally from or corroborated by observable market data by correlation or other means (market-corroborated
inputs).</td>
</tr></table>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.5in"></td><td style="width: 0.5in; text-align: left">Level III</td><td style="text-align: center; width: 0.25in">&#8211;</td>
                                                                                        <td style="text-align: left">Unobservable pricing input at the measurement date for the asset or liability. Unobservable inputs shall be used to measure fair value
to the extent that observable inputs are not available.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">In some instances, the inputs used
to measure fair value might fall in different levels of the fair value hierarchy. The level in the fair value hierarchy within which the
fair value measurement in its entirety falls is determined based on the lowest input level that is significant to the fair value measurement
in its entirety.</p><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Fair value measurements also require additional
disclosure when the volume and level of activity for the asset or liability have significantly decreased, as well as when circumstances
indicate that a transaction is not orderly.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">The following table summarizes the valuation of investments
at June 30, 2023 (unaudited) and December 31, 2022 using the fair value hierarchy:</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"><b>June 30, 2023 (Unaudited)</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"><b>December 31, 2022</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Fund</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Level 1 - <br/>
Money <br/>
Market <br/>
Fund</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Level 2 - <br/>
Futures <br/>
Contracts*</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total <br/>
June 30, <br/>
2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Level 1 - <br/>
Money <br/>
Market <br/>
Fund</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Level 2 - <br/>
Futures <br/>
Contracts*</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total <br/>
December&#160;31, <br/>
2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; text-align: left">-1x Short VIX Futures ETF</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-62">&#8211;</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">6,518,579</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">6,518,579</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,156,106</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,156,106</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">2x Long VIX Futures ETF</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,517,548</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(19,791,036</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(10,273,488</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,250,285</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(9,203,522</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(953,237</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Total Trust</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">9,517,548</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(13,272,457</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(3,754,909</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">8,250,285</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(8,047,416</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">202,869</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>




<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left">*</td><td style="text-align: left">Includes cumulative appreciation (depreciation) of futures
contracts as reported in the Schedule of Investments. Only current day&#8217;s variation margin is reported within the Statements of
Financial Condition in receivable/payable on open futures.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The inputs or methodology used for valuing investments
are not necessarily an indication of the risk associated with investing in those securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Investment Transactions and Related Income</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Investment transactions are recorded on the trade
date. All such transactions are recorded on the identified cost basis and marked to market daily. Unrealized appreciation (depreciation)
on open contracts are reflected in the Statements of Financial Condition and changes in the unrealized appreciation (depreciation) between
periods are reflected in the Statements of Operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Interest income is recognized on an accrual basis
and includes, where applicable, the amortization of premium or discount, and is reflected as Interest Income in the Statement of Operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Brokerage Commissions and Futures Account Fees</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Each Fund pays its respective brokerage commissions,
including applicable exchange fees, National Futures Association (&#8220;NFA&#8221;) fees, give-up fees, pit brokerage fees and other
transaction related fees and expenses charged in connection with trading activities for each Fund&#8217;s investment in U.S. Commodity
Futures Trading Commission (&#8220;CFTC&#8221;) regulated investments. The effects of trading spreads, financing costs/fees associated
with Financial Instruments, and costs relating to the purchase of U.S. Treasury securities or similar high credit quality short-term fixed-income
would also be borne by the Funds. Brokerage commissions on futures contracts are recognized on a half-turn basis (e.g., the first half
is recognized when the contract is purchased (opened) and the second half is recognized when the transaction is closed). The Sponsor is
currently paying brokerage commissions on VIX futures contracts for the Funds that exceed variable create/redeem fees collected by more
than&#160;0.03% and 0.00%, for SVIX and UVIX, respectively, of each Fund's average net assets annually.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Federal Income Tax</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Each Fund is registered as a series of a Delaware
statutory trust and is treated as a partnership for U.S. federal income tax purposes. Accordingly, no Fund expects to incur U.S. federal
income tax liability; rather, each beneficial owner of a Fund&#8217;s Shares is required to take into account its allocable share of its
Fund&#8217;s income, gain, loss, deductions and other items for its Fund&#8217;s taxable year ending with or within the beneficial owner&#8217;s
taxable year.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Management of the Funds has reviewed all open tax
years and major jurisdictions (i.e., the last four tax year ends and the interim tax period since then, as applicable) and concluded that
there is no tax liability resulting from unrecognized tax benefits relating to uncertain income tax positions taken or expected to be
taken in future tax returns. The Funds are also not aware of any tax positions for which it is reasonably possible that the total amounts
of unrecognized tax benefits will significantly change in the next twelve months. On an ongoing basis, management monitors its tax positions
taken under the interpretation to determine if adjustments to conclusions are necessary based on factors including, but not limited to,
on-going analysis of tax law, regulation, and interpretations thereof.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140493289906208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_InvestmentsLineItems', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTextBlock', window );">INVESTMENTS</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 3 &#8211; INVESTMENTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Short-Term Investments</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Funds may purchase U.S. Treasury Bills, agency
securities, and other high-credit quality short-term fixed income or similar securities with original maturities of one year or less.
A portion of these investments may be posted as collateral in connection with swap agreements, futures, and/or forward contracts.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Accounting for Derivative Instruments</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In seeking to achieve each Fund&#8217;s investment
objective, the Sponsor uses a mathematical approach to investing. Using this approach, the Sponsor determines the type, quantity and mix
of investment positions, including derivative positions, which the Sponsor believes in combination, should produce returns consistent
with a Fund&#8217;s objective.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">All open derivative positions at period end are
reflected on each respective Fund&#8217;s Schedule of Investments. Certain Funds utilized a varying level of derivative instruments in
conjunction with investment securities in seeking to meet their investment objectives during the period. While the volume of open positions
may vary on a daily basis as each Fund transacts derivatives contracts in order to achieve the appropriate exposure to meet its investment
objective, the volume of these open positions relative to the net assets of each respective Fund at the date of this report is generally
representative of open positions throughout the reporting period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Following is a description of the derivative instruments
used by the Funds during the reporting period, including the primary underlying risk exposures related to each instrument type.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Futures Contracts</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Funds may enter into futures contracts to gain
exposure to changes in the value of, or as a substitute for investing directly in (or shorting), an underlying benchmark. A futures contract
obligates the seller to deliver (and the purchaser to accept) the future delivery of a specified quantity and type of asset at a specified
time and place. The contractual obligations of a buyer or seller may generally be satisfied by taking or making physical delivery of the
underlying commodity, if applicable, or by making an offsetting sale or purchase of an identical futures contract on the same or linked
exchange before the designated date of delivery, or by cash settlement at expiration of contract.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Upon entering into a futures contract, each Fund
is required to deposit and maintain as collateral at least such initial margin as required by the exchange on which the transaction is
affected. The initial margin is segregated as cash and/or securities balances with brokers for futures contracts, as disclosed in the
Statements of Financial Condition, and is restricted as to its use. The Funds that enter into futures contracts maintain collateral at
the broker in the form of cash and/or securities. Pursuant to the futures contract, each Fund generally agrees to receive from or pay
to the broker(s) an amount of cash equal to the daily fluctuation in value of the futures contract. Such receipts or payments are known
as variation margin and are recorded by each Fund as unrealized gains or losses. Each Fund will realize a gain or loss upon closing of
a futures transaction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Futures contracts involve, to varying degrees,
elements of market risk (specifically exchange rate sensitivity, commodity price risk or equity market volatility risk) and exposure to
loss in excess of the amount of variation margin. The face or contract amounts reflect the extent of the total exposure each Fund has
in the particular classes of instruments. Additional risks associated with the use of futures contracts are imperfect correlation between
movements in the price of the futures contracts and the market value of the underlying Index or commodity and the possibility of an illiquid
market for a futures contract. With futures contracts, there is minimal but some counterparty risk to the Funds since futures contracts
are exchange-traded and the credit risk resides with the Funds&#8217; clearing broker or clearinghouse itself. Many futures exchanges
and boards of trade limit the amount of fluctuation permitted in futures contract prices during a single trading day. Once the daily limit
has been reached in a particular contract, no trades may be made that day at a price beyond that limit or trading may be suspended for
specified times during the trading day. Futures contracts prices could move to the limit for several consecutive trading days with little
or no trading, thereby preventing prompt liquidation of futures positions and potentially subjecting a Fund to substantial losses. If
trading is not possible, or if a Fund determines not to close a futures position in anticipation of adverse price movements, the Fund
will be required to make daily cash payments of variation margin. The risk the Fund will be unable to close out a futures position will
be minimized by entering into such transactions on a national exchange with an active and liquid secondary market.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Option Contracts</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">An option is a contract that gives the buyer the
right, but not the obligation, to buy or sell a specified quantity of a commodity or other instrument at a specific (or strike) price
within a specified period of time, regardless of the market price of that instrument. There are two types of options: calls and puts.
A call option conveys to the option buyer the right to purchase a particular futures contract at a stated price at any time during the
life of the option. A put option conveys to the option buyer the right to sell a particular futures contract at a stated price at any
time during the life of the option. Options written by a Fund may be wholly or partially covered (meaning that the Fund holds an offsetting
position) or uncovered. In the case of the purchase of an option, the risk of loss of an investor&#8217;s entire investment (i.e., the
premium paid plus transaction charges) reflects the nature of an option as a wasting asset that may become worthless when the option expires.
Where an option is written or granted (i.e., sold) uncovered, the seller may be liable to pay substantial additional margin, and the risk
of loss is unlimited, as the seller will be obligated to deliver, or take delivery of, an asset at a predetermined price which may, upon
exercise of the option, be significantly different from the market value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">When a Fund writes a call or put, an amount equal
to the premium received is recorded and subsequently marked to market to reflect the current value of the option written. Premiums received
from writing options which expire are treated as realized gains. Premiums received from writing options which are exercised or closed
are added to the proceeds or offset against amounts paid on the underlying futures, swap or security transaction to determine the realized
gain (loss).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">When a Fund purchases an option, the Fund pays
a premium which is included as an asset on the Statement of Financial Condition and subsequently marked to market to reflect the current
value of the option. Premiums paid for purchasing options which expire are treated as realized losses. The risk associated with purchasing
put and call options is limited to the premium paid. Premiums paid for purchasing options which are exercised or closed are added to the
amounts paid or offset against the proceeds on the underlying investment transaction to determine the realized gain (loss) when the underlying
transaction is executed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Certain options transactions may subject the writer
(seller) to unlimited risk of loss in the event of an increase in the price of the contract to be purchased or delivered. The value of
a Fund&#8217;s options transactions, if any, will be affected by, among other things, changes in the value of a Fund&#8217;s underlying
benchmark relative to the strike price, changes in interest rates, changes in the actual and implied volatility of the Fund&#8217;s underlying
benchmark, and the remaining time until the options expire, or any combination thereof. The value of the options should not be expected
to increase or decrease at the same rate as the level of the Fund&#8217;s underlying benchmark, which may contribute to tracking error.
Options may be less liquid than certain other securities. A Fund&#8217;s ability to trade options will be dependent on the willingness
of counterparties to trade such options with the Fund. In a less liquid market for options, a Fund may have difficulty closing out certain
option positions at desired times and prices. A Fund may experience substantial downside from specific option positions and certain option
positions may expire worthless. Over-the-counter options generally are not assignable except by agreement between the parties concerned,
and no party or purchaser has any obligation to permit such assignments. The over-the-counter market for options is relatively illiquid,
particularly for relatively small transactions. The use of options transactions exposes a Fund to liquidity risk and counterparty credit
risk, and in certain circumstances may expose the Fund to unlimited risk of loss. The Funds may buy and sell options on futures contracts,
which may present even greater volatility and risk of loss.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Swap Agreements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Funds may enter into swap agreements for purposes
of pursuing their investment objectives or as a substitute for investing directly in (or shorting) an underlying Index or to create an
economic hedge against a position. Swap agreements are two-party contracts that have traditionally been entered into primarily with institutional
investors in over-the-counter (&#8220;OTC&#8221;) markets for a specified period, ranging from a day to more than one year. However, the
Dodd-Frank Wall Street Reform and Consumer Protection Act (the &#8220;Dodd-Frank Act&#8221;) provides for significant reforms of the OTC
derivative markets, including a requirement to execute certain swap transactions on a CFTC-regulated market and/or to clear such transactions
through a CFTC-regulated central clearing organization. In a standard swap transaction, two parties agree to exchange the returns earned
or realized on a particular predetermined investment, instrument or Index in exchange for a fixed or floating rate of return in respect
of a predetermined notional amount. Transaction or commission costs are reflected in the benchmark level at which the transaction is entered
into. The gross returns to be exchanged are calculated with respect to a notional amount and the benchmark returns to which the swap is
linked. Swap agreements do not involve the delivery of underlying instruments.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Generally, swap agreements entered into by the
Funds calculate and settle the obligations of the parties to the agreement on a &#8220;net basis&#8221; with a single payment. Consequently,
each Fund&#8217;s current obligations (or rights) under a swap agreement will generally be equal only to the net amount to be paid or
received under the agreement based on the relative values of such obligations (or rights) (the &#8220;net amount&#8221;). In a typical
swap agreement entered into by UVIX, the would be entitled to settlement payments in the event the level of the benchmark increases and
would be required to make payments to the swap counterparties in the event the level of the benchmark decreases, adjusted for any transaction
costs or trading spreads on the notional amount the Funds may pay. In a typical swap agreement entered into by SVIX, the Fund would be
required to make payments to the swap counterparties in the event the level of the benchmark increases and would be entitled to settlement
payments in the event the level of the benchmark decreases, adjusted for any transaction costs or trading spreads on the notional amount
the Funds may pay.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The net amount of the excess, if any, of each Fund&#8217;s
obligations over its entitlements with respect to each OTC swap agreement is accrued on a daily basis and an amount of cash and/or securities
having an aggregate value at least equal to such accrued excess is maintained for the benefit of the counterparty in a segregated account
by the Funds&#8217; Custodian. The net amount of the excess, if any, of each Fund&#8217;s entitlements over its obligations with respect
to each OTC swap agreement is accrued on a daily basis and an amount of cash and/or securities having an aggregate value at least equal
to such accrued excess is maintained for the benefit of the Fund in a segregated account by a third party custodian. Until a swap agreement
is settled in cash, the gain or loss on the notional amount less any transaction costs or trading spreads payable by each Fund on the
notional amount are recorded as &#8220;unrealized appreciation or depreciation on swap agreements&#8221; and, when cash is exchanged,
the gain or loss realized is recorded as &#8220;realized gains or losses on swap agreements.&#8221; Swap agreements are generally valued
at the last settled price of the benchmark referenced asset.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Swap agreements contain various conditions, events
of default, termination events, covenants and representations. The triggering of certain events or the default on certain terms of the
agreement could allow a party to terminate a transaction under the agreement and request immediate payment in an amount equal to the net
positions owed to the party under the agreement. This could cause a Fund to have to enter into a new transaction with the same counterparty,
enter into a transaction with a different counterparty or seek to achieve its investment objective through any number of different investments
or investment techniques.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Swap agreements involve, to varying degrees, elements
of market risk and exposure to loss in excess of the unrealized gain/loss reflected. The notional amounts reflect the extent of the total
investment exposure each Fund has under the swap agreement, which may exceed the NAV of each Fund. Additional risks associated with the
use of swap agreements are imperfect correlations between movements in the notional amount and the price of the underlying reference Index
and the inability of counterparties to perform. Each Fund bears the risk of loss of the amount expected to be received under a swap agreement
in the event of the default or bankruptcy of a swap agreement counterparty. A Fund will typically enter into swap agreements only with
major global financial institutions. The creditworthiness of each of the firms that is a party to a swap agreement is monitored by the
Sponsor. The Sponsor may use various techniques to minimize credit risk including early termination and payment, using different counterparties,
limiting the net amount due from any individual counterparty and generally requiring collateral to be posted by the counterparty in an
amount approximately equal to that owed to the Funds. Outstanding swap agreements contractually terminate within one month but may be
terminated without penalty by either party at any time. Upon termination, the Fund is obligated to pay or receive the &#8220;unrealized
appreciation or depreciation&#8221; amount.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Funds, as applicable, collateralize swap agreements
by segregating or designating cash and/or certain securities as indicated on the Statements of Financial Condition or Schedules of Investments.
As noted above, collateral posted in connection with OTC derivative transactions is held for the benefit of the counterparty in a segregated
tri-party account at the Custodian to protect the counterparty against non-payment by the Funds. The collateral held in this account is
restricted as to its use. In the event of a default by the counterparty, the Funds will seek withdrawal of this collateral from the segregated
account and may incur certain costs in exercising its right with respect to the collateral. If a counterparty becomes bankrupt or otherwise
fails to perform its obligations due to financial difficulties, the Funds may experience significant delays in obtaining any recovery
in a bankruptcy or other reorganizational proceeding. The Funds may obtain only limited recovery or may obtain no recovery in such circumstances.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Funds remain subject to credit risk with respect
to the amount they expect to receive from counterparties. However, the Funds have sought to mitigate these risks in connection with OTC
swaps by generally requiring that the counterparties for each Fund agree to post collateral for the benefit of the Fund, marked to market
daily, in an amount approximately equal to what the counterparty owes the Fund, subject to certain minimum thresholds. In the event of
a bankruptcy of a counterparty, such Fund will have direct access to the collateral received from the counterparty, generally as of the
day prior to the bankruptcy, because there is a one day time lag between the Fund&#8217;s request for collateral and the delivery of such
collateral. To the extent any such collateral is insufficient, the Funds will be exposed to counterparty risk as described above, including
the possible delays in recovering amounts as a result of bankruptcy proceedings.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The counterparty/credit risk for cleared derivative
transactions is generally lower than for OTC derivatives since generally a clearing organization becomes substituted for each counterparty
to a cleared derivative contract and, in effect, guarantees the parties&#8217; performance under the contract as each party to a trade
looks only to the clearing organization for performance of financial obligations. In addition, cleared derivative transactions benefit
from daily marking-to-market and settlement, and segregation and minimum capital requirements applicable to intermediaries.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; white-space: nowrap; text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair Values of Derivative Instruments as of June 30, 2023 (Unaudited)</b></span></td>
    <td style="text-align: left; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td></tr>
  <tr>
    <td style="text-align: center; padding-bottom: 1.5pt; white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt; white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="4" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Asset Derivatives</b></span></td>
    <td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="4" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Liability Derivatives</b></span></td>
    <td style="text-align: left; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td></tr>
  <tr>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: left; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Derivatives Not <br/>
Accounted for as <br/>
Hedging Instruments</b></span></td>
    <td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fund</b></span></td>
    <td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Statements of <br/>
Financial <br/>
Condition&#160;Location</b></span></td>
    <td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unrealized <br/> Appreciation</b></span></td>
    <td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Statements of <br/>
Financial <br/>
Condition&#160;Location</b></span></td>
    <td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unrealized <br/> Depreciation</b></span></td>
    <td style="text-align: left; vertical-align: bottom">&#160;</td></tr>
  <tr>
    <td style="white-space: nowrap; font-size: 10pt; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">VIX Futures Contracts </span></td>
    <td style="width: 1%">&#160;</td>
    <td style="white-space: nowrap; width: 20%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: center; font-size: 10pt; width: 17%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: center; font-size: 10pt; width: 9%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: center; font-size: 10pt; width: 16%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: center; font-size: 10pt; width: 9%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="text-align: right; white-space: nowrap">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left; white-space: nowrap; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-1x Short VIX Futures ETF </span></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right; font-size: 10pt">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">$</td>
    <td style="text-align: right; white-space: nowrap; font-size: 10pt"><span style="-sec-ix-hidden: hidden-fact-63; font-family: Times New Roman, Times, Serif; font-size: 10pt"> 6,518,579</span></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right; white-space: nowrap">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">$</td>
    <td style="text-align: right; white-space: nowrap; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> - </span></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr>
    <td style="padding-bottom: 1.5pt; text-align: right; white-space: nowrap">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left; white-space: nowrap; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2x Long VIX Futures ETF </span></td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right; white-space: nowrap">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right; white-space: nowrap; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- </span></td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right; white-space: nowrap">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right; white-space: nowrap; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(19,791,036</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt; text-align: right; white-space: nowrap">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: left; white-space: nowrap; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total Trust </b></span></td>
    <td style="padding-bottom: 4pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: right; white-space: nowrap">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><b>$</b></td>
    <td style="border-bottom: Black 4pt double; text-align: right; white-space: nowrap; font-size: 10pt"><span style="-sec-ix-hidden: hidden-fact-64; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160; 6,518,579</b></span></td>
    <td style="padding-bottom: 4pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: right; white-space: nowrap">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><b>$</b></td>
    <td style="border-bottom: Black 4pt double; text-align: right; white-space: nowrap; font-size: 10pt"><span style="-sec-ix-hidden: hidden-fact-65; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160; (19,791,036</b></span></td>
    <td style="padding-bottom: 4pt; text-align: left">)</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left">*</td><td style="text-align: left">Includes cumulative appreciation (depreciation) of futures contracts
as reported in the Schedule of Investments. Only current day&#8217;s variation margin is reported within the Statements of Financial
Condition in receivable/payable on open futures.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; white-space: nowrap; text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair Values of Derivative Instruments as of December 31, 2022</b></span></td>
    <td style="text-align: left; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td></tr>
  <tr>
    <td style="text-align: center; padding-bottom: 1.5pt; white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt; white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="4" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Asset Derivatives</b></span></td>
    <td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="4" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Liability Derivatives</b></span></td>
    <td style="text-align: left; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td></tr>
  <tr>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: left; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Derivatives Not <br/>
Accounted for as <br/>
Hedging Instruments</b></span></td>
    <td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fund</b></span></td>
    <td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Statements of <br/>
Financial <br/>
Condition&#160;Location</b></span></td>
    <td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unrealized <br/> Appreciation</b></span></td>
    <td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Statements of <br/>
Financial <br/>
Condition&#160;Location</b></span></td>
    <td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unrealized <br/> Depreciation</b></span></td>
    <td style="text-align: left; vertical-align: bottom">&#160;</td></tr>
  <tr>
    <td style="white-space: nowrap; font-size: 10pt; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">VIX Futures Contracts </span></td>
    <td style="width: 1%">&#160;</td>
    <td style="white-space: nowrap; width: 20%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: center; font-size: 10pt; width: 17%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: center; font-size: 10pt; width: 9%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: center; font-size: 10pt; width: 16%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: center; font-size: 10pt; width: 9%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="text-align: right; white-space: nowrap">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left; white-space: nowrap; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-1x Short VIX Futures ETF </span></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right; font-size: 10pt">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">$</td>
    <td style="text-align: right; white-space: nowrap; font-size: 10pt"><span style="-sec-ix-hidden: hidden-fact-66; font-family: Times New Roman, Times, Serif; font-size: 10pt"> 1,156,106 </span></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right; white-space: nowrap">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">$</td>
    <td style="text-align: right; white-space: nowrap; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> - </span></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr>
    <td style="padding-bottom: 1.5pt; text-align: right; white-space: nowrap">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left; white-space: nowrap; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2x Long VIX Futures ETF </span></td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right; white-space: nowrap">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right; white-space: nowrap; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- </span></td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right; white-space: nowrap">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right; white-space: nowrap; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9,203,522</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt; text-align: right; white-space: nowrap">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: left; white-space: nowrap; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total Trust </b></span></td>
    <td style="padding-bottom: 4pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: right; white-space: nowrap">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><b>$</b></td>
    <td style="border-bottom: Black 4pt double; text-align: right; white-space: nowrap; font-size: 10pt"><span style="-sec-ix-hidden: hidden-fact-67; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160; 1,156,106 </b></span></td>
    <td style="padding-bottom: 4pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: right; white-space: nowrap">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><b>$</b></td>
    <td style="border-bottom: Black 4pt double; text-align: right; white-space: nowrap; font-size: 10pt"><span style="-sec-ix-hidden: hidden-fact-68; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160; (9,203,522</b></span></td>
    <td style="padding-bottom: 4pt; text-align: left">)</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left">*</td><td style="text-align: left">Includes cumulative appreciation (depreciation) of futures contracts
as reported in the Schedule of Investments. Only current day&#8217;s variation margin is reported within the Statements of Financial
Condition in receivable/payable on open futures.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td colspan="21" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">The Effect of Derivative Instruments on the Statement of Operations</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="21" style="font-weight: bold; text-align: center">For the Three Months Ended June 30, 2023 (Unaudited) and June 30, 2022 (Unaudited)</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="21" style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Derivatives Not <br/>
Accounted for as Hedging Instruments</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Location of Gain (Loss) on Derivatives Recognized in Income</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Fund</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Realized Gain <br/>
(Loss) on <br/>
Derivatives Recognized <br/>
in Income <br/>
June 30, <br/>
2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Change in <br/>
Unrealized <br/>
Appreciation <br/>
(Depreciation) <br/>
on Derivatives <br/>
Recognized <br/>
in Income <br/>
June 30, <br/>
2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Realized&#160;Gain<br/>
 (Loss) on <br/>
Derivatives <br/>
Recognized <br/>
in Income <br/>
June 30, <br/>
2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Change in <br/>
Unrealized <br/>
Appreciation <br/>
(Depreciation) <br/>
on Derivatives <br/>
Recognized <br/>
in Income <br/>
June 30, <br/>
2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; vertical-align: top; text-align: left">VIX Futures Contracts</td><td>&#160;</td>
    <td style="text-align: left">Net realized gain (loss) on futures contracts/changes in unrealized appreciation (depreciation) on futures contracts</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 15%">&#160;</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 26%">&#160;</td><td style="width: 0.5%">&#160;</td>
    <td style="white-space: nowrap; width: 16%; text-align: left">-1x Short VIX Futures ETF</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%; text-align: left">$</td><td style="width: 9%; text-align: right">37,164,451</td><td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%; text-align: left">$</td><td style="width: 9%; text-align: right">(811,301</td><td style="width: 0.5%; text-align: left">)</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%; text-align: left">$</td><td style="width: 9%; text-align: right">(4,573,051</td><td style="width: 0.5%; text-align: left">)</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%; text-align: left">$</td><td style="width: 9%; text-align: right">835,808</td><td style="width: 0.5%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">2x Long VIX Futures ETF</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(142,872,642</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(4,374,661</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,528,449</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(256,944</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 4pt; font-weight: bold; text-align: left">Total Trust</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(105,708,191</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(5,185,962</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">2,955,398</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">578,864</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
cumulative appreciation (depreciation) of futures contracts as reported in the Schedule of Investments. Only current day&#8217;s variation
margin is reported within the Statements of Financial Condition in receivable/payable on open futures.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td colspan="21" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">The Effect of Derivative Instruments on the Statement of Operations</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="21" style="font-weight: bold; text-align: center">For the Six Months Ended June 30, 2023 (Unaudited) and June 30, 2022 (Unaudited)</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="21" style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Derivatives Not <br/>
Accounted for as Hedging Instruments</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Location of Gain (Loss) on Derivatives Recognized in Income</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Fund</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Realized Gain <br/>
(Loss) on <br/>
Derivatives <br/>
Recognized <br/>
in Income<br/>
 June 30, <br/>
2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Change in <br/>
Unrealized <br/>
Appreciation <br/>
(Depreciation) <br/>
on Derivatives <br/>
Recognized in <br/>
Income <br/>
June 30, <br/>
2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Realized&#160;Gain<br/>
 (Loss) on <br/>
Derivatives <br/>
Recognized <br/>
in Income <br/>
June 30, <br/>
2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Change in <br/>
Unrealized <br/>
Appreciation <br/>
(Depreciation) <br/>
on Derivatives <br/>
Recognized<br/>
 in Income <br/>
June 30, <br/>
2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; vertical-align: top; text-align: left">VIX Futures Contracts</td><td>&#160;</td>
    <td style="text-align: left">Net realized gain (loss) on futures contracts/changes in unrealized appreciation (depreciation) on futures contracts</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 15%">&#160;</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 26%">&#160;</td><td style="width: 0.5%">&#160;</td>
    <td style="white-space: nowrap; width: 16%; text-align: left">-1x Short VIX Futures ETF</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%; text-align: left">$</td><td style="width: 9%; text-align: right">42,451,505</td><td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%; text-align: left">$</td><td style="width: 9%; text-align: right">5,362,473</td><td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%; text-align: left">$</td><td style="width: 9%; text-align: right">(4,577,129</td><td style="width: 0.5%; text-align: left">)</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%; text-align: left">$</td><td style="width: 9%; text-align: right">700,531</td><td style="width: 0.5%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">2x Long VIX Futures ETF</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(186,102,397</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(10,587,514</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,527,995</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">19,258</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 4pt; font-weight: bold; text-align: left">Total Trust</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(143,650,892</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(5,225,041</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">2,950,866</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">719,789</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
cumulative appreciation (depreciation) of futures contracts as reported in the Schedule of Investments. Only current day&#8217;s variation
margin is reported within the Statements of Financial Condition in receivable/payable on open futures.</span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt"><b>Offsetting Assets and Liabilities</b></span></p>

<p style="text-indent: 0.5in; margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Each Fund is subject to master netting agreements or similar arrangements that allow for amounts owed
between each Fund and the counterparty to be netted upon an early termination. The party that has the larger payable pays the excess of
the larger amount over the smaller amount to the other party. The master netting agreements or similar arrangements do not apply to amounts
owed to/from different counterparties. As described above, the Funds utilize derivative instruments to achieve their investment objective
during the year. The amounts shown in the Statements of Financial Condition do not take into consideration the effects of legally enforceable
master netting agreements or similar arrangements.</p>

<p style="text-indent: 0.5in; margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For financial reporting purposes, the Funds do not offset derivative assets and derivative
liabilities that are subject to netting arrangements in the Statements of Financial Condition. The following table presents each Fund&#8217;s
derivatives by investment type and by counterparty net of amounts available for offset under a master netting agreement and the related
collateral received or pledged by the Funds as of June 30, 2023 and December 31, 2022.</p>

<p style="text-align: center; margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td colspan="25" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Fair Values of Derivative Instruments as of June 30, 2023 (Unaudited)</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="25" style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Assets</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Liabilities</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Fund</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross<br/> Amounts of<br/> Recognized<br/> Assets<br/> presented<br/> in the<br/> Statements<br/> of Financial<br/> Condition</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross<br/> Amounts<br/> Offset<br/> in the<br/> Statements<br/> of Financial<br/> Condition</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Net Amounts<br/> of Assets<br/> presented<br/> in the<br/> Statements<br/> of Financial<br/> Condition</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross<br/> Amounts of<br/> Recognized<br/> Liabilities<br/> presented<br/> in the<br/> Statements<br/> of Financial<br/> Condition</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross<br/> Amounts<br/> Offset<br/> in the<br/> Statements<br/> of Financial<br/> Condition</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Net Amounts<br/> of&#160;Liabilities<br/> presented<br/> in the<br/> Statements<br/> of Financial<br/> Condition</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; text-align: left">-1x Short VIX Futures ETF</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,242,108</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-69">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,242,108</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-70">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-71">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-72">-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">2x Long VIX Futures ETF</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-73">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-74">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-75">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3,406,049</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-76">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,406,049</td><td style="text-align: left">&#160;</td></tr>
  </table>



<p style="text-align: center; margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td colspan="25" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Fair Values of Derivative Instruments as of December 31, 2022</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="25" style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Assets</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Liabilities</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Fund</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross<br/> Amounts of<br/> Recognized<br/> Assets<br/> presented<br/> in the<br/> Statements<br/> of Financial<br/> Condition</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross<br/> Amounts<br/> Offset<br/> in the<br/> Statements<br/> of Financial<br/> Condition</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Net Amounts<br/> of Assets<br/> presented<br/> in the<br/> Statements<br/> of Financial<br/> Condition</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross<br/> Amounts of<br/> Recognized<br/> Liabilities<br/> presented<br/> in the<br/> Statements<br/> of Financial<br/> Condition</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross<br/> Amounts<br/> Offset<br/> in the<br/> Statements<br/> of Financial<br/> Condition</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Net Amounts<br/> of Liabilities<br/> presented<br/> in the<br/> Statements<br/> of Financial<br/> Condition</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; text-align: left">-1x Short VIX Futures ETF</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-77">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">187,030</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-78">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">187,030</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">2x Long VIX Futures ETF</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">830,840</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-79">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">830,840</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-80">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  </table><p style="text-align: center; margin-top: 0; margin-bottom: 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Asset (Liability) amounts shown in the table below represent amounts owed to (by) the Funds for the derivative-related investments at
June 30, 2023 and December 31, 2022. These amounts may be collateralized by cash or financial instruments, segregated for the benefit of
the Funds or the counterparties, depending on whether the related contracts are in an appreciated or depreciated position at period end.
Amounts shown in the column labeled &#8220;Net Amount&#8221; represent the uncollateralized portions of these amounts at period end. These
amounts may be un-collateralized due to timing differences related to market movements or due to minimum thresholds for collateral movement,
as further described above under the caption &#8220;Accounting for Derivative Instruments&#8221;.</p>

<p style="text-align: center; margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td colspan="17" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross Amounts Not Offset in the Statements of Financial Condition as of June 30, 2023 (Unaudited)</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="17" style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Fund</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amounts of<br/> Recognized<br/> Assets /<br/> (Liabilities)<br/> presented<br/> in the<br/> Statements<br/> of Financial<br/> Condition</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Financial<br/> Instruments<br/> for the Benefit<br/> of (the Funds) / the<br/> Counterparties</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Cash<br/> Collateral for<br/> the Benefit of<br/> (the Funds) / the<br/> Counterparties</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Net Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">-1x Short VIX Futures ETF</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,242,108</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-81">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-82">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,242,108</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">2x Long VIX Futures ETF</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,406,049</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-83">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-84">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,406,049</td><td style="text-align: left">)</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td colspan="17" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross Amounts Not Offset in the Statements of Financial Condition as of December 31, 2022</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="17" style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Fund</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amounts of<br/> Recognized<br/> Assets /<br/> (Liabilities)<br/> presented<br/> in the<br/> Statements<br/> of Financial<br/> Condition</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Financial<br/> Instruments<br/> for the Benefit<br/> of (the<br/>
 Funds) / the<br/> Counterparties</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Cash<br/> Collateral for<br/> the Benefit of<br/> (the Funds) / the<br/> Counterparties</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Net Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">-1x Short VIX Futures ETF</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(187,030</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(187,030</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">2x Long VIX Futures ETF</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">830,840</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">830,840</td><td style="text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_InvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_InvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//320/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Topic 321<br> -Publisher FASB<br> -URI https://asc.fasb.org//321/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Topic 325<br> -Publisher FASB<br> -URI https://asc.fasb.org//325/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140493294957952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Agreements<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_AgreementsLineItems', window );"><strong>Agreements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_AgreementsDisclosureTextBlock', window );">AGREEMENTS</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">NOTE 4 &#8211; AGREEMENTS</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Management Fee</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">SVIX pays
the Sponsor a management fee (the &#8220;Management Fee&#8221;), monthly in arrears, in an amount equal to 1.35% per annum of its average
daily net assets. UVIX pays the Sponsor a Management Fee, monthly in arrears, in an amount equal to 1.65% per annum of its average daily
net assets. &#8220;Average daily net assets&#8221; is calculated by dividing the month-end net assets of each Fund by the number of calendar
days in such month.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">No other Management Fee is paid by
the Funds. The Management Fee is paid in consideration of the Sponsor&#8217;s trading advisory services and the other services provided
to the Fund that the Sponsor pays directly.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the Sponsor Agreement
between Sponsor and the Trust, on behalf of the Funds, the Sponsor oversees and pays Penserra Capital Management LLC (&#8220;Commodity
Sub-Adviser&#8221;) for its services as Commodity Sub-Adviser. The Commodity Sub-Adviser is paid by the Sponsor an annual sub-advisory
fee of 0.20% based on each Fund&#8217;s average daily net assets (total assets of the Fund, minus the sum of its accrued liabilities).
The Funds do not directly pay the Commodity Sub-Adviser.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Non-Recurring Fees and Expenses</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Each Fund pays all its non-recurring
and unusual fees and expenses, if any, as determined by the Sponsor. Non-recurring and unusual fees and expenses are fees and expenses
that are unexpected or unusual in nature, such as legal claims and liabilities, litigation costs or indemnification or other material
expenses which are not currently anticipated obligations of the Funds.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">The Administrator, Transfer Agent and Custodian</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">U.S. Bancorp Fund Services, LLC,
doing business as U.S. Bank Global Fund Services (&#8220;Fund Services&#8221;), an indirect subsidiary of U.S. Bancorp, serves as
the Fund&#8217;s fund accountant, administrator and transfer agent pursuant to certain fund accounting servicing, fund
administration servicing and transfer agent servicing agreements. U.S. Bank National Association, a subsidiary of U.S. Bancorp and
parent company of Fund Services, intends to serve as the Fund&#8217;s custodian pursuant to a custody agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">The Marketing Agent</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Foreside Fund Services, LLC (the
&#8220;Marketing Agent&#8221;) serves as the Marketing Agent of the Funds. Its principal duties are: (i) to work with the Transfer Agent
to review and approve orders placed by Authorized Participants and transmitted to the Transfer Agent; (ii) maintain copies of confirmations
of Creation Unit creation and redemption order acceptances; (iii) maintain telephonic, facsimile and/or access to direct computer communications
links with the Transfer Agent; and (iv) review and approve, prior to use, all Trust marketing materials for compliance with applicable
SEC and FINRA advertising rules.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Marketing Agent retains all marketing
materials separately for the Funds, at their offices located at Three Canal Plaza, Suite 100 Portland, Maine 04101.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As compensation for the services it provides, the Marketing
Agent receives a fee from the Funds.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_AgreementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of agreements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_AgreementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_AgreementsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_AgreementsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140493294961472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Offering Costs<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_OfferingCostsLineItems', window );"><strong>Offering Costs [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_OfferingCostsTextBlock', window );">OFFERING COSTS</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">NOTE 5 &#8211; OFFERING COSTS</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Offering costs will be amortized
by the Funds over a twelve month period on a straight-line basis beginning once the fund commences operations. The Sponsor will not charge
its Management Fee in the first year of operations of a Fund in an amount equal to the offering costs. Normal and expected expenses incurred
in connection with the continuous offering of Shares of a Fund after the commencement of its trading operations will be paid by the Sponsor.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_OfferingCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_OfferingCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_OfferingCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of offering costs .</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_OfferingCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140493383772816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Creation and Redemption of Creation Units<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_CreationandRedemptionofCreationUnitsLineItems', window );"><strong>Creation and Redemption of Creation Units [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">CREATION AND REDEMPTION OF CREATION UNITS</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">NOTE 6 &#8211; CREATION AND REDEMPTION OF CREATION UNITS</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Each Fund issues and redeems shares
from time to time, but only in one or more Creation Units. A Creation Unit is a block of at least 10,000 Shares of a Fund. Creation Units
may be created or redeemed only by Authorized Participants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Except when aggregated in Creation
Units, the Shares are not redeemable securities. Retail investors, therefore, generally will not be able to purchase or redeem Shares
directly from or with a Fund. Rather, most retail investors will purchase or sell Shares in the secondary market with the assistance of
a broker. Thus, some of the information contained in these Notes to Financial Statements&#8212;such as references to the Transaction Fees
imposed on purchases and redemptions is not relevant to retail investors.</p>

<p style="text-align: left; text-indent: 0.5in; margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="text-align: left; margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt"><b>Transaction Fees on Creation and Redemption
Transactions</b></span></p>

<p style="text-align: left; text-indent: 0.5in; margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The manner by which Creation Units are purchased or redeemed is governed by the
terms of the Authorized Participant Agreement and Authorized Participant Procedures Handbook. By placing a purchase order, an Authorized
Participant agrees to: (1) deposit cash with the Custodian; and (2) if permitted by the Sponsor in its sole discretion, enter into or
arrange for an exchange of futures contract for related position or block trade with the relevant fund whereby the Authorized Participant
would also transfer to such Fund a number and type of exchange-traded futures contracts at or near the closing settlement price for such
contracts on the purchase order date.</p><p style="text-align: left; text-indent: 0.5in; margin-top: 0; margin-bottom: 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Authorized Participants may pay a fee up to 0.20% of the value of each order they place with each
order to create or redeem a Creation Unit in order to compensate the Administrator, the Custodian and the Transfer Agent of each Fund
and its Shares, for services in processing the creation and redemption of Creation Units and to offset the costs of increasing or decreasing
derivative positions, unless the transaction fee is waived or otherwise adjusted by the Sponsor. The Sponsor provides such Authorized
Participant with prompt notice in advance of any such waiver or adjustment of the transaction fee. Authorized Participants may sell the
Shares included in the Creation Units they purchase from the Funds to other investors in the secondary market.</p>

<p style="text-align: left; text-indent: 0.5in; margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Transaction fees for the three months ended June 30, 2023
and June 30, 2022 were as follows.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Fund</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Three <br/>
Months <br/>
Ended <br/>
June 30, <br/>
2023 <br/>
(Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Three <br/>
Months <br/>
Ended <br/>
June 30, <br/>
2022 <br/>
(Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">-1x Short VIX Futures ETF</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">31,820</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">62,214</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">2x Long VIX Futures ETF</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">66,946</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">45,789</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Trust</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">98,766</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">108,003</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Transaction fees for the Six months ended June 30, 2023 and
June 30, 2022 were as follows.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.4pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Fund</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Six Months <br/>
Ended <br/>
June 30, <br/>
2023 <br/>
(Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Six Months <br/>
Ended <br/>
June 30, <br/>
2022 <br/>
(Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">-1x Short VIX Futures ETF</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">77,483</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">63,870</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">2x Long VIX Futures ETF</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">119,613</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">46,905</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Trust</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">197,096</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">110,775</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_CreationandRedemptionofCreationUnitsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_CreationandRedemptionofCreationUnitsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//718/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140493295043072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Highlights<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_FinancialHighlightsLineItems', window );"><strong>Financial Highlights Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationTextBlock', window );">FINANCIAL HIGHLIGHTS</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 7 - FINANCIAL HIGHLIGHTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Selected data is for a Share outstanding throughout the Three Months
Ended June 30, 2023 (Unaudited) and June 30, 2022 (Unaudited)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">-1x Short VIX Futures ETF</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2x Long VIX Futures ETF</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">-1x Short VIX Futures ETF</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2x Long VIX Futures ETF</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Quarter Ended</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Quarter Ended</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Quarter Ended</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Quarter Ended</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">June 30, <br/>
2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">June 30, <br/>
2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">June 30, <br/>
2022</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">June 30, <br/>
2022</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -10pt; padding-left: 10pt; width: 52%">Net Asset Value, Beginning of Period</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">16.55</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">15.88</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">14.16</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">83.20</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net investment loss <sup>(1)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.09</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.03</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.05</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.60</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net Realized and Unrealized Gain (Loss) on Investments and Futures Contracts <sup>(2)</sup></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">11.67</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(11.41</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3.71</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3.00</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Net Increase (Decrease) in Net Asset Value Resulting from Operations</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">11.58</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(11.44</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3.76</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2.40</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -10pt; padding-left: 10pt; padding-bottom: 4pt">Net Asset Value, End of Period</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">28.13</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">4.44</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">10.40</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">85.60</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -10pt; padding-left: 10pt; padding-bottom: 4pt">Market Value Per Share, at June 30, 2023 and June 30, 2022</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">28.07</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">4.46</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">10.40</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">85.40</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total Return at Net Asset Value <sup>(4)</sup></b></span></td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">69.97</td><td style="font-weight: bold; text-align: left">%</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-72.04</td><td style="font-weight: bold; text-align: left">%</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-26.56</td><td style="font-weight: bold; text-align: left">%</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">2.88</td><td style="font-weight: bold; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -10pt; padding-left: 10pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total Return at Market Value <sup>(4)</sup></b></span></td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">70.02</td><td style="font-weight: bold; text-align: left">%</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-72.09</td><td style="font-weight: bold; text-align: left">%</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-25.93</td><td style="font-weight: bold; text-align: left">%</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">1.30</td><td style="font-weight: bold; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -10pt; padding-left: 10pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -10pt; padding-left: 10pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ratios to Average Net Assets: <sup>(5)</sup></b></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expense ratio <sup>(6)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.20</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.09</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.18</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.91</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">Net Investment Loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-1.75</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-1.14</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-0.50</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-0.67</td><td style="text-align: left">%</td></tr>
  </table>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0in"></td><td style="width: 0.25in; text-align: left">(1)</td><td style="text-align: left">Net investment loss per share represents net investment loss
divided by the daily average shares of beneficial interest outstanding during the period.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0in"></td><td style="width: 0.25in; text-align: left">(2)</td><td style="text-align: left">Due to timing of capital share transactions, per share amounts
may not compare with amounts appearing elsewhere within these Financial Statements.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0in"></td><td style="width: 0.25in; text-align: left">(3)</td><td style="text-align: left">Market values are determined at the close of the applicable
primary listing exchange, which may be later than when the Funds' net asset value is calculated.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0in"></td><td style="width: 0.25in; text-align: left">(4)</td><td style="text-align: left">Percentages are not annualized for the period ended June 30,
2023 and June 30, 2022</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0in"></td><td style="width: 0.25in; text-align: left">(5)</td><td style="text-align: left">Percentages are annualized.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0in"></td><td style="width: 0.25in; text-align: left">(6)</td><td style="text-align: left">The expense ratio would be 2.17% and 2.09% respectively, for
the three months ended June 30, 2023, and 2.00% and 2.81% for the three months ended June 30, 2022 if brokerage commissions and futures
and futures account fees were excluded.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="margin: 0; text-indent: 0.5in">Selected data is for a Share outstanding throughout the Six Months
Ended June 30, 2023 (Unaudited) and June 30, 2022 (Unaudited)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">-1x Short VIX Futures ETF</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2x Long VIX Futures ETF</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">-1x Short VIX Futures ETF</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2x Long VIX Futures ETF</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Six Months Ended</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Six Months Ended</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Six Months Ended</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Six Months Ended</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">June 30, <br/>
2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, <br/>
2023 <sup>(7)</sup></b></span></td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">June 30, <br/>
2022</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, <br/>
2022 <sup>(7)</sup></b></span></td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; width: 52%">Net Asset Value, Beginning of Period</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">14.63</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">29.25</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">15.00</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">75.00</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net investment loss <sup>(1)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.17</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.08</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.06</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1.20</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net Realized and Unrealized Gain (Loss) on Investments and Futures Contracts <sup>(2)</sup></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">13.67</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(24.73</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(4.54</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">11.80</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Net Increase (Decrease) in Net Asset Value Resulting from Operations</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">13.50</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(24.81</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(4.60</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">10.60</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 4pt">Net Asset Value, End of Period</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">28.13</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">4.44</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">10.40</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">85.60</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 4pt">Market Value Per Share, at June 30, 2023 and June 30, 2022</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">28.07</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">4.46</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">10.40</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">85.40</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total Return at Net Asset Value <sup>(4)</sup></b></span></td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">92.28</td><td style="font-weight: bold; text-align: left">%</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-84.82</td><td style="font-weight: bold; text-align: left">%</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-30.67</td><td style="font-weight: bold; text-align: left">%</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">14.13</td><td style="font-weight: bold; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total Return at Market Value <sup>(4)</sup></b></span></td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">91.47</td><td style="font-weight: bold; text-align: left">%</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-84.67</td><td style="font-weight: bold; text-align: left">%</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-30.67</td><td style="font-weight: bold; text-align: left">%</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">13.87</td><td style="font-weight: bold; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ratios to Average Net Assets: <sup>(5)</sup></b></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expense ratio <sup>(6)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.25</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.13</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.18</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.91</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Net Investment Loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-1.84</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-1.35</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-0.50</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-0.67</td><td style="text-align: left">%</td></tr>
  </table>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0in"></td><td style="width: 0.25in; text-align: left">(1)</td><td style="text-align: left">Net investment loss per share represents net investment loss
divided by the daily average shares of beneficial interest outstanding during the period.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0in"></td><td style="width: 0.25in; text-align: left">(2)</td><td style="text-align: left">Due to timing of capital share transactions, per share amounts
may not compare with amounts appearing elsewhere within these Financial Statements.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0in"></td><td style="width: 0.25in; text-align: left">(3)</td><td style="text-align: left">Market values are determined at the close of the applicable
primary listing exchange, which may be later than when the Funds' net asset value is calculated.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0in"></td><td style="width: 0.25in; text-align: left">(4)</td><td style="text-align: left">Percentages are not annualized for the period ended June 30,
2023 and June 30, 2022</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0in"></td><td style="width: 0.25in; text-align: left">(5)</td><td style="text-align: left">Percentages are annualized.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0in"></td><td style="width: 0.25in; text-align: left">(6)</td><td style="text-align: left">The expense ratio would be 2.23% and 2.13% respectively, for
the six months ended June 30, 2023, and 2.01% and 2.84% for the six months ended June 30, 2022 if brokerage commissions and futures and
futures account fees were excluded.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0in"></td><td style="width: 0.25in; text-align: left">(7)</td><td style="text-align: left">For 2x Long VIX Futures ETF, fianancial highlights have been
adjusted to reflect a 1:5 reverse stock split occurring on January 25, 2023, as if it occurred at the commencment of operations.</td>
</tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_FinancialHighlightsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_FinancialHighlightsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482964/270-10-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 270<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//270/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140493383802096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Risk<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_RiskLineItems', window );"><strong>Risk [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskDisclosureTextBlock', window );">RISK</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 8 &#8211; RISK</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Correlation and Compounding Risk</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Funds do not seek to achieve their stated investment objective over a period
of time greater than a single day (as measured from NAV calculation time to NAV calculation time). The return of a Fund for a period longer
than a single day is the result of its return for each day compounded over the period and usually will differ in amount and possibly even
direction from the inverse (-1x) or two times (2x) the return of the Fund&#8217;s benchmark for the period. A Fund will lose money if
its benchmark performance is flat over time, and it is possible for a Fund to lose money over time even if the performance of its benchmark
increases in the case of UVIX (or decreases in the case of SVIX), as a result of daily rebalancing, the benchmark&#8217;s volatility,
compounding, and other factors. Compounding is the cumulative effect of applying investment gains and losses and income to the principal
amount invested over time. Gains or losses experienced over a given period will increase or reduce the principal amount invested from
which the subsequent period&#8217;s returns are calculated. The effects of compounding will likely cause the performance of a Fund to
differ from the Fund&#8217;s stated multiple times the return of its benchmark for the same period. The effect of compounding becomes
more pronounced as benchmark volatility and holding period increase. The impact of compounding will impact each shareholder differently
depending on the period of time an investment in a Fund is held and the volatility of the benchmark during the holding period of an investment
in the Fund. Longer holding periods, higher benchmark volatility, inverse exposure and greater leverage each affect the impact of compounding
on a Fund&#8217;s returns. Daily compounding of a Fund&#8217;s investment returns can dramatically and adversely affect its longer-term
performance during periods of high volatility. Volatility may be at least as important to a Fund&#8217;s return for a period as the return
of the Fund&#8217;s underlying benchmark.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Each Fund uses leverage and should produce daily returns that are more volatile than that of
its benchmark. For example, the daily return of UVIX should be approximately two times as volatile on a daily basis as is the return of
a fund with an objective of matching the same benchmark. The daily return of SVIX is designed to return the inverse (-1x) of the return
that would be expected of a fund with an objective of matching the same benchmark. The Funds are not appropriate for all investors and
present significant risks not applicable to other types of funds. The Funds use leverage and are riskier than similarly benchmarked exchange-traded
funds that do not use leverage. An investor should only consider an investment in a Fund if he or she understands the consequences of
seeking daily leveraged or daily inverse investment results. Shareholders who invest in the Funds should actively manage and monitor their
investments, as frequently as daily.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">While the Funds seek to meet their investment objectives, there is no guarantee they will do so.
Factors that may affect a Fund&#8217;s ability to meet its investment objective include: (1) the Sponsor&#8217;s ability to purchase and
sell Financial Instruments in a manner that correlates to a Fund&#8217;s objective; (2) an imperfect correlation between the performance
of Financial Instruments held by a Fund and the performance of the applicable benchmark; (3) bid-ask spreads on such Financial Instruments;
(4) fees, expenses, transaction costs, financing costs associated with the use of Financial Instruments and commission costs; (5) holding
or trading instruments in a market that has become illiquid or disrupted; (6) a Fund&#8217;s Share prices being rounded to the nearest
cent and/or valuation methodology; (7) changes to a benchmark Index that are not disseminated in advance; (8) the need to conform a Fund&#8217;s
portfolio holdings to comply with investment restrictions or policies or regulatory or tax law requirements; (9) early and unanticipated
closings of the markets on which the holdings of a Fund trade, resulting in the inability of the Fund to execute intended portfolio transactions;
(10) accounting standards; and (11) differences caused by a Fund obtaining exposure to only a representative sample of the components
of a benchmark, over weighting or under weighting certain components of a benchmark or obtaining exposure to assets that are not included
in a benchmark.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">A number of factors may affect a Fund&#8217;s ability to achieve a high degree of correlation with its benchmark, and
there can be no guarantee that a Fund will achieve a high degree of correlation. Failure to achieve a high degree of correlation may prevent
a Fund from achieving its investment objective. In order to achieve a high degree of correlation with their underlying benchmarks, the
Funds seek to rebalance their portfolios daily to keep exposure consistent with their investment objectives. Being materially under- or
over-exposed to the benchmark may prevent such Funds from achieving a high degree of correlation with such benchmark. Market disruptions
or closure, large amounts of assets into or out of the Funds, regulatory restrictions, extreme market volatility, and other factors will
adversely affect such Funds&#8217; ability to adjust exposure to requisite levels. The target amount of portfolio exposure is impacted
dynamically by the benchmarks&#8217; movements during each day. Other things being equal, more significant movement in the value of its
benchmark up or down will require more significant adjustments to a Fund&#8217;s portfolio. Because of this, it is unlikely that the Funds
will be perfectly exposed (i.e., --1x, -2x, as applicable) to its benchmark at the end of each day, and the likelihood of being materially
under- or over-exposed is higher on days when the benchmark levels are volatile near the close of the trading day.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Each Fund seeks to
rebalance its portfolio on a daily basis. The time and manner in which a Fund rebalances its portfolio may vary from day to day depending
upon market conditions and other circumstances at the discretion of the Sponsor. Unlike other funds that do not rebalance their portfolios
as frequently, each Fund may be subject to increased trading costs associated with daily portfolio rebalancing in order to maintain appropriate
exposure to the underlying benchmarks.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Counterparty Risk</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Each Fund may use derivatives such
as swap agreements and forward contracts (collectively referred to herein as &#8220;derivatives&#8221;) in the manner described herein
as a means to achieve their respective investment objectives. The use of derivatives by a Fund exposes the Fund to counterparty risks.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><span style="text-decoration:underline">Regulatory Treatment</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Derivatives are generally traded
in OTC markets and have only recently become subject to comprehensive regulation in the United States. Cash- settled forwards are generally
regulated as &#8220;swaps&#8221;, whereas physically settled forwards are generally not subject to regulation (in the case of commodities
other than currencies) or subject to the federal securities laws (in the case of securities). Title VII of the Dodd-Frank Act (&#8220;Title
VII&#8221;) created a regulatory regime for derivatives, with the CFTC responsible for the regulation of swaps and the SEC responsible
for the regulation of &#8220;security-based swaps.&#8221; The SEC requirements have largely yet to be made effective, but the CFTC requirements
are largely in place. The CFTC requirements have included rules for some of the types of transactions in which the Funds will engage,
including mandatory clearing and exchange trading, reporting, and margin for OTC swaps. Title VII also created new categories of regulated
market participants, such as &#8220;swap dealers,&#8221; &#8220;security- based swap dealers,&#8221; &#8220;major swap participants,&#8221;
and &#8220;major security-based swap participants&#8221; who are, or will be, subject to significant new capital, registration, recordkeeping,
reporting, disclosure, business conduct and other regulatory requirements. The regulatory requirements under Title VII continue to be
developed and there may be further modifications that could materially and adversely impact the Funds, the markets in which a Fund trades
and the counterparties with which the Fund engages in transactions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As noted, the CFTC rules may not
apply to all of the swap agreements and forward contracts entered into by the Funds. Investors, therefore, may not receive the protection
of CFTC regulation or the statutory scheme of the Commodity Exchange Act (the &#8220;CEA&#8221;) in connection with each Fund&#8217;s
swap agreements or forward contracts. The lack of regulation in these markets could expose investors to significant losses under certain
circumstances, including in the event of trading abuses or financial failure by participants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><span style="text-decoration:underline">Counterparty Credit Risk</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Funds will be subject to the
credit risk of the counterparties to the derivatives. In the case of cleared derivatives, the Funds will have credit risk to the clearing
corporation in a similar manner as the Funds would for futures contracts. In the case of OTC derivatives, the Funds will be subject to
the credit risk of the counterparty to the transaction &#8211; typically a single bank or financial institution. As a result, a Fund is
subject to increased credit risk with respect to the amount it expects to receive from counterparties to OTC derivatives entered into
as part of that Fund&#8217;s principal investment strategy. If a counterparty becomes bankrupt or otherwise fails to perform its obligations
due to financial difficulties, a Fund could suffer significant losses on these contracts and the value of an investor&#8217;s investment
in a Fund may decline.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Funds have sought to mitigate
these risks by generally requiring that the counterparties for each Fund agree to post collateral for the benefit of the Fund, marked
to market daily, subject to certain minimum thresholds. However, there are no limitations on the percentage of assets each Fund may invest
in swap agreements or forward contracts with a particular counterparty. To the extent any such collateral is insufficient or there are
delays in accessing the collateral, the Funds will be exposed to counterparty risk as described above, including possible delays in recovering
amounts as a result of bankruptcy proceedings. The Funds typically enter into transactions only with major global financial institutions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">OTC derivatives of the type that
may be utilized by the Funds are generally less liquid than futures contracts because they are not traded on an exchange, do not have
uniform terms and conditions, and are generally entered into based upon the creditworthiness of the parties and the availability of credit
support, such as collateral, and in general, are not transferable without the consent of the counterparty. These agreements contain various
conditions, events of default, termination events, covenants and representations. The triggering of certain events or the default on certain
terms of the agreement could allow a party to terminate a transaction under the agreement and request immediate payment in an amount equal
to the net positions owed to the party under the agreement. For example, if the level of the Fund&#8217;s benchmark has a dramatic intraday
move that would cause a material decline in the Fund&#8217;s NAV, the terms of the swap may permit the counterparty to immediately close
out the transaction with the Fund. In that event, it may not be possible for the Fund to enter into another swap or to invest in other
Financial Instruments necessary to achieve the desired exposure consistent with the Fund&#8217;s objective. This, in turn, may prevent
the Fund from achieving its investment objective, particularly if the level of the Fund&#8217;s benchmark reverses all or part of its
intraday move by the end of the day.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In addition, cleared derivatives
benefit from daily marking-to-market and settlement, and segregation and minimum capital requirements applicable to intermediaries. To
the extent the Fund enters into cleared swap transactions, the Fund will deposit collateral with a FCM in cleared swaps customer accounts,
which are required by CFTC regulations to be separate from its proprietary collateral posted for cleared swaps transactions. Cleared swap
customer collateral is subject to regulations that closely parallel the regulations governing customer segregated funds for futures transactions
but provide certain additional protections to cleared swaps collateral in the event of a clearing broker or clearing broker customer default.
For example, in the event of a default of both the clearing broker and a customer of the clearing broker, a clearing house is only permitted
to access the cleared swaps collateral in the legally separate (but operationally comingled) account of the defaulting cleared swap customer
of the clearing broker, as opposed to the treatment of customer segregated funds, under which the clearing house may access all of the
commingled customer segregated funds of a defaulting clearing broker. Derivatives entered into directly between two counterparties do
not necessarily benefit from such protections, particularly if entered into with an entity that is not registered as a &#8220;swap dealer&#8221;
with the CFTC. This exposes the Funds to the risk that a counterparty will not settle a transaction in accordance with its terms and conditions
because of a dispute over the terms of the contract (whether or not bona fide) or because of a credit or liquidity problem, thus causing
the Funds to suffer a loss.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Sponsor regularly reviews the performance of its counterparties
for, among other things, creditworthiness and execution quality. In addition, the Sponsor periodically considers the addition of new counterparties
and the counterparties used by a Fund may change at any time. Each day, the Funds disclose their portfolio holdings as of the prior Business
Day. Each Fund&#8217;s portfolio holdings identifies its counterparties, as applicable. This portfolio holdings information may be accessed
through the web on the Sponsor&#8217;s website at www.volatilityshares.com.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Each counterparty and/or any of its affiliates may be an
Authorized Participant or shareholder of a Fund, subject to applicable law.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The counterparty risk for cleared derivatives
transactions is generally lower than for OTC derivatives. Once a transaction is cleared, the clearing organization is substituted and
is a Fund&#8217;s counterparty on the derivative. The clearing organization guarantees the performance of the other side of the derivative.
Nevertheless, some risk remains, as there is no assurance that the clearing organization, or its members, will satisfy its obligations
to a Fund.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Leverage Risk</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Funds
may utilize leverage in seeking to achieve their respective investment objectives and will lose more money in market environments adverse
to their respective daily investment objectives than funds that do not employ leverage. The use of leveraged and/or inverse leveraged
positions increases the risk of total loss of an investor&#8217;s investment, even over periods as short as a single day.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For example, because UVIX includes
a two times (2x) multiplier, a single-day movement in the relevant benchmark approaching 50% at any point in the day could result in the
total loss or almost total loss of an investor&#8217;s investment if that movement is contrary to the investment objective of the Fund
in which an investor has invested, even if such Fund&#8217;s benchmark subsequently moves in an opposite direction, eliminating all or
a portion of the movement. This would be the case with downward single-day or intraday movements in the underlying benchmark of a Fund
or upward single-day or intraday movements in the benchmark of a Fund, even if the underlying benchmark maintains a level greater than
zero at all times.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Liquidity Risk</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Financial Instruments cannot always
be liquidated at the desired price. It is difficult to execute a trade at a specific price when there is a relatively small volume of
buy and sell orders in a market. A market disruption can also make it difficult to liquidate a position or find a swap or forward contract
counterparty at a reasonable cost. Market illiquidity may cause losses for the Funds. The large size of the positions which the Funds
may acquire increases the risk of illiquidity by both making their positions more difficult to liquidate and increasing the losses incurred
while trying to do so. Any type of disruption or illiquidity will potentially be exacerbated due to the fact that the Funds will typically
invest in Financial Instruments related to one benchmark, which in many cases is highly concentrated.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#8220;Contango&#8221; and &#8220;Backwardation&#8221;
Risk</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Funds typically hold futures
contracts. As the futures contracts near expiration, they are generally replaced by contracts that have a later expiration. Thus, for
example, a contract purchased and held in November 2019 may specify a January 2020 expiration. As that contract nears expiration, it may
be replaced by selling the January 2020 contract and purchasing the contract expiring in March 2020. This process is referred to as &#8220;rolling.&#8221;
Rolling may have a positive or negative impact on performance. For example, historically, the prices of certain types of futures contracts
have frequently been higher for contracts with shorter-term expirations than for contracts with longer-term expirations, which is referred
to as &#8220;backwardation.&#8221; In these circumstances, absent other factors, the sale of the January 2020 contract would take place
at a price that is higher than the price at which the March 2020 contract is purchased, thereby creating a gain in connection with rolling.
While certain types of futures contracts have historically exhibited consistent periods of backwardation, backwardation will likely not
exist in these markets at all times.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Since the introduction of VIX
futures contracts, there have frequently been periods where VIX futures prices reflect higher expected volatility levels further out in
time. This can result in a loss from &#8220;rolling&#8221; the VIX futures to maintain the constant weighted average maturity of the applicable
Fund benchmark. Losses from exchanging a lower priced VIX future for a higher priced longer-term future in the rolling process could adversely
affect the value of a Fund and, accordingly, decrease the return of a Fund.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Natural Disaster/Epidemic Risk</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Natural or environmental disasters,
such as earthquakes, fires, floods, hurricanes, tsunamis and other severe weather-related phenomena generally, and widespread disease,
including pandemics and epidemics (for example, the novel coronavirus COVID-19), have been and can be highly disruptive to economies and
markets and have recently led, and may continue to lead, to increased market volatility and significant market losses. Such natural disaster
and health crises could exacerbate political, social, and economic risks previously mentioned, and result in significant breakdowns, delays,
shutdowns, social isolation, and other disruptions to important global, local and regional supply chains affected, with potential corresponding
results on the operating performance of the Funds and their investments. A climate of uncertainty and panic, including the contagion of
infectious viruses or diseases, may adversely affect global, regional, and local economies and reduce the availability of potential investment
opportunities, and increases the difficulty of performing due diligence and modeling market conditions, potentially reducing the accuracy
of financial projections. Under these circumstances, the Funds may have difficulty achieving their investment objectives which may adversely
impact performance. Further, such events can be highly disruptive to economies and markets, significantly disrupt the operations of individual
companies (including, but not limited to, the Funds&#8217; Sponsor and third party service providers), sectors, industries, markets, securities
and commodity exchanges, currencies, interest and inflation rates, credit ratings, investor sentiment, and other factors affecting the
value of the Funds&#8217; investments. These factors can cause substantial market volatility, exchange trading suspensions and closures
and can impact the ability of the Funds to complete redemptions and otherwise affect Fund performance and Fund trading in the secondary
market. A widespread crisis may also affect the global economy in ways that cannot necessarily be foreseen at the current time. How long
such events will last and whether they will continue or recur cannot be predicted. Impacts from these events could have significant impact
on a Fund&#8217;s performance, resulting in losses to your investment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Risk that Current Assumptions and Expectations Could
Become Outdated As a Result of Global Economic Shocks</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The onset of the novel coronavirus
(COVID-19) has caused significant shocks to global financial markets and economies, with many governments taking extreme actions to slow
and contain the spread of COVID-19. These actions have had, and likely will continue to have, a severe economic impact on global economies
as economic activity in some instances has essentially ceased. Financial markets across the globe are experiencing severe distress at
least equal to what was experienced during the global financial crisis in 2008. In March 2020, U.S. equity markets entered a bear market
in the fastest such move in the history of U.S. financial markets. Contemporaneous with the onset of the COVID-19 pandemic in the US,
oil experienced shocks to supply and demand, impacting the price and volatility of oil. The global economic shocks being experienced as
of the date hereof may cause the underlying assumptions and expectations of the Funds to become outdated quickly or inaccurate, resulting
in significant losses.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_RiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_RiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 275<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//275/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140493289773232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_SubsequentEventsLineItems', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">NOTE 9 &#8211; SUBSEQUENT EVENTS</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Management has evaluated the possibility
of subsequent events existing in the Trust&#8217;s and the Funds&#8217; financial statements through the date the financial statements
were issued. Management has determined that there are no material events that would require disclosure in the Trust&#8217;s or the Funds&#8217;
financial statements through this date.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_SubsequentEventsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_SubsequentEventsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140493294099904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounting Policies, by Policy (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_EmergingGrowthCompanyPolicyTextBlock', window );">Emerging growth company</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 7.7pt">Emerging growth company</p><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">The Trust is an &#8220;emerging
growth company,&#8221; as defined in the Jumpstart Our Business Startups Act of 2012. It will remain an emerging growth company until
the earlier of (1) the beginning of the first fiscal year following the fifth anniversary of its initial public offering, (2) the beginning
of the first fiscal year after annual gross revenue is $1.07 billion (subject to adjustment for inflation) or more, (3) the date on which
the Fund has, during the previous three-year period, issued more than $1.0 billion in non-convertible debt securities and (4) as of the
end of any fiscal year in which the market value of common equity held by non-affiliates exceeded $700 million as of the end of the second
quarter of that fiscal year.</p><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">For as
long as the Trust remains an &#8220;emerging growth company,&#8221; it may take advantage of certain exemptions from the various reporting
requirements that are applicable to public companies that are not &#8220;emerging growth companies&#8221; including, but not limited
to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure
obligations regarding executive compensation and financial statements in our periodic reports and proxy statements, and exemptions from
the requirements of holding a nonbinding advisory vote to approve executive compensation and shareholder approval of any golden parachute
payments not previously approved. The Trust will take advantage of these reporting exemptions until it is no longer an &#8220;emerging
growth company.&#8221;</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates &amp; Indemnifications</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Use of Estimates &amp; Indemnifications</p><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">The preparation of financial statements
in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities
and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and
expenses during the reporting period. Actual results could differ from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">In
the normal course of business, the Trust enters into contracts that contain a variety of representations which provide general
indemnifications. The Trust&#8217;s maximum exposure under these arrangements cannot be known; however, the Trust expects any risk
of loss to be remote.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Basis of Presentation</p><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Pursuant to rules and regulations
of the SEC, these financial statements are presented for the Trust as a whole, as the SEC registrant, and for each Fund individually.
The debts, liabilities, obligations and expenses incurred, contracted for or otherwise existing with respect to a particular Fund shall
be enforceable only against the assets of such Fund and not against the assets of the Trust generally or any other Fund. Accordingly,
the assets of each Fund of the Trust include only those funds and other assets that are paid to, held by or distributed to the Trust for
the purchase of Shares in that Fund.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_StatementsOfCashFlowsPolicyTextBlock', window );">Statements of Cash Flows</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Statements of Cash Flows</p><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">The
cash amount shown in the Statements of Cash Flows is the amount reported as cash in the Statements of Financial Condition dated June
30, 2023 and December 31, 2022, and represents cash, but does not include short-term investments.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_FinalNetAssetValueForFiscalPeriodPolcyTextBlock', window );">Final Net Asset Value for Fiscal Period</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Final Net Asset Value for Fiscal Period</p><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">The cut-off times and the times
of the calculation of the Funds&#8217; final net asset value for creation and redemption of fund Shares for the three months ended June
30, 2023 were typically as follows. All times are Eastern Standard Time:</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">NAV</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">NAV</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">Create/Redeem</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">Calculation</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">Calculation</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; width: 64%; font-weight: bold; text-align: left">Fund</td><td style="padding-bottom: 1.5pt; width: 1%; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 11%; font-weight: bold; text-align: center">Cut-off*(EST)</td><td style="padding-bottom: 1.5pt; width: 1%; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 11%; font-weight: bold; text-align: center">Time (EST)</td><td style="padding-bottom: 1.5pt; width: 1%; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 11%; font-weight: bold; text-align: center">Date</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">-1x Short VIX Futures ETF and</td><td>&#160;</td>
    <td style="text-align: center">2:00 p.m.</td><td>&#160;</td>
    <td style="text-align: center">4:00 p.m.</td><td>&#160;</td>
    <td style="text-align: center">June 30, 2023</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">2x Long VIX Futures ETF</td><td>&#160;</td>
    <td style="text-align: center">2:00 p.m.</td><td>&#160;</td>
    <td style="text-align: center">4:00 p.m.</td><td>&#160;</td>
    <td style="text-align: center">June 30, 2023</td></tr>
  </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 7.7pt"></td><td style="width: 14.95pt">*</td><td style="padding-right: 7.8pt">Although the Funds&#8217; shares may continue to trade on secondary markets subsequent to the calculation
of the final NAV, these times represent the final opportunity to transact in creation or redemption units for the three months ended June
30, 2023.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Market value per Share is determined at the close of Cboe
BZX and may be later than when the Funds&#8217; NAV per Share is calculated.</p><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">For financial reporting purposes,
the Funds value transactions based upon the final closing price in their primary markets. Accordingly, the investment valuations in these
financial statements may differ from those used in the calculation of certain of the Funds&#8217; final creation/redemption NAV for the
three months ended June 30, 2023.</p><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Investment Valuation</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Investment Valuation</p><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Short-term investments are valued
at amortized cost which approximates fair value for daily NAV purposes. For financial reporting purposes, short-term investments are valued
at their market price using information provided by a third-party pricing service or market quotations. In each of these situations, valuations
are typically categorized as Level I in the fair value hierarchy.</p><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">VIX futures
contracts are valued using the Time Weighted Average Price (TWAP) of the futures during the last 15 minutes of NYSE&#8217;s regular trading
session, rather than solely from the VIX futures&#8217; settlement price. The value of a Fund&#8217;s non-exchange-traded Financial Instruments
typically is determined by applying the then-current disseminated levels for the Index to the terms of the Fund&#8217;s non-exchange-traded
Financial Instruments.</p><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">In certain circumstances (e.g.,
if the Sponsor believes market quotations do not accurately reflect the fair value of a Fund&#8217;s investment, or a trading halt closes
an exchange or market early), the Sponsor may, in its sole discretion, choose to determine a fair value price as the basis for determining
the market value of such investment for such day. Such fair value prices would generally be determined based on available inputs about
the current value of the underlying VIX futures contract and would be based on principles that the Sponsor deems fair and equitable.</p><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">The Funds may use a variety of
money market instruments. Money market instruments generally will be valued using market prices or at amortized cost.</p><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Fair value pricing may require
subjective determinations about the value of an investment. While the Funds&#8217; policies are intended to result in a calculation of
its respective Fund&#8217;s NAV that fairly reflects investment values as of the time of pricing, such Fund cannot ensure that fair values
determined by the Sponsor or persons acting at their direction would accurately reflect the price that a Fund could obtain for an investment
if it were to dispose of that investment as of the time of pricing (for instance, in a forced or distressed sale). The prices used by
such Fund may differ from the value that would be realized if the investments were sold and the differences could be material to the financial
statements.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Fair Value of Financial Instruments</p><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">The
Funds disclose the fair value of their investments in a hierarchy that prioritizes the inputs to valuation techniques used to
measure fair value. The disclosure requirements establish a fair value hierarchy that distinguishes between: (1) market participant
assumptions developed based on market data obtained from sources independent of the Funds (observable inputs); and (2) the
Funds&#8217; own assumptions about market participant assumptions developed based on the best information available under the
circumstances (unobservable inputs). The three levels defined by the disclosure requirements hierarchy are as follows:</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.5in; text-align: left">Level I</td><td style="text-align: center; width: 0.25in">&#8211;</td>
                                                                                      <td style="text-align: left">Quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access
at the measurement date.</td>
</tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.5in"></td><td style="width: 0.5in; text-align: left">Level II</td><td style="text-align: center; width: 0.25in">&#8211;</td>
                                                                                       <td style="text-align: left">Inputs other than quoted prices included within Level I that are observable for the asset or liability, either directly or indirectly.
Level II assets include the following: quoted prices for similar assets or liabilities in active markets, quoted prices for identical
or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or
liability, and inputs that are derived principally from or corroborated by observable market data by correlation or other means (market-corroborated
inputs).</td>
</tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.5in"></td><td style="width: 0.5in; text-align: left">Level III</td><td style="text-align: center; width: 0.25in">&#8211;</td>
                                                                                        <td style="text-align: left">Unobservable pricing input at the measurement date for the asset or liability. Unobservable inputs shall be used to measure fair value
to the extent that observable inputs are not available.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">In some instances, the inputs used
to measure fair value might fall in different levels of the fair value hierarchy. The level in the fair value hierarchy within which the
fair value measurement in its entirety falls is determined based on the lowest input level that is significant to the fair value measurement
in its entirety.</p><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Fair value measurements also require additional
disclosure when the volume and level of activity for the asset or liability have significantly decreased, as well as when circumstances
indicate that a transaction is not orderly.</p><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">The following table summarizes the valuation of investments
at June 30, 2023 (unaudited) and December 31, 2022 using the fair value hierarchy:</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"><b>June 30, 2023 (Unaudited)</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"><b>December 31, 2022</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Fund</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Level 1 - <br/>
Money <br/>
Market <br/>
Fund</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Level 2 - <br/>
Futures <br/>
Contracts*</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total <br/>
June 30, <br/>
2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Level 1 - <br/>
Money <br/>
Market <br/>
Fund</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Level 2 - <br/>
Futures <br/>
Contracts*</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total <br/>
December&#160;31, <br/>
2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; text-align: left">-1x Short VIX Futures ETF</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-62">&#8211;</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">6,518,579</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">6,518,579</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,156,106</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,156,106</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">2x Long VIX Futures ETF</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,517,548</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(19,791,036</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(10,273,488</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,250,285</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(9,203,522</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(953,237</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Total Trust</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">9,517,548</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(13,272,457</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(3,754,909</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">8,250,285</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(8,047,416</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">202,869</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left">*</td><td style="text-align: left">Includes cumulative appreciation (depreciation) of futures
contracts as reported in the Schedule of Investments. Only current day&#8217;s variation margin is reported within the Statements of
Financial Condition in receivable/payable on open futures.</td>
</tr></table><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The inputs or methodology used for valuing investments
are not necessarily an indication of the risk associated with investing in those securities.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnremittedEarningsInForeignInvestmentPolicy', window );">Investment Transactions and Related Income</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Investment Transactions and Related Income</b></p><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Investment transactions are recorded on the trade
date. All such transactions are recorded on the identified cost basis and marked to market daily. Unrealized appreciation (depreciation)
on open contracts are reflected in the Statements of Financial Condition and changes in the unrealized appreciation (depreciation) between
periods are reflected in the Statements of Operations.</p><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Interest income is recognized on an accrual basis
and includes, where applicable, the amortization of premium or discount, and is reflected as Interest Income in the Statement of Operations.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FloorBrokeragePolicy', window );">Brokerage Commissions and Futures Account Fees</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Brokerage Commissions and Futures Account Fees</b></p><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Each Fund pays its respective brokerage commissions,
including applicable exchange fees, National Futures Association (&#8220;NFA&#8221;) fees, give-up fees, pit brokerage fees and other
transaction related fees and expenses charged in connection with trading activities for each Fund&#8217;s investment in U.S. Commodity
Futures Trading Commission (&#8220;CFTC&#8221;) regulated investments. The effects of trading spreads, financing costs/fees associated
with Financial Instruments, and costs relating to the purchase of U.S. Treasury securities or similar high credit quality short-term fixed-income
would also be borne by the Funds. Brokerage commissions on futures contracts are recognized on a half-turn basis (e.g., the first half
is recognized when the contract is purchased (opened) and the second half is recognized when the transaction is closed). The Sponsor is
currently paying brokerage commissions on VIX futures contracts for the Funds that exceed variable create/redeem fees collected by more
than&#160;0.03% and 0.00%, for SVIX and UVIX, respectively, of each Fund's average net assets annually.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Federal Income Tax</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Federal Income Tax</b></p><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Each Fund is registered as a series of a Delaware
statutory trust and is treated as a partnership for U.S. federal income tax purposes. Accordingly, no Fund expects to incur U.S. federal
income tax liability; rather, each beneficial owner of a Fund&#8217;s Shares is required to take into account its allocable share of its
Fund&#8217;s income, gain, loss, deductions and other items for its Fund&#8217;s taxable year ending with or within the beneficial owner&#8217;s
taxable year.</p><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Management of the Funds has reviewed all open tax
years and major jurisdictions (i.e., the last four tax year ends and the interim tax period since then, as applicable) and concluded that
there is no tax liability resulting from unrecognized tax benefits relating to uncertain income tax positions taken or expected to be
taken in future tax returns. The Funds are also not aware of any tax positions for which it is reasonably possible that the total amounts
of unrecognized tax benefits will significantly change in the next twelve months. On an ongoing basis, management monitors its tax positions
taken under the interpretation to determine if adjustments to conclusions are necessary based on factors including, but not limited to,
on-going analysis of tax law, regulation, and interpretations thereof.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_EmergingGrowthCompanyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for emerging growth company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_EmergingGrowthCompanyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_FinalNetAssetValueForFiscalPeriodPolcyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of final net asset value for fiscal period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_FinalNetAssetValueForFiscalPeriodPolcyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_StatementsOfCashFlowsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of statements of cash flows.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_StatementsOfCashFlowsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 60<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482053/820-10-60-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 825<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FloorBrokeragePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the recognition and recording of fees paid to other broker dealers for executing trades. Broker-dealers often use other brokers to execute trades on their behalf. The trading broker-dealer becomes a customer of the executing broker-dealer and pays a floor brokerage fee. Such fees are paid periodically either directly to the executing broker-dealer or through a clearinghouse. These include fees paid to clearing brokers and market specialists.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 8<br> -SubTopic 20<br> -Topic 940<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481913/940-20-25-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FloorBrokeragePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-25<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-19<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(f)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(f)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(f)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 12<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-12<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 19<br> -Subparagraph (2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-19<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnremittedEarningsInForeignInvestmentPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for tax treatment of unremitted earnings in a foreign investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 6<br> -SubTopic 30<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482655/740-30-25-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnremittedEarningsInForeignInvestmentPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140493289045040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock', window );">Schedule of Cut-Off Times and the Times of the Calculation of the Funds</a></td>
<td class="text">The cut-off times and the times
of the calculation of the Funds&#8217; final net asset value for creation and redemption of fund Shares for the three months ended June
30, 2023 were typically as follows. All times are Eastern Standard Time:<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">NAV</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">NAV</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">Create/Redeem</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">Calculation</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">Calculation</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; width: 64%; font-weight: bold; text-align: left">Fund</td><td style="padding-bottom: 1.5pt; width: 1%; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 11%; font-weight: bold; text-align: center">Cut-off*(EST)</td><td style="padding-bottom: 1.5pt; width: 1%; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 11%; font-weight: bold; text-align: center">Time (EST)</td><td style="padding-bottom: 1.5pt; width: 1%; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 11%; font-weight: bold; text-align: center">Date</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">-1x Short VIX Futures ETF and</td><td>&#160;</td>
    <td style="text-align: center">2:00 p.m.</td><td>&#160;</td>
    <td style="text-align: center">4:00 p.m.</td><td>&#160;</td>
    <td style="text-align: center">June 30, 2023</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">2x Long VIX Futures ETF</td><td>&#160;</td>
    <td style="text-align: center">2:00 p.m.</td><td>&#160;</td>
    <td style="text-align: center">4:00 p.m.</td><td>&#160;</td>
    <td style="text-align: center">June 30, 2023</td></tr>
  </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 7.7pt"></td><td style="width: 14.95pt">*</td><td style="padding-right: 7.8pt">Although the Funds&#8217; shares may continue to trade on secondary markets subsequent to the calculation
of the final NAV, these times represent the final opportunity to transact in creation or redemption units for the three months ended June
30, 2023.</td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Valuation of Investments at Using the Fair Value Hierarchy</a></td>
<td class="text">The following table summarizes the valuation of investments
at June 30, 2023 (unaudited) and December 31, 2022 using the fair value hierarchy:<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"><b>June 30, 2023 (Unaudited)</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"><b>December 31, 2022</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Fund</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Level 1 - <br/>
Money <br/>
Market <br/>
Fund</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Level 2 - <br/>
Futures <br/>
Contracts*</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total <br/>
June 30, <br/>
2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Level 1 - <br/>
Money <br/>
Market <br/>
Fund</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Level 2 - <br/>
Futures <br/>
Contracts*</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total <br/>
December&#160;31, <br/>
2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; text-align: left">-1x Short VIX Futures ETF</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-62">&#8211;</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">6,518,579</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">6,518,579</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,156,106</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,156,106</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">2x Long VIX Futures ETF</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,517,548</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(19,791,036</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(10,273,488</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,250,285</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(9,203,522</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(953,237</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Total Trust</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">9,517,548</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(13,272,457</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(3,754,909</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">8,250,285</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(8,047,416</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">202,869</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left">*</td><td style="text-align: left">Includes cumulative appreciation (depreciation) of futures
contracts as reported in the Schedule of Investments. Only current day&#8217;s variation margin is reported within the Statements of
Financial Condition in receivable/payable on open futures.</td>
</tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of cut-off times and times of calculation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140493295410976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_InvestmentsTablesLineItems', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Schedule of Fair Value of Derivative Instruments</a></td>
<td class="text">The counterparty/credit risk for cleared derivative
transactions is generally lower than for OTC derivatives since generally a clearing organization becomes substituted for each counterparty
to a cleared derivative contract and, in effect, guarantees the parties&#8217; performance under the contract as each party to a trade
looks only to the clearing organization for performance of financial obligations. In addition, cleared derivative transactions benefit
from daily marking-to-market and settlement, and segregation and minimum capital requirements applicable to intermediaries.<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; white-space: nowrap; text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair Values of Derivative Instruments as of June 30, 2023 (Unaudited)</b></span></td>
    <td style="text-align: left; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td></tr>
  <tr>
    <td style="text-align: center; padding-bottom: 1.5pt; white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt; white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="4" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Asset Derivatives</b></span></td>
    <td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="4" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Liability Derivatives</b></span></td>
    <td style="text-align: left; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td></tr>
  <tr>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: left; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Derivatives Not <br/>
Accounted for as <br/>
Hedging Instruments</b></span></td>
    <td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fund</b></span></td>
    <td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Statements of <br/>
Financial <br/>
Condition&#160;Location</b></span></td>
    <td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unrealized <br/> Appreciation</b></span></td>
    <td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Statements of <br/>
Financial <br/>
Condition&#160;Location</b></span></td>
    <td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unrealized <br/> Depreciation</b></span></td>
    <td style="text-align: left; vertical-align: bottom">&#160;</td></tr>
  <tr>
    <td style="white-space: nowrap; font-size: 10pt; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">VIX Futures Contracts </span></td>
    <td style="width: 1%">&#160;</td>
    <td style="white-space: nowrap; width: 20%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: center; font-size: 10pt; width: 17%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: center; font-size: 10pt; width: 9%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: center; font-size: 10pt; width: 16%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: center; font-size: 10pt; width: 9%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="text-align: right; white-space: nowrap">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left; white-space: nowrap; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-1x Short VIX Futures ETF </span></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right; font-size: 10pt">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">$</td>
    <td style="text-align: right; white-space: nowrap; font-size: 10pt"><span style="-sec-ix-hidden: hidden-fact-63; font-family: Times New Roman, Times, Serif; font-size: 10pt"> 6,518,579</span></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right; white-space: nowrap">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">$</td>
    <td style="text-align: right; white-space: nowrap; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> - </span></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr>
    <td style="padding-bottom: 1.5pt; text-align: right; white-space: nowrap">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left; white-space: nowrap; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2x Long VIX Futures ETF </span></td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right; white-space: nowrap">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right; white-space: nowrap; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- </span></td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right; white-space: nowrap">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right; white-space: nowrap; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(19,791,036</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt; text-align: right; white-space: nowrap">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: left; white-space: nowrap; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total Trust </b></span></td>
    <td style="padding-bottom: 4pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: right; white-space: nowrap">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><b>$</b></td>
    <td style="border-bottom: Black 4pt double; text-align: right; white-space: nowrap; font-size: 10pt"><span style="-sec-ix-hidden: hidden-fact-64; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160; 6,518,579</b></span></td>
    <td style="padding-bottom: 4pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: right; white-space: nowrap">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><b>$</b></td>
    <td style="border-bottom: Black 4pt double; text-align: right; white-space: nowrap; font-size: 10pt"><span style="-sec-ix-hidden: hidden-fact-65; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160; (19,791,036</b></span></td>
    <td style="padding-bottom: 4pt; text-align: left">)</td></tr>
  </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; white-space: nowrap; text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair Values of Derivative Instruments as of December 31, 2022</b></span></td>
    <td style="text-align: left; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td></tr>
  <tr>
    <td style="text-align: center; padding-bottom: 1.5pt; white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt; white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="4" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Asset Derivatives</b></span></td>
    <td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="4" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Liability Derivatives</b></span></td>
    <td style="text-align: left; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td></tr>
  <tr>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: left; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Derivatives Not <br/>
Accounted for as <br/>
Hedging Instruments</b></span></td>
    <td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fund</b></span></td>
    <td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Statements of <br/>
Financial <br/>
Condition&#160;Location</b></span></td>
    <td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unrealized <br/> Appreciation</b></span></td>
    <td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Statements of <br/>
Financial <br/>
Condition&#160;Location</b></span></td>
    <td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unrealized <br/> Depreciation</b></span></td>
    <td style="text-align: left; vertical-align: bottom">&#160;</td></tr>
  <tr>
    <td style="white-space: nowrap; font-size: 10pt; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">VIX Futures Contracts </span></td>
    <td style="width: 1%">&#160;</td>
    <td style="white-space: nowrap; width: 20%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: center; font-size: 10pt; width: 17%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: center; font-size: 10pt; width: 9%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: center; font-size: 10pt; width: 16%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: center; font-size: 10pt; width: 9%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="text-align: right; white-space: nowrap">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left; white-space: nowrap; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-1x Short VIX Futures ETF </span></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right; font-size: 10pt">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">$</td>
    <td style="text-align: right; white-space: nowrap; font-size: 10pt"><span style="-sec-ix-hidden: hidden-fact-66; font-family: Times New Roman, Times, Serif; font-size: 10pt"> 1,156,106 </span></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right; white-space: nowrap">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">$</td>
    <td style="text-align: right; white-space: nowrap; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> - </span></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr>
    <td style="padding-bottom: 1.5pt; text-align: right; white-space: nowrap">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left; white-space: nowrap; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2x Long VIX Futures ETF </span></td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right; white-space: nowrap">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right; white-space: nowrap; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- </span></td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right; white-space: nowrap">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right; white-space: nowrap; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9,203,522</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt; text-align: right; white-space: nowrap">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: left; white-space: nowrap; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total Trust </b></span></td>
    <td style="padding-bottom: 4pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: right; white-space: nowrap">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><b>$</b></td>
    <td style="border-bottom: Black 4pt double; text-align: right; white-space: nowrap; font-size: 10pt"><span style="-sec-ix-hidden: hidden-fact-67; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160; 1,156,106 </b></span></td>
    <td style="padding-bottom: 4pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: right; white-space: nowrap">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><b>$</b></td>
    <td style="border-bottom: Black 4pt double; text-align: right; white-space: nowrap; font-size: 10pt"><span style="-sec-ix-hidden: hidden-fact-68; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160; (9,203,522</b></span></td>
    <td style="padding-bottom: 4pt; text-align: left">)</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock', window );">Schedule of Effect of Derivative Instruments on The Statement of Operations</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td colspan="21" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">The Effect of Derivative Instruments on the Statement of Operations</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="21" style="font-weight: bold; text-align: center">For the Three Months Ended June 30, 2023 (Unaudited) and June 30, 2022 (Unaudited)</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="21" style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Derivatives Not <br/>
Accounted for as Hedging Instruments</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Location of Gain (Loss) on Derivatives Recognized in Income</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Fund</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Realized Gain <br/>
(Loss) on <br/>
Derivatives Recognized <br/>
in Income <br/>
June 30, <br/>
2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Change in <br/>
Unrealized <br/>
Appreciation <br/>
(Depreciation) <br/>
on Derivatives <br/>
Recognized <br/>
in Income <br/>
June 30, <br/>
2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Realized&#160;Gain<br/>
 (Loss) on <br/>
Derivatives <br/>
Recognized <br/>
in Income <br/>
June 30, <br/>
2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Change in <br/>
Unrealized <br/>
Appreciation <br/>
(Depreciation) <br/>
on Derivatives <br/>
Recognized <br/>
in Income <br/>
June 30, <br/>
2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; vertical-align: top; text-align: left">VIX Futures Contracts</td><td>&#160;</td>
    <td style="text-align: left">Net realized gain (loss) on futures contracts/changes in unrealized appreciation (depreciation) on futures contracts</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 15%">&#160;</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 26%">&#160;</td><td style="width: 0.5%">&#160;</td>
    <td style="white-space: nowrap; width: 16%; text-align: left">-1x Short VIX Futures ETF</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%; text-align: left">$</td><td style="width: 9%; text-align: right">37,164,451</td><td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%; text-align: left">$</td><td style="width: 9%; text-align: right">(811,301</td><td style="width: 0.5%; text-align: left">)</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%; text-align: left">$</td><td style="width: 9%; text-align: right">(4,573,051</td><td style="width: 0.5%; text-align: left">)</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%; text-align: left">$</td><td style="width: 9%; text-align: right">835,808</td><td style="width: 0.5%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">2x Long VIX Futures ETF</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(142,872,642</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(4,374,661</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,528,449</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(256,944</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 4pt; font-weight: bold; text-align: left">Total Trust</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(105,708,191</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(5,185,962</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">2,955,398</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">578,864</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td colspan="21" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">The Effect of Derivative Instruments on the Statement of Operations</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="21" style="font-weight: bold; text-align: center">For the Six Months Ended June 30, 2023 (Unaudited) and June 30, 2022 (Unaudited)</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="21" style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Derivatives Not <br/>
Accounted for as Hedging Instruments</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Location of Gain (Loss) on Derivatives Recognized in Income</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Fund</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Realized Gain <br/>
(Loss) on <br/>
Derivatives <br/>
Recognized <br/>
in Income<br/>
 June 30, <br/>
2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Change in <br/>
Unrealized <br/>
Appreciation <br/>
(Depreciation) <br/>
on Derivatives <br/>
Recognized in <br/>
Income <br/>
June 30, <br/>
2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Realized&#160;Gain<br/>
 (Loss) on <br/>
Derivatives <br/>
Recognized <br/>
in Income <br/>
June 30, <br/>
2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Change in <br/>
Unrealized <br/>
Appreciation <br/>
(Depreciation) <br/>
on Derivatives <br/>
Recognized<br/>
 in Income <br/>
June 30, <br/>
2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; vertical-align: top; text-align: left">VIX Futures Contracts</td><td>&#160;</td>
    <td style="text-align: left">Net realized gain (loss) on futures contracts/changes in unrealized appreciation (depreciation) on futures contracts</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 15%">&#160;</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 26%">&#160;</td><td style="width: 0.5%">&#160;</td>
    <td style="white-space: nowrap; width: 16%; text-align: left">-1x Short VIX Futures ETF</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%; text-align: left">$</td><td style="width: 9%; text-align: right">42,451,505</td><td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%; text-align: left">$</td><td style="width: 9%; text-align: right">5,362,473</td><td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%; text-align: left">$</td><td style="width: 9%; text-align: right">(4,577,129</td><td style="width: 0.5%; text-align: left">)</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%; text-align: left">$</td><td style="width: 9%; text-align: right">700,531</td><td style="width: 0.5%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">2x Long VIX Futures ETF</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(186,102,397</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(10,587,514</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,527,995</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">19,258</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 4pt; font-weight: bold; text-align: left">Total Trust</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(143,650,892</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(5,225,041</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">2,950,866</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">719,789</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsTableTextBlock', window );">Schedule of Pledged By Funds Fair Values of Derivative Instruments</a></td>
<td class="text">For financial reporting purposes, the Funds do not offset derivative assets and derivative
liabilities that are subject to netting arrangements in the Statements of Financial Condition. The following table presents each Fund&#8217;s
derivatives by investment type and by counterparty net of amounts available for offset under a master netting agreement and the related
collateral received or pledged by the Funds as of June 30, 2023 and December 31, 2022.<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td colspan="25" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Fair Values of Derivative Instruments as of June 30, 2023 (Unaudited)</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="25" style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Assets</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Liabilities</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Fund</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross<br/> Amounts of<br/> Recognized<br/> Assets<br/> presented<br/> in the<br/> Statements<br/> of Financial<br/> Condition</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross<br/> Amounts<br/> Offset<br/> in the<br/> Statements<br/> of Financial<br/> Condition</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Net Amounts<br/> of Assets<br/> presented<br/> in the<br/> Statements<br/> of Financial<br/> Condition</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross<br/> Amounts of<br/> Recognized<br/> Liabilities<br/> presented<br/> in the<br/> Statements<br/> of Financial<br/> Condition</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross<br/> Amounts<br/> Offset<br/> in the<br/> Statements<br/> of Financial<br/> Condition</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Net Amounts<br/> of&#160;Liabilities<br/> presented<br/> in the<br/> Statements<br/> of Financial<br/> Condition</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; text-align: left">-1x Short VIX Futures ETF</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,242,108</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-69">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,242,108</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-70">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-71">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-72">-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">2x Long VIX Futures ETF</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-73">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-74">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-75">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3,406,049</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-76">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,406,049</td><td style="text-align: left">&#160;</td></tr>
  </table><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td colspan="25" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Fair Values of Derivative Instruments as of December 31, 2022</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="25" style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Assets</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Liabilities</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Fund</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross<br/> Amounts of<br/> Recognized<br/> Assets<br/> presented<br/> in the<br/> Statements<br/> of Financial<br/> Condition</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross<br/> Amounts<br/> Offset<br/> in the<br/> Statements<br/> of Financial<br/> Condition</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Net Amounts<br/> of Assets<br/> presented<br/> in the<br/> Statements<br/> of Financial<br/> Condition</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross<br/> Amounts of<br/> Recognized<br/> Liabilities<br/> presented<br/> in the<br/> Statements<br/> of Financial<br/> Condition</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross<br/> Amounts<br/> Offset<br/> in the<br/> Statements<br/> of Financial<br/> Condition</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Net Amounts<br/> of Liabilities<br/> presented<br/> in the<br/> Statements<br/> of Financial<br/> Condition</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; text-align: left">-1x Short VIX Futures ETF</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-77">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">187,030</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-78">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">187,030</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">2x Long VIX Futures ETF</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">830,840</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-79">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">830,840</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-80">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  </table><p style="text-align: center; margin-top: 0; margin-bottom: 0">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock', window );">Schedule of Gross Amounts Not Offset In The Statements of Financial Condition</a></td>
<td class="text">Asset (Liability) amounts shown in the table below represent amounts owed to (by) the Funds for the derivative-related investments at
June 30, 2023 and December 31, 2022. These amounts may be collateralized by cash or financial instruments, segregated for the benefit of
the Funds or the counterparties, depending on whether the related contracts are in an appreciated or depreciated position at period end.
Amounts shown in the column labeled &#8220;Net Amount&#8221; represent the uncollateralized portions of these amounts at period end. These
amounts may be un-collateralized due to timing differences related to market movements or due to minimum thresholds for collateral movement,
as further described above under the caption &#8220;Accounting for Derivative Instruments&#8221;.<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td colspan="17" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross Amounts Not Offset in the Statements of Financial Condition as of June 30, 2023 (Unaudited)</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="17" style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Fund</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amounts of<br/> Recognized<br/> Assets /<br/> (Liabilities)<br/> presented<br/> in the<br/> Statements<br/> of Financial<br/> Condition</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Financial<br/> Instruments<br/> for the Benefit<br/> of (the Funds) / the<br/> Counterparties</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Cash<br/> Collateral for<br/> the Benefit of<br/> (the Funds) / the<br/> Counterparties</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Net Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">-1x Short VIX Futures ETF</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,242,108</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-81">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-82">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,242,108</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">2x Long VIX Futures ETF</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,406,049</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-83">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-84">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,406,049</td><td style="text-align: left">)</td></tr>
  </table><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td colspan="17" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross Amounts Not Offset in the Statements of Financial Condition as of December 31, 2022</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="17" style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Fund</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amounts of<br/> Recognized<br/> Assets /<br/> (Liabilities)<br/> presented<br/> in the<br/> Statements<br/> of Financial<br/> Condition</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Financial<br/> Instruments<br/> for the Benefit<br/> of (the<br/>
 Funds) / the<br/> Counterparties</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Cash<br/> Collateral for<br/> the Benefit of<br/> (the Funds) / the<br/> Counterparties</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Net Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">-1x Short VIX Futures ETF</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(187,030</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(187,030</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">2x Long VIX Futures ETF</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">830,840</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">830,840</td><td style="text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_InvestmentsTablesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_InvestmentsTablesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of pledged by funds fair values of derivative instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of supplemental cash flow information for the periods presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for fair value hedging instruments of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4C<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140493294822912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Creation and Redemption of Creation Units (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_CreationandRedemptionofCreationUnitsTablesLineItems', window );"><strong>Creation and Redemption of Creation Units [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_ScheduleOfTransactionFeesTableTextBlock', window );">Schedule of Transaction Fees</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Fund</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Three <br/>
Months <br/>
Ended <br/>
June 30, <br/>
2023 <br/>
(Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Three <br/>
Months <br/>
Ended <br/>
June 30, <br/>
2022 <br/>
(Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">-1x Short VIX Futures ETF</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">31,820</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">62,214</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">2x Long VIX Futures ETF</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">66,946</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">45,789</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Trust</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">98,766</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">108,003</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Fund</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Six Months <br/>
Ended <br/>
June 30, <br/>
2023 <br/>
(Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Six Months <br/>
Ended <br/>
June 30, <br/>
2022 <br/>
(Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">-1x Short VIX Futures ETF</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">77,483</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">63,870</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">2x Long VIX Futures ETF</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">119,613</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">46,905</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Trust</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">197,096</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">110,775</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_CreationandRedemptionofCreationUnitsTablesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_CreationandRedemptionofCreationUnitsTablesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_ScheduleOfTransactionFeesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of transaction fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_ScheduleOfTransactionFeesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140493285737600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Highlights (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_FinancialHighlightsTablesLineItems', window );"><strong>Financial Highlights [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_ScheduleOfShareOutstandingTableTextBlock', window );">Schedule of Share Outstanding</a></td>
<td class="text">Selected data is for a Share outstanding throughout the Three Months
Ended June 30, 2023 (Unaudited) and June 30, 2022 (Unaudited)<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">-1x Short VIX Futures ETF</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2x Long VIX Futures ETF</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">-1x Short VIX Futures ETF</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2x Long VIX Futures ETF</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Quarter Ended</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Quarter Ended</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Quarter Ended</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Quarter Ended</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">June 30, <br/>
2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">June 30, <br/>
2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">June 30, <br/>
2022</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">June 30, <br/>
2022</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -10pt; padding-left: 10pt; width: 52%">Net Asset Value, Beginning of Period</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">16.55</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">15.88</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">14.16</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">83.20</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net investment loss <sup>(1)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.09</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.03</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.05</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.60</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net Realized and Unrealized Gain (Loss) on Investments and Futures Contracts <sup>(2)</sup></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">11.67</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(11.41</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3.71</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3.00</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Net Increase (Decrease) in Net Asset Value Resulting from Operations</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">11.58</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(11.44</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3.76</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2.40</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -10pt; padding-left: 10pt; padding-bottom: 4pt">Net Asset Value, End of Period</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">28.13</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">4.44</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">10.40</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">85.60</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -10pt; padding-left: 10pt; padding-bottom: 4pt">Market Value Per Share, at June 30, 2023 and June 30, 2022</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">28.07</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">4.46</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">10.40</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">85.40</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total Return at Net Asset Value <sup>(4)</sup></b></span></td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">69.97</td><td style="font-weight: bold; text-align: left">%</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-72.04</td><td style="font-weight: bold; text-align: left">%</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-26.56</td><td style="font-weight: bold; text-align: left">%</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">2.88</td><td style="font-weight: bold; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -10pt; padding-left: 10pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total Return at Market Value <sup>(4)</sup></b></span></td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">70.02</td><td style="font-weight: bold; text-align: left">%</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-72.09</td><td style="font-weight: bold; text-align: left">%</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-25.93</td><td style="font-weight: bold; text-align: left">%</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">1.30</td><td style="font-weight: bold; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -10pt; padding-left: 10pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -10pt; padding-left: 10pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ratios to Average Net Assets: <sup>(5)</sup></b></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expense ratio <sup>(6)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.20</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.09</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.18</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.91</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">Net Investment Loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-1.75</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-1.14</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-0.50</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-0.67</td><td style="text-align: left">%</td></tr>
  </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0in"></td><td style="width: 0.25in; text-align: left">(1)</td><td style="text-align: left">Net investment loss per share represents net investment loss
divided by the daily average shares of beneficial interest outstanding during the period.</td>
</tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0in"></td><td style="width: 0.25in; text-align: left">(6)</td><td style="text-align: left">The expense ratio would be 2.17% and 2.09% respectively, for
the three months ended June 30, 2023, and 2.00% and 2.81% for the three months ended June 30, 2022 if brokerage commissions and futures
and futures account fees were excluded.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">-1x Short VIX Futures ETF</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2x Long VIX Futures ETF</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">-1x Short VIX Futures ETF</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2x Long VIX Futures ETF</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Six Months Ended</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Six Months Ended</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Six Months Ended</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Six Months Ended</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">June 30, <br/>
2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, <br/>
2023 <sup>(7)</sup></b></span></td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">June 30, <br/>
2022</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, <br/>
2022 <sup>(7)</sup></b></span></td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; width: 52%">Net Asset Value, Beginning of Period</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">14.63</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">29.25</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">15.00</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">75.00</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net investment loss <sup>(1)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.17</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.08</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.06</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1.20</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net Realized and Unrealized Gain (Loss) on Investments and Futures Contracts <sup>(2)</sup></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">13.67</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(24.73</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(4.54</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">11.80</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Net Increase (Decrease) in Net Asset Value Resulting from Operations</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">13.50</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(24.81</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(4.60</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">10.60</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 4pt">Net Asset Value, End of Period</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">28.13</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">4.44</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">10.40</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">85.60</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 4pt">Market Value Per Share, at June 30, 2023 and June 30, 2022</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">28.07</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">4.46</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">10.40</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">85.40</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total Return at Net Asset Value <sup>(4)</sup></b></span></td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">92.28</td><td style="font-weight: bold; text-align: left">%</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-84.82</td><td style="font-weight: bold; text-align: left">%</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-30.67</td><td style="font-weight: bold; text-align: left">%</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">14.13</td><td style="font-weight: bold; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total Return at Market Value <sup>(4)</sup></b></span></td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">91.47</td><td style="font-weight: bold; text-align: left">%</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-84.67</td><td style="font-weight: bold; text-align: left">%</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-30.67</td><td style="font-weight: bold; text-align: left">%</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">13.87</td><td style="font-weight: bold; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ratios to Average Net Assets: <sup>(5)</sup></b></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expense ratio <sup>(6)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.25</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.13</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.18</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.91</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Net Investment Loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-1.84</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-1.35</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-0.50</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-0.67</td><td style="text-align: left">%</td></tr>
  </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0in"></td><td style="width: 0.25in; text-align: left">(2)</td><td style="text-align: left">Due to timing of capital share transactions, per share amounts
may not compare with amounts appearing elsewhere within these Financial Statements.</td>
</tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0in"></td><td style="width: 0.25in; text-align: left">(4)</td><td style="text-align: left">Percentages are not annualized for the period ended June 30,
2023 and June 30, 2022</td>
</tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0in"></td><td style="width: 0.25in; text-align: left">(5)</td><td style="text-align: left">Percentages are annualized.</td>
</tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0in"></td><td style="width: 0.25in; text-align: left">(6)</td><td style="text-align: left">The expense ratio would be 2.23% and 2.13% respectively, for
the six months ended June 30, 2023, and 2.01% and 2.84% for the six months ended June 30, 2022 if brokerage commissions and futures and
futures account fees were excluded.</td>
</tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0in"></td><td style="width: 0.25in; text-align: left">(7)</td><td style="text-align: left">For 2x Long VIX Futures ETF, fianancial highlights have been
adjusted to reflect a 1:5 reverse stock split occurring on January 25, 2023, as if it occurred at the commencment of operations.</td>
</tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_FinancialHighlightsTablesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_FinancialHighlightsTablesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_ScheduleOfShareOutstandingTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of share outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_ScheduleOfShareOutstandingTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140493288884304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_SignificantAccountingPoliciesDetailsLineItems', window );"><strong>Significant Accounting Policies (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_GrossRevenue', window );">Annual gross revenue</a></td>
<td class="nump">$ 1,070<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_NonconvertibleDebtSecurities', window );">Non-convertible debt securities</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_NonaffiliatesExceeded', window );">Non-affiliates exceeded</a></td>
<td class="nump">$ 700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNetAssetsPercentage', window );">Fund's average net assets percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanFundingStatusAxis=cik0001793497_SVIXMember', window );">SVIX [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_SignificantAccountingPoliciesDetailsLineItems', window );"><strong>Significant Accounting Policies (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNetAssetsPercentage', window );">Fund's average net assets percentage</a></td>
<td class="nump">0.03%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanFundingStatusAxis=cik0001793497_UVIXMember', window );">UVIX [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_SignificantAccountingPoliciesDetailsLineItems', window );"><strong>Significant Accounting Policies (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNetAssetsPercentage', window );">Fund's average net assets percentage</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_GrossRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of gross revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_GrossRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_NonaffiliatesExceeded">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-affiliates exceeded.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_NonaffiliatesExceeded</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_NonconvertibleDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-convertible debt securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_NonconvertibleDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_SignificantAccountingPoliciesDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_SignificantAccountingPoliciesDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNetAssetsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of value of derivative contract to net assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480493/946-210-55-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNetAssetsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanFundingStatusAxis=cik0001793497_SVIXMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanFundingStatusAxis=cik0001793497_SVIXMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanFundingStatusAxis=cik0001793497_UVIXMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanFundingStatusAxis=cik0001793497_UVIXMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140493289914992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Details) - Schedule of Cut-Off Times and the Times of the Calculation of the Funds<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cik0001793497_OneShortVIXFuturesETFMember', window );">-1x Short VIX Futures ETF [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_SignificantAccountingPoliciesDetailsScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsLineItems', window );"><strong>Significant Accounting Policies (Details) - Schedule of Cut-Off Times and the Times of the Calculation of the Funds [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_CreateRedeemCutoffDescription', window );">Create/Redeem Cut-off (EST)</a></td>
<td class="text">2:00 p.m.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_NAVCalculationTimeESTDescription', window );">NAV Calculation Time (EST)</a></td>
<td class="text">4:00 p.m.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_NAVCalculationDate', window );">NAV Calculation Date</a></td>
<td class="text">Jun. 30,  2023<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember', window );">2x Long VIX Futures ETF [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_SignificantAccountingPoliciesDetailsScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsLineItems', window );"><strong>Significant Accounting Policies (Details) - Schedule of Cut-Off Times and the Times of the Calculation of the Funds [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_CreateRedeemCutoffDescription', window );">Create/Redeem Cut-off (EST)</a></td>
<td class="text">2:00 p.m.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_NAVCalculationTimeESTDescription', window );">NAV Calculation Time (EST)</a></td>
<td class="text">4:00 p.m.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_NAVCalculationDate', window );">NAV Calculation Date</a></td>
<td class="text">Jun. 30,  2023<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_CreateRedeemCutoffDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Create/Redeem Cut-off (EST) 2x Long VIX Futures ETF, description</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_CreateRedeemCutoffDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_NAVCalculationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date the NAV calculation date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_NAVCalculationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_NAVCalculationTimeESTDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>NAV Calculation Time (EST), description.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_NAVCalculationTimeESTDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_SignificantAccountingPoliciesDetailsScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_SignificantAccountingPoliciesDetailsScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=cik0001793497_OneShortVIXFuturesETFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=cik0001793497_OneShortVIXFuturesETFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140493288996736">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Significant Accounting Policies (Details) - Schedule of Valuation of Investments at Using the Fair Value Hierarchy - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_SignificantAccountingPoliciesDetailsScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyLineItems', window );"><strong>Significant Accounting Policies (Details) - Schedule of Valuation of Investments at Using the Fair Value Hierarchy [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_AmountOfTotalTrust', window );">Total Trust</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (3,754,909)<span></span>
</td>
<td class="nump">$ 202,869<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cik0001793497_OneShortVIXFuturesETFMember', window );">-1x Short VIX Futures ETF [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_SignificantAccountingPoliciesDetailsScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyLineItems', window );"><strong>Significant Accounting Policies (Details) - Schedule of Valuation of Investments at Using the Fair Value Hierarchy [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_AmountOfTotalTrust', window );">Total Trust</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,518,579<span></span>
</td>
<td class="nump">1,156,106<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember', window );">2x Long VIX Futures ETF [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_SignificantAccountingPoliciesDetailsScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyLineItems', window );"><strong>Significant Accounting Policies (Details) - Schedule of Valuation of Investments at Using the Fair Value Hierarchy [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_AmountOfTotalTrust', window );">Total Trust</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(10,273,488)<span></span>
</td>
<td class="num">(953,237)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 [Member] | Money Market Fund [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_SignificantAccountingPoliciesDetailsScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyLineItems', window );"><strong>Significant Accounting Policies (Details) - Schedule of Valuation of Investments at Using the Fair Value Hierarchy [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_AmountOfTotalTrust', window );">Total Trust</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">9,517,548<span></span>
</td>
<td class="nump">8,250,285<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 [Member] | Money Market Fund [Member] | -1x Short VIX Futures ETF [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_SignificantAccountingPoliciesDetailsScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyLineItems', window );"><strong>Significant Accounting Policies (Details) - Schedule of Valuation of Investments at Using the Fair Value Hierarchy [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_AmountOfTotalTrust', window );">Total Trust</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 [Member] | Money Market Fund [Member] | 2x Long VIX Futures ETF [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_SignificantAccountingPoliciesDetailsScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyLineItems', window );"><strong>Significant Accounting Policies (Details) - Schedule of Valuation of Investments at Using the Fair Value Hierarchy [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_AmountOfTotalTrust', window );">Total Trust</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">9,517,548<span></span>
</td>
<td class="nump">8,250,285<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 [Member] | Futures Contracts [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_SignificantAccountingPoliciesDetailsScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyLineItems', window );"><strong>Significant Accounting Policies (Details) - Schedule of Valuation of Investments at Using the Fair Value Hierarchy [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_AmountOfTotalTrust', window );">Total Trust</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(13,272,457)<span></span>
</td>
<td class="num">(8,047,416)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 [Member] | Futures Contracts [Member] | -1x Short VIX Futures ETF [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_SignificantAccountingPoliciesDetailsScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyLineItems', window );"><strong>Significant Accounting Policies (Details) - Schedule of Valuation of Investments at Using the Fair Value Hierarchy [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_AmountOfTotalTrust', window );">Total Trust</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">6,518,579<span></span>
</td>
<td class="nump">1,156,106<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 [Member] | Futures Contracts [Member] | 2x Long VIX Futures ETF [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_SignificantAccountingPoliciesDetailsScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyLineItems', window );"><strong>Significant Accounting Policies (Details) - Schedule of Valuation of Investments at Using the Fair Value Hierarchy [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_AmountOfTotalTrust', window );">Total Trust</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">$ (19,791,036)<span></span>
</td>
<td class="num">$ (9,203,522)<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes cumulative appreciation (depreciation) of futures
contracts as reported in the Schedule of Investments. Only current day&#8217;s variation margin is reported within the Statements of
Financial Condition in receivable/payable on open futures.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_AmountOfTotalTrust">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount of trust.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_AmountOfTotalTrust</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_SignificantAccountingPoliciesDetailsScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_SignificantAccountingPoliciesDetailsScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=cik0001793497_OneShortVIXFuturesETFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=cik0001793497_OneShortVIXFuturesETFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=cik0001793497_FuturesContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=cik0001793497_FuturesContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140493288909216">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments (Details) - Schedule of Fair Value of Derivative Instruments<br></strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=cik0001793497_AssetDerivativesMember', window );">Asset Derivatives [Member] | Statements of Financial Condition Location [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_TotalTrust', window );">Total Trust</a></td>
<td class="text">$6,518,579<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=cik0001793497_AssetDerivativesMember', window );">Asset Derivatives [Member] | Unrealized Appreciation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_TotalTrust1', window );">Total Trust</a></td>
<td class="text">$(19,791,036)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=cik0001793497_AssetDerivativesMember', window );">Asset Derivatives [Member] | -1x Short VIX Futures ETF [Member] | Statements of Financial Condition Location [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_TotalTrust', window );">Total Trust</a></td>
<td class="text">$6,518,579<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=cik0001793497_AssetDerivativesMember', window );">Asset Derivatives [Member] | 2x Long VIX Futures ETF [Member] | Unrealized Appreciation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_TotalTrust1', window );">Total Trust</a></td>
<td class="text">(19,791,036)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=cik0001793497_LiabilityDerivativesMember', window );">Liability Derivatives [Member] | Statements of Financial Condition Location [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_TotalTrust', window );">Total Trust</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">$1,156,106<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=cik0001793497_LiabilityDerivativesMember', window );">Liability Derivatives [Member] | Unrealized Depreciation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_TotalTrust1', window );">Total Trust</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">$(9,203,522)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=cik0001793497_LiabilityDerivativesMember', window );">Liability Derivatives [Member] | -1x Short VIX Futures ETF [Member] | Statements of Financial Condition Location [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_TotalTrust', window );">Total Trust</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">$1,156,106<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=cik0001793497_LiabilityDerivativesMember', window );">Liability Derivatives [Member] | 2x Long VIX Futures ETF [Member] | Unrealized Depreciation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_TotalTrust1', window );">Total Trust</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">(9,203,522)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_TotalTrust">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total Trust amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_TotalTrust</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_TotalTrust1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total Trust amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_TotalTrust1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=cik0001793497_AssetDerivativesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=cik0001793497_AssetDerivativesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivablesPeriodPastDueAxis=cik0001793497_StatementsOfFinancialConditionLocationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivablesPeriodPastDueAxis=cik0001793497_StatementsOfFinancialConditionLocationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivablesPeriodPastDueAxis=cik0001793497_UnrealizedAppreciationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivablesPeriodPastDueAxis=cik0001793497_UnrealizedAppreciationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=cik0001793497_OnexShortVIXFuturesETFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=cik0001793497_OnexShortVIXFuturesETFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=cik0001793497_LiabilityDerivativesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=cik0001793497_LiabilityDerivativesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivablesPeriodPastDueAxis=cik0001793497_UnrealizedDepreciationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivablesPeriodPastDueAxis=cik0001793497_UnrealizedDepreciationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140493285700304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments (Details) - Schedule of Effect of Derivative Instruments on The Statement of Operations - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_VixFuturesContractsNetRealizedGainLossOnFuturesContractsChangesInUnrealizedAppreciationDepreciationOnFuturesContractsAbstract', window );"><strong>VIX Futures Contracts Net realized gain (loss) on futures contracts/changes in unrealized appreciation (depreciation) on futures contracts</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_RealizedGainLossOnDerivativesRecognizedInIncome', window );">Realized Gain (Loss) on Derivatives Recognized in Income</a></td>
<td class="num">$ (105,708,191)<span></span>
</td>
<td class="nump">$ 2,955,398<span></span>
</td>
<td class="num">$ (143,650,892)<span></span>
</td>
<td class="nump">$ 2,950,866<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_ChangeInUnrealizedAppreciationDepreciationsOnDerivativesRecognizedInIncome', window );">Change in Unrealized Appreciation (Depreciation) on Derivatives Recognized in Income</a></td>
<td class="num">(5,185,962)<span></span>
</td>
<td class="nump">578,864<span></span>
</td>
<td class="num">(5,225,041)<span></span>
</td>
<td class="nump">719,789<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cik0001793497_OnexShortVIXFuturesETFMember', window );">1 x Short VIX Futures ETF [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_VixFuturesContractsNetRealizedGainLossOnFuturesContractsChangesInUnrealizedAppreciationDepreciationOnFuturesContractsAbstract', window );"><strong>VIX Futures Contracts Net realized gain (loss) on futures contracts/changes in unrealized appreciation (depreciation) on futures contracts</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_RealizedGainLossOnDerivativesRecognizedInIncome', window );">Realized Gain (Loss) on Derivatives Recognized in Income</a></td>
<td class="nump">37,164,451<span></span>
</td>
<td class="num">(4,573,051)<span></span>
</td>
<td class="nump">42,451,505<span></span>
</td>
<td class="num">(4,577,129)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_ChangeInUnrealizedAppreciationDepreciationsOnDerivativesRecognizedInIncome', window );">Change in Unrealized Appreciation (Depreciation) on Derivatives Recognized in Income</a></td>
<td class="num">(811,301)<span></span>
</td>
<td class="nump">835,808<span></span>
</td>
<td class="nump">5,362,473<span></span>
</td>
<td class="nump">700,531<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember', window );">2x Long VIX Futures ETF [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_VixFuturesContractsNetRealizedGainLossOnFuturesContractsChangesInUnrealizedAppreciationDepreciationOnFuturesContractsAbstract', window );"><strong>VIX Futures Contracts Net realized gain (loss) on futures contracts/changes in unrealized appreciation (depreciation) on futures contracts</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_RealizedGainLossOnDerivativesRecognizedInIncome', window );">Realized Gain (Loss) on Derivatives Recognized in Income</a></td>
<td class="num">(142,872,642)<span></span>
</td>
<td class="nump">7,528,449<span></span>
</td>
<td class="num">(186,102,397)<span></span>
</td>
<td class="nump">7,527,995<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_ChangeInUnrealizedAppreciationDepreciationsOnDerivativesRecognizedInIncome', window );">Change in Unrealized Appreciation (Depreciation) on Derivatives Recognized in Income</a></td>
<td class="num">$ (4,374,661)<span></span>
</td>
<td class="num">$ (256,944)<span></span>
</td>
<td class="num">$ (10,587,514)<span></span>
</td>
<td class="nump">$ 19,258<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_ChangeInUnrealizedAppreciationDepreciationsOnDerivativesRecognizedInIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in unrealized appreciation (depreciation) on derivatives recognized in income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_ChangeInUnrealizedAppreciationDepreciationsOnDerivativesRecognizedInIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_RealizedGainLossOnDerivativesRecognizedInIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) on derivatives recognized in income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_RealizedGainLossOnDerivativesRecognizedInIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_VixFuturesContractsNetRealizedGainLossOnFuturesContractsChangesInUnrealizedAppreciationDepreciationOnFuturesContractsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_VixFuturesContractsNetRealizedGainLossOnFuturesContractsChangesInUnrealizedAppreciationDepreciationOnFuturesContractsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=cik0001793497_OnexShortVIXFuturesETFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=cik0001793497_OnexShortVIXFuturesETFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140493289932512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments (Details) - Schedule of Pledged By Funds Fair Values of Derivative Instruments - USD ($)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cik0001793497_OnexShortVIXFuturesETFMember', window );">-1x Short VIX Futures ETF [Member] | Other Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_InvestmentsDetailsScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsLineItems', window );"><strong>Investments (Details) - Schedule of Pledged By Funds Fair Values of Derivative Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition', window );">Gross Amounts of Recognized Assets presented in the Statements of Financial Condition</a></td>
<td class="nump">$ 1,242,108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_GrossAmountsOffsetInTheStatementsOfFinancialCondition', window );">Gross Amounts Offset in the Statements of Financial Condition</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition', window );">Net Amounts of Assets presented in the Statements of Financial Condition</a></td>
<td class="nump">1,242,108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cik0001793497_OnexShortVIXFuturesETFMember', window );">-1x Short VIX Futures ETF [Member] | Other Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_InvestmentsDetailsScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsLineItems', window );"><strong>Investments (Details) - Schedule of Pledged By Funds Fair Values of Derivative Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_GrossAmountsOfRecognizedLiabilitiesPresentedInTheStatementsOfFinancialCondition', window );">Gross Amounts of Recognized Liabilities presented in the Statements of Financial Condition</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">187,030<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_GrossAmountsOffsetInTheStatementsOfFinancialCondition1', window );">Gross Amounts Offset in the Statements of Financial Condition</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_NetAmountsOfLiabilitiesPresentedInTheStatementsOfFinancialCondition', window );">Net Amounts of Liabilities presented in the Statements of Financial Condition</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">187,030<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember', window );">2x Long VIX Futures ETF [Member] | Other Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_InvestmentsDetailsScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsLineItems', window );"><strong>Investments (Details) - Schedule of Pledged By Funds Fair Values of Derivative Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition', window );">Gross Amounts of Recognized Assets presented in the Statements of Financial Condition</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">830,840<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_GrossAmountsOffsetInTheStatementsOfFinancialCondition', window );">Gross Amounts Offset in the Statements of Financial Condition</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition', window );">Net Amounts of Assets presented in the Statements of Financial Condition</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">830,840<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember', window );">2x Long VIX Futures ETF [Member] | Other Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_InvestmentsDetailsScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsLineItems', window );"><strong>Investments (Details) - Schedule of Pledged By Funds Fair Values of Derivative Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_GrossAmountsOfRecognizedLiabilitiesPresentedInTheStatementsOfFinancialCondition', window );">Gross Amounts of Recognized Liabilities presented in the Statements of Financial Condition</a></td>
<td class="nump">3,406,049<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_GrossAmountsOffsetInTheStatementsOfFinancialCondition1', window );">Gross Amounts Offset in the Statements of Financial Condition</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_NetAmountsOfLiabilitiesPresentedInTheStatementsOfFinancialCondition', window );">Net Amounts of Liabilities presented in the Statements of Financial Condition</a></td>
<td class="nump">$ 3,406,049<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of gross amounts of recognized assets presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_GrossAmountsOfRecognizedLiabilitiesPresentedInTheStatementsOfFinancialCondition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of gross Amounts of Recognized Liabilities presented in the Statements of Financial Condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_GrossAmountsOfRecognizedLiabilitiesPresentedInTheStatementsOfFinancialCondition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_GrossAmountsOffsetInTheStatementsOfFinancialCondition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of gross amounts offset in the statements of financial condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_GrossAmountsOffsetInTheStatementsOfFinancialCondition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_GrossAmountsOffsetInTheStatementsOfFinancialCondition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of gross amounts offset in the statements of financial condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_GrossAmountsOffsetInTheStatementsOfFinancialCondition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_InvestmentsDetailsScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_InvestmentsDetailsScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net assets presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_NetAmountsOfLiabilitiesPresentedInTheStatementsOfFinancialCondition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amounts of liabilities presented in the statements of financial condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_NetAmountsOfLiabilitiesPresentedInTheStatementsOfFinancialCondition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=cik0001793497_OnexShortVIXFuturesETFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=cik0001793497_OnexShortVIXFuturesETFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140493294119504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments (Details) - Schedule of Gross Amounts Not Offset In The Statements of Financial Condition - USD ($)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cik0001793497_OneShortVIXFuturesETFMember', window );">-1x Short VIX Futures ETF [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_InvestmentsDetailsScheduleofGrossAmountsNotOffsetInTheStatementsofFinancialConditionLineItems', window );"><strong>Investments (Details) - Schedule of Gross Amounts Not Offset In The Statements of Financial Condition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne', window );">Amounts of Recognized Assets / (Liabilities) presented in the Statements of Financial Condition</a></td>
<td class="nump">$ 1,242,108<span></span>
</td>
<td class="num">$ (187,030)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_FinancialInstrumentsForTheBenefitOftheFundsTheCounterpartiesTwo', window );">Financial Instruments for the Benefit of (the Funds) / the Counterparties</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_CashCollateralForTheBenefitOftheFundsTheCounterparties', window );">Cash Collateral for the Benefit of (the Funds) / the Counterparties</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_CapitalUnitNetAmount', window );">Net Amount</a></td>
<td class="nump">1,242,108<span></span>
</td>
<td class="num">(187,030)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember', window );">2x Long VIX Futures ETF [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_InvestmentsDetailsScheduleofGrossAmountsNotOffsetInTheStatementsofFinancialConditionLineItems', window );"><strong>Investments (Details) - Schedule of Gross Amounts Not Offset In The Statements of Financial Condition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne', window );">Amounts of Recognized Assets / (Liabilities) presented in the Statements of Financial Condition</a></td>
<td class="num">(3,406,049)<span></span>
</td>
<td class="nump">830,840<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_FinancialInstrumentsForTheBenefitOftheFundsTheCounterpartiesTwo', window );">Financial Instruments for the Benefit of (the Funds) / the Counterparties</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_CashCollateralForTheBenefitOftheFundsTheCounterparties', window );">Cash Collateral for the Benefit of (the Funds) / the Counterparties</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_CapitalUnitNetAmount', window );">Net Amount</a></td>
<td class="num">$ (3,406,049)<span></span>
</td>
<td class="nump">$ 830,840<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sales price you receive with any selling costs you paid deducted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_CapitalUnitNetAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of capital unit net amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_CapitalUnitNetAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_CashCollateralForTheBenefitOftheFundsTheCounterparties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash collateral for the benefit of (the funds) / the counterparties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_CashCollateralForTheBenefitOftheFundsTheCounterparties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_FinancialInstrumentsForTheBenefitOftheFundsTheCounterpartiesTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_FinancialInstrumentsForTheBenefitOftheFundsTheCounterpartiesTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_InvestmentsDetailsScheduleofGrossAmountsNotOffsetInTheStatementsofFinancialConditionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_InvestmentsDetailsScheduleofGrossAmountsNotOffsetInTheStatementsofFinancialConditionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=cik0001793497_OneShortVIXFuturesETFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=cik0001793497_OneShortVIXFuturesETFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140493288652144">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Agreements (Details)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_AgreementsDetailsLineItems', window );"><strong>Agreements (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_SubadvisoryFeeRate', window );">Sub-advisory fee rate</a></td>
<td class="nump">0.20%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=cik0001793497_SVIXMember', window );">SVIX [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_AgreementsDetailsLineItems', window );"><strong>Agreements (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_AverageDailyNetAssetsRate', window );">Average daily net assets rate</a></td>
<td class="nump">1.35%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=cik0001793497_UVIXMember', window );">UVIX [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_AgreementsDetailsLineItems', window );"><strong>Agreements (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_AverageDailyNetAssetsRate', window );">Average daily net assets rate</a></td>
<td class="nump">1.65%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_AgreementsDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_AgreementsDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_AverageDailyNetAssetsRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Average daily net assets rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_AverageDailyNetAssetsRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_SubadvisoryFeeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of sub-advisory fee rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_SubadvisoryFeeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=cik0001793497_SVIXMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=cik0001793497_SVIXMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=cik0001793497_UVIXMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=cik0001793497_UVIXMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140493294809504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Creation and Redemption of Creation Units (Details)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2023 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Shares of fund</a></td>
<td class="nump">10,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_AuthorizedParticipantsPercentage', window );">Authorized participants percentage</a></td>
<td class="nump">0.20%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_AuthorizedParticipantsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of authorized participants percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_AuthorizedParticipantsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140493282842976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Creation and Redemption of Creation Units (Details) - Schedule of Transaction Fees - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_CreationandRedemptionofCreationUnitsDetailsScheduleofTransactionFeesLineItems', window );"><strong>Creation and Redemption of Creation Units (Details) - Schedule of Transaction Fees [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfTrustAssetsToPayExpenses', window );">Total Trust</a></td>
<td class="nump">$ 98,766<span></span>
</td>
<td class="nump">$ 108,003<span></span>
</td>
<td class="nump">$ 197,096<span></span>
</td>
<td class="nump">$ 110,775<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cik0001793497_OnexShortVIXFuturesETFMember', window );">1 x Short VIX Futures ETF [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_CreationandRedemptionofCreationUnitsDetailsScheduleofTransactionFeesLineItems', window );"><strong>Creation and Redemption of Creation Units (Details) - Schedule of Transaction Fees [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfTrustAssetsToPayExpenses', window );">Total Trust</a></td>
<td class="nump">31,820<span></span>
</td>
<td class="nump">62,214<span></span>
</td>
<td class="nump">77,483<span></span>
</td>
<td class="nump">63,870<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember', window );">2x Long VIX Futures ETF [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_CreationandRedemptionofCreationUnitsDetailsScheduleofTransactionFeesLineItems', window );"><strong>Creation and Redemption of Creation Units (Details) - Schedule of Transaction Fees [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfTrustAssetsToPayExpenses', window );">Total Trust</a></td>
<td class="nump">$ 66,946<span></span>
</td>
<td class="nump">$ 45,789<span></span>
</td>
<td class="nump">$ 119,613<span></span>
</td>
<td class="nump">$ 46,905<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_CreationandRedemptionofCreationUnitsDetailsScheduleofTransactionFeesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_CreationandRedemptionofCreationUnitsDetailsScheduleofTransactionFeesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfTrustAssetsToPayExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of sale of trust assets (includes, but is not limited to, gold and silver) to pay trust expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfTrustAssetsToPayExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=cik0001793497_OnexShortVIXFuturesETFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=cik0001793497_OnexShortVIXFuturesETFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140493289866048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Highlights (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_FinancialHighlightsDetailsLineItems', window );"><strong>Financial Highlights (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpenseRatio', window );">Expense ratio percentage</a></td>
<td class="nump">2.17%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_BrokerageCommissionsRate', window );">Brokerage commissions rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.81%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_FinancialHighlightsDetailsLineItems', window );"><strong>Financial Highlights (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpenseRatio', window );">Expense ratio percentage</a></td>
<td class="nump">2.09%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_BrokerageCommissionsRate', window );">Brokerage commissions rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_BrokerageCommissionsRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Brokerage commissions rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_BrokerageCommissionsRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_FinancialHighlightsDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_FinancialHighlightsDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpenseRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ratio of non-life general and administrative expenses to non-life net premiums earned.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpenseRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140493289081120">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Financial Highlights (Details) - Schedule of Share Outstanding - $ / shares<br></strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="4">6 Months Ended</th>
</tr>
<tr>
<th class="th" colspan="2"><div>Jun. 30, 2023</div></th>
<th class="th" colspan="2"><div>Jun. 30, 2022</div></th>
<th class="th" colspan="2"><div>Jun. 30, 2023</div></th>
<th class="th" colspan="2"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cik0001793497_OnexShortVIXFuturesETFMember', window );">1 x Short VIX Futures ETF [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_FinancialHighlightsDetailsScheduleofShareOutstandingLineItems', window );"><strong>Financial Highlights (Details) - Schedule of Share Outstanding [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyMarketValuePerShare', window );">Net Asset Value, Beginning of Period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 16.55<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 14.16<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 14.63<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 15<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyGainLossOnInvestmentPerShare', window );">Net investment loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(0.09)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(0.05)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(0.17)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(0.06)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts', window );">Net Realized and Unrealized Gain (Loss) on Investments and Futures Contracts</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">11.67<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(3.71)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">13.67<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(4.54)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease', window );">Net Increase (Decrease) in Net Asset Value Resulting from Operations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">11.58<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(3.76)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">13.5<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(4.6)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyMarketValuePerShare', window );">Net Asset Value, End of Period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">28.13<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">10.4<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">28.13<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">10.4<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_MarketValuePerShare', window );">Market Value Per Share, at June 30, 2023 and June 30, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 28.07<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 10.4<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 28.07<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 10.4<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyTotalReturn', window );">Total Return at Net Asset Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">69.97%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(26.56%)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">92.28%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(30.67%)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_TotalReturnAtMarketValue', window );">Total Return at Market Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">70.02%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(25.93%)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">91.47%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(30.67%)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_RatiosToAverageNetAssets5Abstract', window );"><strong>Ratios to Average Net Assets: (5)</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyExpenseRatioAfterIncentiveAllocation', window );">Expense ratio</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">2.20%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">2.18%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">2.25%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[6]</sup></td>
<td class="nump">2.18%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[6]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyTotalReturnAfterIncentiveFees', window );">Net Investment Loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1.75%)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(0.50%)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1.84%)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[6]</sup></td>
<td class="num">(0.50%)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[6]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember', window );">2x Long VIX Futures ETF [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_FinancialHighlightsDetailsScheduleofShareOutstandingLineItems', window );"><strong>Financial Highlights (Details) - Schedule of Share Outstanding [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyMarketValuePerShare', window );">Net Asset Value, Beginning of Period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 15.88<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 83.2<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 29.25<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[7]</sup></td>
<td class="nump">$ 75<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyGainLossOnInvestmentPerShare', window );">Net investment loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(0.03)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(0.6)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(0.08)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[7]</sup></td>
<td class="num">(1.2)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts', window );">Net Realized and Unrealized Gain (Loss) on Investments and Futures Contracts</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="num">(11.41)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(24.73)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[7]</sup></td>
<td class="nump">11.8<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease', window );">Net Increase (Decrease) in Net Asset Value Resulting from Operations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(11.44)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2.4<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(24.81)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[7]</sup></td>
<td class="nump">10.6<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyMarketValuePerShare', window );">Net Asset Value, End of Period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4.44<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[7]</sup></td>
<td class="nump">85.6<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4.44<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[7]</sup></td>
<td class="nump">85.6<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_MarketValuePerShare', window );">Market Value Per Share, at June 30, 2023 and June 30, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 4.46<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[7]</sup></td>
<td class="nump">$ 85.4<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 4.46<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[7]</sup></td>
<td class="nump">$ 85.4<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyTotalReturn', window );">Total Return at Net Asset Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="num">(72.04%)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2.88%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(84.82%)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[7]</sup></td>
<td class="nump">14.13%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_TotalReturnAtMarketValue', window );">Total Return at Market Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="num">(72.09%)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1.30%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(84.67%)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[7]</sup></td>
<td class="nump">13.87%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_RatiosToAverageNetAssets5Abstract', window );"><strong>Ratios to Average Net Assets: (5)</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyExpenseRatioAfterIncentiveAllocation', window );">Expense ratio</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">2.09%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">2.91%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">2.13%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[6],[7]</sup></td>
<td class="nump">2.91%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[6]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyTotalReturnAfterIncentiveFees', window );">Net Investment Loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1.14%)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(0.67%)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1.35%)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[6],[7]</sup></td>
<td class="num">(0.67%)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[6]</sup></td>
</tr>
<tr><td colspan="9"></td></tr>
<tr><td colspan="9"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Net investment loss per share represents net investment loss
divided by the daily average shares of beneficial interest outstanding during the period.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Due to timing of capital share transactions, per share amounts
may not compare with amounts appearing elsewhere within these Financial Statements.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Percentages are not annualized for the period ended June 30,
2023 and June 30, 2022</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">Percentages are annualized.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[5]</td>
<td style="vertical-align: top;" valign="top">The expense ratio would be 2.17% and 2.09% respectively, for
the three months ended June 30, 2023, and 2.00% and 2.81% for the three months ended June 30, 2022 if brokerage commissions and futures
and futures account fees were excluded.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[6]</td>
<td style="vertical-align: top;" valign="top">The expense ratio would be 2.23% and 2.13% respectively, for
the six months ended June 30, 2023, and 2.01% and 2.84% for the six months ended June 30, 2022 if brokerage commissions and futures and
futures account fees were excluded.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[7]</td>
<td style="vertical-align: top;" valign="top">For 2x Long VIX Futures ETF, fianancial highlights have been
adjusted to reflect a 1:5 reverse stock split occurring on January 25, 2023, as if it occurred at the commencment of operations.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_FinancialHighlightsDetailsScheduleofShareOutstandingLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_FinancialHighlightsDetailsScheduleofShareOutstandingLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_MarketValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share excess of market value per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_MarketValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment, and future contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_RatiosToAverageNetAssets5Abstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_RatiosToAverageNetAssets5Abstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_TotalReturnAtMarketValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of return at market value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_TotalReturnAtMarketValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentCompanyExpenseRatioAfterIncentiveAllocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of expense, after incentive allocation, to average net assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480737/946-205-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentCompanyExpenseRatioAfterIncentiveAllocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentCompanyGainLossOnInvestmentPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit amount of realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480737/946-205-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentCompanyGainLossOnInvestmentPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentCompanyMarketValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Market value per share of investment portfolio by investment company. Includes, but is not limited to, per unit, membership interest, or other ownership interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480737/946-205-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentCompanyMarketValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit amount of increase (decrease) in net asset value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480737/946-205-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentCompanyTotalReturn">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage increase (decrease) in fund net asset value, assuming reinvestment of dividends and capital gain distributions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 27<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480737/946-205-50-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480737/946-205-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentCompanyTotalReturn</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentCompanyTotalReturnAfterIncentiveFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage increase (decrease), after deduction of incentive fee, in fund net asset value. Includes, but is not limited to, interest and dividend income (loss) and realized and unrealized gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480737/946-205-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentCompanyTotalReturnAfterIncentiveFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=cik0001793497_OnexShortVIXFuturesETFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=cik0001793497_OnexShortVIXFuturesETFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140493294815552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Risk (Details)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RisksAndUncertaintiesAbstract', window );"><strong>Risk [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_RelevantBenchmark', window );">Relevant benchmark percentage</a></td>
<td class="nump">50.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_RelevantBenchmark">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of relevant benchmark.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_RelevantBenchmark</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RisksAndUncertaintiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RisksAndUncertaintiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>f10q0623_vstrust_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cik0001793497="http://www.vts.com/20230630"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2023"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="cik0001793497-20230630.xsd" xlink:type="simple"/>
    <context id="c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OneShortVIXFuturesETFMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OneShortVIXFuturesETFMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OneShortVIXFuturesETFMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OneShortVIXFuturesETFMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OneShortVIXFuturesETFMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OneShortVIXFuturesETFMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OneShortVIXFuturesETFMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OneShortVIXFuturesETFMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OneShortVIXFuturesETFMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OneShortVIXFuturesETFMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0001793497:CBOEVIXFuturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0001793497:CBOEVIXFuturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0001793497:CBOEVIXFuturesOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0001793497:CBOEVIXFuturesOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0001793497:CBOEVIXFuturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0001793497:CBOEVIXFuturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0001793497:CBOEVIXFuturesOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0001793497:CBOEVIXFuturesOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cik0001793497:FirstAmericanGovernmentObligationsFundMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0001793497:CBOEVIXFuturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0001793497:CBOEVIXFuturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0001793497:CBOEVIXFuturesOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0001793497:CBOEVIXFuturesOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cik0001793497:FirstAmericanGovernmentObligationsFundMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0001793497:CBOEVIXFuturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0001793497:CBOEVIXFuturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0001793497:CBOEVIXFuturesOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0001793497:CBOEVIXFuturesOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanFundingStatusAxis">cik0001793497:SVIXMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanFundingStatusAxis">cik0001793497:UVIXMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OneShortVIXFuturesETFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OneShortVIXFuturesETFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">cik0001793497:FuturesContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OneShortVIXFuturesETFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">cik0001793497:FuturesContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">cik0001793497:FuturesContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">cik0001793497:FuturesContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">cik0001793497:FuturesContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">cik0001793497:FuturesContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">cik0001793497:AssetDerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivablesPeriodPastDueAxis">cik0001793497:StatementsOfFinancialConditionLocationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">cik0001793497:AssetDerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivablesPeriodPastDueAxis">cik0001793497:UnrealizedAppreciationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">cik0001793497:AssetDerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivablesPeriodPastDueAxis">cik0001793497:StatementsOfFinancialConditionLocationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">cik0001793497:AssetDerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivablesPeriodPastDueAxis">cik0001793497:UnrealizedAppreciationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">cik0001793497:LiabilityDerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivablesPeriodPastDueAxis">cik0001793497:StatementsOfFinancialConditionLocationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">cik0001793497:LiabilityDerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivablesPeriodPastDueAxis">cik0001793497:UnrealizedDepreciationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">cik0001793497:LiabilityDerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivablesPeriodPastDueAxis">cik0001793497:StatementsOfFinancialConditionLocationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">cik0001793497:LiabilityDerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivablesPeriodPastDueAxis">cik0001793497:UnrealizedDepreciationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OneShortVIXFuturesETFMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cik0001793497:SVIXMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cik0001793497:UVIXMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPershares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <dei:DocumentType contextRef="c0">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="c0">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="c0">2023-06-30</dei:DocumentPeriodEndDate>
    <dei:DocumentFiscalYearFocus contextRef="c0">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport contextRef="c0">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="c0">001-34200</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c0">VS Trust</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c0">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="c0">84-6704517</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c0">2000 PGA Boulevard</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c0">Suite 4440</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="c0">Palm Beach Gardens</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c0">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c0">33408</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c0">(866)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c0">261-0273</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c1">-1x Short VIX Futures ETF</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c1">SVIX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c1">CboeBZX</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="c2">2x Long VIX Futures ETF</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c2">UVIX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c2">CboeBZX</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus contextRef="c0">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c0">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c0">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c0">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c0">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="c0">false</dei:EntityExTransitionPeriod>
    <dei:EntityShellCompany contextRef="c0">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding contextRef="c3" decimals="INF" unitRef="shares">21800000</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c6" decimals="0" unitRef="usd">504600</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c5" decimals="0" id="ix_0_fact" unitRef="usd">9517548</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c7" decimals="0" id="ix_1_fact" unitRef="usd">8250285</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InterestReceivable contextRef="c4" decimals="0" unitRef="usd">13203</us-gaap:InterestReceivable>
    <us-gaap:InterestReceivable contextRef="c5" decimals="0" unitRef="usd">65352</us-gaap:InterestReceivable>
    <us-gaap:InterestReceivable contextRef="c6" decimals="0" unitRef="usd">12909</us-gaap:InterestReceivable>
    <us-gaap:InterestReceivable contextRef="c7" decimals="0" unitRef="usd">50483</us-gaap:InterestReceivable>
    <us-gaap:PrepaidExpenseAndOtherAssets contextRef="c4" decimals="0" unitRef="usd">34380</us-gaap:PrepaidExpenseAndOtherAssets>
    <us-gaap:PrepaidExpenseAndOtherAssets contextRef="c5" decimals="0" unitRef="usd">25767</us-gaap:PrepaidExpenseAndOtherAssets>
    <us-gaap:PrepaidExpenseAndOtherAssets contextRef="c6" decimals="0" unitRef="usd">10295</us-gaap:PrepaidExpenseAndOtherAssets>
    <us-gaap:PrepaidExpenseAndOtherAssets contextRef="c7" decimals="0" unitRef="usd">15666</us-gaap:PrepaidExpenseAndOtherAssets>
    <cik0001793497:ReceivableForSharesSold contextRef="c4" decimals="0" unitRef="usd">3609654</cik0001793497:ReceivableForSharesSold>
    <cik0001793497:ReceivableForSharesSold contextRef="c5" decimals="0" unitRef="usd">1014706</cik0001793497:ReceivableForSharesSold>
    <cik0001793497:ReceivableForSharesSold contextRef="c7" decimals="0" unitRef="usd">1931028</cik0001793497:ReceivableForSharesSold>
    <us-gaap:CommodityContractAssetCurrent contextRef="c4" decimals="0" unitRef="usd">68703813</us-gaap:CommodityContractAssetCurrent>
    <us-gaap:CommodityContractAssetCurrent contextRef="c5" decimals="0" unitRef="usd">83302779</us-gaap:CommodityContractAssetCurrent>
    <us-gaap:CommodityContractAssetCurrent contextRef="c6" decimals="0" unitRef="usd">48144554</us-gaap:CommodityContractAssetCurrent>
    <us-gaap:CommodityContractAssetCurrent contextRef="c7" decimals="0" unitRef="usd">114821272</us-gaap:CommodityContractAssetCurrent>
    <cik0001793497:VariationMarginReceivable contextRef="c4" decimals="0" unitRef="usd">1242108</cik0001793497:VariationMarginReceivable>
    <cik0001793497:VariationMarginReceivable contextRef="c7" decimals="0" unitRef="usd">830840</cik0001793497:VariationMarginReceivable>
    <us-gaap:OtherReceivablesNetCurrent contextRef="c4" decimals="0" unitRef="usd">253</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent contextRef="c5" decimals="0" unitRef="usd">560</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent contextRef="c6" decimals="0" unitRef="usd">571</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent contextRef="c7" decimals="0" unitRef="usd">579</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:Assets contextRef="c4" decimals="0" unitRef="usd">73603411</us-gaap:Assets>
    <us-gaap:Assets contextRef="c5" decimals="0" unitRef="usd">93926712</us-gaap:Assets>
    <us-gaap:Assets contextRef="c6" decimals="0" unitRef="usd">48672929</us-gaap:Assets>
    <us-gaap:Assets contextRef="c7" decimals="0" unitRef="usd">125900153</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent contextRef="c5" decimals="0" unitRef="usd">3406049</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c6" decimals="0" unitRef="usd">187030</us-gaap:AccountsPayableCurrent>
    <cik0001793497:DueToCustodian contextRef="c4" decimals="0" unitRef="usd">1023713</cik0001793497:DueToCustodian>
    <cik0001793497:DueToCustodian contextRef="c5" decimals="0" unitRef="usd">2874781</cik0001793497:DueToCustodian>
    <cik0001793497:FundSharesRedeemed contextRef="c5" decimals="0" unitRef="usd">1865052</cik0001793497:FundSharesRedeemed>
    <cik0001793497:FundSharesRedeemed contextRef="c6" decimals="0" unitRef="usd">1903018</cik0001793497:FundSharesRedeemed>
    <us-gaap:OtherNotesPayable contextRef="c4" decimals="0" unitRef="usd">70620</us-gaap:OtherNotesPayable>
    <us-gaap:OtherNotesPayable contextRef="c5" decimals="0" unitRef="usd">138850</us-gaap:OtherNotesPayable>
    <us-gaap:OtherNotesPayable contextRef="c6" decimals="0" unitRef="usd">54374</us-gaap:OtherNotesPayable>
    <us-gaap:OtherNotesPayable contextRef="c7" decimals="0" unitRef="usd">176838</us-gaap:OtherNotesPayable>
    <cik0001793497:AdministrativeAccountingAndCustodianFeesPayable contextRef="c4" decimals="0" unitRef="usd">14706</cik0001793497:AdministrativeAccountingAndCustodianFeesPayable>
    <cik0001793497:AdministrativeAccountingAndCustodianFeesPayable contextRef="c5" decimals="0" unitRef="usd">18097</cik0001793497:AdministrativeAccountingAndCustodianFeesPayable>
    <cik0001793497:AdministrativeAccountingAndCustodianFeesPayable contextRef="c6" decimals="0" unitRef="usd">15869</cik0001793497:AdministrativeAccountingAndCustodianFeesPayable>
    <cik0001793497:AdministrativeAccountingAndCustodianFeesPayable contextRef="c7" decimals="0" unitRef="usd">19957</cik0001793497:AdministrativeAccountingAndCustodianFeesPayable>
    <us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent contextRef="c4" decimals="0" unitRef="usd">169032</us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent>
    <us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent contextRef="c5" decimals="0" unitRef="usd">246032</us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent>
    <us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent contextRef="c6" decimals="0" unitRef="usd">125274</us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent>
    <us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent contextRef="c7" decimals="0" unitRef="usd">203411</us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent>
    <cik0001793497:LicensingAndRegistrationFeesPayable contextRef="c4" decimals="0" unitRef="usd">22927</cik0001793497:LicensingAndRegistrationFeesPayable>
    <cik0001793497:LicensingAndRegistrationFeesPayable contextRef="c5" decimals="0" unitRef="usd">39049</cik0001793497:LicensingAndRegistrationFeesPayable>
    <cik0001793497:LicensingAndRegistrationFeesPayable contextRef="c6" decimals="0" unitRef="usd">8761</cik0001793497:LicensingAndRegistrationFeesPayable>
    <cik0001793497:LicensingAndRegistrationFeesPayable contextRef="c7" decimals="0" unitRef="usd">11181</cik0001793497:LicensingAndRegistrationFeesPayable>
    <us-gaap:Liabilities contextRef="c4" decimals="0" unitRef="usd">1300998</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c5" decimals="0" unitRef="usd">8587910</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c6" decimals="0" unitRef="usd">2294326</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c7" decimals="0" unitRef="usd">411387</us-gaap:Liabilities>
    <us-gaap:AssetsNet contextRef="c4" decimals="0" unitRef="usd">72302413</us-gaap:AssetsNet>
    <us-gaap:AssetsNet contextRef="c5" decimals="0" unitRef="usd">85338802</us-gaap:AssetsNet>
    <us-gaap:AssetsNet contextRef="c6" decimals="0" unitRef="usd">46378603</us-gaap:AssetsNet>
    <us-gaap:AssetsNet contextRef="c7" decimals="0" unitRef="usd">125488766</us-gaap:AssetsNet>
    <us-gaap:AdditionalPaidInCapital contextRef="c4" decimals="0" unitRef="usd">-8033985</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="c5" decimals="0" unitRef="usd">-360476596</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="c6" decimals="0" unitRef="usd">-29386125</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="c7" decimals="0" unitRef="usd">-203182472</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c4" decimals="0" unitRef="usd">-64268428</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c5" decimals="0" unitRef="usd">275137794</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c6" decimals="0" unitRef="usd">-16992478</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c7" decimals="0" unitRef="usd">77693706</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AssetsNet contextRef="c4" decimals="0" unitRef="usd">72302413</us-gaap:AssetsNet>
    <us-gaap:AssetsNet contextRef="c5" decimals="0" unitRef="usd">85338802</us-gaap:AssetsNet>
    <us-gaap:AssetsNet contextRef="c6" decimals="0" unitRef="usd">46378603</us-gaap:AssetsNet>
    <us-gaap:AssetsNet contextRef="c7" decimals="0" unitRef="usd">125488766</us-gaap:AssetsNet>
    <us-gaap:AssetsNet contextRef="c4" decimals="0" unitRef="usd">72302413</us-gaap:AssetsNet>
    <us-gaap:AssetsNet contextRef="c5" decimals="0" unitRef="usd">85338802</us-gaap:AssetsNet>
    <us-gaap:AssetsNet contextRef="c6" decimals="0" unitRef="usd">46378603</us-gaap:AssetsNet>
    <us-gaap:AssetsNet contextRef="c7" decimals="0" unitRef="usd">125488766</us-gaap:AssetsNet>
    <us-gaap:SharesOutstanding
      contextRef="c4"
      decimals="INF"
      id="ix_2_fact"
      unitRef="shares">2570000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="c5"
      decimals="INF"
      id="ix_3_fact"
      unitRef="shares">19230000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="c6"
      decimals="INF"
      id="ix_4_fact"
      unitRef="shares">3170000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="c7"
      decimals="INF"
      id="ix_5_fact"
      unitRef="shares">21450000</us-gaap:SharesOutstanding>
    <us-gaap:NetAssetValuePerShare contextRef="c4" decimals="2" unitRef="usdPershares">28.13</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare contextRef="c5" decimals="2" unitRef="usdPershares">4.44</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare contextRef="c6" decimals="2" unitRef="usdPershares">14.63</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare contextRef="c7" decimals="2" unitRef="usdPershares">5.85</us-gaap:NetAssetValuePerShare>
    <us-gaap:AuctionMarketPreferredSecuritiesStockSeriesParValuePerShare contextRef="c4" decimals="2" unitRef="usdPershares">28.07</us-gaap:AuctionMarketPreferredSecuritiesStockSeriesParValuePerShare>
    <us-gaap:AuctionMarketPreferredSecuritiesStockSeriesParValuePerShare contextRef="c5" decimals="2" unitRef="usdPershares">4.46</us-gaap:AuctionMarketPreferredSecuritiesStockSeriesParValuePerShare>
    <us-gaap:AuctionMarketPreferredSecuritiesStockSeriesParValuePerShare contextRef="c6" decimals="2" unitRef="usdPershares">14.66</us-gaap:AuctionMarketPreferredSecuritiesStockSeriesParValuePerShare>
    <us-gaap:AuctionMarketPreferredSecuritiesStockSeriesParValuePerShare contextRef="c7" decimals="2" unitRef="usdPershares">5.82</us-gaap:AuctionMarketPreferredSecuritiesStockSeriesParValuePerShare>
    <us-gaap:OtherInvestmentsAndSecuritiesAtCost contextRef="c5" decimals="0" unitRef="usd">9517548</us-gaap:OtherInvestmentsAndSecuritiesAtCost>
    <us-gaap:OtherInvestmentsAndSecuritiesAtCost contextRef="c7" decimals="0" unitRef="usd">8250285</us-gaap:OtherInvestmentsAndSecuritiesAtCost>
    <us-gaap:InterestAndOtherIncome contextRef="c8" decimals="0" unitRef="usd">74800</us-gaap:InterestAndOtherIncome>
    <us-gaap:InterestAndOtherIncome contextRef="c9" decimals="0" unitRef="usd">301835</us-gaap:InterestAndOtherIncome>
    <us-gaap:InterestAndOtherIncome contextRef="c10" decimals="0" unitRef="usd">18977</us-gaap:InterestAndOtherIncome>
    <us-gaap:InterestAndOtherIncome contextRef="c11" decimals="0" unitRef="usd">16778</us-gaap:InterestAndOtherIncome>
    <us-gaap:OtherIncome contextRef="c10" decimals="0" unitRef="usd">61</us-gaap:OtherIncome>
    <us-gaap:OtherIncome contextRef="c11" decimals="0" unitRef="usd">153</us-gaap:OtherIncome>
    <us-gaap:InvestmentIncomeNet contextRef="c8" decimals="0" unitRef="usd">74800</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet contextRef="c9" decimals="0" unitRef="usd">301835</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet contextRef="c10" decimals="0" unitRef="usd">19037</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet contextRef="c11" decimals="0" unitRef="usd">16931</us-gaap:InvestmentIncomeNet>
    <us-gaap:ManagementFeeExpense contextRef="c8" decimals="0" unitRef="usd">225408</us-gaap:ManagementFeeExpense>
    <us-gaap:ManagementFeeExpense contextRef="c9" decimals="0" unitRef="usd">521809</us-gaap:ManagementFeeExpense>
    <us-gaap:ManagementFeeExpense contextRef="c10" decimals="0" unitRef="usd">163452</us-gaap:ManagementFeeExpense>
    <us-gaap:ManagementFeeExpense contextRef="c11" decimals="0" unitRef="usd">111085</us-gaap:ManagementFeeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c8" decimals="0" unitRef="usd">24727</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c9" decimals="0" unitRef="usd">33684</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c10" decimals="0" unitRef="usd">23357</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c11" decimals="0" unitRef="usd">23323</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:ProfessionalFees contextRef="c8" decimals="0" unitRef="usd">80185</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees contextRef="c9" decimals="0" unitRef="usd">81279</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees contextRef="c10" decimals="0" unitRef="usd">15000</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees contextRef="c11" decimals="0" unitRef="usd">14963</us-gaap:ProfessionalFees>
    <us-gaap:LegalFees contextRef="c8" decimals="0" unitRef="usd">31769</us-gaap:LegalFees>
    <us-gaap:LegalFees contextRef="c9" decimals="0" unitRef="usd">24392</us-gaap:LegalFees>
    <us-gaap:LegalFees contextRef="c10" decimals="0" unitRef="usd">40055</us-gaap:LegalFees>
    <us-gaap:LegalFees contextRef="c11" decimals="0" unitRef="usd">40027</us-gaap:LegalFees>
    <us-gaap:FloorBrokerageExchangeAndClearanceFees contextRef="c8" decimals="0" unitRef="usd">5462</us-gaap:FloorBrokerageExchangeAndClearanceFees>
    <us-gaap:FloorBrokerageExchangeAndClearanceFees contextRef="c9" decimals="0" unitRef="usd">40</us-gaap:FloorBrokerageExchangeAndClearanceFees>
    <us-gaap:FloorBrokerageExchangeAndClearanceFees contextRef="c10" decimals="0" unitRef="usd">19953</us-gaap:FloorBrokerageExchangeAndClearanceFees>
    <us-gaap:FloorBrokerageExchangeAndClearanceFees contextRef="c11" decimals="0" unitRef="usd">8143</us-gaap:FloorBrokerageExchangeAndClearanceFees>
    <us-gaap:CostsAndExpenses contextRef="c8" decimals="0" unitRef="usd">367551</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c9" decimals="0" unitRef="usd">661204</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c10" decimals="0" unitRef="usd">261816</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c11" decimals="0" unitRef="usd">197542</us-gaap:CostsAndExpenses>
    <us-gaap:NetInvestmentInLeaseAccruedInterestWriteoff contextRef="c8" decimals="0" unitRef="usd">292751</us-gaap:NetInvestmentInLeaseAccruedInterestWriteoff>
    <us-gaap:NetInvestmentInLeaseAccruedInterestWriteoff contextRef="c9" decimals="0" unitRef="usd">359369</us-gaap:NetInvestmentInLeaseAccruedInterestWriteoff>
    <us-gaap:NetInvestmentInLeaseAccruedInterestWriteoff contextRef="c10" decimals="0" unitRef="usd">242779</us-gaap:NetInvestmentInLeaseAccruedInterestWriteoff>
    <us-gaap:NetInvestmentInLeaseAccruedInterestWriteoff contextRef="c11" decimals="0" unitRef="usd">180611</us-gaap:NetInvestmentInLeaseAccruedInterestWriteoff>
    <cik0001793497:FuturesContracts contextRef="c8" decimals="0" unitRef="usd">-37164451</cik0001793497:FuturesContracts>
    <cik0001793497:FuturesContracts contextRef="c9" decimals="0" unitRef="usd">142872642</cik0001793497:FuturesContracts>
    <cik0001793497:FuturesContracts contextRef="c10" decimals="0" unitRef="usd">4573051</cik0001793497:FuturesContracts>
    <cik0001793497:FuturesContracts contextRef="c11" decimals="0" unitRef="usd">-7528449</cik0001793497:FuturesContracts>
    <cik0001793497:FuturesContractsUnrealizedAppreciation contextRef="c8" decimals="0" unitRef="usd">811301</cik0001793497:FuturesContractsUnrealizedAppreciation>
    <cik0001793497:FuturesContractsUnrealizedAppreciation contextRef="c9" decimals="0" unitRef="usd">4374661</cik0001793497:FuturesContractsUnrealizedAppreciation>
    <cik0001793497:FuturesContractsUnrealizedAppreciation contextRef="c10" decimals="0" unitRef="usd">-835808</cik0001793497:FuturesContractsUnrealizedAppreciation>
    <cik0001793497:FuturesContractsUnrealizedAppreciation contextRef="c11" decimals="0" unitRef="usd">256944</cik0001793497:FuturesContractsUnrealizedAppreciation>
    <us-gaap:UnrealizedGainLossOnDerivatives contextRef="c8" decimals="0" unitRef="usd">36353150</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives contextRef="c9" decimals="0" unitRef="usd">-147247303</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives contextRef="c10" decimals="0" unitRef="usd">-3737244</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives contextRef="c11" decimals="0" unitRef="usd">7271505</us-gaap:UnrealizedGainLossOnDerivatives>
    <cik0001793497:NetIncreasedecreaseInNetAssetsResultingFromOperations contextRef="c8" decimals="0" unitRef="usd">36060399</cik0001793497:NetIncreasedecreaseInNetAssetsResultingFromOperations>
    <cik0001793497:NetIncreasedecreaseInNetAssetsResultingFromOperations contextRef="c9" decimals="0" unitRef="usd">-147606672</cik0001793497:NetIncreasedecreaseInNetAssetsResultingFromOperations>
    <cik0001793497:NetIncreasedecreaseInNetAssetsResultingFromOperations contextRef="c10" decimals="0" unitRef="usd">-3980023</cik0001793497:NetIncreasedecreaseInNetAssetsResultingFromOperations>
    <cik0001793497:NetIncreasedecreaseInNetAssetsResultingFromOperations contextRef="c11" decimals="0" unitRef="usd">7090894</cik0001793497:NetIncreasedecreaseInNetAssetsResultingFromOperations>
    <us-gaap:InterestAndOtherIncome contextRef="c12" decimals="0" unitRef="usd">121531</us-gaap:InterestAndOtherIncome>
    <us-gaap:InterestAndOtherIncome contextRef="c13" decimals="0" unitRef="usd">434271</us-gaap:InterestAndOtherIncome>
    <us-gaap:InterestAndOtherIncome contextRef="c14" decimals="0" unitRef="usd">18984</us-gaap:InterestAndOtherIncome>
    <us-gaap:InterestAndOtherIncome contextRef="c15" decimals="0" unitRef="usd">16782</us-gaap:InterestAndOtherIncome>
    <us-gaap:OtherIncome contextRef="c14" decimals="0" unitRef="usd">61</us-gaap:OtherIncome>
    <us-gaap:OtherIncome contextRef="c15" decimals="0" unitRef="usd">153</us-gaap:OtherIncome>
    <us-gaap:InvestmentIncomeNet contextRef="c12" decimals="0" unitRef="usd">121531</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet contextRef="c13" decimals="0" unitRef="usd">434271</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet contextRef="c14" decimals="0" unitRef="usd">19045</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet contextRef="c15" decimals="0" unitRef="usd">16935</us-gaap:InvestmentIncomeNet>
    <us-gaap:ManagementFeeExpense contextRef="c12" decimals="0" unitRef="usd">394913</us-gaap:ManagementFeeExpense>
    <us-gaap:ManagementFeeExpense contextRef="c13" decimals="0" unitRef="usd">919658</us-gaap:ManagementFeeExpense>
    <us-gaap:ManagementFeeExpense contextRef="c14" decimals="0" unitRef="usd">163562</us-gaap:ManagementFeeExpense>
    <us-gaap:ManagementFeeExpense contextRef="c15" decimals="0" unitRef="usd">111223</us-gaap:ManagementFeeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c12" decimals="0" unitRef="usd">46808</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c13" decimals="0" unitRef="usd">62699</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c14" decimals="0" unitRef="usd">23901</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c15" decimals="0" unitRef="usd">23867</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:ProfessionalFees contextRef="c12" decimals="0" unitRef="usd">159092</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees contextRef="c13" decimals="0" unitRef="usd">160949</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees contextRef="c14" decimals="0" unitRef="usd">15759</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees contextRef="c15" decimals="0" unitRef="usd">15722</us-gaap:ProfessionalFees>
    <us-gaap:LegalFees contextRef="c12" decimals="0" unitRef="usd">50134</us-gaap:LegalFees>
    <us-gaap:LegalFees contextRef="c13" decimals="0" unitRef="usd">44821</us-gaap:LegalFees>
    <us-gaap:LegalFees contextRef="c14" decimals="0" unitRef="usd">40395</us-gaap:LegalFees>
    <us-gaap:LegalFees contextRef="c15" decimals="0" unitRef="usd">40367</us-gaap:LegalFees>
    <us-gaap:FloorBrokerageExchangeAndClearanceFees contextRef="c12" decimals="0" unitRef="usd">8613</us-gaap:FloorBrokerageExchangeAndClearanceFees>
    <us-gaap:FloorBrokerageExchangeAndClearanceFees contextRef="c13" decimals="0" unitRef="usd">320</us-gaap:FloorBrokerageExchangeAndClearanceFees>
    <us-gaap:FloorBrokerageExchangeAndClearanceFees contextRef="c14" decimals="0" unitRef="usd">20000</us-gaap:FloorBrokerageExchangeAndClearanceFees>
    <us-gaap:FloorBrokerageExchangeAndClearanceFees contextRef="c15" decimals="0" unitRef="usd">8143</us-gaap:FloorBrokerageExchangeAndClearanceFees>
    <us-gaap:CostsAndExpenses contextRef="c12" decimals="0" unitRef="usd">659560</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c13" decimals="0" unitRef="usd">1188447</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c14" decimals="0" unitRef="usd">263617</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c15" decimals="0" unitRef="usd">199322</us-gaap:CostsAndExpenses>
    <us-gaap:NetInvestmentInLeaseAccruedInterestWriteoff contextRef="c12" decimals="0" unitRef="usd">538029</us-gaap:NetInvestmentInLeaseAccruedInterestWriteoff>
    <us-gaap:NetInvestmentInLeaseAccruedInterestWriteoff contextRef="c13" decimals="0" unitRef="usd">754176</us-gaap:NetInvestmentInLeaseAccruedInterestWriteoff>
    <us-gaap:NetInvestmentInLeaseAccruedInterestWriteoff contextRef="c14" decimals="0" unitRef="usd">244572</us-gaap:NetInvestmentInLeaseAccruedInterestWriteoff>
    <us-gaap:NetInvestmentInLeaseAccruedInterestWriteoff contextRef="c15" decimals="0" unitRef="usd">182387</us-gaap:NetInvestmentInLeaseAccruedInterestWriteoff>
    <cik0001793497:FuturesContracts contextRef="c12" decimals="0" unitRef="usd">-42451505</cik0001793497:FuturesContracts>
    <cik0001793497:FuturesContracts contextRef="c13" decimals="0" unitRef="usd">186102397</cik0001793497:FuturesContracts>
    <cik0001793497:FuturesContracts contextRef="c14" decimals="0" unitRef="usd">4577129</cik0001793497:FuturesContracts>
    <cik0001793497:FuturesContracts contextRef="c15" decimals="0" unitRef="usd">-7527995</cik0001793497:FuturesContracts>
    <cik0001793497:FuturesContractsUnrealizedAppreciation contextRef="c12" decimals="0" unitRef="usd">-5362473</cik0001793497:FuturesContractsUnrealizedAppreciation>
    <cik0001793497:FuturesContractsUnrealizedAppreciation contextRef="c13" decimals="0" unitRef="usd">10587514</cik0001793497:FuturesContractsUnrealizedAppreciation>
    <cik0001793497:FuturesContractsUnrealizedAppreciation contextRef="c14" decimals="0" unitRef="usd">-700531</cik0001793497:FuturesContractsUnrealizedAppreciation>
    <cik0001793497:FuturesContractsUnrealizedAppreciation contextRef="c15" decimals="0" unitRef="usd">-19258</cik0001793497:FuturesContractsUnrealizedAppreciation>
    <us-gaap:UnrealizedGainLossOnDerivatives contextRef="c12" decimals="0" unitRef="usd">47813978</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives contextRef="c13" decimals="0" unitRef="usd">-196689911</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives contextRef="c14" decimals="0" unitRef="usd">-3876598</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives contextRef="c15" decimals="0" unitRef="usd">7547253</us-gaap:UnrealizedGainLossOnDerivatives>
    <cik0001793497:NetIncreasedecreaseInNetAssetsResultingFromOperations contextRef="c12" decimals="0" unitRef="usd">47275949</cik0001793497:NetIncreasedecreaseInNetAssetsResultingFromOperations>
    <cik0001793497:NetIncreasedecreaseInNetAssetsResultingFromOperations contextRef="c13" decimals="0" unitRef="usd">-197444087</cik0001793497:NetIncreasedecreaseInNetAssetsResultingFromOperations>
    <cik0001793497:NetIncreasedecreaseInNetAssetsResultingFromOperations contextRef="c14" decimals="0" unitRef="usd">-4121170</cik0001793497:NetIncreasedecreaseInNetAssetsResultingFromOperations>
    <cik0001793497:NetIncreasedecreaseInNetAssetsResultingFromOperations contextRef="c15" decimals="0" unitRef="usd">7364866</cik0001793497:NetIncreasedecreaseInNetAssetsResultingFromOperations>
    <us-gaap:GainLossOnInvestments contextRef="c8" decimals="0" unitRef="usd">-292751</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments contextRef="c9" decimals="0" unitRef="usd">-359369</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments contextRef="c10" decimals="0" unitRef="usd">-242779</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments contextRef="c11" decimals="0" unitRef="usd">-180611</us-gaap:GainLossOnInvestments>
    <cik0001793497:NetRealizedGainlossOnInvestmentsAndFuturesContracts contextRef="c8" decimals="0" unitRef="usd">37164451</cik0001793497:NetRealizedGainlossOnInvestmentsAndFuturesContracts>
    <cik0001793497:NetRealizedGainlossOnInvestmentsAndFuturesContracts contextRef="c9" decimals="0" unitRef="usd">-142872642</cik0001793497:NetRealizedGainlossOnInvestmentsAndFuturesContracts>
    <cik0001793497:NetRealizedGainlossOnInvestmentsAndFuturesContracts contextRef="c10" decimals="0" unitRef="usd">-4573051</cik0001793497:NetRealizedGainlossOnInvestmentsAndFuturesContracts>
    <cik0001793497:NetRealizedGainlossOnInvestmentsAndFuturesContracts contextRef="c11" decimals="0" unitRef="usd">7528449</cik0001793497:NetRealizedGainlossOnInvestmentsAndFuturesContracts>
    <cik0001793497:NetChangeInUnrealizedAppreciationdepreciationOfInvestmentsAndFuturesContracts contextRef="c8" decimals="0" unitRef="usd">-811301</cik0001793497:NetChangeInUnrealizedAppreciationdepreciationOfInvestmentsAndFuturesContracts>
    <cik0001793497:NetChangeInUnrealizedAppreciationdepreciationOfInvestmentsAndFuturesContracts contextRef="c9" decimals="0" unitRef="usd">-4374661</cik0001793497:NetChangeInUnrealizedAppreciationdepreciationOfInvestmentsAndFuturesContracts>
    <cik0001793497:NetChangeInUnrealizedAppreciationdepreciationOfInvestmentsAndFuturesContracts contextRef="c10" decimals="0" unitRef="usd">835808</cik0001793497:NetChangeInUnrealizedAppreciationdepreciationOfInvestmentsAndFuturesContracts>
    <cik0001793497:NetChangeInUnrealizedAppreciationdepreciationOfInvestmentsAndFuturesContracts contextRef="c11" decimals="0" unitRef="usd">-256944</cik0001793497:NetChangeInUnrealizedAppreciationdepreciationOfInvestmentsAndFuturesContracts>
    <cik0001793497:NetIncreasedecreaseInNetAssetsResultingFromOperations contextRef="c8" decimals="0" unitRef="usd">36060399</cik0001793497:NetIncreasedecreaseInNetAssetsResultingFromOperations>
    <cik0001793497:NetIncreasedecreaseInNetAssetsResultingFromOperations contextRef="c9" decimals="0" unitRef="usd">-147606672</cik0001793497:NetIncreasedecreaseInNetAssetsResultingFromOperations>
    <cik0001793497:NetIncreasedecreaseInNetAssetsResultingFromOperations contextRef="c10" decimals="0" unitRef="usd">-3980023</cik0001793497:NetIncreasedecreaseInNetAssetsResultingFromOperations>
    <cik0001793497:NetIncreasedecreaseInNetAssetsResultingFromOperations contextRef="c11" decimals="0" unitRef="usd">7090894</cik0001793497:NetIncreasedecreaseInNetAssetsResultingFromOperations>
    <cik0001793497:SharesSoldinShares contextRef="c8" decimals="0" unitRef="usd">-33849864</cik0001793497:SharesSoldinShares>
    <cik0001793497:SharesSoldinShares contextRef="c9" decimals="0" unitRef="usd">-174563374</cik0001793497:SharesSoldinShares>
    <cik0001793497:SharesSoldinShares contextRef="c10" decimals="0" unitRef="usd">-126466848</cik0001793497:SharesSoldinShares>
    <cik0001793497:SharesSoldinShares contextRef="c11" decimals="0" unitRef="usd">-101014240</cik0001793497:SharesSoldinShares>
    <cik0001793497:SharesSoldNetOfSharesRedeemedinDollarsPerShare contextRef="c8" decimals="0" unitRef="usd">72249312</cik0001793497:SharesSoldNetOfSharesRedeemedinDollarsPerShare>
    <cik0001793497:SharesSoldNetOfSharesRedeemedinDollarsPerShare contextRef="c9" decimals="0" unitRef="usd">48655759</cik0001793497:SharesSoldNetOfSharesRedeemedinDollarsPerShare>
    <cik0001793497:SharesSoldNetOfSharesRedeemedinDollarsPerShare contextRef="c10" decimals="0" unitRef="usd">80976664</cik0001793497:SharesSoldNetOfSharesRedeemedinDollarsPerShare>
    <cik0001793497:SharesSoldNetOfSharesRedeemedinDollarsPerShare contextRef="c11" decimals="0" unitRef="usd">51662990</cik0001793497:SharesSoldNetOfSharesRedeemedinDollarsPerShare>
    <cik0001793497:NetIncreaseInNetAssetsFromCapitalShareTransactions contextRef="c8" decimals="0" unitRef="usd">-38399448</cik0001793497:NetIncreaseInNetAssetsFromCapitalShareTransactions>
    <cik0001793497:NetIncreaseInNetAssetsFromCapitalShareTransactions contextRef="c9" decimals="0" unitRef="usd">125907615</cik0001793497:NetIncreaseInNetAssetsFromCapitalShareTransactions>
    <cik0001793497:NetIncreaseInNetAssetsFromCapitalShareTransactions contextRef="c10" decimals="0" unitRef="usd">45490184</cik0001793497:NetIncreaseInNetAssetsFromCapitalShareTransactions>
    <cik0001793497:NetIncreaseInNetAssetsFromCapitalShareTransactions contextRef="c11" decimals="0" unitRef="usd">49351250</cik0001793497:NetIncreaseInNetAssetsFromCapitalShareTransactions>
    <cik0001793497:IncreasedecreaseInNetAssets contextRef="c8" decimals="0" unitRef="usd">-2339049</cik0001793497:IncreasedecreaseInNetAssets>
    <cik0001793497:IncreasedecreaseInNetAssets contextRef="c9" decimals="0" unitRef="usd">-21699057</cik0001793497:IncreasedecreaseInNetAssets>
    <cik0001793497:IncreasedecreaseInNetAssets contextRef="c10" decimals="0" unitRef="usd">41510161</cik0001793497:IncreasedecreaseInNetAssets>
    <cik0001793497:IncreasedecreaseInNetAssets contextRef="c11" decimals="0" unitRef="usd">56442145</cik0001793497:IncreasedecreaseInNetAssets>
    <us-gaap:AssetsNet contextRef="c16" decimals="0" unitRef="usd">74641462</us-gaap:AssetsNet>
    <us-gaap:AssetsNet contextRef="c17" decimals="0" unitRef="usd">107037859</us-gaap:AssetsNet>
    <us-gaap:AssetsNet contextRef="c18" decimals="0" unitRef="usd">5379210</us-gaap:AssetsNet>
    <us-gaap:AssetsNet contextRef="c19" decimals="0" unitRef="usd">3994311</us-gaap:AssetsNet>
    <us-gaap:AssetsNet contextRef="c4" decimals="0" unitRef="usd">72302413</us-gaap:AssetsNet>
    <us-gaap:AssetsNet contextRef="c5" decimals="0" unitRef="usd">85338802</us-gaap:AssetsNet>
    <us-gaap:AssetsNet contextRef="c20" decimals="0" unitRef="usd">46889371</us-gaap:AssetsNet>
    <us-gaap:AssetsNet contextRef="c21" decimals="0" unitRef="usd">60436456</us-gaap:AssetsNet>
    <us-gaap:GainLossOnInvestments contextRef="c12" decimals="0" unitRef="usd">-538029</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments contextRef="c13" decimals="0" unitRef="usd">-754176</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments contextRef="c14" decimals="0" unitRef="usd">-244572</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments contextRef="c15" decimals="0" unitRef="usd">-182387</us-gaap:GainLossOnInvestments>
    <cik0001793497:NetRealizedGainlossOnInvestmentsAndFuturesContracts contextRef="c12" decimals="0" unitRef="usd">42451505</cik0001793497:NetRealizedGainlossOnInvestmentsAndFuturesContracts>
    <cik0001793497:NetRealizedGainlossOnInvestmentsAndFuturesContracts contextRef="c13" decimals="0" unitRef="usd">-186102397</cik0001793497:NetRealizedGainlossOnInvestmentsAndFuturesContracts>
    <cik0001793497:NetRealizedGainlossOnInvestmentsAndFuturesContracts contextRef="c14" decimals="0" unitRef="usd">-4577129</cik0001793497:NetRealizedGainlossOnInvestmentsAndFuturesContracts>
    <cik0001793497:NetRealizedGainlossOnInvestmentsAndFuturesContracts contextRef="c15" decimals="0" unitRef="usd">7527995</cik0001793497:NetRealizedGainlossOnInvestmentsAndFuturesContracts>
    <cik0001793497:NetChangeInUnrealizedAppreciationdepreciationOfInvestmentsAndFuturesContracts contextRef="c12" decimals="0" unitRef="usd">5362473</cik0001793497:NetChangeInUnrealizedAppreciationdepreciationOfInvestmentsAndFuturesContracts>
    <cik0001793497:NetChangeInUnrealizedAppreciationdepreciationOfInvestmentsAndFuturesContracts contextRef="c13" decimals="0" unitRef="usd">-10587514</cik0001793497:NetChangeInUnrealizedAppreciationdepreciationOfInvestmentsAndFuturesContracts>
    <cik0001793497:NetChangeInUnrealizedAppreciationdepreciationOfInvestmentsAndFuturesContracts contextRef="c14" decimals="0" unitRef="usd">700531</cik0001793497:NetChangeInUnrealizedAppreciationdepreciationOfInvestmentsAndFuturesContracts>
    <cik0001793497:NetChangeInUnrealizedAppreciationdepreciationOfInvestmentsAndFuturesContracts contextRef="c15" decimals="0" unitRef="usd">19258</cik0001793497:NetChangeInUnrealizedAppreciationdepreciationOfInvestmentsAndFuturesContracts>
    <cik0001793497:NetIncreasedecreaseInNetAssetsResultingFromOperations contextRef="c12" decimals="0" unitRef="usd">47275949</cik0001793497:NetIncreasedecreaseInNetAssetsResultingFromOperations>
    <cik0001793497:NetIncreasedecreaseInNetAssetsResultingFromOperations contextRef="c13" decimals="0" unitRef="usd">-197444087</cik0001793497:NetIncreasedecreaseInNetAssetsResultingFromOperations>
    <cik0001793497:NetIncreasedecreaseInNetAssetsResultingFromOperations contextRef="c14" decimals="0" unitRef="usd">-4121170</cik0001793497:NetIncreasedecreaseInNetAssetsResultingFromOperations>
    <cik0001793497:NetIncreasedecreaseInNetAssetsResultingFromOperations contextRef="c15" decimals="0" unitRef="usd">7364866</cik0001793497:NetIncreasedecreaseInNetAssetsResultingFromOperations>
    <cik0001793497:SharesSoldinShares contextRef="c12" decimals="0" unitRef="usd">-118500459</cik0001793497:SharesSoldinShares>
    <cik0001793497:SharesSoldinShares contextRef="c13" decimals="0" unitRef="usd">-278060557</cik0001793497:SharesSoldinShares>
    <cik0001793497:SharesSoldinShares contextRef="c14" decimals="0" unitRef="usd">-131987205</cik0001793497:SharesSoldinShares>
    <cik0001793497:SharesSoldinShares contextRef="c15" decimals="0" unitRef="usd">-104734579</cik0001793497:SharesSoldinShares>
    <cik0001793497:SharesSoldNetOfSharesRedeemedinDollarsPerShare contextRef="c12" decimals="0" unitRef="usd">139852598</cik0001793497:SharesSoldNetOfSharesRedeemedinDollarsPerShare>
    <cik0001793497:SharesSoldNetOfSharesRedeemedinDollarsPerShare contextRef="c13" decimals="0" unitRef="usd">120766434</cik0001793497:SharesSoldNetOfSharesRedeemedinDollarsPerShare>
    <cik0001793497:SharesSoldNetOfSharesRedeemedinDollarsPerShare contextRef="c14" decimals="0" unitRef="usd">80976664</cik0001793497:SharesSoldNetOfSharesRedeemedinDollarsPerShare>
    <cik0001793497:SharesSoldNetOfSharesRedeemedinDollarsPerShare contextRef="c15" decimals="0" unitRef="usd">51662990</cik0001793497:SharesSoldNetOfSharesRedeemedinDollarsPerShare>
    <cik0001793497:NetIncreaseInNetAssetsFromCapitalShareTransactions contextRef="c12" decimals="0" unitRef="usd">-21352139</cik0001793497:NetIncreaseInNetAssetsFromCapitalShareTransactions>
    <cik0001793497:NetIncreaseInNetAssetsFromCapitalShareTransactions contextRef="c13" decimals="0" unitRef="usd">157294123</cik0001793497:NetIncreaseInNetAssetsFromCapitalShareTransactions>
    <cik0001793497:NetIncreaseInNetAssetsFromCapitalShareTransactions contextRef="c14" decimals="0" unitRef="usd">51010541</cik0001793497:NetIncreaseInNetAssetsFromCapitalShareTransactions>
    <cik0001793497:NetIncreaseInNetAssetsFromCapitalShareTransactions contextRef="c15" decimals="0" unitRef="usd">53071589</cik0001793497:NetIncreaseInNetAssetsFromCapitalShareTransactions>
    <cik0001793497:IncreasedecreaseInNetAssets contextRef="c12" decimals="0" unitRef="usd">25923810</cik0001793497:IncreasedecreaseInNetAssets>
    <cik0001793497:IncreasedecreaseInNetAssets contextRef="c13" decimals="0" unitRef="usd">-40149964</cik0001793497:IncreasedecreaseInNetAssets>
    <cik0001793497:IncreasedecreaseInNetAssets contextRef="c14" decimals="0" unitRef="usd">46889371</cik0001793497:IncreasedecreaseInNetAssets>
    <cik0001793497:IncreasedecreaseInNetAssets contextRef="c15" decimals="0" unitRef="usd">60436456</cik0001793497:IncreasedecreaseInNetAssets>
    <us-gaap:AssetsNet contextRef="c6" decimals="0" unitRef="usd">46378603</us-gaap:AssetsNet>
    <us-gaap:AssetsNet contextRef="c7" decimals="0" unitRef="usd">125488766</us-gaap:AssetsNet>
    <us-gaap:AssetsNet contextRef="c4" decimals="0" unitRef="usd">72302413</us-gaap:AssetsNet>
    <us-gaap:AssetsNet contextRef="c5" decimals="0" unitRef="usd">85338802</us-gaap:AssetsNet>
    <us-gaap:AssetsNet contextRef="c20" decimals="0" unitRef="usd">46889371</us-gaap:AssetsNet>
    <us-gaap:AssetsNet contextRef="c21" decimals="0" unitRef="usd">60436456</us-gaap:AssetsNet>
    <us-gaap:NetIncomeLoss contextRef="c8" decimals="0" unitRef="usd">36060399</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c9" decimals="0" unitRef="usd">-147606672</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c10" decimals="0" unitRef="usd">-242779</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c11" decimals="0" unitRef="usd">-180611</us-gaap:NetIncomeLoss>
    <cik0001793497:PurchasesOfInvestments contextRef="c8" decimals="0" unitRef="usd">117945818</cik0001793497:PurchasesOfInvestments>
    <cik0001793497:PurchasesOfInvestments contextRef="c9" decimals="0" unitRef="usd">170380218</cik0001793497:PurchasesOfInvestments>
    <cik0001793497:PurchasesOfInvestments contextRef="c10" decimals="0" unitRef="usd">86248199</cik0001793497:PurchasesOfInvestments>
    <cik0001793497:PurchasesOfInvestments contextRef="c11" decimals="0" unitRef="usd">60472471</cik0001793497:PurchasesOfInvestments>
    <cik0001793497:ProceedsFromSalesOrMaturitiesOfInvestments contextRef="c8" decimals="0" unitRef="usd">123386374</cik0001793497:ProceedsFromSalesOrMaturitiesOfInvestments>
    <cik0001793497:ProceedsFromSalesOrMaturitiesOfInvestments contextRef="c9" decimals="0" unitRef="usd">176796775</cik0001793497:ProceedsFromSalesOrMaturitiesOfInvestments>
    <cik0001793497:ProceedsFromSalesOrMaturitiesOfInvestments contextRef="c10" decimals="0" unitRef="usd">78851911</cik0001793497:ProceedsFromSalesOrMaturitiesOfInvestments>
    <cik0001793497:ProceedsFromSalesOrMaturitiesOfInvestments contextRef="c11" decimals="0" unitRef="usd">43818993</cik0001793497:ProceedsFromSalesOrMaturitiesOfInvestments>
    <us-gaap:IncreaseDecreaseInEarnestMoneyDepositsOutstanding contextRef="c8" decimals="0" unitRef="usd">-12091557</us-gaap:IncreaseDecreaseInEarnestMoneyDepositsOutstanding>
    <us-gaap:IncreaseDecreaseInEarnestMoneyDepositsOutstanding contextRef="c9" decimals="0" unitRef="usd">9303378</us-gaap:IncreaseDecreaseInEarnestMoneyDepositsOutstanding>
    <us-gaap:IncreaseDecreaseInPrepaidExpensesOther contextRef="c8" decimals="0" unitRef="usd">777982</us-gaap:IncreaseDecreaseInPrepaidExpensesOther>
    <us-gaap:IncreaseDecreaseInPrepaidExpensesOther contextRef="c10" decimals="0" unitRef="usd">-835808</us-gaap:IncreaseDecreaseInPrepaidExpensesOther>
    <us-gaap:IncreaseDecreaseInPrepaidExpensesOther contextRef="c11" decimals="0" unitRef="usd">256944</us-gaap:IncreaseDecreaseInPrepaidExpensesOther>
    <us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet contextRef="c8" decimals="0" unitRef="usd">-19618</us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet>
    <us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet contextRef="c9" decimals="0" unitRef="usd">-9245</us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet>
    <us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet contextRef="c10" decimals="0" unitRef="usd">4573051</us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet>
    <us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet contextRef="c11" decimals="0" unitRef="usd">-7528449</us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet>
    <us-gaap:IncreaseDecreaseInOtherReceivables contextRef="c8" decimals="0" unitRef="usd">-492</us-gaap:IncreaseDecreaseInOtherReceivables>
    <us-gaap:IncreaseDecreaseInOtherReceivables contextRef="c9" decimals="0" unitRef="usd">-1775</us-gaap:IncreaseDecreaseInOtherReceivables>
    <us-gaap:IncreaseDecreaseInOtherReceivables contextRef="c10" decimals="0" unitRef="usd">37960927</us-gaap:IncreaseDecreaseInOtherReceivables>
    <us-gaap:IncreaseDecreaseInOtherReceivables contextRef="c11" decimals="0" unitRef="usd">39378470</us-gaap:IncreaseDecreaseInOtherReceivables>
    <cik0001793497:IncreaseDecreaseInVariationMarginPayable contextRef="c8" decimals="0" unitRef="usd">-13235</cik0001793497:IncreaseDecreaseInVariationMarginPayable>
    <cik0001793497:IncreaseDecreaseInVariationMarginPayable contextRef="c9" decimals="0" unitRef="usd">-10933</cik0001793497:IncreaseDecreaseInVariationMarginPayable>
    <cik0001793497:IncreaseDecreaseInVariationMarginPayable contextRef="c10" decimals="0" unitRef="usd">4018702</cik0001793497:IncreaseDecreaseInVariationMarginPayable>
    <cik0001793497:IncreaseDecreaseInVariationMarginPayable contextRef="c11" decimals="0" unitRef="usd">-121254</cik0001793497:IncreaseDecreaseInVariationMarginPayable>
    <us-gaap:IncreaseDecreaseInReceivables contextRef="c8" decimals="0" unitRef="usd">-26</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInReceivables contextRef="c10" decimals="0" unitRef="usd">9596</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInReceivables contextRef="c11" decimals="0" unitRef="usd">12371</us-gaap:IncreaseDecreaseInReceivables>
    <cik0001793497:IncreaseDecreaseInDueToCustodian contextRef="c8" decimals="0" unitRef="usd">-3086000</cik0001793497:IncreaseDecreaseInDueToCustodian>
    <cik0001793497:IncreaseDecreaseInDueToCustodian contextRef="c9" decimals="0" unitRef="usd">2491372</cik0001793497:IncreaseDecreaseInDueToCustodian>
    <cik0001793497:IncreaseDecreaseInDueToCustodian contextRef="c10" decimals="0" unitRef="usd">764</cik0001793497:IncreaseDecreaseInDueToCustodian>
    <cik0001793497:IncreaseDecreaseInDueToCustodian contextRef="c11" decimals="0" unitRef="usd">200</cik0001793497:IncreaseDecreaseInDueToCustodian>
    <us-gaap:IncreaseDecreaseInCustomerAdvances contextRef="c11" decimals="0" unitRef="usd">-161534</us-gaap:IncreaseDecreaseInCustomerAdvances>
    <us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent contextRef="c9" decimals="0" unitRef="usd">2165122</us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent>
    <us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent contextRef="c10" decimals="0" unitRef="usd">4105647</us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent>
    <cik0001793497:IncreaseDecreaseInPayableToSponsor contextRef="c8" decimals="0" unitRef="usd">6936</cik0001793497:IncreaseDecreaseInPayableToSponsor>
    <cik0001793497:IncreaseDecreaseInPayableToSponsor contextRef="c9" decimals="0" unitRef="usd">-4019</cik0001793497:IncreaseDecreaseInPayableToSponsor>
    <cik0001793497:IncreaseDecreaseInPayableToSponsor contextRef="c10" decimals="0" unitRef="usd">-62014</cik0001793497:IncreaseDecreaseInPayableToSponsor>
    <cik0001793497:IncreaseDecreaseInPayableToSponsor contextRef="c11" decimals="0" unitRef="usd">-70197</cik0001793497:IncreaseDecreaseInPayableToSponsor>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities contextRef="c8" decimals="0" unitRef="usd">6731</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities contextRef="c9" decimals="0" unitRef="usd">1677</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities contextRef="c10" decimals="0" unitRef="usd">21906</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities contextRef="c11" decimals="0" unitRef="usd">22082</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
    <cik0001793497:IncreaseInProfessionalFeesPayable contextRef="c8" decimals="0" unitRef="usd">13987</cik0001793497:IncreaseInProfessionalFeesPayable>
    <cik0001793497:IncreaseInProfessionalFeesPayable contextRef="c9" decimals="0" unitRef="usd">12757</cik0001793497:IncreaseInProfessionalFeesPayable>
    <cik0001793497:IncreaseInProfessionalFeesPayable contextRef="c10" decimals="0" unitRef="usd">15000</cik0001793497:IncreaseInProfessionalFeesPayable>
    <cik0001793497:IncreaseInProfessionalFeesPayable contextRef="c11" decimals="0" unitRef="usd">14963</cik0001793497:IncreaseInProfessionalFeesPayable>
    <cik0001793497:IncreaseInLicensingAndRegistrationFeesPayable contextRef="c8" decimals="0" unitRef="usd">8348</cik0001793497:IncreaseInLicensingAndRegistrationFeesPayable>
    <cik0001793497:IncreaseInLicensingAndRegistrationFeesPayable contextRef="c9" decimals="0" unitRef="usd">15892</cik0001793497:IncreaseInLicensingAndRegistrationFeesPayable>
    <cik0001793497:IncreaseInLicensingAndRegistrationFeesPayable contextRef="c10" decimals="0" unitRef="usd">34725</cik0001793497:IncreaseInLicensingAndRegistrationFeesPayable>
    <cik0001793497:IncreaseInLicensingAndRegistrationFeesPayable contextRef="c11" decimals="0" unitRef="usd">36514</cik0001793497:IncreaseInLicensingAndRegistrationFeesPayable>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c8" decimals="0" unitRef="usd">49757561</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c9" decimals="0" unitRef="usd">-145802567</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c10" decimals="0" unitRef="usd">-41088075</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c11" decimals="0" unitRef="usd">-49092257</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <cik0001793497:ProceedsFromSaleOfUnits contextRef="c8" decimals="0" unitRef="usd">30240210</cik0001793497:ProceedsFromSaleOfUnits>
    <cik0001793497:ProceedsFromSaleOfUnits contextRef="c9" decimals="0" unitRef="usd">192593274</cik0001793497:ProceedsFromSaleOfUnits>
    <cik0001793497:ProceedsFromSaleOfUnits contextRef="c10" decimals="0" unitRef="usd">45490185</cik0001793497:ProceedsFromSaleOfUnits>
    <cik0001793497:ProceedsFromSaleOfUnits contextRef="c11" decimals="0" unitRef="usd">49351251</cik0001793497:ProceedsFromSaleOfUnits>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="c8" decimals="0" unitRef="usd">79997771</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="c9" decimals="0" unitRef="usd">46790707</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c8" decimals="0" unitRef="usd">-49757561</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c9" decimals="0" unitRef="usd">145802567</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c10" decimals="0" unitRef="usd">45490185</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c11" decimals="0" unitRef="usd">49351251</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect contextRef="c10" decimals="0" unitRef="usd">-4402110</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect contextRef="c11" decimals="0" unitRef="usd">-258994</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c18" decimals="0" unitRef="usd">-862580</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c19" decimals="0" unitRef="usd">-151213</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c20" decimals="0" unitRef="usd">3539530</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c21" decimals="0" unitRef="usd">107781</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:NetIncomeLoss contextRef="c12" decimals="0" unitRef="usd">47275949</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c13" decimals="0" unitRef="usd">-197444087</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c14" decimals="0" unitRef="usd">-4121170</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c15" decimals="0" unitRef="usd">7364866</us-gaap:NetIncomeLoss>
    <cik0001793497:PurchasesOfInvestments contextRef="c12" decimals="0" unitRef="usd">227091533</cik0001793497:PurchasesOfInvestments>
    <cik0001793497:PurchasesOfInvestments contextRef="c13" decimals="0" unitRef="usd">309353524</cik0001793497:PurchasesOfInvestments>
    <cik0001793497:PurchasesOfInvestments contextRef="c14" decimals="0" unitRef="usd">87243243</cik0001793497:PurchasesOfInvestments>
    <cik0001793497:PurchasesOfInvestments contextRef="c15" decimals="0" unitRef="usd">60968753</cik0001793497:PurchasesOfInvestments>
    <cik0001793497:ProceedsFromSalesOrMaturitiesOfInvestments contextRef="c12" decimals="0" unitRef="usd">227091533</cik0001793497:ProceedsFromSalesOrMaturitiesOfInvestments>
    <cik0001793497:ProceedsFromSalesOrMaturitiesOfInvestments contextRef="c13" decimals="0" unitRef="usd">308086262</cik0001793497:ProceedsFromSalesOrMaturitiesOfInvestments>
    <cik0001793497:ProceedsFromSalesOrMaturitiesOfInvestments contextRef="c14" decimals="0" unitRef="usd">78951910</cik0001793497:ProceedsFromSalesOrMaturitiesOfInvestments>
    <cik0001793497:ProceedsFromSalesOrMaturitiesOfInvestments contextRef="c15" decimals="0" unitRef="usd">43818993</cik0001793497:ProceedsFromSalesOrMaturitiesOfInvestments>
    <us-gaap:IncreaseDecreaseInEarnestMoneyDepositsOutstanding contextRef="c12" decimals="0" unitRef="usd">20559259</us-gaap:IncreaseDecreaseInEarnestMoneyDepositsOutstanding>
    <us-gaap:IncreaseDecreaseInEarnestMoneyDepositsOutstanding contextRef="c13" decimals="0" unitRef="usd">-31518493</us-gaap:IncreaseDecreaseInEarnestMoneyDepositsOutstanding>
    <us-gaap:IncreaseDecreaseInEarnestMoneyDepositsOutstanding contextRef="c14" decimals="0" unitRef="usd">39872983</us-gaap:IncreaseDecreaseInEarnestMoneyDepositsOutstanding>
    <us-gaap:IncreaseDecreaseInEarnestMoneyDepositsOutstanding contextRef="c15" decimals="0" unitRef="usd">40554763</us-gaap:IncreaseDecreaseInEarnestMoneyDepositsOutstanding>
    <us-gaap:IncreaseDecreaseInPrepaidExpensesOther contextRef="c12" decimals="0" unitRef="usd">1242108</us-gaap:IncreaseDecreaseInPrepaidExpensesOther>
    <us-gaap:IncreaseDecreaseInPrepaidExpensesOther contextRef="c13" decimals="0" unitRef="usd">-830840</us-gaap:IncreaseDecreaseInPrepaidExpensesOther>
    <us-gaap:IncreaseDecreaseInPrepaidExpensesOther contextRef="c15" decimals="0" unitRef="usd">1433096</us-gaap:IncreaseDecreaseInPrepaidExpensesOther>
    <us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet contextRef="c12" decimals="0" unitRef="usd">294</us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet>
    <us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet contextRef="c13" decimals="0" unitRef="usd">14869</us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet>
    <us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet contextRef="c14" decimals="0" unitRef="usd">9602</us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet>
    <us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet contextRef="c15" decimals="0" unitRef="usd">12375</us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet>
    <us-gaap:IncreaseDecreaseInOtherReceivables contextRef="c12" decimals="0" unitRef="usd">-318</us-gaap:IncreaseDecreaseInOtherReceivables>
    <us-gaap:IncreaseDecreaseInOtherReceivables contextRef="c13" decimals="0" unitRef="usd">-19</us-gaap:IncreaseDecreaseInOtherReceivables>
    <cik0001793497:IncreaseDecreaseInVariationMarginPayable contextRef="c12" decimals="0" unitRef="usd">-24085</cik0001793497:IncreaseDecreaseInVariationMarginPayable>
    <cik0001793497:IncreaseDecreaseInVariationMarginPayable contextRef="c13" decimals="0" unitRef="usd">-10101</cik0001793497:IncreaseDecreaseInVariationMarginPayable>
    <cik0001793497:IncreaseDecreaseInDueToCustodian contextRef="c12" decimals="0" unitRef="usd">1023713</cik0001793497:IncreaseDecreaseInDueToCustodian>
    <cik0001793497:IncreaseDecreaseInDueToCustodian contextRef="c13" decimals="0" unitRef="usd">2874781</cik0001793497:IncreaseDecreaseInDueToCustodian>
    <us-gaap:IncreaseDecreaseInCustomerAdvances contextRef="c15" decimals="0" unitRef="usd">1016260</us-gaap:IncreaseDecreaseInCustomerAdvances>
    <us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent contextRef="c12" decimals="0" unitRef="usd">-187030</us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent>
    <us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent contextRef="c13" decimals="0" unitRef="usd">3406049</us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent>
    <us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent contextRef="c14" decimals="0" unitRef="usd">583031</us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent>
    <cik0001793497:IncreaseDecreaseInPayableToSponsor contextRef="c12" decimals="0" unitRef="usd">-16246</cik0001793497:IncreaseDecreaseInPayableToSponsor>
    <cik0001793497:IncreaseDecreaseInPayableToSponsor contextRef="c13" decimals="0" unitRef="usd">37988</cik0001793497:IncreaseDecreaseInPayableToSponsor>
    <cik0001793497:IncreaseDecreaseInPayableToSponsor contextRef="c14" decimals="0" unitRef="usd">-62124</cik0001793497:IncreaseDecreaseInPayableToSponsor>
    <cik0001793497:IncreaseDecreaseInPayableToSponsor contextRef="c15" decimals="0" unitRef="usd">-70335</cik0001793497:IncreaseDecreaseInPayableToSponsor>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities contextRef="c12" decimals="0" unitRef="usd">-1163</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities contextRef="c13" decimals="0" unitRef="usd">-1860</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities contextRef="c14" decimals="0" unitRef="usd">22421</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities contextRef="c15" decimals="0" unitRef="usd">22597</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
    <cik0001793497:IncreaseInProfessionalFeesPayable contextRef="c12" decimals="0" unitRef="usd">43758</cik0001793497:IncreaseInProfessionalFeesPayable>
    <cik0001793497:IncreaseInProfessionalFeesPayable contextRef="c13" decimals="0" unitRef="usd">42621</cik0001793497:IncreaseInProfessionalFeesPayable>
    <cik0001793497:IncreaseInProfessionalFeesPayable contextRef="c14" decimals="0" unitRef="usd">15210</cik0001793497:IncreaseInProfessionalFeesPayable>
    <cik0001793497:IncreaseInProfessionalFeesPayable contextRef="c15" decimals="0" unitRef="usd">15174</cik0001793497:IncreaseInProfessionalFeesPayable>
    <cik0001793497:IncreaseInLicensingAndRegistrationFeesPayable contextRef="c12" decimals="0" unitRef="usd">14166</cik0001793497:IncreaseInLicensingAndRegistrationFeesPayable>
    <cik0001793497:IncreaseInLicensingAndRegistrationFeesPayable contextRef="c13" decimals="0" unitRef="usd">27868</cik0001793497:IncreaseInLicensingAndRegistrationFeesPayable>
    <cik0001793497:IncreaseInLicensingAndRegistrationFeesPayable contextRef="c14" decimals="0" unitRef="usd">35642</cik0001793497:IncreaseInLicensingAndRegistrationFeesPayable>
    <cik0001793497:IncreaseInLicensingAndRegistrationFeesPayable contextRef="c15" decimals="0" unitRef="usd">37431</cik0001793497:IncreaseInLicensingAndRegistrationFeesPayable>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c12" decimals="0" unitRef="usd">26360211</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c13" decimals="0" unitRef="usd">-160075496</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c14" decimals="0" unitRef="usd">-51576659</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c15" decimals="0" unitRef="usd">-50623331</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <cik0001793497:ProceedsFromSaleOfUnits contextRef="c12" decimals="0" unitRef="usd">114890805</cik0001793497:ProceedsFromSaleOfUnits>
    <cik0001793497:ProceedsFromSaleOfUnits contextRef="c13" decimals="0" unitRef="usd">278976878</cik0001793497:ProceedsFromSaleOfUnits>
    <cik0001793497:ProceedsFromSaleOfUnits contextRef="c14" decimals="0" unitRef="usd">131987206</cik0001793497:ProceedsFromSaleOfUnits>
    <cik0001793497:ProceedsFromSaleOfUnits contextRef="c15" decimals="0" unitRef="usd">102394101</cik0001793497:ProceedsFromSaleOfUnits>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="c12" decimals="0" unitRef="usd">141755616</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="c13" decimals="0" unitRef="usd">118901382</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="c14" decimals="0" unitRef="usd">76871017</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="c15" decimals="0" unitRef="usd">51662990</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c12" decimals="0" unitRef="usd">-26864811</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c13" decimals="0" unitRef="usd">160075496</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c14" decimals="0" unitRef="usd">55116189</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c15" decimals="0" unitRef="usd">50731111</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect contextRef="c12" decimals="0" unitRef="usd">504600</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect contextRef="c14" decimals="0" unitRef="usd">-3539530</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect contextRef="c15" decimals="0" unitRef="usd">-107781</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c6" decimals="0" unitRef="usd">504600</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c20" decimals="0" unitRef="usd">3539530</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c21" decimals="0" unitRef="usd">107781</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <cik0001793497:OtherAssetsInExcessOfLiabilitiesPercentage contextRef="c25" decimals="2" unitRef="pure">1</cik0001793497:OtherAssetsInExcessOfLiabilitiesPercentage>
    <us-gaap:OtherAssets contextRef="c24" decimals="0" id="ix_6_fact" unitRef="usd">72302413</us-gaap:OtherAssets>
    <us-gaap:DerivativeNetAssetsPercentage contextRef="c24" decimals="2" unitRef="pure">1</us-gaap:DerivativeNetAssetsPercentage>
    <us-gaap:AssetsNet contextRef="c24" decimals="0" unitRef="usd">72302413</us-gaap:AssetsNet>
    <cik0001793497:NumberOfContracts contextRef="c26" decimals="0" unitRef="usd">-2590</cik0001793497:NumberOfContracts>
    <us-gaap:InvestmentOwnedUnrecognizedUnrealizedAppreciation contextRef="c27" decimals="0" unitRef="usd">5483830</us-gaap:InvestmentOwnedUnrecognizedUnrealizedAppreciation>
    <cik0001793497:NumberOfContracts contextRef="c28" decimals="0" unitRef="usd">-1883</cik0001793497:NumberOfContracts>
    <us-gaap:InvestmentOwnedUnrecognizedUnrealizedAppreciation contextRef="c29" decimals="0" unitRef="usd">1034749</us-gaap:InvestmentOwnedUnrecognizedUnrealizedAppreciation>
    <cik0001793497:UnderlyingFaceAmountAtMarketValues contextRef="c25" decimals="0" unitRef="usd">6518579</cik0001793497:UnderlyingFaceAmountAtMarketValues>
    <cik0001793497:Cash1 contextRef="c31" decimals="1" unitRef="usd">1.1</cik0001793497:Cash1>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c30" decimals="0" id="ix_7_fact" unitRef="usd">504600</us-gaap:CashEquivalentsAtCarryingValue>
    <cik0001793497:OtherAssetsInExcessOfLiabilitiesPercentage contextRef="c32" decimals="3" unitRef="pure">0.989</cik0001793497:OtherAssetsInExcessOfLiabilitiesPercentage>
    <us-gaap:OtherAssets contextRef="c30" decimals="0" id="ix_8_fact" unitRef="usd">45874003</us-gaap:OtherAssets>
    <us-gaap:DerivativeNetAssetsPercentage contextRef="c31" decimals="2" unitRef="pure">1</us-gaap:DerivativeNetAssetsPercentage>
    <us-gaap:AssetsNet contextRef="c30" decimals="0" unitRef="usd">46378603</us-gaap:AssetsNet>
    <cik0001793497:NumberOfContracts contextRef="c33" decimals="0" unitRef="usd">-1150</cik0001793497:NumberOfContracts>
    <us-gaap:InvestmentOwnedUnrecognizedUnrealizedAppreciation contextRef="c34" decimals="0" unitRef="usd">1058570</us-gaap:InvestmentOwnedUnrecognizedUnrealizedAppreciation>
    <cik0001793497:NumberOfContracts contextRef="c35" decimals="0" unitRef="usd">-804</cik0001793497:NumberOfContracts>
    <us-gaap:InvestmentOwnedUnrecognizedUnrealizedAppreciation contextRef="c36" decimals="0" unitRef="usd">97536</us-gaap:InvestmentOwnedUnrecognizedUnrealizedAppreciation>
    <cik0001793497:UnderlyingFaceAmountAtMarketValues contextRef="c33" decimals="0" unitRef="usd">1156106</cik0001793497:UnderlyingFaceAmountAtMarketValues>
    <us-gaap:InvestmentInterestRate contextRef="c37" decimals="4" unitRef="pure">0.05</us-gaap:InvestmentInterestRate>
    <us-gaap:MoneyMarketFundsAtCarryingValue contextRef="c37" decimals="0" id="ix_9_fact" unitRef="usd">9517548</us-gaap:MoneyMarketFundsAtCarryingValue>
    <cik0001793497:CashPledgedAsCollateral contextRef="c13" decimals="0" unitRef="usd">9517548</cik0001793497:CashPledgedAsCollateral>
    <us-gaap:OtherShortTermInvestments contextRef="c5" decimals="0" unitRef="usd">9517548</us-gaap:OtherShortTermInvestments>
    <us-gaap:InvestmentInterestRate contextRef="c5" decimals="3" unitRef="pure">0.112</us-gaap:InvestmentInterestRate>
    <us-gaap:OtherInvestments contextRef="c5" decimals="0" unitRef="usd">9517548</us-gaap:OtherInvestments>
    <cik0001793497:OtherAssetsInExcessOfLiabilitiesPercentage contextRef="c13" decimals="3" unitRef="pure">0.888</cik0001793497:OtherAssetsInExcessOfLiabilitiesPercentage>
    <us-gaap:OtherAssets contextRef="c5" decimals="0" id="ix_11_fact" unitRef="usd">75821254</us-gaap:OtherAssets>
    <us-gaap:DerivativeNetAssetsPercentage contextRef="c5" decimals="3" unitRef="pure">1</us-gaap:DerivativeNetAssetsPercentage>
    <us-gaap:AssetsNet contextRef="c5" decimals="0" unitRef="usd">85338802</us-gaap:AssetsNet>
    <cik0001793497:NumberOfContracts contextRef="c38" decimals="0" unitRef="usd">6356</cik0001793497:NumberOfContracts>
    <us-gaap:InvestmentOwnedUnrecognizedUnrealizedAppreciation contextRef="c39" decimals="0" unitRef="usd">-16558756</us-gaap:InvestmentOwnedUnrecognizedUnrealizedAppreciation>
    <cik0001793497:NumberOfContracts contextRef="c40" decimals="0" unitRef="usd">4623</cik0001793497:NumberOfContracts>
    <us-gaap:InvestmentOwnedUnrecognizedUnrealizedAppreciation contextRef="c41" decimals="0" unitRef="usd">-3232280</us-gaap:InvestmentOwnedUnrecognizedUnrealizedAppreciation>
    <cik0001793497:UnderlyingFaceAmountAtMarketValues contextRef="c13" decimals="0" unitRef="usd">-19791036</cik0001793497:UnderlyingFaceAmountAtMarketValues>
    <us-gaap:InvestmentInterestRate contextRef="c42" decimals="5" unitRef="pure">0.04105</us-gaap:InvestmentInterestRate>
    <us-gaap:MoneyMarketFundsAtCarryingValue contextRef="c42" decimals="0" id="ix_10_fact" unitRef="usd">8250285</us-gaap:MoneyMarketFundsAtCarryingValue>
    <cik0001793497:CashPledgedAsCollateral contextRef="c43" decimals="0" unitRef="usd">8250285</cik0001793497:CashPledgedAsCollateral>
    <us-gaap:OtherShortTermInvestments contextRef="c7" decimals="0" unitRef="usd">8250285</us-gaap:OtherShortTermInvestments>
    <us-gaap:InvestmentInterestRate contextRef="c7" decimals="4" unitRef="pure">0.0657</us-gaap:InvestmentInterestRate>
    <us-gaap:OtherInvestments contextRef="c7" decimals="0" unitRef="usd">8250285</us-gaap:OtherInvestments>
    <cik0001793497:OtherAssetsInExcessOfLiabilitiesPercentage contextRef="c43" decimals="4" unitRef="pure">0.9343</cik0001793497:OtherAssetsInExcessOfLiabilitiesPercentage>
    <us-gaap:OtherAssets contextRef="c7" decimals="0" id="ix_12_fact" unitRef="usd">117238481</us-gaap:OtherAssets>
    <us-gaap:DerivativeNetAssetsPercentage contextRef="c7" decimals="3" unitRef="pure">1</us-gaap:DerivativeNetAssetsPercentage>
    <us-gaap:AssetsNet contextRef="c7" decimals="0" unitRef="usd">125488766</us-gaap:AssetsNet>
    <cik0001793497:NumberOfContracts contextRef="c44" decimals="0" unitRef="usd">6221</cik0001793497:NumberOfContracts>
    <us-gaap:InvestmentOwnedUnrecognizedUnrealizedAppreciation contextRef="c45" decimals="0" unitRef="usd">-8416975</us-gaap:InvestmentOwnedUnrecognizedUnrealizedAppreciation>
    <cik0001793497:NumberOfContracts contextRef="c46" decimals="0" unitRef="usd">4355</cik0001793497:NumberOfContracts>
    <us-gaap:InvestmentOwnedUnrecognizedUnrealizedAppreciation contextRef="c47" decimals="0" unitRef="usd">-786547</us-gaap:InvestmentOwnedUnrecognizedUnrealizedAppreciation>
    <cik0001793497:UnderlyingFaceAmountAtMarketValues contextRef="c44" decimals="0" unitRef="usd">-9203522</cik0001793497:UnderlyingFaceAmountAtMarketValues>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"&gt;NOTE 1 &#x2013; ORGANIZATION&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;VS Trust (the &#x201c;Trust&#x201d;)
is a Delaware statutory trust formed on October 24, 2019 and is currently organized into separate series (each, a &#x201c;Fund&#x201d; and
collectively, the &#x201c;Funds&#x201d;). As of June 30, 2023, the following two series of the Trust have commenced investment operations:
-1x Short VIX Futures ETF (&#x201c;SVIX&#x201d;) and 2x Long VIX Futures ETF (&#x201c;UVIX&#x201d;). Each of the Funds listed above issues
common units of beneficial interest (&#x201c;Shares&#x201d;), which represent units of fractional undivided beneficial interest in and ownership
of only that Fund. The Shares of each Fund are listed on the Cboe BZX Exchange (&#x201c;Cboe BZX&#x201d;).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;The Funds&#x2019; inception of operation
was March 28, 2022. Neither the Trust nor the Funds had any operations prior to March 28, 2022, other than matters relating to its organization
and the registration of each series under the Securities Act of 1933.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;Each Fund&#x2019;s investment exposure
to VIX futures contracts will cause each to be deemed a commodity pool, thereby subjecting each Fund to regulation under the Commodity
Exchange Act of 1934 (&#x201c;CEA&#x201d;) and Commodity Futures Trading Commission (&#x201c;CFTC&#x201d;) rules. The Sponsor is registered
as a Commodity Pool Operator (&#x201c;CPO&#x201d;) and the Fund will be operated in accordance with applicable CFTC rules. Registration
as a CPO imposes additional compliance obligations on the Sponsor and the Funds related to additional laws, regulations and enforcement
policies, which could increase compliance costs and may affect the operations and financial performance of the Funds.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;Volatility Shares LLC (the &#x201c;Sponsor&#x201d;)
is the sponsor of the Trust and the Funds. The Sponsor also will serve as the Trust&#x2019;s commodity pool operator. The Funds are commodity
pools, as defined under the Commodity Exchange Act (the &#x201c;CEA&#x201d;), and the applicable regulations of the CFTC and are operated
by the Sponsor, which is registered as a commodity pool operator with the CFTC. The Trust is not an investment company registered under
the Investment Company Act of 1940.&lt;/p&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 7.7pt"&gt;NOTE 2 &#x2013; SIGNIFICANT ACCOUNTING POLICIES&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;Each Fund is an investment company,
as defined by Financial Accounting Standards Board (&#x201c;FASB&#x201d;) Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic 946
&#x201c;Financial Services &#x2014; Investment Companies.&#x201d; As such, the Funds follow the investment company accounting and reporting
guidance. The following is a summary of significant accounting policies followed by each Fund, as applicable, in preparation of its financial
statements. These policies are in conformity with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;The accompanying unaudited financial
statements were prepared in accordance with GAAP for interim financial information and with the instructions for Form 10-Q and the rules
and regulations of the U.S. Securities and Exchange Commission (&#x201c;SEC&#x201d;). In the opinion of management, all material adjustments,
consisting only of normal recurring adjustments, considered necessary for a fair statement of the interim period financial statements
have been made. Interim period results are not necessarily indicative of results for a full-year period.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 7.7pt"&gt;Emerging growth company&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;The Trust is an &#x201c;emerging
growth company,&#x201d; as defined in the Jumpstart Our Business Startups Act of 2012. It will remain an emerging growth company until
the earlier of (1) the beginning of the first fiscal year following the fifth anniversary of its initial public offering, (2) the beginning
of the first fiscal year after annual gross revenue is $1.07 billion (subject to adjustment for inflation) or more, (3) the date on which
the Fund has, during the previous three-year period, issued more than $1.0 billion in non-convertible debt securities and (4) as of the
end of any fiscal year in which the market value of common equity held by non-affiliates exceeded $700 million as of the end of the second
quarter of that fiscal year.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;For as
long as the Trust remains an &#x201c;emerging growth company,&#x201d; it may take advantage of certain exemptions from the various reporting
requirements that are applicable to public companies that are not &#x201c;emerging growth companies&#x201d; including, but not limited
to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure
obligations regarding executive compensation and financial statements in our periodic reports and proxy statements, and exemptions from
the requirements of holding a nonbinding advisory vote to approve executive compensation and shareholder approval of any golden parachute
payments not previously approved. The Trust will take advantage of these reporting exemptions until it is no longer an &#x201c;emerging
growth company.&#x201d;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"&gt;Use of Estimates &amp;amp; Indemnifications&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;The preparation of financial statements
in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities
and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and
expenses during the reporting period. Actual results could differ from those estimates.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;In
the normal course of business, the Trust enters into contracts that contain a variety of representations which provide general
indemnifications. The Trust&#x2019;s maximum exposure under these arrangements cannot be known; however, the Trust expects any risk
of loss to be remote.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"&gt;Basis of Presentation&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;Pursuant to rules and regulations
of the SEC, these financial statements are presented for the Trust as a whole, as the SEC registrant, and for each Fund individually.
The debts, liabilities, obligations and expenses incurred, contracted for or otherwise existing with respect to a particular Fund shall
be enforceable only against the assets of such Fund and not against the assets of the Trust generally or any other Fund. Accordingly,
the assets of each Fund of the Trust include only those funds and other assets that are paid to, held by or distributed to the Trust for
the purchase of Shares in that Fund.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"&gt;Statements of Cash Flows&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;The
cash amount shown in the Statements of Cash Flows is the amount reported as cash in the Statements of Financial Condition dated June
30, 2023 and December 31, 2022, and represents cash, but does not include short-term investments.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"&gt;Final Net Asset Value for Fiscal Period&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;The cut-off times and the times
of the calculation of the Funds&#x2019; final net asset value for creation and redemption of fund Shares for the three months ended June
30, 2023 were typically as follows. All times are Eastern Standard Time:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;NAV&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;NAV&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;Create/Redeem&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;Calculation&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;Calculation&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 64%; font-weight: bold; text-align: left"&gt;Fund&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 11%; font-weight: bold; text-align: center"&gt;Cut-off*(EST)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 11%; font-weight: bold; text-align: center"&gt;Time (EST)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 11%; font-weight: bold; text-align: center"&gt;Date&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;-1x Short VIX Futures ETF and&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;2:00 p.m.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;4:00 p.m.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;June 30, 2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;2x Long VIX Futures ETF&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;2:00 p.m.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;4:00 p.m.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;June 30, 2023&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 7.7pt"&gt;&lt;/td&gt;&lt;td style="width: 14.95pt"&gt;*&lt;/td&gt;&lt;td style="padding-right: 7.8pt"&gt;Although the Funds&#x2019; shares may continue to trade on secondary markets subsequent to the calculation
of the final NAV, these times represent the final opportunity to transact in creation or redemption units for the three months ended June
30, 2023.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;Market value per Share is determined at the close of Cboe
BZX and may be later than when the Funds&#x2019; NAV per Share is calculated.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;For financial reporting purposes,
the Funds value transactions based upon the final closing price in their primary markets. Accordingly, the investment valuations in these
financial statements may differ from those used in the calculation of certain of the Funds&#x2019; final creation/redemption NAV for the
three months ended June 30, 2023.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"&gt;Investment Valuation&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;Short-term investments are valued
at amortized cost which approximates fair value for daily NAV purposes. For financial reporting purposes, short-term investments are valued
at their market price using information provided by a third-party pricing service or market quotations. In each of these situations, valuations
are typically categorized as Level I in the fair value hierarchy.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;VIX futures
contracts are valued using the Time Weighted Average Price (TWAP) of the futures during the last 15 minutes of NYSE&#x2019;s regular trading
session, rather than solely from the VIX futures&#x2019; settlement price. The value of a Fund&#x2019;s non-exchange-traded Financial Instruments
typically is determined by applying the then-current disseminated levels for the Index to the terms of the Fund&#x2019;s non-exchange-traded
Financial Instruments.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;In certain circumstances (e.g.,
if the Sponsor believes market quotations do not accurately reflect the fair value of a Fund&#x2019;s investment, or a trading halt closes
an exchange or market early), the Sponsor may, in its sole discretion, choose to determine a fair value price as the basis for determining
the market value of such investment for such day. Such fair value prices would generally be determined based on available inputs about
the current value of the underlying VIX futures contract and would be based on principles that the Sponsor deems fair and equitable.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;The Funds may use a variety of
money market instruments. Money market instruments generally will be valued using market prices or at amortized cost.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;Fair value pricing may require
subjective determinations about the value of an investment. While the Funds&#x2019; policies are intended to result in a calculation of
its respective Fund&#x2019;s NAV that fairly reflects investment values as of the time of pricing, such Fund cannot ensure that fair values
determined by the Sponsor or persons acting at their direction would accurately reflect the price that a Fund could obtain for an investment
if it were to dispose of that investment as of the time of pricing (for instance, in a forced or distressed sale). The prices used by
such Fund may differ from the value that would be realized if the investments were sold and the differences could be material to the financial
statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"&gt;Fair Value of Financial Instruments&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;The
Funds disclose the fair value of their investments in a hierarchy that prioritizes the inputs to valuation techniques used to
measure fair value. The disclosure requirements establish a fair value hierarchy that distinguishes between: (1) market participant
assumptions developed based on market data obtained from sources independent of the Funds (observable inputs); and (2) the
Funds&#x2019; own assumptions about market participant assumptions developed based on the best information available under the
circumstances (unobservable inputs). The three levels defined by the disclosure requirements hierarchy are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in; text-align: left"&gt;Level I&lt;/td&gt;&lt;td style="text-align: center; width: 0.25in"&gt;&#x2013;&lt;/td&gt;
                                                                                      &lt;td style="text-align: left"&gt;Quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access
at the measurement date.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="text-align: left; width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in; text-align: left"&gt;Level II&lt;/td&gt;&lt;td style="text-align: center; width: 0.25in"&gt;&#x2013;&lt;/td&gt;
                                                                                       &lt;td style="text-align: left"&gt;Inputs other than quoted prices included within Level I that are observable for the asset or liability, either directly or indirectly.
Level II assets include the following: quoted prices for similar assets or liabilities in active markets, quoted prices for identical
or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or
liability, and inputs that are derived principally from or corroborated by observable market data by correlation or other means (market-corroborated
inputs).&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="text-align: left; width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in; text-align: left"&gt;Level III&lt;/td&gt;&lt;td style="text-align: center; width: 0.25in"&gt;&#x2013;&lt;/td&gt;
                                                                                        &lt;td style="text-align: left"&gt;Unobservable pricing input at the measurement date for the asset or liability. Unobservable inputs shall be used to measure fair value
to the extent that observable inputs are not available.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;In some instances, the inputs used
to measure fair value might fall in different levels of the fair value hierarchy. The level in the fair value hierarchy within which the
fair value measurement in its entirety falls is determined based on the lowest input level that is significant to the fair value measurement
in its entirety.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;Fair value measurements also require additional
disclosure when the volume and level of activity for the asset or liability have significantly decreased, as well as when circumstances
indicate that a transaction is not orderly.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;The following table summarizes the valuation of investments
at June 30, 2023 (unaudited) and December 31, 2022 using the fair value hierarchy:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;June 30, 2023 (Unaudited)&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;December 31, 2022&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;Fund&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Level 1 - &lt;br/&gt;
Money &lt;br/&gt;
Market &lt;br/&gt;
Fund&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Level 2 - &lt;br/&gt;
Futures &lt;br/&gt;
Contracts*&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Total &lt;br/&gt;
June 30, &lt;br/&gt;
2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Level 1 - &lt;br/&gt;
Money &lt;br/&gt;
Market &lt;br/&gt;
Fund&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Level 2 - &lt;br/&gt;
Futures &lt;br/&gt;
Contracts*&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Total &lt;br/&gt;
December&#160;31, &lt;br/&gt;
2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 28%; text-align: left"&gt;-1x Short VIX Futures ETF&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-62"&gt;&#x2013;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;6,518,579&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;6,518,579&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,156,106&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,156,106&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;2x Long VIX Futures ETF&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;9,517,548&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(19,791,036&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(10,273,488&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;8,250,285&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(9,203,522&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(953,237&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 4pt"&gt;Total Trust&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;9,517,548&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(13,272,457&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(3,754,909&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;8,250,285&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(8,047,416&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;202,869&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;*&lt;/td&gt;&lt;td style="text-align: left"&gt;Includes cumulative appreciation (depreciation) of futures
contracts as reported in the Schedule of Investments. Only current day&#x2019;s variation margin is reported within the Statements of
Financial Condition in receivable/payable on open futures.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;The inputs or methodology used for valuing investments
are not necessarily an indication of the risk associated with investing in those securities.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Investment Transactions and Related Income&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;Investment transactions are recorded on the trade
date. All such transactions are recorded on the identified cost basis and marked to market daily. Unrealized appreciation (depreciation)
on open contracts are reflected in the Statements of Financial Condition and changes in the unrealized appreciation (depreciation) between
periods are reflected in the Statements of Operations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;Interest income is recognized on an accrual basis
and includes, where applicable, the amortization of premium or discount, and is reflected as Interest Income in the Statement of Operations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Brokerage Commissions and Futures Account Fees&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;Each Fund pays its respective brokerage commissions,
including applicable exchange fees, National Futures Association (&#x201c;NFA&#x201d;) fees, give-up fees, pit brokerage fees and other
transaction related fees and expenses charged in connection with trading activities for each Fund&#x2019;s investment in U.S. Commodity
Futures Trading Commission (&#x201c;CFTC&#x201d;) regulated investments. The effects of trading spreads, financing costs/fees associated
with Financial Instruments, and costs relating to the purchase of U.S. Treasury securities or similar high credit quality short-term fixed-income
would also be borne by the Funds. Brokerage commissions on futures contracts are recognized on a half-turn basis (e.g., the first half
is recognized when the contract is purchased (opened) and the second half is recognized when the transaction is closed). The Sponsor is
currently paying brokerage commissions on VIX futures contracts for the Funds that exceed variable create/redeem fees collected by more
than&#160;0.03% and 0.00%, for SVIX and UVIX, respectively, of each Fund's average net assets annually.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Federal Income Tax&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;Each Fund is registered as a series of a Delaware
statutory trust and is treated as a partnership for U.S. federal income tax purposes. Accordingly, no Fund expects to incur U.S. federal
income tax liability; rather, each beneficial owner of a Fund&#x2019;s Shares is required to take into account its allocable share of its
Fund&#x2019;s income, gain, loss, deductions and other items for its Fund&#x2019;s taxable year ending with or within the beneficial owner&#x2019;s
taxable year.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;Management of the Funds has reviewed all open tax
years and major jurisdictions (i.e., the last four tax year ends and the interim tax period since then, as applicable) and concluded that
there is no tax liability resulting from unrecognized tax benefits relating to uncertain income tax positions taken or expected to be
taken in future tax returns. The Funds are also not aware of any tax positions for which it is reasonably possible that the total amounts
of unrecognized tax benefits will significantly change in the next twelve months. On an ongoing basis, management monitors its tax positions
taken under the interpretation to determine if adjustments to conclusions are necessary based on factors including, but not limited to,
on-going analysis of tax law, regulation, and interpretations thereof.&lt;/p&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <cik0001793497:EmergingGrowthCompanyPolicyTextBlock contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 7.7pt"&gt;Emerging growth company&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;The Trust is an &#x201c;emerging
growth company,&#x201d; as defined in the Jumpstart Our Business Startups Act of 2012. It will remain an emerging growth company until
the earlier of (1) the beginning of the first fiscal year following the fifth anniversary of its initial public offering, (2) the beginning
of the first fiscal year after annual gross revenue is $1.07 billion (subject to adjustment for inflation) or more, (3) the date on which
the Fund has, during the previous three-year period, issued more than $1.0 billion in non-convertible debt securities and (4) as of the
end of any fiscal year in which the market value of common equity held by non-affiliates exceeded $700 million as of the end of the second
quarter of that fiscal year.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;For as
long as the Trust remains an &#x201c;emerging growth company,&#x201d; it may take advantage of certain exemptions from the various reporting
requirements that are applicable to public companies that are not &#x201c;emerging growth companies&#x201d; including, but not limited
to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure
obligations regarding executive compensation and financial statements in our periodic reports and proxy statements, and exemptions from
the requirements of holding a nonbinding advisory vote to approve executive compensation and shareholder approval of any golden parachute
payments not previously approved. The Trust will take advantage of these reporting exemptions until it is no longer an &#x201c;emerging
growth company.&#x201d;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;</cik0001793497:EmergingGrowthCompanyPolicyTextBlock>
    <cik0001793497:GrossRevenue contextRef="c0" decimals="-7" unitRef="usd">1070000000.00</cik0001793497:GrossRevenue>
    <cik0001793497:NonconvertibleDebtSecurities contextRef="c0" decimals="-8" unitRef="usd">1000000000</cik0001793497:NonconvertibleDebtSecurities>
    <cik0001793497:NonaffiliatesExceeded contextRef="c0" decimals="-6" unitRef="usd">700000000</cik0001793497:NonaffiliatesExceeded>
    <us-gaap:UseOfEstimates contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"&gt;Use of Estimates &amp;amp; Indemnifications&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;The preparation of financial statements
in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities
and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and
expenses during the reporting period. Actual results could differ from those estimates.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;In
the normal course of business, the Trust enters into contracts that contain a variety of representations which provide general
indemnifications. The Trust&#x2019;s maximum exposure under these arrangements cannot be known; however, the Trust expects any risk
of loss to be remote.&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"&gt;Basis of Presentation&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;Pursuant to rules and regulations
of the SEC, these financial statements are presented for the Trust as a whole, as the SEC registrant, and for each Fund individually.
The debts, liabilities, obligations and expenses incurred, contracted for or otherwise existing with respect to a particular Fund shall
be enforceable only against the assets of such Fund and not against the assets of the Trust generally or any other Fund. Accordingly,
the assets of each Fund of the Trust include only those funds and other assets that are paid to, held by or distributed to the Trust for
the purchase of Shares in that Fund.&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <cik0001793497:StatementsOfCashFlowsPolicyTextBlock contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"&gt;Statements of Cash Flows&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;The
cash amount shown in the Statements of Cash Flows is the amount reported as cash in the Statements of Financial Condition dated June
30, 2023 and December 31, 2022, and represents cash, but does not include short-term investments.&lt;/p&gt;</cik0001793497:StatementsOfCashFlowsPolicyTextBlock>
    <cik0001793497:FinalNetAssetValueForFiscalPeriodPolcyTextBlock contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"&gt;Final Net Asset Value for Fiscal Period&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;The cut-off times and the times
of the calculation of the Funds&#x2019; final net asset value for creation and redemption of fund Shares for the three months ended June
30, 2023 were typically as follows. All times are Eastern Standard Time:&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;NAV&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;NAV&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;Create/Redeem&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;Calculation&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;Calculation&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 64%; font-weight: bold; text-align: left"&gt;Fund&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 11%; font-weight: bold; text-align: center"&gt;Cut-off*(EST)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 11%; font-weight: bold; text-align: center"&gt;Time (EST)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 11%; font-weight: bold; text-align: center"&gt;Date&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;-1x Short VIX Futures ETF and&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;2:00 p.m.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;4:00 p.m.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;June 30, 2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;2x Long VIX Futures ETF&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;2:00 p.m.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;4:00 p.m.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;June 30, 2023&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 7.7pt"&gt;&lt;/td&gt;&lt;td style="width: 14.95pt"&gt;*&lt;/td&gt;&lt;td style="padding-right: 7.8pt"&gt;Although the Funds&#x2019; shares may continue to trade on secondary markets subsequent to the calculation
of the final NAV, these times represent the final opportunity to transact in creation or redemption units for the three months ended June
30, 2023.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;Market value per Share is determined at the close of Cboe
BZX and may be later than when the Funds&#x2019; NAV per Share is calculated.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;For financial reporting purposes,
the Funds value transactions based upon the final closing price in their primary markets. Accordingly, the investment valuations in these
financial statements may differ from those used in the calculation of certain of the Funds&#x2019; final creation/redemption NAV for the
three months ended June 30, 2023.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;</cik0001793497:FinalNetAssetValueForFiscalPeriodPolcyTextBlock>
    <cik0001793497:ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock contextRef="c0">The cut-off times and the times
of the calculation of the Funds&#x2019; final net asset value for creation and redemption of fund Shares for the three months ended June
30, 2023 were typically as follows. All times are Eastern Standard Time:&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;NAV&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;NAV&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;Create/Redeem&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;Calculation&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;Calculation&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 64%; font-weight: bold; text-align: left"&gt;Fund&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 11%; font-weight: bold; text-align: center"&gt;Cut-off*(EST)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 11%; font-weight: bold; text-align: center"&gt;Time (EST)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 11%; font-weight: bold; text-align: center"&gt;Date&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;-1x Short VIX Futures ETF and&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;2:00 p.m.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;4:00 p.m.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;June 30, 2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;2x Long VIX Futures ETF&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;2:00 p.m.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;4:00 p.m.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;June 30, 2023&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 7.7pt"&gt;&lt;/td&gt;&lt;td style="width: 14.95pt"&gt;*&lt;/td&gt;&lt;td style="padding-right: 7.8pt"&gt;Although the Funds&#x2019; shares may continue to trade on secondary markets subsequent to the calculation
of the final NAV, these times represent the final opportunity to transact in creation or redemption units for the three months ended June
30, 2023.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</cik0001793497:ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock>
    <cik0001793497:CreateRedeemCutoffDescription contextRef="c12">2:00 p.m.</cik0001793497:CreateRedeemCutoffDescription>
    <cik0001793497:NAVCalculationTimeESTDescription contextRef="c12">4:00 p.m.</cik0001793497:NAVCalculationTimeESTDescription>
    <cik0001793497:NAVCalculationDate contextRef="c12">2023-06-30</cik0001793497:NAVCalculationDate>
    <cik0001793497:CreateRedeemCutoffDescription contextRef="c13">2:00 p.m.</cik0001793497:CreateRedeemCutoffDescription>
    <cik0001793497:NAVCalculationTimeESTDescription contextRef="c13">4:00 p.m.</cik0001793497:NAVCalculationTimeESTDescription>
    <cik0001793497:NAVCalculationDate contextRef="c13">2023-06-30</cik0001793497:NAVCalculationDate>
    <us-gaap:InvestmentPolicyTextBlock contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"&gt;Investment Valuation&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;Short-term investments are valued
at amortized cost which approximates fair value for daily NAV purposes. For financial reporting purposes, short-term investments are valued
at their market price using information provided by a third-party pricing service or market quotations. In each of these situations, valuations
are typically categorized as Level I in the fair value hierarchy.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;VIX futures
contracts are valued using the Time Weighted Average Price (TWAP) of the futures during the last 15 minutes of NYSE&#x2019;s regular trading
session, rather than solely from the VIX futures&#x2019; settlement price. The value of a Fund&#x2019;s non-exchange-traded Financial Instruments
typically is determined by applying the then-current disseminated levels for the Index to the terms of the Fund&#x2019;s non-exchange-traded
Financial Instruments.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;In certain circumstances (e.g.,
if the Sponsor believes market quotations do not accurately reflect the fair value of a Fund&#x2019;s investment, or a trading halt closes
an exchange or market early), the Sponsor may, in its sole discretion, choose to determine a fair value price as the basis for determining
the market value of such investment for such day. Such fair value prices would generally be determined based on available inputs about
the current value of the underlying VIX futures contract and would be based on principles that the Sponsor deems fair and equitable.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;The Funds may use a variety of
money market instruments. Money market instruments generally will be valued using market prices or at amortized cost.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;Fair value pricing may require
subjective determinations about the value of an investment. While the Funds&#x2019; policies are intended to result in a calculation of
its respective Fund&#x2019;s NAV that fairly reflects investment values as of the time of pricing, such Fund cannot ensure that fair values
determined by the Sponsor or persons acting at their direction would accurately reflect the price that a Fund could obtain for an investment
if it were to dispose of that investment as of the time of pricing (for instance, in a forced or distressed sale). The prices used by
such Fund may differ from the value that would be realized if the investments were sold and the differences could be material to the financial
statements.&lt;/p&gt;</us-gaap:InvestmentPolicyTextBlock>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"&gt;Fair Value of Financial Instruments&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;The
Funds disclose the fair value of their investments in a hierarchy that prioritizes the inputs to valuation techniques used to
measure fair value. The disclosure requirements establish a fair value hierarchy that distinguishes between: (1) market participant
assumptions developed based on market data obtained from sources independent of the Funds (observable inputs); and (2) the
Funds&#x2019; own assumptions about market participant assumptions developed based on the best information available under the
circumstances (unobservable inputs). The three levels defined by the disclosure requirements hierarchy are as follows:&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in; text-align: left"&gt;Level I&lt;/td&gt;&lt;td style="text-align: center; width: 0.25in"&gt;&#x2013;&lt;/td&gt;
                                                                                      &lt;td style="text-align: left"&gt;Quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access
at the measurement date.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="text-align: left; width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in; text-align: left"&gt;Level II&lt;/td&gt;&lt;td style="text-align: center; width: 0.25in"&gt;&#x2013;&lt;/td&gt;
                                                                                       &lt;td style="text-align: left"&gt;Inputs other than quoted prices included within Level I that are observable for the asset or liability, either directly or indirectly.
Level II assets include the following: quoted prices for similar assets or liabilities in active markets, quoted prices for identical
or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or
liability, and inputs that are derived principally from or corroborated by observable market data by correlation or other means (market-corroborated
inputs).&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="text-align: left; width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in; text-align: left"&gt;Level III&lt;/td&gt;&lt;td style="text-align: center; width: 0.25in"&gt;&#x2013;&lt;/td&gt;
                                                                                        &lt;td style="text-align: left"&gt;Unobservable pricing input at the measurement date for the asset or liability. Unobservable inputs shall be used to measure fair value
to the extent that observable inputs are not available.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;In some instances, the inputs used
to measure fair value might fall in different levels of the fair value hierarchy. The level in the fair value hierarchy within which the
fair value measurement in its entirety falls is determined based on the lowest input level that is significant to the fair value measurement
in its entirety.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;Fair value measurements also require additional
disclosure when the volume and level of activity for the asset or liability have significantly decreased, as well as when circumstances
indicate that a transaction is not orderly.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;The following table summarizes the valuation of investments
at June 30, 2023 (unaudited) and December 31, 2022 using the fair value hierarchy:&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;June 30, 2023 (Unaudited)&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;December 31, 2022&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;Fund&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Level 1 - &lt;br/&gt;
Money &lt;br/&gt;
Market &lt;br/&gt;
Fund&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Level 2 - &lt;br/&gt;
Futures &lt;br/&gt;
Contracts*&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Total &lt;br/&gt;
June 30, &lt;br/&gt;
2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Level 1 - &lt;br/&gt;
Money &lt;br/&gt;
Market &lt;br/&gt;
Fund&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Level 2 - &lt;br/&gt;
Futures &lt;br/&gt;
Contracts*&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Total &lt;br/&gt;
December&#160;31, &lt;br/&gt;
2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 28%; text-align: left"&gt;-1x Short VIX Futures ETF&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-62"&gt;&#x2013;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;6,518,579&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;6,518,579&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,156,106&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,156,106&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;2x Long VIX Futures ETF&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;9,517,548&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(19,791,036&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(10,273,488&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;8,250,285&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(9,203,522&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(953,237&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 4pt"&gt;Total Trust&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;9,517,548&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(13,272,457&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(3,754,909&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;8,250,285&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(8,047,416&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;202,869&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;*&lt;/td&gt;&lt;td style="text-align: left"&gt;Includes cumulative appreciation (depreciation) of futures
contracts as reported in the Schedule of Investments. Only current day&#x2019;s variation margin is reported within the Statements of
Financial Condition in receivable/payable on open futures.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;The inputs or methodology used for valuing investments
are not necessarily an indication of the risk associated with investing in those securities.&lt;/p&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock contextRef="c0">The following table summarizes the valuation of investments
at June 30, 2023 (unaudited) and December 31, 2022 using the fair value hierarchy:&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;June 30, 2023 (Unaudited)&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;December 31, 2022&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;Fund&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Level 1 - &lt;br/&gt;
Money &lt;br/&gt;
Market &lt;br/&gt;
Fund&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Level 2 - &lt;br/&gt;
Futures &lt;br/&gt;
Contracts*&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Total &lt;br/&gt;
June 30, &lt;br/&gt;
2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Level 1 - &lt;br/&gt;
Money &lt;br/&gt;
Market &lt;br/&gt;
Fund&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Level 2 - &lt;br/&gt;
Futures &lt;br/&gt;
Contracts*&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Total &lt;br/&gt;
December&#160;31, &lt;br/&gt;
2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 28%; text-align: left"&gt;-1x Short VIX Futures ETF&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-62"&gt;&#x2013;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;6,518,579&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;6,518,579&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,156,106&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,156,106&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;2x Long VIX Futures ETF&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;9,517,548&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(19,791,036&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(10,273,488&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;8,250,285&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(9,203,522&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(953,237&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 4pt"&gt;Total Trust&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;9,517,548&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(13,272,457&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(3,754,909&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;8,250,285&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(8,047,416&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;202,869&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;*&lt;/td&gt;&lt;td style="text-align: left"&gt;Includes cumulative appreciation (depreciation) of futures
contracts as reported in the Schedule of Investments. Only current day&#x2019;s variation margin is reported within the Statements of
Financial Condition in receivable/payable on open futures.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <cik0001793497:AmountOfTotalTrust contextRef="c51" decimals="0" id="ix_13_fact" unitRef="usd">6518579</cik0001793497:AmountOfTotalTrust>
    <cik0001793497:AmountOfTotalTrust contextRef="c4" decimals="0" unitRef="usd">6518579</cik0001793497:AmountOfTotalTrust>
    <cik0001793497:AmountOfTotalTrust contextRef="c52" decimals="0" id="ix_14_fact" unitRef="usd">1156106</cik0001793497:AmountOfTotalTrust>
    <cik0001793497:AmountOfTotalTrust contextRef="c6" decimals="0" unitRef="usd">1156106</cik0001793497:AmountOfTotalTrust>
    <cik0001793497:AmountOfTotalTrust contextRef="c53" decimals="0" unitRef="usd">9517548</cik0001793497:AmountOfTotalTrust>
    <cik0001793497:AmountOfTotalTrust contextRef="c54" decimals="0" id="ix_15_fact" unitRef="usd">-19791036</cik0001793497:AmountOfTotalTrust>
    <cik0001793497:AmountOfTotalTrust contextRef="c5" decimals="0" unitRef="usd">-10273488</cik0001793497:AmountOfTotalTrust>
    <cik0001793497:AmountOfTotalTrust contextRef="c55" decimals="0" unitRef="usd">8250285</cik0001793497:AmountOfTotalTrust>
    <cik0001793497:AmountOfTotalTrust contextRef="c56" decimals="0" id="ix_16_fact" unitRef="usd">-9203522</cik0001793497:AmountOfTotalTrust>
    <cik0001793497:AmountOfTotalTrust contextRef="c7" decimals="0" unitRef="usd">-953237</cik0001793497:AmountOfTotalTrust>
    <cik0001793497:AmountOfTotalTrust contextRef="c57" decimals="0" unitRef="usd">9517548</cik0001793497:AmountOfTotalTrust>
    <cik0001793497:AmountOfTotalTrust contextRef="c58" decimals="0" id="ix_17_fact" unitRef="usd">-13272457</cik0001793497:AmountOfTotalTrust>
    <cik0001793497:AmountOfTotalTrust contextRef="c3" decimals="0" unitRef="usd">-3754909</cik0001793497:AmountOfTotalTrust>
    <cik0001793497:AmountOfTotalTrust contextRef="c59" decimals="0" unitRef="usd">8250285</cik0001793497:AmountOfTotalTrust>
    <cik0001793497:AmountOfTotalTrust contextRef="c60" decimals="0" id="ix_18_fact" unitRef="usd">-8047416</cik0001793497:AmountOfTotalTrust>
    <cik0001793497:AmountOfTotalTrust contextRef="c31" decimals="0" unitRef="usd">202869</cik0001793497:AmountOfTotalTrust>
    <us-gaap:UnremittedEarningsInForeignInvestmentPolicy contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Investment Transactions and Related Income&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;Investment transactions are recorded on the trade
date. All such transactions are recorded on the identified cost basis and marked to market daily. Unrealized appreciation (depreciation)
on open contracts are reflected in the Statements of Financial Condition and changes in the unrealized appreciation (depreciation) between
periods are reflected in the Statements of Operations.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;Interest income is recognized on an accrual basis
and includes, where applicable, the amortization of premium or discount, and is reflected as Interest Income in the Statement of Operations.&lt;/p&gt;</us-gaap:UnremittedEarningsInForeignInvestmentPolicy>
    <us-gaap:FloorBrokeragePolicy contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Brokerage Commissions and Futures Account Fees&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;Each Fund pays its respective brokerage commissions,
including applicable exchange fees, National Futures Association (&#x201c;NFA&#x201d;) fees, give-up fees, pit brokerage fees and other
transaction related fees and expenses charged in connection with trading activities for each Fund&#x2019;s investment in U.S. Commodity
Futures Trading Commission (&#x201c;CFTC&#x201d;) regulated investments. The effects of trading spreads, financing costs/fees associated
with Financial Instruments, and costs relating to the purchase of U.S. Treasury securities or similar high credit quality short-term fixed-income
would also be borne by the Funds. Brokerage commissions on futures contracts are recognized on a half-turn basis (e.g., the first half
is recognized when the contract is purchased (opened) and the second half is recognized when the transaction is closed). The Sponsor is
currently paying brokerage commissions on VIX futures contracts for the Funds that exceed variable create/redeem fees collected by more
than&#160;0.03% and 0.00%, for SVIX and UVIX, respectively, of each Fund's average net assets annually.&lt;/p&gt;</us-gaap:FloorBrokeragePolicy>
    <us-gaap:DerivativeNetAssetsPercentage contextRef="c48" decimals="4" unitRef="pure">0.0003</us-gaap:DerivativeNetAssetsPercentage>
    <us-gaap:DerivativeNetAssetsPercentage contextRef="c49" decimals="4" unitRef="pure">0</us-gaap:DerivativeNetAssetsPercentage>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Federal Income Tax&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;Each Fund is registered as a series of a Delaware
statutory trust and is treated as a partnership for U.S. federal income tax purposes. Accordingly, no Fund expects to incur U.S. federal
income tax liability; rather, each beneficial owner of a Fund&#x2019;s Shares is required to take into account its allocable share of its
Fund&#x2019;s income, gain, loss, deductions and other items for its Fund&#x2019;s taxable year ending with or within the beneficial owner&#x2019;s
taxable year.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;Management of the Funds has reviewed all open tax
years and major jurisdictions (i.e., the last four tax year ends and the interim tax period since then, as applicable) and concluded that
there is no tax liability resulting from unrecognized tax benefits relating to uncertain income tax positions taken or expected to be
taken in future tax returns. The Funds are also not aware of any tax positions for which it is reasonably possible that the total amounts
of unrecognized tax benefits will significantly change in the next twelve months. On an ongoing basis, management monitors its tax positions
taken under the interpretation to determine if adjustments to conclusions are necessary based on factors including, but not limited to,
on-going analysis of tax law, regulation, and interpretations thereof.&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:InvestmentTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;NOTE 3 &#x2013; INVESTMENTS&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Short-Term Investments&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;The Funds may purchase U.S. Treasury Bills, agency
securities, and other high-credit quality short-term fixed income or similar securities with original maturities of one year or less.
A portion of these investments may be posted as collateral in connection with swap agreements, futures, and/or forward contracts.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Accounting for Derivative Instruments&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;In seeking to achieve each Fund&#x2019;s investment
objective, the Sponsor uses a mathematical approach to investing. Using this approach, the Sponsor determines the type, quantity and mix
of investment positions, including derivative positions, which the Sponsor believes in combination, should produce returns consistent
with a Fund&#x2019;s objective.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;All open derivative positions at period end are
reflected on each respective Fund&#x2019;s Schedule of Investments. Certain Funds utilized a varying level of derivative instruments in
conjunction with investment securities in seeking to meet their investment objectives during the period. While the volume of open positions
may vary on a daily basis as each Fund transacts derivatives contracts in order to achieve the appropriate exposure to meet its investment
objective, the volume of these open positions relative to the net assets of each respective Fund at the date of this report is generally
representative of open positions throughout the reporting period.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Following is a description of the derivative instruments
used by the Funds during the reporting period, including the primary underlying risk exposures related to each instrument type.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Futures Contracts&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;The Funds may enter into futures contracts to gain
exposure to changes in the value of, or as a substitute for investing directly in (or shorting), an underlying benchmark. A futures contract
obligates the seller to deliver (and the purchaser to accept) the future delivery of a specified quantity and type of asset at a specified
time and place. The contractual obligations of a buyer or seller may generally be satisfied by taking or making physical delivery of the
underlying commodity, if applicable, or by making an offsetting sale or purchase of an identical futures contract on the same or linked
exchange before the designated date of delivery, or by cash settlement at expiration of contract.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Upon entering into a futures contract, each Fund
is required to deposit and maintain as collateral at least such initial margin as required by the exchange on which the transaction is
affected. The initial margin is segregated as cash and/or securities balances with brokers for futures contracts, as disclosed in the
Statements of Financial Condition, and is restricted as to its use. The Funds that enter into futures contracts maintain collateral at
the broker in the form of cash and/or securities. Pursuant to the futures contract, each Fund generally agrees to receive from or pay
to the broker(s) an amount of cash equal to the daily fluctuation in value of the futures contract. Such receipts or payments are known
as variation margin and are recorded by each Fund as unrealized gains or losses. Each Fund will realize a gain or loss upon closing of
a futures transaction.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Futures contracts involve, to varying degrees,
elements of market risk (specifically exchange rate sensitivity, commodity price risk or equity market volatility risk) and exposure to
loss in excess of the amount of variation margin. The face or contract amounts reflect the extent of the total exposure each Fund has
in the particular classes of instruments. Additional risks associated with the use of futures contracts are imperfect correlation between
movements in the price of the futures contracts and the market value of the underlying Index or commodity and the possibility of an illiquid
market for a futures contract. With futures contracts, there is minimal but some counterparty risk to the Funds since futures contracts
are exchange-traded and the credit risk resides with the Funds&#x2019; clearing broker or clearinghouse itself. Many futures exchanges
and boards of trade limit the amount of fluctuation permitted in futures contract prices during a single trading day. Once the daily limit
has been reached in a particular contract, no trades may be made that day at a price beyond that limit or trading may be suspended for
specified times during the trading day. Futures contracts prices could move to the limit for several consecutive trading days with little
or no trading, thereby preventing prompt liquidation of futures positions and potentially subjecting a Fund to substantial losses. If
trading is not possible, or if a Fund determines not to close a futures position in anticipation of adverse price movements, the Fund
will be required to make daily cash payments of variation margin. The risk the Fund will be unable to close out a futures position will
be minimized by entering into such transactions on a national exchange with an active and liquid secondary market.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Option Contracts&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;An option is a contract that gives the buyer the
right, but not the obligation, to buy or sell a specified quantity of a commodity or other instrument at a specific (or strike) price
within a specified period of time, regardless of the market price of that instrument. There are two types of options: calls and puts.
A call option conveys to the option buyer the right to purchase a particular futures contract at a stated price at any time during the
life of the option. A put option conveys to the option buyer the right to sell a particular futures contract at a stated price at any
time during the life of the option. Options written by a Fund may be wholly or partially covered (meaning that the Fund holds an offsetting
position) or uncovered. In the case of the purchase of an option, the risk of loss of an investor&#x2019;s entire investment (i.e., the
premium paid plus transaction charges) reflects the nature of an option as a wasting asset that may become worthless when the option expires.
Where an option is written or granted (i.e., sold) uncovered, the seller may be liable to pay substantial additional margin, and the risk
of loss is unlimited, as the seller will be obligated to deliver, or take delivery of, an asset at a predetermined price which may, upon
exercise of the option, be significantly different from the market value.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;When a Fund writes a call or put, an amount equal
to the premium received is recorded and subsequently marked to market to reflect the current value of the option written. Premiums received
from writing options which expire are treated as realized gains. Premiums received from writing options which are exercised or closed
are added to the proceeds or offset against amounts paid on the underlying futures, swap or security transaction to determine the realized
gain (loss).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;When a Fund purchases an option, the Fund pays
a premium which is included as an asset on the Statement of Financial Condition and subsequently marked to market to reflect the current
value of the option. Premiums paid for purchasing options which expire are treated as realized losses. The risk associated with purchasing
put and call options is limited to the premium paid. Premiums paid for purchasing options which are exercised or closed are added to the
amounts paid or offset against the proceeds on the underlying investment transaction to determine the realized gain (loss) when the underlying
transaction is executed.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Certain options transactions may subject the writer
(seller) to unlimited risk of loss in the event of an increase in the price of the contract to be purchased or delivered. The value of
a Fund&#x2019;s options transactions, if any, will be affected by, among other things, changes in the value of a Fund&#x2019;s underlying
benchmark relative to the strike price, changes in interest rates, changes in the actual and implied volatility of the Fund&#x2019;s underlying
benchmark, and the remaining time until the options expire, or any combination thereof. The value of the options should not be expected
to increase or decrease at the same rate as the level of the Fund&#x2019;s underlying benchmark, which may contribute to tracking error.
Options may be less liquid than certain other securities. A Fund&#x2019;s ability to trade options will be dependent on the willingness
of counterparties to trade such options with the Fund. In a less liquid market for options, a Fund may have difficulty closing out certain
option positions at desired times and prices. A Fund may experience substantial downside from specific option positions and certain option
positions may expire worthless. Over-the-counter options generally are not assignable except by agreement between the parties concerned,
and no party or purchaser has any obligation to permit such assignments. The over-the-counter market for options is relatively illiquid,
particularly for relatively small transactions. The use of options transactions exposes a Fund to liquidity risk and counterparty credit
risk, and in certain circumstances may expose the Fund to unlimited risk of loss. The Funds may buy and sell options on futures contracts,
which may present even greater volatility and risk of loss.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Swap Agreements&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;The Funds may enter into swap agreements for purposes
of pursuing their investment objectives or as a substitute for investing directly in (or shorting) an underlying Index or to create an
economic hedge against a position. Swap agreements are two-party contracts that have traditionally been entered into primarily with institutional
investors in over-the-counter (&#x201c;OTC&#x201d;) markets for a specified period, ranging from a day to more than one year. However, the
Dodd-Frank Wall Street Reform and Consumer Protection Act (the &#x201c;Dodd-Frank Act&#x201d;) provides for significant reforms of the OTC
derivative markets, including a requirement to execute certain swap transactions on a CFTC-regulated market and/or to clear such transactions
through a CFTC-regulated central clearing organization. In a standard swap transaction, two parties agree to exchange the returns earned
or realized on a particular predetermined investment, instrument or Index in exchange for a fixed or floating rate of return in respect
of a predetermined notional amount. Transaction or commission costs are reflected in the benchmark level at which the transaction is entered
into. The gross returns to be exchanged are calculated with respect to a notional amount and the benchmark returns to which the swap is
linked. Swap agreements do not involve the delivery of underlying instruments.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Generally, swap agreements entered into by the
Funds calculate and settle the obligations of the parties to the agreement on a &#x201c;net basis&#x201d; with a single payment. Consequently,
each Fund&#x2019;s current obligations (or rights) under a swap agreement will generally be equal only to the net amount to be paid or
received under the agreement based on the relative values of such obligations (or rights) (the &#x201c;net amount&#x201d;). In a typical
swap agreement entered into by UVIX, the would be entitled to settlement payments in the event the level of the benchmark increases and
would be required to make payments to the swap counterparties in the event the level of the benchmark decreases, adjusted for any transaction
costs or trading spreads on the notional amount the Funds may pay. In a typical swap agreement entered into by SVIX, the Fund would be
required to make payments to the swap counterparties in the event the level of the benchmark increases and would be entitled to settlement
payments in the event the level of the benchmark decreases, adjusted for any transaction costs or trading spreads on the notional amount
the Funds may pay.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;The net amount of the excess, if any, of each Fund&#x2019;s
obligations over its entitlements with respect to each OTC swap agreement is accrued on a daily basis and an amount of cash and/or securities
having an aggregate value at least equal to such accrued excess is maintained for the benefit of the counterparty in a segregated account
by the Funds&#x2019; Custodian. The net amount of the excess, if any, of each Fund&#x2019;s entitlements over its obligations with respect
to each OTC swap agreement is accrued on a daily basis and an amount of cash and/or securities having an aggregate value at least equal
to such accrued excess is maintained for the benefit of the Fund in a segregated account by a third party custodian. Until a swap agreement
is settled in cash, the gain or loss on the notional amount less any transaction costs or trading spreads payable by each Fund on the
notional amount are recorded as &#x201c;unrealized appreciation or depreciation on swap agreements&#x201d; and, when cash is exchanged,
the gain or loss realized is recorded as &#x201c;realized gains or losses on swap agreements.&#x201d; Swap agreements are generally valued
at the last settled price of the benchmark referenced asset.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Swap agreements contain various conditions, events
of default, termination events, covenants and representations. The triggering of certain events or the default on certain terms of the
agreement could allow a party to terminate a transaction under the agreement and request immediate payment in an amount equal to the net
positions owed to the party under the agreement. This could cause a Fund to have to enter into a new transaction with the same counterparty,
enter into a transaction with a different counterparty or seek to achieve its investment objective through any number of different investments
or investment techniques.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Swap agreements involve, to varying degrees, elements
of market risk and exposure to loss in excess of the unrealized gain/loss reflected. The notional amounts reflect the extent of the total
investment exposure each Fund has under the swap agreement, which may exceed the NAV of each Fund. Additional risks associated with the
use of swap agreements are imperfect correlations between movements in the notional amount and the price of the underlying reference Index
and the inability of counterparties to perform. Each Fund bears the risk of loss of the amount expected to be received under a swap agreement
in the event of the default or bankruptcy of a swap agreement counterparty. A Fund will typically enter into swap agreements only with
major global financial institutions. The creditworthiness of each of the firms that is a party to a swap agreement is monitored by the
Sponsor. The Sponsor may use various techniques to minimize credit risk including early termination and payment, using different counterparties,
limiting the net amount due from any individual counterparty and generally requiring collateral to be posted by the counterparty in an
amount approximately equal to that owed to the Funds. Outstanding swap agreements contractually terminate within one month but may be
terminated without penalty by either party at any time. Upon termination, the Fund is obligated to pay or receive the &#x201c;unrealized
appreciation or depreciation&#x201d; amount.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;The Funds, as applicable, collateralize swap agreements
by segregating or designating cash and/or certain securities as indicated on the Statements of Financial Condition or Schedules of Investments.
As noted above, collateral posted in connection with OTC derivative transactions is held for the benefit of the counterparty in a segregated
tri-party account at the Custodian to protect the counterparty against non-payment by the Funds. The collateral held in this account is
restricted as to its use. In the event of a default by the counterparty, the Funds will seek withdrawal of this collateral from the segregated
account and may incur certain costs in exercising its right with respect to the collateral. If a counterparty becomes bankrupt or otherwise
fails to perform its obligations due to financial difficulties, the Funds may experience significant delays in obtaining any recovery
in a bankruptcy or other reorganizational proceeding. The Funds may obtain only limited recovery or may obtain no recovery in such circumstances.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;The Funds remain subject to credit risk with respect
to the amount they expect to receive from counterparties. However, the Funds have sought to mitigate these risks in connection with OTC
swaps by generally requiring that the counterparties for each Fund agree to post collateral for the benefit of the Fund, marked to market
daily, in an amount approximately equal to what the counterparty owes the Fund, subject to certain minimum thresholds. In the event of
a bankruptcy of a counterparty, such Fund will have direct access to the collateral received from the counterparty, generally as of the
day prior to the bankruptcy, because there is a one day time lag between the Fund&#x2019;s request for collateral and the delivery of such
collateral. To the extent any such collateral is insufficient, the Funds will be exposed to counterparty risk as described above, including
the possible delays in recovering amounts as a result of bankruptcy proceedings.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;The counterparty/credit risk for cleared derivative
transactions is generally lower than for OTC derivatives since generally a clearing organization becomes substituted for each counterparty
to a cleared derivative contract and, in effect, guarantees the parties&#x2019; performance under the contract as each party to a trade
looks only to the clearing organization for performance of financial obligations. In addition, cleared derivative transactions benefit
from daily marking-to-market and settlement, and segregation and minimum capital requirements applicable to intermediaries.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; white-space: nowrap; text-align: center; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fair Values of Derivative Instruments as of June 30, 2023 (Unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt; white-space: nowrap; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt; white-space: nowrap; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="4" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Asset Derivatives&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="4" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Liability Derivatives&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: left; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Derivatives Not &lt;br/&gt;
Accounted for as &lt;br/&gt;
Hedging Instruments&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fund&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Statements of &lt;br/&gt;
Financial &lt;br/&gt;
Condition&#160;Location&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Unrealized &lt;br/&gt; Appreciation&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Statements of &lt;br/&gt;
Financial &lt;br/&gt;
Condition&#160;Location&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Unrealized &lt;br/&gt; Depreciation&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; font-size: 10pt; width: 20%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;VIX Futures Contracts &lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; width: 20%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; font-size: 10pt; width: 17%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; font-size: 10pt; width: 9%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; font-size: 10pt; width: 16%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; font-size: 10pt; width: 9%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-1x Short VIX Futures ETF &lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right; white-space: nowrap; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-63; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt; 6,518,579&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right; white-space: nowrap; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt; - &lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: right; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left; white-space: nowrap; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2x Long VIX Futures ETF &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: right; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right; white-space: nowrap; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;- &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: right; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right; white-space: nowrap; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(19,791,036&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt; text-align: right; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left; white-space: nowrap; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Total Trust &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: right; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right; white-space: nowrap; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-64; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160; 6,518,579&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: right; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right; white-space: nowrap; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-65; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160; (19,791,036&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;*&lt;/td&gt;&lt;td style="text-align: left"&gt;Includes cumulative appreciation (depreciation) of futures contracts
as reported in the Schedule of Investments. Only current day&#x2019;s variation margin is reported within the Statements of Financial
Condition in receivable/payable on open futures.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; white-space: nowrap; text-align: center; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fair Values of Derivative Instruments as of December 31, 2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt; white-space: nowrap; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt; white-space: nowrap; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="4" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Asset Derivatives&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="4" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Liability Derivatives&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: left; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Derivatives Not &lt;br/&gt;
Accounted for as &lt;br/&gt;
Hedging Instruments&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fund&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Statements of &lt;br/&gt;
Financial &lt;br/&gt;
Condition&#160;Location&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Unrealized &lt;br/&gt; Appreciation&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Statements of &lt;br/&gt;
Financial &lt;br/&gt;
Condition&#160;Location&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Unrealized &lt;br/&gt; Depreciation&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; font-size: 10pt; width: 20%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;VIX Futures Contracts &lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; width: 20%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; font-size: 10pt; width: 17%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; font-size: 10pt; width: 9%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; font-size: 10pt; width: 16%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; font-size: 10pt; width: 9%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-1x Short VIX Futures ETF &lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right; white-space: nowrap; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-66; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt; 1,156,106 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right; white-space: nowrap; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt; - &lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: right; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left; white-space: nowrap; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2x Long VIX Futures ETF &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: right; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right; white-space: nowrap; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;- &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: right; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right; white-space: nowrap; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(9,203,522&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt; text-align: right; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left; white-space: nowrap; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Total Trust &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: right; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right; white-space: nowrap; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-67; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160; 1,156,106 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: right; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right; white-space: nowrap; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-68; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160; (9,203,522&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;*&lt;/td&gt;&lt;td style="text-align: left"&gt;Includes cumulative appreciation (depreciation) of futures contracts
as reported in the Schedule of Investments. Only current day&#x2019;s variation margin is reported within the Statements of Financial
Condition in receivable/payable on open futures.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="21" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;The Effect of Derivative Instruments on the Statement of Operations&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="21" style="font-weight: bold; text-align: center"&gt;For the Three Months Ended June 30, 2023 (Unaudited) and June 30, 2022 (Unaudited)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="21" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;Derivatives Not &lt;br/&gt;
Accounted for as Hedging Instruments&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Location of Gain (Loss) on Derivatives Recognized in Income&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Fund&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Realized Gain &lt;br/&gt;
(Loss) on &lt;br/&gt;
Derivatives Recognized &lt;br/&gt;
in Income &lt;br/&gt;
June 30, &lt;br/&gt;
2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Change in &lt;br/&gt;
Unrealized &lt;br/&gt;
Appreciation &lt;br/&gt;
(Depreciation) &lt;br/&gt;
on Derivatives &lt;br/&gt;
Recognized &lt;br/&gt;
in Income &lt;br/&gt;
June 30, &lt;br/&gt;
2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Realized&#160;Gain&lt;br/&gt;
 (Loss) on &lt;br/&gt;
Derivatives &lt;br/&gt;
Recognized &lt;br/&gt;
in Income &lt;br/&gt;
June 30, &lt;br/&gt;
2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Change in &lt;br/&gt;
Unrealized &lt;br/&gt;
Appreciation &lt;br/&gt;
(Depreciation) &lt;br/&gt;
on Derivatives &lt;br/&gt;
Recognized &lt;br/&gt;
in Income &lt;br/&gt;
June 30, &lt;br/&gt;
2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; vertical-align: top; text-align: left"&gt;VIX Futures Contracts&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Net realized gain (loss) on futures contracts/changes in unrealized appreciation (depreciation) on futures contracts&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 15%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 0.5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 26%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 0.5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; width: 16%; text-align: left"&gt;-1x Short VIX Futures ETF&lt;/td&gt;&lt;td style="width: 0.5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;37,164,451&lt;/td&gt;&lt;td style="width: 0.5%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 0.5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(811,301&lt;/td&gt;&lt;td style="width: 0.5%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 0.5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(4,573,051&lt;/td&gt;&lt;td style="width: 0.5%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 0.5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;835,808&lt;/td&gt;&lt;td style="width: 0.5%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;2x Long VIX Futures ETF&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(142,872,642&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(4,374,661&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;7,528,449&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(256,944&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;Total Trust&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(105,708,191&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(5,185,962&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;2,955,398&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;578,864&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Includes
cumulative appreciation (depreciation) of futures contracts as reported in the Schedule of Investments. Only current day&#x2019;s variation
margin is reported within the Statements of Financial Condition in receivable/payable on open futures.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="21" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;The Effect of Derivative Instruments on the Statement of Operations&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="21" style="font-weight: bold; text-align: center"&gt;For the Six Months Ended June 30, 2023 (Unaudited) and June 30, 2022 (Unaudited)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="21" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;Derivatives Not &lt;br/&gt;
Accounted for as Hedging Instruments&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Location of Gain (Loss) on Derivatives Recognized in Income&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Fund&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Realized Gain &lt;br/&gt;
(Loss) on &lt;br/&gt;
Derivatives &lt;br/&gt;
Recognized &lt;br/&gt;
in Income&lt;br/&gt;
 June 30, &lt;br/&gt;
2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Change in &lt;br/&gt;
Unrealized &lt;br/&gt;
Appreciation &lt;br/&gt;
(Depreciation) &lt;br/&gt;
on Derivatives &lt;br/&gt;
Recognized in &lt;br/&gt;
Income &lt;br/&gt;
June 30, &lt;br/&gt;
2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Realized&#160;Gain&lt;br/&gt;
 (Loss) on &lt;br/&gt;
Derivatives &lt;br/&gt;
Recognized &lt;br/&gt;
in Income &lt;br/&gt;
June 30, &lt;br/&gt;
2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Change in &lt;br/&gt;
Unrealized &lt;br/&gt;
Appreciation &lt;br/&gt;
(Depreciation) &lt;br/&gt;
on Derivatives &lt;br/&gt;
Recognized&lt;br/&gt;
 in Income &lt;br/&gt;
June 30, &lt;br/&gt;
2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; vertical-align: top; text-align: left"&gt;VIX Futures Contracts&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Net realized gain (loss) on futures contracts/changes in unrealized appreciation (depreciation) on futures contracts&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 15%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 0.5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 26%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 0.5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; width: 16%; text-align: left"&gt;-1x Short VIX Futures ETF&lt;/td&gt;&lt;td style="width: 0.5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;42,451,505&lt;/td&gt;&lt;td style="width: 0.5%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 0.5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;5,362,473&lt;/td&gt;&lt;td style="width: 0.5%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 0.5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(4,577,129&lt;/td&gt;&lt;td style="width: 0.5%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 0.5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;700,531&lt;/td&gt;&lt;td style="width: 0.5%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;2x Long VIX Futures ETF&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(186,102,397&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(10,587,514&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;7,527,995&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;19,258&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;Total Trust&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(143,650,892&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(5,225,041&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;2,950,866&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;719,789&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Includes
cumulative appreciation (depreciation) of futures contracts as reported in the Schedule of Investments. Only current day&#x2019;s variation
margin is reported within the Statements of Financial Condition in receivable/payable on open futures.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Offsetting Assets and Liabilities&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="text-indent: 0.5in; margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Each Fund is subject to master netting agreements or similar arrangements that allow for amounts owed
between each Fund and the counterparty to be netted upon an early termination. The party that has the larger payable pays the excess of
the larger amount over the smaller amount to the other party. The master netting agreements or similar arrangements do not apply to amounts
owed to/from different counterparties. As described above, the Funds utilize derivative instruments to achieve their investment objective
during the year. The amounts shown in the Statements of Financial Condition do not take into consideration the effects of legally enforceable
master netting agreements or similar arrangements.&lt;/p&gt;

&lt;p style="text-indent: 0.5in; margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;For financial reporting purposes, the Funds do not offset derivative assets and derivative
liabilities that are subject to netting arrangements in the Statements of Financial Condition. The following table presents each Fund&#x2019;s
derivatives by investment type and by counterparty net of amounts available for offset under a master netting agreement and the related
collateral received or pledged by the Funds as of June 30, 2023 and December 31, 2022.&lt;/p&gt;

&lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="25" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Fair Values of Derivative Instruments as of June 30, 2023 (Unaudited)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="25" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Assets&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;Fund&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Gross&lt;br/&gt; Amounts of&lt;br/&gt; Recognized&lt;br/&gt; Assets&lt;br/&gt; presented&lt;br/&gt; in the&lt;br/&gt; Statements&lt;br/&gt; of Financial&lt;br/&gt; Condition&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Gross&lt;br/&gt; Amounts&lt;br/&gt; Offset&lt;br/&gt; in the&lt;br/&gt; Statements&lt;br/&gt; of Financial&lt;br/&gt; Condition&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Net Amounts&lt;br/&gt; of Assets&lt;br/&gt; presented&lt;br/&gt; in the&lt;br/&gt; Statements&lt;br/&gt; of Financial&lt;br/&gt; Condition&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Gross&lt;br/&gt; Amounts of&lt;br/&gt; Recognized&lt;br/&gt; Liabilities&lt;br/&gt; presented&lt;br/&gt; in the&lt;br/&gt; Statements&lt;br/&gt; of Financial&lt;br/&gt; Condition&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Gross&lt;br/&gt; Amounts&lt;br/&gt; Offset&lt;br/&gt; in the&lt;br/&gt; Statements&lt;br/&gt; of Financial&lt;br/&gt; Condition&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Net Amounts&lt;br/&gt; of&#160;Liabilities&lt;br/&gt; presented&lt;br/&gt; in the&lt;br/&gt; Statements&lt;br/&gt; of Financial&lt;br/&gt; Condition&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 28%; text-align: left"&gt;-1x Short VIX Futures ETF&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,242,108&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-69"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,242,108&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-70"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-71"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-72"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;2x Long VIX Futures ETF&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-73"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-74"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-75"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;3,406,049&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-76"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,406,049&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="25" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Fair Values of Derivative Instruments as of December 31, 2022&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="25" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Assets&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;Fund&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Gross&lt;br/&gt; Amounts of&lt;br/&gt; Recognized&lt;br/&gt; Assets&lt;br/&gt; presented&lt;br/&gt; in the&lt;br/&gt; Statements&lt;br/&gt; of Financial&lt;br/&gt; Condition&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Gross&lt;br/&gt; Amounts&lt;br/&gt; Offset&lt;br/&gt; in the&lt;br/&gt; Statements&lt;br/&gt; of Financial&lt;br/&gt; Condition&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Net Amounts&lt;br/&gt; of Assets&lt;br/&gt; presented&lt;br/&gt; in the&lt;br/&gt; Statements&lt;br/&gt; of Financial&lt;br/&gt; Condition&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Gross&lt;br/&gt; Amounts of&lt;br/&gt; Recognized&lt;br/&gt; Liabilities&lt;br/&gt; presented&lt;br/&gt; in the&lt;br/&gt; Statements&lt;br/&gt; of Financial&lt;br/&gt; Condition&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Gross&lt;br/&gt; Amounts&lt;br/&gt; Offset&lt;br/&gt; in the&lt;br/&gt; Statements&lt;br/&gt; of Financial&lt;br/&gt; Condition&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Net Amounts&lt;br/&gt; of Liabilities&lt;br/&gt; presented&lt;br/&gt; in the&lt;br/&gt; Statements&lt;br/&gt; of Financial&lt;br/&gt; Condition&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 28%; text-align: left"&gt;-1x Short VIX Futures ETF&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-77"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;187,030&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-78"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;187,030&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;2x Long VIX Futures ETF&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;830,840&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-79"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;830,840&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-80"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Asset (Liability) amounts shown in the table below represent amounts owed to (by) the Funds for the derivative-related investments at
June 30, 2023 and December 31, 2022. These amounts may be collateralized by cash or financial instruments, segregated for the benefit of
the Funds or the counterparties, depending on whether the related contracts are in an appreciated or depreciated position at period end.
Amounts shown in the column labeled &#x201c;Net Amount&#x201d; represent the uncollateralized portions of these amounts at period end. These
amounts may be un-collateralized due to timing differences related to market movements or due to minimum thresholds for collateral movement,
as further described above under the caption &#x201c;Accounting for Derivative Instruments&#x201d;.&lt;/p&gt;

&lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="17" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Gross Amounts Not Offset in the Statements of Financial Condition as of June 30, 2023 (Unaudited)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="17" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;Fund&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Amounts of&lt;br/&gt; Recognized&lt;br/&gt; Assets /&lt;br/&gt; (Liabilities)&lt;br/&gt; presented&lt;br/&gt; in the&lt;br/&gt; Statements&lt;br/&gt; of Financial&lt;br/&gt; Condition&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Financial&lt;br/&gt; Instruments&lt;br/&gt; for the Benefit&lt;br/&gt; of (the Funds) / the&lt;br/&gt; Counterparties&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Cash&lt;br/&gt; Collateral for&lt;br/&gt; the Benefit of&lt;br/&gt; (the Funds) / the&lt;br/&gt; Counterparties&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Net Amount&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;-1x Short VIX Futures ETF&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,242,108&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-81"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-82"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,242,108&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;2x Long VIX Futures ETF&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,406,049&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-83"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-84"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,406,049&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="17" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Gross Amounts Not Offset in the Statements of Financial Condition as of December 31, 2022&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="17" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;Fund&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Amounts of&lt;br/&gt; Recognized&lt;br/&gt; Assets /&lt;br/&gt; (Liabilities)&lt;br/&gt; presented&lt;br/&gt; in the&lt;br/&gt; Statements&lt;br/&gt; of Financial&lt;br/&gt; Condition&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Financial&lt;br/&gt; Instruments&lt;br/&gt; for the Benefit&lt;br/&gt; of (the&lt;br/&gt;
 Funds) / the&lt;br/&gt; Counterparties&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Cash&lt;br/&gt; Collateral for&lt;br/&gt; the Benefit of&lt;br/&gt; (the Funds) / the&lt;br/&gt; Counterparties&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Net Amount&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;-1x Short VIX Futures ETF&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(187,030&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(187,030&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;2x Long VIX Futures ETF&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;830,840&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;830,840&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:InvestmentTextBlock>
    <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock contextRef="c0">The counterparty/credit risk for cleared derivative
transactions is generally lower than for OTC derivatives since generally a clearing organization becomes substituted for each counterparty
to a cleared derivative contract and, in effect, guarantees the parties&#x2019; performance under the contract as each party to a trade
looks only to the clearing organization for performance of financial obligations. In addition, cleared derivative transactions benefit
from daily marking-to-market and settlement, and segregation and minimum capital requirements applicable to intermediaries.&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; white-space: nowrap; text-align: center; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fair Values of Derivative Instruments as of June 30, 2023 (Unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt; white-space: nowrap; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt; white-space: nowrap; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="4" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Asset Derivatives&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="4" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Liability Derivatives&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: left; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Derivatives Not &lt;br/&gt;
Accounted for as &lt;br/&gt;
Hedging Instruments&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fund&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Statements of &lt;br/&gt;
Financial &lt;br/&gt;
Condition&#160;Location&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Unrealized &lt;br/&gt; Appreciation&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Statements of &lt;br/&gt;
Financial &lt;br/&gt;
Condition&#160;Location&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Unrealized &lt;br/&gt; Depreciation&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; font-size: 10pt; width: 20%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;VIX Futures Contracts &lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; width: 20%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; font-size: 10pt; width: 17%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; font-size: 10pt; width: 9%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; font-size: 10pt; width: 16%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; font-size: 10pt; width: 9%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-1x Short VIX Futures ETF &lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right; white-space: nowrap; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-63; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt; 6,518,579&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right; white-space: nowrap; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt; - &lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: right; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left; white-space: nowrap; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2x Long VIX Futures ETF &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: right; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right; white-space: nowrap; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;- &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: right; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right; white-space: nowrap; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(19,791,036&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt; text-align: right; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left; white-space: nowrap; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Total Trust &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: right; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right; white-space: nowrap; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-64; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160; 6,518,579&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: right; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right; white-space: nowrap; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-65; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160; (19,791,036&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; white-space: nowrap; text-align: center; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fair Values of Derivative Instruments as of December 31, 2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt; white-space: nowrap; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt; white-space: nowrap; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="4" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Asset Derivatives&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="4" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Liability Derivatives&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: left; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Derivatives Not &lt;br/&gt;
Accounted for as &lt;br/&gt;
Hedging Instruments&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fund&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Statements of &lt;br/&gt;
Financial &lt;br/&gt;
Condition&#160;Location&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Unrealized &lt;br/&gt; Appreciation&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Statements of &lt;br/&gt;
Financial &lt;br/&gt;
Condition&#160;Location&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Unrealized &lt;br/&gt; Depreciation&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; font-size: 10pt; width: 20%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;VIX Futures Contracts &lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; width: 20%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; font-size: 10pt; width: 17%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; font-size: 10pt; width: 9%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; font-size: 10pt; width: 16%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; font-size: 10pt; width: 9%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-1x Short VIX Futures ETF &lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right; white-space: nowrap; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-66; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt; 1,156,106 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right; white-space: nowrap; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt; - &lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: right; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left; white-space: nowrap; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2x Long VIX Futures ETF &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: right; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right; white-space: nowrap; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;- &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: right; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right; white-space: nowrap; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(9,203,522&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt; text-align: right; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left; white-space: nowrap; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Total Trust &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: right; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right; white-space: nowrap; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-67; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160; 1,156,106 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: right; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right; white-space: nowrap; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-68; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160; (9,203,522&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
    <cik0001793497:TotalTrust1 contextRef="c62">(19,791,036)</cik0001793497:TotalTrust1>
    <cik0001793497:TotalTrust1 contextRef="c66">(9,203,522)</cik0001793497:TotalTrust1>
    <us-gaap:ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="21" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;The Effect of Derivative Instruments on the Statement of Operations&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="21" style="font-weight: bold; text-align: center"&gt;For the Three Months Ended June 30, 2023 (Unaudited) and June 30, 2022 (Unaudited)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="21" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;Derivatives Not &lt;br/&gt;
Accounted for as Hedging Instruments&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Location of Gain (Loss) on Derivatives Recognized in Income&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Fund&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Realized Gain &lt;br/&gt;
(Loss) on &lt;br/&gt;
Derivatives Recognized &lt;br/&gt;
in Income &lt;br/&gt;
June 30, &lt;br/&gt;
2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Change in &lt;br/&gt;
Unrealized &lt;br/&gt;
Appreciation &lt;br/&gt;
(Depreciation) &lt;br/&gt;
on Derivatives &lt;br/&gt;
Recognized &lt;br/&gt;
in Income &lt;br/&gt;
June 30, &lt;br/&gt;
2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Realized&#160;Gain&lt;br/&gt;
 (Loss) on &lt;br/&gt;
Derivatives &lt;br/&gt;
Recognized &lt;br/&gt;
in Income &lt;br/&gt;
June 30, &lt;br/&gt;
2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Change in &lt;br/&gt;
Unrealized &lt;br/&gt;
Appreciation &lt;br/&gt;
(Depreciation) &lt;br/&gt;
on Derivatives &lt;br/&gt;
Recognized &lt;br/&gt;
in Income &lt;br/&gt;
June 30, &lt;br/&gt;
2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; vertical-align: top; text-align: left"&gt;VIX Futures Contracts&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Net realized gain (loss) on futures contracts/changes in unrealized appreciation (depreciation) on futures contracts&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 15%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 0.5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 26%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 0.5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; width: 16%; text-align: left"&gt;-1x Short VIX Futures ETF&lt;/td&gt;&lt;td style="width: 0.5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;37,164,451&lt;/td&gt;&lt;td style="width: 0.5%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 0.5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(811,301&lt;/td&gt;&lt;td style="width: 0.5%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 0.5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(4,573,051&lt;/td&gt;&lt;td style="width: 0.5%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 0.5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;835,808&lt;/td&gt;&lt;td style="width: 0.5%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;2x Long VIX Futures ETF&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(142,872,642&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(4,374,661&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;7,528,449&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(256,944&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;Total Trust&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(105,708,191&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(5,185,962&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;2,955,398&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;578,864&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="21" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;The Effect of Derivative Instruments on the Statement of Operations&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="21" style="font-weight: bold; text-align: center"&gt;For the Six Months Ended June 30, 2023 (Unaudited) and June 30, 2022 (Unaudited)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="21" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;Derivatives Not &lt;br/&gt;
Accounted for as Hedging Instruments&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Location of Gain (Loss) on Derivatives Recognized in Income&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Fund&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Realized Gain &lt;br/&gt;
(Loss) on &lt;br/&gt;
Derivatives &lt;br/&gt;
Recognized &lt;br/&gt;
in Income&lt;br/&gt;
 June 30, &lt;br/&gt;
2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Change in &lt;br/&gt;
Unrealized &lt;br/&gt;
Appreciation &lt;br/&gt;
(Depreciation) &lt;br/&gt;
on Derivatives &lt;br/&gt;
Recognized in &lt;br/&gt;
Income &lt;br/&gt;
June 30, &lt;br/&gt;
2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Realized&#160;Gain&lt;br/&gt;
 (Loss) on &lt;br/&gt;
Derivatives &lt;br/&gt;
Recognized &lt;br/&gt;
in Income &lt;br/&gt;
June 30, &lt;br/&gt;
2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Change in &lt;br/&gt;
Unrealized &lt;br/&gt;
Appreciation &lt;br/&gt;
(Depreciation) &lt;br/&gt;
on Derivatives &lt;br/&gt;
Recognized&lt;br/&gt;
 in Income &lt;br/&gt;
June 30, &lt;br/&gt;
2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; vertical-align: top; text-align: left"&gt;VIX Futures Contracts&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Net realized gain (loss) on futures contracts/changes in unrealized appreciation (depreciation) on futures contracts&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 15%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 0.5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 26%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 0.5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; width: 16%; text-align: left"&gt;-1x Short VIX Futures ETF&lt;/td&gt;&lt;td style="width: 0.5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;42,451,505&lt;/td&gt;&lt;td style="width: 0.5%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 0.5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;5,362,473&lt;/td&gt;&lt;td style="width: 0.5%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 0.5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(4,577,129&lt;/td&gt;&lt;td style="width: 0.5%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 0.5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;700,531&lt;/td&gt;&lt;td style="width: 0.5%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;2x Long VIX Futures ETF&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(186,102,397&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(10,587,514&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;7,527,995&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;19,258&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;Total Trust&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(143,650,892&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(5,225,041&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;2,950,866&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;719,789&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock>
    <cik0001793497:RealizedGainLossOnDerivativesRecognizedInIncome contextRef="c69" decimals="0" unitRef="usd">37164451</cik0001793497:RealizedGainLossOnDerivativesRecognizedInIncome>
    <cik0001793497:ChangeInUnrealizedAppreciationDepreciationsOnDerivativesRecognizedInIncome contextRef="c69" decimals="0" unitRef="usd">-811301</cik0001793497:ChangeInUnrealizedAppreciationDepreciationsOnDerivativesRecognizedInIncome>
    <cik0001793497:RealizedGainLossOnDerivativesRecognizedInIncome contextRef="c70" decimals="0" unitRef="usd">-4573051</cik0001793497:RealizedGainLossOnDerivativesRecognizedInIncome>
    <cik0001793497:ChangeInUnrealizedAppreciationDepreciationsOnDerivativesRecognizedInIncome contextRef="c70" decimals="0" unitRef="usd">835808</cik0001793497:ChangeInUnrealizedAppreciationDepreciationsOnDerivativesRecognizedInIncome>
    <cik0001793497:RealizedGainLossOnDerivativesRecognizedInIncome contextRef="c71" decimals="0" unitRef="usd">-142872642</cik0001793497:RealizedGainLossOnDerivativesRecognizedInIncome>
    <cik0001793497:ChangeInUnrealizedAppreciationDepreciationsOnDerivativesRecognizedInIncome contextRef="c71" decimals="0" unitRef="usd">-4374661</cik0001793497:ChangeInUnrealizedAppreciationDepreciationsOnDerivativesRecognizedInIncome>
    <cik0001793497:RealizedGainLossOnDerivativesRecognizedInIncome contextRef="c72" decimals="0" unitRef="usd">7528449</cik0001793497:RealizedGainLossOnDerivativesRecognizedInIncome>
    <cik0001793497:ChangeInUnrealizedAppreciationDepreciationsOnDerivativesRecognizedInIncome contextRef="c72" decimals="0" unitRef="usd">-256944</cik0001793497:ChangeInUnrealizedAppreciationDepreciationsOnDerivativesRecognizedInIncome>
    <cik0001793497:RealizedGainLossOnDerivativesRecognizedInIncome contextRef="c73" decimals="0" unitRef="usd">-105708191</cik0001793497:RealizedGainLossOnDerivativesRecognizedInIncome>
    <cik0001793497:ChangeInUnrealizedAppreciationDepreciationsOnDerivativesRecognizedInIncome contextRef="c73" decimals="0" unitRef="usd">-5185962</cik0001793497:ChangeInUnrealizedAppreciationDepreciationsOnDerivativesRecognizedInIncome>
    <cik0001793497:RealizedGainLossOnDerivativesRecognizedInIncome contextRef="c74" decimals="0" unitRef="usd">2955398</cik0001793497:RealizedGainLossOnDerivativesRecognizedInIncome>
    <cik0001793497:ChangeInUnrealizedAppreciationDepreciationsOnDerivativesRecognizedInIncome contextRef="c74" decimals="0" unitRef="usd">578864</cik0001793497:ChangeInUnrealizedAppreciationDepreciationsOnDerivativesRecognizedInIncome>
    <cik0001793497:RealizedGainLossOnDerivativesRecognizedInIncome contextRef="c25" decimals="0" unitRef="usd">42451505</cik0001793497:RealizedGainLossOnDerivativesRecognizedInIncome>
    <cik0001793497:ChangeInUnrealizedAppreciationDepreciationsOnDerivativesRecognizedInIncome contextRef="c25" decimals="0" unitRef="usd">5362473</cik0001793497:ChangeInUnrealizedAppreciationDepreciationsOnDerivativesRecognizedInIncome>
    <cik0001793497:RealizedGainLossOnDerivativesRecognizedInIncome contextRef="c75" decimals="0" unitRef="usd">-4577129</cik0001793497:RealizedGainLossOnDerivativesRecognizedInIncome>
    <cik0001793497:ChangeInUnrealizedAppreciationDepreciationsOnDerivativesRecognizedInIncome contextRef="c75" decimals="0" unitRef="usd">700531</cik0001793497:ChangeInUnrealizedAppreciationDepreciationsOnDerivativesRecognizedInIncome>
    <cik0001793497:RealizedGainLossOnDerivativesRecognizedInIncome contextRef="c13" decimals="0" unitRef="usd">-186102397</cik0001793497:RealizedGainLossOnDerivativesRecognizedInIncome>
    <cik0001793497:ChangeInUnrealizedAppreciationDepreciationsOnDerivativesRecognizedInIncome contextRef="c13" decimals="0" unitRef="usd">-10587514</cik0001793497:ChangeInUnrealizedAppreciationDepreciationsOnDerivativesRecognizedInIncome>
    <cik0001793497:RealizedGainLossOnDerivativesRecognizedInIncome contextRef="c15" decimals="0" unitRef="usd">7527995</cik0001793497:RealizedGainLossOnDerivativesRecognizedInIncome>
    <cik0001793497:ChangeInUnrealizedAppreciationDepreciationsOnDerivativesRecognizedInIncome contextRef="c15" decimals="0" unitRef="usd">19258</cik0001793497:ChangeInUnrealizedAppreciationDepreciationsOnDerivativesRecognizedInIncome>
    <cik0001793497:RealizedGainLossOnDerivativesRecognizedInIncome contextRef="c0" decimals="0" unitRef="usd">-143650892</cik0001793497:RealizedGainLossOnDerivativesRecognizedInIncome>
    <cik0001793497:ChangeInUnrealizedAppreciationDepreciationsOnDerivativesRecognizedInIncome contextRef="c0" decimals="0" unitRef="usd">-5225041</cik0001793497:ChangeInUnrealizedAppreciationDepreciationsOnDerivativesRecognizedInIncome>
    <cik0001793497:RealizedGainLossOnDerivativesRecognizedInIncome contextRef="c76" decimals="0" unitRef="usd">2950866</cik0001793497:RealizedGainLossOnDerivativesRecognizedInIncome>
    <cik0001793497:ChangeInUnrealizedAppreciationDepreciationsOnDerivativesRecognizedInIncome contextRef="c76" decimals="0" unitRef="usd">719789</cik0001793497:ChangeInUnrealizedAppreciationDepreciationsOnDerivativesRecognizedInIncome>
    <cik0001793497:ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsTableTextBlock contextRef="c0">For financial reporting purposes, the Funds do not offset derivative assets and derivative
liabilities that are subject to netting arrangements in the Statements of Financial Condition. The following table presents each Fund&#x2019;s
derivatives by investment type and by counterparty net of amounts available for offset under a master netting agreement and the related
collateral received or pledged by the Funds as of June 30, 2023 and December 31, 2022.&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="25" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Fair Values of Derivative Instruments as of June 30, 2023 (Unaudited)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="25" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Assets&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;Fund&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Gross&lt;br/&gt; Amounts of&lt;br/&gt; Recognized&lt;br/&gt; Assets&lt;br/&gt; presented&lt;br/&gt; in the&lt;br/&gt; Statements&lt;br/&gt; of Financial&lt;br/&gt; Condition&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Gross&lt;br/&gt; Amounts&lt;br/&gt; Offset&lt;br/&gt; in the&lt;br/&gt; Statements&lt;br/&gt; of Financial&lt;br/&gt; Condition&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Net Amounts&lt;br/&gt; of Assets&lt;br/&gt; presented&lt;br/&gt; in the&lt;br/&gt; Statements&lt;br/&gt; of Financial&lt;br/&gt; Condition&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Gross&lt;br/&gt; Amounts of&lt;br/&gt; Recognized&lt;br/&gt; Liabilities&lt;br/&gt; presented&lt;br/&gt; in the&lt;br/&gt; Statements&lt;br/&gt; of Financial&lt;br/&gt; Condition&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Gross&lt;br/&gt; Amounts&lt;br/&gt; Offset&lt;br/&gt; in the&lt;br/&gt; Statements&lt;br/&gt; of Financial&lt;br/&gt; Condition&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Net Amounts&lt;br/&gt; of&#160;Liabilities&lt;br/&gt; presented&lt;br/&gt; in the&lt;br/&gt; Statements&lt;br/&gt; of Financial&lt;br/&gt; Condition&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 28%; text-align: left"&gt;-1x Short VIX Futures ETF&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,242,108&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-69"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,242,108&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-70"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-71"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-72"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;2x Long VIX Futures ETF&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-73"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-74"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-75"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;3,406,049&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-76"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,406,049&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="25" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Fair Values of Derivative Instruments as of December 31, 2022&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="25" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Assets&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;Fund&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Gross&lt;br/&gt; Amounts of&lt;br/&gt; Recognized&lt;br/&gt; Assets&lt;br/&gt; presented&lt;br/&gt; in the&lt;br/&gt; Statements&lt;br/&gt; of Financial&lt;br/&gt; Condition&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Gross&lt;br/&gt; Amounts&lt;br/&gt; Offset&lt;br/&gt; in the&lt;br/&gt; Statements&lt;br/&gt; of Financial&lt;br/&gt; Condition&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Net Amounts&lt;br/&gt; of Assets&lt;br/&gt; presented&lt;br/&gt; in the&lt;br/&gt; Statements&lt;br/&gt; of Financial&lt;br/&gt; Condition&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Gross&lt;br/&gt; Amounts of&lt;br/&gt; Recognized&lt;br/&gt; Liabilities&lt;br/&gt; presented&lt;br/&gt; in the&lt;br/&gt; Statements&lt;br/&gt; of Financial&lt;br/&gt; Condition&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Gross&lt;br/&gt; Amounts&lt;br/&gt; Offset&lt;br/&gt; in the&lt;br/&gt; Statements&lt;br/&gt; of Financial&lt;br/&gt; Condition&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Net Amounts&lt;br/&gt; of Liabilities&lt;br/&gt; presented&lt;br/&gt; in the&lt;br/&gt; Statements&lt;br/&gt; of Financial&lt;br/&gt; Condition&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 28%; text-align: left"&gt;-1x Short VIX Futures ETF&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-77"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;187,030&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-78"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;187,030&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;2x Long VIX Futures ETF&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;830,840&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-79"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;830,840&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-80"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;</cik0001793497:ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsTableTextBlock>
    <cik0001793497:GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition contextRef="c77" decimals="0" unitRef="usd">1242108</cik0001793497:GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition>
    <cik0001793497:NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition contextRef="c77" decimals="0" unitRef="usd">1242108</cik0001793497:NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition>
    <cik0001793497:GrossAmountsOfRecognizedLiabilitiesPresentedInTheStatementsOfFinancialCondition contextRef="c81" decimals="0" unitRef="usd">3406049</cik0001793497:GrossAmountsOfRecognizedLiabilitiesPresentedInTheStatementsOfFinancialCondition>
    <cik0001793497:NetAmountsOfLiabilitiesPresentedInTheStatementsOfFinancialCondition contextRef="c82" decimals="0" unitRef="usd">3406049</cik0001793497:NetAmountsOfLiabilitiesPresentedInTheStatementsOfFinancialCondition>
    <cik0001793497:GrossAmountsOfRecognizedLiabilitiesPresentedInTheStatementsOfFinancialCondition contextRef="c84" decimals="0" unitRef="usd">187030</cik0001793497:GrossAmountsOfRecognizedLiabilitiesPresentedInTheStatementsOfFinancialCondition>
    <cik0001793497:NetAmountsOfLiabilitiesPresentedInTheStatementsOfFinancialCondition contextRef="c85" decimals="0" unitRef="usd">187030</cik0001793497:NetAmountsOfLiabilitiesPresentedInTheStatementsOfFinancialCondition>
    <cik0001793497:GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition contextRef="c86" decimals="0" unitRef="usd">830840</cik0001793497:GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition>
    <cik0001793497:NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition contextRef="c86" decimals="0" unitRef="usd">830840</cik0001793497:NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition>
    <us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock contextRef="c0">Asset (Liability) amounts shown in the table below represent amounts owed to (by) the Funds for the derivative-related investments at
June 30, 2023 and December 31, 2022. These amounts may be collateralized by cash or financial instruments, segregated for the benefit of
the Funds or the counterparties, depending on whether the related contracts are in an appreciated or depreciated position at period end.
Amounts shown in the column labeled &#x201c;Net Amount&#x201d; represent the uncollateralized portions of these amounts at period end. These
amounts may be un-collateralized due to timing differences related to market movements or due to minimum thresholds for collateral movement,
as further described above under the caption &#x201c;Accounting for Derivative Instruments&#x201d;.&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="17" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Gross Amounts Not Offset in the Statements of Financial Condition as of June 30, 2023 (Unaudited)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="17" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;Fund&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Amounts of&lt;br/&gt; Recognized&lt;br/&gt; Assets /&lt;br/&gt; (Liabilities)&lt;br/&gt; presented&lt;br/&gt; in the&lt;br/&gt; Statements&lt;br/&gt; of Financial&lt;br/&gt; Condition&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Financial&lt;br/&gt; Instruments&lt;br/&gt; for the Benefit&lt;br/&gt; of (the Funds) / the&lt;br/&gt; Counterparties&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Cash&lt;br/&gt; Collateral for&lt;br/&gt; the Benefit of&lt;br/&gt; (the Funds) / the&lt;br/&gt; Counterparties&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Net Amount&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;-1x Short VIX Futures ETF&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,242,108&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-81"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-82"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,242,108&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;2x Long VIX Futures ETF&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,406,049&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-83"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-84"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,406,049&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="17" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Gross Amounts Not Offset in the Statements of Financial Condition as of December 31, 2022&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="17" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;Fund&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Amounts of&lt;br/&gt; Recognized&lt;br/&gt; Assets /&lt;br/&gt; (Liabilities)&lt;br/&gt; presented&lt;br/&gt; in the&lt;br/&gt; Statements&lt;br/&gt; of Financial&lt;br/&gt; Condition&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Financial&lt;br/&gt; Instruments&lt;br/&gt; for the Benefit&lt;br/&gt; of (the&lt;br/&gt;
 Funds) / the&lt;br/&gt; Counterparties&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Cash&lt;br/&gt; Collateral for&lt;br/&gt; the Benefit of&lt;br/&gt; (the Funds) / the&lt;br/&gt; Counterparties&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Net Amount&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;-1x Short VIX Futures ETF&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(187,030&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(187,030&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;2x Long VIX Futures ETF&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;830,840&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;830,840&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock>
    <cik0001793497:AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne contextRef="c12" decimals="0" unitRef="usd">1242108</cik0001793497:AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne>
    <cik0001793497:CapitalUnitNetAmount contextRef="c4" decimals="0" unitRef="usd">1242108</cik0001793497:CapitalUnitNetAmount>
    <cik0001793497:AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne contextRef="c13" decimals="0" unitRef="usd">-3406049</cik0001793497:AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne>
    <cik0001793497:CapitalUnitNetAmount contextRef="c5" decimals="0" unitRef="usd">-3406049</cik0001793497:CapitalUnitNetAmount>
    <cik0001793497:AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne contextRef="c88" decimals="0" unitRef="usd">-187030</cik0001793497:AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne>
    <cik0001793497:CapitalUnitNetAmount contextRef="c6" decimals="0" unitRef="usd">-187030</cik0001793497:CapitalUnitNetAmount>
    <cik0001793497:AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne contextRef="c43" decimals="0" unitRef="usd">830840</cik0001793497:AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne>
    <cik0001793497:CapitalUnitNetAmount contextRef="c7" decimals="0" unitRef="usd">830840</cik0001793497:CapitalUnitNetAmount>
    <cik0001793497:AgreementsDisclosureTextBlock contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"&gt;NOTE 4 &#x2013; AGREEMENTS&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"&gt;Management Fee&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;SVIX pays
the Sponsor a management fee (the &#x201c;Management Fee&#x201d;), monthly in arrears, in an amount equal to 1.35% per annum of its average
daily net assets. UVIX pays the Sponsor a Management Fee, monthly in arrears, in an amount equal to 1.65% per annum of its average daily
net assets. &#x201c;Average daily net assets&#x201d; is calculated by dividing the month-end net assets of each Fund by the number of calendar
days in such month.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;No other Management Fee is paid by
the Funds. The Management Fee is paid in consideration of the Sponsor&#x2019;s trading advisory services and the other services provided
to the Fund that the Sponsor pays directly.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Pursuant to the Sponsor Agreement
between Sponsor and the Trust, on behalf of the Funds, the Sponsor oversees and pays Penserra Capital Management LLC (&#x201c;Commodity
Sub-Adviser&#x201d;) for its services as Commodity Sub-Adviser. The Commodity Sub-Adviser is paid by the Sponsor an annual sub-advisory
fee of 0.20% based on each Fund&#x2019;s average daily net assets (total assets of the Fund, minus the sum of its accrued liabilities).
The Funds do not directly pay the Commodity Sub-Adviser.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"&gt;Non-Recurring Fees and Expenses&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Each Fund pays all its non-recurring
and unusual fees and expenses, if any, as determined by the Sponsor. Non-recurring and unusual fees and expenses are fees and expenses
that are unexpected or unusual in nature, such as legal claims and liabilities, litigation costs or indemnification or other material
expenses which are not currently anticipated obligations of the Funds.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"&gt;The Administrator, Transfer Agent and Custodian&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;U.S. Bancorp Fund Services, LLC,
doing business as U.S. Bank Global Fund Services (&#x201c;Fund Services&#x201d;), an indirect subsidiary of U.S. Bancorp, serves as
the Fund&#x2019;s fund accountant, administrator and transfer agent pursuant to certain fund accounting servicing, fund
administration servicing and transfer agent servicing agreements. U.S. Bank National Association, a subsidiary of U.S. Bancorp and
parent company of Fund Services, intends to serve as the Fund&#x2019;s custodian pursuant to a custody agreement.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"&gt;The Marketing Agent&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Foreside Fund Services, LLC (the
&#x201c;Marketing Agent&#x201d;) serves as the Marketing Agent of the Funds. Its principal duties are: (i) to work with the Transfer Agent
to review and approve orders placed by Authorized Participants and transmitted to the Transfer Agent; (ii) maintain copies of confirmations
of Creation Unit creation and redemption order acceptances; (iii) maintain telephonic, facsimile and/or access to direct computer communications
links with the Transfer Agent; and (iv) review and approve, prior to use, all Trust marketing materials for compliance with applicable
SEC and FINRA advertising rules.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;The Marketing Agent retains all marketing
materials separately for the Funds, at their offices located at Three Canal Plaza, Suite 100 Portland, Maine 04101.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;As compensation for the services it provides, the Marketing
Agent receives a fee from the Funds.&lt;/p&gt;</cik0001793497:AgreementsDisclosureTextBlock>
    <cik0001793497:AverageDailyNetAssetsRate contextRef="c89" decimals="4" unitRef="pure">0.0135</cik0001793497:AverageDailyNetAssetsRate>
    <cik0001793497:AverageDailyNetAssetsRate contextRef="c90" decimals="4" unitRef="pure">0.0165</cik0001793497:AverageDailyNetAssetsRate>
    <cik0001793497:SubadvisoryFeeRate contextRef="c3" decimals="4" unitRef="pure">0.002</cik0001793497:SubadvisoryFeeRate>
    <cik0001793497:OfferingCostsTextBlock contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"&gt;NOTE 5 &#x2013; OFFERING COSTS&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Offering costs will be amortized
by the Funds over a twelve month period on a straight-line basis beginning once the fund commences operations. The Sponsor will not charge
its Management Fee in the first year of operations of a Fund in an amount equal to the offering costs. Normal and expected expenses incurred
in connection with the continuous offering of Shares of a Fund after the commencement of its trading operations will be paid by the Sponsor.&lt;/p&gt;</cik0001793497:OfferingCostsTextBlock>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"&gt;NOTE 6 &#x2013; CREATION AND REDEMPTION OF CREATION UNITS&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Each Fund issues and redeems shares
from time to time, but only in one or more Creation Units. A Creation Unit is a block of at least 10,000 Shares of a Fund. Creation Units
may be created or redeemed only by Authorized Participants.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Except when aggregated in Creation
Units, the Shares are not redeemable securities. Retail investors, therefore, generally will not be able to purchase or redeem Shares
directly from or with a Fund. Rather, most retail investors will purchase or sell Shares in the secondary market with the assistance of
a broker. Thus, some of the information contained in these Notes to Financial Statements&#x2014;such as references to the Transaction Fees
imposed on purchases and redemptions is not relevant to retail investors.&lt;/p&gt;

&lt;p style="text-align: left; text-indent: 0.5in; margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="text-align: left; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Transaction Fees on Creation and Redemption
Transactions&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="text-align: left; text-indent: 0.5in; margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;The manner by which Creation Units are purchased or redeemed is governed by the
terms of the Authorized Participant Agreement and Authorized Participant Procedures Handbook. By placing a purchase order, an Authorized
Participant agrees to: (1) deposit cash with the Custodian; and (2) if permitted by the Sponsor in its sole discretion, enter into or
arrange for an exchange of futures contract for related position or block trade with the relevant fund whereby the Authorized Participant
would also transfer to such Fund a number and type of exchange-traded futures contracts at or near the closing settlement price for such
contracts on the purchase order date.&lt;/p&gt;&lt;p style="text-align: left; text-indent: 0.5in; margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Authorized Participants may pay a fee up to 0.20% of the value of each order they place with each
order to create or redeem a Creation Unit in order to compensate the Administrator, the Custodian and the Transfer Agent of each Fund
and its Shares, for services in processing the creation and redemption of Creation Units and to offset the costs of increasing or decreasing
derivative positions, unless the transaction fee is waived or otherwise adjusted by the Sponsor. The Sponsor provides such Authorized
Participant with prompt notice in advance of any such waiver or adjustment of the transaction fee. Authorized Participants may sell the
Shares included in the Creation Units they purchase from the Funds to other investors in the secondary market.&lt;/p&gt;

&lt;p style="text-align: left; text-indent: 0.5in; margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Transaction fees for the three months ended June 30, 2023
and June 30, 2022 were as follows.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;Fund&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Three &lt;br/&gt;
Months &lt;br/&gt;
Ended &lt;br/&gt;
June 30, &lt;br/&gt;
2023 &lt;br/&gt;
(Unaudited)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Three &lt;br/&gt;
Months &lt;br/&gt;
Ended &lt;br/&gt;
June 30, &lt;br/&gt;
2022 &lt;br/&gt;
(Unaudited)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;-1x Short VIX Futures ETF&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;31,820&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;62,214&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;2x Long VIX Futures ETF&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;66,946&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;45,789&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Total Trust&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;98,766&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;108,003&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Transaction fees for the Six months ended June 30, 2023 and
June 30, 2022 were as follows.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.4pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;Fund&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Six Months &lt;br/&gt;
Ended &lt;br/&gt;
June 30, &lt;br/&gt;
2023 &lt;br/&gt;
(Unaudited)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Six Months &lt;br/&gt;
Ended &lt;br/&gt;
June 30, &lt;br/&gt;
2022 &lt;br/&gt;
(Unaudited)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;-1x Short VIX Futures ETF&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;77,483&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;63,870&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;2x Long VIX Futures ETF&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;119,613&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;46,905&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Total Trust&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;197,096&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;110,775&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:SharesIssued contextRef="c3" decimals="0" unitRef="shares">10000</us-gaap:SharesIssued>
    <cik0001793497:AuthorizedParticipantsPercentage contextRef="c0" decimals="4" unitRef="pure">0.002</cik0001793497:AuthorizedParticipantsPercentage>
    <cik0001793497:ScheduleOfTransactionFeesTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;Fund&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Three &lt;br/&gt;
Months &lt;br/&gt;
Ended &lt;br/&gt;
June 30, &lt;br/&gt;
2023 &lt;br/&gt;
(Unaudited)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Three &lt;br/&gt;
Months &lt;br/&gt;
Ended &lt;br/&gt;
June 30, &lt;br/&gt;
2022 &lt;br/&gt;
(Unaudited)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;-1x Short VIX Futures ETF&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;31,820&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;62,214&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;2x Long VIX Futures ETF&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;66,946&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;45,789&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Total Trust&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;98,766&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;108,003&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;Fund&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Six Months &lt;br/&gt;
Ended &lt;br/&gt;
June 30, &lt;br/&gt;
2023 &lt;br/&gt;
(Unaudited)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Six Months &lt;br/&gt;
Ended &lt;br/&gt;
June 30, &lt;br/&gt;
2022 &lt;br/&gt;
(Unaudited)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;-1x Short VIX Futures ETF&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;77,483&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;63,870&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;2x Long VIX Futures ETF&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;119,613&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;46,905&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Total Trust&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;197,096&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;110,775&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</cik0001793497:ScheduleOfTransactionFeesTableTextBlock>
    <us-gaap:SaleOfTrustAssetsToPayExpenses contextRef="c91" decimals="0" unitRef="usd">31820</us-gaap:SaleOfTrustAssetsToPayExpenses>
    <us-gaap:SaleOfTrustAssetsToPayExpenses contextRef="c92" decimals="0" unitRef="usd">62214</us-gaap:SaleOfTrustAssetsToPayExpenses>
    <us-gaap:SaleOfTrustAssetsToPayExpenses contextRef="c9" decimals="0" unitRef="usd">66946</us-gaap:SaleOfTrustAssetsToPayExpenses>
    <us-gaap:SaleOfTrustAssetsToPayExpenses contextRef="c11" decimals="0" unitRef="usd">45789</us-gaap:SaleOfTrustAssetsToPayExpenses>
    <us-gaap:SaleOfTrustAssetsToPayExpenses contextRef="c93" decimals="0" unitRef="usd">98766</us-gaap:SaleOfTrustAssetsToPayExpenses>
    <us-gaap:SaleOfTrustAssetsToPayExpenses contextRef="c94" decimals="0" unitRef="usd">108003</us-gaap:SaleOfTrustAssetsToPayExpenses>
    <us-gaap:SaleOfTrustAssetsToPayExpenses contextRef="c25" decimals="0" unitRef="usd">77483</us-gaap:SaleOfTrustAssetsToPayExpenses>
    <us-gaap:SaleOfTrustAssetsToPayExpenses contextRef="c75" decimals="0" unitRef="usd">63870</us-gaap:SaleOfTrustAssetsToPayExpenses>
    <us-gaap:SaleOfTrustAssetsToPayExpenses contextRef="c13" decimals="0" unitRef="usd">119613</us-gaap:SaleOfTrustAssetsToPayExpenses>
    <us-gaap:SaleOfTrustAssetsToPayExpenses contextRef="c15" decimals="0" unitRef="usd">46905</us-gaap:SaleOfTrustAssetsToPayExpenses>
    <us-gaap:SaleOfTrustAssetsToPayExpenses contextRef="c0" decimals="0" unitRef="usd">197096</us-gaap:SaleOfTrustAssetsToPayExpenses>
    <us-gaap:SaleOfTrustAssetsToPayExpenses contextRef="c76" decimals="0" unitRef="usd">110775</us-gaap:SaleOfTrustAssetsToPayExpenses>
    <us-gaap:QuarterlyFinancialInformationTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;NOTE 7 - FINANCIAL HIGHLIGHTS&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Selected data is for a Share outstanding throughout the Three Months
Ended June 30, 2023 (Unaudited) and June 30, 2022 (Unaudited)&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;-1x Short VIX Futures ETF&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2x Long VIX Futures ETF&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;-1x Short VIX Futures ETF&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2x Long VIX Futures ETF&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Quarter Ended&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Quarter Ended&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Quarter Ended&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Quarter Ended&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;June 30, &lt;br/&gt;
2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;June 30, &lt;br/&gt;
2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;June 30, &lt;br/&gt;
2022&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;June 30, &lt;br/&gt;
2022&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;(Unaudited)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;(Unaudited)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;(Unaudited)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;(Unaudited)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; width: 52%"&gt;Net Asset Value, Beginning of Period&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;16.55&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;15.88&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;14.16&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;83.20&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net investment loss &lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(0.09&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(0.03&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(0.05&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(0.60&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net Realized and Unrealized Gain (Loss) on Investments and Futures Contracts &lt;sup&gt;(2)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;11.67&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(11.41&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(3.71&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3.00&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"&gt;Net Increase (Decrease) in Net Asset Value Resulting from Operations&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;11.58&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(11.44&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(3.76&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2.40&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; padding-bottom: 4pt"&gt;Net Asset Value, End of Period&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;28.13&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;4.44&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;10.40&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;85.60&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; padding-bottom: 4pt"&gt;Market Value Per Share, at June 30, 2023 and June 30, 2022&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;28.07&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;4.46&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;10.40&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;85.40&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Total Return at Net Asset Value &lt;sup&gt;(4)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;69.97&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;-72.04&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;-26.56&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;2.88&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Total Return at Market Value &lt;sup&gt;(4)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;70.02&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;-72.09&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;-25.93&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;1.30&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Ratios to Average Net Assets: &lt;sup&gt;(5)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expense ratio &lt;sup&gt;(6)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2.20&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2.09&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2.18&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2.91&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; text-align: left"&gt;Net Investment Loss&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-1.75&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-1.14&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-0.50&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-0.67&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="text-align: left; width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;(1)&lt;/td&gt;&lt;td style="text-align: left"&gt;Net investment loss per share represents net investment loss
divided by the daily average shares of beneficial interest outstanding during the period.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="text-align: left; width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;(2)&lt;/td&gt;&lt;td style="text-align: left"&gt;Due to timing of capital share transactions, per share amounts
may not compare with amounts appearing elsewhere within these Financial Statements.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="text-align: left; width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;(3)&lt;/td&gt;&lt;td style="text-align: left"&gt;Market values are determined at the close of the applicable
primary listing exchange, which may be later than when the Funds' net asset value is calculated.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="text-align: left; width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;(4)&lt;/td&gt;&lt;td style="text-align: left"&gt;Percentages are not annualized for the period ended June 30,
2023 and June 30, 2022&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="text-align: left; width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;(5)&lt;/td&gt;&lt;td style="text-align: left"&gt;Percentages are annualized.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="text-align: left; width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;(6)&lt;/td&gt;&lt;td style="text-align: left"&gt;The expense ratio would be 2.17% and 2.09% respectively, for
the three months ended June 30, 2023, and 2.00% and 2.81% for the three months ended June 30, 2022 if brokerage commissions and futures
and futures account fees were excluded.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="margin: 0; text-indent: 0.5in"&gt;Selected data is for a Share outstanding throughout the Six Months
Ended June 30, 2023 (Unaudited) and June 30, 2022 (Unaudited)&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;-1x Short VIX Futures ETF&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2x Long VIX Futures ETF&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;-1x Short VIX Futures ETF&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2x Long VIX Futures ETF&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Six Months Ended&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Six Months Ended&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Six Months Ended&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Six Months Ended&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;June 30, &lt;br/&gt;
2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;June 30, &lt;br/&gt;
2023 &lt;sup&gt;(7)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;June 30, &lt;br/&gt;
2022&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;June 30, &lt;br/&gt;
2022 &lt;sup&gt;(7)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;(Unaudited)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;(Unaudited)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;(Unaudited)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;(Unaudited)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; width: 52%"&gt;Net Asset Value, Beginning of Period&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;14.63&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;29.25&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;15.00&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;75.00&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net investment loss &lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(0.17&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(0.08&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(0.06&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1.20&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net Realized and Unrealized Gain (Loss) on Investments and Futures Contracts &lt;sup&gt;(2)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;13.67&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(24.73&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(4.54&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;11.80&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Net Increase (Decrease) in Net Asset Value Resulting from Operations&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;13.50&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(24.81&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(4.60&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;10.60&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 4pt"&gt;Net Asset Value, End of Period&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;28.13&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;4.44&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;10.40&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;85.60&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 4pt"&gt;Market Value Per Share, at June 30, 2023 and June 30, 2022&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;28.07&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;4.46&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;10.40&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;85.40&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Total Return at Net Asset Value &lt;sup&gt;(4)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;92.28&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;-84.82&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;-30.67&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;14.13&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Total Return at Market Value &lt;sup&gt;(4)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;91.47&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;-84.67&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;-30.67&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;13.87&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Ratios to Average Net Assets: &lt;sup&gt;(5)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expense ratio &lt;sup&gt;(6)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2.25&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2.13&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2.18&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2.91&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Net Investment Loss&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-1.84&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-1.35&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-0.50&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-0.67&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="text-align: left; width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;(1)&lt;/td&gt;&lt;td style="text-align: left"&gt;Net investment loss per share represents net investment loss
divided by the daily average shares of beneficial interest outstanding during the period.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="text-align: left; width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;(2)&lt;/td&gt;&lt;td style="text-align: left"&gt;Due to timing of capital share transactions, per share amounts
may not compare with amounts appearing elsewhere within these Financial Statements.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="text-align: left; width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;(3)&lt;/td&gt;&lt;td style="text-align: left"&gt;Market values are determined at the close of the applicable
primary listing exchange, which may be later than when the Funds' net asset value is calculated.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="text-align: left; width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;(4)&lt;/td&gt;&lt;td style="text-align: left"&gt;Percentages are not annualized for the period ended June 30,
2023 and June 30, 2022&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="text-align: left; width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;(5)&lt;/td&gt;&lt;td style="text-align: left"&gt;Percentages are annualized.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="text-align: left; width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;(6)&lt;/td&gt;&lt;td style="text-align: left"&gt;The expense ratio would be 2.23% and 2.13% respectively, for
the six months ended June 30, 2023, and 2.01% and 2.84% for the six months ended June 30, 2022 if brokerage commissions and futures and
futures account fees were excluded.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="text-align: left; width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;(7)&lt;/td&gt;&lt;td style="text-align: left"&gt;For 2x Long VIX Futures ETF, fianancial highlights have been
adjusted to reflect a 1:5 reverse stock split occurring on January 25, 2023, as if it occurred at the commencment of operations.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</us-gaap:QuarterlyFinancialInformationTextBlock>
    <cik0001793497:ScheduleOfShareOutstandingTableTextBlock contextRef="c0">Selected data is for a Share outstanding throughout the Three Months
Ended June 30, 2023 (Unaudited) and June 30, 2022 (Unaudited)&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;-1x Short VIX Futures ETF&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2x Long VIX Futures ETF&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;-1x Short VIX Futures ETF&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2x Long VIX Futures ETF&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Quarter Ended&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Quarter Ended&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Quarter Ended&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Quarter Ended&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;June 30, &lt;br/&gt;
2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;June 30, &lt;br/&gt;
2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;June 30, &lt;br/&gt;
2022&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;June 30, &lt;br/&gt;
2022&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;(Unaudited)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;(Unaudited)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;(Unaudited)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;(Unaudited)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; width: 52%"&gt;Net Asset Value, Beginning of Period&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;16.55&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;15.88&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;14.16&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;83.20&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net investment loss &lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(0.09&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(0.03&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(0.05&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(0.60&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net Realized and Unrealized Gain (Loss) on Investments and Futures Contracts &lt;sup&gt;(2)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;11.67&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(11.41&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(3.71&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3.00&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"&gt;Net Increase (Decrease) in Net Asset Value Resulting from Operations&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;11.58&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(11.44&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(3.76&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2.40&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; padding-bottom: 4pt"&gt;Net Asset Value, End of Period&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;28.13&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;4.44&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;10.40&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;85.60&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; padding-bottom: 4pt"&gt;Market Value Per Share, at June 30, 2023 and June 30, 2022&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;28.07&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;4.46&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;10.40&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;85.40&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Total Return at Net Asset Value &lt;sup&gt;(4)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;69.97&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;-72.04&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;-26.56&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;2.88&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Total Return at Market Value &lt;sup&gt;(4)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;70.02&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;-72.09&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;-25.93&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;1.30&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Ratios to Average Net Assets: &lt;sup&gt;(5)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expense ratio &lt;sup&gt;(6)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2.20&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2.09&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2.18&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2.91&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; text-align: left"&gt;Net Investment Loss&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-1.75&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-1.14&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-0.50&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-0.67&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="text-align: left; width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;(1)&lt;/td&gt;&lt;td style="text-align: left"&gt;Net investment loss per share represents net investment loss
divided by the daily average shares of beneficial interest outstanding during the period.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="text-align: left; width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;(6)&lt;/td&gt;&lt;td style="text-align: left"&gt;The expense ratio would be 2.17% and 2.09% respectively, for
the three months ended June 30, 2023, and 2.00% and 2.81% for the three months ended June 30, 2022 if brokerage commissions and futures
and futures account fees were excluded.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;-1x Short VIX Futures ETF&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2x Long VIX Futures ETF&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;-1x Short VIX Futures ETF&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2x Long VIX Futures ETF&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Six Months Ended&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Six Months Ended&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Six Months Ended&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Six Months Ended&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;June 30, &lt;br/&gt;
2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;June 30, &lt;br/&gt;
2023 &lt;sup&gt;(7)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;June 30, &lt;br/&gt;
2022&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;June 30, &lt;br/&gt;
2022 &lt;sup&gt;(7)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;(Unaudited)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;(Unaudited)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;(Unaudited)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;(Unaudited)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; width: 52%"&gt;Net Asset Value, Beginning of Period&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;14.63&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;29.25&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;15.00&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;75.00&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net investment loss &lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(0.17&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(0.08&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(0.06&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1.20&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net Realized and Unrealized Gain (Loss) on Investments and Futures Contracts &lt;sup&gt;(2)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;13.67&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(24.73&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(4.54&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;11.80&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Net Increase (Decrease) in Net Asset Value Resulting from Operations&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;13.50&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(24.81&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(4.60&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;10.60&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 4pt"&gt;Net Asset Value, End of Period&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;28.13&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;4.44&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;10.40&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;85.60&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 4pt"&gt;Market Value Per Share, at June 30, 2023 and June 30, 2022&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;28.07&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;4.46&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;10.40&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;85.40&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Total Return at Net Asset Value &lt;sup&gt;(4)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;92.28&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;-84.82&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;-30.67&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;14.13&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Total Return at Market Value &lt;sup&gt;(4)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;91.47&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;-84.67&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;-30.67&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;13.87&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Ratios to Average Net Assets: &lt;sup&gt;(5)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expense ratio &lt;sup&gt;(6)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2.25&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2.13&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2.18&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2.91&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Net Investment Loss&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-1.84&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-1.35&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-0.50&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-0.67&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="text-align: left; width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;(2)&lt;/td&gt;&lt;td style="text-align: left"&gt;Due to timing of capital share transactions, per share amounts
may not compare with amounts appearing elsewhere within these Financial Statements.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="text-align: left; width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;(4)&lt;/td&gt;&lt;td style="text-align: left"&gt;Percentages are not annualized for the period ended June 30,
2023 and June 30, 2022&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="text-align: left; width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;(5)&lt;/td&gt;&lt;td style="text-align: left"&gt;Percentages are annualized.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="text-align: left; width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;(6)&lt;/td&gt;&lt;td style="text-align: left"&gt;The expense ratio would be 2.23% and 2.13% respectively, for
the six months ended June 30, 2023, and 2.01% and 2.84% for the six months ended June 30, 2022 if brokerage commissions and futures and
futures account fees were excluded.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="text-align: left; width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;(7)&lt;/td&gt;&lt;td style="text-align: left"&gt;For 2x Long VIX Futures ETF, fianancial highlights have been
adjusted to reflect a 1:5 reverse stock split occurring on January 25, 2023, as if it occurred at the commencment of operations.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</cik0001793497:ScheduleOfShareOutstandingTableTextBlock>
    <us-gaap:InvestmentCompanyMarketValuePerShare contextRef="c99" decimals="2" unitRef="usdPershares">16.55</us-gaap:InvestmentCompanyMarketValuePerShare>
    <us-gaap:InvestmentCompanyMarketValuePerShare contextRef="c17" decimals="2" unitRef="usdPershares">15.88</us-gaap:InvestmentCompanyMarketValuePerShare>
    <us-gaap:InvestmentCompanyMarketValuePerShare contextRef="c100" decimals="2" unitRef="usdPershares">14.16</us-gaap:InvestmentCompanyMarketValuePerShare>
    <us-gaap:InvestmentCompanyMarketValuePerShare contextRef="c19" decimals="2" unitRef="usdPershares">83.2</us-gaap:InvestmentCompanyMarketValuePerShare>
    <us-gaap:InvestmentCompanyGainLossOnInvestmentPerShare
      contextRef="c91"
      decimals="2"
      id="ix_19_fact"
      unitRef="usdPershares">-0.09</us-gaap:InvestmentCompanyGainLossOnInvestmentPerShare>
    <us-gaap:InvestmentCompanyGainLossOnInvestmentPerShare
      contextRef="c9"
      decimals="2"
      id="ix_20_fact"
      unitRef="usdPershares">-0.03</us-gaap:InvestmentCompanyGainLossOnInvestmentPerShare>
    <us-gaap:InvestmentCompanyGainLossOnInvestmentPerShare
      contextRef="c92"
      decimals="2"
      id="ix_21_fact"
      unitRef="usdPershares">-0.05</us-gaap:InvestmentCompanyGainLossOnInvestmentPerShare>
    <us-gaap:InvestmentCompanyGainLossOnInvestmentPerShare
      contextRef="c11"
      decimals="2"
      id="ix_22_fact"
      unitRef="usdPershares">-0.6</us-gaap:InvestmentCompanyGainLossOnInvestmentPerShare>
    <cik0001793497:NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts
      contextRef="c91"
      decimals="2"
      id="ix_27_fact"
      unitRef="usdPershares">11.67</cik0001793497:NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts>
    <cik0001793497:NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts
      contextRef="c9"
      decimals="2"
      id="ix_28_fact"
      unitRef="usdPershares">-11.41</cik0001793497:NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts>
    <cik0001793497:NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts
      contextRef="c92"
      decimals="2"
      id="ix_29_fact"
      unitRef="usdPershares">-3.71</cik0001793497:NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts>
    <cik0001793497:NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts
      contextRef="c11"
      decimals="2"
      id="ix_30_fact"
      unitRef="usdPershares">3</cik0001793497:NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts>
    <us-gaap:InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease contextRef="c91" decimals="2" unitRef="usdPershares">11.58</us-gaap:InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease>
    <us-gaap:InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease contextRef="c9" decimals="2" unitRef="usdPershares">-11.44</us-gaap:InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease>
    <us-gaap:InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease contextRef="c92" decimals="2" unitRef="usdPershares">-3.76</us-gaap:InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease>
    <us-gaap:InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease contextRef="c11" decimals="2" unitRef="usdPershares">2.4</us-gaap:InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease>
    <us-gaap:InvestmentCompanyMarketValuePerShare contextRef="c24" decimals="2" unitRef="usdPershares">28.13</us-gaap:InvestmentCompanyMarketValuePerShare>
    <us-gaap:InvestmentCompanyMarketValuePerShare contextRef="c5" decimals="2" unitRef="usdPershares">4.44</us-gaap:InvestmentCompanyMarketValuePerShare>
    <us-gaap:InvestmentCompanyMarketValuePerShare contextRef="c101" decimals="2" unitRef="usdPershares">10.4</us-gaap:InvestmentCompanyMarketValuePerShare>
    <us-gaap:InvestmentCompanyMarketValuePerShare contextRef="c21" decimals="2" unitRef="usdPershares">85.6</us-gaap:InvestmentCompanyMarketValuePerShare>
    <cik0001793497:MarketValuePerShare contextRef="c24" decimals="2" unitRef="usdPershares">28.07</cik0001793497:MarketValuePerShare>
    <cik0001793497:MarketValuePerShare contextRef="c5" decimals="2" unitRef="usdPershares">4.46</cik0001793497:MarketValuePerShare>
    <cik0001793497:MarketValuePerShare contextRef="c101" decimals="2" unitRef="usdPershares">10.4</cik0001793497:MarketValuePerShare>
    <cik0001793497:MarketValuePerShare contextRef="c21" decimals="2" unitRef="usdPershares">85.4</cik0001793497:MarketValuePerShare>
    <us-gaap:InvestmentCompanyTotalReturn
      contextRef="c91"
      decimals="4"
      id="ix_35_fact"
      unitRef="pure">0.6997</us-gaap:InvestmentCompanyTotalReturn>
    <us-gaap:InvestmentCompanyTotalReturn contextRef="c9" decimals="4" id="ix_36_fact" unitRef="pure">-0.7204</us-gaap:InvestmentCompanyTotalReturn>
    <us-gaap:InvestmentCompanyTotalReturn
      contextRef="c92"
      decimals="4"
      id="ix_37_fact"
      unitRef="pure">-0.2656</us-gaap:InvestmentCompanyTotalReturn>
    <us-gaap:InvestmentCompanyTotalReturn
      contextRef="c11"
      decimals="4"
      id="ix_38_fact"
      unitRef="pure">0.0288</us-gaap:InvestmentCompanyTotalReturn>
    <cik0001793497:TotalReturnAtMarketValue
      contextRef="c91"
      decimals="4"
      id="ix_39_fact"
      unitRef="pure">0.7002</cik0001793497:TotalReturnAtMarketValue>
    <cik0001793497:TotalReturnAtMarketValue contextRef="c9" decimals="4" id="ix_40_fact" unitRef="pure">-0.7209</cik0001793497:TotalReturnAtMarketValue>
    <cik0001793497:TotalReturnAtMarketValue
      contextRef="c92"
      decimals="4"
      id="ix_41_fact"
      unitRef="pure">-0.2593</cik0001793497:TotalReturnAtMarketValue>
    <cik0001793497:TotalReturnAtMarketValue
      contextRef="c11"
      decimals="4"
      id="ix_42_fact"
      unitRef="pure">0.013</cik0001793497:TotalReturnAtMarketValue>
    <us-gaap:InvestmentCompanyExpenseRatioAfterIncentiveAllocation
      contextRef="c91"
      decimals="4"
      id="ix_51_fact"
      unitRef="pure">0.022</us-gaap:InvestmentCompanyExpenseRatioAfterIncentiveAllocation>
    <us-gaap:InvestmentCompanyExpenseRatioAfterIncentiveAllocation contextRef="c9" decimals="4" id="ix_52_fact" unitRef="pure">0.0209</us-gaap:InvestmentCompanyExpenseRatioAfterIncentiveAllocation>
    <us-gaap:InvestmentCompanyExpenseRatioAfterIncentiveAllocation
      contextRef="c92"
      decimals="4"
      id="ix_53_fact"
      unitRef="pure">0.0218</us-gaap:InvestmentCompanyExpenseRatioAfterIncentiveAllocation>
    <us-gaap:InvestmentCompanyExpenseRatioAfterIncentiveAllocation
      contextRef="c11"
      decimals="4"
      id="ix_54_fact"
      unitRef="pure">0.0291</us-gaap:InvestmentCompanyExpenseRatioAfterIncentiveAllocation>
    <us-gaap:InvestmentCompanyTotalReturnAfterIncentiveFees contextRef="c91" decimals="4" unitRef="pure">-0.0175</us-gaap:InvestmentCompanyTotalReturnAfterIncentiveFees>
    <us-gaap:InvestmentCompanyTotalReturnAfterIncentiveFees contextRef="c9" decimals="4" unitRef="pure">-0.0114</us-gaap:InvestmentCompanyTotalReturnAfterIncentiveFees>
    <us-gaap:InvestmentCompanyTotalReturnAfterIncentiveFees contextRef="c92" decimals="4" unitRef="pure">-0.005</us-gaap:InvestmentCompanyTotalReturnAfterIncentiveFees>
    <us-gaap:InvestmentCompanyTotalReturnAfterIncentiveFees contextRef="c11" decimals="4" unitRef="pure">-0.0067</us-gaap:InvestmentCompanyTotalReturnAfterIncentiveFees>
    <us-gaap:GeneralAndAdministrativeExpenseRatio contextRef="c95" decimals="4" unitRef="pure">0.0217</us-gaap:GeneralAndAdministrativeExpenseRatio>
    <us-gaap:GeneralAndAdministrativeExpenseRatio contextRef="c96" decimals="4" unitRef="pure">0.0209</us-gaap:GeneralAndAdministrativeExpenseRatio>
    <cik0001793497:BrokerageCommissionsRate contextRef="c97" decimals="4" unitRef="pure">0.02</cik0001793497:BrokerageCommissionsRate>
    <cik0001793497:BrokerageCommissionsRate contextRef="c98" decimals="4" unitRef="pure">0.0281</cik0001793497:BrokerageCommissionsRate>
    <us-gaap:InvestmentCompanyMarketValuePerShare contextRef="c30" decimals="2" unitRef="usdPershares">14.63</us-gaap:InvestmentCompanyMarketValuePerShare>
    <us-gaap:InvestmentCompanyMarketValuePerShare
      contextRef="c7"
      decimals="2"
      id="ix_63_fact"
      unitRef="usdPershares">29.25</us-gaap:InvestmentCompanyMarketValuePerShare>
    <us-gaap:InvestmentCompanyMarketValuePerShare contextRef="c102" decimals="2" unitRef="usdPershares">15</us-gaap:InvestmentCompanyMarketValuePerShare>
    <us-gaap:InvestmentCompanyMarketValuePerShare contextRef="c23" decimals="2" unitRef="usdPershares">75</us-gaap:InvestmentCompanyMarketValuePerShare>
    <us-gaap:InvestmentCompanyGainLossOnInvestmentPerShare
      contextRef="c25"
      decimals="2"
      id="ix_23_fact"
      unitRef="usdPershares">-0.17</us-gaap:InvestmentCompanyGainLossOnInvestmentPerShare>
    <us-gaap:InvestmentCompanyGainLossOnInvestmentPerShare
      contextRef="c13"
      decimals="2"
      id="ix_24_fact"
      unitRef="usdPershares">-0.08</us-gaap:InvestmentCompanyGainLossOnInvestmentPerShare>
    <us-gaap:InvestmentCompanyGainLossOnInvestmentPerShare
      contextRef="c75"
      decimals="2"
      id="ix_25_fact"
      unitRef="usdPershares">-0.06</us-gaap:InvestmentCompanyGainLossOnInvestmentPerShare>
    <us-gaap:InvestmentCompanyGainLossOnInvestmentPerShare
      contextRef="c15"
      decimals="2"
      id="ix_26_fact"
      unitRef="usdPershares">-1.2</us-gaap:InvestmentCompanyGainLossOnInvestmentPerShare>
    <cik0001793497:NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts
      contextRef="c25"
      decimals="2"
      id="ix_31_fact"
      unitRef="usdPershares">13.67</cik0001793497:NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts>
    <cik0001793497:NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts
      contextRef="c13"
      decimals="2"
      id="ix_32_fact"
      unitRef="usdPershares">-24.73</cik0001793497:NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts>
    <cik0001793497:NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts
      contextRef="c75"
      decimals="2"
      id="ix_33_fact"
      unitRef="usdPershares">-4.54</cik0001793497:NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts>
    <cik0001793497:NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts
      contextRef="c15"
      decimals="2"
      id="ix_34_fact"
      unitRef="usdPershares">11.8</cik0001793497:NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts>
    <us-gaap:InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease contextRef="c25" decimals="2" unitRef="usdPershares">13.5</us-gaap:InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease>
    <us-gaap:InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease
      contextRef="c13"
      decimals="2"
      id="ix_64_fact"
      unitRef="usdPershares">-24.81</us-gaap:InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease>
    <us-gaap:InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease contextRef="c75" decimals="2" unitRef="usdPershares">-4.6</us-gaap:InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease>
    <us-gaap:InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease contextRef="c15" decimals="2" unitRef="usdPershares">10.6</us-gaap:InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease>
    <us-gaap:InvestmentCompanyMarketValuePerShare contextRef="c24" decimals="2" unitRef="usdPershares">28.13</us-gaap:InvestmentCompanyMarketValuePerShare>
    <us-gaap:InvestmentCompanyMarketValuePerShare
      contextRef="c5"
      decimals="2"
      id="ix_65_fact"
      unitRef="usdPershares">4.44</us-gaap:InvestmentCompanyMarketValuePerShare>
    <us-gaap:InvestmentCompanyMarketValuePerShare contextRef="c101" decimals="2" unitRef="usdPershares">10.4</us-gaap:InvestmentCompanyMarketValuePerShare>
    <us-gaap:InvestmentCompanyMarketValuePerShare contextRef="c21" decimals="2" unitRef="usdPershares">85.6</us-gaap:InvestmentCompanyMarketValuePerShare>
    <cik0001793497:MarketValuePerShare contextRef="c24" decimals="2" unitRef="usdPershares">28.07</cik0001793497:MarketValuePerShare>
    <cik0001793497:MarketValuePerShare
      contextRef="c5"
      decimals="2"
      id="ix_66_fact"
      unitRef="usdPershares">4.46</cik0001793497:MarketValuePerShare>
    <cik0001793497:MarketValuePerShare contextRef="c101" decimals="2" unitRef="usdPershares">10.4</cik0001793497:MarketValuePerShare>
    <cik0001793497:MarketValuePerShare contextRef="c21" decimals="2" unitRef="usdPershares">85.4</cik0001793497:MarketValuePerShare>
    <us-gaap:InvestmentCompanyTotalReturn
      contextRef="c25"
      decimals="4"
      id="ix_43_fact"
      unitRef="pure">0.9228</us-gaap:InvestmentCompanyTotalReturn>
    <us-gaap:InvestmentCompanyTotalReturn
      contextRef="c13"
      decimals="4"
      id="ix_44_fact"
      unitRef="pure">-0.8482</us-gaap:InvestmentCompanyTotalReturn>
    <us-gaap:InvestmentCompanyTotalReturn
      contextRef="c75"
      decimals="4"
      id="ix_45_fact"
      unitRef="pure">-0.3067</us-gaap:InvestmentCompanyTotalReturn>
    <us-gaap:InvestmentCompanyTotalReturn
      contextRef="c15"
      decimals="4"
      id="ix_46_fact"
      unitRef="pure">0.1413</us-gaap:InvestmentCompanyTotalReturn>
    <cik0001793497:TotalReturnAtMarketValue
      contextRef="c25"
      decimals="4"
      id="ix_47_fact"
      unitRef="pure">0.9147</cik0001793497:TotalReturnAtMarketValue>
    <cik0001793497:TotalReturnAtMarketValue
      contextRef="c13"
      decimals="4"
      id="ix_48_fact"
      unitRef="pure">-0.8467</cik0001793497:TotalReturnAtMarketValue>
    <cik0001793497:TotalReturnAtMarketValue
      contextRef="c75"
      decimals="4"
      id="ix_49_fact"
      unitRef="pure">-0.3067</cik0001793497:TotalReturnAtMarketValue>
    <cik0001793497:TotalReturnAtMarketValue
      contextRef="c15"
      decimals="4"
      id="ix_50_fact"
      unitRef="pure">0.1387</cik0001793497:TotalReturnAtMarketValue>
    <us-gaap:InvestmentCompanyExpenseRatioAfterIncentiveAllocation
      contextRef="c25"
      decimals="4"
      id="ix_55_fact"
      unitRef="pure">0.0225</us-gaap:InvestmentCompanyExpenseRatioAfterIncentiveAllocation>
    <us-gaap:InvestmentCompanyExpenseRatioAfterIncentiveAllocation
      contextRef="c13"
      decimals="4"
      id="ix_56_fact"
      unitRef="pure">0.0213</us-gaap:InvestmentCompanyExpenseRatioAfterIncentiveAllocation>
    <us-gaap:InvestmentCompanyExpenseRatioAfterIncentiveAllocation
      contextRef="c75"
      decimals="4"
      id="ix_57_fact"
      unitRef="pure">0.0218</us-gaap:InvestmentCompanyExpenseRatioAfterIncentiveAllocation>
    <us-gaap:InvestmentCompanyExpenseRatioAfterIncentiveAllocation
      contextRef="c15"
      decimals="4"
      id="ix_58_fact"
      unitRef="pure">0.0291</us-gaap:InvestmentCompanyExpenseRatioAfterIncentiveAllocation>
    <us-gaap:InvestmentCompanyTotalReturnAfterIncentiveFees
      contextRef="c25"
      decimals="4"
      id="ix_59_fact"
      unitRef="pure">-0.0184</us-gaap:InvestmentCompanyTotalReturnAfterIncentiveFees>
    <us-gaap:InvestmentCompanyTotalReturnAfterIncentiveFees
      contextRef="c13"
      decimals="4"
      id="ix_60_fact"
      unitRef="pure">-0.0135</us-gaap:InvestmentCompanyTotalReturnAfterIncentiveFees>
    <us-gaap:InvestmentCompanyTotalReturnAfterIncentiveFees
      contextRef="c75"
      decimals="4"
      id="ix_61_fact"
      unitRef="pure">-0.005</us-gaap:InvestmentCompanyTotalReturnAfterIncentiveFees>
    <us-gaap:InvestmentCompanyTotalReturnAfterIncentiveFees
      contextRef="c15"
      decimals="4"
      id="ix_62_fact"
      unitRef="pure">-0.0067</us-gaap:InvestmentCompanyTotalReturnAfterIncentiveFees>
    <us-gaap:ConcentrationRiskDisclosureTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;NOTE 8 &#x2013; RISK&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Correlation and Compounding Risk&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;The Funds do not seek to achieve their stated investment objective over a period
of time greater than a single day (as measured from NAV calculation time to NAV calculation time). The return of a Fund for a period longer
than a single day is the result of its return for each day compounded over the period and usually will differ in amount and possibly even
direction from the inverse (-1x) or two times (2x) the return of the Fund&#x2019;s benchmark for the period. A Fund will lose money if
its benchmark performance is flat over time, and it is possible for a Fund to lose money over time even if the performance of its benchmark
increases in the case of UVIX (or decreases in the case of SVIX), as a result of daily rebalancing, the benchmark&#x2019;s volatility,
compounding, and other factors. Compounding is the cumulative effect of applying investment gains and losses and income to the principal
amount invested over time. Gains or losses experienced over a given period will increase or reduce the principal amount invested from
which the subsequent period&#x2019;s returns are calculated. The effects of compounding will likely cause the performance of a Fund to
differ from the Fund&#x2019;s stated multiple times the return of its benchmark for the same period. The effect of compounding becomes
more pronounced as benchmark volatility and holding period increase. The impact of compounding will impact each shareholder differently
depending on the period of time an investment in a Fund is held and the volatility of the benchmark during the holding period of an investment
in the Fund. Longer holding periods, higher benchmark volatility, inverse exposure and greater leverage each affect the impact of compounding
on a Fund&#x2019;s returns. Daily compounding of a Fund&#x2019;s investment returns can dramatically and adversely affect its longer-term
performance during periods of high volatility. Volatility may be at least as important to a Fund&#x2019;s return for a period as the return
of the Fund&#x2019;s underlying benchmark.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Each Fund uses leverage and should produce daily returns that are more volatile than that of
its benchmark. For example, the daily return of UVIX should be approximately two times as volatile on a daily basis as is the return of
a fund with an objective of matching the same benchmark. The daily return of SVIX is designed to return the inverse (-1x) of the return
that would be expected of a fund with an objective of matching the same benchmark. The Funds are not appropriate for all investors and
present significant risks not applicable to other types of funds. The Funds use leverage and are riskier than similarly benchmarked exchange-traded
funds that do not use leverage. An investor should only consider an investment in a Fund if he or she understands the consequences of
seeking daily leveraged or daily inverse investment results. Shareholders who invest in the Funds should actively manage and monitor their
investments, as frequently as daily.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;While the Funds seek to meet their investment objectives, there is no guarantee they will do so.
Factors that may affect a Fund&#x2019;s ability to meet its investment objective include: (1) the Sponsor&#x2019;s ability to purchase and
sell Financial Instruments in a manner that correlates to a Fund&#x2019;s objective; (2) an imperfect correlation between the performance
of Financial Instruments held by a Fund and the performance of the applicable benchmark; (3) bid-ask spreads on such Financial Instruments;
(4) fees, expenses, transaction costs, financing costs associated with the use of Financial Instruments and commission costs; (5) holding
or trading instruments in a market that has become illiquid or disrupted; (6) a Fund&#x2019;s Share prices being rounded to the nearest
cent and/or valuation methodology; (7) changes to a benchmark Index that are not disseminated in advance; (8) the need to conform a Fund&#x2019;s
portfolio holdings to comply with investment restrictions or policies or regulatory or tax law requirements; (9) early and unanticipated
closings of the markets on which the holdings of a Fund trade, resulting in the inability of the Fund to execute intended portfolio transactions;
(10) accounting standards; and (11) differences caused by a Fund obtaining exposure to only a representative sample of the components
of a benchmark, over weighting or under weighting certain components of a benchmark or obtaining exposure to assets that are not included
in a benchmark.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;A number of factors may affect a Fund&#x2019;s ability to achieve a high degree of correlation with its benchmark, and
there can be no guarantee that a Fund will achieve a high degree of correlation. Failure to achieve a high degree of correlation may prevent
a Fund from achieving its investment objective. In order to achieve a high degree of correlation with their underlying benchmarks, the
Funds seek to rebalance their portfolios daily to keep exposure consistent with their investment objectives. Being materially under- or
over-exposed to the benchmark may prevent such Funds from achieving a high degree of correlation with such benchmark. Market disruptions
or closure, large amounts of assets into or out of the Funds, regulatory restrictions, extreme market volatility, and other factors will
adversely affect such Funds&#x2019; ability to adjust exposure to requisite levels. The target amount of portfolio exposure is impacted
dynamically by the benchmarks&#x2019; movements during each day. Other things being equal, more significant movement in the value of its
benchmark up or down will require more significant adjustments to a Fund&#x2019;s portfolio. Because of this, it is unlikely that the Funds
will be perfectly exposed (i.e., --1x, -2x, as applicable) to its benchmark at the end of each day, and the likelihood of being materially
under- or over-exposed is higher on days when the benchmark levels are volatile near the close of the trading day.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Each Fund seeks to
rebalance its portfolio on a daily basis. The time and manner in which a Fund rebalances its portfolio may vary from day to day depending
upon market conditions and other circumstances at the discretion of the Sponsor. Unlike other funds that do not rebalance their portfolios
as frequently, each Fund may be subject to increased trading costs associated with daily portfolio rebalancing in order to maintain appropriate
exposure to the underlying benchmarks.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"&gt;Counterparty Risk&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Each Fund may use derivatives such
as swap agreements and forward contracts (collectively referred to herein as &#x201c;derivatives&#x201d;) in the manner described herein
as a means to achieve their respective investment objectives. The use of derivatives by a Fund exposes the Fund to counterparty risks.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;Regulatory Treatment&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Derivatives are generally traded
in OTC markets and have only recently become subject to comprehensive regulation in the United States. Cash- settled forwards are generally
regulated as &#x201c;swaps&#x201d;, whereas physically settled forwards are generally not subject to regulation (in the case of commodities
other than currencies) or subject to the federal securities laws (in the case of securities). Title VII of the Dodd-Frank Act (&#x201c;Title
VII&#x201d;) created a regulatory regime for derivatives, with the CFTC responsible for the regulation of swaps and the SEC responsible
for the regulation of &#x201c;security-based swaps.&#x201d; The SEC requirements have largely yet to be made effective, but the CFTC requirements
are largely in place. The CFTC requirements have included rules for some of the types of transactions in which the Funds will engage,
including mandatory clearing and exchange trading, reporting, and margin for OTC swaps. Title VII also created new categories of regulated
market participants, such as &#x201c;swap dealers,&#x201d; &#x201c;security- based swap dealers,&#x201d; &#x201c;major swap participants,&#x201d;
and &#x201c;major security-based swap participants&#x201d; who are, or will be, subject to significant new capital, registration, recordkeeping,
reporting, disclosure, business conduct and other regulatory requirements. The regulatory requirements under Title VII continue to be
developed and there may be further modifications that could materially and adversely impact the Funds, the markets in which a Fund trades
and the counterparties with which the Fund engages in transactions.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;As noted, the CFTC rules may not
apply to all of the swap agreements and forward contracts entered into by the Funds. Investors, therefore, may not receive the protection
of CFTC regulation or the statutory scheme of the Commodity Exchange Act (the &#x201c;CEA&#x201d;) in connection with each Fund&#x2019;s
swap agreements or forward contracts. The lack of regulation in these markets could expose investors to significant losses under certain
circumstances, including in the event of trading abuses or financial failure by participants.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;Counterparty Credit Risk&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;The Funds will be subject to the
credit risk of the counterparties to the derivatives. In the case of cleared derivatives, the Funds will have credit risk to the clearing
corporation in a similar manner as the Funds would for futures contracts. In the case of OTC derivatives, the Funds will be subject to
the credit risk of the counterparty to the transaction &#x2013; typically a single bank or financial institution. As a result, a Fund is
subject to increased credit risk with respect to the amount it expects to receive from counterparties to OTC derivatives entered into
as part of that Fund&#x2019;s principal investment strategy. If a counterparty becomes bankrupt or otherwise fails to perform its obligations
due to financial difficulties, a Fund could suffer significant losses on these contracts and the value of an investor&#x2019;s investment
in a Fund may decline.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;The Funds have sought to mitigate
these risks by generally requiring that the counterparties for each Fund agree to post collateral for the benefit of the Fund, marked
to market daily, subject to certain minimum thresholds. However, there are no limitations on the percentage of assets each Fund may invest
in swap agreements or forward contracts with a particular counterparty. To the extent any such collateral is insufficient or there are
delays in accessing the collateral, the Funds will be exposed to counterparty risk as described above, including possible delays in recovering
amounts as a result of bankruptcy proceedings. The Funds typically enter into transactions only with major global financial institutions.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;OTC derivatives of the type that
may be utilized by the Funds are generally less liquid than futures contracts because they are not traded on an exchange, do not have
uniform terms and conditions, and are generally entered into based upon the creditworthiness of the parties and the availability of credit
support, such as collateral, and in general, are not transferable without the consent of the counterparty. These agreements contain various
conditions, events of default, termination events, covenants and representations. The triggering of certain events or the default on certain
terms of the agreement could allow a party to terminate a transaction under the agreement and request immediate payment in an amount equal
to the net positions owed to the party under the agreement. For example, if the level of the Fund&#x2019;s benchmark has a dramatic intraday
move that would cause a material decline in the Fund&#x2019;s NAV, the terms of the swap may permit the counterparty to immediately close
out the transaction with the Fund. In that event, it may not be possible for the Fund to enter into another swap or to invest in other
Financial Instruments necessary to achieve the desired exposure consistent with the Fund&#x2019;s objective. This, in turn, may prevent
the Fund from achieving its investment objective, particularly if the level of the Fund&#x2019;s benchmark reverses all or part of its
intraday move by the end of the day.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;In addition, cleared derivatives
benefit from daily marking-to-market and settlement, and segregation and minimum capital requirements applicable to intermediaries. To
the extent the Fund enters into cleared swap transactions, the Fund will deposit collateral with a FCM in cleared swaps customer accounts,
which are required by CFTC regulations to be separate from its proprietary collateral posted for cleared swaps transactions. Cleared swap
customer collateral is subject to regulations that closely parallel the regulations governing customer segregated funds for futures transactions
but provide certain additional protections to cleared swaps collateral in the event of a clearing broker or clearing broker customer default.
For example, in the event of a default of both the clearing broker and a customer of the clearing broker, a clearing house is only permitted
to access the cleared swaps collateral in the legally separate (but operationally comingled) account of the defaulting cleared swap customer
of the clearing broker, as opposed to the treatment of customer segregated funds, under which the clearing house may access all of the
commingled customer segregated funds of a defaulting clearing broker. Derivatives entered into directly between two counterparties do
not necessarily benefit from such protections, particularly if entered into with an entity that is not registered as a &#x201c;swap dealer&#x201d;
with the CFTC. This exposes the Funds to the risk that a counterparty will not settle a transaction in accordance with its terms and conditions
because of a dispute over the terms of the contract (whether or not bona fide) or because of a credit or liquidity problem, thus causing
the Funds to suffer a loss.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;The Sponsor regularly reviews the performance of its counterparties
for, among other things, creditworthiness and execution quality. In addition, the Sponsor periodically considers the addition of new counterparties
and the counterparties used by a Fund may change at any time. Each day, the Funds disclose their portfolio holdings as of the prior Business
Day. Each Fund&#x2019;s portfolio holdings identifies its counterparties, as applicable. This portfolio holdings information may be accessed
through the web on the Sponsor&#x2019;s website at www.volatilityshares.com.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Each counterparty and/or any of its affiliates may be an
Authorized Participant or shareholder of a Fund, subject to applicable law.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;The counterparty risk for cleared derivatives
transactions is generally lower than for OTC derivatives. Once a transaction is cleared, the clearing organization is substituted and
is a Fund&#x2019;s counterparty on the derivative. The clearing organization guarantees the performance of the other side of the derivative.
Nevertheless, some risk remains, as there is no assurance that the clearing organization, or its members, will satisfy its obligations
to a Fund.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"&gt;Leverage Risk&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;The Funds
may utilize leverage in seeking to achieve their respective investment objectives and will lose more money in market environments adverse
to their respective daily investment objectives than funds that do not employ leverage. The use of leveraged and/or inverse leveraged
positions increases the risk of total loss of an investor&#x2019;s investment, even over periods as short as a single day.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;For example, because UVIX includes
a two times (2x) multiplier, a single-day movement in the relevant benchmark approaching 50% at any point in the day could result in the
total loss or almost total loss of an investor&#x2019;s investment if that movement is contrary to the investment objective of the Fund
in which an investor has invested, even if such Fund&#x2019;s benchmark subsequently moves in an opposite direction, eliminating all or
a portion of the movement. This would be the case with downward single-day or intraday movements in the underlying benchmark of a Fund
or upward single-day or intraday movements in the benchmark of a Fund, even if the underlying benchmark maintains a level greater than
zero at all times.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"&gt;Liquidity Risk&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Financial Instruments cannot always
be liquidated at the desired price. It is difficult to execute a trade at a specific price when there is a relatively small volume of
buy and sell orders in a market. A market disruption can also make it difficult to liquidate a position or find a swap or forward contract
counterparty at a reasonable cost. Market illiquidity may cause losses for the Funds. The large size of the positions which the Funds
may acquire increases the risk of illiquidity by both making their positions more difficult to liquidate and increasing the losses incurred
while trying to do so. Any type of disruption or illiquidity will potentially be exacerbated due to the fact that the Funds will typically
invest in Financial Instruments related to one benchmark, which in many cases is highly concentrated.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"&gt;&#x201c;Contango&#x201d; and &#x201c;Backwardation&#x201d;
Risk&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;The Funds typically hold futures
contracts. As the futures contracts near expiration, they are generally replaced by contracts that have a later expiration. Thus, for
example, a contract purchased and held in November 2019 may specify a January 2020 expiration. As that contract nears expiration, it may
be replaced by selling the January 2020 contract and purchasing the contract expiring in March 2020. This process is referred to as &#x201c;rolling.&#x201d;
Rolling may have a positive or negative impact on performance. For example, historically, the prices of certain types of futures contracts
have frequently been higher for contracts with shorter-term expirations than for contracts with longer-term expirations, which is referred
to as &#x201c;backwardation.&#x201d; In these circumstances, absent other factors, the sale of the January 2020 contract would take place
at a price that is higher than the price at which the March 2020 contract is purchased, thereby creating a gain in connection with rolling.
While certain types of futures contracts have historically exhibited consistent periods of backwardation, backwardation will likely not
exist in these markets at all times.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Since the introduction of VIX
futures contracts, there have frequently been periods where VIX futures prices reflect higher expected volatility levels further out in
time. This can result in a loss from &#x201c;rolling&#x201d; the VIX futures to maintain the constant weighted average maturity of the applicable
Fund benchmark. Losses from exchanging a lower priced VIX future for a higher priced longer-term future in the rolling process could adversely
affect the value of a Fund and, accordingly, decrease the return of a Fund.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"&gt;Natural Disaster/Epidemic Risk&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Natural or environmental disasters,
such as earthquakes, fires, floods, hurricanes, tsunamis and other severe weather-related phenomena generally, and widespread disease,
including pandemics and epidemics (for example, the novel coronavirus COVID-19), have been and can be highly disruptive to economies and
markets and have recently led, and may continue to lead, to increased market volatility and significant market losses. Such natural disaster
and health crises could exacerbate political, social, and economic risks previously mentioned, and result in significant breakdowns, delays,
shutdowns, social isolation, and other disruptions to important global, local and regional supply chains affected, with potential corresponding
results on the operating performance of the Funds and their investments. A climate of uncertainty and panic, including the contagion of
infectious viruses or diseases, may adversely affect global, regional, and local economies and reduce the availability of potential investment
opportunities, and increases the difficulty of performing due diligence and modeling market conditions, potentially reducing the accuracy
of financial projections. Under these circumstances, the Funds may have difficulty achieving their investment objectives which may adversely
impact performance. Further, such events can be highly disruptive to economies and markets, significantly disrupt the operations of individual
companies (including, but not limited to, the Funds&#x2019; Sponsor and third party service providers), sectors, industries, markets, securities
and commodity exchanges, currencies, interest and inflation rates, credit ratings, investor sentiment, and other factors affecting the
value of the Funds&#x2019; investments. These factors can cause substantial market volatility, exchange trading suspensions and closures
and can impact the ability of the Funds to complete redemptions and otherwise affect Fund performance and Fund trading in the secondary
market. A widespread crisis may also affect the global economy in ways that cannot necessarily be foreseen at the current time. How long
such events will last and whether they will continue or recur cannot be predicted. Impacts from these events could have significant impact
on a Fund&#x2019;s performance, resulting in losses to your investment.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"&gt;Risk that Current Assumptions and Expectations Could
Become Outdated As a Result of Global Economic Shocks&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;The onset of the novel coronavirus
(COVID-19) has caused significant shocks to global financial markets and economies, with many governments taking extreme actions to slow
and contain the spread of COVID-19. These actions have had, and likely will continue to have, a severe economic impact on global economies
as economic activity in some instances has essentially ceased. Financial markets across the globe are experiencing severe distress at
least equal to what was experienced during the global financial crisis in 2008. In March 2020, U.S. equity markets entered a bear market
in the fastest such move in the history of U.S. financial markets. Contemporaneous with the onset of the COVID-19 pandemic in the US,
oil experienced shocks to supply and demand, impacting the price and volatility of oil. The global economic shocks being experienced as
of the date hereof may cause the underlying assumptions and expectations of the Funds to become outdated quickly or inaccurate, resulting
in significant losses.&lt;/p&gt;</us-gaap:ConcentrationRiskDisclosureTextBlock>
    <cik0001793497:RelevantBenchmark contextRef="c0" decimals="2" unitRef="pure">0.50</cik0001793497:RelevantBenchmark>
    <us-gaap:SubsequentEventsTextBlock contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"&gt;NOTE 9 &#x2013; SUBSEQUENT EVENTS&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Management has evaluated the possibility
of subsequent events existing in the Trust&#x2019;s and the Funds&#x2019; financial statements through the date the financial statements
were issued. Management has determined that there are no material events that would require disclosure in the Trust&#x2019;s or the Funds&#x2019;
financial statements through this date.&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <dei:CurrentFiscalYearEndDate contextRef="c0" id="hidden-fact-0">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="c4"
      id="hidden-fact-1"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="c5"
      id="hidden-fact-2"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="c7"
      id="hidden-fact-3"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:InvestmentOwnedAtFairValue
      contextRef="c4"
      id="hidden-fact-4"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:InvestmentOwnedAtFairValue
      contextRef="c6"
      id="hidden-fact-5"
      unitRef="usd"
      xsi:nil="true"/>
    <cik0001793497:ReceivableForSharesSold
      contextRef="c6"
      id="hidden-fact-6"
      unitRef="usd"
      xsi:nil="true"/>
    <cik0001793497:VariationMarginReceivable
      contextRef="c5"
      id="hidden-fact-7"
      unitRef="usd"
      xsi:nil="true"/>
    <cik0001793497:DueFromOther
      contextRef="c4"
      id="hidden-fact-8"
      unitRef="usd"
      xsi:nil="true"/>
    <cik0001793497:DueFromOther
      contextRef="c5"
      id="hidden-fact-9"
      unitRef="usd"
      xsi:nil="true"/>
    <cik0001793497:DueFromOther
      contextRef="c7"
      id="hidden-fact-10"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AccountsPayableCurrent
      contextRef="c4"
      id="hidden-fact-11"
      unitRef="usd"
      xsi:nil="true"/>
    <cik0001793497:FundSharesRedeemed
      contextRef="c4"
      id="hidden-fact-12"
      unitRef="usd"
      xsi:nil="true"/>
    <cik0001793497:FundSharesRedeemed
      contextRef="c7"
      id="hidden-fact-13"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:OtherInvestmentsAndSecuritiesAtCost
      contextRef="c4"
      id="hidden-fact-14"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:OtherIncome
      contextRef="c8"
      id="hidden-fact-15"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:OtherIncome
      contextRef="c9"
      id="hidden-fact-16"
      unitRef="usd"
      xsi:nil="true"/>
    <cik0001793497:ShortTermInvestmentsRealized
      contextRef="c8"
      id="hidden-fact-17"
      unitRef="usd"
      xsi:nil="true"/>
    <cik0001793497:ShortTermInvestmentsRealized
      contextRef="c9"
      id="hidden-fact-18"
      unitRef="usd"
      xsi:nil="true"/>
    <cik0001793497:ShortTermInvestmentsRealized
      contextRef="c10"
      id="hidden-fact-19"
      unitRef="usd"
      xsi:nil="true"/>
    <cik0001793497:ShortTermInvestmentsRealized
      contextRef="c11"
      id="hidden-fact-20"
      unitRef="usd"
      xsi:nil="true"/>
    <cik0001793497:ShortTermInvestmentsUnrealized
      contextRef="c8"
      id="hidden-fact-21"
      unitRef="usd"
      xsi:nil="true"/>
    <cik0001793497:ShortTermInvestmentsUnrealized
      contextRef="c9"
      id="hidden-fact-22"
      unitRef="usd"
      xsi:nil="true"/>
    <cik0001793497:ShortTermInvestmentsUnrealized
      contextRef="c10"
      id="hidden-fact-23"
      unitRef="usd"
      xsi:nil="true"/>
    <cik0001793497:ShortTermInvestmentsUnrealized
      contextRef="c11"
      id="hidden-fact-24"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:OtherInterestAndDividendIncome
      contextRef="c12"
      id="hidden-fact-25"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:OtherInterestAndDividendIncome
      contextRef="c13"
      id="hidden-fact-26"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:OtherInterestAndDividendIncome
      contextRef="c14"
      id="hidden-fact-27"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:OtherInterestAndDividendIncome
      contextRef="c15"
      id="hidden-fact-28"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInEarnestMoneyDepositsOutstanding
      contextRef="c10"
      id="hidden-fact-29"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInPrepaidExpensesOther
      contextRef="c9"
      id="hidden-fact-30"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="c9"
      id="hidden-fact-31"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInCustomerAdvances
      contextRef="c8"
      id="hidden-fact-32"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInCustomerAdvances
      contextRef="c9"
      id="hidden-fact-33"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInCustomerAdvances
      contextRef="c10"
      id="hidden-fact-34"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent
      contextRef="c8"
      id="hidden-fact-35"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent
      contextRef="c11"
      id="hidden-fact-36"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="c10"
      id="hidden-fact-37"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="c11"
      id="hidden-fact-38"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="c8"
      id="hidden-fact-39"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="c9"
      id="hidden-fact-40"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="c16"
      id="hidden-fact-41"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="c17"
      id="hidden-fact-42"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="c4"
      id="hidden-fact-43"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInPrepaidExpensesOther
      contextRef="c14"
      id="hidden-fact-44"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInOtherReceivables
      contextRef="c14"
      id="hidden-fact-45"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInOtherReceivables
      contextRef="c15"
      id="hidden-fact-46"
      unitRef="usd"
      xsi:nil="true"/>
    <cik0001793497:IncreaseDecreaseInVariationMarginPayable
      contextRef="c14"
      id="hidden-fact-47"
      unitRef="usd"
      xsi:nil="true"/>
    <cik0001793497:IncreaseDecreaseInVariationMarginPayable
      contextRef="c15"
      id="hidden-fact-48"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="c14"
      id="hidden-fact-49"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="c15"
      id="hidden-fact-50"
      unitRef="usd"
      xsi:nil="true"/>
    <cik0001793497:IncreaseDecreaseInDueToCustodian
      contextRef="c14"
      id="hidden-fact-51"
      unitRef="usd"
      xsi:nil="true"/>
    <cik0001793497:IncreaseDecreaseInDueToCustodian
      contextRef="c15"
      id="hidden-fact-52"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInCustomerAdvances
      contextRef="c14"
      id="hidden-fact-53"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent
      contextRef="c15"
      id="hidden-fact-54"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="c13"
      id="hidden-fact-55"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="c7"
      id="hidden-fact-56"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="c22"
      id="hidden-fact-57"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="c23"
      id="hidden-fact-58"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="c4"
      id="hidden-fact-59"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="c5"
      id="hidden-fact-60"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:OtherInvestments
      contextRef="c24"
      id="hidden-fact-61"
      unitRef="usd"
      xsi:nil="true"/>
    <cik0001793497:AmountOfTotalTrust
      contextRef="c50"
      id="hidden-fact-62"
      unitRef="usd"
      xsi:nil="true"/>
    <cik0001793497:TotalTrust contextRef="c61" id="hidden-fact-63">$6,518,579</cik0001793497:TotalTrust>
    <cik0001793497:TotalTrust contextRef="c63" id="hidden-fact-64">$6,518,579</cik0001793497:TotalTrust>
    <cik0001793497:TotalTrust1 contextRef="c64" id="hidden-fact-65">$(19,791,036)</cik0001793497:TotalTrust1>
    <cik0001793497:TotalTrust contextRef="c65" id="hidden-fact-66">$1,156,106</cik0001793497:TotalTrust>
    <cik0001793497:TotalTrust contextRef="c67" id="hidden-fact-67">$1,156,106</cik0001793497:TotalTrust>
    <cik0001793497:TotalTrust1 contextRef="c68" id="hidden-fact-68">$(9,203,522)</cik0001793497:TotalTrust1>
    <cik0001793497:GrossAmountsOffsetInTheStatementsOfFinancialCondition
      contextRef="c77"
      id="hidden-fact-69"
      unitRef="usd"
      xsi:nil="true"/>
    <cik0001793497:GrossAmountsOfRecognizedLiabilitiesPresentedInTheStatementsOfFinancialCondition
      contextRef="c78"
      id="hidden-fact-70"
      unitRef="usd"
      xsi:nil="true"/>
    <cik0001793497:GrossAmountsOffsetInTheStatementsOfFinancialCondition1
      contextRef="c78"
      id="hidden-fact-71"
      unitRef="usd"
      xsi:nil="true"/>
    <cik0001793497:NetAmountsOfLiabilitiesPresentedInTheStatementsOfFinancialCondition
      contextRef="c79"
      id="hidden-fact-72"
      unitRef="usd"
      xsi:nil="true"/>
    <cik0001793497:GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition
      contextRef="c80"
      id="hidden-fact-73"
      unitRef="usd"
      xsi:nil="true"/>
    <cik0001793497:GrossAmountsOffsetInTheStatementsOfFinancialCondition
      contextRef="c80"
      id="hidden-fact-74"
      unitRef="usd"
      xsi:nil="true"/>
    <cik0001793497:NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition
      contextRef="c80"
      id="hidden-fact-75"
      unitRef="usd"
      xsi:nil="true"/>
    <cik0001793497:GrossAmountsOffsetInTheStatementsOfFinancialCondition1
      contextRef="c81"
      id="hidden-fact-76"
      unitRef="usd"
      xsi:nil="true"/>
    <cik0001793497:GrossAmountsOffsetInTheStatementsOfFinancialCondition
      contextRef="c83"
      id="hidden-fact-77"
      unitRef="usd"
      xsi:nil="true"/>
    <cik0001793497:GrossAmountsOffsetInTheStatementsOfFinancialCondition1
      contextRef="c84"
      id="hidden-fact-78"
      unitRef="usd"
      xsi:nil="true"/>
    <cik0001793497:GrossAmountsOffsetInTheStatementsOfFinancialCondition
      contextRef="c86"
      id="hidden-fact-79"
      unitRef="usd"
      xsi:nil="true"/>
    <cik0001793497:GrossAmountsOffsetInTheStatementsOfFinancialCondition1
      contextRef="c87"
      id="hidden-fact-80"
      unitRef="usd"
      xsi:nil="true"/>
    <cik0001793497:FinancialInstrumentsForTheBenefitOftheFundsTheCounterpartiesTwo
      contextRef="c12"
      id="hidden-fact-81"
      unitRef="usd"
      xsi:nil="true"/>
    <cik0001793497:CashCollateralForTheBenefitOftheFundsTheCounterparties
      contextRef="c12"
      id="hidden-fact-82"
      unitRef="usd"
      xsi:nil="true"/>
    <cik0001793497:FinancialInstrumentsForTheBenefitOftheFundsTheCounterpartiesTwo
      contextRef="c13"
      id="hidden-fact-83"
      unitRef="usd"
      xsi:nil="true"/>
    <cik0001793497:CashCollateralForTheBenefitOftheFundsTheCounterparties
      contextRef="c13"
      id="hidden-fact-84"
      unitRef="usd"
      xsi:nil="true"/>
    <dei:AmendmentFlag contextRef="c0">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus contextRef="c0">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="c0">0001793497</dei:EntityCentralIndexKey>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#ix_0_fact"
          xlink:label="ix_0_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-5"
          xlink:label="hidden-fact-5"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-4"
          xlink:label="hidden-fact-4"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_1_fact"
          xlink:label="ix_1_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_0_footnote" xlink:label="ix_0_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Investments in securities, at cost</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_0_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-5"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-4"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_1_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_4_fact"
          xlink:label="ix_4_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_2_fact"
          xlink:label="ix_2_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_5_fact"
          xlink:label="ix_5_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_3_fact"
          xlink:label="ix_3_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_1_footnote" xlink:label="ix_1_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">No Par Value</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_4_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_2_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_5_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_3_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_6_fact"
          xlink:label="ix_6_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_2_footnote" xlink:label="ix_2_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">$68,703,813 of cash is pledged as collateral for futures
contracts.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_6_fact"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_7_fact"
          xlink:label="ix_7_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_8_fact"
          xlink:label="ix_8_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_3_footnote" xlink:label="ix_3_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$48,144,554
of cash os pledged as collateral for futures contracts</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_7_fact"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_8_fact"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_9_fact"
          xlink:label="ix_9_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_4_footnote" xlink:label="ix_4_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents annualized seven-day yield at June 30, 2023 (Unaudited)</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_9_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_10_fact"
          xlink:label="ix_10_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_5_footnote" xlink:label="ix_5_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents annualized seven-day yield at December 31, 2022</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_10_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_11_fact"
          xlink:label="ix_11_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_6_footnote" xlink:label="ix_6_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">$83,302,779 of cash is pledged as collateral for futures
contracts.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_11_fact"
          xlink:to="ix_6_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_12_fact"
          xlink:label="ix_12_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_7_footnote" xlink:label="ix_7_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">$114,821,272 of cash is pledged as collateral for futures contracts.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_12_fact"
          xlink:to="ix_7_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_15_fact"
          xlink:label="ix_15_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_16_fact"
          xlink:label="ix_16_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_13_fact"
          xlink:label="ix_13_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_18_fact"
          xlink:label="ix_18_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_14_fact"
          xlink:label="ix_14_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_17_fact"
          xlink:label="ix_17_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_8_footnote" xlink:label="ix_8_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Includes cumulative appreciation (depreciation) of futures
contracts as reported in the Schedule of Investments. Only current day&#x2019;s variation margin is reported within the Statements of
Financial Condition in receivable/payable on open futures.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_15_fact"
          xlink:to="ix_8_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_16_fact"
          xlink:to="ix_8_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_13_fact"
          xlink:to="ix_8_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_18_fact"
          xlink:to="ix_8_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_14_fact"
          xlink:to="ix_8_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_17_fact"
          xlink:to="ix_8_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_22_fact"
          xlink:label="ix_22_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_26_fact"
          xlink:label="ix_26_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_24_fact"
          xlink:label="ix_24_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_23_fact"
          xlink:label="ix_23_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_25_fact"
          xlink:label="ix_25_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_20_fact"
          xlink:label="ix_20_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_19_fact"
          xlink:label="ix_19_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_21_fact"
          xlink:label="ix_21_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_9_footnote" xlink:label="ix_9_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Net investment loss per share represents net investment loss
divided by the daily average shares of beneficial interest outstanding during the period.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_22_fact"
          xlink:to="ix_9_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_26_fact"
          xlink:to="ix_9_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_24_fact"
          xlink:to="ix_9_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_23_fact"
          xlink:to="ix_9_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_25_fact"
          xlink:to="ix_9_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_20_fact"
          xlink:to="ix_9_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_19_fact"
          xlink:to="ix_9_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_21_fact"
          xlink:to="ix_9_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_28_fact"
          xlink:label="ix_28_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_31_fact"
          xlink:label="ix_31_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_29_fact"
          xlink:label="ix_29_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_33_fact"
          xlink:label="ix_33_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_30_fact"
          xlink:label="ix_30_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_27_fact"
          xlink:label="ix_27_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_34_fact"
          xlink:label="ix_34_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_32_fact"
          xlink:label="ix_32_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_10_footnote" xlink:label="ix_10_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Due to timing of capital share transactions, per share amounts
may not compare with amounts appearing elsewhere within these Financial Statements.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_28_fact"
          xlink:to="ix_10_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_31_fact"
          xlink:to="ix_10_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_29_fact"
          xlink:to="ix_10_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_33_fact"
          xlink:to="ix_10_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_30_fact"
          xlink:to="ix_10_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_27_fact"
          xlink:to="ix_10_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_34_fact"
          xlink:to="ix_10_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_32_fact"
          xlink:to="ix_10_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_50_fact"
          xlink:label="ix_50_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_43_fact"
          xlink:label="ix_43_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_39_fact"
          xlink:label="ix_39_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_42_fact"
          xlink:label="ix_42_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_45_fact"
          xlink:label="ix_45_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_37_fact"
          xlink:label="ix_37_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_38_fact"
          xlink:label="ix_38_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_35_fact"
          xlink:label="ix_35_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_44_fact"
          xlink:label="ix_44_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_40_fact"
          xlink:label="ix_40_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_46_fact"
          xlink:label="ix_46_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_48_fact"
          xlink:label="ix_48_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_47_fact"
          xlink:label="ix_47_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_49_fact"
          xlink:label="ix_49_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_36_fact"
          xlink:label="ix_36_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_41_fact"
          xlink:label="ix_41_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_11_footnote" xlink:label="ix_11_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Percentages are not annualized for the period ended June 30,
2023 and June 30, 2022</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_50_fact"
          xlink:to="ix_11_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_43_fact"
          xlink:to="ix_11_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_39_fact"
          xlink:to="ix_11_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_42_fact"
          xlink:to="ix_11_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_45_fact"
          xlink:to="ix_11_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_37_fact"
          xlink:to="ix_11_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_38_fact"
          xlink:to="ix_11_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_35_fact"
          xlink:to="ix_11_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_44_fact"
          xlink:to="ix_11_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_40_fact"
          xlink:to="ix_11_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_46_fact"
          xlink:to="ix_11_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_48_fact"
          xlink:to="ix_11_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_47_fact"
          xlink:to="ix_11_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_49_fact"
          xlink:to="ix_11_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_36_fact"
          xlink:to="ix_11_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_41_fact"
          xlink:to="ix_11_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_54_fact"
          xlink:label="ix_54_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_55_fact"
          xlink:label="ix_55_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_58_fact"
          xlink:label="ix_58_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_53_fact"
          xlink:label="ix_53_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_56_fact"
          xlink:label="ix_56_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_51_fact"
          xlink:label="ix_51_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_52_fact"
          xlink:label="ix_52_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_57_fact"
          xlink:label="ix_57_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_12_footnote" xlink:label="ix_12_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Percentages are annualized.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_54_fact"
          xlink:to="ix_12_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_55_fact"
          xlink:to="ix_12_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_58_fact"
          xlink:to="ix_12_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_53_fact"
          xlink:to="ix_12_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_56_fact"
          xlink:to="ix_12_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_51_fact"
          xlink:to="ix_12_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_52_fact"
          xlink:to="ix_12_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_57_fact"
          xlink:to="ix_12_footnote"
          xlink:type="arc"/>
        <link:footnote id="ix_13_footnote" xlink:label="ix_13_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The expense ratio would be 2.17% and 2.09% respectively, for
the three months ended June 30, 2023, and 2.00% and 2.81% for the three months ended June 30, 2022 if brokerage commissions and futures
and futures account fees were excluded.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_52_fact"
          xlink:to="ix_13_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_53_fact"
          xlink:to="ix_13_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_54_fact"
          xlink:to="ix_13_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_51_fact"
          xlink:to="ix_13_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_61_fact"
          xlink:label="ix_61_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_62_fact"
          xlink:label="ix_62_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_60_fact"
          xlink:label="ix_60_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_59_fact"
          xlink:label="ix_59_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_14_footnote" xlink:label="ix_14_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The expense ratio would be 2.23% and 2.13% respectively, for
the six months ended June 30, 2023, and 2.01% and 2.84% for the six months ended June 30, 2022 if brokerage commissions and futures and
futures account fees were excluded.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_55_fact"
          xlink:to="ix_14_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_61_fact"
          xlink:to="ix_14_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_62_fact"
          xlink:to="ix_14_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_58_fact"
          xlink:to="ix_14_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_60_fact"
          xlink:to="ix_14_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_56_fact"
          xlink:to="ix_14_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_59_fact"
          xlink:to="ix_14_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_57_fact"
          xlink:to="ix_14_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_65_fact"
          xlink:label="ix_65_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_63_fact"
          xlink:label="ix_63_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_66_fact"
          xlink:label="ix_66_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_64_fact"
          xlink:label="ix_64_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_15_footnote" xlink:label="ix_15_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">For 2x Long VIX Futures ETF, fianancial highlights have been
adjusted to reflect a 1:5 reverse stock split occurring on January 25, 2023, as if it occurred at the commencment of operations.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_65_fact"
          xlink:to="ix_15_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_24_fact"
          xlink:to="ix_15_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_60_fact"
          xlink:to="ix_15_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_63_fact"
          xlink:to="ix_15_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_66_fact"
          xlink:to="ix_15_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_44_fact"
          xlink:to="ix_15_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_56_fact"
          xlink:to="ix_15_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_48_fact"
          xlink:to="ix_15_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_64_fact"
          xlink:to="ix_15_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_32_fact"
          xlink:to="ix_15_footnote"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>46
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MS^'^\CS&%1W'M888FPD7%+?XO#,GDK/+*+C LV&__QS[2F""A(/[^KW(,[-
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M1!65@+E_GYLIV'RI'K!Y;>W\+U!+ P04    "  ;:0Y751&OJW<)  "(/0
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MU2[%_[?.(;46UGMOJ7;)%CEEBUVQ=8/6ENO47J[OD3,.V'P/YPQ'1-$A1)9
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M\<+D%0"^O\^R\O-%]8#],;NK?P%02P,$%     @ &VD.5VN2\3OX"P  'TD
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MRZX81]>N)049\.'%TK521=N(B_[JXN#DT,SB'[3(_6[2M.M2X?YW+5W/80:
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M2 C@RT?0#14?-/B4ZI&%F0XU*SOD:(K6/$/>V Y\M&D[.!,TI=Z2)85IX/!
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M(_ 8$X \*/XI<.-4>.?9%.6L803*'G@%+)L@5,0<YJ8EU.^Z&EQ>+Z07.=@
M>@"VI913JNJ$$V)18:?!M"0I18@^"8I2/HF/CE>6O"2J23VD>GQH#+_87&"%
M3S)]J0HQ$>;.84#TE%VC6XL-'*\G:<Z]-IP2K8027<Z$5W*98#Z5.!W(B3R%
M/TIU(RA);IH</&7+514Y,\P_>&ART"=,!H54#-\)<NC(5=?CY)Q-55!U*4N3
M8X%0 L%"$]M&G+"_Z#T"LSO?W'*XFCOH@G$X@+B'VKO!BHH$G0=;$'Y[37=0
MTO5Y8LSPT#[A 85YEGH-NK72Q:,.(-4KF>PWVH9D&4[E;$.I&@,[LA:4+.,P
MBFJJ6NJ%E,U$4:>B.F:LI%6#=T8#E M4N0%B*/?':#SGTR_?/KRD3[,O3T07
MK"2SAWF5%'Q"]4C0&HU)1KE11*!<'44P+-U0D^3/]593E(: Z]NZ*$Y?P^#W
MR2^H)?< )4'E?M)4*4.Y *1KNS50]6-3M]+_= >0XQAE5PB-9H&?/,T U9XH
MH4WYT!"Q(1R&Z7WF!_:IHKX&V6K<I9"Y;""#N]I!,:]A)(;C=-S+UP\O3QO]
MV''[@A@4*?Q1%A ;Q$:Y/"6-&N,9<HV24(9D?-T\9I7Y>\9B1'X'];S QJ\A
M42DEKIP9)6GCO4BJD$$'-S/!]&!A%5DR0:OU($G>#Z&#9J5QJ@XF8*7@(A4O
M)!41ZJ_#JFY99Z1FC13.F0@<(JTPBJ!<?T'P'IQ$8-".O7\!+4NIQEC+&2XK
M.A4ZJ02T!1C(2 ;4ZU!QV^F70OUBN_C8(&QV/&,4[';)X06$-+F<'>FA;(AZ
M-89;\,@OQJ9^ZD 6G:NQBKL1QL:CJ,FU2@%3NA-")T4O8HEJ<W]RSCD=6=6>
M9>%^ ,7FV.]/O *6$P9I7Z]G,81"O.R]/$F6Z#+V0U$CEZBQ)+!=<4<R[Q.R
M"R[F3=6X.='E.F(ZT'13-M.>,!=PWMY6&17V>E6X.%Y7Y:[7LL4G)H$/AXO*
MIS=X\OXF%QP95:)F$G,0-B<.,9X\0&UL[<+RSM*)XK>[#1:>U6!+P\-[]_.;
MOW)68DLA .X14^\EQ\%1@XHO<_0"PQ'L#^+J0@="C<I//RJE^(E=R(44#X#V
MIZ[I0A1$U,6O'37/+B4DBA18L1&(:G)R-< =R5 9VQ[DV& A+N;R4'"&7+[W
M7.:LG_!"_4MYT>/_QXY7??;Q?B*KD\]DM=K#ZH>^G@DIW.80\@.N8S+6?-6S
M/-@J9]B"F=8U;0PM,<T!*&!XIECTRO.F<\ZOUV:*#2JC3II13X\"L":-:-FC
M]#Y)0.X;L'S[#<<ELJ*T=)C07B3<EC/12].&1$P4"7#E*VJTXJ9O%;=GNJ+^
M2[RV49BL^F<XWF>N9WE\#C''U;^6X\FG<ES],QPGI3[ :2Y<M2O3%!*:YH'-
M[RB-,_0[BGKC6E)2#-A@9VP\>KU,!RP5)1H^60=!O2C<[K5:\<QJ!$CBWBP(
MD<0#15U9V"BM<RF 4\(H_KL:(@GGU.'44DYYTB&:T"@"P?1HWWZU7O7#DW.H
M16S/^A-'P+Z *[A]$I="2=*KI"Y).9U> C0&:E0!RHDPB\7TX0H8Q&742@<1
M4T=_%^[R 5E>BE?EEA8</N%<YB/_G%*ML\HJZ5N*V[U]4J$%Q/#(?0*H(1*>
M\ 2)B+*L@>QQ#^!J#J>IH([<8))A4[A@?P9!0AO6J&.9VP=[F%( :L!#LU[K
M@GKJQ?5PAT:O\A6!K"C/!#%C* ,0&7O60@X8UQ639QW5T%UZ@X/F.LX=  #7
MV]X&?!J/\IRQ506(&0\<#<JB(F#/&I-MTN_C"P;]^P,A$9'XL ]TN>K6"\R<
M+:.)H]M"JNXE,R R7E4&N3P6O.<:&1/7R*@&C8R#1L-D?Z/AH#WS3+158BSQ
M*7V;\M$F0Q5M:W^_873V??6.T\M(J.9PZH>[GWM^Z]/:$)7DYX:QT,$F1.NS
ME:,NQ$.!7L^8Q-<?G#7AX%FYYT'I0JOA.#&-1-7-.FZ-74 @;_?V*Y#JB.))
M]E_"F4$8,_95@S)1SZ;@S=/J?=-MVMQ=.>B[^%@[?)Z:PBY!UN6S"3X*Q/",
MU#K[%3L3RGJ!G?N^-!IENL0F<FJ4\M/8-A8NVKBV4(/&C_M];&SG1K0C-*@K
MT]:A+U[)=3%>RMT=0PE$^7'&/N@GX7[IZ^IU7X9LDZ8L<NP ,JX>LXQWEE.2
M>\P-7G!4E,9U?381HBLZR?6C>3'@?)Y,T5&'8&2NLEYG.0<K?-_"=[9+S,O7
M% 54C@!HI9RHXTVJ#V8-@_%@@XD';L=6G6#I)'G;M92_(L2RQX/*G9.(/]SB
M9CC%N,9+OM1^QH4CY9]BQ<:"R@9\*!99$  9*A_)UD/_E%S B(X@"N6,[;>=
M8'\+Y<FX]SZ*U(-Y5,_A) ^*7"++L8.Z7N*[+>$44'H&_$& [\"H7*AQEU+H
M!".T[-.6 35GEF0BS]J0I?CH/0I<PUTYM,,[A^J..C01$2WJIQ[U3GKV7&O%
MH"!*QO9RJL#YE2Y_4Q2D !A)-MVA=$%W/@2BL^0D\W@ZE[2OZNK4@9<XH'*W
MHOP.B5"RE!S3T)+&JL,W3MX,J^_>J.Y1LB"/4LDDD($<+)ILFY7^HF!$DF].
MBMCBF2'%0K!"79 /#B+([5/W!.4,T8532^ PC&Y[',"67NKDC+C([6C6NPC?
MW;DU5JLE!'NQ'QM%D6C!\ *.%T1?,J6;W?TT0ESVC'+_!7CK'=<]%JW4UU'M
M,:[ #*DBP8E]F&M ;72<;$<AYE80NK[<+U#QU.RK?%5-%DC$/<@S51U^08W$
M@+17KXOGYI: T-U1]SS(,,B./#Q\W(F;']T3ZON/?H%&UB7P;!&;MNR_6C)_
M^(35 J'VZS(E(RU*\#ZOXGLU!U@&%3RZ!^0J%6@U>@)].#9/1WU0BG():3_D
M.."=MGOHVJ&[LM$"\2F(OI!C[U#)X!BH]72DUBH; :2^7I,$!% DK0%8?Z3;
MG=:.56W05S>V%5'=W4=Y!15F#1>BB(N>+&QQY/BI=7=1,G*O5-;#9I0R>^S5
MYGOI(!?N+:D*$V[$"8B-:Q&X617;C(<ZC@M0,5DCHE<AH*C9#A7?$!X:&,*%
MW-CFLQ]?F<$+@W2O>1$\D\=>E'MP%P\B6R$J2L9"PABJ&,,Q$^I=QH<:[()W
M"X&(LUACE^X2#=X:]4Y/#9U>.#X(Q"GR 0G&L7UGZ6X 1:>]OU#H[7 H>!=!
MYV)J%:'@,8E1QW=%][D332U:(&I=1KW"HBJBT2[?*)8=#5L4Q87)Y.Y^A,"I
MV4:5=?W>]HHP^S=&Y?]H#;RCXKU%Y$HXEU^XVZ![-M@[ S$PW G+.4DT*K#\
M:5N?AK)NE%U/Y6_!8P+BG8'(LXUI27%]63E&>OQN#(2?F"]IT"RKUYEIDI]]
MN>C NSM8O__2@;*ZE],DQ^^J#*0;#OD$,!DV-'X;R<QWQL64T;<J?N*'NF6#
MU,>#[T+P?^@']?.;OX[OYJO3V0=^N4L2__[JX77R'\E5>CF[22^O;^'SJ9I_
M2+[#;K_A<Z?)\>PVO;Z=I=/SJ^1$/=#UQ(<&L-Q@COYS_PG,HF9;+!"N.RG"
M]<#Y<0S-3_9>1%29>P%#*"0??//&6Q1:5XT$ ^K-Y.@VK(EFE9CF&12N @IG
M P4> &7GS"5X$9[C^Q^$_,^3H&]A/DI G<](BN;_]R5GELXNK]+9].ICDG.;
MSJ?GZ>5\/A*<>(K>8__6<H,N[!69]V?$9E^_^ELPQ6QOU6N!:@\KQ'+QN[@.
M&RNRF/&O\YXI&PK:=W7NK_G]B3JKOZ/.:O@F?O0G\'T0#OR=C^ -O]Z)A/0G
M)Y0T^B7WJL"G ]_O%]'D!TRA[NOPWM<E=Q;U$!^JJ@P%:\\TS^K%^74ZN[I(
M+RYG*-4WLUEZ/ITE)_C'!1C)\W1ZR7_>G%^F-].;@ZIS/+N8IS?7\_3J G0"
M1Y]?7Z175SCZ&A3E)KVXN$V.YZ!"MQ<7(^4ZGDTOT^OI33J[E>4OT]G-97I[
M-:<_Y^GMY65Z?GL#GR^O;]*;JXM([]0_H7?)[ZMWZC?I7?*_JG?WYL/_:]W_
MI-:!JH#&I9?32Q3G]/P*_KX^=TH'*CF_):F_GD[3R_/9,TIW@QYI#HIQC4HW
M@\=O0-MF%Z)UU^GM[64"*&=^>3/2N(OS].IRFM[<SIW&S>>7Z?1BYC4.?KQ"
M=W>-..GF]M]:XY*WX5U!=_Q.+E0&AW,P,Q$J*\;&&8!U9K%D4<GHN& 1WAR8
M-=@F*]]3[H-+J]1#(V$EYL25"ZVC'(A[7T,<SW(F'M?$8LV&8HQQ]8!C4!G!
M_<-R=P-OF#:^(0"OIT4]'YBKB)YR;1=/KO*&7>WA>W=Y..33>=G/YXMT+V(P
MQ"$@,T9)L>",8[ #U8\)G-LXO \9 GGQW:&7W/7? G>@7UQ%UYBYI?G!)]KH
M7LVV2CY9,&6W=%V5ZEWT%L%"[#<?![D FJ&$6)+K8R RN<9C4Y_-87S-6Q.%
MQ='KV:1Q/N:8$"@WX2*^94%!HM1%&>D*2WBC8SWQ9,9'_JG<DK?7^)?4M2RW
MW 5A][2"Q;F1Q:Y7,,<7GM$K279]G<*"&6;E7);G":)]6F89[@.ZNN@AUD=7
MN*CU5^U+U6&FHL0+ 8,7Y^V+X'&^443VNZ8$;&SEJ+<W^1,U-_._T;W>"4L.
M?/^1V&P.#G$V16QWNN?OTX_$;*?TQ'EZ,;T"[W4+?_G/OT=8^R_>_6GTSPR<
M]_1\VO_KX,YOX,1N+J;P;/B$_^-@_-A'X"?[[0\KR +?9QW:A7JN!G7R>+$[
MB01PZ=N$'"-/W?L7X]?59JWZ%"%%E;7!/,I]OEXAL_ OQ^O9I<@PIW&7W3CK
M'S60ULW035)IB"_Y4;H0WUZGVY5[N87L;/"2*:X1.-#C;K2&/_VK6GHO:YVH
MNWVGD.,;02MPI' 0,%:*PT%X7/TWG!"W@PR8)"\/=@G\B*E](ICC:L#QKCH=
MS"?5M!9<1-1/D/=?MRFYS=#1@HS@@>-BQS#C[T:EF/A8=@UQ?>"=XS1PQG</
MA4&?]+)BX=U$L48Z_F-DPF#NTUWQQ^PDF06W0'\.E-UPGI]E"7O6\' 4$$S?
M"1F ^(O?;>]CZ_C[[/G8&;V3:-/ART^P?L'^[7N)^5GT4OFU!KB*K\ZW; 3X
M_?+^6_]V_CM^*7UXG%_M_ST%&A:0UA*&3B?7ET=<[79_M/6&7E&_J-NV7M/'
ME<Y A/$!^'U9UZW[ Q?P_Y\%+_X!4$L#!!0    ( !MI#E=1UD"CX@8  'T0
M   9    >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;)5866\;-Q!^WU]!*$@1
M XHN.T[@"Y!=.W41NX:/M$#1!VIW)!'FDAN2:T?Y]?V&>WCER"X*!-'RF)EO
M[J$/'JV[]TNB(+[GVOC#WC*$8F\X].F2<ND'MB"#D[EUN0Q8NL70%XYD%HER
M/9R,1KO#7"K3.SJ(>U?NZ,"602M#5T[X,L^E6QV3MH^'O7&OV;A6BV7@C>'1
M02$7=$/AKKAR6 U;+IG*R7AEC7 T/^Q-QWO'.WP_7OBJZ-%WO@5K,K/VGA?G
MV6%OQ(!(4QJ8@\3/ YV0ULP(,+[5/'NM2";L?C?<SZ+NT&4F/9U8_:?*PO*P
M]ZDG,IK+4H=K^_@;U?I\8'ZIU3[^+QZKNY-)3Z2E#S:OB8$@5Z;ZE=]K.W0(
M/HU>()C4!).(NQ(44?XJ@SPZ</91.+X-;OP158W4 *<,.^4F.)PJT(6CZ<(1
MP<C!'PP#^/'N,*UICRO:R0NTN^+"FK#TXM1DE*W3#X&C!3-IP!Q/7F7X>VD&
M8GO4%Y/19/L5?MNM<MN1W_9_*B?^GLY\<(B!?S;I6;'9V<R&\V+/%S*EPQX"
MWY-[H-[1+V_&NZ/]5T#NM"!W7N-^-/U\?7IZ<7IY>[,)V>NTEW_<GHH=\<N;
M3Y/Q>%\\L1(7TB"G6'=Q1B1NOI[_)0JY\DE88E58XZT3$I'47IOCVCL^96Z3
MT?XZA[@YWM_JBYQ]KE="(:4<ZH#S_?B-?[DM<9N^E5*+8,5XL/WAK2@(@HPI
M<V'G0L$5\H$<.">95&!C4'BD]X32(NX:E&(=Y3J4_P=A]Q4((D)(NA!JY:?=
M"QV,M1F$\B*5.BVU#)2)V4IDZD%ERBPB\HCO/9FL0\FB2:9+<5::2,$7 6D&
M;#@"-]R7#E:!^E#&E[@;&0W$I146U]USKP)%(15SBVYESE#A%I\O7 3?%$95
M&;2+11&2.Z:.<?1Q'^9W,BHCLP>%_97@H%<IP7( SQ05GG:[<!;Z4Y; Y@T4
M?,BPYLGHVDPY5&2]&HBKTOE2 F)-U%QKTS:947@D,D^A4$N_=:B,?0$%9K24
M>M[H$2W07V-FX4E/-?((X HMA9R3XD06*B!..L;Z\N5$O*MCX,3FN<U46"4W
MY>S]E$U!KLD#@7X80^G),EZT%*)#43EDXU''@>L1;V*X IK'Y<8)"6<H%!T-
M)J.WL15E;($VJ%KOR1>"%^EM6=^G@&QLUN?64E9IYSMIDJ:NA!2MY$QI%13Y
MK4%RVQA:9%88&UJ/LGDCBQ?L<&G-^VM*2^<XMLX:IYQ^+]@C:"-M>D0_2:TC
M"@,RUY E3%$"*UMGWK"@F@7*P!P;JSY[(Z- #GK1<_M62%J6XE66J##T\VX2
M8YN/2L-[*9<!>*YA@T0S,I0.Q2HF,N!H6N @U5+E%:^.5?N"?Q=53J;6LW<0
M'6BKN5%SE=;)ZNJTPS!"3DF=M" ?EXJE  \[A!5#-,,CR"Z5JB)6*3O3M8@U
MW]<58YK!5(I[9+"NCPR3QL^)DY'S@O&>\#22*03GW>!F((ZE2:TK*H?=U%G0
MYPSJ)YEEN\Y*#^O[F!H-R;WXK.T,AE@C:W-N;?>IYT FC!'#C%,"!4QA@F0M
MNE#Z,1EC*K;UL$V*.7-&0'-_@%7 LZMP55D:G674N>B4IY1<P(2[QH55K+(?
M7_UXE'28LL?:XTW\.X?MG#+H&.HR\H"IIM[;5,458+]B ):2%))]CRC*"V0"
M7WGF(64"<?9"K6@O=L]/YDI;9W?-(.O]U1/DIM^X>XH6J>(%$S-QF]D0'7'(
M2-HA8XVNK:ZM(R.RY]S7H_<\</]1AN-<BZSDA.)4V!/OU!:CYG<!QNJPK'M'
M-[*Y83EZX.<#NT@6W,E09AU:)-AJ3'VQ?$S+L+1._<#J2KHJJ7BN;/V:J\!)
M5K>R=2'[0 (H_$:*493:@C%RV[=FKOAQP5F98.,$XTP,G3NCX,1FQ6(<H1P4
M=27(.(S2E H$,RP;)71%!+Q[BJ4U*D5DRM2K7&EB-D-;$?H8 '5.<;"4J"G\
MD9>F+C@^P;QY[U\RW7Y$]4X];&VP8)]= E&047JLN)C'K@V(C3.;,N9C,V4,
M*(G0IA((1AI 9IJ2F].3R/OL_/)ZRD,)LE%Y9N%*37YS"#IB0U1MI)69/,GT
MA$S!"E62Q7?&AVIJ43R7S6-UTC:-%10'MTO$/28'SLLK+7_(/GJ<"B3&HY&X
MLBYHR>WT J))C';&H_$ ^1N50Z6NG-F(:T<'>+H>H.KAI=4E:71)2<6$B&/Z
MW-F\DP&;'B'#SI,P)[>(#U_&@<)5O0[;W?9M/:V>E$_7JX<YP"S8D)KF(!T-
M/G[H"5<]=JM%L$5\8,YLP',U?BY)(D+Y L[GUH9FP0+:OS@<_0M02P,$%
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MT'[O\VD NNEJS<2JTG>2E;+4E_PPIQ\!:A= ^YE2=CMQ!W2_EO@?4$L#!!0
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M#^\!/ZKZ?>"W7^?7-*8??Y@.^OV/])?-T[5(<[IIP+2RMI'6DVY NBPMV5S
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MW31'D:'F#?1^II1=+5A =W]Y]!M02P,$%     @ &VD.5YX3E8ZI'P  /5L
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M6L=K+*&5,,N6))BG,T>1X/-40 H(4ER6%[U<&BI3,**E4%^CRO*O/T(!%M;
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M+'],PX$_D+P>IFG8\_]2)$$LP0OT?#,0?M,_L$#X8O;3_P-02P,$%     @
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M0,GT0?V=JK3-V7\\\WOL&!C5W2X>*\2)6*EPDYRIXZP=H,[HYFM(Z@I(M>J
MO3.'#,]G=1M*3Z)4JB3YA;@F\NY]*QIDE^3874U)I*R,VB G3QML DJ/3(+&
M?KLEC-2/<9V-1$QLB?"ET.3!W++Q^2 ED8RV;V=6)V_^^Q^L'1(/HA/VR#E-
M1E6\KA]+DXQF;8$@&JI+J-0>PGN4&G8-<B8$W+YYX3RO018<@:DG6ZAN:>M(
M>,0NTVA,KCTDFH8>JTAGZQ&.IP^@Q6OY*"\$G$ZVIB$DA<>I:N>&AM>&^X?"
M?S<2! V?1.HE(7KE)CN4JP;E[D'<9SWB/MN+N!\&67P.LM@&K_\\%7'X1V&"
M<8=57"24'51D";]C;[FEJI63<*YG'WRQ-,^@U $KB\P TMC8O.U\@W7M"%D;
MO(C]^,Z46%7'%F9J.1JA7?D"@;.8#%-,4QQ32K?B&32:H@O-M3VMKYUM0_GP
MH9:\JJ_%G6F]"::1.2;9&H2C^M"WMF%! <[_CJ*A5!^"Z44B6ABD>LB;5B,&
MR[F 93(41,.6_>8X\2*\_I5/-_#^"A4)M0L^L@@.;WZ]^GC4UXD>?:-"KT00
M49-S.KGH6BE!?_JOZW=]>21)?\.X2NT#*(3.>U*%&GL1,,4AB<<^^]Y8Q'P/
MU[IM2RFI63E2BO4=Q(Q]K%^56H?Z 0DDBJ]CAO0BRI ^(%]N.JGE!RFOH^*,
M&ROE*NP3_]7'G/R# V2O3F,<YU<EJ6- 9>HJ/(0 0>1<C +[.$RV<LA&$_ D
M-TW>54"F.H>L#_7H=I0FQM=2 $@')F:Z-&#)/;8_)'-2,N38"'C'IAL]+T/C
M(3*DQQ(='"?E0B(H5*& :25X4#]"A3U%#D"]^M51NL8D$#4E Z9X1MKG-D:C
M6S:-?&$)7R'#7B%8,&)/W-,7?3,N01D=_&BRLVUM9BZ>(ORG.?RNR. QU_1K
M<Q&G[KE1,511,[UF)AR;*'F[ S1Q]6;J94>N-K-=RVP$J^GYH)?<)1#SBJR]
M+RLY^,K2,SVL IY@(,LR-'YCD5*:Y@&3:U9JIA-#XBD272F0==27B'HA"8*,
M#A%3F=CR?MSQET@<W&F<;:!*C**.S643ZP';ZY*6::O00TO\D0BU38.X0T%.
M@O4M]&"K=:36D?IU84K]./ NP[$?IRAU*U&56A3<DU+<(UH/Y G9IR_@B94U
MEZ P).<*V,K@2VXSQ: 5>Q"@=)!^^SVG447O^T.ZYC923]G32-;!*=:\Y0ZW
M8^'D'/OZ>%9 EM*"%V/:X?KB4%*Q>V9XN)TQ[,RY=1#MBS#'M+[4L.2\2Y\]
M,HU( #MWK@[E?$O +!7I<P^DZ!L$B!5X<EFICT:^.\L6Q9G7;)4,LGN<H07S
M8(9Z3T+65;(1>M",\P'>#<"HZ"L\H:@9;/- @A*3AD#:8WR?>R1#QKBO')Z,
MAY/[\?Z"F+3_.1CYUNBP]=#^_TV5^Q:"&+Z]K+=$"+&P6(*LPSX)$=%#998.
M"W_7SDN<X1'"Z_,=A,E\49NO75!M:Y-*9^P&PY)B 4.[>_U8AHZ@9J6A5LO6
MC$B8*:0QUV$<UIKI]E[K^CD?(0?,X@:=668P\KA+7U"4M\L8\OV,(FLS[RC4
M#"3K<[9K<NY8%7I),%.W:Z6 .K0S2A2C>''T0LY2Y80Y60,NZAG%O @"/F98
M_0'#<G3-3;PAI1T"5]^X3C;2C*Y^S*YH0ZH4GP&%.P >G79I:E )'V_V[8GG
M24AL>=^3%^H_D;GH(C@]V)##<5T<L:4))(?JG-&$)$WI7-_';-:./OJ8&1V!
M80*=.?MD0L9R/0ZH!/[XTD!Y>V1,H[[:*' [L/M!+-L.>>W7M0WX#EK!;6%L
M(&RW;Y1&4@[9I#2+HFT@;=*&5Q!HE[XNM;7E*>++RR T[MB!PP6(YQN\<2ID
M*D.I^G;9/9)XNH5$KX#D6^@%U:V=8<LB:<")G=+\%JDED=0R[OX+]H2IL'>L
M582TBA,:=F!JR]FFL3/;<(Y/3>MAF=CQ9RL>J<N^7R,<PU[@A(<R]#@FE@0/
MZC4UF-"GV--"H.3Q:H<=[K&4T3HYOWD^<: XYI%6/4;:Q$<V_=!*QPIK/R;4
M*RP "%<JSE:ZC^HNC2&?%DRV+HCJ$<4G7H SV$4(NVU EE!^;JUT"8=XW+Z"
M./A<?P<EB5>/9.IK$C+CAO)CXLEMUH8QH,*?!%))2<*'Y$ 0=73]+"0+6U=-
M-E9=RXZC<1!ZZ6R 4Y45TNB'NT5@VS?H[FR)<"[GO\P79<KD701PN\T&6'BG
M8][A%(6F?I6C@Z^,$J6RY']II;5802>F=%C:YY)1(T]N%M!:7/F(XJ(;66Q;
M<G>T3Q:&%(&N9@V9!J'R6CN,HP-=2*'@L/6,(VIX;#.0Y\D&O4\#O4>TI.LM
M[CM1Q_[7%+]N4&N7N_^RIQ?^I >!)^II>CZY3,\OGFW\/L9_DW1R_C2=C)_&
MOW?VR)^H9YA_D9Z?72++>99>/)NDX].GZ@A/XW1Z<9J>75[BZ3*=GN/Y\EP=
M/DNGX]/T'!+#H&?GI^GT]$(=);(S.:2+J3X!)8RYF*9GYQA'SZ?IQ?E9^FS\
MC!\'TOC393H^NTC/)D_Y3Y!E>OGT6?(]D(.#%-+LKN+RZXYO/B&F&='_8:&'
MIR,Y''G4W7+#85DX),L7NNA*SE<_1,=5ZF<ZO^S[.=FJK^JH,)8E88BWALVV
MI^I1Y-'Q6[+M^,W0?:A<&T;-DV6V\H>[BFY<!_;%#4*PH[C1+FQA2WN[$H0F
M1R5;E4@0>8"'WUI3F@*FZ:RG5MX!HV,HND9 ;FY)>'X/GI+0].WLX5;?WNHE
MNG<\^=:V\$W<SB?O_$7ST0"I'?%B:Q'S9Q&/U+Y^K)!Q8DJG P.8<R,NX?R.
M#\NXP/S#69+US$WH8TM'2HY/$/XERH:<P90<F/M"=(^5)\%6UANXOG"/C/P/
M3X*)%^G+A:,.9/O?PD*HD1*YQO--#/R,L4/#&U%3XB,K@YTIMX@MO_N^&:65
M>4-7@UALB>1I@@8IA9BU.Y!I.!FG7E)OYF"X,EWE^P9\S]LG?"YB%O#0L^-M
M8Y/_#?;W^<%T\(/I_BLRC?TB+?6WMJH,M[_%.@)0^ZOIZKW6VPOZ/W,!]:Z_
MV %(<FJCPS7KB>4#L33I;XS&]U'[7N]<DZY^RB09&9;UH,-FY>\1_O3^RE\9
M//+3;K'L<;?T3TO31CS0N^%F21)G$XWW\GY(?TD'3#6W8IQPG#KTO_C>JF]:
M^S3(^+*EO^NRI=U-9#Z-KD<L7 M_6B5A?S>>VB#V?IMOW]^\[??I+SXQ2U$(
M(N#7?.]/,EQ/S7]\DX;&$EX1JK@3V6D/Y GO:&O_1HR?9XF<./.1##2^6,/[
MNFDXP5S%U[JCZFV!U)Q.*[%S5& 99XC1@=K</.CB6+P[\3U&RE&I:VT;9%2^
M&\ -C9%ZL\V\" <V&^ #TD9808<-\V,,K#W&R@F(;\/1%7P:D*R#3)\/][UU
M_#U(H5"'A+ A:VS[R^-,2>V@M)'5<H.L\"V1T)0%E/GT H$9GD8JV.I<M+-M
M1P##D9+TC#BCEDOPDJ20"^9R2:.12QIL(3E2:@$\B)YN]B=</8]'X]._\B;Q
M:_S7E*E?T\+T[A-^I!$.T&EY? GLWZ /?S#8WV%Q_O,&!+1]0#E\K#/9^T7-
MZ_?81,.&S-A\DSUL!<-_ED@$>*Q.NAZH&XD'&9W7&CFVS)#GE]E]1H</B ==
M2Y>Y6[EJ*'-;%K:?2'VW6C=N898L2O:EN5_=1[L6JP\'U6M7$6HK+(4+G_!.
MOERX1B>)Z/3UV0M_=)J*=F:P7M1IA #VOI:O'3;.[L+].;=VGY^OA_.%V<R'
M!\,%9FD%W?F"C/\D)MD 1^(*R)V9.N7KJ2DJQ**+<C!I@J!\JGQC"*37:&!+
MO I_'*+E"CT#&@9'6?;F[L+\))Y/%UWZ"]=K?=8%EP1W1M^3VLI2TBG,36A>
MR-%^PYJ_ ?H<4F?9PJ$9:8\K?, ]IZ\(2 N!W>$6&!TD-:827<N5,12:N9P8
M<[D\1,PCC\NA$4@N34>$<F6FMNN*]N=2)!EN2E'&UF,1C13A;&!\5X?#XM@(
MK3/^MCFTSFTJ,3PQA1DP@M^; ,0\J]$$M2X^0.26+>$[=W[NO870M=+U94CG
MTFN13PHHQB WF!$6PE[X6Z*^&]MR:>FOE]-%JMT[Y>/&]=Z$ST&\P=3Z 43O
M=7D7;L]0K4=I)LICRR!,D2.-[^AC''W)(KG0VCZ\6/K.N&@; =I?=%X[HC;S
MZ.LM)Y_,D*9=7SB$6FTUM)#F0'I>>N<G.71U%I7 L7 /KLN5OW/-UI+=I]'-
MZM#GC+GD5DJC[7PK3)]$GY;2-Q[\ 2T?=]6M?&7:O^T_TKV23U.'X?*%[X]<
M,#M5ZCFFCD<7YP>H/OFC67EH[9(_5)W9MK45_UP@U]$-#<#?Y]:VX8$6Z#]=
M?OU_4$L#!!0    ( !MI#E<J[F6E\P0  &,+   9    >&PO=V]R:W-H965T
M<R]S:&5E=#$X+GAM;)U6VV[;.!!]]U<,W*)("L6ZV/(E30PD:8)FT6Z#VLTN
ML-@'6AI;1"52)2D[WJ_?(24K3IMXBWV(PY%FSEQX#L6SC53?=(9HX*'(A3[O
M9L:4I[ZODPP+IGNR1$%OEE(5S)"I5KXN%;+4!16Y'P7!T"\8%]WIF7MVIZ9G
MLC(Y%WBG0%=%P=3V$G.Y.>^&W=V#+WR5&?O GYZ5;(4S-%_+.T66WZ*DO$"A
MN12@<'G>O0A/+V/K[QSN.6[TWAIL)PLIOUGC-CWO!K8@S#$Q%H'1OS5>89Y;
M("KC>X/9;5/:P/WU#OW&]4Z]+)C&*YG_P5.3G7?'74AQR:K<?)&;#]CTXPI,
M9*[=+VQJWU'4A:321A9-,%50<%'_9P_-'/8"QL$+ 5$3$+FZZT2NRO?,L.F9
MDAM0UIO0[,*UZJ*I."[LILR,HK><XLQTQE>"+WG"A(&+))&5,%RLX$[F/.&H
MX6C.%CGJXS/?4#8;XR<-\F6-'+V /(1/4IA,P[5(,7T:[U.5;:G1KM3+Z"#@
M;Y7H03_P( JB_@&\?MMZW^'U_V?K?UTLM%%$F[^?:[[&'CR/;:5TJDN6X'F7
MM*)1K;$[??,J' ;O#E0^:"L?'$*?SDB::94CR"5<5>;D\W()<Y**!B92,!DV
M%KVVQA7+DRIG3@7-HYM*I/JYM@XGGE-H0@DE)31/$CJKTZ G+R1\\VH<A:-W
ML.2"Y2#HR&%:T^^:Y14"G3"0T,%2JY5P%:98E#N4)2' +&,T3N?JLF8*$8J:
M9VAY!L02[.Q8 AM4Y+4M:9?S?$OI*#2G@TCWX"+/=SV0SS73!I6 F:',3*5N
M@J>=WR_N@?XZ5[8N]+]015@\&>C>NF.;=!M"\WE[=#V;'SL8J)>D3^R<A _4
MA%0&[F__I*F8RO9S/;]Q'4>G00!EK^C!H%W9AEK:=Z('^"B)I3]&_W?D6^K8
M9+):93]OB*['6K M)-+*@+;#2"#VIT0R 1KI,8UE2R[J&QI-A_A"X_<*23O6
M\>FF[WA0[S/-S[.F;EA"^^HT84-;)UF6-)1*<+-M,@M-T@,N'CE!F[Y'">O[
MZTSH'9!=W,HN_F79W1-E6X+?BC5J0Y\J*H@9^*KM.>*&S+ARK@@?."JFDFS[
MG.H.Y[6JJVGK<.V!W'Q$^3\T3IMHO5\.?RRG0^4\H0$<58)5*3>8'CO*O<<$
MBP4JZ(?.(X*J+7]IRZ_%F>W*/^W\@/?U$>\GK%H1'W&-.81PTJPB6LVEH5U_
M\<T!G;P&Q]KP':V&7AR.O7@T^6%]0G^A%\9#+PR&^^L7]?,:)A0_\N+!&(["
MB3>:A%[0'\(Q68$7C?K>8#PF:^Q%,=GC&(XF7A3TO9@F1DZ3N.]%_1$<=^K.
MYHJ^W4]07Q,2^8PB;Q"3G[7[WB@>>)-@XLQ':'HU]H+!R!N$0_>*9NF-AQ/2
M\*U(\BJEHI.J<&I;(["2])3P>O^/4GRTCNN#T[79L<JVGS-MCT'2( V75$("
MLUN]S^T].O?@LZ!S,ZF4LGI-V;8Y,C3Q0C4IB8@K@N%[J!MNLAVRH7.OUH9<
M=FY([8*JR^&*3A3NXKF]WB7(UY;9?LFVCN&6RW3UW)7_K(#]O8M/@6KEKG<T
M&_LMK^] [=/V!GE17YP>W>OKYR?7A(8<EQ0:]$:D255?Z6K#R-)=HQ;2T*7,
M+3.Z!:.R#O1^*:79&39!>Z^>_@M02P,$%     @ &VD.5X8OB(H4"   E!D
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MS\&ES(&++WXH&^V4@ST9P7:[20*PH0_XKC84Y3WKJ5ZUK^W[,=@YQP+0SPJ
MHOD78>2\"<F>^>]T5SX4ON<BC$]VC"??Z;HFEB*@H1M#E<YAU'V_1F/Z'_9^
M,OCK 4BY@;L]VNMY CN6A"[0]E_XYP :S3HTFKT8C6IW6A?Q^/I89_KUDU9R
M7V7N J:#ZG<#4WU+&'=7@Z.N#O5:WI<M4-1UO\!'.D2ONOX[4KCG9P@UXP7P
M]W6U;$[\'A,F37D.< 'RQ#@OJ3T,B^:=SH(]@CVDKW-[<"*V,+TF6W K^J2D
MW26W>41 ^YH+,P3:Z8V7[6V_0RJ!, UG,8<=P*M\2>[7'&C4$'CZ,]GBL,";
M='^<UR#4G><P!/07]87;X%N D!D!^<?.^:Y= &>KHB2 CAQPC"#H^N[;OB;L
MA/=VL$/(595/@F0/'WPI@,PR6T'=-J*.N/,DXE4Y>2(OJ^P;@!$%QB43T"@J
M7J904&U08+5Y=RCD79O6JF5LWQD,7$K W[Q)G0&$MUS4 5!95LI&/>,Z56*!
M[=("UH=/-&QC8]H$Z#RUNXC&H=S=<-7$[MC96YDO/3._"_\6[5H%VS(P=_O]
M_$L OP7R^YNX'M&/+*X-)U[-]^>@_SH^CULL/QHXW4^^ -1[6-\%Z-/!2WG!
MU<K^'J!K$*@?S;O9[B>'\_JEO2>O?Z_XE:D5  _)^1)8W>,9W/A5_1M /3!R
M8]_=%](86=C/-6>0PD@ ZTLI33M !=T/,6?_!E!+ P04    "  ;:0Y7XVW*
MN:0"  #U!0  &0   'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6RE5-]OTS 0
M?N]?806$0 J+\Z-).MI(ZUC%$).FM1M(B <WN3;1'#O8SEK^>VRGS0IT?>$E
MN;/O^^X[VW?C#1>/L@10:%M3)B=.J51S[GDR+Z$F\HPWP/3.BHN:*.V*M2<;
M :2PH)IZ <:Q5Y.*.=G8KMV*;,Q;12L&MP+)MJZ)^#4%RC<3QW?V"W?5NE1F
MP<O&#5G#'-1]<RNTY_4L154#DQ5G2,!JXESXY]/(Q-N APHV\L!&II(EYX_&
MN2XF#C:"@$*N# /1OR>X!$H-D9;Q<\?I]"D-\-#>L\]L[;J6)9%PR>G7JE#E
MQ$D=5,"*M%3=\<TGV-4S-'PYI])^T::+'88.RENI>+T#:P5UQ;H_V>[.X0"0
MXA< P0X06-U=(JOR(U$D&PN^0<)$:S9CV%(M6HNKF+F4N1)ZM](XE5WJF^R.
MAQ7H#@JH&^OR%>JW[EFE)'J[($L*\MW84SJO07OY+L>TRQ&\D"-&-YRI4J(K
M5D#Q)][3>GO1P5[T-#A)^+EE9RC$+@IP$)[@"_M#""U?^-^'\/UB*9703^G'
ML6/HLD3'LYCV.I<-R6'BZ/Z1()[ R=Z\\F/\X40-45]#=(H]F^MV+5H*1O1"
M$"9)]^QG /*8UI-LQ[7.6GT\BU( =-_!>W^+YB47"CU<?T.S5K4Z%ETM9N@U
M"GTW#; VXL -_&@0;-$7SM;_1,:Q.XIB% W=)!T-%EP1JO7KAZ^AH]1-XE@;
M/DY=C,.!53"OMOL']6R>U)(D;I2&1DOHI@E^48OOC]S8#U&D->'A7V+\4>+B
MD57C8S=)ANC8K7D'K5B#6-N!(U'.6Z:ZKNQ7^YEVT;7R<W@W$&^(6%=,(@HK
M#<5GR=!!HALRG:-X8QM[R94>$]8L]5P&80+T_HISM7=,@G[29[\!4$L#!!0
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M55F64:6A1>Y*EYG0IA!RS<R4GB#M!#.>"J%7AEV@+F:'?P!02P,$%     @
M&VD.5X2G2KYB!0  9R$  !D   !X;"]W;W)K<VAE971S+W-H965T,C0N>&UL
MU5I=3^,X%'V?7V%U5B.0%A([29,RI=( 6PTKT*+A8U="^V 2M[5(XJ[CM"#M
MCU\[*?DHJ4N8(&U?:)WXGMQ[?$]ZB#-<,OZ8S @1X"D*X^2X-Q-B?F08B3\C
M$4X.V9S$\LR$\0@+.>13(YES@H,L* H-9)I](\(T[HV&V;$K/AJR5(0T)E<<
M)&D48?Y\0D*V/.[!WLN!'W0Z$^J ,1K.\91<$W$[O^)R9!0H 8U(G% 6 TXF
MQ[UO\.@,#51 -N..DF52^0Y4*0^,/:K!>7#<,U5&)"2^4!!8?BS(*0E#A23S
M^&<%VBNNJ0*KWU_0QUGQLI@'G)!3%OY) S$[[GD]$) )3D/Q@RV_DU5!CL+S
M69AD?\%R-=?L 3]-!(M6P3*#B,;Y)WY:$5$)@-:& +0*0.L!]H8 :Q5@O37
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M$PS]7X[)8XFL)E90BA5H]N!-\4N9W,/R^'JO;@0SI94X*D!@4P!+9#4!.J4
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MX"7A^0WJ^HHQ^3K(MX_*[<+Q?U!+ P04    "  ;:0Y7X;R+GX8$  #'%0
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M,6$*(']?4"H.-VJ"ZNQV\B]02P,$%     @ &VD.5VQ.A($]!   =1H  !D
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MS:]AJLW]Q!Q;PFGDR]9(\)I[\$[\1S1><*'0P^AOO2HJ%GHMWOPY1.]O(9J
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MJ-RU'P?&*Y!S*HT?==H:NZX?2E)7$L_@V5D29Y5!9XT&#:A*4&J:XMA*M.E
MUC1VNH<US^#9:4VGLJ;3:,T;7$.*&5.GL,">[BSLQW&-A7U>)7?>F%SP0&X$
MG^VU+30R[KN.'8AL2[SOK0\VWO]@8RB3/)"CAV+;MG3CK.C_US:',J.MR1&V
MO+;7.O]F%M5$=D*OTWIB%OG!6G7P\S:(YK[W6 :?0[2[--:'4+_Y%/J#-HGF
M7O>QYT><4?WU(=5O/+3MV"A*</L[BOQQ9&V1NQLWP@SDS%Z4%8E,!L7EL'I;
M7<8O[17478<7-_E;*F>,*Y+"%*'>R1G.,%E<CHN&%G-[OYP(C;=5^Y@ C4&:
M /P^%4*O&J:#ZE\4_:]02P,$%     @ &VD.5[2>EDA9 @  J@<  !D   !X
M;"]W;W)K<VAE971S+W-H965T,CDN>&ULM95K:]LP%(;_BO!@;+#%CITXESF&
MI&4L8X70T&Y0]D&)CV-1V_(D)6[^_8YDQV3#\5AIO\2ZO:\>G:,<!247CS(!
M4.0I2W,YLQ*EBJEMRVT"&94]7D".,S$7&578%3M;%@)H9$19:KN.X]L99;D5
M!F9L)<* [U7*<E@)(O=91L5Q 2DO9U;?.@W<LEVB]( =!@7=P1K47;$2V+,;
MEXAED$O&<R(@GEGS_G0QT>O-@GL&I3QK$WV2#>>/NK.,9I:C@2"%K=(.%#\'
MN((TU4:(\:OVM)HMM?"\?7+_;,Z.9]E0"5<\_<XBE<RLL44BB.D^5;>\_ +U
M>8;:;\M3:7Y)6:WU!A;9[J7B62U&@HSEU9<^U7$X$_0O"=Q:X!KN:B-#>4T5
M#0/!2R+T:G33#7-4HT8XENNDK)7 688Z%<YW @"#K"1Y=PV*LE2^#VR%SGK>
MWM8NB\K%O>#R=9_WB.=\(*[C>G_*;01JJ-R&RC5^WG]0D8=ON(HL%63R9QMB
M93EHM]27>RH+NH69A;=7@CB %;Y]T_>=3QW 7@/L=;F'Z_WF(XT.3')Q)#$
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MENC]@BXY9RO^0KV';*XUESMP]H_YUJ"F1OIYK@:>^^8\MQVNJ6EX!K. IL>
MWD.0OGXUG$0?KRB_Z97?7&/WRHV]M:*5^3EU'C]V>#NI^W08T2\)]V?2CONT
MXZMIYRV62HO?5*^&:Q29:+BD7FE 9U0PFNIS4CSG[8F4:!!%\7]2PI.FKD'O
MW.@:EJE6HN_O?K5_'>9^*/Z&^Z?E@>N=D(954! T&GP@!=J/JW=0-6Y$M@II
MX)Q9T@L'V@;0?J$4'AV;H'\STS]02P,$%     @ &VD.5S4_SRUZ P  U!
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M=0,D!ZX%U/F*,?FXT KZ/S*2_P!02P,$%     @ &VD.5_;-+M#1 @  ' L
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M+ K2PS5UES3F ^#[512QW0E74/PLY/*_4$L#!!0    ( !MI#E<HLPK1#P(
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MJW9,MDUKJ&XZ&=<!_6TUI[TM>_DFW:#@C\I\7MKIR*H/-<IN-<OXJNJOLM8
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MXXG;]Y4MYW-;MQ3?)2UV'W)W'Z'/_@)02P,$%     @ &VD.5XS?7ZUN 0
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M<',O87!P+GAM;%!+ 0(4 Q0    ( !MI#E=)F2ZW[P   "L"   1
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M965T,BYX;6Q02P$"% ,4    "  ;:0Y751&OJW<)  "(/0  &
M    @('[%P  >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%     @
M&VD.5Q497)18!P  <B<  !@              ("!J"$  'AL+W=O<FMS:&5E
M=',O<VAE970T+GAM;%!+ 0(4 Q0    ( !MI#E=KDO$[^ L  !])   8
M          " @38I  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"% ,4
M    "  ;:0Y7.0 1RS\&  #5'@  &               @(%D-0  >&PO=V]R
M:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @ &VD.5SSMS?_2 P  ,P\
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M:&5E=#$Q+GAM;%!+ 0(4 Q0    ( !MI#E</H0V=] (  &8&   9
M      " @2R!  !X;"]W;W)K<VAE971S+W-H965T,3(N>&UL4$L! A0#%
M  @ &VD.5Z>-?CR?!@  G \  !D              ("!5X0  'AL+W=O<FMS
M:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4    "  ;:0Y7DDA'2Y8&  #+%
M&0              @($MBP  >&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+
M 0(4 Q0    ( !MI#E>>$Y6.J1\  #U;   9              " @?J1  !X
M;"]W;W)K<VAE971S+W-H965T,34N>&UL4$L! A0#%     @ &VD.5R]*#3>O
M @  % 8  !D              ("!VK$  'AL+W=O<FMS:&5E=',O<VAE970Q
M-BYX;6Q02P$"% ,4    "  ;:0Y7B\QB8HP5  #&/   &0
M@(' M   >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    ( !MI
M#E<J[F6E\P0  &,+   9              " @8/*  !X;"]W;W)K<VAE971S
M+W-H965T,3@N>&UL4$L! A0#%     @ &VD.5X8OB(H4"   E!D  !D
M         ("!K<\  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"% ,4
M    "  ;:0Y7XVW*N:0"  #U!0  &0              @('XUP  >&PO=V]R
M:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    ( !MI#E>=D6EM&@8  $<1
M   9              " @=/:  !X;"]W;W)K<VAE971S+W-H965T,C$N>&UL
M4$L! A0#%     @ &VD.5Q8?K696 P  !PX  !D              ("!).$
M 'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"% ,4    "  ;:0Y7=(G+
M5>D"  #8"@  &0              @(&QY   >&PO=V]R:W-H965T<R]S:&5E
M=#(S+GAM;%!+ 0(4 Q0    ( !MI#E>$ITJ^8@4  &<A   9
M  " @='G  !X;"]W;W)K<VAE971S+W-H965T,C0N>&UL4$L! A0#%     @
M&VD.5Z^:!ITE!   .AP  !D              ("!:NT  'AL+W=O<FMS:&5E
M=',O<VAE970R-2YX;6Q02P$"% ,4    "  ;:0Y7X;R+GX8$  #'%0  &0
M            @('&\0  >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4
M Q0    ( !MI#E=L3H2!/00  '4:   9              " @8/V  !X;"]W
M;W)K<VAE971S+W-H965T,C<N>&UL4$L! A0#%     @ &VD.5]9)3(/" P
MKA   !D              ("!]_H  'AL+W=O<FMS:&5E=',O<VAE970R."YX
M;6Q02P$"% ,4    "  ;:0Y7M)Z62%D"  "J!P  &0              @('P
M_@  >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    ( !MI#E>7
MBPH=6 (  #\%   9              " @8 ! 0!X;"]W;W)K<VAE971S+W-H
M965T,S N>&UL4$L! A0#%     @ &VD.5S4_SRUZ P  U!   !D
M     ("!#P0! 'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q02P$"% ,4
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M  "L%   #0              @ &R%@$ >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0
M   ( !MI#E>7BKL<P    !,"   +              "  1\: 0!?<F5L<R\N
M<F5L<U!+ 0(4 Q0    ( !MI#E=O6 E].P,   @7   /              "
M 0@; 0!X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    "  ;:0Y7C-]?K6X!  #=
M%   &@              @ %P'@$ >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E
M;'-02P$"% ,4    "  ;:0Y7!E="=X\!  !P%0  $P              @ $6
L( $ 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     *@ J %T+  #6(0$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>103</ContextCount>
  <ElementCount>180</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>25</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="f10q0623_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="f10q0623_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>001 - Statement - Statements of Assets and Liabilities (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/ConsolidatedBalanceSheet</Role>
      <ShortName>Statements of Assets and Liabilities (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="f10q0623_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>002 - Statement - Statements of Operations (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/ConsolidatedIncomeStatement</Role>
      <ShortName>Statements of Operations (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="f10q0623_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>003 - Statement - Statement of Changes in Net Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/ConsolidatedIncomeStatement0</Role>
      <ShortName>Statement of Changes in Net Assets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="f10q0623_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>004 - Statement - Statements of Cash Flows (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/ConsolidatedCashFlow</Role>
      <ShortName>Statements of Cash Flows (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="f10q0623_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>005 - Statement - Schedule of Investments (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable</Role>
      <ShortName>Schedule of Investments (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="f10q0623_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>006 - Statement - Schedule of Investments (Unaudited) (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable_Parentheticals</Role>
      <ShortName>Schedule of Investments (Unaudited) (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="f10q0623_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>007 - Disclosure - Organization</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/Organization</Role>
      <ShortName>Organization</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="f10q0623_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>008 - Disclosure - Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/SignificantAccountingPolicies</Role>
      <ShortName>Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="f10q0623_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>009 - Disclosure - Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/Investments</Role>
      <ShortName>Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="f10q0623_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>010 - Disclosure - Agreements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/Agreements</Role>
      <ShortName>Agreements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="f10q0623_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>011 - Disclosure - Offering Costs</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/OfferingCosts</Role>
      <ShortName>Offering Costs</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="f10q0623_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>012 - Disclosure - Creation and Redemption of Creation Units</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/CreationandRedemptionofCreationUnits</Role>
      <ShortName>Creation and Redemption of Creation Units</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="f10q0623_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>013 - Disclosure - Financial Highlights</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/FinancialHighlights</Role>
      <ShortName>Financial Highlights</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="f10q0623_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>014 - Disclosure - Risk</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/Risk</Role>
      <ShortName>Risk</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="f10q0623_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>015 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="f10q0623_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>016 - Disclosure - Accounting Policies, by Policy (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/AccountingPoliciesByPolicy</Role>
      <ShortName>Accounting Policies, by Policy (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.vts.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>17</Position>
    </Report>
    <Report instance="f10q0623_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>017 - Disclosure - Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/SignificantAccountingPoliciesTables</Role>
      <ShortName>Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.vts.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="f10q0623_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>018 - Disclosure - Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/InvestmentsTables</Role>
      <ShortName>Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.vts.com/role/Investments</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="f10q0623_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>019 - Disclosure - Creation and Redemption of Creation Units (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/CreationandRedemptionofCreationUnitsTables</Role>
      <ShortName>Creation and Redemption of Creation Units (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.vts.com/role/CreationandRedemptionofCreationUnits</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="f10q0623_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>020 - Disclosure - Financial Highlights (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/FinancialHighlightsTables</Role>
      <ShortName>Financial Highlights (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.vts.com/role/FinancialHighlights</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="f10q0623_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>021 - Disclosure - Significant Accounting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/SignificantAccountingPoliciesDetails</Role>
      <ShortName>Significant Accounting Policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.vts.com/role/SignificantAccountingPoliciesTables</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="f10q0623_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>022 - Disclosure - Significant Accounting Policies (Details) - Schedule of Cut-Off Times and the Times of the Calculation of the Funds</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/ScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsTable</Role>
      <ShortName>Significant Accounting Policies (Details) - Schedule of Cut-Off Times and the Times of the Calculation of the Funds</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.vts.com/role/SignificantAccountingPoliciesTables</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="f10q0623_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>023 - Disclosure - Significant Accounting Policies (Details) - Schedule of Valuation of Investments at Using the Fair Value Hierarchy</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/ScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyTable</Role>
      <ShortName>Significant Accounting Policies (Details) - Schedule of Valuation of Investments at Using the Fair Value Hierarchy</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.vts.com/role/SignificantAccountingPoliciesTables</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="f10q0623_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>024 - Disclosure - Investments (Details) - Schedule of Fair Value of Derivative Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/ScheduleofFairValueofDerivativeInstrumentsTable</Role>
      <ShortName>Investments (Details) - Schedule of Fair Value of Derivative Instruments</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.vts.com/role/InvestmentsTables</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="f10q0623_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>025 - Disclosure - Investments (Details) - Schedule of Effect of Derivative Instruments on The Statement of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/ScheduleofEffectofDerivativeInstrumentsonTheStatementofOperationsTable</Role>
      <ShortName>Investments (Details) - Schedule of Effect of Derivative Instruments on The Statement of Operations</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.vts.com/role/InvestmentsTables</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="f10q0623_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>026 - Disclosure - Investments (Details) - Schedule of Pledged By Funds Fair Values of Derivative Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/ScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsTable</Role>
      <ShortName>Investments (Details) - Schedule of Pledged By Funds Fair Values of Derivative Instruments</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.vts.com/role/InvestmentsTables</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="f10q0623_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>027 - Disclosure - Investments (Details) - Schedule of Gross Amounts Not Offset In The Statements of Financial Condition</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/ScheduleofGrossAmountsNotOffsetInTheStatementsofFinancialConditionTable</Role>
      <ShortName>Investments (Details) - Schedule of Gross Amounts Not Offset In The Statements of Financial Condition</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.vts.com/role/InvestmentsTables</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="f10q0623_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>028 - Disclosure - Agreements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/AgreementsDetails</Role>
      <ShortName>Agreements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.vts.com/role/Agreements</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="f10q0623_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>029 - Disclosure - Creation and Redemption of Creation Units (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/CreationandRedemptionofCreationUnitsDetails</Role>
      <ShortName>Creation and Redemption of Creation Units (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.vts.com/role/CreationandRedemptionofCreationUnitsTables</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="f10q0623_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>030 - Disclosure - Creation and Redemption of Creation Units (Details) - Schedule of Transaction Fees</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/ScheduleofTransactionFeesTable</Role>
      <ShortName>Creation and Redemption of Creation Units (Details) - Schedule of Transaction Fees</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.vts.com/role/CreationandRedemptionofCreationUnitsTables</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="f10q0623_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>031 - Disclosure - Financial Highlights (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/FinancialHighlightsDetails</Role>
      <ShortName>Financial Highlights (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.vts.com/role/FinancialHighlightsTables</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="f10q0623_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>032 - Disclosure - Financial Highlights (Details) - Schedule of Share Outstanding</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/ScheduleofShareOutstandingTable</Role>
      <ShortName>Financial Highlights (Details) - Schedule of Share Outstanding</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.vts.com/role/FinancialHighlightsTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="f10q0623_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>033 - Disclosure - Risk (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/RiskDetails</Role>
      <ShortName>Risk (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.vts.com/role/Risk</ParentRole>
      <Position>34</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="f10q0623_vstrust.htm">f10q0623_vstrust.htm</File>
    <File>cik0001793497-20230630.xsd</File>
    <File>cik0001793497-20230630_cal.xml</File>
    <File>cik0001793497-20230630_def.xml</File>
    <File>cik0001793497-20230630_lab.xml</File>
    <File>cik0001793497-20230630_pre.xml</File>
    <File>f10q0623ex31-1_vstrust.htm</File>
    <File>f10q0623ex31-2_vstrust.htm</File>
    <File>f10q0623ex32-1_vstrust.htm</File>
    <File>f10q0623ex32-2_vstrust.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="427">http://fasb.org/us-gaap/2023</BaseTaxonomy>
    <BaseTaxonomy items="34">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>52
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "f10q0623_vstrust.htm": {
   "axisCustom": 0,
   "axisStandard": 12,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2023": 427,
    "http://xbrl.sec.gov/dei/2023": 34
   },
   "contextCount": 103,
   "dts": {
    "calculationLink": {
     "local": [
      "cik0001793497-20230630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "cik0001793497-20230630_def.xml"
     ]
    },
    "inline": {
     "local": [
      "f10q0623_vstrust.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cik0001793497-20230630_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cik0001793497-20230630_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "cik0001793497-20230630.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/sic/2023/sic-2023.xsd"
     ]
    }
   },
   "elementCount": 309,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2023": 42,
    "http://www.vts.com/20230630": 42,
    "http://xbrl.sec.gov/dei/2023": 4,
    "total": 88
   },
   "keyCustom": 69,
   "keyStandard": 111,
   "memberCustom": 14,
   "memberStandard": 7,
   "nsprefix": "cik0001793497",
   "nsuri": "http://www.vts.com/20230630",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000 - Document - Document And Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.vts.com/role/DocumentAndEntityInformation",
     "shortName": "Document And Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "009 - Disclosure - Investments",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://www.vts.com/role/Investments",
     "shortName": "Investments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cik0001793497:AgreementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "010 - Disclosure - Agreements",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.vts.com/role/Agreements",
     "shortName": "Agreements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cik0001793497:AgreementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cik0001793497:OfferingCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "011 - Disclosure - Offering Costs",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.vts.com/role/OfferingCosts",
     "shortName": "Offering Costs",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cik0001793497:OfferingCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "012 - Disclosure - Creation and Redemption of Creation Units",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.vts.com/role/CreationandRedemptionofCreationUnits",
     "shortName": "Creation and Redemption of Creation Units",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:QuarterlyFinancialInformationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "013 - Disclosure - Financial Highlights",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.vts.com/role/FinancialHighlights",
     "shortName": "Financial Highlights",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:QuarterlyFinancialInformationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "014 - Disclosure - Risk",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.vts.com/role/Risk",
     "shortName": "Risk",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "015 - Disclosure - Subsequent Events",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://www.vts.com/role/SubsequentEvents",
     "shortName": "Subsequent Events",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cik0001793497:EmergingGrowthCompanyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "016 - Disclosure - Accounting Policies, by Policy (Policies)",
     "menuCat": "Policies",
     "order": "17",
     "role": "http://www.vts.com/role/AccountingPoliciesByPolicy",
     "shortName": "Accounting Policies, by Policy (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cik0001793497:EmergingGrowthCompanyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cik0001793497:ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "017 - Disclosure - Significant Accounting Policies (Tables)",
     "menuCat": "Tables",
     "order": "18",
     "role": "http://www.vts.com/role/SignificantAccountingPoliciesTables",
     "shortName": "Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cik0001793497:ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "018 - Disclosure - Investments (Tables)",
     "menuCat": "Tables",
     "order": "19",
     "role": "http://www.vts.com/role/InvestmentsTables",
     "shortName": "Investments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c6",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "001 - Statement - Statements of Assets and Liabilities (Unaudited)",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://www.vts.com/role/ConsolidatedBalanceSheet",
     "shortName": "Statements of Assets and Liabilities (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c6",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cik0001793497:ScheduleOfTransactionFeesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "019 - Disclosure - Creation and Redemption of Creation Units (Tables)",
     "menuCat": "Tables",
     "order": "20",
     "role": "http://www.vts.com/role/CreationandRedemptionofCreationUnitsTables",
     "shortName": "Creation and Redemption of Creation Units (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cik0001793497:ScheduleOfTransactionFeesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:QuarterlyFinancialInformationTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cik0001793497:ScheduleOfShareOutstandingTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "020 - Disclosure - Financial Highlights (Tables)",
     "menuCat": "Tables",
     "order": "21",
     "role": "http://www.vts.com/role/FinancialHighlightsTables",
     "shortName": "Financial Highlights (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:QuarterlyFinancialInformationTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cik0001793497:ScheduleOfShareOutstandingTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c0",
      "decimals": "-7",
      "first": true,
      "lang": null,
      "name": "cik0001793497:GrossRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "021 - Disclosure - Significant Accounting Policies (Details)",
     "menuCat": "Details",
     "order": "22",
     "role": "http://www.vts.com/role/SignificantAccountingPoliciesDetails",
     "shortName": "Significant Accounting Policies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c0",
      "decimals": "-7",
      "first": true,
      "lang": null,
      "name": "cik0001793497:GrossRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c12",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cik0001793497:CreateRedeemCutoffDescription",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "022 - Disclosure - Significant Accounting Policies (Details) - Schedule of Cut-Off Times and the Times of the Calculation of the Funds",
     "menuCat": "Details",
     "order": "23",
     "role": "http://www.vts.com/role/ScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsTable",
     "shortName": "Significant Accounting Policies (Details) - Schedule of Cut-Off Times and the Times of the Calculation of the Funds",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c12",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cik0001793497:CreateRedeemCutoffDescription",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c3",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cik0001793497:AmountOfTotalTrust",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "023 - Disclosure - Significant Accounting Policies (Details) - Schedule of Valuation of Investments at Using the Fair Value Hierarchy",
     "menuCat": "Details",
     "order": "24",
     "role": "http://www.vts.com/role/ScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyTable",
     "shortName": "Significant Accounting Policies (Details) - Schedule of Valuation of Investments at Using the Fair Value Hierarchy",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c3",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cik0001793497:AmountOfTotalTrust",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c62",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cik0001793497:TotalTrust1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "024 - Disclosure - Investments (Details) - Schedule of Fair Value of Derivative Instruments",
     "menuCat": "Details",
     "order": "25",
     "role": "http://www.vts.com/role/ScheduleofFairValueofDerivativeInstrumentsTable",
     "shortName": "Investments (Details) - Schedule of Fair Value of Derivative Instruments",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c62",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cik0001793497:TotalTrust1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c73",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cik0001793497:RealizedGainLossOnDerivativesRecognizedInIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "025 - Disclosure - Investments (Details) - Schedule of Effect of Derivative Instruments on The Statement of Operations",
     "menuCat": "Details",
     "order": "26",
     "role": "http://www.vts.com/role/ScheduleofEffectofDerivativeInstrumentsonTheStatementofOperationsTable",
     "shortName": "Investments (Details) - Schedule of Effect of Derivative Instruments on The Statement of Operations",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c73",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cik0001793497:RealizedGainLossOnDerivativesRecognizedInIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c77",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cik0001793497:GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "026 - Disclosure - Investments (Details) - Schedule of Pledged By Funds Fair Values of Derivative Instruments",
     "menuCat": "Details",
     "order": "27",
     "role": "http://www.vts.com/role/ScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsTable",
     "shortName": "Investments (Details) - Schedule of Pledged By Funds Fair Values of Derivative Instruments",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c77",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cik0001793497:GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c12",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cik0001793497:AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "027 - Disclosure - Investments (Details) - Schedule of Gross Amounts Not Offset In The Statements of Financial Condition",
     "menuCat": "Details",
     "order": "28",
     "role": "http://www.vts.com/role/ScheduleofGrossAmountsNotOffsetInTheStatementsofFinancialConditionTable",
     "shortName": "Investments (Details) - Schedule of Gross Amounts Not Offset In The Statements of Financial Condition",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c12",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cik0001793497:AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "cik0001793497:AgreementsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c3",
      "decimals": "4",
      "first": true,
      "lang": null,
      "name": "cik0001793497:SubadvisoryFeeRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "028 - Disclosure - Agreements (Details)",
     "menuCat": "Details",
     "order": "29",
     "role": "http://www.vts.com/role/AgreementsDetails",
     "shortName": "Agreements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "cik0001793497:AgreementsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c3",
      "decimals": "4",
      "first": true,
      "lang": null,
      "name": "cik0001793497:SubadvisoryFeeRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c8",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:InterestAndOtherIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "002 - Statement - Statements of Operations (Unaudited)",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.vts.com/role/ConsolidatedIncomeStatement",
     "shortName": "Statements of Operations (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c8",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:InterestAndOtherIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c3",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:SharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "029 - Disclosure - Creation and Redemption of Creation Units (Details)",
     "menuCat": "Details",
     "order": "30",
     "role": "http://www.vts.com/role/CreationandRedemptionofCreationUnitsDetails",
     "shortName": "Creation and Redemption of Creation Units (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c3",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:SharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "cik0001793497:ScheduleOfTransactionFeesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c93",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:SaleOfTrustAssetsToPayExpenses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "030 - Disclosure - Creation and Redemption of Creation Units (Details) - Schedule of Transaction Fees",
     "menuCat": "Details",
     "order": "31",
     "role": "http://www.vts.com/role/ScheduleofTransactionFeesTable",
     "shortName": "Creation and Redemption of Creation Units (Details) - Schedule of Transaction Fees",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "cik0001793497:ScheduleOfTransactionFeesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c93",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:SaleOfTrustAssetsToPayExpenses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "link:footnote",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:QuarterlyFinancialInformationTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c95",
      "decimals": "4",
      "first": true,
      "lang": null,
      "name": "us-gaap:GeneralAndAdministrativeExpenseRatio",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "031 - Disclosure - Financial Highlights (Details)",
     "menuCat": "Details",
     "order": "32",
     "role": "http://www.vts.com/role/FinancialHighlightsDetails",
     "shortName": "Financial Highlights (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "link:footnote",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:QuarterlyFinancialInformationTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c95",
      "decimals": "4",
      "first": true,
      "lang": null,
      "name": "us-gaap:GeneralAndAdministrativeExpenseRatio",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:QuarterlyFinancialInformationTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c99",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:InvestmentCompanyMarketValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPershares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "032 - Disclosure - Financial Highlights (Details) - Schedule of Share Outstanding",
     "menuCat": "Details",
     "order": "33",
     "role": "http://www.vts.com/role/ScheduleofShareOutstandingTable",
     "shortName": "Financial Highlights (Details) - Schedule of Share Outstanding",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:QuarterlyFinancialInformationTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c99",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:InvestmentCompanyMarketValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPershares",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c0",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "cik0001793497:RelevantBenchmark",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "033 - Disclosure - Risk (Details)",
     "menuCat": "Details",
     "order": "34",
     "role": "http://www.vts.com/role/RiskDetails",
     "shortName": "Risk (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c0",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "cik0001793497:RelevantBenchmark",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c8",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:GainLossOnInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "003 - Statement - Statement of Changes in Net Assets",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.vts.com/role/ConsolidatedIncomeStatement0",
     "shortName": "Statement of Changes in Net Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c8",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:GainLossOnInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c8",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "004 - Statement - Statements of Cash Flows (Unaudited)",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.vts.com/role/ConsolidatedCashFlow",
     "shortName": "Statements of Cash Flows (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c8",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c24",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OtherAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "005 - Statement - Schedule of Investments (Unaudited)",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable",
     "shortName": "Schedule of Investments (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c24",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OtherAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c32",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "cik0001793497:OtherAssetsInExcessOfLiabilitiesPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "006 - Statement - Schedule of Investments (Unaudited) (Parentheticals)",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable_Parentheticals",
     "shortName": "Schedule of Investments (Unaudited) (Parentheticals)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c32",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "cik0001793497:OtherAssetsInExcessOfLiabilitiesPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "007 - Disclosure - Organization",
     "menuCat": "Notes",
     "order": "8",
     "role": "http://www.vts.com/role/Organization",
     "shortName": "Organization",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "008 - Disclosure - Significant Accounting Policies",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://www.vts.com/role/SignificantAccountingPolicies",
     "shortName": "Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0623_vstrust.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 25,
   "tag": {
    "cik0001793497_AdjustmentsToReconcileNetIncomeLossToNetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments To Reconcile Net Income Loss To Net Cash Provided By Used In Operating Activities Abstract",
        "terseLabel": "Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToNetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_AdministrativeAccountingAndCustodianFeesPayable": {
     "auth_ref": [],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedBalanceSheet": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligations incurred classified as other, payable within one year or the normal operating cycle, if longer.",
        "label": "Administrative Accounting And Custodian Fees Payable",
        "terseLabel": "Administrative, accounting and custodian fees payable"
       }
      }
     },
     "localname": "AdministrativeAccountingAndCustodianFeesPayable",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_AgreementsDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Agreements (Details) [Line Items]"
       }
      }
     },
     "localname": "AgreementsDetailsLineItems",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/AgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_AgreementsDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Agreements (Details) [Table]"
       }
      }
     },
     "localname": "AgreementsDetailsTable",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/AgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_AgreementsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Agreements Disclosure Abstract"
       }
      }
     },
     "localname": "AgreementsDisclosureAbstract",
     "nsuri": "http://www.vts.com/20230630",
     "xbrltype": "stringItemType"
    },
    "cik0001793497_AgreementsDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of agreements disclosure.",
        "label": "Agreements Disclosure Text Block",
        "terseLabel": "AGREEMENTS"
       }
      }
     },
     "localname": "AgreementsDisclosureTextBlock",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/Agreements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cik0001793497_AgreementsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Agreements [Abstract]"
       }
      }
     },
     "localname": "AgreementsLineItems",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/Agreements"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_AgreementsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Agreements [Table]"
       }
      }
     },
     "localname": "AgreementsTable",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/Agreements"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_AmountOfTotalTrust": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total amount of trust.",
        "label": "Amount Of Total Trust",
        "terseLabel": "Total Trust"
       }
      }
     },
     "localname": "AmountOfTotalTrust",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sales price you receive with any selling costs you paid deducted.",
        "label": "Amounts Of Recognized Assets Liabilities Presented In The Statements Of Financial Condition One",
        "terseLabel": "Amounts of Recognized Assets / (Liabilities) presented in the Statements of Financial Condition"
       }
      }
     },
     "localname": "AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ScheduleofGrossAmountsNotOffsetInTheStatementsofFinancialConditionTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_AssetDerivativesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset Derivatives Member",
        "terseLabel": "Asset Derivatives [Member]"
       }
      }
     },
     "localname": "AssetDerivativesMember",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ScheduleofFairValueofDerivativeInstrumentsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cik0001793497_AuthorizedParticipantsPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of authorized participants percentage.",
        "label": "Authorized Participants Percentage",
        "terseLabel": "Authorized participants percentage"
       }
      }
     },
     "localname": "AuthorizedParticipantsPercentage",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/CreationandRedemptionofCreationUnitsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cik0001793497_AverageDailyNetAssetsRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Average daily net assets rate.",
        "label": "Average Daily Net Assets Rate",
        "terseLabel": "Average daily net assets rate"
       }
      }
     },
     "localname": "AverageDailyNetAssetsRate",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/AgreementsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cik0001793497_BrokerageCommissionsRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Brokerage commissions rate.",
        "label": "Brokerage Commissions Rate",
        "terseLabel": "Brokerage commissions rate"
       }
      }
     },
     "localname": "BrokerageCommissionsRate",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/FinancialHighlightsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cik0001793497_CBOEVIXFuturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CBOEVIXFutures Member",
        "terseLabel": "CBOE VIX Futures [Member]",
        "verboseLabel": "CBOE VIX Futures\t[Member]"
       }
      }
     },
     "localname": "CBOEVIXFuturesMember",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cik0001793497_CBOEVIXFuturesOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CBOEVIXFutures One Member",
        "terseLabel": "CBOE VIX Futures One [Member]",
        "verboseLabel": "CBOE VIX Futures [Member]"
       }
      }
     },
     "localname": "CBOEVIXFuturesOneMember",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cik0001793497_CapitalShareTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Share Transactions Abstract",
        "terseLabel": "CAPITAL SHARE TRANSACTIONS"
       }
      }
     },
     "localname": "CapitalShareTransactionsAbstract",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement0"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_CapitalUnitNetAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of capital unit net amount.",
        "label": "Capital Unit Net Amount",
        "terseLabel": "Net Amount"
       }
      }
     },
     "localname": "CapitalUnitNetAmount",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ScheduleofGrossAmountsNotOffsetInTheStatementsofFinancialConditionTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_Cash1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash.",
        "label": "Cash1",
        "terseLabel": "Cash (in Dollars)"
       }
      }
     },
     "localname": "Cash1",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable_Parentheticals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_CashCollateralForTheBenefitOftheFundsTheCounterparties": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash collateral for the benefit of (the funds) / the counterparties.",
        "label": "Cash Collateral For The Benefit Ofthe Funds The Counterparties",
        "terseLabel": "Cash Collateral for the Benefit of (the Funds) / the Counterparties"
       }
      }
     },
     "localname": "CashCollateralForTheBenefitOftheFundsTheCounterparties",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ScheduleofGrossAmountsNotOffsetInTheStatementsofFinancialConditionTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_CashPledgedAsCollateral": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash pledged as collateral.",
        "label": "Cash Pledged As Collateral",
        "terseLabel": "Cash pledged as collateral (in Dollars)"
       }
      }
     },
     "localname": "CashPledgedAsCollateral",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable_Parentheticals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_ChangeInUnrealizedAppreciationDepreciationsOnDerivativesRecognizedInIncome": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in unrealized appreciation (depreciation) on derivatives recognized in income.",
        "label": "Change In Unrealized Appreciation Depreciations On Derivatives Recognized In Income",
        "terseLabel": "Change in Unrealized Appreciation (Depreciation) on Derivatives Recognized in Income"
       }
      }
     },
     "localname": "ChangeInUnrealizedAppreciationDepreciationsOnDerivativesRecognizedInIncome",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ScheduleofEffectofDerivativeInstrumentsonTheStatementofOperationsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_ClassIUnlimitedSharesAuthorizedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class IUnlimited Shares Authorized Abstract",
        "terseLabel": "Class I (unlimited shares authorized):"
       }
      }
     },
     "localname": "ClassIUnlimitedSharesAuthorizedAbstract",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_CreateRedeemCutoffDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Create/Redeem Cut-off (EST) 2x Long VIX Futures ETF, description",
        "label": "Create Redeem Cutoff Description",
        "terseLabel": "Create/Redeem Cut-off (EST)"
       }
      }
     },
     "localname": "CreateRedeemCutoffDescription",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_CreationandRedemptionofCreationUnitsDetailsScheduleofTransactionFeesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Creation and Redemption of Creation Units (Details) - Schedule of Transaction Fees [Line Items]"
       }
      }
     },
     "localname": "CreationandRedemptionofCreationUnitsDetailsScheduleofTransactionFeesLineItems",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ScheduleofTransactionFeesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_CreationandRedemptionofCreationUnitsDetailsScheduleofTransactionFeesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Creation and Redemption of Creation Units (Details) - Schedule of Transaction Fees [Table]"
       }
      }
     },
     "localname": "CreationandRedemptionofCreationUnitsDetailsScheduleofTransactionFeesTable",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ScheduleofTransactionFeesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_CreationandRedemptionofCreationUnitsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Creation and Redemption of Creation Units [Abstract]"
       }
      }
     },
     "localname": "CreationandRedemptionofCreationUnitsLineItems",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/CreationandRedemptionofCreationUnits"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_CreationandRedemptionofCreationUnitsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Creation and Redemption of Creation Units [Table]"
       }
      }
     },
     "localname": "CreationandRedemptionofCreationUnitsTable",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/CreationandRedemptionofCreationUnits"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_CreationandRedemptionofCreationUnitsTablesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Creationand Redemptionof Creation Units Tables Line Items",
        "terseLabel": "Creation and Redemption of Creation Units [Abstract]"
       }
      }
     },
     "localname": "CreationandRedemptionofCreationUnitsTablesLineItems",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/CreationandRedemptionofCreationUnitsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_CreationandRedemptionofCreationUnitsTablesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Creation and Redemption of Creation Units (Tables) [Table]"
       }
      }
     },
     "localname": "CreationandRedemptionofCreationUnitsTablesTable",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/CreationandRedemptionofCreationUnitsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_DocumentAndEntityInformationAbstract": {
     "auth_ref": [],
     "localname": "DocumentAndEntityInformationAbstract",
     "nsuri": "http://www.vts.com/20230630",
     "xbrltype": "stringItemType"
    },
    "cik0001793497_DueFromOther": {
     "auth_ref": [],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedBalanceSheet": {
       "order": 9.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of due from others.",
        "label": "Due From Other",
        "terseLabel": "Due from Other"
       }
      }
     },
     "localname": "DueFromOther",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_DueToCustodian": {
     "auth_ref": [],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount payable to related parties classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Due To Custodian",
        "terseLabel": "Due to Custodian"
       }
      }
     },
     "localname": "DueToCustodian",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_EmergingGrowthCompanyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for emerging growth company.",
        "label": "Emerging Growth Company Policy Text Block",
        "terseLabel": "Emerging growth company"
       }
      }
     },
     "localname": "EmergingGrowthCompanyPolicyTextBlock",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cik0001793497_ExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expenses Abstract",
        "terseLabel": "Expenses:"
       }
      }
     },
     "localname": "ExpensesAbstract",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_ExpensesAbstract0": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expenses Abstract0",
        "terseLabel": "Expenses:"
       }
      }
     },
     "localname": "ExpensesAbstract0",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_FinalNetAssetValueForFiscalPeriodPolcyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of final net asset value for fiscal period.",
        "label": "Final Net Asset Value For Fiscal Period Polcy Text Block",
        "terseLabel": "Final Net Asset Value for Fiscal Period"
       }
      }
     },
     "localname": "FinalNetAssetValueForFiscalPeriodPolcyTextBlock",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cik0001793497_FinancialHighlightsDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Highlights (Details) [Line Items]"
       }
      }
     },
     "localname": "FinancialHighlightsDetailsLineItems",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/FinancialHighlightsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_FinancialHighlightsDetailsScheduleofShareOutstandingLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Highlights (Details) - Schedule of Share Outstanding [Line Items]"
       }
      }
     },
     "localname": "FinancialHighlightsDetailsScheduleofShareOutstandingLineItems",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ScheduleofShareOutstandingTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_FinancialHighlightsDetailsScheduleofShareOutstandingTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Highlights (Details) - Schedule of Share Outstanding [Table]"
       }
      }
     },
     "localname": "FinancialHighlightsDetailsScheduleofShareOutstandingTable",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ScheduleofShareOutstandingTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_FinancialHighlightsDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Highlights (Details) [Table]"
       }
      }
     },
     "localname": "FinancialHighlightsDetailsTable",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/FinancialHighlightsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_FinancialHighlightsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Highlights Disclosure [Abstract]"
       }
      }
     },
     "localname": "FinancialHighlightsLineItems",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/FinancialHighlights"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_FinancialHighlightsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Highlights [Table]"
       }
      }
     },
     "localname": "FinancialHighlightsTable",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/FinancialHighlights"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_FinancialHighlightsTablesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Highlights [Abstract]"
       }
      }
     },
     "localname": "FinancialHighlightsTablesLineItems",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/FinancialHighlightsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_FinancialHighlightsTablesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Highlights (Tables) [Table]"
       }
      }
     },
     "localname": "FinancialHighlightsTablesTable",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/FinancialHighlightsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_FinancialInstrumentsForTheBenefitOftheFundsTheCounterpartiesTwo": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of financial instruments.",
        "label": "Financial Instruments For The Benefit Ofthe Funds The Counterparties Two",
        "terseLabel": "Financial Instruments for the Benefit of (the Funds) / the Counterparties"
       }
      }
     },
     "localname": "FinancialInstrumentsForTheBenefitOftheFundsTheCounterpartiesTwo",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ScheduleofGrossAmountsNotOffsetInTheStatementsofFinancialConditionTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_FirstAmericanGovernmentObligationsFundMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "First American Government Obligations Fund Member",
        "terseLabel": "First American Government Obligations Fund [Member]"
       }
      }
     },
     "localname": "FirstAmericanGovernmentObligationsFundMember",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable",
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable_Parentheticals"
     ],
     "xbrltype": "domainItemType"
    },
    "cik0001793497_FundSharesRedeemed": {
     "auth_ref": [],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tha amount of Fund shares redeemed.",
        "label": "Fund Shares Redeemed",
        "terseLabel": "Fund shares redeemed"
       }
      }
     },
     "localname": "FundSharesRedeemed",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_FuturesContracts": {
     "auth_ref": [],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedIncomeStatement": {
       "order": 2.0,
       "parentTag": "us-gaap_UnrealizedGainLossOnDerivatives",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of futures contracts.",
        "label": "Futures Contracts",
        "negatedLabel": "Futures"
       }
      }
     },
     "localname": "FuturesContracts",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_FuturesContractsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Futures Contracts Member",
        "terseLabel": "Futures Contracts [Member]"
       }
      }
     },
     "localname": "FuturesContractsMember",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cik0001793497_FuturesContractsUnrealizedAppreciation": {
     "auth_ref": [],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedIncomeStatement": {
       "order": 4.0,
       "parentTag": "us-gaap_UnrealizedGainLossOnDerivatives",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of futures contracts unrealized appreciation.",
        "label": "Futures Contracts Unrealized Appreciation",
        "negatedLabel": "Futures"
       }
      }
     },
     "localname": "FuturesContractsUnrealizedAppreciation",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of gross amounts of recognized assets presented.",
        "label": "Gross Amounts Of Recognized Assets Presented In The Statements Of Financial Condition",
        "terseLabel": "Gross Amounts of Recognized Assets presented in the Statements of Financial Condition"
       }
      }
     },
     "localname": "GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_GrossAmountsOfRecognizedLiabilitiesPresentedInTheStatementsOfFinancialCondition": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of gross Amounts of Recognized Liabilities presented in the Statements of Financial Condition.",
        "label": "Gross Amounts Of Recognized Liabilities Presented In The Statements Of Financial Condition",
        "terseLabel": "Gross Amounts of Recognized Liabilities presented in the Statements of Financial Condition"
       }
      }
     },
     "localname": "GrossAmountsOfRecognizedLiabilitiesPresentedInTheStatementsOfFinancialCondition",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_GrossAmountsOffsetInTheStatementsOfFinancialCondition": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of gross amounts offset in the statements of financial condition.",
        "label": "Gross Amounts Offset In The Statements Of Financial Condition",
        "terseLabel": "Gross Amounts Offset in the Statements of Financial Condition"
       }
      }
     },
     "localname": "GrossAmountsOffsetInTheStatementsOfFinancialCondition",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_GrossAmountsOffsetInTheStatementsOfFinancialCondition1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of gross amounts offset in the statements of financial condition.",
        "label": "Gross Amounts Offset In The Statements Of Financial Condition1",
        "terseLabel": "Gross Amounts Offset in the Statements of Financial Condition"
       }
      }
     },
     "localname": "GrossAmountsOffsetInTheStatementsOfFinancialCondition1",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_GrossRevenue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of gross revenue.",
        "label": "Gross Revenue",
        "terseLabel": "Annual gross revenue"
       }
      }
     },
     "localname": "GrossRevenue",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_IncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Abstract",
        "terseLabel": "Income:"
       }
      }
     },
     "localname": "IncomeAbstract",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_IncreaseDecreaseInDueToCustodian": {
     "auth_ref": [],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedCashFlow": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase decrease in due to custodian.",
        "label": "Increase Decrease In Due To Custodian",
        "terseLabel": "Increase (Decrease) in Due to Custodian"
       }
      }
     },
     "localname": "IncreaseDecreaseInDueToCustodian",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_IncreaseDecreaseInPayableToSponsor": {
     "auth_ref": [],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedCashFlow": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase Decrease In Payable To Sponsor",
        "negatedLabel": "Increase (Decrease) in Payable to Sponsor"
       }
      }
     },
     "localname": "IncreaseDecreaseInPayableToSponsor",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_IncreaseDecreaseInVariationMarginPayable": {
     "auth_ref": [],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedCashFlow": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase decrease in variation margin payable.",
        "label": "Increase Decrease In Variation Margin Payable",
        "terseLabel": "Decrease (Increase) in Prepaid expenses and other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInVariationMarginPayable",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_IncreaseInLicensingAndRegistrationFeesPayable": {
     "auth_ref": [],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedCashFlow": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase in licensing and registration fees payable.",
        "label": "Increase In Licensing And Registration Fees Payable",
        "terseLabel": "Increase (Decrease) in Licensing and registration fees payable"
       }
      }
     },
     "localname": "IncreaseInLicensingAndRegistrationFeesPayable",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_IncreaseInProfessionalFeesPayable": {
     "auth_ref": [],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedCashFlow": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase in professional fees payable.",
        "label": "Increase In Professional Fees Payable",
        "terseLabel": "Increase (Decrease) in Professional fees payable"
       }
      }
     },
     "localname": "IncreaseInProfessionalFeesPayable",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_IncreasedecreaseInNetAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedIncomeStatement0": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of total increase (decrease) in net assets.",
        "label": "Increasedecrease In Net Assets",
        "totalLabel": "Total increase (decrease) in net assets"
       }
      }
     },
     "localname": "IncreasedecreaseInNetAssets",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement0"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_InvestmentIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Income Abstract",
        "terseLabel": "INVESTMENT INCOME"
       }
      }
     },
     "localname": "InvestmentIncomeAbstract",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_InvestmentIncomeAbstract0": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Income Abstract0",
        "terseLabel": "INVESTMENT INCOME"
       }
      }
     },
     "localname": "InvestmentIncomeAbstract0",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_InvestmentsDetailsScheduleofEffectofDerivativeInstrumentsonTheStatementofOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments (Details) - Schedule of Effect of Derivative Instruments on The Statement of Operations [Line Items]"
       }
      }
     },
     "localname": "InvestmentsDetailsScheduleofEffectofDerivativeInstrumentsonTheStatementofOperationsLineItems",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ScheduleofEffectofDerivativeInstrumentsonTheStatementofOperationsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_InvestmentsDetailsScheduleofEffectofDerivativeInstrumentsonTheStatementofOperationsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments (Details) - Schedule of Effect of Derivative Instruments on The Statement of Operations [Table]"
       }
      }
     },
     "localname": "InvestmentsDetailsScheduleofEffectofDerivativeInstrumentsonTheStatementofOperationsTable",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ScheduleofEffectofDerivativeInstrumentsonTheStatementofOperationsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_InvestmentsDetailsScheduleofGrossAmountsNotOffsetInTheStatementsofFinancialConditionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments (Details) - Schedule of Gross Amounts Not Offset In The Statements of Financial Condition [Line Items]"
       }
      }
     },
     "localname": "InvestmentsDetailsScheduleofGrossAmountsNotOffsetInTheStatementsofFinancialConditionLineItems",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ScheduleofGrossAmountsNotOffsetInTheStatementsofFinancialConditionTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_InvestmentsDetailsScheduleofGrossAmountsNotOffsetInTheStatementsofFinancialConditionTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments (Details) - Schedule of Gross Amounts Not Offset In The Statements of Financial Condition [Table]"
       }
      }
     },
     "localname": "InvestmentsDetailsScheduleofGrossAmountsNotOffsetInTheStatementsofFinancialConditionTable",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ScheduleofGrossAmountsNotOffsetInTheStatementsofFinancialConditionTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_InvestmentsDetailsScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments (Details) - Schedule of Pledged By Funds Fair Values of Derivative Instruments [Line Items]"
       }
      }
     },
     "localname": "InvestmentsDetailsScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsLineItems",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_InvestmentsDetailsScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments (Details) - Schedule of Pledged By Funds Fair Values of Derivative Instruments [Table]"
       }
      }
     },
     "localname": "InvestmentsDetailsScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsTable",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_InvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments [Abstract]"
       }
      }
     },
     "localname": "InvestmentsLineItems",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/Investments"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_InvestmentsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments [Table]"
       }
      }
     },
     "localname": "InvestmentsTable",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/Investments"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_InvestmentsTablesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments Tables Line Items",
        "terseLabel": "Investments [Abstract]"
       }
      }
     },
     "localname": "InvestmentsTablesLineItems",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/InvestmentsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_InvestmentsTablesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments (Tables) [Table]"
       }
      }
     },
     "localname": "InvestmentsTablesTable",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/InvestmentsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_LiabilityDerivativesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability Derivatives Member",
        "terseLabel": "Liability Derivatives [Member]"
       }
      }
     },
     "localname": "LiabilityDerivativesMember",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ScheduleofFairValueofDerivativeInstrumentsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cik0001793497_LicensingAndRegistrationFeesPayable": {
     "auth_ref": [],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedBalanceSheet": {
       "order": 7.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of licensing and registration fees payable.",
        "label": "Licensing And Registration Fees Payable",
        "terseLabel": "Licensing and registration fees payable"
       }
      }
     },
     "localname": "LicensingAndRegistrationFeesPayable",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_MarketValuePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share excess of market value per share.",
        "label": "Market Value Per Share",
        "terseLabel": "Market Value Per Share, at June 30, 2023 and June 30, 2022"
       }
      }
     },
     "localname": "MarketValuePerShare",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ScheduleofShareOutstandingTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "cik0001793497_NAVCalculationDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date the NAV calculation date.",
        "label": "NAVCalculation Date",
        "terseLabel": "NAV Calculation Date"
       }
      }
     },
     "localname": "NAVCalculationDate",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsTable"
     ],
     "xbrltype": "dateItemType"
    },
    "cik0001793497_NAVCalculationTimeESTDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "NAV Calculation Time (EST), description.",
        "label": "NAVCalculation Time ESTDescription",
        "terseLabel": "NAV Calculation Time (EST)"
       }
      }
     },
     "localname": "NAVCalculationTimeESTDescription",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net assets presented.",
        "label": "Net Amounts Of Assets Presented In The Statements Of Financial Condition",
        "terseLabel": "Net Amounts of Assets presented in the Statements of Financial Condition"
       }
      }
     },
     "localname": "NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_NetAmountsOfLiabilitiesPresentedInTheStatementsOfFinancialCondition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amounts of liabilities presented in the statements of financial condition.",
        "label": "Net Amounts Of Liabilities Presented In The Statements Of Financial Condition",
        "terseLabel": "Net Amounts of Liabilities presented in the Statements of Financial Condition"
       }
      }
     },
     "localname": "NetAmountsOfLiabilitiesPresentedInTheStatementsOfFinancialCondition",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_NetAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Assets Abstract",
        "terseLabel": "NET ASSETS"
       }
      }
     },
     "localname": "NetAssetsAbstract",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement0"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_NetAssetsConsistOfAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Assets Consist Of Abstract",
        "terseLabel": "NET ASSETS CONSIST OF:"
       }
      }
     },
     "localname": "NetAssetsConsistOfAbstract",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_NetChangeInUnrealizedAppreciationDepreciationOfAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Change In Unrealized Appreciation Depreciation Of Abstract",
        "terseLabel": "Net change in unrealized appreciation (depreciation) of:"
       }
      }
     },
     "localname": "NetChangeInUnrealizedAppreciationDepreciationOfAbstract",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_NetChangeInUnrealizedAppreciationdepreciationOfInvestmentsAndFuturesContracts": {
     "auth_ref": [],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedIncomeStatement0": {
       "order": 3.0,
       "parentTag": "cik0001793497_NetIncreasedecreaseInNetAssetsResultingFromOperations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment.",
        "label": "Net Change In Unrealized Appreciationdepreciation Of Investments And Futures Contracts",
        "terseLabel": "Net change in unrealized appreciation (depreciation) of investments and futures contracts"
       }
      }
     },
     "localname": "NetChangeInUnrealizedAppreciationdepreciationOfInvestmentsAndFuturesContracts",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement0"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_NetIncreaseInNetAssetsFromCapitalShareTransactions": {
     "auth_ref": [],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedIncomeStatement0": {
       "order": 2.0,
       "parentTag": "cik0001793497_IncreasedecreaseInNetAssets",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net increase in net assets from capital share transactions.",
        "label": "Net Increase In Net Assets From Capital Share Transactions",
        "totalLabel": "Net increase (decrease) in net assets from capital share transactions"
       }
      }
     },
     "localname": "NetIncreaseInNetAssetsFromCapitalShareTransactions",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement0"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_NetIncreasedecreaseInNetAssetsResultingFromOperations": {
     "auth_ref": [],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedIncomeStatement": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.vts.com/role/ConsolidatedIncomeStatement0": {
       "order": 1.0,
       "parentTag": "cik0001793497_IncreasedecreaseInNetAssets",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in net assets from operations of investment company.",
        "label": "Net Increasedecrease In Net Assets Resulting From Operations",
        "terseLabel": "Net increase (decrease) in net assets resulting from operations",
        "totalLabel": "NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS"
       }
      }
     },
     "localname": "NetIncreasedecreaseInNetAssetsResultingFromOperations",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement",
      "http://www.vts.com/role/ConsolidatedIncomeStatement0"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized and unrealized gain (loss) on investment, and future contracts.",
        "label": "Net Realized And Unrealized Gain Loss On Investments And Futures Contracts",
        "terseLabel": "Net Realized and Unrealized Gain (Loss) on Investments and Futures Contracts"
       }
      }
     },
     "localname": "NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ScheduleofShareOutstandingTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "cik0001793497_NetRealizedGainLossOnAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Realized Gain Loss On Abstract",
        "terseLabel": "Net realized gain (loss) on:"
       }
      }
     },
     "localname": "NetRealizedGainLossOnAbstract",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_NetRealizedGainlossOnInvestmentsAndFuturesContracts": {
     "auth_ref": [],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedIncomeStatement0": {
       "order": 2.0,
       "parentTag": "cik0001793497_NetIncreasedecreaseInNetAssetsResultingFromOperations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized gain (loss) on investment.",
        "label": "Net Realized Gainloss On Investments And Futures Contracts",
        "terseLabel": "Net realized gain (loss) on investments and futures contracts"
       }
      }
     },
     "localname": "NetRealizedGainlossOnInvestmentsAndFuturesContracts",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement0"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_NonaffiliatesExceeded": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of non-affiliates exceeded.",
        "label": "Nonaffiliates Exceeded",
        "terseLabel": "Non-affiliates exceeded"
       }
      }
     },
     "localname": "NonaffiliatesExceeded",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_NonconvertibleDebtSecurities": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of non-convertible debt securities.",
        "label": "Nonconvertible Debt Securities",
        "terseLabel": "Non-convertible debt securities"
       }
      }
     },
     "localname": "NonconvertibleDebtSecurities",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_NumberOfContracts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of number of contracts.",
        "label": "Number Of Contracts",
        "terseLabel": "Contracts"
       }
      }
     },
     "localname": "NumberOfContracts",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_OfferingCostsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Costs Abstract"
       }
      }
     },
     "localname": "OfferingCostsAbstract",
     "nsuri": "http://www.vts.com/20230630",
     "xbrltype": "stringItemType"
    },
    "cik0001793497_OfferingCostsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Costs [Abstract]"
       }
      }
     },
     "localname": "OfferingCostsLineItems",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/OfferingCosts"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_OfferingCostsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Costs [Table]"
       }
      }
     },
     "localname": "OfferingCostsTable",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/OfferingCosts"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_OfferingCostsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of offering costs .",
        "label": "Offering Costs Text Block",
        "terseLabel": "OFFERING COSTS"
       }
      }
     },
     "localname": "OfferingCostsTextBlock",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/OfferingCosts"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cik0001793497_OneShortVIXFuturesETFMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "-1x Short VIX Futures ETF [Member]",
        "netLabel": "1x Short VIX Futures ETF",
        "terseLabel": "1 Short VIX Futures ETF [Member]",
        "verboseLabel": "-1x Short VIX Futures ETF"
       }
      }
     },
     "localname": "OneShortVIXFuturesETFMember",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedBalanceSheet",
      "http://www.vts.com/role/ConsolidatedCashFlow",
      "http://www.vts.com/role/ConsolidatedIncomeStatement",
      "http://www.vts.com/role/ConsolidatedIncomeStatement0",
      "http://www.vts.com/role/ScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsTable",
      "http://www.vts.com/role/ScheduleofGrossAmountsNotOffsetInTheStatementsofFinancialConditionTable",
      "http://www.vts.com/role/ScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cik0001793497_OnexShortVIXFuturesETFMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "1 x Short VIX Futures ETF [Member]",
        "netLabel": "-1x Short VIX Futures ETF [Member]",
        "terseLabel": "-1x Short VIX Futures ETF",
        "verboseLabel": "-1 x Short VIX Futures ETF [Member]"
       }
      }
     },
     "localname": "OnexShortVIXFuturesETFMember",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation",
      "http://www.vts.com/role/ScheduleofEffectofDerivativeInstrumentsonTheStatementofOperationsTable",
      "http://www.vts.com/role/ScheduleofFairValueofDerivativeInstrumentsTable",
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable",
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable_Parentheticals",
      "http://www.vts.com/role/ScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsTable",
      "http://www.vts.com/role/ScheduleofShareOutstandingTable",
      "http://www.vts.com/role/ScheduleofTransactionFeesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cik0001793497_OperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operations Abstract",
        "terseLabel": "OPERATIONS"
       }
      }
     },
     "localname": "OperationsAbstract",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement0"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_OtherAssetsInExcessOfLiabilitiesPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of other assets in excess of liabilities.",
        "label": "Other Assets In Excess Of Liabilities Percentage",
        "terseLabel": "Other assets in excess of liabilities, percentage"
       }
      }
     },
     "localname": "OtherAssetsInExcessOfLiabilitiesPercentage",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable_Parentheticals"
     ],
     "xbrltype": "percentItemType"
    },
    "cik0001793497_PayablesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables Abstract",
        "terseLabel": "Payables"
       }
      }
     },
     "localname": "PayablesAbstract",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_ProceedsFromSaleOfUnits": {
     "auth_ref": [],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedCashFlow": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from sale of units.",
        "label": "Proceeds From Sale Of Units",
        "terseLabel": "Proceeds from shares sold, net of cost from shares purchased"
       }
      }
     },
     "localname": "ProceedsFromSaleOfUnits",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_ProceedsFromSalesOrMaturitiesOfInvestments": {
     "auth_ref": [],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedCashFlow": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from sales or maturities of investments.",
        "label": "Proceeds From Sales Or Maturities Of Investments",
        "terseLabel": "Proceeds from sales or maturities of investments held"
       }
      }
     },
     "localname": "ProceedsFromSalesOrMaturitiesOfInvestments",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_PurchasesOfInvestments": {
     "auth_ref": [],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedCashFlow": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of all investments during the period.",
        "label": "Purchases Of Investments",
        "negatedLabel": "Purchase of investments"
       }
      }
     },
     "localname": "PurchasesOfInvestments",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_RatiosToAverageNetAssets5Abstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ratios To Average Net Assets5 Abstract",
        "terseLabel": "Ratios to Average Net Assets: (5)"
       }
      }
     },
     "localname": "RatiosToAverageNetAssets5Abstract",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ScheduleofShareOutstandingTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_RealizedGainLossOnDerivativesRecognizedInIncome": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized gain (loss) on derivatives recognized in income.",
        "label": "Realized Gain Loss On Derivatives Recognized In Income",
        "terseLabel": "Realized Gain (Loss) on Derivatives Recognized in Income"
       }
      }
     },
     "localname": "RealizedGainLossOnDerivativesRecognizedInIncome",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ScheduleofEffectofDerivativeInstrumentsonTheStatementofOperationsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_ReceivableForSharesSold": {
     "auth_ref": [],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedBalanceSheet": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represent receivable for shares sold.",
        "label": "Receivable For Shares Sold",
        "terseLabel": "Receivable for shares sold"
       }
      }
     },
     "localname": "ReceivableForSharesSold",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_RelevantBenchmark": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of relevant benchmark.",
        "label": "Relevant Benchmark",
        "terseLabel": "Relevant benchmark percentage"
       }
      }
     },
     "localname": "RelevantBenchmark",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/RiskDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cik0001793497_RiskLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk Line Items",
        "terseLabel": "Risk [Abstract]"
       }
      }
     },
     "localname": "RiskLineItems",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/Risk"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_RiskTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk [Table]"
       }
      }
     },
     "localname": "RiskTable",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/Risk"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_SVIXMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SVIXMember",
        "terseLabel": "SVIX [Member]"
       }
      }
     },
     "localname": "SVIXMember",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/AgreementsDetails",
      "http://www.vts.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cik0001793497_ScheduleOfCutOffTimesAndTheTimesOfTheCalculationOfTheFundsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Cut Off Times And The Times Of The Calculation Of The Funds Abstract"
       }
      }
     },
     "localname": "ScheduleOfCutOffTimesAndTheTimesOfTheCalculationOfTheFundsAbstract",
     "nsuri": "http://www.vts.com/20230630",
     "xbrltype": "stringItemType"
    },
    "cik0001793497_ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of cut-off times and times of calculation.",
        "label": "Schedule Of Cutoff Times And Times Of Calculation Table Text Block",
        "terseLabel": "Schedule of Cut-Off Times and the Times of the Calculation of the Funds"
       }
      }
     },
     "localname": "ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cik0001793497_ScheduleOfEffectOfDerivativeInstrumentsOnTheStatementOfOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Effect Of Derivative Instruments On The Statement Of Operations Abstract"
       }
      }
     },
     "localname": "ScheduleOfEffectOfDerivativeInstrumentsOnTheStatementOfOperationsAbstract",
     "nsuri": "http://www.vts.com/20230630",
     "xbrltype": "stringItemType"
    },
    "cik0001793497_ScheduleOfFairValueOfDerivativeInstrumentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Fair Value Of Derivative Instruments Abstract"
       }
      }
     },
     "localname": "ScheduleOfFairValueOfDerivativeInstrumentsAbstract",
     "nsuri": "http://www.vts.com/20230630",
     "xbrltype": "stringItemType"
    },
    "cik0001793497_ScheduleOfGrossAmountsNotOffsetInTheStatementsOfFinancialConditionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Gross Amounts Not Offset In The Statements Of Financial Condition Abstract"
       }
      }
     },
     "localname": "ScheduleOfGrossAmountsNotOffsetInTheStatementsOfFinancialConditionAbstract",
     "nsuri": "http://www.vts.com/20230630",
     "xbrltype": "stringItemType"
    },
    "cik0001793497_ScheduleOfInvestmentsUnauditedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Investments Unaudited Abstract"
       }
      }
     },
     "localname": "ScheduleOfInvestmentsUnauditedAbstract",
     "nsuri": "http://www.vts.com/20230630",
     "xbrltype": "stringItemType"
    },
    "cik0001793497_ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Pledged By Funds Fair Values Of Derivative Instruments Abstract"
       }
      }
     },
     "localname": "ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsAbstract",
     "nsuri": "http://www.vts.com/20230630",
     "xbrltype": "stringItemType"
    },
    "cik0001793497_ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of pledged by funds fair values of derivative instruments.",
        "label": "Schedule Of Pledged By Funds Fair Values Of Derivative Instruments Table Text Block",
        "terseLabel": "Schedule of Pledged By Funds Fair Values of Derivative Instruments"
       }
      }
     },
     "localname": "ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsTableTextBlock",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cik0001793497_ScheduleOfShareOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Share Outstanding Abstract"
       }
      }
     },
     "localname": "ScheduleOfShareOutstandingAbstract",
     "nsuri": "http://www.vts.com/20230630",
     "xbrltype": "stringItemType"
    },
    "cik0001793497_ScheduleOfShareOutstandingTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of share outstanding.",
        "label": "Schedule Of Share Outstanding Table Text Block",
        "terseLabel": "Schedule of Share Outstanding"
       }
      }
     },
     "localname": "ScheduleOfShareOutstandingTableTextBlock",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/FinancialHighlightsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cik0001793497_ScheduleOfTransactionFeesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Transaction Fees Abstract"
       }
      }
     },
     "localname": "ScheduleOfTransactionFeesAbstract",
     "nsuri": "http://www.vts.com/20230630",
     "xbrltype": "stringItemType"
    },
    "cik0001793497_ScheduleOfTransactionFeesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of transaction fees.",
        "label": "Schedule Of Transaction Fees Table Text Block",
        "terseLabel": "Schedule of Transaction Fees"
       }
      }
     },
     "localname": "ScheduleOfTransactionFeesTableTextBlock",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/CreationandRedemptionofCreationUnitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cik0001793497_ScheduleOfValuationOfInvestmentsAtUsingTheFairValueHierarchyAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Valuation Of Investments At Using The Fair Value Hierarchy Abstract"
       }
      }
     },
     "localname": "ScheduleOfValuationOfInvestmentsAtUsingTheFairValueHierarchyAbstract",
     "nsuri": "http://www.vts.com/20230630",
     "xbrltype": "stringItemType"
    },
    "cik0001793497_SharesSoldNetOfSharesRedeemedinDollarsPerShare": {
     "auth_ref": [],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedIncomeStatement0": {
       "order": 2.0,
       "parentTag": "cik0001793497_NetIncreaseInNetAssetsFromCapitalShareTransactions",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of shares sold, net of shares redeemed.",
        "label": "Shares Sold Net Of Shares Redeemedin Dollars Per Share",
        "negatedLabel": "Shares redeemed"
       }
      }
     },
     "localname": "SharesSoldNetOfSharesRedeemedinDollarsPerShare",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement0"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_SharesSoldinShares": {
     "auth_ref": [],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedIncomeStatement0": {
       "order": 1.0,
       "parentTag": "cik0001793497_NetIncreaseInNetAssetsFromCapitalShareTransactions",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares Soldin Shares",
        "negatedLabel": "Shares sold"
       }
      }
     },
     "localname": "SharesSoldinShares",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement0"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_ShortTermInvestmentsRealized": {
     "auth_ref": [],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedIncomeStatement": {
       "order": 1.0,
       "parentTag": "us-gaap_UnrealizedGainLossOnDerivatives",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.",
        "label": "Short Term Investments Realized",
        "negatedLabel": "Short Term Investments"
       }
      }
     },
     "localname": "ShortTermInvestmentsRealized",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_ShortTermInvestmentsUnrealized": {
     "auth_ref": [],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedIncomeStatement": {
       "order": 3.0,
       "parentTag": "us-gaap_UnrealizedGainLossOnDerivatives",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.",
        "label": "Short Term Investments Unrealized",
        "negatedLabel": "Short Term Investments"
       }
      }
     },
     "localname": "ShortTermInvestmentsUnrealized",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_SignificantAccountingPoliciesDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies (Details) [Line Items]"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesDetailsLineItems",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_SignificantAccountingPoliciesDetailsScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies (Details) - Schedule of Cut-Off Times and the Times of the Calculation of the Funds [Line Items]"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesDetailsScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsLineItems",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_SignificantAccountingPoliciesDetailsScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies (Details) - Schedule of Cut-Off Times and the Times of the Calculation of the Funds [Table]"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesDetailsScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsTable",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_SignificantAccountingPoliciesDetailsScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies (Details) - Schedule of Valuation of Investments at Using the Fair Value Hierarchy [Line Items]"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesDetailsScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyLineItems",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_SignificantAccountingPoliciesDetailsScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies (Details) - Schedule of Valuation of Investments at Using the Fair Value Hierarchy [Table]"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesDetailsScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyTable",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_SignificantAccountingPoliciesDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies (Details) [Table]"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesDetailsTable",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_StatementsOfCashFlowsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of statements of cash flows.",
        "label": "Statements Of Cash Flows Policy Text Block",
        "terseLabel": "Statements of Cash Flows"
       }
      }
     },
     "localname": "StatementsOfCashFlowsPolicyTextBlock",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cik0001793497_StatementsOfFinancialConditionLocationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statements Of Financial Condition Location Member",
        "terseLabel": "Statements of Financial Condition Location [Member]"
       }
      }
     },
     "localname": "StatementsOfFinancialConditionLocationMember",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ScheduleofFairValueofDerivativeInstrumentsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cik0001793497_SubadvisoryFeeRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of sub-advisory fee rate.",
        "label": "Subadvisory Fee Rate",
        "terseLabel": "Sub-advisory fee rate"
       }
      }
     },
     "localname": "SubadvisoryFeeRate",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/AgreementsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cik0001793497_SubsequentEventsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsLineItems",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/SubsequentEvents"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_SubsequentEventsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Table]"
       }
      }
     },
     "localname": "SubsequentEventsTable",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/SubsequentEvents"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_TotalReturnAtMarketValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of return at market value",
        "label": "Total Return At Market Value",
        "terseLabel": "Total Return at Market Value"
       }
      }
     },
     "localname": "TotalReturnAtMarketValue",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ScheduleofShareOutstandingTable"
     ],
     "xbrltype": "percentItemType"
    },
    "cik0001793497_TotalTrust": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total Trust amount.",
        "label": "Total Trust",
        "terseLabel": "Total Trust"
       }
      }
     },
     "localname": "TotalTrust",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ScheduleofFairValueofDerivativeInstrumentsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_TotalTrust1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total Trust amount.",
        "label": "Total Trust1",
        "terseLabel": "Total Trust"
       }
      }
     },
     "localname": "TotalTrust1",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ScheduleofFairValueofDerivativeInstrumentsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_TwoxLongVIXFuturesETFMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Twox Long VIXFutures ETFMember",
        "terseLabel": "2x Long VIX Futures ETF",
        "verboseLabel": "2x Long VIX Futures ETF [Member]"
       }
      }
     },
     "localname": "TwoxLongVIXFuturesETFMember",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedBalanceSheet",
      "http://www.vts.com/role/ConsolidatedCashFlow",
      "http://www.vts.com/role/ConsolidatedIncomeStatement",
      "http://www.vts.com/role/ConsolidatedIncomeStatement0",
      "http://www.vts.com/role/DocumentAndEntityInformation",
      "http://www.vts.com/role/ScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsTable",
      "http://www.vts.com/role/ScheduleofEffectofDerivativeInstrumentsonTheStatementofOperationsTable",
      "http://www.vts.com/role/ScheduleofFairValueofDerivativeInstrumentsTable",
      "http://www.vts.com/role/ScheduleofGrossAmountsNotOffsetInTheStatementsofFinancialConditionTable",
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable",
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable_Parentheticals",
      "http://www.vts.com/role/ScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsTable",
      "http://www.vts.com/role/ScheduleofShareOutstandingTable",
      "http://www.vts.com/role/ScheduleofTransactionFeesTable",
      "http://www.vts.com/role/ScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cik0001793497_UVIXMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UVIXMember",
        "terseLabel": "UVIX [Member]"
       }
      }
     },
     "localname": "UVIXMember",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/AgreementsDetails",
      "http://www.vts.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cik0001793497_UnderlyingFaceAmountAtMarketValues": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The nominal value of any stock at its issuing is termed its face value. The market value of any stock refers to the current market price of that stock as stated on the stock exchange. This value remains unaffected by the market conditions. Market conditions (such as government policies) can alter the market value.",
        "label": "Underlying Face Amount At Market Values",
        "terseLabel": "Underlying Face Amount at Market Value"
       }
      }
     },
     "localname": "UnderlyingFaceAmountAtMarketValues",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_UnrealizedAppreciationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrealized Appreciation Member",
        "terseLabel": "Unrealized Appreciation [Member]"
       }
      }
     },
     "localname": "UnrealizedAppreciationMember",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ScheduleofFairValueofDerivativeInstrumentsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cik0001793497_UnrealizedDepreciationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrealized Depreciation Member",
        "terseLabel": "Unrealized Depreciation [Member]"
       }
      }
     },
     "localname": "UnrealizedDepreciationMember",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ScheduleofFairValueofDerivativeInstrumentsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cik0001793497_VariationMarginReceivable": {
     "auth_ref": [],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedBalanceSheet": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of variation margin receivable.",
        "label": "Variation Margin Receivable",
        "terseLabel": "Variation margin receivable"
       }
      }
     },
     "localname": "VariationMarginReceivable",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_VixFuturesContractsNetRealizedGainLossOnFuturesContractsChangesInUnrealizedAppreciationDepreciationOnFuturesContractsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vix Futures Contracts Net Realized Gain Loss On Futures Contracts Changes In Unrealized Appreciation Depreciation On Futures Contracts Abstract",
        "terseLabel": "VIX Futures Contracts Net realized gain (loss) on futures contracts/changes in unrealized appreciation (depreciation) on futures contracts"
       }
      }
     },
     "localname": "VixFuturesContractsNetRealizedGainLossOnFuturesContractsChangesInUnrealizedAppreciationDepreciationOnFuturesContractsAbstract",
     "nsuri": "http://www.vts.com/20230630",
     "presentation": [
      "http://www.vts.com/role/ScheduleofEffectofDerivativeInstrumentsonTheStatementofOperationsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r331"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r329"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r329"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r329"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r333"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r329"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r329"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r329"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r329"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_ConsolidatedEntitiesAxis": {
     "auth_ref": [
      "r77",
      "r150",
      "r151",
      "r152",
      "r153",
      "r160",
      "r304",
      "r351",
      "r354",
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Axis]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesAxis",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedBalanceSheet",
      "http://www.vts.com/role/ConsolidatedCashFlow",
      "http://www.vts.com/role/ConsolidatedIncomeStatement",
      "http://www.vts.com/role/ConsolidatedIncomeStatement0",
      "http://www.vts.com/role/ScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsTable",
      "http://www.vts.com/role/ScheduleofEffectofDerivativeInstrumentsonTheStatementofOperationsTable",
      "http://www.vts.com/role/ScheduleofFairValueofDerivativeInstrumentsTable",
      "http://www.vts.com/role/ScheduleofGrossAmountsNotOffsetInTheStatementsofFinancialConditionTable",
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable",
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable_Parentheticals",
      "http://www.vts.com/role/ScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsTable",
      "http://www.vts.com/role/ScheduleofShareOutstandingTable",
      "http://www.vts.com/role/ScheduleofTransactionFeesTable",
      "http://www.vts.com/role/ScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyTable"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesDomain": {
     "auth_ref": [
      "r77",
      "r150",
      "r151",
      "r152",
      "r153",
      "r160",
      "r304",
      "r351",
      "r354",
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Domain]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesDomain",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.vts.com/role/ScheduleofEffectofDerivativeInstrumentsonTheStatementofOperationsTable",
      "http://www.vts.com/role/ScheduleofFairValueofDerivativeInstrumentsTable",
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable_Parentheticals",
      "http://www.vts.com/role/ScheduleofTransactionFeesTable",
      "http://www.vts.com/role/ScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyTable"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [
      "r103",
      "r104",
      "r105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable",
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable_Parentheticals"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r109",
      "r110",
      "r111",
      "r112",
      "r135",
      "r167",
      "r176",
      "r216",
      "r217",
      "r267",
      "r274",
      "r277",
      "r278",
      "r291",
      "r305",
      "r306",
      "r311",
      "r315",
      "r319",
      "r322",
      "r356",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum [Member]"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.vts.com/role/FinancialHighlightsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r109",
      "r110",
      "r111",
      "r112",
      "r135",
      "r167",
      "r176",
      "r216",
      "r217",
      "r267",
      "r274",
      "r277",
      "r278",
      "r291",
      "r305",
      "r306",
      "r311",
      "r315",
      "r319",
      "r322",
      "r356",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum [Member]"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.vts.com/role/FinancialHighlightsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r109",
      "r110",
      "r111",
      "r112",
      "r128",
      "r135",
      "r138",
      "r139",
      "r140",
      "r166",
      "r167",
      "r176",
      "r216",
      "r217",
      "r267",
      "r274",
      "r277",
      "r278",
      "r291",
      "r305",
      "r306",
      "r311",
      "r315",
      "r319",
      "r322",
      "r324",
      "r350",
      "r356",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.vts.com/role/FinancialHighlightsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r103",
      "r104",
      "r105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable",
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable_Parentheticals"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r13",
      "r321"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Variation margin payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent": {
     "auth_ref": [
      "r29"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedBalanceSheet": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received.",
        "label": "Accrued Professional Fees",
        "terseLabel": "Professional fees payable"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r32",
      "r321",
      "r431"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedBalanceSheetAlt0": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "negatedLabel": "Paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r50",
      "r66",
      "r76",
      "r97",
      "r99",
      "r101",
      "r106",
      "r113",
      "r114",
      "r115",
      "r116",
      "r117",
      "r118",
      "r119",
      "r120",
      "r121",
      "r150",
      "r152",
      "r157",
      "r171",
      "r238",
      "r321",
      "r327",
      "r352",
      "r353",
      "r418"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total Assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsNet": {
     "auth_ref": [
      "r8"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedBalanceSheet": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.vts.com/role/ConsolidatedBalanceSheetAlt0": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net assets (liabilities).",
        "label": "Net Assets",
        "periodEndLabel": "End of Period",
        "periodStartLabel": "Beginning of Period",
        "terseLabel": "TOTAL NET ASSETS",
        "totalLabel": "NET ASSETS",
        "verboseLabel": "Net Assets"
       }
      }
     },
     "localname": "AssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedBalanceSheet",
      "http://www.vts.com/role/ConsolidatedIncomeStatement0",
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AuctionMarketPreferredSecuritiesStockSeriesParValuePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The par value of the auction market preferred security.",
        "label": "Auction Market Preferred Securities, Stock Series, Par Value Per Share",
        "terseLabel": "Market Value per Share (Note 2) (in Dollars per share)"
       }
      }
     },
     "localname": "AuctionMarketPreferredSecuritiesStockSeriesParValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.",
        "label": "Basis of Presentation and Significant Accounting Policies [Text Block]",
        "terseLabel": "SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/SignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r16",
      "r64",
      "r307"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAxis": {
     "auth_ref": [
      "r64"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of cash and cash equivalent balance.",
        "label": "Cash and Cash Equivalents [Axis]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r16",
      "r41",
      "r75"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "End of Period",
        "periodStartLabel": "Beginning of Period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": {
     "auth_ref": [
      "r4",
      "r41"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedCashFlow": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect",
        "negatedTotalLabel": "NET INCREASE (DECREASE) IN CASH"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r340",
      "r427"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash - 1.1% (a)"
       }
      }
     },
     "localname": "CashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r62",
      "r67",
      "r68",
      "r69",
      "r76",
      "r88",
      "r89",
      "r91",
      "r92",
      "r95",
      "r96",
      "r106",
      "r113",
      "r115",
      "r116",
      "r117",
      "r120",
      "r121",
      "r123",
      "r124",
      "r125",
      "r126",
      "r127",
      "r157",
      "r186",
      "r187",
      "r188",
      "r189",
      "r192",
      "r194",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r226",
      "r247",
      "r265",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r336",
      "r345",
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommodityContractAssetCurrent": {
     "auth_ref": [
      "r344"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedBalanceSheet": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the asset arising from commodity contracts such as futures contracts tied to the movement of a particular commodity, which are expected to be converted into cash or otherwise disposed of within a year or the normal operating cycle, if longer.",
        "label": "Commodity Contract Asset, Current",
        "terseLabel": "Deposit at Broker for Futures"
       }
      }
     },
     "localname": "CommodityContractAssetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConcentrationRiskDisclosureTextBlock": {
     "auth_ref": [
      "r46"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.",
        "label": "Concentration Risk Disclosure [Text Block]",
        "terseLabel": "RISK"
       }
      }
     },
     "localname": "ConcentrationRiskDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/Risk"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedIncomeStatement": {
       "order": 1.0,
       "parentTag": "us-gaap_NetInvestmentInLeaseAccruedInterestWriteoff",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total Expenses"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r21",
      "r23",
      "r24",
      "r26",
      "r214",
      "r217",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r239",
      "r240",
      "r241",
      "r242",
      "r253",
      "r254",
      "r255",
      "r256",
      "r259",
      "r260",
      "r261",
      "r262",
      "r284",
      "r285",
      "r287",
      "r288",
      "r308",
      "r323",
      "r324"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ScheduleofFairValueofDerivativeInstrumentsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNetAssetsPercentage": {
     "auth_ref": [
      "r209",
      "r212",
      "r213",
      "r214",
      "r324",
      "r430"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of value of derivative contract to net assets.",
        "label": "Derivative, Net Assets, Percentage",
        "terseLabel": "Total net assets, percentage",
        "verboseLabel": "Fund's average net assets percentage"
       }
      }
     },
     "localname": "DerivativeNetAssetsPercentage",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable_Parentheticals",
      "http://www.vts.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DerivativesFairValueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivatives, Fair Value [Line Items]"
       }
      }
     },
     "localname": "DerivativesFairValueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ScheduleofFairValueofDerivativeInstrumentsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r136",
      "r137",
      "r141",
      "r142",
      "r143",
      "r320"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "terseLabel": "CREATION AND REDEMPTION OF CREATION UNITS"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/CreationandRedemptionofCreationUnits"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisclosureTextBlockSupplementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Text Block Supplement [Abstract]"
       }
      }
     },
     "localname": "DisclosureTextBlockSupplementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r122",
      "r129",
      "r130",
      "r131",
      "r132",
      "r133",
      "r134",
      "r156",
      "r163",
      "r164",
      "r165",
      "r313",
      "r314",
      "r316",
      "r317",
      "r318"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r122",
      "r129",
      "r134",
      "r156",
      "r163",
      "r316",
      "r317",
      "r318"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r122",
      "r129",
      "r134",
      "r156",
      "r164",
      "r313",
      "r314",
      "r316",
      "r317",
      "r318"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r122",
      "r129",
      "r130",
      "r131",
      "r132",
      "r133",
      "r134",
      "r163",
      "r164",
      "r165",
      "r313",
      "r314",
      "r316",
      "r317",
      "r318"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r7",
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "terseLabel": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": {
     "auth_ref": [
      "r20",
      "r22",
      "r27"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]"
       }
      }
     },
     "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ScheduleofFairValueofDerivativeInstrumentsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancingReceivablesPeriodPastDueAxis": {
     "auth_ref": [
      "r61",
      "r107",
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by period in which financial asset is past due or not past due.",
        "label": "Financial Asset, Aging [Axis]"
       }
      }
     },
     "localname": "FinancingReceivablesPeriodPastDueAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ScheduleofFairValueofDerivativeInstrumentsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FloorBrokerageExchangeAndClearanceFees": {
     "auth_ref": [],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedIncomeStatement": {
       "order": 5.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense during the period for floor brokerage fees paid to other broker-dealers to execute trades on their behalf, stock exchange fees, order flow fees, and clearance fees.",
        "label": "Floor Brokerage, Exchange and Clearance Fees",
        "terseLabel": "Broker interest expense"
       }
      }
     },
     "localname": "FloorBrokerageExchangeAndClearanceFees",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FloorBrokeragePolicy": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the recognition and recording of fees paid to other broker dealers for executing trades. Broker-dealers often use other brokers to execute trades on their behalf. The trading broker-dealer becomes a customer of the executing broker-dealer and pays a floor brokerage fee. Such fees are paid periodically either directly to the executing broker-dealer or through a clearinghouse. These include fees paid to clearing brokers and market specialists.",
        "label": "Floor Brokerage, Policy [Policy Text Block]",
        "terseLabel": "Brokerage Commissions and Futures Account Fees"
       }
      }
     },
     "localname": "FloorBrokeragePolicy",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GainLossOnInvestments": {
     "auth_ref": [
      "r39",
      "r335"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedIncomeStatement0": {
       "order": 1.0,
       "parentTag": "cik0001793497_NetIncreasedecreaseInNetAssetsResultingFromOperations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized and unrealized gain (loss) on investment.",
        "label": "Gain (Loss) on Investments",
        "terseLabel": "Net investment loss"
       }
      }
     },
     "localname": "GainLossOnInvestments",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement0"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r37",
      "r250"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedIncomeStatement": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "Administrative, accounting and custodian fees"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ratio of non-life general and administrative expenses to non-life net premiums earned.",
        "label": "General and Administrative Expense Ratio",
        "terseLabel": "Expense ratio percentage"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseRatio",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/FinancialHighlightsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r72",
      "r144",
      "r145",
      "r146",
      "r147",
      "r148",
      "r149",
      "r185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Federal Income Tax"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet": {
     "auth_ref": [
      "r5"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedCashFlow": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amount due from borrowers for interest payments.",
        "label": "Increase (Decrease) in Accrued Interest Receivable, Net",
        "negatedLabel": "Decrease (Increase) in interest receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedInterestReceivableNet",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInCustomerAdvances": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedCashFlow": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amount of prepayments by customers for goods or services to be provided at a later date.",
        "label": "Increase (Decrease) in Customer Advances",
        "terseLabel": "Increase (Decrease) in Due to Other"
       }
      }
     },
     "localname": "IncreaseDecreaseInCustomerAdvances",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent": {
     "auth_ref": [
      "r5"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedCashFlow": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence.",
        "label": "Increase (Decrease) in Due to Related Parties, Current",
        "terseLabel": "Increase (Decrease) in Variation margin payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInDueToRelatedPartiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInEarnestMoneyDepositsOutstanding": {
     "auth_ref": [
      "r5"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedCashFlow": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amount of deposits given by the reporting entity to a seller which shows that the prospective buyer is serious about purchasing a property.",
        "label": "Increase (Decrease) in Earnest Money Deposits Outstanding",
        "negatedLabel": "Decrease (Increase) in Deposits at broker for futures contracts"
       }
      }
     },
     "localname": "IncreaseDecreaseInEarnestMoneyDepositsOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r5"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedCashFlow": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Other Accounts Payable and Accrued Liabilities",
        "terseLabel": "Increase (Decrease) in Administrative, accounting and custodian fees payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherReceivables": {
     "auth_ref": [
      "r5"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedCashFlow": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in receivables classified as other.",
        "label": "Increase (Decrease) in Other Receivables",
        "negatedLabel": "Decrease (Increase) in other receivables"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherReceivables",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpensesOther": {
     "auth_ref": [
      "r5"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedCashFlow": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods.",
        "label": "Increase (Decrease) in Prepaid Expenses, Other",
        "negatedLabel": "Decrease (Increase) in Variation margin receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidExpensesOther",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInReceivables": {
     "auth_ref": [
      "r5"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedCashFlow": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Receivables",
        "negatedLabel": "Decrease (Increase) in Due from Other"
       }
      }
     },
     "localname": "IncreaseDecreaseInReceivables",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestAndOtherIncome": {
     "auth_ref": [],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedIncomeStatement": {
       "order": 1.0,
       "parentTag": "us-gaap_InvestmentIncomeNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business).",
        "label": "Interest and Other Income",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InterestAndOtherIncome",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestReceivable": {
     "auth_ref": [
      "r343",
      "r435"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of interest earned but not received. Also called accrued interest or accrued interest receivable.",
        "label": "Interest Receivable",
        "terseLabel": "Interest receivable"
       }
      }
     },
     "localname": "InterestReceivable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentCompanyExpenseRatioAfterIncentiveAllocation": {
     "auth_ref": [
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of expense, after incentive allocation, to average net assets.",
        "label": "Investment Company, Expense Ratio after Incentive Allocation",
        "terseLabel": "Expense ratio"
       }
      }
     },
     "localname": "InvestmentCompanyExpenseRatioAfterIncentiveAllocation",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ScheduleofShareOutstandingTable"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_InvestmentCompanyGainLossOnInvestmentPerShare": {
     "auth_ref": [
      "r199"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit amount of realized and unrealized gain (loss) on investment.",
        "label": "Investment Company, Gain (Loss) on Investment, Per Share",
        "terseLabel": "Net investment loss"
       }
      }
     },
     "localname": "InvestmentCompanyGainLossOnInvestmentPerShare",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ScheduleofShareOutstandingTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_InvestmentCompanyMarketValuePerShare": {
     "auth_ref": [
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Market value per share of investment portfolio by investment company. Includes, but is not limited to, per unit, membership interest, or other ownership interest.",
        "label": "Investment Company, Market Value, Per Share",
        "periodEndLabel": "Net Asset Value, End of Period",
        "periodStartLabel": "Net Asset Value, Beginning of Period"
       }
      }
     },
     "localname": "InvestmentCompanyMarketValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ScheduleofShareOutstandingTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease": {
     "auth_ref": [
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit amount of increase (decrease) in net asset value.",
        "label": "Investment Company, Net Asset Value Per Share, Period Increase (Decrease)",
        "terseLabel": "Net Increase (Decrease) in Net Asset Value Resulting from Operations"
       }
      }
     },
     "localname": "InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ScheduleofShareOutstandingTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_InvestmentCompanyTotalReturn": {
     "auth_ref": [
      "r191",
      "r193",
      "r196"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage increase (decrease) in fund net asset value, assuming reinvestment of dividends and capital gain distributions.",
        "label": "Investment Company, Total Return",
        "terseLabel": "Total Return at Net Asset Value"
       }
      }
     },
     "localname": "InvestmentCompanyTotalReturn",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ScheduleofShareOutstandingTable"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_InvestmentCompanyTotalReturnAfterIncentiveFees": {
     "auth_ref": [
      "r195"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage increase (decrease), after deduction of incentive fee, in fund net asset value. Includes, but is not limited to, interest and dividend income (loss) and realized and unrealized gain (loss).",
        "label": "Investment Company, Total Return after Incentive Fees",
        "terseLabel": "Net Investment Loss"
       }
      }
     },
     "localname": "InvestmentCompanyTotalReturnAfterIncentiveFees",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ScheduleofShareOutstandingTable"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_InvestmentIncomeNet": {
     "auth_ref": [
      "r38",
      "r40"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedIncomeStatement": {
       "order": 2.0,
       "parentTag": "us-gaap_NetInvestmentInLeaseAccruedInterestWriteoff",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.",
        "label": "Investment Income, Net",
        "totalLabel": "Total Income"
       }
      }
     },
     "localname": "InvestmentIncomeNet",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentInterestRate": {
     "auth_ref": [
      "r267",
      "r268",
      "r274",
      "r275",
      "r276",
      "r277",
      "r291",
      "r292",
      "r324",
      "r348",
      "r349"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rate of interest on investment.",
        "label": "Investment Interest Rate",
        "terseLabel": "Money market fund, percentage"
       }
      }
     },
     "localname": "InvestmentInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable_Parentheticals"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_InvestmentOwnedAtFairValue": {
     "auth_ref": [
      "r181",
      "r206",
      "r207",
      "r208",
      "r210",
      "r211",
      "r212",
      "r213",
      "r215",
      "r218",
      "r219",
      "r229",
      "r230",
      "r266",
      "r269",
      "r270",
      "r271",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r289",
      "r290",
      "r296",
      "r297",
      "r298",
      "r324",
      "r327",
      "r430"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in security owned.",
        "label": "Investment Owned, Fair Value",
        "terseLabel": "Investments in securities, at value"
       }
      }
     },
     "localname": "InvestmentOwnedAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentOwnedUnrecognizedUnrealizedAppreciation": {
     "auth_ref": [
      "r55"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the excess of the cost (face amount, notional amount) of an investment (security, contract) over its fair value which deficiency has not been recognized in earnings of the entity.",
        "label": "Investment Owned, Unrecognized Unrealized Appreciation",
        "terseLabel": "Unrealized Appreciation/ (Depreciation)"
       }
      }
     },
     "localname": "InvestmentOwnedUnrecognizedUnrealizedAppreciation",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "auth_ref": [
      "r174",
      "r181",
      "r182",
      "r183",
      "r184",
      "r272",
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment in financial asset.",
        "label": "Investment, Policy [Policy Text Block]",
        "terseLabel": "Investment Valuation"
       }
      }
     },
     "localname": "InvestmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentTextBlock": {
     "auth_ref": [
      "r338",
      "r339",
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for investment.",
        "label": "Investment [Text Block]",
        "terseLabel": "INVESTMENTS"
       }
      }
     },
     "localname": "InvestmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/Investments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LegalFees": {
     "auth_ref": [
      "r36"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedIncomeStatement": {
       "order": 4.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.",
        "label": "Legal Fees",
        "terseLabel": "Licensing and registration fees"
       }
      }
     },
     "localname": "LegalFees",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r14",
      "r76",
      "r106",
      "r113",
      "r114",
      "r115",
      "r116",
      "r117",
      "r118",
      "r119",
      "r120",
      "r121",
      "r151",
      "r152",
      "r153",
      "r157",
      "r225",
      "r309",
      "r327",
      "r352",
      "r418",
      "r419"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total Liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities [Abstract]",
        "terseLabel": "LIABILITIES"
       }
      }
     },
     "localname": "LiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ManagementFeeExpense": {
     "auth_ref": [
      "r28",
      "r250",
      "r326",
      "r432"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedIncomeStatement": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for investment management fee, including, but not limited to, expense in connection with research, selection, supervision, and custody of investment.",
        "label": "Management Fee Expense",
        "terseLabel": "Management fees"
       }
      }
     },
     "localname": "ManagementFeeExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MoneyMarketFundsAtCarryingValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment in short-term money-market instruments (such as commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and so forth) which are highly liquid (that is, readily convertible to known amounts of cash) and so near their maturity that they present an insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify as cash equivalents by definition. Original maturity means an original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.",
        "label": "Money Market Funds, at Carrying Value",
        "terseLabel": "First American Government Obligations Fund"
       }
      }
     },
     "localname": "MoneyMarketFundsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money Market Fund [Member]"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetAssetValuePerShare": {
     "auth_ref": [
      "r2",
      "r3",
      "r10",
      "r197",
      "r204",
      "r205",
      "r228",
      "r244",
      "r299",
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net asset value per share or per unit of investments in certain entities that calculate net asset value per share. Includes, but is not limited to, by unit, membership interest, or other ownership interest. Investment includes, but is not limited to, investment in certain hedge funds, venture capital funds, private equity funds, real estate partnerships or funds. Excludes fair value disclosure.",
        "label": "Net Asset Value Per Share",
        "terseLabel": "Net Asset Value, Offering and Redemption Price per Share (in Dollars per share)"
       }
      }
     },
     "localname": "NetAssetValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedCashFlow": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by (used in) financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "CASH FLOW FROM FINANCING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r41",
      "r42",
      "r43"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedCashFlow": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by (used in) operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "CASH FLOW FROM OPERATING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r34",
      "r43",
      "r53",
      "r63",
      "r70",
      "r71",
      "r73",
      "r76",
      "r81",
      "r82",
      "r83",
      "r84",
      "r85",
      "r86",
      "r87",
      "r90",
      "r97",
      "r98",
      "r100",
      "r102",
      "r106",
      "r113",
      "r114",
      "r115",
      "r116",
      "r117",
      "r118",
      "r119",
      "r120",
      "r121",
      "r154",
      "r157",
      "r173",
      "r246",
      "r263",
      "r264",
      "r310",
      "r326",
      "r352"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedCashFlow": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net increase (decrease) in net assets resulting from operations"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetInvestmentInLeaseAccruedInterestWriteoff": {
     "auth_ref": [
      "r108"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedIncomeStatement": {
       "order": 2.0,
       "parentTag": "cik0001793497_NetIncreasedecreaseInNetAssetsResultingFromOperations",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of writeoff of accrued interest on net investment in sales-type and direct financing leases recognized by reversing interest income.",
        "label": "Net Investment in Lease, Accrued Interest, Writeoff",
        "negatedTotalLabel": "Net Investment loss"
       }
      }
     },
     "localname": "NetInvestmentInLeaseAccruedInterestWriteoff",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r31",
      "r48",
      "r179",
      "r180"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "ORGANIZATION"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/Organization"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAssets": {
     "auth_ref": [
      "r49",
      "r65",
      "r170",
      "r327"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets classified as other.",
        "label": "Other Assets",
        "terseLabel": "Other Assets in Excess of Liabilities"
       }
      }
     },
     "localname": "OtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsMember": {
     "auth_ref": [
      "r20",
      "r27"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other assets.",
        "label": "Other Assets [Member]",
        "terseLabel": "Other Assets [Member]"
       }
      }
     },
     "localname": "OtherAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherIncome": {
     "auth_ref": [
      "r175",
      "r248",
      "r293",
      "r294",
      "r295"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedIncomeStatement": {
       "order": 2.0,
       "parentTag": "us-gaap_InvestmentIncomeNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue and income classified as other.",
        "label": "Other Income",
        "terseLabel": "Other Income"
       }
      }
     },
     "localname": "OtherIncome",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherInterestAndDividendIncome": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedIncomeStatement": {
       "order": 3.0,
       "parentTag": "us-gaap_InvestmentIncomeNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after discount, accretion and premium amortization, of interest income and dividend income classified as other.",
        "label": "Other Interest and Dividend Income",
        "terseLabel": "Dividends"
       }
      }
     },
     "localname": "OtherInterestAndDividendIncome",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherInvestments": {
     "auth_ref": [
      "r341"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investments classified as other.",
        "label": "Other Investments",
        "terseLabel": "TOTAL INVESTMENTS"
       }
      }
     },
     "localname": "OtherInvestments",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherInvestmentsAndSecuritiesAtCost": {
     "auth_ref": [
      "r52",
      "r342"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Includes other investments and securities that are not at fair value as of the balance sheet date and those that are not accounted for under the equity method.",
        "label": "Other Investments and Securities, at Cost",
        "terseLabel": "Investments in securities, at cost"
       }
      }
     },
     "localname": "OtherInvestmentsAndSecuritiesAtCost",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesMember": {
     "auth_ref": [
      "r20",
      "r27"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other liabilities.",
        "label": "Other Liabilities [Member]",
        "terseLabel": "Other Liabilities [Member]"
       }
      }
     },
     "localname": "OtherLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ScheduleofPledgedByFundsFairValuesofDerivativeInstrumentsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNotesPayable": {
     "auth_ref": [
      "r12",
      "r51",
      "r426"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedBalanceSheet": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term notes payable classified as other.",
        "label": "Other Notes Payable",
        "terseLabel": "Payable to Sponsor"
       }
      }
     },
     "localname": "OtherNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherReceivablesNetCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedBalanceSheet": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.",
        "label": "Other Receivables, Net, Current",
        "terseLabel": "Other receivable"
       }
      }
     },
     "localname": "OtherReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherShortTermInvestments": {
     "auth_ref": [
      "r30",
      "r169",
      "r344"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term investments classified as other.",
        "label": "Other Short-Term Investments",
        "terseLabel": "TOTAL SHORT TERM INVESTMENT"
       }
      }
     },
     "localname": "OtherShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "auth_ref": [
      "r15"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedCashFlow": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.",
        "label": "Payments of Stock Issuance Costs",
        "negatedLabel": "Cost of shares redeemed"
       }
      }
     },
     "localname": "PaymentsOfStockIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedBalanceSheet": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets.",
        "label": "Prepaid Expense and Other Assets",
        "terseLabel": "Prepaid expenses and other assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfessionalFees": {
     "auth_ref": [
      "r326",
      "r433",
      "r434"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedIncomeStatement": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.",
        "label": "Professional Fees",
        "terseLabel": "Professional fees"
       }
      }
     },
     "localname": "ProfessionalFees",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_QuarterlyFinancialInformationDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Quarterly Financial Information Disclosure [Abstract]"
       }
      }
     },
     "localname": "QuarterlyFinancialInformationDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_QuarterlyFinancialInformationTextBlock": {
     "auth_ref": [
      "r45",
      "r93"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.",
        "label": "Quarterly Financial Information [Text Block]",
        "terseLabel": "FINANCIAL HIGHLIGHTS"
       }
      }
     },
     "localname": "QuarterlyFinancialInformationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/FinancialHighlights"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "auth_ref": [
      "r158",
      "r159",
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party transaction.",
        "label": "Related Party Transaction [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/AgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transaction between related party.",
        "label": "Related Party Transaction [Domain]"
       }
      }
     },
     "localname": "RelatedPartyTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/AgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": {
     "auth_ref": [
      "r64"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Domain]"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r33",
      "r47",
      "r172",
      "r177",
      "r178",
      "r190",
      "r227",
      "r321"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedBalanceSheetAlt0": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated undistributed earnings (deficit).",
        "label": "Retained Earnings (Accumulated Deficit)",
        "negatedLabel": "Total distributable earnings (accumulated deficit)"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetirementPlanFundingStatusAxis": {
     "auth_ref": [
      "r337",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by status of funding for defined benefit plan designed to provide retirement benefits.",
        "label": "Defined Benefit Plan, Funding Status [Axis]"
       }
      }
     },
     "localname": "RetirementPlanFundingStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanFundingStatusDomain": {
     "auth_ref": [
      "r337",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of funding for defined benefit plan designed to provide retirement benefits.",
        "label": "Defined Benefit Plan, Funding Status [Domain]"
       }
      }
     },
     "localname": "RetirementPlanFundingStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RisksAndUncertaintiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk [Abstract]"
       }
      }
     },
     "localname": "RisksAndUncertaintiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SaleOfTrustAssetsToPayExpenses": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of sale of trust assets (includes, but is not limited to, gold and silver) to pay trust expenses.",
        "label": "Sale of Trust Assets to Pay Expenses",
        "terseLabel": "Total Trust"
       }
      }
     },
     "localname": "SaleOfTrustAssetsToPayExpenses",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ScheduleofTransactionFeesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented.",
        "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]",
        "terseLabel": "Schedule of Gross Amounts Not Offset In The Statements of Financial Condition"
       }
      }
     },
     "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]",
        "terseLabel": "Schedule of Fair Value of Derivative Instruments"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r155",
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of Valuation of Investments at Using the Fair Value Hierarchy"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for fair value hedging instruments of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.",
        "label": "Schedule of Fair Value Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]",
        "terseLabel": "Schedule of Effect of Derivative Instruments on The Statement of Operations"
       }
      }
     },
     "localname": "ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharesIssued": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "Shares, Issued",
        "terseLabel": "Shares of fund"
       }
      }
     },
     "localname": "SharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/CreationandRedemptionofCreationUnitsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "terseLabel": "Shares Outstanding (in Shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r62",
      "r67",
      "r68",
      "r69",
      "r76",
      "r88",
      "r89",
      "r91",
      "r92",
      "r95",
      "r96",
      "r106",
      "r113",
      "r115",
      "r116",
      "r117",
      "r120",
      "r121",
      "r123",
      "r124",
      "r125",
      "r126",
      "r127",
      "r157",
      "r186",
      "r187",
      "r188",
      "r189",
      "r192",
      "r194",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r226",
      "r247",
      "r265",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r336",
      "r345",
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [
      "r78",
      "r79",
      "r80",
      "r94",
      "r168",
      "r181",
      "r205",
      "r218",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r226",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r245",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r265",
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedBalanceSheet",
      "http://www.vts.com/role/ConsolidatedCashFlow",
      "http://www.vts.com/role/ConsolidatedIncomeStatement",
      "http://www.vts.com/role/ConsolidatedIncomeStatement0",
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable",
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable_Parentheticals"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r78",
      "r79",
      "r80",
      "r94",
      "r168",
      "r181",
      "r205",
      "r218",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r226",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r245",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r265",
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedBalanceSheet",
      "http://www.vts.com/role/ConsolidatedCashFlow",
      "http://www.vts.com/role/ConsolidatedIncomeStatement",
      "http://www.vts.com/role/ConsolidatedIncomeStatement0",
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable",
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable_Parentheticals"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract] [Standard Label]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r161",
      "r162"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "SUBSEQUENT EVENTS"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_UnrealizedGainLossOnDerivatives": {
     "auth_ref": [
      "r6",
      "r259",
      "r260",
      "r261",
      "r262",
      "r286"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedIncomeStatement": {
       "order": 1.0,
       "parentTag": "cik0001793497_NetIncreasedecreaseInNetAssetsResultingFromOperations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.",
        "label": "Unrealized Gain (Loss) on Derivatives",
        "totalLabel": "Net realized and unrealized gain (loss) on investments and futures contracts"
       }
      }
     },
     "localname": "UnrealizedGainLossOnDerivatives",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnremittedEarningsInForeignInvestmentPolicy": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for tax treatment of unremitted earnings in a foreign investment.",
        "label": "Unremitted Earnings in Foreign Investment, Policy [Policy Text Block]",
        "terseLabel": "Investment Transactions and Related Income"
       }
      }
     },
     "localname": "UnremittedEarningsInForeignInvestmentPolicy",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r17",
      "r18",
      "r19",
      "r57",
      "r58",
      "r59",
      "r60"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates &amp; Indemnifications"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.vts.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    }
   },
   "unitCount": 4
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482655/740-30-25-6",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-8",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "323",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-14",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-3D",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482053/820-10-60-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org//718/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org//1943274/2147481435/852-10-45-14",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "https://asc.fasb.org//855/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(g))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.6-03(d))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.6-03(f)(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.6-03(f)(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.6-03(f)(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "205",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "205",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-18",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "205",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "205",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "27",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "205",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "205",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "205",
   "Subparagraph": "(b)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "205",
   "Subparagraph": "(c)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482134/820-10-35-54B",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "205",
   "Subparagraph": "(d)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "205",
   "Subparagraph": "(e)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "205",
   "Subparagraph": "(f)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "205",
   "Subparagraph": "(g)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "205",
   "Subparagraph": "(h)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(a)(1)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(b)(1)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(b)(2)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(c)(1)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(c)(2)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(a)(1)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(a)(2)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(a)(4)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(c)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(e)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(f)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(11))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(14))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(17))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(19))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(8))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-05(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-05(4))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "220",
   "Subparagraph": "(b)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "220",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "220",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(1)(c))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(9))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 4))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480401/815-10-55-182",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12(Column C))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(i)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-12",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(2)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-19",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 9))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13A(Column F))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(5))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-14(Column E)(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-14(Column E)(Footnote 4))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-14(Column E)(Footnote 6)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 4))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-14(Column F))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "59",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482134/820-10-35-59",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.5)",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Subparagraph": "(b)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Subparagraph": "(c)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Subparagraph": "(d)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org//205/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "80",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479294/326-20-55-80",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(b)(1)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Subparagraph": "(d)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "830",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "830",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r328": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r329": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r331": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r332": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r333": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r334": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "321",
   "URI": "https://asc.fasb.org//321/tableOfContent",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "325",
   "URI": "https://asc.fasb.org//325/tableOfContent",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(12))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org//320/tableOfContent",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(a),(b))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(c),9(a))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-8",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "205",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-13",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "205",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(a)(3)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(18))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "220",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "220",
   "Subparagraph": "(k)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(2)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org//235/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "270",
   "URI": "https://asc.fasb.org//270/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "https://asc.fasb.org//275/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org//810/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.4)",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-22",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-7A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r62": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "205",
   "URI": "https://asc.fasb.org//1943274/2147479910/205-30-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "https://asc.fasb.org//1943274/2147482964/270-10-50-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>53
<FILENAME>0001213900-23-066764-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-23-066764-xbrl.zip
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M_>V%I9VX3D'H0N5NA4E-K?^RDPE<Y$YXTW8W_DO>3E0K"CN]7A<. 67F+!P
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M4(!-@4/02Z&I]:U67[T_C+GHWAM=;F+M(:IOT W9H)4I^VF/=?'MB!E/O([
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M7^>5F_O_S>_UX<&T>3VY?0#/0Q,Q]O4.?>]_K8"GFH'NU1EY,&!_</#XO3W
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M%5RP8F?KZ*<USXHN_[)&D2MM<+3925ORA(I>,Y6QT=Q2%[^C]U3+86JX96]
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MS"8E-5!4DT899A*0:/'N'4!SJ*C[Q996-Y*(.*=F6K^?@4+I ]<;VOPO6O,
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M &9OR^(C)'H43U).V$Y@3FU9<DEQ'L>+:3=]DR*M_G297[L8:5*G)>P]]>R
MI>C8KBI'!@HP#EFQ/@K >;C2E7NFJ2^\%E%&6BH%:2G-08:30 =%;1+=43@=
MV?%N5Q2L,*ZY513(>QYJ!Y4 M-6=2XR2R%LO)BCV4FO:I)9:6Y<47#!RXBL]
M91O6#629.""M6Z8V3FK+Q,YQTC*)92>S3 )6&.1;+;('F- ;OH,$$]KPQP\A
MM' 052W"XXK2L&Y$#X3B86,&?/IZ1K8),*:4Z^&THKV()=5H(2+5#[9^O4-*
M(A192U/XY/94EQN8!0GQRZ\1K_#M2A!ML*^^3R=/P= 9;JK5!@X[A1+-4: B
M4*%SN XBW%(T+_Z)YQZ!?#:@T\%O&("M,$)'P;+:I<.2_O?Z>4VJ:R_)GIEB
M0 ?1,O%*@YLHN8X)$1'EAM 9@$RIE81R1*F4,JPKE)S^CC8K3;)_WN 6T+HZ
M@R8P^H+^5>E*'=8(=J>VH"0\%*19L/)"\!EZ.*N&9,FV93^F\+ELQV)NDS1
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MRN$4P-0X\" -'U[KH@LJZ\#J0]LX.* /&I9!1*W90ZK%>@V3(-I,X]3,,G
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M^]$#L$RE, >0CSV-VV</<8()P4&\8!7L/(3K-40+HND;H?I4(XB=+J$@!:G
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MGD[HHR/0D6H*8)JA%).<V!ETY*;7\+W&BY&^6N-$&=ZKQ (,P'  !@06$6!
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MQ'2.7!OA]@&&8?YL2U$+@0PM7K[9+WS 8MY,H!#19O,!XC+.O/ &9OLDZO+
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M7Y1V9NBX=2ZODW@-TQ2M[H6X#9'P(V/&D99,EB75Q)LG!#YM@[Q#5@1"[ME
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M1U6%3BZ=1I-\:A.+B+/-DD *HKA.KPX?K%_W-%O ]LK4$G20=N,ZH$FAWE4
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M/J[#9R-];F .\OR]PTC)1LFLUCL;X4TEYPV3 YE(' +$%E9(+<MYH[=[C;9
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M.:XB74VEV0'NM:06$B@6F"9O1@P)X>LF_-_LW_O@T0NQZW>#/O4D6&70QW]
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MG3S[V(5#EL).R$RKK%"^+[H3_*VC+8T6M<@;U;4Y\](@7:S9.D3X1CG81*3
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MC$O,-,/&'L/$65D!N!)!F:QJ'836MHCI"0;C9/ )M$(4G>LG@6\]32!R:"
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MV08U.,K1)7/2C&2!O,D0O)@NY[O3[$M)GULN68V2]6AO(,!P>R,H.7#_@9P
M^K.9_AH5[I&[';F3DJ5R#>U4_AX(8?0> I?677P CG?C8SPJ:;4N<OV@@F:W
M :R1AQG/)4H832%:9DH@$BXE,:HD:2;NQZ6*%*-J<1BZ:[#-&26=QK D+@4R
MA@[.W& 4YZWS2H"P,1M&V^^U]^"A+?N#%6'"BEN.7<#T9QVWK*1&Z_"%.&D!
M&BJM8UF"E'&-IC%#U-3%'17-+K.:65EIM)N"*.Z;$/8,-1G4$N+&MCQ56'F%
M9_JB5LI7NI^D+^WI/B+6C=:)HJW*$T2MO!0.^0J'Q>A@8R%ZGK%A_/>UM[M6
M> ]QZ-(&(5%#O=W3D?(;K,18':FR*=M?9:2G4-DL?S(LRVZ=2J)93J_##E&%
M$ SWU-BF?7>%$!?.VK&A9S=9@5 V6,?RKZ<L>UHG+Q,U/OLQ7]FE5:1CIDR$
M P[&E#4^(M&!JQNGKQ2>LSA<WCA<WCA<WCA<WCA<WNCF'8'#NX8=!^APB:,#
MESC2HZMBA)U!J"/B9QX66?,V6T:XBQQE8KZZBP>98YBP$>5JERL:9,O$U#N$
M>WDV=Y\S<E+5E%F4&<G0P;X:22F1&>GS4AO>MW/A_:9@U\A#]]:U9AF;*? X
M1-4EH5>(IK>=J]XVPXQZT4P1\#"P=/A(M60[<<1E^DOU$C%QE2Q]Y]'QXI^E
MZP@*A QU3./4O+A*H#A[<Y4!*3=D68]F^7<]'._"=UV ,+NOE@1.7(.8:E,H
M!2*?V$S5!F0,>,9P4WM=-EOU/8]W(#.=T01 EA&>KN[FHNNX8IN6SB:74^SN
MCE<I!Z.MYW5UG.^!V\&8L\G+4"_T!892S:I^>$$B $-<>\>W">8HD-R'"NR\
MO&;B8G!\5DK+QX!<>GMN0=N)^2' BRO7__)*;EWNC,AHEE!JZN'5RJ$.>?D7
MEY?G4:U#<KX;+L0A.=^7W.\A.=]Q@ [)^0XDYS,WE.G>,T8^K8.USS</F-8R
M;@/EWGQ@!<ZZR=?F)1CH1:]R&<$:K1*( TG^$M*TN'Z0,[1-^UWR.E^XVY_*
MRPAV _NO<)O&G/KWT/(]RW%ACK.IK[K$!9XY;H:;3CB S,7>F/Q-9+S&(;(6
M $.<2X]+ZD(),1-0-KQ(J!Z4B4YKRDP(2^1;$-I1'F "7,(8N@7!]J4,+?CR
M#_!2,1<0L='GI9)LP\4NVT"?$"3,W?H>W%S E8^=H,$7P\3'-Q*I;D%E%!"1
M.![HL23E/(\17 %GU[<JNEG7N.HP!S7E4!I5&;;X)5)86N_W%_G<ZW=%Q 2=
M-3T9-]&466CP%[HQR4(AT4F@1'7T*$ZDT2F/NL^D' -^>_M04>8230?T;#Q%
MYCX"%-?OW@(T=[PQV!3S6<*5([7D7ZH2\,M78XL#3::A3:OP;1L$EBUXVP%;
M<!'"J3\D<O%M!\@VA:HE^T(]A'IQ;I%^UY$#:\39$J*!O::M=)M?](4!O[V5
M7Y3Y5BG>=T0I(IV]ARXU+&. Z R'(:*R;%P]*H;^]A2E"H<D\-7^2V7[I^78
MF9GZDQ5-4<OFW#D(O^!@!(]8$\1UW"+0>(XD1U\_)*+9,DP?"XD/PS<.>'3<
M:,KM'#"Y./GVK(@ 2HF*M7P[,[UFL?^4B9Z3:#E=,_4L+1J4"I$F8+=]3S-E
M[<:QH(?I7#S['LZW[POYGD[D><9XJ39!4-*)0B@_:])LN92Q,JF7:RUD0$BT
M1;EIJD9MN7(\<J(R6%Q7Q4"?B^LJ!:NMI8-*'<9H]N YVHHN$FIFZUWEM9Q5
M1K&3D,96/%+/]H%-9,Q&LTG@6T_7&(<T#!*]UJ1YE58.U=%B24YT^:2I]:F0
M9@VU,0/=ZT4N(V<3]Z 3/BF3],_EWZ&S)D8I>EF(3,NQMA<*(P<U^XO,)\?1
MO<?]$^[EL^6&M)8G>1ONGBCNY6P&M6_Z+3/?"X>A;4"5RW"F*@]L:YEUE[32
M: FX&6.@37MUWZEO71&UW\)75D6#YJ[GRJB[HT!+_00FU@+:H0O]6>[5+$#$
M1FUU%)@2;"^VI3AB4E2\B,-)7+K(\]!0H%L-!<24J>&6 F)PT4O#*?O44@2;
M6Q@LJ)E*IE+\+81W8 DU-1Y0&KZK5XW5Y:I%%81UH8RG"W\)'$\#VC4#F,%3
MURI(D*^38L8C%%ZQ5P["P6!)MF(+>!_\-41>U,/DT77F<6_5J]"SE3H;" UA
MRNCJQ$Q,IB8NAQZ:O^ROL=KF+RJM'(2;OSSK[_Y23M*<D>1L %,A#7T=8 [=
M7V30::C[BVI['ALZGV_@'+@1WYL:LX:A]=W<7Y^0;\56C?R0&C06K6X\;EDP
M9,QIR[?!E/7\*!LQ![5^7KWH<X1,+(4*74IDGI_LOCLFV%'^?'29KB8EH\(D
M941U:V3(GK-6\R$/ =F -**04C.S[0HAD9FZO!=4 *.#AI.CE9=$@9I2*Z_M
MT[9-O?!4(-\)U[PRZU>4B+ZB$FF$6/W.]8#3^;[G3#GH[OAW:+LMC$>Q_[9R
ME9Q0]_F0[ABCF?(;5P4ZW5T*C#F;[#Z?&LG1%P_:] DMRY][]!$M]G-:FI>+
M^/@]6%820I5W'>1UX,$C8[H;^D06L.!@26_@#();@)Y@\!&XH?3+1QR$35<W
M5@/)(QF)_A@:MZ^H853,$(T0XT$P! A1CB/^-*_2NM&Z:VZYY:6OUX6T@QC%
M+J<0+1OVY9GC]**:KT),$BTJ]-U1WRMV:78QU@S6"R#K!*:S#45'ZH0^CR/9
M+6#@6,#%A[*A0]G0H6SH4#;4D;#FH6SH4#9T*!OJ"V:'LJ%#V9#B)LIB1YO1
MK"!N<OGQE*G4R4;%%![*M83+M32D] _E6C+H\)1KZ4CQ=],=YLCRJU1)"1F-
M-&=Z[5T^6Q#CT2S3%FL,D47E-I=M1B0P0"=V5V9@241*NFH!9,(,%\1G6Q.Q
MK>'N1=XR )4C#M5C]2"/5B,L$WXM#5R>R99W1=_ML-RWD]/6,$>VD6-R'-J]
M5T"8;BSOG!ND(^&9RE51)A]=902"L$5]/5QHSZ$]P$/?I>U@$7 5U@B+6I>!
M*96 KJ1^6UF,$9H#S_D:ER1(IS(S1%)'DV+EV>,,KZ/9MOL+<'?B;:H=FAZ>
M9%,+2J-?.-AR?4P<\"D!\YR,]-0EX;#8,YR!U*J N>RS=ARU5J6VDN=TYIXS
MHU''8-NRU_'F8R((B[9NDG_IHTBL(4M0,9"D1W\.L$/.&ED%(/I0*:BF5K(2
M*X97;;T&9)>BFM U=AAL:^%E:UTDMR&&!9J$JY4;V:>&EAO?F!(=N7?28)04
M"+1AWB,CTRUZ1Z+@&\IS<Y,K$3"V)H4T)N[HO(^+SJQPBQ(H4["]21:C@BVF
MOXOGP:;V%=8(1A2S:K6QC\C]MOJ#.8(P,?HBNI%^,5W#JH^\5Y$4MN I-14#
MOD]%](26?E_5>+,H&7L0A@/\Z!'[?0PTV#"#DRT8:B:Z.NRTZDHLL=-*2W'?
MD3>)!-,VUPA"8U*FE5#9C'!(3A=Q(VOAO3OW=47#S*8E[D_DZ*A8908A\5*)
M+ U5XUQ"S(2YJ@0^2F0R4-!GLTS-M&";R_!MO: XSZ:B82XA9ES1F :Y;.;:
M_.263/$0P8@,H.UG;;A<T7_XL^37\:L2RC$3>F-WN8(>CHAN7SV,1#=9$! >
M ::/(&Z:S&(H,B.\-'@$J[)/\-.7R$IRT%;=5L3&Z$@D1T6/HV0GOU+T-/8C
MK/:\8NE$M(A;$\ZSFM!49$F5&U-G'2GSDBMM4H5![RM);>S3NZ3HK\Y\X9(_
M@4K&\/<0H(!>TM^1O?9F/EI&G-8%O93U5G1TB5LS!6&I;+6EY"3:SC%HJ>ZD
ME23-EOY(ZEE\2Z<,PUX>Z.I4LF3*VG<]_>:BJ=V-<U!3FQC/0L[N6;PR[-L!
M\M[!3PH[$?TZ'GCV@V=!% #':_!=S^JQ1&/3E)K*KI)^7V)ETB^K[AMY&F8W
M"BXUH,LI(_6>GI *>I-,2XNM9V9;Q5NR^!Z]*!"_(TUY:[Z0DFM($[% YE++
MM6/A$E8/$^B3\!'#OT-"[7*M4CNU3Z<A\UXZC*AEWR>D8N79M,0C$/MT5(U_
M.3VS5VQJ5(6NNQ)X=.3??_[WX^.C__WC]N,/__>_?UJK\/F3]\-[^^O;]?S3
MQGNX"+]\>(O>O_WM]5\/TPUVWZZMKZ?N/X.38 +_^?7MFZ?G,^LF./W7U=7K
MR6\GZ^?SX:?3M3U!P)_>_K:R;T<?'VZ#^U5X_B[X^".\_?#'R>E;[^X=>OOZ
M^^M/GX)?PS=73Z^=AW<?W]D_?(7('[R?+\;H>?SC.P!^>' W(1C]=?+VX]B]
M^?/WY],/T_]^GMJS-ZOKR^7-1_ T\YT@^/W.^=?#[Z?@<> ZTY,U^NC"AT]O
M_OC7Z)/WZ>S3VS_^_@1.?K2^_V/V[OO?_KI]_/['^7IY._C[+^OU\JO[]Y?9
MYLMD<S>\M.WSZ?\=#2?WQ\<FM*%R ;)4H!/!P0+7#>V4Y>,8\FAJ;5/N4G"Y
ME'I6Q5"LDC[?1#]M9#?*'A;R7RXAFA,Z'Y#_)5C08"SPME)0S0=SD>Y%X3V?
MD,QV67_ M+$.#IPE"+0_V+Y'W*B+(7978E\L&D]F"O=E]N90O>!TW8RI&]1T
M0PJI2S"UDM1WGUO(W=]=?1O-Z W9*]?_@O6852[2O3"K?$+2=[-;-,_C)HT7
MHKZL5SZZ<K %W/@]:<*G.I:BHYAL0<*'J;#<M%T35[T_TJP-+A^G%TN50USZ
M6L++(7D%'!0I7.8&\K5'IA)&)F;KV>M%E6],LZ%Y,8 YI:BM8;R4J^LAN'0"
MVK\+((],#%][Q,I 9^[MZZ=N/UA@Y'ZY4T(RU=9N7FZAN[Z/SI'_!!&8PV;6
M-6N(7AEJMI"T=9:7WFTM?PFGX+GIS;9DF!X=7,M%M07Q?7^*WZI;$]#@L.@5
MSQY'W-(VR,,P\&>SJ;.$-'4>_4T/0JX5NG%5"96,\G%1=KA>F#MY89J-UJ5\
M[QRNN,4?X3W3N/$6 IJ&MD?>/;1"1"^L1'&/*LU0ST]HY:U/SJ]F5+3%&MMO
ML[(SRH=N*_M"T=ES)2TG4&*ID+!39>MF[QI_!Z[N2#9AT7L=QWPOELJ.+ 5M
M,-$DMFA,TTZVF4C"M;<+_V9"#6,?.U2J._O;_":GASO3'6%*# %[=],$B,E6
MTHRM^E=HTR1M9DK9!$,Z(XBBNFW/@F1;+TSTA@Y;XWPWX6(URKV)O(&L<K:$
MIYD'N--I;GOFGF^B%SEWD\8EJU/S65!M]([T)6-KE#81:^P$KFCBDN1HZOH
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M_>GRQ BS'KO6?M)-XS_L\\>55?LDW\8"Q:_GYOSQO'>.NM/9Q'HCMK> 52Y
M=];Y!M0^;3XQ(>4+KFA1J=31&AE<#C]9Z+LU 0Q,8&N@'BAJ>.CM[57)09"$
M>[@S&@&<CO^?6_#&>!I0XCCT\'L'_6:!A@-7>;2^WW J]V'S9<+I96]NP Z1
M)"F=(W%HS%W!G_=VWWHQ3R\?],D4_4;TX3/Z'9!&3"=7O#%9<F\_@!8S:%'&
MY?7M1I@OR_,?+-"2D_\S9I[*$T6):Q^8)F<^:-0TGMFP:F.F3Q!Y)<.Y:_RD
M%C-('>)\1&< ]@F%.YYIG(^0.52@,S9Y*7-V;*)[!#UK*\K'+6&^N$^\M4"?
M/CQ;YB(.("A\BQ/4B ATN9RR=/'^ZZ]M@5<O'+AT0F845C_H@<&-&D[FU#8^
M ?%,RX7*99@F7I&',U5+6@PN0^%PS\LG-CCV$;%TQ MG@X\G?A2],W0_5X!%
M*^!=KGH[SV VM.B[X3K3>K'UV05:-_@]_V?Q%E%([QKE:47W:<TB56G,5!A.
M=,>)LO)WN#'+3?EA-QGW/*JJ"+)URF*H]S8=6),S)]()*@ ]A3$59>#"!,N=
M'SMDW$2"3!O($5@.?+,4-@LQ$M=;AH7!0IYL:VZ.Z+:T[,_HKU=7W>[U=0Q'
M>H=-P8=M"E\POO'"@.V,G)FIQ;^".T;SEM]O_H6NY^Z<>F;=_G62\$L")LJ$
M"Y_S/<;/&1$]6']UUKP>H:.,NQF<"W@C2"#[X?L\T7(UL CZ[?_^M4A2EQ1G
MVH$>H<3M(;RB6PMD;34WAU#6YOA6G<TA','F*"#0MR__40W#_6G%<$=WX'U6
MP'IO',P#E,D618S3RQMS1(/MA'9(#I\)( (N^ 'V'F%9!LI]H43R&?\1/>L.
M*_\8(7TR\>NXG!.;MD519@8>'A#_ GCF@I\3%W6A$?P*VH1>.K/)D# [GA<0
M*ZUTT!D\CY8[.7.P3!UJE1'[Q"]V<I]U=QWV%YUNNB64K(2%W>ROX2-&NCE"
M9X*WQ@&(2/A]\&]8 ;V>70HW42C\Y] J. <%-5<SW7&1QJ&1_N:<!P*&5?BF
M"J5>S6T;GN_5UE%=Y>HNK='\7[(1"PZ]3/)?=F<5+"?^/7=<8_P6@S?#=TW(
MV/740PG<2JD(!)P:+FT!)A,@I&V9U+R:O)T0,+7>T W=7_J018"_Z*Z.:%T2
M6F/FY3/"DIH* 21Q,N771_(TGW@IJUZKC\XH3M0+013._0O<9\,!B/49+;D(
M<?9)7,Y&"3C;@W?!L,3YF ,[AC!%$>5S9PW9L23F WKK: )/($@?#H'Y6"/Z
M":6'305-^%L4?(L BZV('UAI*;S##H0!HKW,NOF&J52%AX$HHK ^(?"P7]SG
MX.=S6 IAD(W(V#!902C-@)S0P+; 76S Y[V0_<I?8.1?MO>"K?#Y%S+!ZE^[
M!NK)VI6&Z>TL\%%:0J JPOKA/'=..NY0I:!\R-.2OV4LTPEQ!!69]K:06AJ(
MY5P!7A2E)X_Y\=J.&IDTI,AW9842(6=8(ZBP"'ZDA35QZ19AFHQ),"K(GRS[
M+:J B^'RRK\@3R2 "]?:3K1]95N)$'/ [9/'ELES!3U?.2TL:38*!E1.#MLE
MA_9 C^<8D+_-'<,DCI,[_92+6%'(& F>A/F@V)=7D&^Z@:'RNV=359!K A ]
M"'T #\,]A=?CE6'ACW?8TK3D(](!,,9KMO\)=3R9NPDRWK28MSAW/#L<%L2Z
M2J,ZM,"4I^^:O-&7OQCP:G@M,@%XBYK6/PV'V=^F;@X-?4+-=EI73"^FLW5&
MNCUR$"U,-D8A5_4D'%04S_2/D39UXB;7+;V!/EN^+CO]O/[6K;V![](M=)[!
M@PCX"IWIS@ESS[SFC#W>SXHO'[C7X(0G]_!CD[-'P5T(%^K*%TS#LJ+/-!J5
MD( GJ^'/D=\+ZS /UP\DKL>/UH.A#I 7IXF(.O.! X\FWJYF;CT%RQC,_2IP
MY"R?P)HB@=EF$Y!I0/NQ84\],&BUVMQVHX)"JXQ4P>@-NPL$,:$O94.G4G$"
M.$^L$M1OH<=L=!_>#"".3OQ-=,UB7Y:YNHO$4S0B0P-L-^?7TYN[Z]5-9<ZG
MK9'%.E7I)1$A7FLZI2TBUO"'5^5]/W>9* >9?HIH;SYA 8:Y:7@O=-A5IY<"
MC]L<A[EERV0 WR7RKJ&+&[+' ^;@^1C]C4,SW48_]<F<4)7C78B1M7QG_J&5
MTJ5Q-:>;+::7;9ENMIA^=L#:QH-1A:[F FZD@HW:SOQR:6Q GW?#%FKQ0@2Y
ME! 5UL;(A;-\T2D*+^>V>.8NGEA!V0+,;6 /;*+_: T(B A8Y8RM.OP2)>(E
M='EA0%=$V-Z7AQFGF'3E 8I?5[MM\^?5TA?49T%FD-?^2$FG[)4=.,I]@O96
M0'E,O=&@V%Z+SVZYC(]W%5>-BE6Z42-[WO;B:6>-9;#JRU]T]&Q38^*O/_[@
M.#YWZ&T7W9RCZYN[SMW53><6@5ET__BUTU\?XZA?KE CBD+A[^*A8.LZA3S7
M>>.2*7 %R-; %V<-55-O\\9?7SG-EGPYG"3FCF'A''W53=@.%+&+5IPOAC.<
M>U-(J,_5,?7)FV,P@W=)#Q"E(R^X0J]Y),Y\XK)+[F?$ZXZM(*&$Y(3:2@TI
M=VJ(Y^@?-*!D *O3<@F*6/AB$GRF=)E8#JOZ[ S JP#BV3^(BQX-YT?UD-TN
M9U?(N=-!.F>&@FU-O*##@VT-R8BBO7I(UC)Q]!Z-D%Y+I"&D4HBB!$UYW_^?
M[F-%M*1:A):\)4\@D1F;LDJG"O(ISY4C#=KYX[=SS@0LNM:'KF4?"6ZW(E K
MPLCX9H:*L7OZQ(N>=?^<L_$+RX@JE;;?'.:J^=Q\).A.P<H\5X2!\86,=6:I
M?9O14DIB&I8=HL!Q8'LK2G/UQ0);X:MA$F#J,0%>#IEHQX'*-(R;OR<H@Q)G
MJ:(;<W&.SG'@=RL2\W?VE'/4?7TV!D8E7>AH'SI&S4.% I )P_#"!3C+S%/^
M3%\0U!"4'IOW5FO2C36)M>C4P?PP-@(\7"!Z=L%G=&N]$)N][@+1YC@/7W<6
MQ8>Q$F@/[F28:A(#&RS'_J4C8_3K:1" 9!L]+QZ/%8,L8&_MGN"SMFHA_U7O
M"DK&&TM<(5FU-5ER8X[(:YD#@8XQ:1)GRD2^8RJ#,IGUQ$:3L=EOOP;W^WS6
MHE5+GY%&E<)*-4Q+8_#D5S>]$!];8NMPZ_"9C.9>]O+&_$D<EUV/T>J]RZ#[
M^B]7K,C)H75OK +FV9H -1T_V._[X%Y?YMJ-NO.,KB?6B_,YBI\*C).-#3/O
MO-F.N2)5LX2O6VKQ;IJ'XEP=M:VS*:J'X&Q!\W4LYNJI?>]Y>/$+,*J'NRV.
M6@'<F6N"[<YRX7K7JDE&>2N>C]HA%M^=0]S:Y1%W;'U@##>]87ZK-]QJW.&C
MJ9/;/N)FQ4SK. [QB^-O#>"7B1_'+P^DE0IO=/;-U.=@O9+11P;4%S(D=)XK
M$GEVA7 $=7=;O<:U$N;=BC'H5(NTGI>*ANF&%V(\/;OTG@GX6X&?LMB;5(Q%
M^W, &=4BOYX*BW7NDX07*++1+@*.*&X 2]N#@YG;WI_4)/2FSZ\8AJOKC%Q4
MQ&M/JX.GF"C9:AG7'@$-H]2'4?9;ZFD%4FQ$Q43#0J%XK. =F9D$A@;8+<"N
M*.,%P$+U ?:>F@GJXOB_,O(C9'N]'Z%9X**SK7#/U-%$[ZDF4'&WU 7:C+5'
M$*'3ZW7[O0".N,$7K\4X>@WAZVSZJC@71CVP :8&P,1GQ\UPI/TT.!,X"0MB
M&PNR_'%K<D^FI[K1W,@Z;,D2:Q^B^N3_MN69VMK5/H["(9U=!YGS-,[DM[MN
M@3D*FF@25'>90LV7N:L-7@FWP7.QFN#G3NM)UV>?*:]VS!']#TWV_=0G-'34
M<:]TVZ9S4+[3=O7(7OBY T)9ADVA1'3!UQ/',5E)S,Y*671CU 2-1>J79G*7
M0R@PTEUOXL!_%RR1X^).VHJ[ ZF2G1M+3K*Q:&V1\?H']P==Z/H^6Y+H_L4D
MHXY[K1OVGLVE89E7L2RU]VZO0^$N)M'E6A%=34%T/C>B4P.#PT);SDCT8LV=
M*!E$^S<<%]&!RJ!'!A-R2")*Z55BL)+'Q4*V4XL7L<")E=V?N<FV]!A29"S*
M0BTQE,&L2L1# M8XK9882B0JTV,(!*+4SKK+\C6Y'FPRTXT1(J\S8CI^<YIW
M,K3.<JXU%7[^NKK>LL S8)TU7AIY.X%$"8OM_5Y %5DX@QA,ARM!QJJBUA)7
M&01B.ESQ8 EI62VAVHG&E+B2L:(H-;,:E]+?.W'#FYWG6)-1S>3GT/C!<1RO
M:J*DJ9^7R[JV;&^T8(\&L;<+4*QP&E9DJ9:\GD*&9L07CSE>PBJ7E=\/[AHK
MQ^L:YT1H301B"UEC(/E:?U_(S'(,ET;7?K.M'\0[+\@ORJB9Y%I$@NFTTA&;
MBFJZ].%,X03G#&WW[]JP#47<YM^=%YP286T1BYR 5;6>+E^67$,ZA$EMS$L2
MEFNJ'#,8@BD1QH-J; L\%M2L<9>RS<'ONFVP1C6_A+>^P<15M;=8UU>VK%A1
M(2Q( N:YV@?_U:I9.*V*P%&LI96"Y=HBA]M2UC!.OI:6-]BEMF(@D.1L&4L:
M.'<QQ+@@OSN3*@V:9*6>@<<,AE0J-*E\+=&4P7Q*AZ:L9GG9-M.7.4%CVYIZ
M,[#684U0#^K?L;_T-BZIDSTIH5G1WFI6;*GKC0OUT6),:S"VS0)\;PB(71O*
MY<LS66S#U?$KW#DOR(89]<*^Y>H3O_-U']12&CK!36ADS4&EQ"HZ3/2,@NW0
M?4DDE28B1"SQ^XV%"%2FWS&UI$,&0W<?'301:X*"57Y_!*>A0P9+>A\=I#96
M5 %HL=\J;.B0P53?F]P69*QQ'.9C^,0I"%&,S5[=7I@&F%H DW,'W>U-Y[>;
MVYO^3;=IHVN *9PG$XG*!_V-Q6@JN.(&F%H 4XION9&@G'E\FPX?&R99%E=]
M>Q]GOD2,!711;I-WY+KC2XN]T5SP9#D%<U+9I1:9<93%I4F(([ZM8DXL.X<2
M!T,)$[7%!MYCBP@:CW<M=#5W7&MDZ&;-,I:K66183-]:+&5G/:8@8O7]%(&E
M0Y. VZJ$U79E4W%5J8TH;.O'W-BGE]<@'8)Z=)N,")F2PFO2XZKZ[;,,CG)W
M45)XM<*//B%V":*V(F/N_70<9D&5QHF8XVM?8<9O'\A0"XO!M]2HU=";6:9C
MV8?DP:Q53FR6MK^D'8DF#BM"/0MWLM8WQ4,0#WS5ENN)H:RE3?$P)$M85-]=
M37@2%E(5W!8/V3D36P1V1E/#-!S79F=98Z1[3BS<RQJKAX%IC<8$[+%,09>*
M>%:K*^XLUDN',06KO29QJ%SM/KA"+</\D-C&G/9NFK*+0J(,QG<]NYHRE]OG
MAT0-:W)63JR*86M;8^(X +\^J;/D#H56[3D9A9=%:>J'6('4=Y8YW!MO533,
MB?7T3[.%[K/C3I"4VN(N6T@_![X39"R\/WLY'[Z+61-9 4OZUA@2TPD,9YL\
M^4K)BK:=UY]?GQ+F0JWS!1:!01Y#.(REP@5:,+A?A;^[HO-"78%,%!.U6$GB
MAF)Y^AV9*-;&JI*\1OU=$RRSCY.)8#R/^1AYSX+;2@IU=[S&DY5SUHZ9GS(X
M4B$<[<I/B1R'-6U_ +/9YOGX:+'(TL9R6\4:OS\UT9 E'_<O%ED$+&@2%H7]
MD>"&+/EXEK'( EXC%ML%.0.Y]@=$O>RNVT>KY^YL@[>6#4N9&RGOR(Z@@2JP
M05]2C**XIG<L<R_E3E*T92S2?#K7M%.6T$ZYDQ22@D6U3;N,&U(4WU&YDQ0T
M(BRUJ2>=W&AHFBJKW0W3 %,!HPE=W=_U;GI]='_]N8*8:("I!3!E#Y1ZT(U1
MRP!-I,\,5Y^DPTCF#J@LMCFH*I=E^NA2;LPK;R%A1>@ '+^>MC9C&YPH8BWS
MX4NE8RN+^9P:6Z+"84E5L*R577YVT/ZZU/@2-"RV%0QF5]W0E<4.38\N3L1\
M&QSH$L<8QY&/7IA_1-,?QF#NLM)]HMLFF,<..M.'P_ET/M%=,@*<C8VAX<8[
M>;JV(;0,DOJ1N+IADE'71U]GB;PO'NYB\(D"ZDUI8RG&&0'O+?1Y5I322$:X
MM7VMRI@75:QJ^XN18A/LR/=8!GV5RQ[C%:QI5!0W>RS9'LN@.;/L,57%BB;&
M:@Q(NL4JDFR_(VXSX[%)332IB?=$BB8U41E2O)/41)-X:("I:1QW82$A=N0\
M.IN;$V-JT,"$/]=$G[O/EFW\AXP^-OF)!IBJ)M2N)KKCH)N&@1M@CDLPIYQV
M>M#<6J[.9<72')7Q]"J&E\JX717#2W5\H +<'6^,&+J?NXZKF]3#^J^_OLJD
M_@';^*+QYNYZ#U&-$?WA#^$/.HALG<8>!D,(C*2U9\K0 GY9Y3#'-7T5Z65V
M;(*).1",UT#K-Q3+%L2+33$I!XJ)F&^V6,907VR"R7G(1!Y+<H$4*ZA$>2WR
M@M']>$SL8"8#G<PYG3$T/]C&D* 9L1'#RU$&BE<TJI#(2 (\,C0R+#X0FR%I
MF\$$OR_8IGW>9+:2ZLYR2".=2\FK/MX?993R*<-+YTJS:1)JPW)((Y_'J$@N
M*PWV5;=_+'(*"]6%SNA,4B3LK<.J)<TSZ+#.G#W/P]J#3< 0L,FH1X9SF[4.
M]UQK^*,'U@&=H6&GT'1<\N;B][=I,VBZ8@D(^K"0#/>1T2^#/BR6?E1K-@0L
M5&L62T#0K8547C7=KPTP%00FWU:8__8>O?O?-^9/XKA38KH.,DSD+#8N1KH+
M4L)Q"\93['-$I&,_5V?E$($073IF2)YVW"N@R8ZSR;',JUB6*GMN3%4.L2KT
M"(BTU*,:A<-"YA;70)!\8@UP;(]=GL#__/TS"U?X?$8\![9#WY@2!]V1%_1H
M3743>U]@1'7W^,(_4?,SHI=RRY?-@F?[3_8:[H9D,O&U,ELD_>S,]&'P.>7;
M6ZXU8Q LO@A4/OONQ1BYS_1YW <@[W89"D]9M0_^/7=<8_P&,C6$8/]I'#UN
M;!WYP6_GV_H?HI.QD>^D?#BV+->D'KH?G>?_"+XY1:_3R>>)3A$'DO!;[_3R
MSD)@27DN/F.3X%H/S!-&_#7*%T[W[$_>?.9?6BUT;9#)Z#,L^ G,VA[Y<T[,
M(0$3[P+=LR"]\YF^ #88_7#A(05>CUHM_V%,8'C/"RF:,#_Q0@1#*?2[?<F:
MTXUUFU1.3&(M/\P,0Q 4Q([%YJ>7UZTP9@*<7*#^VPR6WK'U@3&\0'<@E#R\
M ;\ -OCP39^"NQB>*.(7&-J&L8%-]!^M 0%)",^=,7J$P54BP*68#>,H1/$5
M3HI^>1A>NHXE3:O/SE'D!4P,+K_W4-^&K0^+'$2P?&'O[;FZ2SPKSQK#WB'>
M<%BG3#"N+1N!<D3]9YL0]!4>_>R@KCDB(_3WN4F0R&$D<(+(\G#TFQ/_&P&=
M?3/U^8@6EWXL0O:4K,U\N0+^Y$2?.;"=@K_6=%@<5V![D]Y:KG57[YX!1*#
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M$H^1CT42>,_?HN#,^O2 TP<%IT=9$?C0IK7?<!W[[XT)7W8<A[C.(W'F$SK
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MR3!-&C:QQLA#4?WY+Z[8WCYU]MUMV;@HVSY.[KVA;$\)7X;@7"8Q%^<P.D7
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M:?\I.3N7'2VRRL?GGFH*L0"$;JN.T%0L21+F8DQ^WXF!#9E:.:Q*Y6%5PKS
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MNEC;?KY(7F*MM$30G'B% $RS%HS?C8E5!Z)S5>"(S6_;1TQ7'')Y^Z3G&AL
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M H 8'K9D_A8W? O=<(ZZ@(@ ,+8X-#$<5IHQL ! PW'F;+3K= IXIT8Y6\:
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M<ASUO"EX] B5SSLFL&-4[VPZZH&">X<I5RW_IK(K8#Q@Q0%AY1+E'(V8D0U
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M2184N;PBUQ).5RL]Q'GD#<-X9(OABB,"&3#V]]"$J+.XJ'NFZTBS,[&L4/D
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MQ5.E1VGZ-7<26NH/1GG7UCNP&Y&V.RRCA/,B!JIM8<T!'1R(4. B6PZ0HB"
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M:L]5]8]&ZA94W!T_\>AJ&J@Q;S9VV6M2L\RBG9:(?KW#U%^8Q9[2-19L-G,
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MWB.2^?WM)O-[&R7S^^LG\UO%*G][UN:W3YV5W"0"OYQ$X$_QMR8-N$D#;M*
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M;0OO0Z!O? WR4($"O (9TUS>HYEI%H%^#.R6"IO@IP1M5#.!=<!R$T8C[L$
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MP?.F"G8H ^M,!>^)%--:5;RY'Q;>*I6R6#><FQ+Z<3C#O@:F*I=&JF E, #
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M0&$I)"Q-+$VB'V5%"'?+7@6/R((:_A705YZU*%X<_77=^M:7VG_0L@#UGM8
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M)/9^N[R,[JLB$9>5 7G<HO)I(@,>1@JT5[R>Q9G0)4%WSH_^S-)^-*!LWG_
MSWII^K7E_SHCWPGY&.TK.<#;"U@V:WGV6N3<PZOPLW_4.<9V<]ADCAOCZ8NJ
M'=CB@.@>8PQD@I&/HJB$/O!>4F0S!=8S -4&[@7Y,REW"WV2*>S+"S,@F-N(
MK$C87_0-=HQ_ X"&DJNL^N/1;U1_.-T%#SYCN8C*9V1VJZ\D:>T/R"%E@_7P
M]![2*:A+("Q3X[=%C^E4"?I0I2^0[VDVH4VJ#9_0ZP>535.'/-AC@DH^Z<V@
MXK$CN2BXJ!4]-GV& +[,,X^FS#M=//H#  #KSKN[3G/4\MIFKXL2-L^;A,T%
M"9O=[R5A<SLTN;RMZ_8LM5VU@)WGST9]&',+V"4VG2S-.'M\PIG>B;V1/Z,,
M*1]0NT'"ADBU>[SQ.O^+F19\SJ))6#1^Y<E7J9@!EE8:ENT?Y7O''RO$LE>F
M%'EU))65ZN/$8^W<-(KSHZ1BA35@1JR=F0DZ,]%MKY+=YL8&AA6](*&X1,KU
M]NPTR3DK)4YP&5J3VKNJOSS3^5:+.-C2-!E1X #[ZEK*V)#SQQY"^/E !^T?
M8NS/.O@7 *$F(<'V5"DW+0NY.;H!H0M^"<=$71=%%3JE!O>BLF,6!"] ^\AP
M'_SVL14S*FV[-3>P@Q>![ =4EK0-T1]-!UK7+\.9:4L)2=>=3 B@5 9CK\PQ
M29Y64=^NDNI"US12+B@601[/'#OT @R=?J)$_/8G7?\!-"4TD8;I:)0^[,K<
M7L/_-F^LL75HM$K6:X-=2E=;;=&#ZRSR_32\X* ;=U+X@\F=_WA#1,__UH3.
M?U)#7?YGI:WN]] E8$.8=7<%LR?I,G!Y<6A=!A87'G0>X>4-F>.!J.9R@\\I
MJ,0JK7-^3>-I)[BJT?\.LIA\,7 WZ"/Z6.!>=(-NYVP_6PO.Y5Q+2LP7LH6%
MJ%[&Q%8GK?566HDZGH$X+H+KLXNEQ#&'_:X*JI>%ILXS<,BS\^#R:GDSOHWP
MM%LIN42Y6,@%/E/I!4'K>4BJPOMW<.D?$U7=D)JNKX++BQ=RZY\"11OT WXL
MBCKMJZ#=/MWMC;>[/UB^>6\'G3F?V$WQ*?ZVP$E!6>Y/XJ2@_SUOG;F^\#F=
M2A_KEVB<"?MJ&",Y-DZ$G<"J<1[LD7W;W:!?]6,EY>5E<':U7% >OO/@\AF
M>W$:7%WNZ1SPQGG@6*7/8$=T.M?!16='2NJ+1=0S7..SB^"Z76WLTK@/#MXV
M;3_#K;^^#-K7C?M@9;F]00?9QW/F=G!YN>,;OT'SR/VJP_G/:9B!53*:Z03O
M=R8C?.URF]56VT(B&.504VG,I7^"M;0W[U^_N_G=_\>[O__C=_A_K'_96K7*
MD_AQMI&]0:D]'Z8%IOXC36\G?6/QJF"M1B.NC!N$18BY4Y1WS*E??FJ>P\29
M='I[!Q]Q_AB%RMG.%0MW[EQ>OYI3XUB[BZ=%[V:RSC91(O.B'XW8 _5_.1?B
MI$,YP8HO(_-5A1.'YLA9V8GQ<GU9C[%$7P0 &AK8+0UL/K-JRUQGNW#]X1=1
MIGP2C>N]O=GF][C-%WL3:L)#^XO! ]]L]R5O=O,;LLA+L/'%V4C@+0+D<L_-
MBJ#>8=BU.71SZ!=WZ-U& %;C,MIF/^_^*.,*T5_*Q<*!_ZMIOC3T_Z1.37L>
M[;UVLH&[:WF-WU%E&E;+O>8>GMPPC6 !AR>'RCS?,7RO>[%<M,Z7NY //[#>
MN7Q^4)^WKJZ^!U"WV\\/Z[-69WGTZ@7 ^ODYR-5I75WW\V6/K"!&JCNHMK,9
MAN-X-/MYF3^]TOKF/4U)5Y#U1SA(_6_Y=/++40=$,?Y#=[<I=CG/;O' 2[<"
M;!G=H.<^_O;/SO4_A[#84CKZ>Q@GO\.Y/R3FJSJ"JAV*:5%6N]5>7@Y1!='Q
M\T)V \!VVT\.V.4)/7L'V.XFD.T\.627:U/[!MG.)LR@VWUJR%YL,A!S[>&X
MNS1?5LYJVJXX^AC!.[%G!L:8OR29^A-1XQ\A<HZQ:Y3!#W<A48&,UZEJ+<5R
MK%LOQUYF)M]&@K)[Z=P--^\ ,*(0<I,,##KJ+DH.OQ T:"RLHOUV6A>7+R-W
M:XMXWH'<OGHB/"]CCH#PL\[V$+Z:S^B <;V1*G&])\@^;5TVN-ZLD'M%5)^V
MGY=_G[9JVB,_<2+W$V@YJ)N\XYYFD7_T&_<SBXZQU5;)N0LJ3#X=T1 .ZM3U
M0?>*?]G4NY[VL4035P-B'0</^\D5%A0.5M,QSI=[,QL=8V,=8S?87$636-Y(
MYCN2+MO4))X'I: O;+&0X_ QND5]X4DY;K=U]NQ:P2Z](^6MGRD=P8GRODD&
M\^.[M4NL2XGPD#](I[U1M'DQT;PU5BJP/GOVF$[WJK5!R>?98T3[0:+J_-DQ
M=;:)N/[^$-5I;Y.O;QB3;F_"P+\_7'6?'U57YZM$&S9 U5/8W[5$P' 0:QI.
MRM5K-).RTC;)K4-[F32V@8QUW4 ;"];V^I[Y[X\';"!8MX$>D*;KFTK?'W8V
MDJ;;P$\C0G<G0K>!'Y";N\'/?EBH*S0JV6;L'J>H47N3CU$QS1*4U66_.$?D
MSW1$OC<O*K]B3OIJ]2J+[L^21]?W>B\;4Z-B-N>KY:,01!F@BX;57%RWKI<+
MZI7@]..>X^)D=9_UJKBX>!PNJAY-1LIEM]5>;NU^#TCI;H*5R]U@I7O1.E^N
M-;T(K*SA.EX5*5=;95O=54H,UD'%4QBLSR]6'>NXD:F:.!>EO%@4>5-8ZN(B
M\KQLM]K=[X-5;%^JGBW*2ED)&XODZO),^^\!+9O(U;/.KO#2/6]=+P_#O B\
M;%^RGG6WS+PZK=/EMNUN9.ONC-HRUG94@+#\AW4+-ILY@,V\3 WQ(Z87TB#0
M&S@.#BW6KI?\9U$1S^>KB'N$GV8S![&9?1 &N[U5TM'6I\Q=N4(73UH3NWT+
MZ7S%^D(Y.W&5FV$19>\2;-41WT<WHU':IUSFQ7;]"C76"[2^9P'H)O!<L:KP
M\?#<J+3X>>&YB7%R?OI4 .TL=SSM&4 W,BO.SYX*H-?+JWR>U6U7?3D7=.C>
M!U@-LV/\+C'GUT+PZAY8%Y\XKVLE<[[36J%;^]/?D2UZJIX A"N,N=T[$*[%
MN'<.PW;K?!]UB<4P7(]7/P$,5RBP7LJ=YPY7L'N[EU=9O5GY\W5[/]U*M_?N
MNMW>UP7,29%."#CZ Y628G>;PP[QN).YHA16<:7AOZ9Y$0]G(%H74(->OTW3
M$4JTH[YK=<_CI$[64CNA9?2&2!ZF:9&D1:04F.M_JD]^\+^-1S^/0@1BE)Q\
M^53?O6@2P<EIUD$63;(HIP812?6'WB"^CW'(06]&XP\&(9B)?BCN$TX1PM*-
M7I1$PQAG9\ *</M@#6>*PF":\3"%"%\=IX,671"U:P:51Y=HX0UJ2&<>Z717
M()W?IA%ZOXIX+!T5^^$DQJ@IDT)AYI4": R)A.-T"O3AC<.9#]@"K@(<%SY_
MB(L[]:4?3B912$B.1GGT<!?)#^($L9Y'OIZNXG\JPB*B4NI6#=X;+"_ \ND*
M6); ]SW&/@ O@(=!!%<2<([M8GB,21\N=X04@'\ ZD9P-("Y-\E V&8S?Q3G
M5)D=?>O? 2^) O_A+N[?^4@"O<@?A=CNNX"OX/.(,.SC9-?\?Q$3"2F;C3:
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M-' 8@R.WQ'NV/2W-2,9]GWG8['3O=OK"[\9!S6C<:N)VS<DEU_3RL15]SXO
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MA<W-\L#FNC9S1GE;(-M5LLUV&%3\<D2"7L4H-P>7F^%<#(JX.LR#>'T>%ZS
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MI#*?"TEMRUG#9\9*[N@J<DO@<1@X6N#X4X8"R%XWBJ(SKBT+G%2.Z'8&:,!
MMP,WR3\FB&#0C6(7* H>8D 5<B7:D63!D%L][0$78.GO#5AQ,'#$B'_<QUP#
M1*O CIEK/J5$ZQI^FBIN;&26SB-60:?0Y+K5)-1Z)K=M3&[]/K*0_>&>:_$%
MNI=Y.@4V2CYY,,ENT0_/,.*D1) 3QGYD!8^S(74QID-4NMJ$<YLH(HMH37-4
MWD;4K02ED,AQ;L+D1%,#%I4#CZ($'*?%H(*C^:K<BG&<Q.,IYM/#;<"L%& !
M_T@?,'50I:YQ_H0_ HY2B"II,LZE;8 5XW6#((QX1/HJ6H!DD(I@G2(#L^\
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M1];62-^:I!@;X+Q[RBL*^U'6(XJ3]#Q\[Y S\.W."?RXSOKQ3(2ZGK:Y*=>
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M)1;2?!FZ49^Z7\"+J6&7P<S()08'C@#(-DD863$K;[GQ*;<O4;@TLBM4WYU
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M SCP*58YW_MQDEY9M@G[7HR;XF)>&-I@U%78,@8^AK\ PWP-)+_T,BN,5AT
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M(V5LMJ&8CI77:\6Q\F7"GG/<O+EGO_.NW/$@B>VOHS 0 P0^X'8IHXUCX^O
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M8 U4*HIHS4;ELU-IT[+ .(WY,"43EDV&$M!U)?V;"Y@(*RHIM()".B5X)O4
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M51O\S9IH=2H<Q@)*(2%9 ?Z(ACGZ$\J64EZZ>^;<)0RREKX :"M5,0\RI84
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M[&0O$P0G)D".7B;M@-PK#<L1+"A@T.]$VCC3ML \"B-&9P&O0Z-CD:#9LBW
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M,C R,S V,S N>'-D4$L! A0#%     @ '&D.5R\MXV#5"@  F'4  !X
M         ( !]10  &-I:S P,#$W.3,T.3<M,C R,S V,S!?8V%L+GAM;%!+
M 0(4 Q0    ( !QI#E?##(C%G2D  (2W @ >              "  08@  !C
M:6LP,# Q-SDS-#DW+3(P,C,P-C,P7V1E9BYX;6Q02P$"% ,4    "  <:0Y7
MS4F+F(EQ   5O@4 '@              @ '?20  8VEK,# P,3<Y,S0Y-RTR
M,#(S,#8S,%]L86(N>&UL4$L! A0#%     @ '&D.5]LS_O[I*@  :<<" !X
M             ( !I+L  &-I:S P,#$W.3,T.3<M,C R,S V,S!?<')E+GAM
M;%!+ 0(4 Q0    ( !QI#E="I870$2(! ,H"#  4              "  <GF
M  !F,3!Q,#8R,U]V<W1R=7-T+FAT;5!+ 0(4 Q0    ( !QI#E<@^*Z$> <
M %<M   :              "  0P) @!F,3!Q,#8R,V5X,S$M,5]V<W1R=7-T
M+FAT;5!+ 0(4 Q0    ( !QI#E>;D/Q-A <  %HJ   :              "
M ;P0 @!F,3!Q,#8R,V5X,S$M,E]V<W1R=7-T+FAT;5!+ 0(4 Q0    ( !QI
M#E?B;OH(S@,  ",2   :              "  7@8 @!F,3!Q,#8R,V5X,S(M
M,5]V<W1R=7-T+FAT;5!+ 0(4 Q0    ( !QI#E<[0'5S^@,   41   :
M          "  7X< @!F,3!Q,#8R,V5X,S(M,E]V<W1R=7-T+FAT;5!+!08
1    "@ * -H"  "P( (    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
